data_2kgy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kgy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.837 0.351 . . . . 73.120000000000005 110.88 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -67.69 -41.69 83.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 110.909 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.44 ' CB ' ' HB2' ' A' ' 85' ' ' LEU . 3.8 p-10 -62.55 -161.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 75.420000000000002 110.868 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.7 pt -86.73 129.57 52.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.646 0.736 . . . . 74.409999999999997 111.133 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 0.56 5.43 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.697 2.265 . . . . 74.129999999999995 112.326 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 m -109.1 25.02 12.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 73.409999999999997 111.136 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.419 ' HB ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -78.86 -168.2 1.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 71.150000000000006 111.136 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.402 ' H ' HD21 ' A' ' 92' ' ' LEU . 9.5 mm-40 -73.97 -100.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 75.019999999999996 110.883 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.06 7.76 45.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 72.450000000000003 110.892 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.598 ' CD2' ' HB3' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -69.08 -13.41 62.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 74.140000000000001 110.895 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -94.05 0.64 56.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 110.904 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.13 -40.41 8.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 74.329999999999998 110.869 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -43.98 80.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.439999999999998 110.926 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -43.88 -30.01 1.56 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.76 . . . . 75.019999999999996 112.512 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.16 -56.91 12.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 71.109999999999999 111.076 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 20.4 ptp -72.01 -5.03 32.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.443 . . . . 75.099999999999994 110.883 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' A' ' 31' ' ' GLU . . . -74.43 -24.34 59.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 71.010000000000005 111.119 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -64.3 -9.09 15.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.349999999999994 110.861 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.09 -77.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 52.149999999999999 110.882 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.31 9.98 2.98 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 64.540000000000006 112.499 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 2.8 tt0 -60.02 99.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 74.209999999999994 110.872 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.05 -164.06 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 72.010000000000005 110.846 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.81 122.54 44.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.905 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.506 ' CG1' ' H ' ' A' ' 35' ' ' THR . 2.7 t -84.1 -133.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 63.100000000000001 111.118 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.506 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 21.0 p -136.09 -58.55 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 74.530000000000001 111.113 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.46 -68.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 71.209999999999994 112.494 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.4 Cg_endo -69.75 171.24 14.82 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 2.243 . . . . 72.230000000000004 112.362 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -71.92 -24.61 61.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 65.400000000000006 110.836 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.86 72.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 64.450000000000003 111.084 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.68 -41.35 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 63.039999999999999 110.887 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.421 ' HD3' ' HG ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -61.24 -37.7 84.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 74.519999999999996 110.854 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.53 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -67.74 -33.97 75.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 73.420000000000002 111.09 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -78.88 -39.62 34.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 73.120000000000005 110.91 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.491 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -80.34 -60.79 2.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 62.140000000000001 111.103 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.496 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -52.71 -23.24 6.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 75.299999999999997 111.088 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.609 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -57.25 -77.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 54.130000000000003 111.056 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.708 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 40.6 t -113.32 -13.97 11.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 74.150000000000006 111.121 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.6 tp60 -75.92 -32.94 59.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 110.872 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 1.009 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.68 -2.63 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.530000000000001 111.101 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.974 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.1 -4.56 0.11 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.637 0.732 . . . . 73.310000000000002 111.146 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.009 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.3 Cg_endo -69.78 -28.16 25.5 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.676 2.251 . . . . 72.430000000000007 112.326 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.54 -54.95 3.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.758 . . . . 72.140000000000001 112.469 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.79 -33.45 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.7 -0.762 . . . . 74.099999999999994 112.474 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.687 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -144.81 150.12 36.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 74.040000000000006 111.112 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.444 ' CB ' HG21 ' A' ' 50' ' ' VAL . . . -72.42 76.46 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 72.540000000000006 111.099 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.695 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -149.7 108.94 0.42 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 62.520000000000003 112.521 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.513 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 3.2 tt0 -102.97 -168.54 1.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.893 0.378 . . . . 75.129999999999995 110.888 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.3 t -132.98 118.29 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.209999999999994 111.117 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -96.98 158.14 15.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 74.129999999999995 110.923 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.4 ' HA ' ' HB3' ' A' ' 69' ' ' TYR . 1.7 t -137.06 111.02 8.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 72.340000000000003 111.159 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.95 166.39 16.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.888 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.81 118.15 29.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 61.240000000000002 111.163 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.07 -144.3 9.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 74.120000000000005 112.5 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.97 -14.29 42.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.901 0.382 . . . . 65.5 110.895 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.89 -120.89 1.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 73.109999999999999 112.491 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.97 -76.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 74.109999999999999 111.128 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.648 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -103.04 86.33 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 73.239999999999995 111.087 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.28 62.93 6.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 75.239999999999995 111.076 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -109.04 174.39 5.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 110.913 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -153.91 157.75 27.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.725 -0.75 . . . . 61.340000000000003 112.454 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.6 115.03 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.372 . . . . 74.510000000000005 111.132 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.75 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -107.53 135.88 48.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 74.030000000000001 110.918 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.695 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.7 p -151.55 124.43 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 71.120000000000005 111.154 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.763 ' HB ' ' O ' ' A' ' 79' ' ' THR . 4.1 m -168.06 -131.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 74.450000000000003 111.17 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.541 ' H ' ' CG2' ' A' ' 74' ' ' THR . 0.5 OUTLIER -103.0 139.33 20.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.63 0.729 . . . . 64.109999999999999 110.886 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 16.83 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.711 2.274 . . . . 62.039999999999999 112.34 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 75' ' ' ARG . 4.1 m-20 -94.97 13.61 24.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 71.340000000000003 110.874 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.84 -12.1 34.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 51.0 112.457 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.763 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.8 t -95.55 130.63 42.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 73.019999999999996 111.175 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.53 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -142.2 158.79 43.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 74.299999999999997 110.924 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.75 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 72.8 t -117.79 80.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 65.129999999999995 111.119 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.429 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 3.0 tp10 -75.09 121.82 22.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 110.853 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.0 t -103.82 139.5 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 70.430000000000007 111.172 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.496 ' C ' HG11 ' A' ' 91' ' ' VAL . 17.9 m-70 -86.61 118.13 25.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.540000000000006 110.843 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.598 ' HB3' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -128.3 105.86 8.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 74.319999999999993 110.91 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.651 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.3 t0 -139.66 131.96 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 71.409999999999997 110.843 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -61.21 5.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.219999999999999 110.863 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.606 ' H ' ' C ' ' A' ' 86' ' ' ASP . 13.9 t0 -67.23 -3.33 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 110.863 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 67.53 12.2 8.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 110.879 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -137.31 2.18 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.882 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.651 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 58.5 t -116.38 70.87 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 71.310000000000002 111.143 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.402 HD21 ' H ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -128.56 12.47 6.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 72.530000000000001 110.941 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -92.92 -179.1 5.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 74.099999999999994 110.864 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.8 t -124.61 166.96 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 71.420000000000002 111.132 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -145.97 123.38 6.12 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.658 0.742 . . . . 75.420000000000002 110.872 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 96.48 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.637 2.225 . . . . 72.200000000000003 112.351 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.09 111.35 2.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 73.129999999999995 111.097 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -88.83 11.03 19.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 64.150000000000006 110.831 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.18 -21.11 7.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.727 . . . . 72.420000000000002 112.462 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -97.92 -38.54 9.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.861 0.363 . . . . 73.239999999999995 110.888 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.26 25.14 52.6 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.751 . . . . 62.439999999999998 112.518 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.782 -0.723 . . . . 31.309999999999999 112.472 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.832 0.349 . . . . 75.349999999999994 110.879 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.402 ' HB2' ' CE2' ' A' ' 69' ' ' TYR . 77.6 m-85 -64.68 -32.91 74.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 110.929 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 10.6 p-10 -65.98 -122.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 74.340000000000003 110.885 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 16' ' ' THR . 30.8 mt -77.37 127.55 82.69 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.633 0.73 . . . . 73.349999999999994 111.138 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 15.86 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.637 2.225 . . . . 74.540000000000006 112.394 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.478 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.3 OUTLIER -150.77 37.86 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 70.140000000000001 111.117 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.501 HG23 ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -71.61 -161.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 64.319999999999993 111.133 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.408 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 29.4 mm-40 -84.13 -111.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 75.109999999999999 110.835 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -86.7 9.76 17.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.129999999999995 110.86 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.565 ' CD2' ' HB3' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -66.91 -12.23 58.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 75.430000000000007 110.877 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -63.65 -12.27 32.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 73.450000000000003 110.912 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -115.18 52.93 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 110.85 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 88.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 74.549999999999997 110.904 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 42.93 38.17 3.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 71.519999999999996 112.487 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.86 -26.7 66.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 75.420000000000002 111.122 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.0 -9.9 34.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.846 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.445 ' C ' ' H ' ' A' ' 29' ' ' ASP . . . -118.14 61.91 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 63.340000000000003 111.152 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -59.34 -6.15 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 75.129999999999995 110.926 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 27' ' ' ALA . 3.8 m-20 -126.08 -35.52 2.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 73.319999999999993 110.863 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 -20.52 60.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.716 -0.754 . . . . 52.119999999999997 112.475 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -62.47 93.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 61.140000000000001 110.892 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.09 179.62 3.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 71.409999999999997 110.873 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -95.62 115.73 27.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 64.530000000000001 110.894 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.6 ' CG1' ' H ' ' A' ' 35' ' ' THR . 3.1 t -75.03 -135.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 74.209999999999994 111.184 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.6 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 80.6 p -140.15 -60.43 0.53 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 74.049999999999997 111.108 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.44 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 175.76 -60.88 0.11 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 70.120000000000005 112.5 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.9 Cg_endo -69.73 164.64 33.76 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.711 2.274 . . . . 73.019999999999996 112.369 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 9.0 p-10 -71.53 -25.67 62.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 65.319999999999993 110.804 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.14 -36.86 73.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 70.530000000000001 111.067 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.49 -36.31 24.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 65.319999999999993 110.876 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.568 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 11.8 ptt180 -70.39 -43.97 68.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.842 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.485 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . . . -69.39 -34.47 74.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 72.230000000000004 111.12 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.3 ptt85 -80.11 -41.5 25.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 72.439999999999998 110.851 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -75.26 -62.26 1.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 70.310000000000002 111.102 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -53.7 -19.57 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 111.101 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.578 ' O ' ' CG2' ' A' ' 50' ' ' VAL . . . -60.15 -68.28 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 54.420000000000002 111.1 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.722 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 19.4 t -111.07 -10.45 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 74.549999999999997 111.158 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.619 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.2 tp60 -83.65 -38.61 21.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 74.409999999999997 110.93 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.745 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -101.88 -6.32 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 72.140000000000001 111.116 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.945 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -81.26 -24.79 0.39 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.657 0.741 . . . . 71.140000000000001 111.139 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.945 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 53.8 Cg_endo -69.78 -7.15 20.33 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.661 2.24 . . . . 72.010000000000005 112.399 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.04 -21.51 15.44 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 74.430000000000007 112.483 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.68 -33.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 55.329999999999998 112.487 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.686 ' O ' ' O ' ' A' ' 49' ' ' ALA . 2.0 t -155.16 161.86 41.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 74.209999999999994 111.133 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.511 ' HB2' ' HD3' ' A' ' 76' ' ' PRO . . . -76.63 69.48 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 73.219999999999999 111.089 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.7 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -144.29 103.15 0.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.735 -0.745 . . . . 74.030000000000001 112.463 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.533 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 3.8 tt0 -97.55 -171.89 2.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 70.030000000000001 110.889 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.421 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 78.0 t -133.08 120.94 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 74.030000000000001 111.098 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 14.5 tm-20 -95.88 149.8 21.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 74.140000000000001 110.89 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.2 t -135.46 113.92 11.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.114 -0.493 . . . . 71.400000000000006 111.124 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.64 161.31 37.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 64.129999999999995 110.858 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.64 119.83 31.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 73.099999999999994 111.164 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.14 -159.65 30.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.742 -0.742 . . . . 70.049999999999997 112.554 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -82.97 -23.67 33.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 73.019999999999996 110.88 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.9 -112.99 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 63.420000000000002 112.466 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.25 -69.19 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 44.25 111.118 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.3 157.15 19.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 74.299999999999997 111.106 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -155.08 61.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 74.329999999999998 111.123 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 84' ' ' HIS . 1.2 m-85 -113.67 173.43 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 73.150000000000006 110.922 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -159.59 117.55 0.78 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 44.219999999999999 112.472 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.52 122.01 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.914 0.388 . . . . 72.340000000000003 111.117 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.602 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -111.86 144.21 41.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 73.409999999999997 110.917 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.7 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 t -148.22 116.75 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 72.25 111.146 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.8 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 1.3 m -173.74 -135.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 72.019999999999996 111.166 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.402 ' H ' ' CG2' ' A' ' 74' ' ' THR . 20.0 mtm-85 -107.61 149.29 38.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.642 0.734 . . . . 75.319999999999993 110.857 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.72 5.13 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.702 2.268 . . . . 74.219999999999999 112.341 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.36 27.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 64.530000000000001 110.903 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 76' ' ' PRO . . . 76.8 -11.03 15.77 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.727 -0.749 . . . . 74.109999999999999 112.485 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.421 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.1 p -98.62 102.27 13.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.807 0.337 . . . . 75.120000000000005 111.104 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.8 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 1.1 ptp85 -141.34 162.46 35.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 74.239999999999995 110.912 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 23.8 t -112.85 100.02 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 60.119999999999997 111.088 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.568 ' HB2' ' HD2' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -89.06 117.72 28.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 75.349999999999994 110.884 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.478 ' O ' ' HA2' ' A' ' 70' ' ' GLY . 0.2 OUTLIER -98.28 111.42 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 64.519999999999996 111.194 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.483 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 3.3 t-160 -78.45 123.22 26.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 65.230000000000004 110.868 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.678 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -106.84 96.48 6.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 61.530000000000001 110.888 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.628 ' H ' ' HA ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -130.1 119.48 23.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 73.540000000000006 110.891 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -6.67 14.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.239999999999995 110.895 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.692 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 15.0 t0 -84.01 31.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 73.010000000000005 110.893 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.692 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 19.5 m-85 98.03 -27.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 74.319999999999993 110.875 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.501 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 79.6 mmt-85 -91.83 38.84 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 110.893 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -61.54 -40.18 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 74.230000000000004 111.14 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.501 ' CD2' HG23 ' A' ' 17' ' ' THR . 3.2 mm? -116.41 30.05 7.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 74.540000000000006 110.9 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 13.5 t0 -72.47 69.58 0.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 71.340000000000003 110.862 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.424 ' HB ' HG12 ' A' ' 83' ' ' VAL . 5.5 t -79.09 161.12 26.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 73.200000000000003 111.148 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.53 128.23 8.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.638 0.732 . . . . 62.329999999999998 110.88 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 95.33 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.669 2.246 . . . . 71.400000000000006 112.371 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.04 110.18 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 71.25 111.086 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -105.85 18.42 22.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 110.839 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.62 -19.15 30.18 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 72.219999999999999 112.474 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.09 -44.39 7.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.813 0.34 . . . . 74.420000000000002 110.836 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.65 23.61 57.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.716 -0.754 . . . . 61.140000000000001 112.466 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 60.420000000000002 112.477 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.85 0.357 . . . . 74.409999999999997 110.921 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.6 179.96 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 73.030000000000001 110.908 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.515 ' HB2' ' HB2' ' A' ' 87' ' ' ARG . 15.7 p-10 -117.43 -46.73 2.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 71.549999999999997 110.873 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.429 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -133.62 165.71 34.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 73.430000000000007 111.171 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 14' ' ' ILE . 53.4 Cg_endo -69.74 -3.68 12.48 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.71 2.273 . . . . 65.430000000000007 112.324 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -128.98 74.62 1.59 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 74.409999999999997 111.18 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.472 ' CB ' ' HB2' ' A' ' 20' ' ' LEU . 59.9 p -96.69 -166.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 75.109999999999999 111.111 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.43 ' C ' ' H ' ' A' ' 20' ' ' LEU . 18.9 tt0 -129.55 -92.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 74.239999999999995 110.867 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -72.02 7.15 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 73.439999999999998 110.869 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.472 ' HB2' ' CB ' ' A' ' 17' ' ' THR . 11.2 mp -84.72 -37.56 20.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 73.099999999999994 110.923 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -82.86 4.03 27.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 74.030000000000001 110.946 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.6 -52.77 3.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 72.319999999999993 110.911 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -78.12 -31.81 50.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 72.109999999999999 110.924 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.81 -41.63 4.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 72.010000000000005 112.521 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.51 -60.75 2.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.736 0.303 . . . . 74.140000000000001 111.107 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.2 ptm -69.51 -8.4 46.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 75.510000000000005 110.842 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.94 -32.99 17.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 65.400000000000006 111.093 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -75.73 46.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 74.329999999999998 110.839 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.21 -74.62 0.49 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.125 -0.488 . . . . 75.420000000000002 110.871 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.26 16.64 5.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.691 -0.766 . . . . 73.439999999999998 112.44 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -54.94 168.17 0.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 71.129999999999995 110.894 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.94 -165.92 1.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 75.099999999999994 110.866 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -128.84 120.46 26.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 72.530000000000001 110.902 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 40.1 t -73.32 162.67 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 64.019999999999996 111.096 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.7 p -91.81 -49.03 6.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.349999999999994 111.118 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.07 -64.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 71.409999999999997 112.491 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 150.3 68.14 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.646 2.231 . . . . 74.540000000000006 112.366 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -59.01 -30.85 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 74.019999999999996 110.876 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.39 -28.7 60.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 62.25 111.063 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 0.6 OUTLIER -78.97 -30.02 44.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 74.420000000000002 110.848 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.527 ' HA ' ' OE1' ' A' ' 57' ' ' GLU . 3.2 ptt180 -68.57 -43.13 77.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 110.842 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . . . -74.47 -32.04 62.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 74.340000000000003 111.123 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 19.7 ptt85 -77.93 -41.54 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.219999999999999 110.884 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -78.18 -62.29 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 111.058 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.512 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -51.54 -21.39 2.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 111.092 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.715 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -53.81 -66.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 73.519999999999996 111.094 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.617 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 22.0 t -111.35 -17.04 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 75.200000000000003 111.098 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 52.3 mt-30 -79.26 -28.92 42.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 71.540000000000006 110.952 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 1.076 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -109.31 -10.27 14.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 71.230000000000004 111.081 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.53 -0.03 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 73.230000000000004 111.126 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.076 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.5 Cg_endo -69.76 -27.23 26.73 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.689 2.259 . . . . 72.200000000000003 112.337 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.14 -51.83 3.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 62.219999999999999 112.464 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.24 -35.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 75.540000000000006 112.46 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.803 ' O ' ' O ' ' A' ' 49' ' ' ALA . 4.4 m -143.15 147.51 35.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.769 0.318 . . . . 75.409999999999997 111.128 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.24 81.43 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 62.130000000000003 111.156 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.69 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -145.41 97.9 0.19 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 70.109999999999999 112.516 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.527 ' OE1' ' HA ' ' A' ' 41' ' ' ARG . 1.1 pt-20 -99.43 -179.47 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 64.420000000000002 110.897 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.417 ' N ' ' HG3' ' A' ' 57' ' ' GLU . 70.3 t -115.04 139.22 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 111.142 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.564 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 19.9 tt0 -106.88 155.89 19.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 73.120000000000005 110.879 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.401 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 1.2 t -129.35 110.77 12.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 73.129999999999995 111.162 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.13 160.52 38.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 63.219999999999999 110.894 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 64.4 p -132.69 93.21 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 65.219999999999999 111.113 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.2 -139.47 2.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.75 . . . . 65.239999999999995 112.445 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.15 -0.13 56.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.392 . . . . 75.510000000000005 110.881 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -100.7 -122.83 5.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.792 -0.718 . . . . 70.450000000000003 112.5 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' A' ' 87' ' ' ARG . . . -122.82 -82.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.795 0.331 . . . . 74.420000000000002 111.081 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 85' ' ' LEU . . . -100.45 90.15 4.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 71.239999999999995 111.079 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.49 79.86 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 72.120000000000005 111.091 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.401 ' CG ' ' HA ' ' A' ' 60' ' ' THR . 3.1 m-85 -106.75 163.27 13.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 74.030000000000001 110.927 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -137.65 107.02 0.56 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 75.140000000000001 112.474 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.11 111.07 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.899 0.381 . . . . 75.209999999999994 111.098 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.69 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -103.45 149.45 24.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.349999999999994 110.914 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.648 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.7 p -150.42 115.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 111.103 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.757 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 1.4 m -173.43 -136.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 73.340000000000003 111.126 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.462 ' H ' ' CG2' ' A' ' 74' ' ' THR . 0.6 OUTLIER -104.26 145.86 31.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.597 0.713 . . . . 73.140000000000001 110.847 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.415 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.9 Cg_endo -69.74 7.88 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.695 2.264 . . . . 75.310000000000002 112.329 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 75' ' ' ARG . 6.6 m-20 -83.3 25.81 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 75.5 110.885 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.45 -13.22 47.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 72.329999999999998 112.499 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.571 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.6 t -97.03 102.8 14.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 72.409999999999997 111.18 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.757 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.6 OUTLIER -138.3 162.47 34.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 74.209999999999994 110.909 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 5.1 m -118.03 98.04 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.121 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.473 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -81.52 127.05 32.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 75.230000000000004 110.901 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.9 t -91.92 116.9 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 111.141 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 2.3 t-160 -84.36 117.35 23.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 75.25 110.833 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.914 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -123.49 122.89 39.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 74.400000000000006 110.912 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.484 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 7.8 t0 -132.74 119.46 20.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 75.209999999999994 110.85 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.515 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 2.1 tmt_? -68.44 0.19 4.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.109999999999999 110.864 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.533 ' HB3' ' CE1' ' A' ' 89' ' ' PHE . 6.5 t0 -65.79 -14.17 60.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 73.230000000000004 110.848 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -176.71 -91.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 74.010000000000005 110.915 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.31 31.44 0.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 74.239999999999995 110.876 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.914 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 2.0 t -71.82 81.42 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 73.25 111.16 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -120.39 18.62 12.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 75.400000000000006 110.934 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -83.09 137.67 34.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 73.030000000000001 110.882 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.0 t -92.05 165.88 12.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 74.040000000000006 111.158 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -139.12 162.83 50.02 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.677 0.751 . . . . 74.409999999999997 110.858 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 92.85 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.712 2.275 . . . . 65.219999999999999 112.343 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.23 111.19 11.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 75.400000000000006 111.059 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 101' ' ' GLY . 19.8 t0 -122.25 113.0 18.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 65.319999999999993 110.863 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -47.06 -21.54 1.02 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.732 -0.747 . . . . 72.329999999999998 112.513 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -93.74 -24.92 17.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 75.239999999999995 110.913 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 98' ' ' ASP . . . 100.4 -6.39 57.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.748 -0.739 . . . . 75.120000000000005 112.517 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.698 -0.763 . . . . 75.549999999999997 112.498 -179.878 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.779 0.323 . . . . 63.130000000000003 110.842 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -67.13 -18.02 65.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 73.450000000000003 110.974 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 6.3 p-10 -58.44 -100.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 74.0 110.889 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.475 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -113.7 163.9 17.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.616 0.722 . . . . 73.299999999999997 111.132 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -2.87 10.93 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.709 2.273 . . . . 71.109999999999999 112.294 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -144.22 72.66 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 65.329999999999998 111.129 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.471 ' HB ' ' HG ' ' A' ' 92' ' ' LEU . 3.9 p -74.6 -169.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 70.120000000000005 111.11 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 3.3 mm-40 -116.78 -97.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 75.209999999999994 110.896 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.29 6.04 7.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 73.340000000000003 110.908 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.426 HD13 ' HB ' ' A' ' 83' ' ' VAL . 2.3 tp -79.97 -2.2 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.473 . . . . 61.240000000000002 110.882 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.44 ' CD2' ' O ' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -59.91 -14.26 14.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 110.973 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.6 49.49 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 74.409999999999997 110.835 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 24' ' ' GLY . 1.1 pt20 -64.47 82.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 73.129999999999995 110.917 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' GLN . . . 36.5 44.26 0.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 64.150000000000006 112.544 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.94 76.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.766 0.317 . . . . 61.109999999999999 111.09 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -16.64 63.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.349999999999994 110.899 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.73 54.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 73.109999999999999 111.086 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.47 49.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 74.140000000000001 110.906 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 175.22 -31.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 71.25 110.828 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.47 -2.68 56.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.752 . . . . 61.219999999999999 112.479 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.35 85.74 3.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 74.450000000000003 110.909 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.89 -167.24 1.2 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 73.200000000000003 110.869 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 22.1 pt-20 -101.67 166.27 10.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 74.140000000000001 110.885 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.591 ' CG1' ' H ' ' A' ' 35' ' ' THR . 2.8 t -123.25 -139.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 73.510000000000005 111.163 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.591 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 59.0 p -138.71 -70.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 75.439999999999998 111.166 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.46 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -175.24 -59.79 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 60.329999999999998 112.475 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.4 Cg_endo -69.8 164.16 35.62 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.267 . . . . 75.209999999999994 112.318 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.41 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -72.7 -25.09 61.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 110.919 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.36 82.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 60.439999999999998 111.12 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -80.58 -34.59 35.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 74.409999999999997 110.864 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.47 ' CG ' ' N ' ' A' ' 42' ' ' ALA . 8.3 ptt180 -72.78 -45.67 57.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 74.209999999999994 110.872 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.594 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -64.65 -33.07 75.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.239999999999995 111.084 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 13.3 ptt85 -83.41 -43.36 15.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 73.439999999999998 110.86 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -74.88 -60.84 2.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 64.310000000000002 111.125 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.477 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -51.47 -22.92 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 75.010000000000005 111.112 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.71 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -59.15 -75.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 74.150000000000006 111.075 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.619 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 26.3 t -107.78 -21.73 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 72.450000000000003 111.078 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -69.99 -31.48 69.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 71.420000000000002 110.917 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 1.033 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.34 -0.11 22.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 73.340000000000003 111.101 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.992 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -100.05 3.14 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.627 0.727 . . . . 72.430000000000007 111.158 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.033 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.8 Cg_endo -69.7 -27.39 26.82 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.769 2.313 . . . . 74.540000000000006 112.356 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.86 -49.38 5.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 62.049999999999997 112.455 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.33 -32.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.797 -0.715 . . . . 55.439999999999998 112.534 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.69 ' O ' ' O ' ' A' ' 49' ' ' ALA . 11.8 t -141.91 149.83 40.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 72.209999999999994 111.182 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.471 ' HB2' ' C ' ' A' ' 75' ' ' ARG . . . -74.99 78.83 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 65.439999999999998 111.121 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.59 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -144.86 101.17 0.24 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 73.510000000000005 112.5 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -95.4 -173.09 2.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 65.209999999999994 110.909 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 20.2 t -135.5 116.69 19.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 111.139 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.573 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -94.89 150.84 19.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.040000000000006 110.829 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.402 ' HA ' ' HB3' ' A' ' 69' ' ' TYR . 1.8 t -136.67 107.34 6.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 74.230000000000004 111.126 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -129.39 167.76 17.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 74.510000000000005 110.911 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.405 ' HA ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -121.74 120.51 34.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 74.530000000000001 111.139 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.2 -168.55 30.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 73.230000000000004 112.514 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -59.82 -23.45 63.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.907 0.384 . . . . 71.150000000000006 110.906 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.86 -118.2 1.56 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.777 -0.725 . . . . 72.340000000000003 112.495 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.47 -71.22 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.809 0.338 . . . . 63.420000000000002 111.13 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -89.3 134.88 33.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 62.240000000000002 111.078 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.405 ' HB2' ' HA ' ' A' ' 62' ' ' THR . . . -150.8 62.53 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 72.200000000000003 111.115 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.573 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -111.98 162.64 15.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 73.319999999999993 110.925 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.66 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -144.98 118.99 1.17 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.718 -0.754 . . . . 62.329999999999998 112.49 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.8 p -103.02 119.86 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.371 . . . . 62.210000000000001 111.111 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.699 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -104.27 142.65 34.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 61.329999999999998 110.902 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.589 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 2.8 t -150.8 117.01 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 72.230000000000004 111.158 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.753 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 2.2 m -169.14 -137.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 73.200000000000003 111.123 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.554 ' H ' ' CG2' ' A' ' 74' ' ' THR . 55.8 mtm180 -98.61 150.01 36.29 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.585 0.707 . . . . 74.200000000000003 110.888 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 78' ' ' GLY . 53.7 Cg_endo -69.79 5.83 1.56 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.672 2.248 . . . . 75.310000000000002 112.336 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.57 29.4 0.31 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 73.450000000000003 110.901 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 76' ' ' PRO . . . 75.24 -9.98 11.87 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.763 -0.732 . . . . 71.340000000000003 112.48 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.577 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.9 p -98.38 109.49 22.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 74.129999999999995 111.174 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.753 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -137.94 160.93 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 73.439999999999998 110.878 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 12.5 m -110.94 101.8 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 63.340000000000003 111.108 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.47 ' HB2' ' HD2' ' A' ' 41' ' ' ARG . 8.2 tm-20 -82.86 122.92 28.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 64.439999999999998 110.908 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.677 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 2.3 t -96.26 109.36 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 71.310000000000002 111.115 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 93' ' ' ASP . 4.2 p-80 -79.57 121.09 24.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 73.549999999999997 110.899 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.798 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -120.17 116.85 26.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 74.25 110.908 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.693 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 25.9 t0 -127.3 114.2 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 70.340000000000003 110.886 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.73 1.74 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 71.430000000000007 110.897 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.448 ' C ' ' CG ' ' A' ' 89' ' ' PHE . 52.1 t0 -70.31 -12.36 61.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 70.400000000000006 110.86 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.448 ' CG ' ' C ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -172.62 -94.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 70.230000000000004 110.853 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.59 30.7 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 74.310000000000002 110.875 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.9 t -77.58 77.16 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 71.140000000000001 111.145 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.548 HD11 ' C ' ' A' ' 91' ' ' VAL . 0.3 OUTLIER -120.19 18.05 12.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 73.319999999999993 110.952 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 84' ' ' HIS . 1.1 m-20 -80.95 167.5 19.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 71.519999999999996 110.875 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 5.9 t -121.19 169.43 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 111.198 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -143.73 110.7 5.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.575 0.703 . . . . 74.400000000000006 110.894 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 103.78 1.21 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.68 2.253 . . . . 70.409999999999997 112.4 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.33 -178.88 3.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 71.25 111.092 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.54 -156.62 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 74.239999999999995 110.845 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.16 -14.97 60.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 44.43 112.492 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.39 -53.09 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 64.030000000000001 110.847 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.54 28.89 4.39 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 72.200000000000003 112.48 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 72.310000000000002 112.512 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.832 0.349 . . . . 75.310000000000002 110.863 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -66.84 -52.16 46.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 73.540000000000006 110.906 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.457 ' CG ' ' HB2' ' A' ' 87' ' ' ARG . 75.0 m-20 -58.22 -97.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 71.319999999999993 110.876 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.515 ' C ' ' H ' ' A' ' 16' ' ' THR . 30.2 mt -101.72 105.28 40.23 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.617 0.722 . . . . 75.319999999999993 111.163 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 21.72 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 72.040000000000006 112.328 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.515 ' H ' ' C ' ' A' ' 14' ' ' ILE . 1.8 m -124.21 17.11 9.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 74.310000000000002 111.128 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.49 ' CG2' ' HB3' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -76.2 -160.75 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 74.430000000000007 111.164 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -61.25 -109.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 70.239999999999995 110.899 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -97.21 11.3 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.893 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.485 ' CD2' ' HB2' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -61.9 -34.65 76.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 72.519999999999996 110.915 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -86.34 7.83 23.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 74.519999999999996 110.951 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -108.5 -37.36 5.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 71.310000000000002 110.871 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.4 mm100 -67.46 -45.53 75.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 53.420000000000002 110.921 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -43.91 -30.71 1.75 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 73.420000000000002 112.478 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 27' ' ' ALA . . . -56.64 -72.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.754 0.312 . . . . 74.349999999999994 111.091 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.6 ptp -63.52 -3.69 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 72.439999999999998 110.881 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.443 ' HA ' ' CG ' ' A' ' 31' ' ' GLU . . . -64.76 -26.79 68.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 70.530000000000001 111.129 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.457 ' C ' ' HD1' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -82.81 8.43 12.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 73.109999999999999 110.888 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -89.87 -78.35 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.139 -0.482 . . . . 63.210000000000001 110.832 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.13 -5.04 2.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 71.140000000000001 112.508 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' CG ' ' HA ' ' A' ' 27' ' ' ALA . 23.1 mt-10 -62.18 105.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 74.209999999999994 110.892 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -161.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 64.519999999999996 110.853 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -118.46 116.56 26.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 72.019999999999996 110.899 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.633 ' HB ' ' CB ' ' A' ' 59' ' ' GLU . 4.2 t -72.21 171.36 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 73.310000000000002 111.131 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.422 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 71.9 p -91.97 -41.51 10.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 73.340000000000003 111.148 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.401 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 164.52 -62.95 0.24 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.718 -0.753 . . . . 63.450000000000003 112.479 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 54.2 Cg_endo -69.69 156.15 64.3 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.683 2.255 . . . . 75.239999999999995 112.377 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.474 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -60.82 -27.52 68.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 64.239999999999995 110.834 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.27 68.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 75.019999999999996 111.086 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.44 -32.81 23.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 64.319999999999993 110.841 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -69.99 -44.07 70.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 75.230000000000004 110.865 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.478 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . . . -70.79 -35.01 72.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 74.510000000000005 111.106 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -79.41 -41.4 27.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 75.319999999999993 110.923 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.574 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -77.22 -61.71 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 71.120000000000005 111.097 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.545 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -53.05 -21.73 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 70.319999999999993 111.093 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.749 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -54.27 -71.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 72.430000000000007 111.093 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.627 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.5 t -111.9 -12.79 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.549999999999997 111.129 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.574 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.8 tp60 -80.5 -34.11 35.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.140000000000001 110.892 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 1.017 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.97 -5.66 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 64.230000000000004 111.119 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.32 -5.69 0.11 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.731 . . . . 65.209999999999994 111.112 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.017 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.7 Cg_endo -69.79 -26.57 27.29 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 72.120000000000005 112.356 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.37 -57.46 2.62 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.687 -0.768 . . . . 62.200000000000003 112.502 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.65 -34.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.723 -0.751 . . . . 55.439999999999998 112.496 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.716 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.4 m -149.1 151.47 34.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.777 0.322 . . . . 75.120000000000005 111.173 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.22 79.23 0.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 111.126 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.753 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -144.78 102.54 0.27 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 71.530000000000001 112.505 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.568 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.5 tt0 -95.46 -177.77 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 75.109999999999999 110.86 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.3 t -131.03 117.0 35.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 72.129999999999995 111.123 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.633 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 1.4 pp20? -95.57 129.91 42.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 71.0 110.911 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 t -100.38 118.29 36.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.479 . . . . 75.040000000000006 111.179 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -134.93 101.7 4.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 63.409999999999997 110.896 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.2 p -93.97 127.07 39.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 74.299999999999997 111.141 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.0 -154.98 10.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 75.019999999999996 112.499 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -87.77 -0.3 56.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.883 0.373 . . . . 71.239999999999995 110.877 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.98 -96.95 2.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.76 -0.733 . . . . 61.43 112.464 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.45 -136.07 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 74.450000000000003 111.112 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.517 ' O ' ' O ' ' A' ' 85' ' ' LEU . . . -113.15 93.46 4.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 54.109999999999999 111.087 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 61' ' ' GLU . . . -79.76 95.31 5.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 75.010000000000005 111.091 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -116.66 115.75 26.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.209999999999994 110.897 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 84' ' ' HIS . . . -98.88 109.62 3.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 75.540000000000006 112.482 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.458 ' O ' HG21 ' A' ' 83' ' ' VAL . 4.6 p -104.19 109.75 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 71.25 111.177 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.753 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -97.74 142.43 29.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 74.420000000000002 110.889 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.65 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.8 p -150.39 120.78 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 111.083 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.763 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 2.8 m -171.36 -130.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 74.319999999999993 111.139 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.479 ' H ' ' CG2' ' A' ' 74' ' ' THR . 2.1 mtt-85 -107.0 145.73 31.71 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.718 . . . . 72.420000000000002 110.83 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.73 13.36 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.653 2.235 . . . . 72.530000000000001 112.392 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 75' ' ' ARG . 3.9 m-20 -89.91 25.65 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.872 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.17 -12.52 43.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 74.099999999999994 112.488 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.545 ' O ' ' HB ' ' A' ' 74' ' ' THR . 24.7 p -97.45 105.25 17.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 71.430000000000007 111.145 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.763 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 1.3 ptp85 -139.57 162.27 35.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 74.120000000000005 110.931 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 42.8 t -115.09 100.5 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 111.177 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.526 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 5.4 tm-20 -84.51 115.91 22.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 73.540000000000006 110.877 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -102.53 105.44 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 73.209999999999994 111.147 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.547 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.6 OUTLIER -83.76 124.74 31.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 74.219999999999999 110.893 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -111.39 111.76 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 74.230000000000004 110.946 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.587 ' N ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -126.42 114.98 18.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 74.430000000000007 110.907 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.457 ' HB2' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -72.94 -0.25 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 74.540000000000006 110.844 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -74.04 -19.38 60.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 70.200000000000003 110.849 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 90' ' ' ARG . 3.9 p90 169.8 -36.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.109999999999999 110.906 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.409 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 1.9 mmm180 -117.87 68.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 73.400000000000006 110.874 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.5 t -61.31 -14.23 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 73.319999999999993 111.147 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.49 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 0.0 OUTLIER -124.8 32.14 5.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 72.510000000000005 110.926 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 0.8 OUTLIER -65.75 80.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 65.0 110.879 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 10.1 t -79.76 153.51 29.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 111.088 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -148.76 129.76 7.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.678 0.751 . . . . 73.329999999999998 110.882 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 125.4 12.13 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.723 2.282 . . . . 75.400000000000006 112.37 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -115.26 108.93 17.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 72.400000000000006 111.09 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -103.99 20.79 17.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 73.310000000000002 110.854 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.12 -19.22 31.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.74 . . . . 71.230000000000004 112.466 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -94.66 -43.47 8.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 62.100000000000001 110.85 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.55 28.03 52.99 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 74.200000000000003 112.478 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 64.349999999999994 112.44 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.806 0.336 . . . . 72.349999999999994 110.873 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -67.66 -19.28 65.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.933 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.99 -161.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 73.150000000000006 110.905 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.506 HG13 ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -117.42 156.92 48.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.6 0.715 . . . . 63.219999999999999 111.135 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HD2' HG13 ' A' ' 14' ' ' ILE . 53.8 Cg_endo -69.72 45.38 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.676 2.251 . . . . 64.549999999999997 112.37 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -151.26 17.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 73.010000000000005 111.12 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.446 ' CG2' HD21 ' A' ' 20' ' ' LEU . 43.9 p -75.4 -167.41 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 73.310000000000002 111.139 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . 2.9 mm-40 -116.0 -95.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 73.319999999999993 110.921 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -89.69 8.53 31.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 72.400000000000006 110.881 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -75.29 -10.97 59.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.25 110.912 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -76.36 -23.63 54.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 75.329999999999998 110.882 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -74.1 -34.58 64.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 110.888 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -66.37 -49.58 66.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 73.239999999999995 110.9 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.54 -30.43 2.13 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.71 -0.757 . . . . 72.129999999999995 112.496 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.28 -62.54 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.767 0.317 . . . . 74.340000000000003 111.052 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 35.1 tpp -67.09 -13.49 61.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 75.319999999999993 110.871 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.421 ' HA ' ' HG3' ' A' ' 31' ' ' GLU . . . -67.07 -22.38 65.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 73.120000000000005 111.114 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -85.78 10.81 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 71.439999999999998 110.862 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.01 -75.67 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 74.099999999999994 110.909 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.08 13.66 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.704 -0.76 . . . . 64.439999999999998 112.491 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HG3' ' HA ' ' A' ' 27' ' ' ALA . 20.9 mt-10 -59.59 104.57 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 74.319999999999993 110.881 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.93 -164.47 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 74.010000000000005 110.9 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.23 121.6 43.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 63.5 110.862 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.491 ' HB ' ' CB ' ' A' ' 59' ' ' GLU . 2.6 t -82.6 178.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 73.120000000000005 111.121 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.48 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 71.0 p -94.35 -59.94 1.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 75.230000000000004 111.215 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.0 -64.6 0.1 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.733 . . . . 71.349999999999994 112.5 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 164.85 32.96 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 73.400000000000006 112.415 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -70.43 -26.07 63.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 64.150000000000006 110.865 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.73 -46.45 77.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 73.430000000000007 111.081 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -41.61 25.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 110.879 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.531 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -59.99 -37.93 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 75.040000000000006 110.882 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.525 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -62.9 -33.3 75.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 111.116 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.513 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 1.3 ptt-85 -78.66 -40.12 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 74.519999999999996 110.84 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.513 ' N ' ' HG2' ' A' ' 43' ' ' ARG . . . -77.83 -59.32 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 75.239999999999995 111.154 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.418 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -54.64 -20.81 8.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 71.109999999999999 111.123 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.634 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -62.0 -81.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 75.120000000000005 111.089 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.788 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 58.4 t -108.8 -19.87 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.439999999999998 111.116 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 1.3 tp60 -69.33 -33.15 72.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 65.409999999999997 110.919 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 1.02 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.64 1.88 25.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 73.540000000000006 111.07 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.991 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.74 -7.17 0.12 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.637 0.732 . . . . 73.340000000000003 111.103 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.02 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.6 Cg_endo -69.75 -26.11 27.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.671 2.247 . . . . 72.409999999999997 112.327 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.71 -61.41 2.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.725 -0.75 . . . . 65.420000000000002 112.498 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -156.31 -33.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 65.040000000000006 112.473 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.626 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -148.01 159.78 43.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 71.340000000000003 111.181 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.402 ' HB3' HG23 ' A' ' 50' ' ' VAL . . . -72.09 70.98 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 70.340000000000003 111.099 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.779 ' HA3' ' HA ' ' A' ' 73' ' ' VAL . . . -149.68 112.72 0.57 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 61.229999999999997 112.475 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' N ' HD22 ' A' ' 72' ' ' LEU . 2.2 tt0 -98.49 -169.73 1.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.846 0.355 . . . . 75.109999999999999 110.89 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.7 t -133.42 120.84 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 73.439999999999998 111.142 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.779 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 11.2 tm-20 -90.3 158.47 17.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.439999999999998 110.875 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 t -137.97 111.22 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 72.430000000000007 111.151 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.2 169.6 17.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 72.150000000000006 110.907 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.54 149.78 40.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 73.239999999999995 111.125 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.69 -154.29 8.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.758 -0.734 . . . . 74.340000000000003 112.53 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -78.44 -23.99 46.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.383 . . . . 74.340000000000003 110.935 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.79 -114.06 2.86 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.713 -0.756 . . . . 73.129999999999995 112.538 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.98 -78.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 70.310000000000002 111.093 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.658 ' O ' ' CG ' ' A' ' 86' ' ' ASP . . . -87.99 139.95 29.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 71.209999999999994 111.067 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -154.65 73.36 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 73.340000000000003 111.107 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.779 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 11.5 p90 -132.41 -172.16 2.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 75.040000000000006 110.918 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -153.96 129.12 2.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.727 -0.749 . . . . 71.400000000000006 112.474 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.35 120.01 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 64.010000000000005 111.141 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.668 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -98.18 139.14 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 73.010000000000005 110.888 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.779 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 3.0 m -147.34 111.42 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 65.540000000000006 111.137 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.794 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.2 m -167.38 -137.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 64.439999999999998 111.112 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.533 ' H ' ' CG2' ' A' ' 74' ' ' THR . 10.7 mtm180 -108.28 153.88 41.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.59 0.709 . . . . 74.510000000000005 110.888 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.72 2.17 3.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.72 2.28 . . . . 65.109999999999999 112.372 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -85.94 45.94 1.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 73.129999999999995 110.877 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.95 -6.02 7.19 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 71.109999999999999 112.491 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.794 ' O ' ' HB ' ' A' ' 74' ' ' THR . 72.2 p -91.83 123.79 35.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 74.420000000000002 111.121 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.531 ' CD ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -146.2 143.89 29.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 72.099999999999994 110.889 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 87.1 t -110.87 84.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 72.109999999999999 111.114 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 72' ' ' LEU . 2.4 tm-20 -77.52 118.0 19.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 74.340000000000003 110.899 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.608 ' O ' ' HA2' ' A' ' 70' ' ' GLY . 2.4 t -95.44 136.28 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 75.420000000000002 111.147 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.468 ' CD2' HG13 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -87.86 117.42 26.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 75.519999999999996 110.878 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.537 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -124.75 111.88 16.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 75.049999999999997 110.945 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.87 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.6 t70 -138.75 120.94 15.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 64.310000000000002 110.831 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.81 1.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 73.150000000000006 110.854 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.63 ' H ' ' C ' ' A' ' 86' ' ' ASP . 49.8 t0 -65.83 -6.49 12.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 70.329999999999998 110.847 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 70.43 19.32 6.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 75.129999999999995 110.918 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.68 -0.03 1.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 54.119999999999997 110.846 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.87 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 89.2 t -120.94 70.02 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 71.340000000000003 111.128 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -124.55 14.36 8.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.319999999999993 110.935 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.69 -172.6 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 74.099999999999994 110.881 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.7 t -116.43 174.34 6.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 71.420000000000002 111.147 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 82' ' ' GLU . 2.6 tp10 -141.1 119.28 7.98 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.729 . . . . 74.340000000000003 110.908 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 115.64 4.19 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.653 2.236 . . . . 74.340000000000003 112.341 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.7 112.8 21.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 72.129999999999995 111.144 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 100' ' ' ASP . 2.5 t70 -128.93 56.8 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 71.200000000000003 110.864 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.28 -17.95 2.91 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.761 -0.733 . . . . 71.239999999999995 112.517 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 98' ' ' ASP . 1.2 m-20 -96.25 -61.35 1.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 74.5 110.849 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.44 18.1 65.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 52.219999999999999 112.519 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 61.310000000000002 112.508 -179.906 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.832 0.348 . . . . 73.239999999999995 110.888 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -67.01 -42.5 84.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 75.549999999999997 110.935 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -66.31 -143.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 53.439999999999998 110.866 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.496 ' C ' ' H ' ' A' ' 16' ' ' THR . 19.7 mm -75.32 114.07 31.98 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.613 0.72 . . . . 75.510000000000005 111.087 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 16.64 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.652 2.235 . . . . 73.450000000000003 112.366 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.496 ' H ' ' C ' ' A' ' 14' ' ' ILE . 2.8 m -134.76 23.52 3.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 71.209999999999994 111.096 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.494 HG23 HG22 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -75.66 -145.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 75.420000000000002 111.127 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.455 ' H ' ' CG2' ' A' ' 17' ' ' THR . 59.5 mt-10 -84.65 -104.23 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 73.040000000000006 110.877 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.62 6.19 45.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 73.049999999999997 110.878 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.404 HD23 HG22 ' A' ' 91' ' ' VAL . 7.7 mp -65.33 -34.87 79.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 75.310000000000002 110.923 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -83.26 3.73 30.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.972 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -105.6 -36.32 7.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 72.519999999999996 110.885 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -66.68 -49.01 67.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.477 . . . . 75.230000000000004 110.877 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -43.27 -33.09 1.88 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 64.450000000000003 112.507 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.37 -56.49 19.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.768 0.318 . . . . 64.430000000000007 111.05 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 19.6 ptp -70.18 -7.96 46.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 75.129999999999995 110.905 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . -79.62 -17.49 53.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.329999999999998 111.096 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -82.43 9.74 8.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.898 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -93.69 -79.21 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 64.219999999999999 110.87 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.05 7.88 5.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 74.109999999999999 112.484 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.53 ' HG2' ' N ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -61.92 152.4 32.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 73.239999999999995 110.891 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.53 ' N ' ' HG2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -116.47 -165.1 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 73.129999999999995 110.836 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -114.16 116.77 29.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 73.349999999999994 110.876 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.455 ' HB ' ' CB ' ' A' ' 59' ' ' GLU . 10.2 t -74.9 167.39 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 72.439999999999998 111.131 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.451 ' OG1' ' HD2' ' A' ' 37' ' ' PRO . 65.7 p -94.67 -44.3 7.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 111.126 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.427 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 164.98 -61.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.727 . . . . 50.210000000000001 112.489 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.9 Cg_endo -69.71 159.73 52.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 74.209999999999994 112.357 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.596 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 1.2 t70 -65.06 -27.18 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 72.319999999999993 110.859 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -36.41 73.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 71.239999999999995 111.062 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.427 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -85.21 -37.34 20.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 74.340000000000003 110.863 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.596 ' NE ' ' HA ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -70.01 -45.57 66.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 73.140000000000001 110.859 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.589 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -68.74 -36.03 77.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 73.340000000000003 111.1 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.427 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 10.5 ptt180 -79.51 -41.47 27.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.349999999999994 110.858 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -74.7 -62.3 1.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 71.340000000000003 111.075 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.61 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -53.79 -19.64 4.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 74.129999999999995 111.097 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.685 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -55.43 -67.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 71.319999999999993 111.112 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.657 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 3.5 p -112.7 -18.48 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 75.120000000000005 111.159 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 5.4 mt-30 -77.67 -29.14 51.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 63.420000000000002 110.938 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 1.044 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.86 -7.81 15.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 73.019999999999996 111.131 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.988 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.46 -0.51 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.606 0.717 . . . . 70.140000000000001 111.149 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.044 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.2 Cg_endo -69.77 -29.1 24.37 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.654 2.236 . . . . 75.530000000000001 112.304 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.43 -52.27 4.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.736 -0.745 . . . . 74.109999999999999 112.479 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.1 -34.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 75.319999999999993 112.488 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.746 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -144.4 149.47 36.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 65.329999999999998 111.137 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.3 81.17 1.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 70.5 111.085 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.708 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -143.12 99.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 64.219999999999999 112.45 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.538 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.6 tt0 -90.66 179.97 5.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 74.019999999999996 110.925 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.3 t -130.81 121.97 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 63.350000000000001 111.153 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.455 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 11.8 tm-20 -93.39 153.56 18.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 75.409999999999997 110.91 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.428 ' HA ' ' CD2' ' A' ' 69' ' ' TYR . 1.5 t -132.98 112.34 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 71.319999999999993 111.094 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -140.91 162.91 34.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 73.140000000000001 110.854 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.92 120.07 34.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 71.329999999999998 111.134 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.41 -169.03 32.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 74.120000000000005 112.452 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.69 -23.12 49.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 75.040000000000006 110.908 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.52 -109.23 0.36 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.756 -0.735 . . . . 74.219999999999999 112.515 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.09 -74.43 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 63.340000000000003 111.122 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.401 ' O ' ' CB ' ' A' ' 86' ' ' ASP . . . -111.14 162.01 15.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 111.12 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -156.24 72.06 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 53.219999999999999 111.138 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 84' ' ' HIS . 4.2 m-85 -110.53 163.65 13.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 74.430000000000007 110.915 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.09 100.07 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.753 . . . . 74.0 112.479 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.18 119.37 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 72.430000000000007 111.151 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.708 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -113.26 144.63 42.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 74.109999999999999 110.934 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.566 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 10.8 t -149.38 123.37 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 111.118 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.765 ' OG1' ' HA ' ' A' ' 80' ' ' ARG . 1.9 m -172.2 -135.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 74.420000000000002 111.127 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.507 ' H ' ' CG2' ' A' ' 74' ' ' THR . 27.0 mtm-85 -96.02 145.93 30.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.576 0.703 . . . . 75.340000000000003 110.866 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.504 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.2 Cg_endo -69.75 10.64 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.698 2.265 . . . . 71.409999999999997 112.339 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 75' ' ' ARG . 7.6 m-20 -88.59 25.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.510000000000005 110.854 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.24 -9.76 24.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 71.150000000000006 112.521 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.42 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.5 t -97.58 102.54 14.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 65.329999999999998 111.154 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.765 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -142.2 172.39 12.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 73.0 110.9 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 27.9 t -119.93 113.03 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 72.310000000000002 111.138 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.55 ' HA ' ' HB3' ' A' ' 72' ' ' LEU . 2.1 pt-20 -88.34 122.26 31.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.902 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.421 HG11 ' HB ' ' A' ' 94' ' ' THR . 2.1 t -100.96 117.01 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 72.109999999999999 111.153 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.508 ' O ' ' O ' ' A' ' 91' ' ' VAL . 3.5 t-160 -82.02 116.2 21.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 74.540000000000006 110.846 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -104.03 98.09 7.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 74.230000000000004 110.937 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 1.073 ' H ' ' HA ' ' A' ' 91' ' ' VAL . 3.3 p30 -134.84 119.25 17.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 75.019999999999996 110.845 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.41 ' C ' ' H ' ' A' ' 89' ' ' PHE . 1.3 tmt_? -65.35 10.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 75.519999999999996 110.868 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.643 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 19.3 t0 -80.03 20.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 75.099999999999994 110.86 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.643 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 15.3 m-85 91.5 -17.8 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 74.329999999999998 110.908 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 38.23 3.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 75.420000000000002 110.895 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 1.073 ' HA ' ' H ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -64.35 -6.8 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 75.540000000000006 111.125 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.08 28.48 8.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 75.340000000000003 110.965 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -80.04 75.08 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 71.310000000000002 110.891 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.421 ' HB ' HG11 ' A' ' 83' ' ' VAL . 4.8 t -86.02 151.36 23.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 73.239999999999995 111.122 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.18 110.45 4.0 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.631 0.729 . . . . 73.099999999999994 110.884 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 120.22 7.04 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.686 2.257 . . . . 72.209999999999994 112.369 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.46 ' C ' HH12 ' A' ' 80' ' ' ARG . . . -116.81 167.47 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 73.219999999999999 111.081 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.49 7.71 7.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 65.219999999999999 110.859 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.415 ' HA2' ' CB ' ' A' ' 42' ' ' ALA . . . 86.1 -18.68 30.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 34.299999999999997 112.476 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.21 -16.55 22.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 74.409999999999997 110.859 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.53 -24.16 63.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 75.439999999999998 112.472 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 61.520000000000003 112.53 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.1 t0 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.834 0.349 . . . . 64.329999999999998 110.843 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -68.34 -43.89 76.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.904 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -60.74 -167.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.874 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 16' ' ' THR . 46.6 mm -76.69 122.07 85.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.62 0.724 . . . . 65.239999999999995 111.119 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 9.27 0.6 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.697 2.265 . . . . 75.150000000000006 112.3 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -125.52 36.69 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 71.540000000000006 111.133 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.449 ' HB ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -91.6 -166.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 64.420000000000002 111.176 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -64.42 -103.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 75.530000000000001 110.904 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.77 7.69 45.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.239999999999995 110.892 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.684 ' HG ' ' CD1' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.02 -14.35 53.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 72.340000000000003 110.911 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -94.4 5.66 51.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 71.540000000000006 110.946 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -108.44 -43.36 4.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 72.319999999999993 110.905 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -64.64 -53.04 53.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 110.9 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.54 -54.32 7.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.774 -0.726 . . . . 74.420000000000002 112.455 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.18 49.0 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.762 0.315 . . . . 75.510000000000005 111.124 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.2 ptm -66.47 -40.83 89.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 110.885 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -122.54 -92.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 70.319999999999993 111.055 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -145.12 -35.14 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 72.299999999999997 110.884 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.26 30.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.230000000000004 110.831 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.98 7.63 65.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 70.310000000000002 112.512 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -74.22 161.99 29.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 72.329999999999998 110.854 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.66 -166.03 1.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 70.230000000000004 110.837 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.13 118.94 22.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 72.109999999999999 110.91 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 87.6 t -71.36 155.76 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 72.230000000000004 111.119 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.6 p -107.82 -22.04 12.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 73.329999999999998 111.211 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.48 -139.71 2.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 41.32 112.455 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -162.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.722 2.282 . . . . 74.409999999999997 112.31 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.35 -27.42 64.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 64.409999999999997 110.896 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.81 -39.13 70.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 75.329999999999998 111.105 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -82.45 -37.58 25.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 110.874 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.534 ' HG3' ' HD3' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -68.53 -38.34 80.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.430000000000007 110.893 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.08 74.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 74.329999999999998 111.168 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.481 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 2.7 ptt85 -77.61 -40.45 42.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 72.040000000000006 110.909 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -77.9 -57.53 3.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 73.319999999999993 111.105 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.567 ' HA ' ' HB1' ' A' ' 49' ' ' ALA . . . -52.78 -18.11 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 64.530000000000001 111.085 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -63.75 -78.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.530000000000001 111.096 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.749 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 80.5 t -111.91 -20.07 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 64.120000000000005 111.134 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 16.6 mt-30 -72.01 -26.62 62.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.94 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 1.076 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -109.09 -4.99 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 111.135 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.999 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.78 0.59 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.615 0.722 . . . . 64.409999999999997 111.123 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.076 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.0 Cg_endo -69.79 -26.47 27.41 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 74.239999999999995 112.33 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.36 -54.58 2.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 73.409999999999997 112.47 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.74 -31.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 63.43 112.512 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.737 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -140.51 146.14 37.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 72.519999999999996 111.17 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.68 74.87 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 74.150000000000006 111.116 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.699 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -153.45 109.34 0.4 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 73.209999999999994 112.483 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.661 ' HB3' ' HB1' ' A' ' 49' ' ' ALA . 2.3 pt-20 -100.91 -161.21 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 64.209999999999994 110.896 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.84 142.88 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 74.129999999999995 111.096 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.514 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 1.0 OUTLIER -108.82 153.5 23.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 74.200000000000003 110.886 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.86 105.56 7.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 74.530000000000001 111.117 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.85 165.76 25.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 73.019999999999996 110.878 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -124.28 115.42 21.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 63.409999999999997 111.124 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.04 -151.31 14.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.731 -0.747 . . . . 61.329999999999998 112.518 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -78.38 -23.43 46.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.364 . . . . 73.25 110.88 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.86 -120.41 0.22 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 74.329999999999998 112.489 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.65 -76.95 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 71.340000000000003 111.117 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -102.9 92.53 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 53.039999999999999 111.082 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.55 72.98 10.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 71.420000000000002 111.085 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 6.8 m-85 -106.76 165.62 11.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.409999999999997 110.904 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -146.89 111.68 0.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 51.329999999999998 112.518 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.66 117.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.362 . . . . 73.430000000000007 111.111 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.798 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -104.14 145.45 30.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 75.040000000000006 110.962 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.697 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 18.1 m -151.23 118.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 75.129999999999995 111.14 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.786 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.3 m -165.87 -136.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.340000000000003 111.153 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.538 ' H ' ' CG2' ' A' ' 74' ' ' THR . 0.0 OUTLIER -102.68 149.85 37.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 73.319999999999993 110.858 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.442 ' HD3' HG22 ' A' ' 50' ' ' VAL . 53.3 Cg_endo -69.77 6.01 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.63 2.22 . . . . 64.239999999999995 112.359 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -85.91 35.34 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 72.329999999999998 110.837 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.41 -8.68 52.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 51.009999999999998 112.478 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.786 ' O ' ' HB ' ' A' ' 74' ' ' THR . 3.2 t -92.34 125.43 37.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 75.409999999999997 111.126 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.536 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -144.24 144.35 31.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 75.430000000000007 110.891 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 87.9 t -104.81 88.97 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 72.319999999999993 111.132 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.53 122.78 21.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 65.5 110.887 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 16.3 t -102.29 139.26 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 75.25 111.161 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.506 ' CD2' HG11 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -89.43 115.14 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 72.109999999999999 110.883 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.684 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -125.62 105.63 9.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 73.310000000000002 110.937 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.696 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 4.3 m-20 -135.12 129.06 33.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 73.219999999999999 110.879 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.48 6.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 64.549999999999997 110.893 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.657 ' H ' ' C ' ' A' ' 86' ' ' ASP . 3.8 t0 -64.89 -5.84 6.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 75.150000000000006 110.88 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 70.71 13.17 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 110.903 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 2.73 1.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 75.120000000000005 110.909 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.696 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 69.0 t -119.13 81.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 73.099999999999994 111.069 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.27 10.6 3.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 74.450000000000003 110.924 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.419 ' O ' HG12 ' A' ' 83' ' ' VAL . 24.3 t0 -93.25 167.61 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 74.0 110.839 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 9.8 t -108.17 166.9 10.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 73.010000000000005 111.122 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -144.53 119.96 6.03 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.636 0.732 . . . . 73.329999999999998 110.885 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 119.02 6.03 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.697 2.264 . . . . 74.239999999999995 112.325 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.34 163.07 16.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 73.239999999999995 111.063 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -125.62 -135.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 74.040000000000006 110.816 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.13 -14.94 27.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.667 -0.778 . . . . 74.219999999999999 112.484 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -91.5 -48.66 6.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 70.450000000000003 110.862 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.76 23.2 9.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 71.310000000000002 112.465 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 60.210000000000001 112.49 -179.921 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.824 0.345 . . . . 64.430000000000007 110.865 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -67.59 -23.16 65.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 73.329999999999998 110.893 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.427 ' HB2' HD22 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -62.23 -157.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 70.150000000000006 110.859 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.55 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 20.7 pt -77.21 160.87 74.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.587 0.708 . . . . 73.129999999999995 111.153 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.8 -3.11 11.37 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.64 2.227 . . . . 74.450000000000003 112.358 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.0 p -148.2 79.87 1.46 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 73.019999999999996 111.153 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.607 ' CG2' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -98.98 -166.34 1.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 111.153 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . 10.6 tt0 -80.58 -100.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 64.140000000000001 110.881 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.58 10.83 40.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 110.908 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.493 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 3.3 tp -65.01 -21.15 66.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 75.200000000000003 110.904 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -83.78 7.12 18.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 73.209999999999994 110.918 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -108.8 -42.08 4.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 74.430000000000007 110.868 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -66.43 -46.68 75.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 75.329999999999998 110.934 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.22 -29.19 1.57 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 73.239999999999995 112.513 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.25 -58.63 5.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.78 0.324 . . . . 75.140000000000001 111.121 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -9.99 59.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 64.120000000000005 110.865 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.92 -17.84 45.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 72.420000000000002 111.085 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -79.04 5.07 12.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 73.430000000000007 110.915 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -73.63 -82.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 75.219999999999999 110.852 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.06 12.62 0.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 75.430000000000007 112.504 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -66.38 168.66 8.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 72.540000000000006 110.877 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -112.12 -149.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 74.010000000000005 110.867 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.96 170.18 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 70.099999999999994 110.881 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.592 ' N ' ' O ' ' A' ' 58' ' ' VAL . 14.8 t -118.45 169.42 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 73.140000000000001 111.105 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.483 ' OG1' ' HD2' ' A' ' 37' ' ' PRO . 63.0 p -90.53 -41.59 11.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 111.137 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.414 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 162.01 -61.83 0.28 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 74.219999999999999 112.515 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 54.0 Cg_endo -69.74 157.01 61.9 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.712 2.275 . . . . 72.5 112.337 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -62.74 -26.84 68.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 73.099999999999994 110.889 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.28 -35.83 72.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 71.099999999999994 111.15 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.42 -36.13 24.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 65.430000000000007 110.893 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.446 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 12.8 ptt180 -70.22 -43.64 70.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 74.019999999999996 110.894 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.618 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . . . -70.41 -34.41 72.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 72.129999999999995 111.143 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -79.92 -41.22 26.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.109999999999999 110.89 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.587 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -76.85 -62.24 1.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 71.230000000000004 111.067 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.53 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -52.74 -22.31 5.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 64.230000000000004 111.117 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.737 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -53.59 -69.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 63.43 111.154 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.637 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.3 t -112.17 -11.11 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 72.409999999999997 111.093 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.587 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.3 tp60 -83.19 -34.19 26.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 74.319999999999993 110.926 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.969 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.44 -6.02 18.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 73.450000000000003 111.098 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.979 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.93 -9.42 0.14 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.628 0.728 . . . . 72.310000000000002 111.152 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.979 ' CD ' ' N ' ' A' ' 50' ' ' VAL . 53.6 Cg_endo -69.78 -22.73 31.59 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.68 2.253 . . . . 74.140000000000001 112.322 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.65 -54.36 2.96 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.794 -0.717 . . . . 73.319999999999993 112.488 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.64 -34.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 62.039999999999999 112.455 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.672 ' O ' ' O ' ' A' ' 49' ' ' ALA . 2.0 t -148.34 152.81 37.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.757 0.313 . . . . 72.420000000000002 111.194 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.38 75.28 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 71.209999999999994 111.077 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.741 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -147.09 104.51 0.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.722 . . . . 74.519999999999996 112.503 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.476 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 1.9 tt0 -97.6 -170.37 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.37 . . . . 74.25 110.888 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.592 ' O ' ' N ' ' A' ' 34' ' ' VAL . 2.6 t -129.25 139.17 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 72.319999999999993 111.159 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 10.6 tt0 -106.31 128.16 53.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 71.319999999999993 110.923 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -118.31 95.57 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 73.010000000000005 111.077 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.28 168.87 18.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 61.340000000000003 110.85 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.4 m -98.07 -19.34 18.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 73.319999999999993 111.144 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 49.97 -159.2 1.39 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 45.140000000000001 112.488 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.36 -25.37 23.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.357 . . . . 71.510000000000005 110.892 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.05 -116.89 0.47 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.683 -0.77 . . . . 72.129999999999995 112.475 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.11 -65.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 74.109999999999999 111.089 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.689 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -111.83 94.39 4.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 74.120000000000005 111.144 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.71 84.67 7.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 74.349999999999994 111.063 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.523 ' CE1' ' HB ' ' A' ' 71' ' ' VAL . 6.5 t80 -110.81 123.43 50.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 64.109999999999999 110.92 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -126.32 111.89 1.51 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 74.409999999999997 112.476 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.523 ' HB ' ' CE1' ' A' ' 69' ' ' TYR . 7.9 p -107.83 121.03 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 73.430000000000007 111.11 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.741 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -114.12 134.31 54.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 75.319999999999993 110.936 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.654 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.5 m -144.92 122.77 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 72.25 111.143 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.781 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 5.0 m -171.95 -126.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 63.219999999999999 111.131 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.467 ' H ' ' CG2' ' A' ' 74' ' ' THR . 0.0 OUTLIER -106.33 146.08 32.28 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.665 0.745 . . . . 63.130000000000003 110.868 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.497 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.4 Cg_endo -69.74 12.36 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.667 2.245 . . . . 64.510000000000005 112.355 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 75' ' ' ARG . 38.2 t70 -91.55 28.82 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 73.010000000000005 110.835 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.35 -10.88 26.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 72.420000000000002 112.463 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.575 ' O ' ' HB ' ' A' ' 74' ' ' THR . 32.1 p -97.1 104.99 17.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 73.340000000000003 111.151 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.781 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.4 OUTLIER -138.17 165.7 25.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 75.219999999999999 110.85 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 5.7 m -115.0 98.94 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 72.25 111.166 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . 8.8 tm-20 -85.69 125.64 33.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 110.882 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.582 ' O ' ' HA2' ' A' ' 70' ' ' GLY . 2.5 t -92.43 113.04 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.420000000000002 111.14 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -85.79 113.0 21.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 73.120000000000005 110.902 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.65 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 4.0 mm? -130.36 121.76 26.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 74.349999999999994 110.877 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.7 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.4 t0 -137.8 134.92 35.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 65.200000000000003 110.892 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.35 3.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.439999999999998 110.827 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.593 ' H ' ' C ' ' A' ' 86' ' ' ASP . 8.2 t0 -65.7 -3.53 4.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 73.400000000000006 110.834 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 68.5 10.73 8.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 71.209999999999994 110.899 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.04 -1.29 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 74.219999999999999 110.871 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.7 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 58.3 t -117.6 90.99 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 74.519999999999996 111.123 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.631 ' HA ' ' CD1' ' A' ' 85' ' ' LEU . 5.5 mp -146.33 14.6 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 74.030000000000001 110.886 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -113.43 140.96 47.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.439999999999998 110.869 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.3 t -87.91 151.41 22.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 64.129999999999995 111.194 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -123.83 149.8 60.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 71.409999999999997 110.904 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 143.12 49.77 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.705 2.27 . . . . 72.409999999999997 112.325 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.432 ' HB2' ' CG ' ' A' ' 80' ' ' ARG . . . -118.81 110.2 16.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 64.140000000000001 111.067 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -98.46 4.79 48.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 73.329999999999998 110.818 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.61 -20.91 8.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.774 -0.727 . . . . 71.349999999999994 112.487 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.3 -16.03 20.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.825 0.345 . . . . 64.319999999999993 110.865 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.99 -14.0 54.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.796 -0.716 . . . . 70.409999999999997 112.488 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 75.409999999999997 112.479 -179.908 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.83 0.348 . . . . 72.349999999999994 110.872 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.401 ' HB2' ' HB2' ' A' ' 68' ' ' ALA . 92.7 m-85 -67.52 -36.53 81.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 74.200000000000003 110.926 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.59 -164.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 71.409999999999997 110.831 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.508 ' C ' ' H ' ' A' ' 16' ' ' THR . 24.4 mm -77.78 129.84 75.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.651 0.739 . . . . 71.310000000000002 111.13 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 14' ' ' ILE . 53.4 Cg_endo -69.8 18.0 0.2 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.645 2.23 . . . . 73.239999999999995 112.35 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.508 ' H ' ' C ' ' A' ' 14' ' ' ILE . 3.1 m -138.73 27.13 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 75.409999999999997 111.172 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.458 ' HB ' HD23 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -74.36 -167.5 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 74.109999999999999 111.132 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -63.94 -103.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 74.409999999999997 110.887 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.75 8.56 44.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 73.120000000000005 110.882 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.729 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.71 -13.24 53.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.200000000000003 110.911 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -95.34 7.74 45.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.454 . . . . 73.109999999999999 110.91 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -106.98 -40.08 5.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 63.310000000000002 110.855 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -66.24 -47.63 73.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 72.420000000000002 110.914 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -43.55 -31.9 1.81 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 73.109999999999999 112.485 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.33 -64.51 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 71.340000000000003 111.075 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -70.45 -7.94 47.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 71.530000000000001 110.921 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.42 ' HA ' ' HB2' ' A' ' 31' ' ' GLU . . . -76.91 -19.98 56.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 65.230000000000004 111.087 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -77.97 5.79 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 72.519999999999996 110.864 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.72 -81.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 72.519999999999996 110.85 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.92 14.52 5.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 75.420000000000002 112.499 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 1.1 tt0 -54.82 103.4 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.902 0.382 . . . . 74.310000000000002 110.926 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.95 -170.2 1.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 74.230000000000004 110.857 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.18 125.46 52.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 71.400000000000006 110.863 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 35' ' ' THR . 1.9 t -71.03 161.92 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 75.510000000000005 111.101 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' CG1' ' A' ' 34' ' ' VAL . 1.7 p -84.93 -45.75 11.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 72.040000000000006 111.125 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.43 -81.17 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.724 -0.751 . . . . 73.129999999999995 112.476 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 169.48 18.78 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.701 2.267 . . . . 72.040000000000006 112.337 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -68.17 -26.39 65.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 75.340000000000003 110.872 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.53 -28.4 20.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 75.109999999999999 111.098 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.401 ' HB2' HG11 ' A' ' 34' ' ' VAL . 13.5 m-20 -76.81 -30.79 56.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 110.905 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.453 ' HG2' ' N ' ' A' ' 42' ' ' ALA . 4.3 ptt180 -56.7 -38.96 73.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 72.099999999999994 110.892 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.453 ' N ' ' HG2' ' A' ' 41' ' ' ARG . . . -70.12 -30.44 67.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 111.086 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 40' ' ' ASP . 10.5 mtt-85 -74.34 -45.16 48.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 73.140000000000001 110.875 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.596 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -78.25 -57.52 3.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 74.219999999999999 111.118 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -54.02 -17.36 2.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 64.129999999999995 111.106 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.632 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -62.69 -68.05 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 70.140000000000001 111.106 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.687 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 26.0 t -122.21 -14.16 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 71.340000000000003 111.14 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 27.9 mt-30 -79.64 -41.64 26.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 110.92 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.897 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -104.43 0.05 28.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 62.329999999999998 111.074 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.965 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.29 -13.19 0.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 74.319999999999993 111.136 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.965 ' CD ' ' N ' ' A' ' 50' ' ' VAL . 53.5 Cg_endo -69.77 -32.24 18.92 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.654 2.236 . . . . 74.209999999999994 112.362 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.16 -51.46 38.5 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.785 -0.722 . . . . 74.540000000000006 112.51 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.58 -33.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 64.450000000000003 112.496 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.566 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -150.24 158.63 44.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 65.209999999999994 111.152 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.48 ' CB ' HG21 ' A' ' 50' ' ' VAL . . . -70.99 77.78 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 111.102 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.716 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -144.94 106.9 0.41 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.733 . . . . 71.430000000000007 112.46 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.42 ' H ' HD21 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -101.33 -159.24 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 71.420000000000002 110.884 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.475 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 0.9 OUTLIER -126.62 121.3 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 75.030000000000001 111.159 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.758 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -94.69 171.47 8.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 75.239999999999995 110.87 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.421 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -113.88 128.86 56.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 75.140000000000001 111.12 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.534 ' N ' ' HA ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -142.72 91.29 2.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 75.5 110.903 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.0 p -94.81 149.4 21.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 73.430000000000007 111.144 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.18 179.46 17.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.778 -0.725 . . . . 73.230000000000004 112.509 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -76.41 -24.14 54.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.899 0.381 . . . . 75.019999999999996 110.884 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.59 -117.39 2.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 65.319999999999993 112.468 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.45 38.93 3.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 72.329999999999998 111.095 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.405 ' HA ' ' HB3' ' A' ' 86' ' ' ASP . . . -59.06 -171.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 71.540000000000006 111.083 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 12' ' ' TYR . . . -156.29 -95.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 71.219999999999999 111.109 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.758 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -162.29 -163.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 75.439999999999998 110.888 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -138.99 156.64 24.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.749 -0.739 . . . . 74.510000000000005 112.505 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.4 p -125.61 121.1 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 73.040000000000006 111.124 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.758 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -112.14 142.91 44.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 63.409999999999997 110.94 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.716 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 11.0 p -157.88 125.84 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 63.530000000000001 111.139 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.697 ' HB ' ' HA ' ' A' ' 80' ' ' ARG . 5.6 m -168.6 -125.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 72.109999999999999 111.14 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.48 ' H ' ' CG2' ' A' ' 74' ' ' THR . 3.8 ttm-85 -107.82 139.32 20.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 75.219999999999999 110.876 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.4 ' HD3' ' HB1' ' A' ' 55' ' ' ALA . 53.8 Cg_endo -69.75 13.89 0.27 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.679 2.252 . . . . 71.409999999999997 112.369 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.472 ' H ' ' C ' ' A' ' 75' ' ' ARG . 1.3 m-20 -94.1 23.79 4.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 72.540000000000006 110.877 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.51 -16.3 61.28 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.718 -0.753 . . . . 53.329999999999998 112.48 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.687 ' O ' ' HB ' ' A' ' 74' ' ' THR . 6.0 t -94.0 122.55 36.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.763 0.316 . . . . 64.019999999999996 111.105 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.697 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -141.65 161.52 37.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 72.219999999999999 110.852 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.758 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 94.1 t -118.05 85.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 73.439999999999998 111.103 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.444 ' HA ' ' CB ' ' A' ' 72' ' ' LEU . 6.9 tm-20 -77.27 121.86 24.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 71.140000000000001 110.841 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.3 t -100.33 137.4 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 73.219999999999999 111.124 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.46 ' C ' HG12 ' A' ' 91' ' ' VAL . 6.5 m-70 -92.56 118.23 30.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 63.399999999999999 110.871 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.729 ' CD2' ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -122.48 101.36 7.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 110.892 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.676 ' C ' ' H ' ' A' ' 88' ' ' ASP . 34.4 m-20 -140.78 131.74 26.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 110.858 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.36 11.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.854 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.676 ' H ' ' C ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -65.37 -5.93 8.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.856 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 74.27 6.88 4.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 75.120000000000005 110.865 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -141.54 7.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 74.439999999999998 110.894 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.672 ' CG2' ' HB2' ' A' ' 86' ' ' ASP . 40.9 t -118.31 69.52 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 111.137 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.91 10.72 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 70.120000000000005 110.953 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.23 -179.95 3.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 74.310000000000002 110.791 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 13.4 t -126.42 171.18 11.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 71.340000000000003 111.138 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -144.84 159.64 49.68 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.663 0.744 . . . . 74.400000000000006 110.86 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 107.01 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.648 2.232 . . . . 72.450000000000003 112.341 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.69 112.15 11.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 73.239999999999995 111.099 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -85.68 6.36 27.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 64.200000000000003 110.92 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.402 ' HA2' ' CB ' ' A' ' 42' ' ' ALA . . . 79.56 -20.93 4.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.744 -0.741 . . . . 65.310000000000002 112.502 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.36 -33.06 10.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 74.109999999999999 110.873 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.07 24.85 54.0 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 71.329999999999998 112.491 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 74.140000000000001 112.457 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.78 0.324 . . . . 74.439999999999998 110.806 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -65.41 -56.38 12.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 75.430000000000007 110.852 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 25.5 t0 -65.36 -115.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 62.009999999999998 110.862 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.517 ' C ' ' H ' ' A' ' 16' ' ' THR . 12.6 mm -100.13 108.64 53.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.586 0.708 . . . . 75.120000000000005 111.103 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 23.1 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.714 2.276 . . . . 74.349999999999994 112.322 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.517 ' H ' ' C ' ' A' ' 14' ' ' ILE . 3.1 m -131.17 20.22 4.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.230000000000004 111.163 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -165.99 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 62.340000000000003 111.113 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.405 ' H ' HD23 ' A' ' 92' ' ' LEU . 21.1 mt-10 -61.3 -105.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 71.519999999999996 110.873 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.8 8.23 44.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 75.310000000000002 110.898 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.769 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -65.29 -15.81 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 73.329999999999998 110.88 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -97.02 4.39 51.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 74.219999999999999 110.91 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -103.65 -42.21 5.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 74.120000000000005 110.868 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -66.35 -51.39 57.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 75.0 110.961 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.3 -27.86 4.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 75.329999999999998 112.5 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.35 49.23 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 71.230000000000004 111.122 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.442 ' HG3' HG23 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -70.36 -42.77 71.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 74.040000000000006 110.905 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.456 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -119.42 -93.28 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 71.209999999999994 111.1 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -150.39 -37.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 73.400000000000006 110.927 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.38 -0.05 1.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 74.219999999999999 110.841 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.62 -20.33 7.55 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.757 -0.735 . . . . 73.340000000000003 112.508 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.9 103.25 13.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 75.430000000000007 110.91 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.68 179.08 4.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.491 . . . . 65.439999999999998 110.846 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.3 119.14 37.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 64.400000000000006 110.911 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.521 ' CG1' ' H ' ' A' ' 35' ' ' THR . 8.4 t -84.2 -125.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 65.109999999999999 111.09 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.521 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 71.4 p -139.52 -71.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 70.540000000000006 111.129 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.22 -65.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.755 -0.736 . . . . 75.25 112.51 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 166.63 26.9 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.649 2.233 . . . . 74.310000000000002 112.325 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.558 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -72.21 -28.94 63.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 110.846 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.0 -32.9 62.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.095 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.95 -31.57 31.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 65.540000000000006 110.882 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -69.34 -43.13 74.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 71.230000000000004 110.872 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.564 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . . . -70.95 -33.28 70.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 111.129 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -81.01 -40.97 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 70.310000000000002 110.883 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.562 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -75.55 -63.06 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 53.43 111.12 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -53.54 -21.26 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 62.530000000000001 111.119 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.711 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -52.98 -68.92 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 63.140000000000001 111.062 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.614 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 19.0 t -111.75 -13.31 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 75.030000000000001 111.107 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.7 tp60 -80.53 -32.92 36.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 72.510000000000005 110.928 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 1.026 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.36 -6.68 17.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 71.329999999999998 111.153 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.987 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.08 -4.33 0.11 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.58 0.705 . . . . 75.319999999999993 111.094 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.026 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.1 Cg_endo -69.75 -24.46 29.69 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.731 2.288 . . . . 72.540000000000006 112.31 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.62 -56.33 2.26 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.718 -0.753 . . . . 72.129999999999995 112.487 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.1 -36.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.744 . . . . 64.540000000000006 112.473 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.746 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.7 t -146.42 150.44 35.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 65.209999999999994 111.185 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.12 80.3 1.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 72.349999999999994 111.095 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.721 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -146.86 99.51 0.21 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 62.439999999999998 112.491 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.492 ' O ' HD22 ' A' ' 72' ' ' LEU . 3.5 tt0 -99.79 -167.05 1.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 75.120000000000005 110.892 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.6 t -137.78 117.62 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 111.165 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.506 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 1.9 pp20? -96.08 155.16 16.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 74.5 110.857 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.453 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.5 t -127.65 118.7 24.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 74.540000000000006 111.178 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.62 170.88 14.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.420000000000002 110.916 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.75 114.48 22.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 62.340000000000003 111.128 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.43 -147.47 12.76 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 73.439999999999998 112.467 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -87.58 -1.63 58.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 73.239999999999995 110.904 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.02 -118.12 4.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 71.310000000000002 112.468 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.13 -78.27 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.775 0.321 . . . . 74.129999999999995 111.08 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -107.01 92.97 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 64.439999999999998 111.081 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.84 59.34 3.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 72.450000000000003 111.093 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CE1' ' HB2' ' A' ' 85' ' ' LEU . 2.6 p90 -110.74 132.11 54.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.409999999999997 110.935 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -118.71 150.37 18.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.777 -0.725 . . . . 73.109999999999999 112.494 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.5 119.78 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.368 . . . . 72.120000000000005 111.12 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.721 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -107.14 138.33 43.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 75.329999999999998 110.925 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.694 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.1 t -148.98 122.03 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 73.120000000000005 111.147 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.777 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 3.6 m -171.52 -128.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 71.439999999999998 111.121 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.48 ' H ' ' CG2' ' A' ' 74' ' ' THR . 0.0 OUTLIER -104.28 142.61 24.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.662 0.744 . . . . 74.430000000000007 110.844 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.485 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.9 Cg_endo -69.76 14.19 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.695 2.264 . . . . 74.219999999999999 112.311 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.474 ' H ' ' C ' ' A' ' 75' ' ' ARG . 7.2 m-20 -93.01 27.01 2.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.267 -0.424 . . . . 75.030000000000001 110.864 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.85 -12.89 51.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.792 -0.718 . . . . 70.230000000000004 112.51 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.587 ' O ' ' HB ' ' A' ' 74' ' ' THR . 33.6 p -97.18 106.64 19.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 73.530000000000001 111.141 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.777 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.7 OUTLIER -137.79 164.68 28.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 75.549999999999997 110.858 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 10.3 m -116.92 96.97 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 74.120000000000005 111.102 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.461 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 1.3 tm-20 -80.93 121.97 26.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 73.010000000000005 110.898 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.668 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.4 t -93.9 137.33 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 70.340000000000003 111.133 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.437 ' CD2' HG11 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -84.85 112.81 20.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 73.540000000000006 110.849 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.769 ' CD2' ' HG ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -121.21 109.53 15.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 71.219999999999999 110.911 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.628 ' C ' ' H ' ' A' ' 88' ' ' ASP . 2.2 t0 -140.28 131.35 26.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 110.864 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.8 7.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 70.409999999999997 110.865 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.628 ' H ' ' C ' ' A' ' 86' ' ' ASP . 19.8 t0 -66.44 -4.6 8.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 65.219999999999999 110.877 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 70.02 11.43 7.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 75.310000000000002 110.916 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.79 5.63 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 72.439999999999998 110.898 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.626 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 49.7 t -117.43 74.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 74.150000000000006 111.137 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.405 HD23 ' H ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -133.59 11.7 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 110.931 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.412 ' O ' HG11 ' A' ' 83' ' ' VAL . 59.5 m-20 -92.95 163.49 13.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 75.209999999999994 110.905 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.668 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 8.3 t -98.9 161.76 13.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 70.519999999999996 111.171 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -147.6 127.52 6.65 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 75.549999999999997 110.904 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 123.5 10.16 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.73 2.287 . . . . 71.219999999999999 112.306 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.59 161.66 18.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.109999999999999 111.135 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -128.8 -146.24 0.32 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.429 . . . . 72.420000000000002 110.887 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.62 -15.85 30.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.772 -0.728 . . . . 73.310000000000002 112.434 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.59 -36.35 13.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.369 . . . . 74.109999999999999 110.852 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.62 54.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 45.109999999999999 112.499 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.736 . . . . 65.430000000000007 112.485 -179.93 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.825 0.345 . . . . 72.209999999999994 110.864 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -75.09 -33.61 61.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 71.409999999999997 110.93 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.479 ' OD2' HD23 ' A' ' 20' ' ' LEU . 2.5 p-10 -64.53 -152.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 72.319999999999993 110.851 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.44 ' N ' ' OD2' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -78.17 163.37 62.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.652 0.739 . . . . 72.420000000000002 111.153 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -9.32 25.83 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.702 2.268 . . . . 73.219999999999999 112.383 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 p -154.2 130.15 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 73.340000000000003 111.144 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.614 ' OG1' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -149.76 -158.78 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 75.319999999999993 111.185 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -70.44 -101.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 64.25 110.892 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -91.17 11.21 24.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 74.030000000000001 110.881 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.623 ' CD2' ' HB3' ' A' ' 85' ' ' LEU . 10.7 mp -65.35 -30.08 70.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 74.200000000000003 110.956 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -80.31 4.72 16.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 75.0 110.962 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.12 -53.8 2.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 75.140000000000001 110.917 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -66.95 -46.55 74.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 75.439999999999998 110.935 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -46.94 -25.37 2.37 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 62.409999999999997 112.498 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 27' ' ' ALA . . . -51.2 -80.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 63.210000000000001 111.08 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.9 ptm -66.85 -0.49 3.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 73.409999999999997 110.873 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 25' ' ' ALA . . . -77.25 -32.93 56.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 73.519999999999996 111.071 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -82.95 10.05 8.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 73.219999999999999 110.856 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -68.6 -72.71 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 73.230000000000004 110.911 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.04 11.74 0.59 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 75.409999999999997 112.519 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 1.7 pt-20 -67.3 171.24 6.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 74.239999999999995 110.884 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -127.93 -153.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.239999999999995 110.844 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -109.85 163.61 13.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 75.400000000000006 110.835 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.642 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 1.0 OUTLIER -91.73 162.35 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 72.109999999999999 111.15 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.577 ' N ' ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -104.5 -32.73 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 74.040000000000006 111.163 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.404 ' H ' HG11 ' A' ' 34' ' ' VAL . . . -157.62 -139.09 2.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 73.319999999999993 112.498 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -160.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.669 2.246 . . . . 71.099999999999994 112.321 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -55.07 -34.21 63.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 70.019999999999996 110.896 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.86 -37.87 66.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 73.430000000000007 111.077 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -84.34 -42.05 16.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.888 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.513 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 7.1 ptt180 -61.9 -37.63 85.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 75.439999999999998 110.838 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.534 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -65.8 -34.76 78.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 53.240000000000002 111.093 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.488 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -78.08 -39.26 42.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 65.430000000000007 110.897 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.639 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -77.12 -58.55 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 64.239999999999995 111.084 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.538 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -57.2 -17.73 12.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 72.219999999999999 111.129 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.522 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -62.63 -79.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 111.118 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.749 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 61.1 t -110.91 -23.08 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 74.340000000000003 111.125 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.639 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 3.5 mt-30 -68.55 -27.7 66.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 74.409999999999997 110.883 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 1.056 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.77 -0.82 19.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 72.239999999999995 111.073 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 1.005 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.37 -1.1 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.62 0.724 . . . . 74.209999999999994 111.103 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.056 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.9 Cg_endo -69.76 -31.22 20.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.702 2.268 . . . . 74.420000000000002 112.33 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.98 -54.23 5.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 75.019999999999996 112.493 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.2 -33.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 35.520000000000003 112.525 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.62 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.4 m -145.08 152.65 40.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 62.210000000000001 111.152 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.57 76.07 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 72.319999999999993 111.11 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.697 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -146.59 104.94 0.31 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 73.510000000000005 112.515 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.544 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -98.56 -153.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 73.109999999999999 110.858 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -131.68 133.78 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 73.230000000000004 111.127 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.642 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -100.99 122.91 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 73.319999999999993 110.903 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.9 t -108.03 111.39 23.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 63.350000000000001 111.174 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.48 159.94 40.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 75.040000000000006 110.887 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 p -124.24 117.43 24.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 73.120000000000005 111.079 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.98 -147.87 11.85 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 74.439999999999998 112.497 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.33 -1.64 57.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.391 . . . . 74.420000000000002 110.894 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.51 -120.62 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.721 -0.752 . . . . 74.530000000000001 112.472 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.95 -75.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 63.420000000000002 111.057 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -104.67 85.85 2.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 73.239999999999995 111.038 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.49 59.26 4.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 70.019999999999996 111.072 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.422 ' HB2' ' HA ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -116.98 158.58 23.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 75.120000000000005 110.886 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -141.41 158.96 26.66 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.708 -0.758 . . . . 74.530000000000001 112.497 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -116.39 120.46 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 75.25 111.122 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.708 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -111.57 133.33 53.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 74.120000000000005 110.911 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.697 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.3 p -148.43 124.13 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.540000000000006 111.119 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.803 ' HB ' ' O ' ' A' ' 79' ' ' THR . 3.8 m -167.77 -129.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 73.319999999999993 111.178 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.496 ' H ' ' CG2' ' A' ' 74' ' ' THR . 0.3 OUTLIER -101.84 146.77 32.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.603 0.716 . . . . 74.150000000000006 110.895 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.72 7.68 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.699 2.266 . . . . 74.310000000000002 112.371 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 75' ' ' ARG . 21.6 m-20 -91.28 41.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 74.120000000000005 110.891 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.19 -4.94 16.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 65.299999999999997 112.527 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.803 ' O ' ' HB ' ' A' ' 74' ' ' THR . 43.9 p -96.07 117.02 29.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 75.409999999999997 111.161 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.613 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -144.75 158.1 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 74.230000000000004 110.867 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 31.4 m -118.13 92.13 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 62.200000000000003 111.126 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.562 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -81.12 123.43 28.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 73.420000000000002 110.888 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.679 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.4 t -94.93 131.75 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.499 . . . . 73.109999999999999 111.134 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.426 ' C ' HG11 ' A' ' 91' ' ' VAL . 1.2 t-160 -83.65 117.19 23.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 63.450000000000003 110.865 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.623 ' HB3' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -135.86 121.28 19.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 75.319999999999993 110.918 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.682 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 6.3 t0 -140.49 132.5 27.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 74.219999999999999 110.871 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -60.36 4.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 74.349999999999994 110.847 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.587 ' H ' ' C ' ' A' ' 86' ' ' ASP . 22.5 t0 -67.94 -3.92 11.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.519999999999996 110.879 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 69.31 14.85 8.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 75.5 110.865 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.05 -1.06 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 75.209999999999994 110.853 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.682 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 92.7 t -117.91 91.39 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 111.117 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.47 8.25 2.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.899 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.7 162.27 14.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 74.329999999999998 110.864 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.2 t -93.41 172.45 8.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 111.126 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 82' ' ' GLU . 3.4 tt0 -145.96 123.71 6.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.688 0.756 . . . . 65.510000000000005 110.852 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 129.48 17.58 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.249 . . . . 75.340000000000003 112.345 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -117.86 117.17 28.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 63.450000000000003 111.126 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 100' ' ' ASP . 3.4 m-20 -121.67 49.13 1.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 74.099999999999994 110.855 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.411 ' HA2' HH12 ' A' ' 80' ' ' ARG . . . 71.68 -16.92 1.28 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 75.0 112.485 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 98' ' ' ASP . 3.0 t0 -95.32 -62.14 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 72.019999999999996 110.857 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.36 26.02 60.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.759 -0.734 . . . . 73.150000000000006 112.472 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 75.409999999999997 112.48 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.428 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.817 0.341 . . . . 75.409999999999997 110.884 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -67.5 -54.34 20.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 75.040000000000006 110.938 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.405 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 9.0 t0 -64.19 -154.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 74.200000000000003 110.859 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 16' ' ' THR . 35.4 mm -92.24 123.68 61.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.612 0.72 . . . . 74.430000000000007 111.172 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 10.45 0.49 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.693 2.262 . . . . 72.230000000000004 112.324 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.445 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -124.24 43.74 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 73.310000000000002 111.184 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.425 ' HB ' HD23 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -97.89 -162.99 1.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 73.200000000000003 111.16 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -60.83 -102.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 71.129999999999995 110.936 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -96.85 7.16 47.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 75.109999999999999 110.887 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.714 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -66.49 -16.77 64.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 75.5 110.898 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -94.25 3.64 54.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 73.319999999999993 110.876 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -97.21 -53.36 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 75.140000000000001 110.907 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -64.73 -35.51 81.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 75.010000000000005 110.899 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -46.13 -30.06 3.79 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.732 -0.747 . . . . 73.340000000000003 112.486 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 28' ' ' PHE . . . -57.29 -57.36 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.826 0.346 . . . . 73.230000000000004 111.131 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.21 -5.06 16.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.519999999999996 110.882 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -113.06 38.83 2.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 70.530000000000001 111.107 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -110.41 14.7 22.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 72.340000000000003 110.9 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.28 -78.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 75.299999999999997 110.866 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.73 8.57 41.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.738 . . . . 64.430000000000007 112.478 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -64.61 103.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.875 0.369 . . . . 73.450000000000003 110.901 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.05 -172.53 2.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 70.420000000000002 110.886 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -115.78 120.85 40.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 72.010000000000005 110.87 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.602 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 46.1 t -71.93 159.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 63.210000000000001 111.13 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 65.8 p -99.59 -30.38 12.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 64.099999999999994 111.173 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.403 ' H ' HG13 ' A' ' 34' ' ' VAL . . . -150.42 -144.06 3.85 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 64.140000000000001 112.501 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -158.94 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.711 2.274 . . . . 75.120000000000005 112.4 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.431 ' HA ' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -56.69 -29.33 62.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 74.310000000000002 110.834 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.2 -43.57 70.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 63.119999999999997 111.085 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -85.6 -41.91 14.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 70.140000000000001 110.876 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.479 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -60.45 -36.16 77.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 110.86 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.527 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -65.25 -32.24 73.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 72.430000000000007 111.125 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.499 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 4.0 ptt180 -74.78 -40.97 60.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 71.519999999999996 110.898 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.499 ' N ' ' HG2' ' A' ' 43' ' ' ARG . . . -81.06 -57.84 3.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 72.349999999999994 111.142 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.496 ' HA ' ' HB2' ' A' ' 57' ' ' GLU . . . -52.12 -20.97 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 72.319999999999993 111.077 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.633 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -62.91 -76.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 70.109999999999999 111.11 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.712 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.3 t -111.4 -17.01 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.040000000000006 111.124 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.491 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -73.94 -32.0 63.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 71.510000000000005 110.908 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 1.017 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.39 -1.23 21.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 61.009999999999998 111.099 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.995 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.92 -2.7 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.656 0.741 . . . . 72.510000000000005 111.156 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.017 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.8 Cg_endo -69.78 -29.93 22.99 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.641 2.228 . . . . 71.329999999999998 112.345 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.52 -51.46 6.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.752 -0.737 . . . . 35.210000000000001 112.506 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.08 -33.55 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 70.019999999999996 112.518 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.671 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -145.74 151.1 37.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.79 0.328 . . . . 73.340000000000003 111.157 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.63 78.36 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 111.062 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.684 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -143.8 99.91 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 55.329999999999998 112.539 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.567 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -92.86 -164.72 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 75.239999999999995 110.928 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 t -143.49 124.76 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 73.109999999999999 111.106 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.602 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 9.6 pt-20 -95.18 155.83 16.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 74.120000000000005 110.837 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.467 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.3 t -131.58 117.18 18.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.097 -0.501 . . . . 74.329999999999998 111.122 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -137.85 158.97 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 74.200000000000003 110.877 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -22.61 19.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 72.310000000000002 111.102 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 42.99 -157.46 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.739 -0.743 . . . . 65.040000000000006 112.516 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -91.81 -23.61 19.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.913 0.387 . . . . 65.049999999999997 110.871 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.54 -119.1 1.13 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.767 -0.73 . . . . 73.120000000000005 112.471 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.61 -81.63 0.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.752 0.311 . . . . 60.350000000000001 111.113 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.649 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -93.03 79.57 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 74.530000000000001 111.147 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.49 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -81.74 62.57 5.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 70.329999999999998 111.102 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.467 ' HB2' ' HA ' ' A' ' 60' ' ' THR . 0.1 OUTLIER -114.61 155.64 26.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 73.299999999999997 110.937 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.489 ' HA2' ' HG ' ' A' ' 85' ' ' LEU . . . -138.49 157.61 24.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 75.209999999999994 112.449 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 p -126.62 117.97 49.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 75.510000000000005 111.16 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.794 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -105.99 137.01 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.340000000000003 110.917 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.673 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.1 p -147.23 124.14 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 54.130000000000003 111.146 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.791 ' HB ' ' O ' ' A' ' 79' ' ' THR . 4.4 m -168.19 -129.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 52.509999999999998 111.116 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.506 ' H ' ' CG2' ' A' ' 74' ' ' THR . 0.6 OUTLIER -104.65 148.8 36.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.562 0.696 . . . . 73.519999999999996 110.838 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 6.76 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.7 2.267 . . . . 64.329999999999998 112.31 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -92.67 43.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 63.219999999999999 110.862 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.51 -5.26 23.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 74.430000000000007 112.477 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.791 ' O ' ' HB ' ' A' ' 74' ' ' THR . 13.9 p -93.42 123.67 36.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 72.129999999999995 111.147 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.551 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -146.69 156.69 43.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 73.140000000000001 110.826 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.794 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 97.0 t -115.75 83.55 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 72.340000000000003 111.154 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.562 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 3.7 tm-20 -75.93 122.0 23.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 75.439999999999998 110.894 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 4.8 t -105.49 138.55 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 73.140000000000001 111.069 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.478 ' C ' HG12 ' A' ' 91' ' ' VAL . 40.8 m-70 -83.69 115.05 22.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 74.099999999999994 110.843 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.714 ' CD2' ' HG ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -125.25 105.98 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 74.5 110.905 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.653 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 5.3 t0 -139.08 131.63 28.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.129999999999995 110.887 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.98 6.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 110.848 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.619 ' H ' ' C ' ' A' ' 86' ' ' ASP . 37.5 t0 -67.21 -3.28 7.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 74.109999999999999 110.904 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 67.9 12.42 8.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 74.140000000000001 110.876 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -139.01 3.53 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 75.040000000000006 110.86 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.653 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 60.8 t -117.74 73.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 74.439999999999998 111.119 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.48 12.61 4.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 73.439999999999998 110.895 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.404 ' O ' HG13 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -94.53 164.52 12.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 75.519999999999996 110.873 179.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 9.9 t -104.08 169.45 8.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 74.329999999999998 111.16 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.409 ' HB2' ' NE2' ' A' ' 84' ' ' HIS . 11.6 tp10 -146.95 124.74 5.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.652 0.739 . . . . 74.329999999999998 110.873 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 124.85 11.5 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.727 2.285 . . . . 74.200000000000003 112.363 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -115.49 117.4 30.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 63.130000000000003 111.086 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 100' ' ' ASP . 52.5 m-20 -124.33 46.0 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.510000000000005 110.843 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.28 -17.83 4.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 70.439999999999998 112.445 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 98' ' ' ASP . 4.0 m-20 -94.46 -56.6 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 72.310000000000002 110.828 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.48 23.16 44.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.721 . . . . 54.310000000000002 112.484 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 40.520000000000003 112.504 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 t0 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.786 0.327 . . . . 71.420000000000002 110.838 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -67.84 -21.47 65.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 73.310000000000002 110.915 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 85' ' ' LEU . 12.4 t70 -58.63 -87.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 74.040000000000006 110.867 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.43 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -114.79 165.32 14.21 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.693 0.759 . . . . 72.430000000000007 111.13 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.79 -1.12 7.95 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.252 . . . . 70.109999999999999 112.343 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.42 71.13 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 73.010000000000005 111.154 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.474 HG23 HD11 ' A' ' 92' ' ' LEU . 70.7 p -76.38 -166.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 71.150000000000006 111.134 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.461 ' C ' ' H ' ' A' ' 20' ' ' LEU . 2.9 mm-40 -130.56 -93.12 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 74.530000000000001 110.892 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -69.22 5.88 1.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 74.540000000000006 110.849 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 18' ' ' GLU . 10.8 mp -87.0 -34.07 19.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 75.439999999999998 110.931 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -64.89 -16.66 63.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 73.310000000000002 110.897 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.75 -63.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 72.430000000000007 110.87 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.6 -46.93 77.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 73.329999999999998 110.937 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.78 -53.15 8.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 62.310000000000002 112.487 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.64 51.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 70.219999999999999 111.102 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -35.71 80.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 74.310000000000002 110.917 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.407 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . . . -121.32 -97.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 73.439999999999998 111.141 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.426 ' O ' ' CB ' ' A' ' 29' ' ' ASP . 1.4 p90 -149.43 -18.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 75.450000000000003 110.857 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER 165.99 -10.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 74.209999999999994 110.839 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.69 -22.0 3.83 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.766 -0.731 . . . . 60.520000000000003 112.472 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.94 105.32 0.45 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 74.409999999999997 110.921 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.496 ' C ' ' HG3' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -70.17 -158.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 74.140000000000001 110.815 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -138.17 118.75 13.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 72.340000000000003 110.901 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 40.4 t -72.06 149.13 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 75.319999999999993 111.106 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -123.31 -0.59 8.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 74.349999999999994 111.16 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.83 -154.75 6.39 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.726 . . . . 73.510000000000005 112.512 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -166.12 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.667 2.244 . . . . 71.030000000000001 112.302 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -59.09 -30.43 68.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 74.120000000000005 110.812 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.93 -30.17 67.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 70.530000000000001 111.116 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 1.6 m-20 -76.51 -34.32 58.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 70.209999999999994 110.865 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.561 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -73.89 -44.18 56.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 74.010000000000005 110.853 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.538 ' HA ' ' NE ' ' A' ' 80' ' ' ARG . . . -67.88 -30.64 70.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.239999999999995 111.121 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.403 ' CG ' ' N ' ' A' ' 44' ' ' ALA . 14.7 ptt180 -85.1 -45.2 12.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 74.450000000000003 110.902 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.518 ' HB2' ' OE1' ' A' ' 57' ' ' GLU . . . -77.9 -60.58 2.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 73.140000000000001 111.106 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 41' ' ' ARG . . . -48.27 -22.18 0.63 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 71.299999999999997 111.082 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.675 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -54.55 -67.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 64.349999999999994 111.127 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.602 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 26.9 t -110.41 -15.82 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 71.329999999999998 111.136 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 50.0 mt-30 -80.74 -29.02 36.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 73.530000000000001 110.913 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 1.064 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.37 -10.86 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 72.209999999999994 111.087 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 1.0 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.74 0.07 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.634 0.731 . . . . 74.420000000000002 111.158 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.064 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.2 Cg_endo -69.76 -27.11 26.86 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.65 2.234 . . . . 63.340000000000003 112.335 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.11 -53.62 2.94 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 64.329999999999998 112.542 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.63 -35.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 62.310000000000002 112.489 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.803 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -146.26 149.35 33.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 64.109999999999999 111.143 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.82 82.83 1.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 62.149999999999999 111.102 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -140.62 99.68 0.25 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.713 -0.756 . . . . 73.319999999999993 112.478 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.518 ' OE1' ' HB2' ' A' ' 44' ' ' ALA . 63.3 tt0 -96.18 164.62 12.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.946 0.403 . . . . 73.540000000000006 110.843 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 t -111.76 119.13 59.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 73.439999999999998 111.112 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.745 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.21 133.57 43.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 52.219999999999999 110.898 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -133.39 121.86 22.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 74.239999999999995 111.131 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.465 ' H ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -123.16 162.76 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.430000000000007 110.854 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.41 135.72 34.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 61.520000000000003 111.106 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.44 -119.38 1.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 61.109999999999999 112.525 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -87.83 -23.62 23.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 73.420000000000002 110.889 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.3 -112.61 1.9 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 71.439999999999998 112.478 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.12 -82.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 75.420000000000002 111.104 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.417 ' CB ' ' HA ' ' A' ' 13' ' ' ASP . . . -75.78 125.93 30.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 73.230000000000004 111.072 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.47 74.52 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 71.150000000000006 111.071 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.745 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -165.38 -131.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 74.129999999999995 110.912 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.606 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -167.99 172.24 42.63 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 62.130000000000003 112.539 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 57' ' ' GLU . 6.0 p -130.07 120.16 48.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 72.319999999999993 111.129 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.705 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -98.36 142.3 30.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 75.439999999999998 110.919 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.655 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 10.9 t -152.03 114.15 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 71.129999999999995 111.121 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.74 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.6 m -169.45 -133.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.329999999999998 111.141 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.518 ' H ' ' CG2' ' A' ' 74' ' ' THR . 0.1 OUTLIER -104.62 144.77 29.39 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.636 0.731 . . . . 74.310000000000002 110.841 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.439 ' HD3' HG23 ' A' ' 50' ' ' VAL . 53.8 Cg_endo -69.75 13.84 0.28 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.712 2.275 . . . . 74.340000000000003 112.341 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 75' ' ' ARG . 20.2 m-20 -93.94 35.49 1.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 74.129999999999995 110.855 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.36 -13.2 41.47 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.683 -0.77 . . . . 71.109999999999999 112.509 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.74 ' O ' ' HB ' ' A' ' 74' ' ' THR . 37.6 p -95.28 119.7 34.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.749 0.309 . . . . 71.140000000000001 111.163 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.617 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -141.61 161.13 38.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.869 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 97.3 t -119.0 81.5 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.140000000000001 111.092 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 72' ' ' LEU . 15.2 pt-20 -77.68 116.73 18.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.450000000000003 110.864 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.729 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 0.8 OUTLIER -94.99 144.72 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 71.310000000000002 111.103 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 93' ' ' ASP . 2.5 t-160 -83.82 108.85 17.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 63.450000000000003 110.872 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.939 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 1.3 pp -124.98 110.26 13.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 75.299999999999997 110.919 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.585 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 3.9 m-20 -127.02 106.68 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 74.140000000000001 110.885 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.428 ' HA ' HG22 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -63.09 -0.34 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 110.892 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 86' ' ' ASP . 51.2 t0 -69.59 -13.15 62.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 73.040000000000006 110.876 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -165.66 -93.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 74.129999999999995 110.857 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.06 33.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 74.129999999999995 110.865 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.939 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 2.4 t -72.51 95.93 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 75.329999999999998 111.109 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -127.68 18.82 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 73.340000000000003 110.922 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 84' ' ' HIS . 9.0 t0 -75.99 128.78 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 73.439999999999998 110.895 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.729 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 7.0 t -79.23 155.8 28.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 73.030000000000001 111.119 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.95 153.1 53.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.666 0.746 . . . . 73.329999999999998 110.872 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 140.37 42.61 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.66 2.24 . . . . 61.109999999999999 112.35 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.42 111.06 17.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 74.430000000000007 111.103 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -96.28 4.26 52.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 73.319999999999993 110.911 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.78 -21.98 7.12 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.738 . . . . 61.420000000000002 112.497 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.34 -31.24 12.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.779 0.323 . . . . 73.549999999999997 110.835 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.16 26.07 58.44 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.773 -0.727 . . . . 62.039999999999999 112.442 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.769 -0.729 . . . . 63.450000000000003 112.489 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.815 0.34 . . . . 74.430000000000007 110.878 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -65.88 -37.09 85.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 110.922 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.411 ' CB ' ' HB2' ' A' ' 85' ' ' LEU . 11.8 p-10 -65.54 -149.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 74.510000000000005 110.846 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.43 127.92 88.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.672 0.748 . . . . 74.319999999999993 111.12 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -1.52 8.6 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.638 2.225 . . . . 74.439999999999998 112.364 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.79 38.54 3.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 71.150000000000006 111.094 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -73.07 -168.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 65.109999999999999 111.159 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -72.78 -100.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 70.310000000000002 110.925 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -98.73 8.29 45.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 72.319999999999993 110.894 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.664 ' CD2' ' HB3' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -72.21 -9.43 58.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 64.219999999999999 110.921 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -89.99 -8.81 50.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 74.209999999999994 110.964 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -74.39 -58.65 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 75.299999999999997 110.879 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -66.13 -42.66 88.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 74.230000000000004 110.874 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.71 -31.49 2.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.728 -0.748 . . . . 71.319999999999993 112.484 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.7 -72.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.318 . . . . 73.340000000000003 111.077 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.6 ptm -70.6 -7.1 41.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.099999999999994 110.904 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.427 ' HA ' ' HG3' ' A' ' 31' ' ' GLU . . . -65.53 -47.19 76.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 55.32 111.057 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -81.86 6.1 16.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 75.450000000000003 110.879 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -72.04 -68.59 0.45 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 110.857 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.89 8.98 2.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.776 -0.726 . . . . 72.409999999999997 112.532 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.427 ' HG3' ' HA ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -79.37 177.67 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 74.010000000000005 110.904 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.09 -168.8 2.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 75.209999999999994 110.874 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -109.54 119.88 40.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 73.010000000000005 110.909 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.498 ' CG1' ' H ' ' A' ' 35' ' ' THR . 2.2 t -73.12 -136.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 75.299999999999997 111.131 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.504 ' OG1' ' HD2' ' A' ' 37' ' ' PRO . 71.5 p -136.72 -47.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 73.010000000000005 111.158 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 163.0 -61.18 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 75.409999999999997 112.493 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.5 Cg_endo -69.7 159.18 54.39 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.747 2.298 . . . . 74.430000000000007 112.318 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 2.1 p30 -64.88 -26.04 68.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 75.140000000000001 110.852 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.03 -39.14 74.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 74.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -86.06 -39.85 16.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.340000000000003 110.882 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 6.8 ptt180 -68.05 -38.81 82.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 74.319999999999993 110.868 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.601 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -68.3 -35.29 77.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.530000000000001 111.071 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.03 -40.53 21.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 75.450000000000003 110.898 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 48' ' ' GLN . . . -77.48 -59.84 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 72.219999999999999 111.101 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.534 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -52.76 -20.22 3.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 111.091 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.65 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -63.63 -78.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 111.092 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.723 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.6 t -108.44 -17.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 73.109999999999999 111.179 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -74.41 -29.79 61.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.120000000000005 110.905 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 1.047 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.94 -2.82 19.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 70.200000000000003 111.132 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.999 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -95.7 -2.9 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.612 0.72 . . . . 75.019999999999996 111.143 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.047 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.9 Cg_endo -69.77 -27.66 26.13 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.666 2.244 . . . . 74.0 112.343 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.11 -57.15 2.87 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.78 -0.724 . . . . 65.239999999999995 112.502 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.07 -34.76 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 71.019999999999996 112.504 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.675 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -146.41 152.1 38.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 64.430000000000007 111.151 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.39 77.01 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 111.116 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.703 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -148.53 105.68 0.31 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 75.349999999999994 112.487 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.509 ' H ' HD23 ' A' ' 72' ' ' LEU . 3.2 tt0 -95.78 -171.95 2.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.907 0.384 . . . . 74.540000000000006 110.896 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.8 t -136.86 131.43 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 74.530000000000001 111.126 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -99.1 121.78 41.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 73.040000000000006 110.852 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 t -110.35 119.19 38.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 71.420000000000002 111.137 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -143.47 121.92 12.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 110.908 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.74 148.8 24.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 74.400000000000006 111.159 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.13 -106.71 0.99 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.781 -0.723 . . . . 53.240000000000002 112.529 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -87.91 -25.7 23.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 74.019999999999996 110.936 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.33 -121.56 2.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 60.0 112.465 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.32 33.87 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.768 0.318 . . . . 73.319999999999993 111.112 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.464 ' HA ' ' H ' ' A' ' 87' ' ' ARG . . . -63.71 -155.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 72.040000000000006 111.122 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.567 ' O ' ' O ' ' A' ' 61' ' ' GLU . . . -157.06 -104.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 71.109999999999999 111.111 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.564 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 2.9 t80 -170.29 -85.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.902 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.611 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -168.53 157.04 28.96 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 64.519999999999996 112.494 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.8 t -123.45 120.8 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.838 0.351 . . . . 73.530000000000001 111.093 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.672 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -106.17 134.19 49.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 73.230000000000004 110.93 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.703 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.2 p -147.67 118.61 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 72.129999999999995 111.12 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.744 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.7 m -169.19 -133.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 111.141 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.504 ' H ' ' CG2' ' A' ' 74' ' ' THR . 3.6 mtt-85 -101.53 148.4 35.18 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.636 0.732 . . . . 74.019999999999996 110.831 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.447 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.4 Cg_endo -69.84 9.41 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.652 2.234 . . . . 75.230000000000004 112.342 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 75' ' ' ARG . 40.6 m-20 -88.38 38.67 0.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 75.140000000000001 110.87 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.11 -7.05 8.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 64.200000000000003 112.428 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.744 ' O ' ' HB ' ' A' ' 74' ' ' THR . 31.1 p -98.85 115.42 28.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.793 0.33 . . . . 74.400000000000006 111.175 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.616 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -138.62 160.59 39.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 72.319999999999993 110.861 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 61.6 t -113.88 87.02 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 54.399999999999999 111.132 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -81.04 121.37 25.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.200000000000003 110.908 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.611 ' O ' ' CA ' ' A' ' 70' ' ' GLY . 1.8 t -97.55 160.57 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 111.137 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.3 OUTLIER -104.55 109.14 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 74.319999999999993 110.873 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.735 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -128.72 111.14 12.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 74.409999999999997 110.925 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.616 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 21.1 m-20 -136.51 108.66 7.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 64.519999999999996 110.846 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.464 ' H ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -66.36 0.61 2.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.540000000000006 110.903 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 89' ' ' PHE . 51.6 t0 -69.88 -11.88 61.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 73.420000000000002 110.852 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -166.54 -93.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 72.450000000000003 110.903 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 35.53 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 74.230000000000004 110.86 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.735 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 9.2 t -69.47 100.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 72.109999999999999 111.145 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -135.04 16.89 3.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 72.140000000000001 110.932 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 84' ' ' HIS . 14.6 t0 -80.75 147.65 30.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 63.219999999999999 110.881 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.425 ' HA ' HG12 ' A' ' 83' ' ' VAL . 15.3 t -90.38 165.0 14.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 74.400000000000006 111.11 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -146.45 122.61 5.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 71.129999999999995 110.915 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 128.91 16.73 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.684 2.256 . . . . 73.150000000000006 112.364 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.82 114.09 23.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 74.230000000000004 111.116 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 100' ' ' ASP . 4.8 t0 -124.9 46.4 2.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 73.030000000000001 110.898 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 -17.34 1.69 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 63.450000000000003 112.509 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 98' ' ' ASP . 0.4 OUTLIER -95.93 -65.39 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 74.319999999999993 110.88 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.64 21.67 12.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 75.439999999999998 112.467 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 74.140000000000001 112.486 -179.926 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.819 0.342 . . . . 74.540000000000006 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -74.1 -25.19 59.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 72.239999999999995 110.917 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -64.12 -151.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 75.140000000000001 110.886 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.456 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -102.3 166.88 11.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 65.010000000000005 111.086 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HD2' ' CB ' ' A' ' 14' ' ' ILE . 54.0 Cg_endo -69.76 -2.52 10.31 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 74.129999999999995 112.361 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.1 p -141.83 94.2 2.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 74.129999999999995 111.168 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.525 ' CG2' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -118.83 -167.25 1.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 75.010000000000005 111.141 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -110.36 -94.29 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 75.400000000000006 110.883 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -57.0 -17.9 11.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.937 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.455 ' CD1' ' HG ' ' A' ' 85' ' ' LEU . 2.4 mp -84.11 -19.51 34.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 71.239999999999995 110.88 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -66.23 -17.71 64.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 110.941 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.17 -22.58 15.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 74.0 110.891 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -66.72 -29.82 69.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 73.439999999999998 110.936 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.4 -29.7 1.83 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.733 -0.746 . . . . 73.200000000000003 112.503 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.403 ' O ' ' CD2' ' A' ' 28' ' ' PHE . . . -73.57 -64.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 73.019999999999996 111.105 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -7.02 8.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 70.329999999999998 110.872 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.79 25.3 10.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 74.439999999999998 111.072 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -73.54 2.3 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 71.349999999999994 110.862 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 t70 179.92 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 64.129999999999995 110.873 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.31 -2.48 48.79 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 74.219999999999999 112.473 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -94.4 105.05 17.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 71.450000000000003 110.913 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.409 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 3.9 m-20 -119.34 -152.29 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 73.120000000000005 110.855 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -118.63 109.57 16.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 74.209999999999994 110.84 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.632 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 21.3 t -81.03 -119.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 72.230000000000004 111.137 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.511 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 68.5 p -141.8 -77.85 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 63.299999999999997 111.123 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.436 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -171.73 -61.1 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.762 -0.732 . . . . 73.340000000000003 112.51 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.8 Cg_endo -69.77 158.96 55.15 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.692 2.262 . . . . 65.439999999999998 112.35 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.47 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -66.56 -32.44 73.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 74.239999999999995 110.861 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.66 -30.78 14.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 51.310000000000002 111.096 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.42 -31.85 26.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 73.099999999999994 110.859 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.47 ' HD3' ' CA ' ' A' ' 38' ' ' ASP . 9.0 ptt-85 -57.71 -36.69 72.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 75.400000000000006 110.852 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -71.25 -33.02 69.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 61.409999999999997 111.11 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.457 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 2.2 ptt85 -77.71 -38.73 46.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 75.230000000000004 110.898 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -79.74 -59.15 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 72.340000000000003 111.136 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.47 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -57.63 -18.29 19.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 62.310000000000002 111.104 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.577 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -59.45 -81.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 73.510000000000005 111.077 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.773 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 59.7 t -114.99 -15.96 9.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 111.117 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.2 mt-30 -73.78 -31.96 63.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 74.540000000000006 110.893 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 1.021 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.88 -1.58 20.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.439 . . . . 73.219999999999999 111.144 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.989 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.34 -5.48 0.11 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.602 0.715 . . . . 74.349999999999994 111.141 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.021 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.4 Cg_endo -69.73 -29.32 24.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.281 . . . . 74.329999999999998 112.319 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.44 -54.04 5.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.72 -0.752 . . . . 62.109999999999999 112.442 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.49 -33.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.725 -0.75 . . . . 71.409999999999997 112.458 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.587 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -145.92 156.0 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 74.549999999999997 111.141 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.43 ' CB ' HG21 ' A' ' 50' ' ' VAL . . . -71.28 76.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 72.150000000000006 111.084 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.741 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -145.99 107.26 0.41 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.744 -0.741 . . . . 72.140000000000001 112.517 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.472 ' HG2' ' HB1' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -98.1 -169.27 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.353 . . . . 73.209999999999994 110.909 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 53.4 t -141.56 110.93 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 74.409999999999997 111.092 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.761 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 5.0 mt-10 -94.96 162.87 13.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 63.229999999999997 110.906 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.598 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -126.26 119.56 27.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 71.120000000000005 111.162 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 159.51 37.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 75.340000000000003 110.914 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.0 p -125.1 100.52 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 72.450000000000003 111.126 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.83 -141.54 8.76 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 61.399999999999999 112.487 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -88.05 0.53 55.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.857 0.361 . . . . 73.439999999999998 110.874 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -102.75 -121.71 4.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 53.32 112.517 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.82 -77.07 0.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.743 0.306 . . . . 64.200000000000003 111.062 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -111.21 86.65 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 71.299999999999997 111.065 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.67 85.47 3.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 72.430000000000007 111.1 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.761 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 0.5 OUTLIER -115.55 158.72 22.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 74.510000000000005 110.873 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.637 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -124.94 127.69 6.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 73.310000000000002 112.481 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 0.2 OUTLIER -109.26 123.42 65.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 74.109999999999999 111.146 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.741 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -84.61 142.92 29.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 75.150000000000006 110.895 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.5 t -151.21 95.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 73.209999999999994 111.082 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.743 ' HB ' ' O ' ' A' ' 79' ' ' THR . 1.3 m -168.27 -149.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 111.16 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.559 ' H ' ' CG2' ' A' ' 74' ' ' THR . 7.7 mtm180 -103.94 151.92 38.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.614 0.721 . . . . 75.219999999999999 110.853 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 78' ' ' GLY . 53.8 Cg_endo -69.79 7.56 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.686 2.258 . . . . 61.109999999999999 112.368 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 75' ' ' ARG . 3.6 m-20 -76.49 19.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 75.319999999999993 110.877 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 76' ' ' PRO . . . 94.71 -14.09 65.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 53.32 112.484 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.743 ' O ' ' HB ' ' A' ' 74' ' ' THR . 3.0 t -98.05 125.37 43.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.778 0.323 . . . . 73.209999999999994 111.144 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.598 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -136.56 159.81 40.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 75.540000000000006 110.894 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 42.8 t -118.11 92.67 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 74.209999999999994 111.129 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 95' ' ' GLU . 87.3 tt0 -82.77 119.83 24.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 74.010000000000005 110.874 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.637 ' O ' ' HA2' ' A' ' 70' ' ' GLY . 2.0 t -100.01 111.61 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 111.159 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.461 ' O ' HD22 ' A' ' 85' ' ' LEU . 3.9 t-160 -86.68 110.53 19.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 64.129999999999995 110.857 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.641 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 3.0 mm? -127.6 127.96 44.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 74.150000000000006 110.923 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.76 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 13.3 t0 -135.45 132.68 37.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 63.420000000000002 110.869 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -57.99 2.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 75.530000000000001 110.885 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.599 ' H ' ' C ' ' A' ' 86' ' ' ASP . 4.7 t0 -66.78 -4.69 9.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 73.120000000000005 110.876 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 68.23 12.18 8.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 74.340000000000003 110.883 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -135.54 -1.23 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 75.450000000000003 110.851 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.76 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 96.8 t -116.67 92.91 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 63.329999999999998 111.151 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.553 ' HA ' ' CD1' ' A' ' 85' ' ' LEU . 5.3 mp -144.41 14.52 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 73.430000000000007 110.879 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.06 137.14 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.883 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -96.47 130.01 43.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 111.167 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLU . 71.4 tt0 -99.94 127.16 34.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.615 0.721 . . . . 73.219999999999999 110.933 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 114.63 3.77 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.675 2.25 . . . . 73.430000000000007 112.333 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.499 ' CB ' ' HB2' ' A' ' 80' ' ' ARG . . . -64.53 114.33 4.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 73.140000000000001 111.11 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -87.08 15.09 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 65.430000000000007 110.899 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.65 -21.51 2.46 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.763 . . . . 73.439999999999998 112.482 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 98' ' ' ASP . 5.4 m-20 -97.55 -38.44 9.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.835 0.35 . . . . 74.030000000000001 110.869 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.85 47.0 5.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 62.340000000000003 112.482 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 74.219999999999999 112.464 -179.937 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 75.340000000000003 110.867 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -68.93 -44.22 73.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.120000000000005 110.905 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.33 -147.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 70.310000000000002 110.857 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.433 ' CG2' ' H ' ' A' ' 16' ' ' THR . 26.3 mm -75.76 119.15 75.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.596 0.713 . . . . 74.439999999999998 111.138 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 4.06 2.38 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.74 2.293 . . . . 74.409999999999997 112.32 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.433 ' H ' ' CG2' ' A' ' 14' ' ' ILE . 2.8 m -115.03 20.95 14.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 63.409999999999997 111.193 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.48 HG22 ' CD2' ' A' ' 92' ' ' LEU . 1.2 p -81.36 -165.15 0.88 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 62.210000000000001 111.142 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 20' ' ' LEU . 1.1 mm-40 -71.89 -131.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.242 -0.435 . . . . 72.219999999999999 110.883 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.41 12.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 110.916 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.583 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 7.5 mp -57.42 -27.54 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 72.400000000000006 110.895 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -95.96 7.04 47.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.913 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -110.55 -42.72 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 72.219999999999999 110.861 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -65.11 -51.8 59.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 75.439999999999998 110.922 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.76 -54.55 6.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 72.349999999999994 112.528 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.96 52.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.768 0.318 . . . . 73.030000000000001 111.119 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.4 ptm -66.98 -39.8 87.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 75.439999999999998 110.911 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HB1' ' CD1' ' A' ' 28' ' ' PHE . . . -120.77 -92.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 71.430000000000007 111.095 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.403 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 6.2 p90 -145.0 -27.17 0.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 110.855 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.68 28.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 73.430000000000007 110.848 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.16 9.62 25.18 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.729 -0.748 . . . . 63.520000000000003 112.519 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -93.61 98.46 11.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 74.420000000000002 110.909 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.84 -162.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 73.409999999999997 110.835 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -129.15 102.2 6.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 74.329999999999998 110.9 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 1.0 OUTLIER -72.7 159.0 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 71.230000000000004 111.124 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.513 ' N ' ' CG1' ' A' ' 34' ' ' VAL . 70.0 p -91.36 -38.07 12.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 71.109999999999999 111.143 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.47 -64.44 0.21 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.737 . . . . 63.420000000000002 112.476 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 160.4 49.83 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 75.549999999999997 112.338 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 2.2 p-10 -60.62 -29.18 69.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 75.349999999999994 110.866 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.04 -30.92 49.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 73.040000000000006 111.063 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.24 -35.04 28.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 73.230000000000004 110.896 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -71.74 -41.09 68.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 70.540000000000006 110.822 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.526 ' HA ' ' CD ' ' A' ' 80' ' ' ARG . . . -70.97 -35.05 71.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 72.150000000000006 111.072 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.7 ptt85 -80.57 -39.5 27.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 71.530000000000001 110.885 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.631 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -75.81 -60.38 2.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 62.130000000000003 111.064 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.612 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -56.47 -16.94 6.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 75.019999999999996 111.082 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.63 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -62.51 -67.42 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 74.549999999999997 111.112 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.686 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.7 t -122.31 -14.79 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 72.319999999999993 111.118 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.631 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 50.5 mt-30 -79.69 -41.46 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.230000000000004 110.906 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.908 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -104.71 -0.23 27.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 71.310000000000002 111.089 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.955 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -93.72 -11.68 0.17 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 74.0 111.089 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.955 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 54.2 Cg_endo -69.76 -28.04 25.75 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.681 2.254 . . . . 72.120000000000005 112.372 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.26 -44.14 44.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 73.299999999999997 112.475 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.36 -31.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 70.420000000000002 112.475 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.543 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -149.92 157.24 42.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.824 0.345 . . . . 73.219999999999999 111.139 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.452 ' CB ' HG23 ' A' ' 50' ' ' VAL . . . -71.0 75.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 52.25 111.111 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.662 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -146.58 111.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 72.439999999999998 112.456 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -103.93 -170.69 1.81 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 70.420000000000002 110.869 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.445 ' N ' ' HG2' ' A' ' 57' ' ' GLU . 3.3 t -131.21 120.77 47.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 75.530000000000001 111.14 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.556 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -93.38 126.07 38.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.540000000000006 110.872 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.8 t -107.99 105.31 15.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 72.439999999999998 111.148 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.36 158.19 45.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 73.319999999999993 110.903 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.6 p -125.13 113.77 18.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 74.329999999999998 111.143 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -92.46 -179.37 40.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.74 . . . . 73.420000000000002 112.491 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.63 -14.38 62.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 63.229999999999997 110.852 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -86.35 -111.18 0.83 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 55.130000000000003 112.458 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.99 -77.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.772 0.32 . . . . 72.310000000000002 111.1 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -108.67 158.21 17.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 60.409999999999997 111.103 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.94 49.78 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 64.010000000000005 111.107 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.493 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -120.35 129.32 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 75.310000000000002 110.979 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -112.05 159.03 13.94 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 34.229999999999997 112.516 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.5 p -124.25 113.23 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 74.319999999999993 111.146 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.662 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 2.3 tt -91.1 145.14 24.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 73.409999999999997 110.929 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.549 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 14.6 t -158.57 112.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 71.439999999999998 111.159 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.822 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -174.89 -148.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 74.439999999999998 111.119 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.449 ' C ' ' H ' ' A' ' 77' ' ' ASP . 9.9 mmm180 -106.0 143.86 27.75 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.59 0.71 . . . . 75.439999999999998 110.85 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.413 ' HD3' ' HB1' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.83 11.46 0.4 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.716 2.277 . . . . 72.329999999999998 112.301 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' A' ' 75' ' ' ARG . 9.0 m-20 -86.16 32.36 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 75.340000000000003 110.905 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.48 -14.58 34.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 60.310000000000002 112.495 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.486 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.4 t -99.81 106.17 18.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.786 0.327 . . . . 74.329999999999998 111.149 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.822 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -135.58 154.97 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 74.430000000000007 110.877 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.56 ' N ' ' OG1' ' A' ' 74' ' ' THR . 47.9 t -114.19 100.37 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.349999999999994 111.1 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.435 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 9.2 pt-20 -85.61 109.19 18.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 71.420000000000002 110.866 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.571 ' O ' HD21 ' A' ' 85' ' ' LEU . 2.1 t -99.62 107.84 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 111.136 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.536 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 5.4 m-70 -84.3 121.17 27.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.239999999999995 110.855 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.683 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -106.98 105.57 15.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 75.129999999999995 110.913 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.685 ' N ' ' HA ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -128.65 115.34 17.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 70.109999999999999 110.888 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -61.45 -7.8 3.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 71.209999999999994 110.85 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.71 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 24.5 t70 -83.72 32.81 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 72.209999999999994 110.839 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.71 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 18.8 m-85 97.68 -30.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 74.109999999999999 110.853 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.46 35.36 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 75.519999999999996 110.808 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.685 ' HA ' ' N ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -59.69 -28.0 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 73.430000000000007 111.115 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.48 ' CD2' HG22 ' A' ' 17' ' ' THR . 1.9 mt -122.43 29.57 6.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 74.019999999999996 110.893 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 84' ' ' HIS . 33.0 t70 -71.34 66.58 0.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.030000000000001 110.918 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.402 ' HB ' ' CG1' ' A' ' 83' ' ' VAL . 10.2 t -84.86 151.41 24.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 111.118 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -146.06 157.78 49.53 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.654 0.74 . . . . 74.430000000000007 110.861 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 131.92 22.19 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.633 2.222 . . . . 75.140000000000001 112.317 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -112.59 103.19 11.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 65.230000000000004 111.111 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.21 11.28 38.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 72.140000000000001 110.911 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.44 -19.32 28.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 54.140000000000001 112.495 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -95.67 -41.99 8.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 71.409999999999997 110.907 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.85 28.69 45.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 53.43 112.484 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.757 -0.735 . . . . 41.229999999999997 112.528 -179.94 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.804 0.335 . . . . 74.409999999999997 110.825 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.434 ' CE1' ' HB3' ' A' ' 33' ' ' GLU . 82.8 m-85 -65.43 -54.31 30.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 74.450000000000003 110.92 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.02 -158.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 71.120000000000005 110.878 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.2 mp -74.42 121.64 85.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.591 0.71 . . . . 73.409999999999997 111.13 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -5.47 16.26 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.689 2.259 . . . . 74.299999999999997 112.341 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 p -145.44 88.3 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.230000000000004 111.16 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.452 ' HB ' HD11 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -132.55 -159.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 74.120000000000005 111.149 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.08 -94.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 52.32 110.927 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -87.88 11.18 16.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 74.109999999999999 110.887 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.46 HD11 ' HG ' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -93.55 -34.72 13.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 73.5 110.922 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -67.45 -11.54 58.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 75.420000000000002 110.892 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -93.94 -59.76 1.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 71.019999999999996 110.842 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -66.32 -41.36 89.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 74.239999999999995 110.927 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.35 -34.89 1.72 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.717 -0.754 . . . . 64.25 112.44 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.9 -60.6 3.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.77 0.319 . . . . 74.329999999999998 111.061 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.5 ptp -69.79 -9.52 54.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 73.230000000000004 110.878 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.85 -19.67 57.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.109999999999999 111.056 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -82.03 8.94 9.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 73.530000000000001 110.896 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -70.7 -80.85 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 71.099999999999994 110.866 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.05 11.4 0.19 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 71.420000000000002 112.493 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.52 176.94 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 73.030000000000001 110.894 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.22 -164.12 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 74.239999999999995 110.86 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.434 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 1.5 pt-20 -111.0 166.58 10.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 73.230000000000004 110.883 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.497 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -100.03 167.8 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.485 . . . . 71.109999999999999 111.078 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.419 ' OG1' ' HD2' ' A' ' 37' ' ' PRO . 44.3 p -94.79 -42.08 8.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.148 -0.478 . . . . 71.230000000000004 111.188 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.89 -64.65 0.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.736 . . . . 64.120000000000005 112.501 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.8 Cg_endo -69.74 157.26 61.04 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.684 2.256 . . . . 74.409999999999997 112.333 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -59.79 -28.95 67.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 74.400000000000006 110.908 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.11 -33.51 57.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.010000000000005 111.137 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -84.1 -32.07 24.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 71.209999999999994 110.905 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HB2' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -69.45 -44.84 70.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 74.549999999999997 110.832 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.48 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . . . -71.77 -34.72 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 72.010000000000005 111.061 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 21.3 ptt85 -76.37 -39.84 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 73.439999999999998 110.863 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.564 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -75.44 -59.76 2.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 73.420000000000002 111.118 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -58.03 -13.55 4.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 72.129999999999995 111.089 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.555 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -71.28 -71.96 0.24 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 64.129999999999995 111.15 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.714 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.3 t -113.56 -9.34 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 74.319999999999993 111.147 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -83.0 -39.92 20.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.430000000000007 110.921 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.716 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -102.41 -5.87 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 71.209999999999994 111.067 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.94 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -81.13 -25.51 0.41 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.64 0.733 . . . . 74.140000000000001 111.129 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.94 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 53.9 Cg_endo -69.72 -10.19 27.97 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.69 2.26 . . . . 74.209999999999994 112.342 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.6 -27.34 15.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.74 . . . . 53.130000000000003 112.498 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.81 -32.54 0.3 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.737 . . . . 73.409999999999997 112.535 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.586 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -155.15 164.7 38.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 63.399999999999999 111.113 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.457 ' HA ' HG22 ' A' ' 50' ' ' VAL . . . -75.17 65.96 1.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 64.049999999999997 111.114 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.712 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -141.13 105.85 0.45 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 64.200000000000003 112.514 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -162.06 0.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 72.340000000000003 110.931 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 29.4 t -129.31 119.36 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 75.430000000000007 111.14 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.797 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 1.6 mt-10 -93.34 136.01 34.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 73.510000000000005 110.857 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.5 t -138.44 115.62 11.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 74.530000000000001 111.168 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.486 ' H ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -122.31 178.3 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 110.865 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.77 128.87 49.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 111.109 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.49 -144.77 5.87 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.768 -0.729 . . . . 35.329999999999998 112.517 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -87.25 -21.32 25.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.887 0.375 . . . . 75.230000000000004 110.889 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.67 -109.93 3.01 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.737 . . . . 73.439999999999998 112.516 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.47 -81.48 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.326 . . . . 54.32 111.113 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -78.08 128.04 33.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 64.049999999999997 111.105 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.69 45.71 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 73.329999999999998 111.067 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.797 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -170.86 -152.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 74.540000000000006 110.928 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 83' ' ' VAL . . . -158.8 -126.84 0.88 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 63.310000000000002 112.488 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 4.5 m -152.67 151.95 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.373 . . . . 73.200000000000003 111.131 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.712 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -104.81 152.41 22.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 75.450000000000003 110.923 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.532 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 2.1 p -155.17 106.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 75.420000000000002 111.119 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.834 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -172.32 -142.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 111.158 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.425 ' C ' ' H ' ' A' ' 77' ' ' ASP . 3.6 mtm180 -110.13 149.18 39.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.599 0.714 . . . . 72.239999999999995 110.887 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.437 ' HD3' ' HB3' ' A' ' 55' ' ' ALA . 53.4 Cg_endo -69.77 8.36 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.694 2.263 . . . . 74.319999999999993 112.361 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -82.16 33.09 0.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 71.239999999999995 110.914 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.73 -11.45 10.4 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.753 -0.737 . . . . 70.340000000000003 112.456 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.464 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.2 t -101.61 105.21 16.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.318 . . . . 75.310000000000002 111.168 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.834 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 2.4 ptp85 -138.64 157.48 46.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.209999999999994 110.856 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 18.0 m -114.03 96.65 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 74.129999999999995 111.098 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.438 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . 1.3 pp20? -87.24 125.07 33.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 70.019999999999996 110.902 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.557 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 4.5 t -91.52 139.89 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 75.409999999999997 111.141 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.577 ' O ' ' CG1' ' A' ' 91' ' ' VAL . 12.7 t-160 -117.9 106.04 12.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 110.833 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.488 ' HA ' ' CG1' ' A' ' 91' ' ' VAL . 2.7 mt -131.6 139.12 49.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 75.219999999999999 110.893 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.611 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -103.68 111.77 24.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 73.140000000000001 110.84 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.458 ' C ' ' H ' ' A' ' 89' ' ' PHE . 1.3 tmt_? -50.07 -21.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 75.340000000000003 110.851 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.472 ' HB3' ' OD1' ' A' ' 86' ' ' ASP . 4.7 t0 -68.28 5.36 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 65.420000000000002 110.879 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.458 ' H ' ' C ' ' A' ' 87' ' ' ARG . 37.5 m-85 67.08 42.51 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 110.898 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.43 ' HD2' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -129.09 -29.76 2.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 73.349999999999994 110.848 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' A' ' 86' ' ' ASP . 54.2 t -125.0 125.82 70.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 74.349999999999994 111.133 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.41 ' CA ' HD23 ' A' ' 85' ' ' LEU . 1.9 mp -145.27 17.27 1.53 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 72.109999999999999 110.891 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 84' ' ' HIS . 21.1 t0 -101.35 143.97 30.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 72.030000000000001 110.867 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 13.9 t -84.83 176.3 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 73.540000000000006 111.133 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 82' ' ' GLU . 3.7 tt0 -145.72 128.89 8.27 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.604 0.716 . . . . 72.310000000000002 110.897 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 115.17 3.96 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 63.32 112.392 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.41 ' HB3' ' HG3' ' A' ' 80' ' ' ARG . . . -94.58 115.73 27.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 72.230000000000004 111.069 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -102.19 15.13 30.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 73.030000000000001 110.891 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.63 -19.46 9.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.745 -0.74 . . . . 74.450000000000003 112.514 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -96.11 -42.69 8.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 60.109999999999999 110.834 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.07 26.68 54.97 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.728 -0.748 . . . . 75.140000000000001 112.465 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.712 -0.756 . . . . 74.420000000000002 112.535 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.826 0.346 . . . . 70.409999999999997 110.856 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.413 ' CG ' HG23 ' A' ' 17' ' ' THR . 4.5 p90 -94.43 -175.44 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 75.340000000000003 110.907 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -119.4 -31.56 4.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.519 . . . . 75.25 110.852 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.511 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.8 OUTLIER -101.07 127.57 31.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.607 0.718 . . . . 74.239999999999995 111.129 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 18.73 0.19 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.747 2.298 . . . . 62.340000000000003 112.305 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.511 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -138.95 39.76 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 74.310000000000002 111.12 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.524 ' HB ' HD23 ' A' ' 20' ' ' LEU . 65.0 p -72.73 -166.5 0.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 75.200000000000003 111.161 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -132.79 -86.7 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 74.340000000000003 110.901 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -75.08 6.64 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 74.510000000000005 110.911 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.524 HD23 ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -92.59 -37.85 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 74.299999999999997 110.904 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -75.17 -7.49 53.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 73.219999999999999 110.969 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -94.43 -26.31 16.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 74.319999999999993 110.886 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -30.03 29.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 72.430000000000007 110.896 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.9 -30.7 1.04 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.746 -0.74 . . . . 60.009999999999998 112.486 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.56 -56.88 4.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 72.120000000000005 111.112 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.6 ptp -65.15 -11.77 43.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 74.099999999999994 110.866 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.5 26.11 7.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.450000000000003 111.104 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.416 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 7.4 p90 -63.15 -16.65 60.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 72.030000000000001 110.857 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -147.6 -44.97 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 110.881 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.97 -18.21 25.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.724 . . . . 64.409999999999997 112.46 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -64.7 92.12 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.883 0.373 . . . . 74.319999999999993 110.868 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.412 ' HB3' ' CD ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -103.22 -161.04 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 110.882 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -122.63 114.01 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 110.911 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.619 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 11.4 t -90.7 172.34 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 61.240000000000002 111.112 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.49 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 34.3 p -89.73 -54.1 4.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 74.329999999999998 111.178 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.73 -64.89 0.11 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.721 -0.752 . . . . 74.409999999999997 112.51 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.9 Cg_endo -69.74 159.04 54.9 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.693 2.262 . . . . 75.430000000000007 112.375 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -60.65 -29.0 68.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 74.010000000000005 110.882 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.37 -35.66 63.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 70.120000000000005 111.077 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.519 ' HA ' ' CG ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -85.45 -28.59 24.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 71.439999999999998 110.846 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.465 ' HD3' ' HA ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -73.99 -42.61 60.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 75.450000000000003 110.894 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.464 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . . . -70.43 -33.71 71.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 111.058 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.519 ' CG ' ' HA ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -79.72 -42.56 24.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 74.299999999999997 110.843 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -75.22 -61.61 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 72.109999999999999 111.097 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.627 ' CB ' ' HB2' ' A' ' 57' ' ' GLU . . . -51.08 -23.76 3.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 62.229999999999997 111.107 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.62 ' O ' ' CG2' ' A' ' 50' ' ' VAL . . . -51.93 -67.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 72.519999999999996 111.142 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.645 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 25.3 t -111.18 -22.0 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 111.119 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 45.2 mt-30 -73.98 -29.21 61.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 61.310000000000002 110.911 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 1.089 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.42 -6.95 15.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.340000000000003 111.134 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 14.3 t -95.66 1.92 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.713 . . . . 74.209999999999994 111.108 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 1.089 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.0 Cg_endo -69.71 -20.35 35.16 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.265 . . . . 75.030000000000001 112.373 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.72 -40.54 3.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.731 . . . . 64.140000000000001 112.52 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.96 -32.8 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.738 -0.744 . . . . 64.430000000000007 112.471 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.957 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -147.3 163.31 36.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 74.409999999999997 111.15 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.759 ' O ' ' HA ' ' A' ' 73' ' ' VAL . . . -76.81 69.06 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 61.229999999999997 111.08 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.815 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -111.22 82.27 0.3 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.721 -0.752 . . . . 70.230000000000004 112.488 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.627 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -88.98 175.92 7.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 74.219999999999999 110.91 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.472 ' O ' HG22 ' A' ' 34' ' ' VAL . 62.7 t -131.17 123.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.549999999999997 111.107 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.619 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 8.0 mt-10 -92.08 129.1 38.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.924 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -100.48 104.46 15.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 71.230000000000004 111.154 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.56 160.68 39.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 72.510000000000005 110.887 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -131.37 112.63 12.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 71.200000000000003 111.129 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.73 -178.53 43.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 75.310000000000002 112.487 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -65.13 -24.03 67.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.856 0.36 . . . . 75.540000000000006 110.855 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.72 -112.51 0.14 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.715 -0.755 . . . . 73.230000000000004 112.427 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 87' ' ' ARG . . . -111.7 -82.65 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.321 . . . . 63.450000000000003 111.102 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.85 161.53 14.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 75.010000000000005 111.074 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.78 72.6 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 72.420000000000002 111.138 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 4.7 m-85 -115.79 125.12 52.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.968 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -105.93 110.21 3.34 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.695 -0.764 . . . . 65.340000000000003 112.457 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.4 t -102.45 113.95 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 74.200000000000003 111.128 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.815 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -105.72 131.72 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 74.420000000000002 110.94 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.759 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.3 p -139.1 119.41 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 70.230000000000004 111.138 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.808 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 2.3 m -170.11 -133.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 64.329999999999998 111.165 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.477 ' H ' ' CG2' ' A' ' 74' ' ' THR . 9.5 mtm180 -105.84 143.55 27.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 75.349999999999994 110.876 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 13.08 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.663 2.242 . . . . 72.120000000000005 112.361 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 75' ' ' ARG . 5.7 m-20 -88.79 24.6 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 73.540000000000006 110.9 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.21 -13.69 53.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.769 -0.729 . . . . 74.140000000000001 112.465 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.486 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.0 p -98.54 108.34 21.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.825 0.345 . . . . 73.400000000000006 111.155 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.808 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 2.2 ptp85 -140.09 163.07 33.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 74.409999999999997 110.895 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 60.1 t -120.58 105.0 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 74.200000000000003 111.177 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' ' HB ' ' A' ' 94' ' ' THR . 34.4 tt0 -82.62 142.84 31.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 72.5 110.938 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.595 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 12.1 m -118.37 118.24 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 111.123 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.654 ' N ' ' OG1' ' A' ' 94' ' ' THR . 0.0 OUTLIER -83.18 119.37 24.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 73.409999999999997 110.894 179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.656 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 2.8 pp -113.77 110.9 20.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 74.420000000000002 110.922 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.603 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -134.28 118.79 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 73.049999999999997 110.885 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.411 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 2.0 ttt180 -69.14 5.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 73.549999999999997 110.895 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.522 ' HB3' ' CE2' ' A' ' 89' ' ' PHE . 29.8 t0 -64.57 -25.43 67.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 74.230000000000004 110.876 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.522 ' CE2' ' HB3' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -160.69 -89.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 74.310000000000002 110.877 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.53 45.63 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 73.329999999999998 110.862 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -99.09 111.84 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 64.25 111.096 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.595 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 0.4 OUTLIER -128.23 17.06 6.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 73.319999999999993 110.937 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.622 ' C ' ' H ' ' A' ' 84' ' ' HIS . 10.2 t70 -140.49 151.51 44.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 73.409999999999997 110.874 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.654 ' OG1' ' N ' ' A' ' 84' ' ' HIS . 81.4 m -122.58 -101.52 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 52.329999999999998 111.101 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -166.47 154.74 9.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.63 0.729 . . . . 74.310000000000002 110.906 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 148.46 65.04 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.671 2.247 . . . . 75.349999999999994 112.352 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.58 161.15 20.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 74.409999999999997 111.117 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.98 0.41 6.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 74.049999999999997 110.878 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.0 -20.84 26.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.735 -0.745 . . . . 64.409999999999997 112.476 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -97.08 -16.79 20.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.871 0.367 . . . . 73.439999999999998 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.45 -20.32 79.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 33.140000000000001 112.508 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 74.040000000000006 112.49 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.6 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.81 0.338 . . . . 75.340000000000003 110.883 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -63.94 -22.49 66.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 110.946 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.23 -124.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 73.400000000000006 110.876 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.552 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 3.0 tt -92.0 139.36 24.47 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.606 0.717 . . . . 74.430000000000007 111.135 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.552 ' HD2' ' CG1' ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.75 23.87 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.717 2.278 . . . . 71.019999999999996 112.311 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.527 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -151.04 37.4 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 63.32 111.154 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.51 ' CB ' ' HB2' ' A' ' 20' ' ' LEU . 66.5 p -66.87 -165.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 75.129999999999995 111.15 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.444 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 3.0 mt-10 -123.46 -86.99 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.862 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.87 12.3 3.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 74.140000000000001 110.856 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.557 ' HG ' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -94.25 -36.31 12.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 74.099999999999994 110.964 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.444 ' CD2' ' O ' ' A' ' 18' ' ' GLU . 2.1 p90 -75.83 -2.41 29.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 74.209999999999994 110.865 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -96.25 -32.04 12.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 74.450000000000003 110.877 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -81.05 -31.02 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 73.519999999999996 110.917 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -41.82 -38.63 2.44 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.768 -0.73 . . . . 64.340000000000003 112.437 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.52 -60.68 3.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 74.420000000000002 111.118 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.1 ptm -67.57 -10.94 56.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 74.310000000000002 110.849 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.443 ' C ' ' H ' ' A' ' 29' ' ' ASP . . . -82.37 -29.93 30.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.422 . . . . 53.25 111.122 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -73.86 42.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 73.230000000000004 110.876 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -148.34 -41.87 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 70.430000000000007 110.872 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.34 13.27 3.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.711 -0.757 . . . . 63.109999999999999 112.484 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 27' ' ' ALA . 2.7 tt0 -58.16 104.49 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 73.120000000000005 110.859 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.41 -171.04 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 74.310000000000002 110.838 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -109.48 120.5 42.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 71.439999999999998 110.85 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.548 ' CG1' ' H ' ' A' ' 35' ' ' THR . 2.3 t -91.74 -140.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 73.219999999999999 111.132 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.548 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 43.6 p -137.06 -63.92 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 75.439999999999998 111.146 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.05 -64.6 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.71 -0.757 . . . . 74.319999999999993 112.469 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.7 Cg_endo -69.77 167.17 25.23 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.636 2.224 . . . . 72.430000000000007 112.381 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -70.32 -26.06 63.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 73.239999999999995 110.835 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.51 -37.42 70.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 70.420000000000002 111.118 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.07 -33.54 24.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 73.230000000000004 110.893 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -71.23 -43.85 66.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 75.549999999999997 110.863 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . . . -70.48 -34.33 72.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 111.093 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -79.35 -41.02 28.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 74.439999999999998 110.905 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.58 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -77.34 -63.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 63.219999999999999 111.112 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.57 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -52.9 -19.72 2.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 55.210000000000001 111.074 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.701 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -53.63 -67.96 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 74.400000000000006 111.114 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.641 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.5 t -115.55 -13.85 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 72.519999999999996 111.093 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.58 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 41.5 mt-30 -80.09 -34.54 37.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 75.340000000000003 110.909 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.988 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.29 -4.1 19.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 75.120000000000005 111.1 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.988 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.71 -6.4 0.12 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.639 0.733 . . . . 75.25 111.172 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.988 ' CD ' ' N ' ' A' ' 50' ' ' VAL . 53.8 Cg_endo -69.83 -26.58 27.11 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 2.236 . . . . 75.040000000000006 112.361 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.83 -50.49 5.56 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.721 -0.752 . . . . 73.299999999999997 112.53 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.5 -32.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.703 -0.761 . . . . 63.200000000000003 112.486 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.659 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -146.94 150.73 35.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 75.239999999999995 111.148 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.409 ' CB ' HG22 ' A' ' 50' ' ' VAL . . . -71.98 79.1 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 62.0 111.076 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.748 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -145.64 101.89 0.25 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 64.109999999999999 112.496 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.5 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.5 tt0 -95.39 -177.72 4.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 63.119999999999997 110.9 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.409 HG23 ' HG3' ' A' ' 31' ' ' GLU . 82.1 t -132.29 118.11 34.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 71.299999999999997 111.121 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.772 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 7.6 pt-20 -92.47 159.5 15.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 75.239999999999995 110.906 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.486 ' HA ' ' CB ' ' A' ' 69' ' ' TYR . 1.6 t -132.8 116.4 16.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 73.120000000000005 111.146 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -136.73 163.71 29.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 70.230000000000004 110.876 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.09 149.89 38.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 74.439999999999998 111.166 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.07 -142.51 5.34 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 44.329999999999998 112.506 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.74 -22.06 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.379 . . . . 64.150000000000006 110.866 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.1 -114.34 3.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 74.319999999999993 112.449 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.05 -84.71 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.748 0.308 . . . . 75.040000000000006 111.107 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -76.34 131.78 39.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 111.112 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -150.4 60.72 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 50.119999999999997 111.113 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.772 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 4.2 p90 -128.19 -169.17 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 70.049999999999997 110.922 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -157.07 163.9 32.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.771 -0.728 . . . . 71.109999999999999 112.525 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 83' ' ' VAL . 61.1 t -136.85 122.69 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 73.349999999999994 111.09 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.748 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -110.56 141.5 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 110.948 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.655 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.2 p -152.19 124.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 74.420000000000002 111.106 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.819 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 3.0 m -171.82 -129.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 74.400000000000006 111.125 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.489 ' C ' ' H ' ' A' ' 77' ' ' ASP . 6.4 mtm-85 -103.53 141.5 22.62 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.624 0.726 . . . . 74.129999999999995 110.883 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.499 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.0 Cg_endo -69.74 15.57 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 70.209999999999994 112.342 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 75' ' ' ARG . 5.7 m-20 -93.69 24.52 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 110.879 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.25 -12.71 53.83 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.74 . . . . 72.329999999999998 112.5 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.43 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.7 t -98.64 103.95 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 74.239999999999995 111.152 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.819 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.9 OUTLIER -137.3 163.75 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 74.310000000000002 110.925 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 45.6 t -115.88 105.66 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 73.239999999999995 111.069 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.514 ' O ' ' HB ' ' A' ' 94' ' ' THR . 0.0 OUTLIER -88.65 139.29 30.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 75.530000000000001 110.874 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 71' ' ' VAL . 32.3 m -116.11 146.88 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 74.540000000000006 111.111 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.712 ' HB2' ' OG1' ' A' ' 94' ' ' THR . 2.1 t-160 -98.46 123.99 42.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 65.329999999999998 110.861 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.673 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -118.91 103.15 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.901 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.511 ' N ' HG12 ' A' ' 91' ' ' VAL . 1.6 t70 -131.37 111.62 12.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 70.019999999999996 110.899 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -70.99 4.21 2.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 110.867 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 86' ' ' ASP . 50.5 t0 -72.73 -13.92 61.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 64.010000000000005 110.841 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.63 -95.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.409999999999997 110.897 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -149.21 29.33 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 74.549999999999997 110.84 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 2.3 t -73.92 97.0 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 111.119 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.502 HD12 ' CD2' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -124.87 15.29 8.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.439999999999998 110.853 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' A' ' 84' ' ' HIS . 4.4 m-20 -154.61 157.95 38.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 40.100000000000001 110.845 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.712 ' OG1' ' HB2' ' A' ' 84' ' ' HIS . 86.0 m -130.39 -99.8 0.32 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 72.349999999999994 111.135 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -159.34 162.61 25.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.627 0.727 . . . . 73.340000000000003 110.883 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 104.48 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.652 2.235 . . . . 71.099999999999994 112.335 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.79 108.22 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 73.340000000000003 111.092 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.85 16.58 12.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 70.129999999999995 110.894 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.59 -19.91 21.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 73.510000000000005 112.513 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.4 -45.94 6.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 75.400000000000006 110.886 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.06 27.46 45.05 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 71.450000000000003 112.455 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.749 . . . . 54.210000000000001 112.468 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.837 0.351 . . . . 73.120000000000005 110.88 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -67.69 -41.69 83.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 110.909 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.44 ' CB ' ' HB2' ' A' ' 85' ' ' LEU . 3.8 p-10 -62.55 -161.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 75.420000000000002 110.868 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.7 pt -86.73 129.57 52.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.646 0.736 . . . . 74.409999999999997 111.133 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 0.56 5.43 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.697 2.265 . . . . 74.129999999999995 112.326 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 m -109.1 25.02 12.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 73.409999999999997 111.136 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.419 ' HB ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -78.86 -168.2 1.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 71.150000000000006 111.136 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.402 ' H ' HD21 ' A' ' 92' ' ' LEU . 9.5 mm-40 -73.97 -100.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 75.019999999999996 110.883 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.06 7.76 45.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 72.450000000000003 110.892 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.598 ' CD2' ' HB3' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -69.08 -13.41 62.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 74.140000000000001 110.895 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -94.05 0.64 56.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 110.904 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.13 -40.41 8.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 74.329999999999998 110.869 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -43.98 80.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.439999999999998 110.926 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -43.88 -30.01 1.56 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.76 . . . . 75.019999999999996 112.512 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.16 -56.91 12.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 71.109999999999999 111.076 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 20.4 ptp -72.01 -5.03 32.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.443 . . . . 75.099999999999994 110.883 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' A' ' 31' ' ' GLU . . . -74.43 -24.34 59.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 71.010000000000005 111.119 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -64.3 -9.09 15.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.349999999999994 110.861 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.09 -77.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 52.149999999999999 110.882 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.31 9.98 2.98 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 64.540000000000006 112.499 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 2.8 tt0 -60.02 99.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 74.209999999999994 110.872 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.05 -164.06 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 72.010000000000005 110.846 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.81 122.54 44.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.905 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.506 ' CG1' ' H ' ' A' ' 35' ' ' THR . 2.7 t -84.1 -133.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 63.100000000000001 111.118 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.506 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 21.0 p -136.09 -58.55 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 74.530000000000001 111.113 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.46 -68.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 71.209999999999994 112.494 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.4 Cg_endo -69.75 171.24 14.82 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 2.243 . . . . 72.230000000000004 112.362 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -71.92 -24.61 61.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 65.400000000000006 110.836 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.86 72.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 64.450000000000003 111.084 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.68 -41.35 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 63.039999999999999 110.887 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.421 ' HD3' ' HG ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -61.24 -37.7 84.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 74.519999999999996 110.854 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.53 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -67.74 -33.97 75.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 73.420000000000002 111.09 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -78.88 -39.62 34.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 73.120000000000005 110.91 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.491 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -80.34 -60.79 2.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 62.140000000000001 111.103 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.496 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -52.71 -23.24 6.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 75.299999999999997 111.088 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.609 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -57.25 -77.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 54.130000000000003 111.056 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.708 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 40.6 t -113.32 -13.97 11.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 74.150000000000006 111.121 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.6 tp60 -75.92 -32.94 59.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 110.872 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 1.009 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.68 -2.63 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.530000000000001 111.101 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.974 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.1 -4.56 0.11 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.637 0.732 . . . . 73.310000000000002 111.146 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.009 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.3 Cg_endo -69.78 -28.16 25.5 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.676 2.251 . . . . 72.430000000000007 112.326 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.54 -54.95 3.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.758 . . . . 72.140000000000001 112.469 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.79 -33.45 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.7 -0.762 . . . . 74.099999999999994 112.474 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.687 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -144.81 150.12 36.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 74.040000000000006 111.112 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.444 ' CB ' HG21 ' A' ' 50' ' ' VAL . . . -72.42 76.46 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 72.540000000000006 111.099 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.695 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -149.7 108.94 0.42 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 62.520000000000003 112.521 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.513 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 3.2 tt0 -102.97 -168.54 1.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.893 0.378 . . . . 75.129999999999995 110.888 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.3 t -132.98 118.29 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.209999999999994 111.117 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -96.98 158.14 15.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 74.129999999999995 110.923 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.4 ' HA ' ' HB3' ' A' ' 69' ' ' TYR . 1.7 t -137.06 111.02 8.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 72.340000000000003 111.159 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.95 166.39 16.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.888 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.81 118.15 29.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 61.240000000000002 111.163 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.07 -144.3 9.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 74.120000000000005 112.5 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.97 -14.29 42.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.901 0.382 . . . . 65.5 110.895 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.89 -120.89 1.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 73.109999999999999 112.491 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.97 -76.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 74.109999999999999 111.128 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.648 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -103.04 86.33 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 73.239999999999995 111.087 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.28 62.93 6.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 75.239999999999995 111.076 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -109.04 174.39 5.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 110.913 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -153.91 157.75 27.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.725 -0.75 . . . . 61.340000000000003 112.454 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.6 115.03 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.372 . . . . 74.510000000000005 111.132 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.75 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -107.53 135.88 48.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 74.030000000000001 110.918 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.695 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.7 p -151.55 124.43 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 71.120000000000005 111.154 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.763 ' HB ' ' O ' ' A' ' 79' ' ' THR . 4.1 m -168.06 -131.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 74.450000000000003 111.17 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.541 ' H ' ' CG2' ' A' ' 74' ' ' THR . 0.5 OUTLIER -103.0 139.33 20.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.63 0.729 . . . . 64.109999999999999 110.886 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 16.83 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.711 2.274 . . . . 62.039999999999999 112.34 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 75' ' ' ARG . 4.1 m-20 -94.97 13.61 24.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 71.340000000000003 110.874 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.84 -12.1 34.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 51.0 112.457 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.763 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.8 t -95.55 130.63 42.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 73.019999999999996 111.175 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.53 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -142.2 158.79 43.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 74.299999999999997 110.924 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.75 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 72.8 t -117.79 80.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 65.129999999999995 111.119 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.429 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 3.0 tp10 -75.09 121.82 22.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 110.853 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.0 t -103.82 139.5 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 70.430000000000007 111.172 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.496 ' C ' HG11 ' A' ' 91' ' ' VAL . 17.9 m-70 -86.61 118.13 25.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.540000000000006 110.843 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.598 ' HB3' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -128.3 105.86 8.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 74.319999999999993 110.91 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.651 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.3 t0 -139.66 131.96 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 71.409999999999997 110.843 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -61.21 5.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.219999999999999 110.863 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.606 ' H ' ' C ' ' A' ' 86' ' ' ASP . 13.9 t0 -67.23 -3.33 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 110.863 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 67.53 12.2 8.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 110.879 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -137.31 2.18 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.882 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.651 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 58.5 t -116.38 70.87 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 71.310000000000002 111.143 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.402 HD21 ' H ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -128.56 12.47 6.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 72.530000000000001 110.941 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -92.92 -179.1 5.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 74.099999999999994 110.864 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.8 t -124.61 166.96 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 71.420000000000002 111.132 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -145.97 123.38 6.12 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.658 0.742 . . . . 75.420000000000002 110.872 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 96.48 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.637 2.225 . . . . 72.200000000000003 112.351 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.09 111.35 2.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 73.129999999999995 111.097 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -88.83 11.03 19.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 64.150000000000006 110.831 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.18 -21.11 7.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.727 . . . . 72.420000000000002 112.462 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -97.92 -38.54 9.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.861 0.363 . . . . 73.239999999999995 110.888 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.26 25.14 52.6 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.751 . . . . 62.439999999999998 112.518 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.782 -0.723 . . . . 31.309999999999999 112.472 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.832 0.349 . . . . 75.349999999999994 110.879 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.402 ' HB2' ' CE2' ' A' ' 69' ' ' TYR . 77.6 m-85 -64.68 -32.91 74.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 110.929 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 10.6 p-10 -65.98 -122.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 74.340000000000003 110.885 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 16' ' ' THR . 30.8 mt -77.37 127.55 82.69 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.633 0.73 . . . . 73.349999999999994 111.138 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 15.86 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.637 2.225 . . . . 74.540000000000006 112.394 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.478 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.3 OUTLIER -150.77 37.86 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 70.140000000000001 111.117 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.501 HG23 ' CD2' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -71.61 -161.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 64.319999999999993 111.133 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.408 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 29.4 mm-40 -84.13 -111.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 75.109999999999999 110.835 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -86.7 9.76 17.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.129999999999995 110.86 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.565 ' CD2' ' HB3' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -66.91 -12.23 58.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 75.430000000000007 110.877 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -63.65 -12.27 32.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 73.450000000000003 110.912 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -115.18 52.93 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 110.85 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 88.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 74.549999999999997 110.904 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 42.93 38.17 3.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 71.519999999999996 112.487 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.86 -26.7 66.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 75.420000000000002 111.122 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.0 -9.9 34.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.846 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.445 ' C ' ' H ' ' A' ' 29' ' ' ASP . . . -118.14 61.91 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 63.340000000000003 111.152 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -59.34 -6.15 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 75.129999999999995 110.926 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 27' ' ' ALA . 3.8 m-20 -126.08 -35.52 2.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 73.319999999999993 110.863 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 -20.52 60.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.716 -0.754 . . . . 52.119999999999997 112.475 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -62.47 93.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 61.140000000000001 110.892 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.09 179.62 3.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 71.409999999999997 110.873 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -95.62 115.73 27.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 64.530000000000001 110.894 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.6 ' CG1' ' H ' ' A' ' 35' ' ' THR . 3.1 t -75.03 -135.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 74.209999999999994 111.184 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.6 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 80.6 p -140.15 -60.43 0.53 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 74.049999999999997 111.108 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.44 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 175.76 -60.88 0.11 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 70.120000000000005 112.5 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.9 Cg_endo -69.73 164.64 33.76 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.711 2.274 . . . . 73.019999999999996 112.369 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 9.0 p-10 -71.53 -25.67 62.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 65.319999999999993 110.804 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.14 -36.86 73.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 70.530000000000001 111.067 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.49 -36.31 24.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 65.319999999999993 110.876 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.568 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 11.8 ptt180 -70.39 -43.97 68.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.842 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.485 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . . . -69.39 -34.47 74.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 72.230000000000004 111.12 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.3 ptt85 -80.11 -41.5 25.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 72.439999999999998 110.851 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -75.26 -62.26 1.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 70.310000000000002 111.102 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -53.7 -19.57 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 111.101 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.578 ' O ' ' CG2' ' A' ' 50' ' ' VAL . . . -60.15 -68.28 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 54.420000000000002 111.1 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.722 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 19.4 t -111.07 -10.45 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 74.549999999999997 111.158 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.619 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.2 tp60 -83.65 -38.61 21.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 74.409999999999997 110.93 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.745 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -101.88 -6.32 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 72.140000000000001 111.116 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.945 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -81.26 -24.79 0.39 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.657 0.741 . . . . 71.140000000000001 111.139 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.945 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 53.8 Cg_endo -69.78 -7.15 20.33 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.661 2.24 . . . . 72.010000000000005 112.399 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.04 -21.51 15.44 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 74.430000000000007 112.483 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.68 -33.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 55.329999999999998 112.487 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.686 ' O ' ' O ' ' A' ' 49' ' ' ALA . 2.0 t -155.16 161.86 41.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 74.209999999999994 111.133 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.511 ' HB2' ' HD3' ' A' ' 76' ' ' PRO . . . -76.63 69.48 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 73.219999999999999 111.089 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.7 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -144.29 103.15 0.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.735 -0.745 . . . . 74.030000000000001 112.463 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.533 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 3.8 tt0 -97.55 -171.89 2.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 70.030000000000001 110.889 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.421 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 78.0 t -133.08 120.94 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 74.030000000000001 111.098 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 14.5 tm-20 -95.88 149.8 21.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 74.140000000000001 110.89 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.2 t -135.46 113.92 11.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.114 -0.493 . . . . 71.400000000000006 111.124 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.64 161.31 37.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 64.129999999999995 110.858 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.64 119.83 31.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 73.099999999999994 111.164 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.14 -159.65 30.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.742 -0.742 . . . . 70.049999999999997 112.554 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -82.97 -23.67 33.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 73.019999999999996 110.88 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.9 -112.99 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 63.420000000000002 112.466 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.25 -69.19 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 44.25 111.118 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.3 157.15 19.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 74.299999999999997 111.106 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -155.08 61.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 74.329999999999998 111.123 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 84' ' ' HIS . 1.2 m-85 -113.67 173.43 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 73.150000000000006 110.922 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -159.59 117.55 0.78 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 44.219999999999999 112.472 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.52 122.01 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.914 0.388 . . . . 72.340000000000003 111.117 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.602 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -111.86 144.21 41.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 73.409999999999997 110.917 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.7 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 t -148.22 116.75 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 72.25 111.146 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.8 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 1.3 m -173.74 -135.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 72.019999999999996 111.166 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.402 ' H ' ' CG2' ' A' ' 74' ' ' THR . 20.0 mtm-85 -107.61 149.29 38.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.642 0.734 . . . . 75.319999999999993 110.857 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.72 5.13 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.702 2.268 . . . . 74.219999999999999 112.341 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.36 27.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 64.530000000000001 110.903 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 76' ' ' PRO . . . 76.8 -11.03 15.77 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.727 -0.749 . . . . 74.109999999999999 112.485 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.421 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.1 p -98.62 102.27 13.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.807 0.337 . . . . 75.120000000000005 111.104 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.8 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 1.1 ptp85 -141.34 162.46 35.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 74.239999999999995 110.912 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 23.8 t -112.85 100.02 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 60.119999999999997 111.088 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.568 ' HB2' ' HD2' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -89.06 117.72 28.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 75.349999999999994 110.884 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.478 ' O ' ' HA2' ' A' ' 70' ' ' GLY . 0.2 OUTLIER -98.28 111.42 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 64.519999999999996 111.194 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.483 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 3.3 t-160 -78.45 123.22 26.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 65.230000000000004 110.868 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.678 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -106.84 96.48 6.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 61.530000000000001 110.888 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.628 ' H ' ' HA ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -130.1 119.48 23.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 73.540000000000006 110.891 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -6.67 14.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.239999999999995 110.895 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.692 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 15.0 t0 -84.01 31.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 73.010000000000005 110.893 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.692 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 19.5 m-85 98.03 -27.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 74.319999999999993 110.875 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.501 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 79.6 mmt-85 -91.83 38.84 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 110.893 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -61.54 -40.18 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 74.230000000000004 111.14 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.501 ' CD2' HG23 ' A' ' 17' ' ' THR . 3.2 mm? -116.41 30.05 7.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 74.540000000000006 110.9 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 13.5 t0 -72.47 69.58 0.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 71.340000000000003 110.862 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.424 ' HB ' HG12 ' A' ' 83' ' ' VAL . 5.5 t -79.09 161.12 26.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 73.200000000000003 111.148 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.53 128.23 8.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.638 0.732 . . . . 62.329999999999998 110.88 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 95.33 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.669 2.246 . . . . 71.400000000000006 112.371 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.04 110.18 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 71.25 111.086 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -105.85 18.42 22.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 110.839 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.62 -19.15 30.18 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 72.219999999999999 112.474 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.09 -44.39 7.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.813 0.34 . . . . 74.420000000000002 110.836 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.65 23.61 57.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.716 -0.754 . . . . 61.140000000000001 112.466 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 60.420000000000002 112.477 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.85 0.357 . . . . 74.409999999999997 110.921 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.6 179.96 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 73.030000000000001 110.908 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.515 ' HB2' ' HB2' ' A' ' 87' ' ' ARG . 15.7 p-10 -117.43 -46.73 2.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 71.549999999999997 110.873 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.429 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -133.62 165.71 34.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 73.430000000000007 111.171 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 14' ' ' ILE . 53.4 Cg_endo -69.74 -3.68 12.48 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.71 2.273 . . . . 65.430000000000007 112.324 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -128.98 74.62 1.59 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 74.409999999999997 111.18 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.472 ' CB ' ' HB2' ' A' ' 20' ' ' LEU . 59.9 p -96.69 -166.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 75.109999999999999 111.111 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.43 ' C ' ' H ' ' A' ' 20' ' ' LEU . 18.9 tt0 -129.55 -92.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 74.239999999999995 110.867 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -72.02 7.15 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 73.439999999999998 110.869 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.472 ' HB2' ' CB ' ' A' ' 17' ' ' THR . 11.2 mp -84.72 -37.56 20.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 73.099999999999994 110.923 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -82.86 4.03 27.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 74.030000000000001 110.946 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.6 -52.77 3.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 72.319999999999993 110.911 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -78.12 -31.81 50.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 72.109999999999999 110.924 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.81 -41.63 4.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 72.010000000000005 112.521 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.51 -60.75 2.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.736 0.303 . . . . 74.140000000000001 111.107 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.2 ptm -69.51 -8.4 46.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 75.510000000000005 110.842 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.94 -32.99 17.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 65.400000000000006 111.093 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -75.73 46.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 74.329999999999998 110.839 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.21 -74.62 0.49 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.125 -0.488 . . . . 75.420000000000002 110.871 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.26 16.64 5.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.691 -0.766 . . . . 73.439999999999998 112.44 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -54.94 168.17 0.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 71.129999999999995 110.894 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.94 -165.92 1.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 75.099999999999994 110.866 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -128.84 120.46 26.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 72.530000000000001 110.902 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 40.1 t -73.32 162.67 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 64.019999999999996 111.096 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.7 p -91.81 -49.03 6.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.349999999999994 111.118 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.07 -64.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 71.409999999999997 112.491 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 150.3 68.14 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.646 2.231 . . . . 74.540000000000006 112.366 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -59.01 -30.85 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 74.019999999999996 110.876 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.39 -28.7 60.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 62.25 111.063 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 0.6 OUTLIER -78.97 -30.02 44.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 74.420000000000002 110.848 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.527 ' HA ' ' OE1' ' A' ' 57' ' ' GLU . 3.2 ptt180 -68.57 -43.13 77.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 110.842 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . . . -74.47 -32.04 62.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 74.340000000000003 111.123 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 19.7 ptt85 -77.93 -41.54 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.219999999999999 110.884 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -78.18 -62.29 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 111.058 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.512 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -51.54 -21.39 2.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 111.092 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.715 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -53.81 -66.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 73.519999999999996 111.094 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.617 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 22.0 t -111.35 -17.04 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 75.200000000000003 111.098 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 52.3 mt-30 -79.26 -28.92 42.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 71.540000000000006 110.952 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 1.076 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -109.31 -10.27 14.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 71.230000000000004 111.081 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.53 -0.03 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 73.230000000000004 111.126 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.076 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.5 Cg_endo -69.76 -27.23 26.73 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.689 2.259 . . . . 72.200000000000003 112.337 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.14 -51.83 3.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 62.219999999999999 112.464 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.24 -35.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 75.540000000000006 112.46 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.803 ' O ' ' O ' ' A' ' 49' ' ' ALA . 4.4 m -143.15 147.51 35.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.769 0.318 . . . . 75.409999999999997 111.128 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.24 81.43 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 62.130000000000003 111.156 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.69 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -145.41 97.9 0.19 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 70.109999999999999 112.516 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.527 ' OE1' ' HA ' ' A' ' 41' ' ' ARG . 1.1 pt-20 -99.43 -179.47 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 64.420000000000002 110.897 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.417 ' N ' ' HG3' ' A' ' 57' ' ' GLU . 70.3 t -115.04 139.22 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 111.142 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.564 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 19.9 tt0 -106.88 155.89 19.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 73.120000000000005 110.879 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.401 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 1.2 t -129.35 110.77 12.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 73.129999999999995 111.162 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.13 160.52 38.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 63.219999999999999 110.894 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 64.4 p -132.69 93.21 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 65.219999999999999 111.113 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.2 -139.47 2.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.75 . . . . 65.239999999999995 112.445 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.15 -0.13 56.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.392 . . . . 75.510000000000005 110.881 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -100.7 -122.83 5.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.792 -0.718 . . . . 70.450000000000003 112.5 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' A' ' 87' ' ' ARG . . . -122.82 -82.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.795 0.331 . . . . 74.420000000000002 111.081 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 85' ' ' LEU . . . -100.45 90.15 4.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 71.239999999999995 111.079 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.49 79.86 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 72.120000000000005 111.091 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.401 ' CG ' ' HA ' ' A' ' 60' ' ' THR . 3.1 m-85 -106.75 163.27 13.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 74.030000000000001 110.927 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -137.65 107.02 0.56 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 75.140000000000001 112.474 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.11 111.07 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.899 0.381 . . . . 75.209999999999994 111.098 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.69 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -103.45 149.45 24.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.349999999999994 110.914 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.648 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.7 p -150.42 115.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 111.103 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.757 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 1.4 m -173.43 -136.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 73.340000000000003 111.126 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.462 ' H ' ' CG2' ' A' ' 74' ' ' THR . 0.6 OUTLIER -104.26 145.86 31.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.597 0.713 . . . . 73.140000000000001 110.847 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.415 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.9 Cg_endo -69.74 7.88 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.695 2.264 . . . . 75.310000000000002 112.329 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 75' ' ' ARG . 6.6 m-20 -83.3 25.81 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 75.5 110.885 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.45 -13.22 47.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 72.329999999999998 112.499 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.571 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.6 t -97.03 102.8 14.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 72.409999999999997 111.18 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.757 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.6 OUTLIER -138.3 162.47 34.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 74.209999999999994 110.909 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 5.1 m -118.03 98.04 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.121 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.473 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -81.52 127.05 32.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 75.230000000000004 110.901 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.9 t -91.92 116.9 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 111.141 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 2.3 t-160 -84.36 117.35 23.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 75.25 110.833 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.914 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -123.49 122.89 39.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 74.400000000000006 110.912 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.484 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 7.8 t0 -132.74 119.46 20.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 75.209999999999994 110.85 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.515 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 2.1 tmt_? -68.44 0.19 4.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.109999999999999 110.864 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.533 ' HB3' ' CE1' ' A' ' 89' ' ' PHE . 6.5 t0 -65.79 -14.17 60.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 73.230000000000004 110.848 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -176.71 -91.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 74.010000000000005 110.915 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.31 31.44 0.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 74.239999999999995 110.876 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.914 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 2.0 t -71.82 81.42 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 73.25 111.16 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -120.39 18.62 12.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 75.400000000000006 110.934 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -83.09 137.67 34.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 73.030000000000001 110.882 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.0 t -92.05 165.88 12.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 74.040000000000006 111.158 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -139.12 162.83 50.02 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.677 0.751 . . . . 74.409999999999997 110.858 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 92.85 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.712 2.275 . . . . 65.219999999999999 112.343 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.23 111.19 11.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 75.400000000000006 111.059 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 101' ' ' GLY . 19.8 t0 -122.25 113.0 18.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 65.319999999999993 110.863 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -47.06 -21.54 1.02 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.732 -0.747 . . . . 72.329999999999998 112.513 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -93.74 -24.92 17.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 75.239999999999995 110.913 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 98' ' ' ASP . . . 100.4 -6.39 57.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.748 -0.739 . . . . 75.120000000000005 112.517 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.698 -0.763 . . . . 75.549999999999997 112.498 -179.878 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.779 0.323 . . . . 63.130000000000003 110.842 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -67.13 -18.02 65.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 73.450000000000003 110.974 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 6.3 p-10 -58.44 -100.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 74.0 110.889 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.475 ' H ' ' CG ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -113.7 163.9 17.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.616 0.722 . . . . 73.299999999999997 111.132 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -2.87 10.93 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.709 2.273 . . . . 71.109999999999999 112.294 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -144.22 72.66 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 65.329999999999998 111.129 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.471 ' HB ' ' HG ' ' A' ' 92' ' ' LEU . 3.9 p -74.6 -169.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 70.120000000000005 111.11 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 3.3 mm-40 -116.78 -97.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 75.209999999999994 110.896 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.29 6.04 7.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 73.340000000000003 110.908 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.426 HD13 ' HB ' ' A' ' 83' ' ' VAL . 2.3 tp -79.97 -2.2 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.473 . . . . 61.240000000000002 110.882 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.44 ' CD2' ' O ' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -59.91 -14.26 14.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 110.973 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.6 49.49 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 74.409999999999997 110.835 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 24' ' ' GLY . 1.1 pt20 -64.47 82.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 73.129999999999995 110.917 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' GLN . . . 36.5 44.26 0.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 64.150000000000006 112.544 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.94 76.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.766 0.317 . . . . 61.109999999999999 111.09 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -16.64 63.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.349999999999994 110.899 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.73 54.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 73.109999999999999 111.086 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.47 49.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 74.140000000000001 110.906 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 175.22 -31.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 71.25 110.828 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.47 -2.68 56.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.752 . . . . 61.219999999999999 112.479 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.35 85.74 3.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 74.450000000000003 110.909 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.89 -167.24 1.2 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 73.200000000000003 110.869 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 22.1 pt-20 -101.67 166.27 10.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 74.140000000000001 110.885 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.591 ' CG1' ' H ' ' A' ' 35' ' ' THR . 2.8 t -123.25 -139.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 73.510000000000005 111.163 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.591 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 59.0 p -138.71 -70.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 75.439999999999998 111.166 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.46 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -175.24 -59.79 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 60.329999999999998 112.475 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.4 Cg_endo -69.8 164.16 35.62 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.267 . . . . 75.209999999999994 112.318 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.41 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -72.7 -25.09 61.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 110.919 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.36 82.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 60.439999999999998 111.12 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -80.58 -34.59 35.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 74.409999999999997 110.864 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.47 ' CG ' ' N ' ' A' ' 42' ' ' ALA . 8.3 ptt180 -72.78 -45.67 57.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 74.209999999999994 110.872 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.594 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -64.65 -33.07 75.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.239999999999995 111.084 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 13.3 ptt85 -83.41 -43.36 15.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 73.439999999999998 110.86 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -74.88 -60.84 2.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 64.310000000000002 111.125 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.477 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -51.47 -22.92 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 75.010000000000005 111.112 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.71 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -59.15 -75.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 74.150000000000006 111.075 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.619 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 26.3 t -107.78 -21.73 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 72.450000000000003 111.078 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -69.99 -31.48 69.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 71.420000000000002 110.917 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 1.033 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.34 -0.11 22.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 73.340000000000003 111.101 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.992 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -100.05 3.14 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.627 0.727 . . . . 72.430000000000007 111.158 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.033 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.8 Cg_endo -69.7 -27.39 26.82 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.769 2.313 . . . . 74.540000000000006 112.356 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.86 -49.38 5.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 62.049999999999997 112.455 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.33 -32.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.797 -0.715 . . . . 55.439999999999998 112.534 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.69 ' O ' ' O ' ' A' ' 49' ' ' ALA . 11.8 t -141.91 149.83 40.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 72.209999999999994 111.182 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.471 ' HB2' ' C ' ' A' ' 75' ' ' ARG . . . -74.99 78.83 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 65.439999999999998 111.121 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.59 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -144.86 101.17 0.24 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 73.510000000000005 112.5 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -95.4 -173.09 2.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 65.209999999999994 110.909 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 20.2 t -135.5 116.69 19.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 111.139 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.573 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -94.89 150.84 19.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.040000000000006 110.829 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.402 ' HA ' ' HB3' ' A' ' 69' ' ' TYR . 1.8 t -136.67 107.34 6.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 74.230000000000004 111.126 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -129.39 167.76 17.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 74.510000000000005 110.911 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.405 ' HA ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -121.74 120.51 34.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 74.530000000000001 111.139 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.2 -168.55 30.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 73.230000000000004 112.514 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -59.82 -23.45 63.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.907 0.384 . . . . 71.150000000000006 110.906 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.86 -118.2 1.56 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.777 -0.725 . . . . 72.340000000000003 112.495 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.47 -71.22 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.809 0.338 . . . . 63.420000000000002 111.13 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -89.3 134.88 33.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 62.240000000000002 111.078 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.405 ' HB2' ' HA ' ' A' ' 62' ' ' THR . . . -150.8 62.53 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 72.200000000000003 111.115 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.573 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -111.98 162.64 15.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 73.319999999999993 110.925 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.66 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -144.98 118.99 1.17 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.718 -0.754 . . . . 62.329999999999998 112.49 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.8 p -103.02 119.86 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.371 . . . . 62.210000000000001 111.111 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.699 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -104.27 142.65 34.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 61.329999999999998 110.902 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.589 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 2.8 t -150.8 117.01 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 72.230000000000004 111.158 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.753 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 2.2 m -169.14 -137.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 73.200000000000003 111.123 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.554 ' H ' ' CG2' ' A' ' 74' ' ' THR . 55.8 mtm180 -98.61 150.01 36.29 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.585 0.707 . . . . 74.200000000000003 110.888 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 78' ' ' GLY . 53.7 Cg_endo -69.79 5.83 1.56 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.672 2.248 . . . . 75.310000000000002 112.336 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.57 29.4 0.31 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 73.450000000000003 110.901 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 76' ' ' PRO . . . 75.24 -9.98 11.87 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.763 -0.732 . . . . 71.340000000000003 112.48 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.577 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.9 p -98.38 109.49 22.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 74.129999999999995 111.174 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.753 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -137.94 160.93 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 73.439999999999998 110.878 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 12.5 m -110.94 101.8 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 63.340000000000003 111.108 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' HB2' ' HD2' ' A' ' 41' ' ' ARG . 8.2 tm-20 -82.86 122.92 28.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 64.439999999999998 110.908 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.677 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 2.3 t -96.26 109.36 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 71.310000000000002 111.115 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 93' ' ' ASP . 4.2 p-80 -79.57 121.09 24.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 73.549999999999997 110.899 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.798 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -120.17 116.85 26.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 74.25 110.908 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.693 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 25.9 t0 -127.3 114.2 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 70.340000000000003 110.886 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.73 1.74 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 71.430000000000007 110.897 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.448 ' C ' ' CG ' ' A' ' 89' ' ' PHE . 52.1 t0 -70.31 -12.36 61.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 70.400000000000006 110.86 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.448 ' CG ' ' C ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -172.62 -94.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 70.230000000000004 110.853 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.59 30.7 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 74.310000000000002 110.875 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.9 t -77.58 77.16 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 71.140000000000001 111.145 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.548 HD11 ' C ' ' A' ' 91' ' ' VAL . 0.3 OUTLIER -120.19 18.05 12.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 73.319999999999993 110.952 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 84' ' ' HIS . 1.1 m-20 -80.95 167.5 19.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 71.519999999999996 110.875 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 5.9 t -121.19 169.43 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 111.198 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -143.73 110.7 5.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.575 0.703 . . . . 74.400000000000006 110.894 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 103.78 1.21 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.68 2.253 . . . . 70.409999999999997 112.4 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.33 -178.88 3.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 71.25 111.092 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.54 -156.62 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 74.239999999999995 110.845 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.16 -14.97 60.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 44.43 112.492 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.39 -53.09 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 64.030000000000001 110.847 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.54 28.89 4.39 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 72.200000000000003 112.48 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 72.310000000000002 112.512 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.832 0.349 . . . . 75.310000000000002 110.863 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -66.84 -52.16 46.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 73.540000000000006 110.906 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.457 ' CG ' ' HB2' ' A' ' 87' ' ' ARG . 75.0 m-20 -58.22 -97.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 71.319999999999993 110.876 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.515 ' C ' ' H ' ' A' ' 16' ' ' THR . 30.2 mt -101.72 105.28 40.23 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.617 0.722 . . . . 75.319999999999993 111.163 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 21.72 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 72.040000000000006 112.328 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.515 ' H ' ' C ' ' A' ' 14' ' ' ILE . 1.8 m -124.21 17.11 9.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 74.310000000000002 111.128 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.49 ' CG2' ' HB3' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -76.2 -160.75 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 74.430000000000007 111.164 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -61.25 -109.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 70.239999999999995 110.899 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -97.21 11.3 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.893 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.485 ' CD2' ' HB2' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -61.9 -34.65 76.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 72.519999999999996 110.915 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -86.34 7.83 23.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 74.519999999999996 110.951 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -108.5 -37.36 5.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 71.310000000000002 110.871 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.4 mm100 -67.46 -45.53 75.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 53.420000000000002 110.921 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -43.91 -30.71 1.75 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 73.420000000000002 112.478 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 27' ' ' ALA . . . -56.64 -72.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.754 0.312 . . . . 74.349999999999994 111.091 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.6 ptp -63.52 -3.69 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 72.439999999999998 110.881 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.443 ' HA ' ' CG ' ' A' ' 31' ' ' GLU . . . -64.76 -26.79 68.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 70.530000000000001 111.129 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.457 ' C ' ' HD1' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -82.81 8.43 12.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 73.109999999999999 110.888 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -89.87 -78.35 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.139 -0.482 . . . . 63.210000000000001 110.832 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.13 -5.04 2.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 71.140000000000001 112.508 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' CG ' ' HA ' ' A' ' 27' ' ' ALA . 23.1 mt-10 -62.18 105.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 74.209999999999994 110.892 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -161.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 64.519999999999996 110.853 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -118.46 116.56 26.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 72.019999999999996 110.899 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.633 ' HB ' ' CB ' ' A' ' 59' ' ' GLU . 4.2 t -72.21 171.36 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 73.310000000000002 111.131 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.422 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 71.9 p -91.97 -41.51 10.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 73.340000000000003 111.148 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.401 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 164.52 -62.95 0.24 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.718 -0.753 . . . . 63.450000000000003 112.479 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 54.2 Cg_endo -69.69 156.15 64.3 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.683 2.255 . . . . 75.239999999999995 112.377 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.474 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -60.82 -27.52 68.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 64.239999999999995 110.834 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.27 68.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 75.019999999999996 111.086 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.44 -32.81 23.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 64.319999999999993 110.841 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -69.99 -44.07 70.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 75.230000000000004 110.865 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.478 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . . . -70.79 -35.01 72.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 74.510000000000005 111.106 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -79.41 -41.4 27.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 75.319999999999993 110.923 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.574 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -77.22 -61.71 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 71.120000000000005 111.097 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.545 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -53.05 -21.73 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 70.319999999999993 111.093 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.749 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -54.27 -71.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 72.430000000000007 111.093 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.627 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.5 t -111.9 -12.79 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.549999999999997 111.129 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.574 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.8 tp60 -80.5 -34.11 35.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.140000000000001 110.892 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 1.017 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.97 -5.66 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 64.230000000000004 111.119 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.32 -5.69 0.11 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.731 . . . . 65.209999999999994 111.112 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.017 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.7 Cg_endo -69.79 -26.57 27.29 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 72.120000000000005 112.356 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.37 -57.46 2.62 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.687 -0.768 . . . . 62.200000000000003 112.502 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.65 -34.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.723 -0.751 . . . . 55.439999999999998 112.496 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.716 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.4 m -149.1 151.47 34.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.777 0.322 . . . . 75.120000000000005 111.173 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.22 79.23 0.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 111.126 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.753 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -144.78 102.54 0.27 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 71.530000000000001 112.505 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.568 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.5 tt0 -95.46 -177.77 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 75.109999999999999 110.86 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.3 t -131.03 117.0 35.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 72.129999999999995 111.123 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.633 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 1.4 pp20? -95.57 129.91 42.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 71.0 110.911 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 t -100.38 118.29 36.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.479 . . . . 75.040000000000006 111.179 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -134.93 101.7 4.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 63.409999999999997 110.896 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.2 p -93.97 127.07 39.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 74.299999999999997 111.141 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.0 -154.98 10.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 75.019999999999996 112.499 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -87.77 -0.3 56.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.883 0.373 . . . . 71.239999999999995 110.877 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.98 -96.95 2.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.76 -0.733 . . . . 61.43 112.464 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.45 -136.07 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 74.450000000000003 111.112 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.517 ' O ' ' O ' ' A' ' 85' ' ' LEU . . . -113.15 93.46 4.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 54.109999999999999 111.087 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 61' ' ' GLU . . . -79.76 95.31 5.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 75.010000000000005 111.091 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -116.66 115.75 26.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.209999999999994 110.897 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 84' ' ' HIS . . . -98.88 109.62 3.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 75.540000000000006 112.482 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.458 ' O ' HG21 ' A' ' 83' ' ' VAL . 4.6 p -104.19 109.75 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 71.25 111.177 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.753 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -97.74 142.43 29.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 74.420000000000002 110.889 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.65 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.8 p -150.39 120.78 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 111.083 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.763 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 2.8 m -171.36 -130.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 74.319999999999993 111.139 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.479 ' H ' ' CG2' ' A' ' 74' ' ' THR . 2.1 mtt-85 -107.0 145.73 31.71 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.718 . . . . 72.420000000000002 110.83 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.73 13.36 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.653 2.235 . . . . 72.530000000000001 112.392 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 75' ' ' ARG . 3.9 m-20 -89.91 25.65 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.872 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.17 -12.52 43.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 74.099999999999994 112.488 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.545 ' O ' ' HB ' ' A' ' 74' ' ' THR . 24.7 p -97.45 105.25 17.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 71.430000000000007 111.145 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.763 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 1.3 ptp85 -139.57 162.27 35.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 74.120000000000005 110.931 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 42.8 t -115.09 100.5 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 111.177 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.526 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 5.4 tm-20 -84.51 115.91 22.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 73.540000000000006 110.877 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -102.53 105.44 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 73.209999999999994 111.147 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.547 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.6 OUTLIER -83.76 124.74 31.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 74.219999999999999 110.893 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -111.39 111.76 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 74.230000000000004 110.946 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.587 ' N ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -126.42 114.98 18.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 74.430000000000007 110.907 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.457 ' HB2' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -72.94 -0.25 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 74.540000000000006 110.844 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -74.04 -19.38 60.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 70.200000000000003 110.849 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 90' ' ' ARG . 3.9 p90 169.8 -36.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.109999999999999 110.906 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.409 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 1.9 mmm180 -117.87 68.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 73.400000000000006 110.874 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.5 t -61.31 -14.23 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 73.319999999999993 111.147 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.49 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 0.0 OUTLIER -124.8 32.14 5.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 72.510000000000005 110.926 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 0.8 OUTLIER -65.75 80.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 65.0 110.879 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 10.1 t -79.76 153.51 29.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 111.088 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -148.76 129.76 7.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.678 0.751 . . . . 73.329999999999998 110.882 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 125.4 12.13 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.723 2.282 . . . . 75.400000000000006 112.37 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -115.26 108.93 17.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 72.400000000000006 111.09 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -103.99 20.79 17.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 73.310000000000002 110.854 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.12 -19.22 31.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.74 . . . . 71.230000000000004 112.466 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -94.66 -43.47 8.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 62.100000000000001 110.85 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.55 28.03 52.99 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 74.200000000000003 112.478 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 64.349999999999994 112.44 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.806 0.336 . . . . 72.349999999999994 110.873 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -67.66 -19.28 65.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.933 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.99 -161.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 73.150000000000006 110.905 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.506 HG13 ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -117.42 156.92 48.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.6 0.715 . . . . 63.219999999999999 111.135 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HD2' HG13 ' A' ' 14' ' ' ILE . 53.8 Cg_endo -69.72 45.38 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.676 2.251 . . . . 64.549999999999997 112.37 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -151.26 17.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 73.010000000000005 111.12 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.446 ' CG2' HD21 ' A' ' 20' ' ' LEU . 43.9 p -75.4 -167.41 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 73.310000000000002 111.139 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . 2.9 mm-40 -116.0 -95.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 73.319999999999993 110.921 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -89.69 8.53 31.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 72.400000000000006 110.881 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -75.29 -10.97 59.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.25 110.912 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -76.36 -23.63 54.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 75.329999999999998 110.882 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -74.1 -34.58 64.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 110.888 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -66.37 -49.58 66.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 73.239999999999995 110.9 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.54 -30.43 2.13 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.71 -0.757 . . . . 72.129999999999995 112.496 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.28 -62.54 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.767 0.317 . . . . 74.340000000000003 111.052 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 35.1 tpp -67.09 -13.49 61.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 75.319999999999993 110.871 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.421 ' HA ' ' HG3' ' A' ' 31' ' ' GLU . . . -67.07 -22.38 65.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 73.120000000000005 111.114 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -85.78 10.81 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 71.439999999999998 110.862 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.01 -75.67 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 74.099999999999994 110.909 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.08 13.66 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.704 -0.76 . . . . 64.439999999999998 112.491 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HG3' ' HA ' ' A' ' 27' ' ' ALA . 20.9 mt-10 -59.59 104.57 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 74.319999999999993 110.881 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.93 -164.47 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 74.010000000000005 110.9 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.23 121.6 43.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 63.5 110.862 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.491 ' HB ' ' CB ' ' A' ' 59' ' ' GLU . 2.6 t -82.6 178.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 73.120000000000005 111.121 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.48 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 71.0 p -94.35 -59.94 1.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 75.230000000000004 111.215 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.0 -64.6 0.1 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.733 . . . . 71.349999999999994 112.5 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 164.85 32.96 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 73.400000000000006 112.415 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -70.43 -26.07 63.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 64.150000000000006 110.865 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.73 -46.45 77.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 73.430000000000007 111.081 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -41.61 25.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 110.879 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.531 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -59.99 -37.93 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 75.040000000000006 110.882 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.525 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -62.9 -33.3 75.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 111.116 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.513 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 1.3 ptt-85 -78.66 -40.12 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 74.519999999999996 110.84 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.513 ' N ' ' HG2' ' A' ' 43' ' ' ARG . . . -77.83 -59.32 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 75.239999999999995 111.154 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.418 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -54.64 -20.81 8.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 71.109999999999999 111.123 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.634 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -62.0 -81.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 75.120000000000005 111.089 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.788 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 58.4 t -108.8 -19.87 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.439999999999998 111.116 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 1.3 tp60 -69.33 -33.15 72.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 65.409999999999997 110.919 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 1.02 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.64 1.88 25.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 73.540000000000006 111.07 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.991 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.74 -7.17 0.12 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.637 0.732 . . . . 73.340000000000003 111.103 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.02 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.6 Cg_endo -69.75 -26.11 27.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.671 2.247 . . . . 72.409999999999997 112.327 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.71 -61.41 2.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.725 -0.75 . . . . 65.420000000000002 112.498 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -156.31 -33.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 65.040000000000006 112.473 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.626 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -148.01 159.78 43.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 71.340000000000003 111.181 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.402 ' HB3' HG23 ' A' ' 50' ' ' VAL . . . -72.09 70.98 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 70.340000000000003 111.099 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.779 ' HA3' ' HA ' ' A' ' 73' ' ' VAL . . . -149.68 112.72 0.57 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 61.229999999999997 112.475 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' N ' HD22 ' A' ' 72' ' ' LEU . 2.2 tt0 -98.49 -169.73 1.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.846 0.355 . . . . 75.109999999999999 110.89 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.7 t -133.42 120.84 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 73.439999999999998 111.142 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.779 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 11.2 tm-20 -90.3 158.47 17.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.439999999999998 110.875 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 t -137.97 111.22 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 72.430000000000007 111.151 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.2 169.6 17.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 72.150000000000006 110.907 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.54 149.78 40.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 73.239999999999995 111.125 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.69 -154.29 8.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.758 -0.734 . . . . 74.340000000000003 112.53 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -78.44 -23.99 46.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.383 . . . . 74.340000000000003 110.935 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.79 -114.06 2.86 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.713 -0.756 . . . . 73.129999999999995 112.538 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.98 -78.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 70.310000000000002 111.093 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.658 ' O ' ' CG ' ' A' ' 86' ' ' ASP . . . -87.99 139.95 29.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 71.209999999999994 111.067 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -154.65 73.36 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 73.340000000000003 111.107 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.779 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 11.5 p90 -132.41 -172.16 2.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 75.040000000000006 110.918 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -153.96 129.12 2.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.727 -0.749 . . . . 71.400000000000006 112.474 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -107.35 120.01 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 64.010000000000005 111.141 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.668 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -98.18 139.14 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 73.010000000000005 110.888 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.779 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 3.0 m -147.34 111.42 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 65.540000000000006 111.137 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.794 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.2 m -167.38 -137.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 64.439999999999998 111.112 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.533 ' H ' ' CG2' ' A' ' 74' ' ' THR . 10.7 mtm180 -108.28 153.88 41.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.59 0.709 . . . . 74.510000000000005 110.888 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.72 2.17 3.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.72 2.28 . . . . 65.109999999999999 112.372 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -85.94 45.94 1.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 73.129999999999995 110.877 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.95 -6.02 7.19 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 71.109999999999999 112.491 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.794 ' O ' ' HB ' ' A' ' 74' ' ' THR . 72.2 p -91.83 123.79 35.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 74.420000000000002 111.121 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.531 ' CD ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -146.2 143.89 29.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 72.099999999999994 110.889 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 87.1 t -110.87 84.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 72.109999999999999 111.114 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 72' ' ' LEU . 2.4 tm-20 -77.52 118.0 19.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 74.340000000000003 110.899 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.608 ' O ' ' HA2' ' A' ' 70' ' ' GLY . 2.4 t -95.44 136.28 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 75.420000000000002 111.147 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.468 ' CD2' HG13 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -87.86 117.42 26.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 75.519999999999996 110.878 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.537 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -124.75 111.88 16.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 75.049999999999997 110.945 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.87 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.6 t70 -138.75 120.94 15.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 64.310000000000002 110.831 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.81 1.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 73.150000000000006 110.854 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.63 ' H ' ' C ' ' A' ' 86' ' ' ASP . 49.8 t0 -65.83 -6.49 12.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 70.329999999999998 110.847 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 70.43 19.32 6.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 75.129999999999995 110.918 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.68 -0.03 1.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 54.119999999999997 110.846 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.87 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 89.2 t -120.94 70.02 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 71.340000000000003 111.128 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -124.55 14.36 8.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.319999999999993 110.935 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.69 -172.6 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 74.099999999999994 110.881 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.7 t -116.43 174.34 6.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 71.420000000000002 111.147 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 82' ' ' GLU . 2.6 tp10 -141.1 119.28 7.98 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.729 . . . . 74.340000000000003 110.908 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 115.64 4.19 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.653 2.236 . . . . 74.340000000000003 112.341 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.7 112.8 21.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 72.129999999999995 111.144 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 100' ' ' ASP . 2.5 t70 -128.93 56.8 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 71.200000000000003 110.864 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.28 -17.95 2.91 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.761 -0.733 . . . . 71.239999999999995 112.517 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 98' ' ' ASP . 1.2 m-20 -96.25 -61.35 1.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 74.5 110.849 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.44 18.1 65.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 52.219999999999999 112.519 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 61.310000000000002 112.508 -179.906 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.832 0.348 . . . . 73.239999999999995 110.888 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -67.01 -42.5 84.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 75.549999999999997 110.935 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -66.31 -143.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 53.439999999999998 110.866 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.496 ' C ' ' H ' ' A' ' 16' ' ' THR . 19.7 mm -75.32 114.07 31.98 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.613 0.72 . . . . 75.510000000000005 111.087 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 16.64 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.652 2.235 . . . . 73.450000000000003 112.366 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.496 ' H ' ' C ' ' A' ' 14' ' ' ILE . 2.8 m -134.76 23.52 3.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 71.209999999999994 111.096 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.494 HG23 HG22 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -75.66 -145.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 75.420000000000002 111.127 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.455 ' H ' ' CG2' ' A' ' 17' ' ' THR . 59.5 mt-10 -84.65 -104.23 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 73.040000000000006 110.877 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.62 6.19 45.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 73.049999999999997 110.878 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.404 HD23 HG22 ' A' ' 91' ' ' VAL . 7.7 mp -65.33 -34.87 79.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 75.310000000000002 110.923 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -83.26 3.73 30.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.972 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -105.6 -36.32 7.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 72.519999999999996 110.885 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -66.68 -49.01 67.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.477 . . . . 75.230000000000004 110.877 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -43.27 -33.09 1.88 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 64.450000000000003 112.507 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.37 -56.49 19.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.768 0.318 . . . . 64.430000000000007 111.05 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 19.6 ptp -70.18 -7.96 46.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 75.129999999999995 110.905 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . -79.62 -17.49 53.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.329999999999998 111.096 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -82.43 9.74 8.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.898 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -93.69 -79.21 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 64.219999999999999 110.87 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.05 7.88 5.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 74.109999999999999 112.484 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.53 ' HG2' ' N ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -61.92 152.4 32.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 73.239999999999995 110.891 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.53 ' N ' ' HG2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -116.47 -165.1 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 73.129999999999995 110.836 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -114.16 116.77 29.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 73.349999999999994 110.876 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.455 ' HB ' ' CB ' ' A' ' 59' ' ' GLU . 10.2 t -74.9 167.39 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 72.439999999999998 111.131 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.451 ' OG1' ' HD2' ' A' ' 37' ' ' PRO . 65.7 p -94.67 -44.3 7.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 111.126 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.427 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 164.98 -61.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.727 . . . . 50.210000000000001 112.489 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.9 Cg_endo -69.71 159.73 52.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 74.209999999999994 112.357 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.596 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 1.2 t70 -65.06 -27.18 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 72.319999999999993 110.859 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -36.41 73.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 71.239999999999995 111.062 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.427 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -85.21 -37.34 20.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 74.340000000000003 110.863 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.596 ' NE ' ' HA ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -70.01 -45.57 66.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 73.140000000000001 110.859 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.589 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -68.74 -36.03 77.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 73.340000000000003 111.1 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.427 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 10.5 ptt180 -79.51 -41.47 27.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.349999999999994 110.858 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -74.7 -62.3 1.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 71.340000000000003 111.075 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.61 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -53.79 -19.64 4.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 74.129999999999995 111.097 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.685 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -55.43 -67.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 71.319999999999993 111.112 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.657 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 3.5 p -112.7 -18.48 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 75.120000000000005 111.159 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 5.4 mt-30 -77.67 -29.14 51.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 63.420000000000002 110.938 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 1.044 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.86 -7.81 15.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 73.019999999999996 111.131 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.988 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.46 -0.51 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.606 0.717 . . . . 70.140000000000001 111.149 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.044 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.2 Cg_endo -69.77 -29.1 24.37 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.654 2.236 . . . . 75.530000000000001 112.304 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.43 -52.27 4.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.736 -0.745 . . . . 74.109999999999999 112.479 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.1 -34.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 75.319999999999993 112.488 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.746 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -144.4 149.47 36.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 65.329999999999998 111.137 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.3 81.17 1.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 70.5 111.085 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.708 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -143.12 99.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 64.219999999999999 112.45 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.538 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.6 tt0 -90.66 179.97 5.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 74.019999999999996 110.925 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.3 t -130.81 121.97 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 63.350000000000001 111.153 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.455 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 11.8 tm-20 -93.39 153.56 18.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 75.409999999999997 110.91 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.428 ' HA ' ' CD2' ' A' ' 69' ' ' TYR . 1.5 t -132.98 112.34 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 71.319999999999993 111.094 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -140.91 162.91 34.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 73.140000000000001 110.854 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.92 120.07 34.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 71.329999999999998 111.134 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.41 -169.03 32.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 74.120000000000005 112.452 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.69 -23.12 49.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 75.040000000000006 110.908 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.52 -109.23 0.36 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.756 -0.735 . . . . 74.219999999999999 112.515 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.09 -74.43 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 63.340000000000003 111.122 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.401 ' O ' ' CB ' ' A' ' 86' ' ' ASP . . . -111.14 162.01 15.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 111.12 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -156.24 72.06 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 53.219999999999999 111.138 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 84' ' ' HIS . 4.2 m-85 -110.53 163.65 13.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 74.430000000000007 110.915 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.09 100.07 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.753 . . . . 74.0 112.479 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.18 119.37 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 72.430000000000007 111.151 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.708 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -113.26 144.63 42.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 74.109999999999999 110.934 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.566 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 10.8 t -149.38 123.37 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 111.118 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.765 ' OG1' ' HA ' ' A' ' 80' ' ' ARG . 1.9 m -172.2 -135.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 74.420000000000002 111.127 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.507 ' H ' ' CG2' ' A' ' 74' ' ' THR . 27.0 mtm-85 -96.02 145.93 30.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.576 0.703 . . . . 75.340000000000003 110.866 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.504 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.2 Cg_endo -69.75 10.64 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.698 2.265 . . . . 71.409999999999997 112.339 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 75' ' ' ARG . 7.6 m-20 -88.59 25.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.510000000000005 110.854 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.24 -9.76 24.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 71.150000000000006 112.521 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.42 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.5 t -97.58 102.54 14.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 65.329999999999998 111.154 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.765 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -142.2 172.39 12.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 73.0 110.9 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 27.9 t -119.93 113.03 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 72.310000000000002 111.138 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.55 ' HA ' ' HB3' ' A' ' 72' ' ' LEU . 2.1 pt-20 -88.34 122.26 31.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.902 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.421 HG11 ' HB ' ' A' ' 94' ' ' THR . 2.1 t -100.96 117.01 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 72.109999999999999 111.153 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.508 ' O ' ' O ' ' A' ' 91' ' ' VAL . 3.5 t-160 -82.02 116.2 21.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 74.540000000000006 110.846 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -104.03 98.09 7.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 74.230000000000004 110.937 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 1.073 ' H ' ' HA ' ' A' ' 91' ' ' VAL . 3.3 p30 -134.84 119.25 17.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 75.019999999999996 110.845 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.41 ' C ' ' H ' ' A' ' 89' ' ' PHE . 1.3 tmt_? -65.35 10.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 75.519999999999996 110.868 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.643 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 19.3 t0 -80.03 20.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 75.099999999999994 110.86 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.643 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 15.3 m-85 91.5 -17.8 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 74.329999999999998 110.908 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 38.23 3.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 75.420000000000002 110.895 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 1.073 ' HA ' ' H ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -64.35 -6.8 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 75.540000000000006 111.125 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.08 28.48 8.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 75.340000000000003 110.965 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -80.04 75.08 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 71.310000000000002 110.891 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.421 ' HB ' HG11 ' A' ' 83' ' ' VAL . 4.8 t -86.02 151.36 23.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 73.239999999999995 111.122 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.18 110.45 4.0 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.631 0.729 . . . . 73.099999999999994 110.884 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 120.22 7.04 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.686 2.257 . . . . 72.209999999999994 112.369 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.46 ' C ' HH12 ' A' ' 80' ' ' ARG . . . -116.81 167.47 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 73.219999999999999 111.081 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.49 7.71 7.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 65.219999999999999 110.859 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.415 ' HA2' ' CB ' ' A' ' 42' ' ' ALA . . . 86.1 -18.68 30.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 34.299999999999997 112.476 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.21 -16.55 22.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 74.409999999999997 110.859 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.53 -24.16 63.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 75.439999999999998 112.472 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 61.520000000000003 112.53 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.1 t0 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.834 0.349 . . . . 64.329999999999998 110.843 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -68.34 -43.89 76.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.904 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -60.74 -167.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.874 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 16' ' ' THR . 46.6 mm -76.69 122.07 85.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.62 0.724 . . . . 65.239999999999995 111.119 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 9.27 0.6 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.697 2.265 . . . . 75.150000000000006 112.3 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -125.52 36.69 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 71.540000000000006 111.133 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.449 ' HB ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -91.6 -166.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 64.420000000000002 111.176 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -64.42 -103.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 75.530000000000001 110.904 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.77 7.69 45.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.239999999999995 110.892 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.684 ' HG ' ' CD1' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.02 -14.35 53.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 72.340000000000003 110.911 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -94.4 5.66 51.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 71.540000000000006 110.946 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -108.44 -43.36 4.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 72.319999999999993 110.905 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -64.64 -53.04 53.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 110.9 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.54 -54.32 7.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.774 -0.726 . . . . 74.420000000000002 112.455 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.18 49.0 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.762 0.315 . . . . 75.510000000000005 111.124 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.2 ptm -66.47 -40.83 89.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 110.885 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -122.54 -92.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 70.319999999999993 111.055 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -145.12 -35.14 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 72.299999999999997 110.884 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.26 30.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.230000000000004 110.831 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.98 7.63 65.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 70.310000000000002 112.512 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -74.22 161.99 29.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 72.329999999999998 110.854 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.66 -166.03 1.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 70.230000000000004 110.837 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.13 118.94 22.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 72.109999999999999 110.91 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 87.6 t -71.36 155.76 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 72.230000000000004 111.119 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.6 p -107.82 -22.04 12.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 73.329999999999998 111.211 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.48 -139.71 2.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 41.32 112.455 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -162.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.722 2.282 . . . . 74.409999999999997 112.31 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.35 -27.42 64.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 64.409999999999997 110.896 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.81 -39.13 70.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 75.329999999999998 111.105 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -82.45 -37.58 25.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 110.874 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.534 ' HG3' ' HD3' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -68.53 -38.34 80.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.430000000000007 110.893 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.08 74.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 74.329999999999998 111.168 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.481 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 2.7 ptt85 -77.61 -40.45 42.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 72.040000000000006 110.909 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -77.9 -57.53 3.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 73.319999999999993 111.105 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.567 ' HA ' ' HB1' ' A' ' 49' ' ' ALA . . . -52.78 -18.11 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 64.530000000000001 111.085 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -63.75 -78.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.530000000000001 111.096 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.749 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 80.5 t -111.91 -20.07 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 64.120000000000005 111.134 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 16.6 mt-30 -72.01 -26.62 62.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.94 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 1.076 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -109.09 -4.99 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 111.135 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.999 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.78 0.59 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.615 0.722 . . . . 64.409999999999997 111.123 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.076 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.0 Cg_endo -69.79 -26.47 27.41 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 74.239999999999995 112.33 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.36 -54.58 2.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 73.409999999999997 112.47 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.74 -31.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 63.43 112.512 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.737 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -140.51 146.14 37.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 72.519999999999996 111.17 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.68 74.87 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 74.150000000000006 111.116 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.699 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -153.45 109.34 0.4 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 73.209999999999994 112.483 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.661 ' HB3' ' HB1' ' A' ' 49' ' ' ALA . 2.3 pt-20 -100.91 -161.21 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 64.209999999999994 110.896 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.84 142.88 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 74.129999999999995 111.096 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.514 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 1.0 OUTLIER -108.82 153.5 23.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 74.200000000000003 110.886 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.86 105.56 7.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 74.530000000000001 111.117 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.85 165.76 25.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 73.019999999999996 110.878 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -124.28 115.42 21.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 63.409999999999997 111.124 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.04 -151.31 14.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.731 -0.747 . . . . 61.329999999999998 112.518 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -78.38 -23.43 46.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.364 . . . . 73.25 110.88 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.86 -120.41 0.22 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 74.329999999999998 112.489 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.65 -76.95 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 71.340000000000003 111.117 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -102.9 92.53 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 53.039999999999999 111.082 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.55 72.98 10.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 71.420000000000002 111.085 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 6.8 m-85 -106.76 165.62 11.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.409999999999997 110.904 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -146.89 111.68 0.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 51.329999999999998 112.518 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.66 117.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.362 . . . . 73.430000000000007 111.111 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.798 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -104.14 145.45 30.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 75.040000000000006 110.962 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.697 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 18.1 m -151.23 118.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 75.129999999999995 111.14 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.786 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.3 m -165.87 -136.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.340000000000003 111.153 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.538 ' H ' ' CG2' ' A' ' 74' ' ' THR . 0.0 OUTLIER -102.68 149.85 37.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 73.319999999999993 110.858 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.442 ' HD3' HG22 ' A' ' 50' ' ' VAL . 53.3 Cg_endo -69.77 6.01 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.63 2.22 . . . . 64.239999999999995 112.359 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -85.91 35.34 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 72.329999999999998 110.837 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.41 -8.68 52.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 51.009999999999998 112.478 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.786 ' O ' ' HB ' ' A' ' 74' ' ' THR . 3.2 t -92.34 125.43 37.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 75.409999999999997 111.126 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.536 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -144.24 144.35 31.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 75.430000000000007 110.891 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 87.9 t -104.81 88.97 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 72.319999999999993 111.132 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.53 122.78 21.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 65.5 110.887 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 16.3 t -102.29 139.26 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 75.25 111.161 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.506 ' CD2' HG11 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -89.43 115.14 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 72.109999999999999 110.883 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.684 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -125.62 105.63 9.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 73.310000000000002 110.937 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.696 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 4.3 m-20 -135.12 129.06 33.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 73.219999999999999 110.879 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.48 6.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 64.549999999999997 110.893 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.657 ' H ' ' C ' ' A' ' 86' ' ' ASP . 3.8 t0 -64.89 -5.84 6.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 75.150000000000006 110.88 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 70.71 13.17 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 110.903 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 2.73 1.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 75.120000000000005 110.909 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.696 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 69.0 t -119.13 81.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 73.099999999999994 111.069 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.27 10.6 3.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 74.450000000000003 110.924 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.419 ' O ' HG12 ' A' ' 83' ' ' VAL . 24.3 t0 -93.25 167.61 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 74.0 110.839 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 9.8 t -108.17 166.9 10.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 73.010000000000005 111.122 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -144.53 119.96 6.03 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.636 0.732 . . . . 73.329999999999998 110.885 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 119.02 6.03 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.697 2.264 . . . . 74.239999999999995 112.325 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.34 163.07 16.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 73.239999999999995 111.063 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -125.62 -135.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 74.040000000000006 110.816 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.13 -14.94 27.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.667 -0.778 . . . . 74.219999999999999 112.484 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -91.5 -48.66 6.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 70.450000000000003 110.862 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.76 23.2 9.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 71.310000000000002 112.465 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 60.210000000000001 112.49 -179.921 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.824 0.345 . . . . 64.430000000000007 110.865 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -67.59 -23.16 65.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 73.329999999999998 110.893 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.427 ' HB2' HD22 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -62.23 -157.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 70.150000000000006 110.859 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.55 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 20.7 pt -77.21 160.87 74.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.587 0.708 . . . . 73.129999999999995 111.153 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.8 -3.11 11.37 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.64 2.227 . . . . 74.450000000000003 112.358 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.0 p -148.2 79.87 1.46 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 73.019999999999996 111.153 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.607 ' CG2' HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -98.98 -166.34 1.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 111.153 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . 10.6 tt0 -80.58 -100.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 64.140000000000001 110.881 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.58 10.83 40.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 110.908 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.493 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 3.3 tp -65.01 -21.15 66.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 75.200000000000003 110.904 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -83.78 7.12 18.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 73.209999999999994 110.918 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -108.8 -42.08 4.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 74.430000000000007 110.868 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -66.43 -46.68 75.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 75.329999999999998 110.934 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.22 -29.19 1.57 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 73.239999999999995 112.513 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.25 -58.63 5.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.78 0.324 . . . . 75.140000000000001 111.121 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -9.99 59.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 64.120000000000005 110.865 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.92 -17.84 45.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 72.420000000000002 111.085 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -79.04 5.07 12.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 73.430000000000007 110.915 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -73.63 -82.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 75.219999999999999 110.852 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.06 12.62 0.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 75.430000000000007 112.504 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -66.38 168.66 8.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 72.540000000000006 110.877 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -112.12 -149.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 74.010000000000005 110.867 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.96 170.18 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 70.099999999999994 110.881 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.592 ' N ' ' O ' ' A' ' 58' ' ' VAL . 14.8 t -118.45 169.42 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 73.140000000000001 111.105 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.483 ' OG1' ' HD2' ' A' ' 37' ' ' PRO . 63.0 p -90.53 -41.59 11.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 111.137 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.414 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 162.01 -61.83 0.28 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 74.219999999999999 112.515 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 54.0 Cg_endo -69.74 157.01 61.9 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.712 2.275 . . . . 72.5 112.337 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -62.74 -26.84 68.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 73.099999999999994 110.889 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.28 -35.83 72.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 71.099999999999994 111.15 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.42 -36.13 24.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 65.430000000000007 110.893 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.446 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 12.8 ptt180 -70.22 -43.64 70.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 74.019999999999996 110.894 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.618 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . . . -70.41 -34.41 72.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 72.129999999999995 111.143 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -79.92 -41.22 26.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.109999999999999 110.89 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.587 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -76.85 -62.24 1.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 71.230000000000004 111.067 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.53 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -52.74 -22.31 5.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 64.230000000000004 111.117 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.737 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -53.59 -69.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 63.43 111.154 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.637 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.3 t -112.17 -11.11 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 72.409999999999997 111.093 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.587 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.3 tp60 -83.19 -34.19 26.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 74.319999999999993 110.926 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.969 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.44 -6.02 18.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 73.450000000000003 111.098 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.979 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.93 -9.42 0.14 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.628 0.728 . . . . 72.310000000000002 111.152 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.979 ' CD ' ' N ' ' A' ' 50' ' ' VAL . 53.6 Cg_endo -69.78 -22.73 31.59 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.68 2.253 . . . . 74.140000000000001 112.322 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.65 -54.36 2.96 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.794 -0.717 . . . . 73.319999999999993 112.488 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.64 -34.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 62.039999999999999 112.455 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.672 ' O ' ' O ' ' A' ' 49' ' ' ALA . 2.0 t -148.34 152.81 37.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.757 0.313 . . . . 72.420000000000002 111.194 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.38 75.28 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 71.209999999999994 111.077 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.741 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -147.09 104.51 0.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.722 . . . . 74.519999999999996 112.503 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.476 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 1.9 tt0 -97.6 -170.37 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.37 . . . . 74.25 110.888 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.592 ' O ' ' N ' ' A' ' 34' ' ' VAL . 2.6 t -129.25 139.17 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 72.319999999999993 111.159 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 10.6 tt0 -106.31 128.16 53.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 71.319999999999993 110.923 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -118.31 95.57 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 73.010000000000005 111.077 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.28 168.87 18.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 61.340000000000003 110.85 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.4 m -98.07 -19.34 18.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 73.319999999999993 111.144 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 49.97 -159.2 1.39 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 45.140000000000001 112.488 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.36 -25.37 23.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.357 . . . . 71.510000000000005 110.892 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.05 -116.89 0.47 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.683 -0.77 . . . . 72.129999999999995 112.475 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.11 -65.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 74.109999999999999 111.089 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.689 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -111.83 94.39 4.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 74.120000000000005 111.144 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.71 84.67 7.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 74.349999999999994 111.063 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.523 ' CE1' ' HB ' ' A' ' 71' ' ' VAL . 6.5 t80 -110.81 123.43 50.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 64.109999999999999 110.92 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -126.32 111.89 1.51 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 74.409999999999997 112.476 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.523 ' HB ' ' CE1' ' A' ' 69' ' ' TYR . 7.9 p -107.83 121.03 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 73.430000000000007 111.11 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.741 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -114.12 134.31 54.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 75.319999999999993 110.936 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.654 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.5 m -144.92 122.77 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 72.25 111.143 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.781 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 5.0 m -171.95 -126.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 63.219999999999999 111.131 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.467 ' H ' ' CG2' ' A' ' 74' ' ' THR . 0.0 OUTLIER -106.33 146.08 32.28 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.665 0.745 . . . . 63.130000000000003 110.868 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.497 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.4 Cg_endo -69.74 12.36 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.667 2.245 . . . . 64.510000000000005 112.355 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 75' ' ' ARG . 38.2 t70 -91.55 28.82 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 73.010000000000005 110.835 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.35 -10.88 26.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 72.420000000000002 112.463 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.575 ' O ' ' HB ' ' A' ' 74' ' ' THR . 32.1 p -97.1 104.99 17.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 73.340000000000003 111.151 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.781 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.4 OUTLIER -138.17 165.7 25.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 75.219999999999999 110.85 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 5.7 m -115.0 98.94 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 72.25 111.166 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . 8.8 tm-20 -85.69 125.64 33.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 110.882 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.582 ' O ' ' HA2' ' A' ' 70' ' ' GLY . 2.5 t -92.43 113.04 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.420000000000002 111.14 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -85.79 113.0 21.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 73.120000000000005 110.902 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.65 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 4.0 mm? -130.36 121.76 26.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 74.349999999999994 110.877 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.7 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.4 t0 -137.8 134.92 35.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 65.200000000000003 110.892 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.35 3.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.439999999999998 110.827 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.593 ' H ' ' C ' ' A' ' 86' ' ' ASP . 8.2 t0 -65.7 -3.53 4.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 73.400000000000006 110.834 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 68.5 10.73 8.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 71.209999999999994 110.899 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.04 -1.29 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 74.219999999999999 110.871 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.7 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 58.3 t -117.6 90.99 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 74.519999999999996 111.123 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.631 ' HA ' ' CD1' ' A' ' 85' ' ' LEU . 5.5 mp -146.33 14.6 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 74.030000000000001 110.886 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -113.43 140.96 47.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.439999999999998 110.869 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.3 t -87.91 151.41 22.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 64.129999999999995 111.194 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -123.83 149.8 60.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 71.409999999999997 110.904 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 143.12 49.77 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.705 2.27 . . . . 72.409999999999997 112.325 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.432 ' HB2' ' CG ' ' A' ' 80' ' ' ARG . . . -118.81 110.2 16.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 64.140000000000001 111.067 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -98.46 4.79 48.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 73.329999999999998 110.818 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.61 -20.91 8.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.774 -0.727 . . . . 71.349999999999994 112.487 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.3 -16.03 20.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.825 0.345 . . . . 64.319999999999993 110.865 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.99 -14.0 54.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.796 -0.716 . . . . 70.409999999999997 112.488 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 75.409999999999997 112.479 -179.908 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.83 0.348 . . . . 72.349999999999994 110.872 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.401 ' HB2' ' HB2' ' A' ' 68' ' ' ALA . 92.7 m-85 -67.52 -36.53 81.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 74.200000000000003 110.926 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.59 -164.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 71.409999999999997 110.831 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.508 ' C ' ' H ' ' A' ' 16' ' ' THR . 24.4 mm -77.78 129.84 75.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.651 0.739 . . . . 71.310000000000002 111.13 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 14' ' ' ILE . 53.4 Cg_endo -69.8 18.0 0.2 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.645 2.23 . . . . 73.239999999999995 112.35 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.508 ' H ' ' C ' ' A' ' 14' ' ' ILE . 3.1 m -138.73 27.13 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 75.409999999999997 111.172 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.458 ' HB ' HD23 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -74.36 -167.5 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 74.109999999999999 111.132 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -63.94 -103.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 74.409999999999997 110.887 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.75 8.56 44.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 73.120000000000005 110.882 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.729 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.71 -13.24 53.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.200000000000003 110.911 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -95.34 7.74 45.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.454 . . . . 73.109999999999999 110.91 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -106.98 -40.08 5.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 63.310000000000002 110.855 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -66.24 -47.63 73.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 72.420000000000002 110.914 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -43.55 -31.9 1.81 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 73.109999999999999 112.485 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.33 -64.51 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 71.340000000000003 111.075 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -70.45 -7.94 47.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 71.530000000000001 110.921 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.42 ' HA ' ' HB2' ' A' ' 31' ' ' GLU . . . -76.91 -19.98 56.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 65.230000000000004 111.087 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -77.97 5.79 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 72.519999999999996 110.864 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.72 -81.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 72.519999999999996 110.85 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.92 14.52 5.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 75.420000000000002 112.499 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 1.1 tt0 -54.82 103.4 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.902 0.382 . . . . 74.310000000000002 110.926 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.95 -170.2 1.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 74.230000000000004 110.857 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.18 125.46 52.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 71.400000000000006 110.863 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 35' ' ' THR . 1.9 t -71.03 161.92 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 75.510000000000005 111.101 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' CG1' ' A' ' 34' ' ' VAL . 1.7 p -84.93 -45.75 11.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 72.040000000000006 111.125 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.43 -81.17 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.724 -0.751 . . . . 73.129999999999995 112.476 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 169.48 18.78 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.701 2.267 . . . . 72.040000000000006 112.337 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -68.17 -26.39 65.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 75.340000000000003 110.872 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.53 -28.4 20.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 75.109999999999999 111.098 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.401 ' HB2' HG11 ' A' ' 34' ' ' VAL . 13.5 m-20 -76.81 -30.79 56.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 110.905 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.453 ' HG2' ' N ' ' A' ' 42' ' ' ALA . 4.3 ptt180 -56.7 -38.96 73.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 72.099999999999994 110.892 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.453 ' N ' ' HG2' ' A' ' 41' ' ' ARG . . . -70.12 -30.44 67.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 111.086 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 40' ' ' ASP . 10.5 mtt-85 -74.34 -45.16 48.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 73.140000000000001 110.875 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.596 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -78.25 -57.52 3.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 74.219999999999999 111.118 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -54.02 -17.36 2.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 64.129999999999995 111.106 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.632 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -62.69 -68.05 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 70.140000000000001 111.106 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.687 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 26.0 t -122.21 -14.16 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 71.340000000000003 111.14 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 27.9 mt-30 -79.64 -41.64 26.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 110.92 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.897 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -104.43 0.05 28.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 62.329999999999998 111.074 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.965 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.29 -13.19 0.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 74.319999999999993 111.136 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.965 ' CD ' ' N ' ' A' ' 50' ' ' VAL . 53.5 Cg_endo -69.77 -32.24 18.92 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.654 2.236 . . . . 74.209999999999994 112.362 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.16 -51.46 38.5 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.785 -0.722 . . . . 74.540000000000006 112.51 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.58 -33.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 64.450000000000003 112.496 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.566 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -150.24 158.63 44.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 65.209999999999994 111.152 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.48 ' CB ' HG21 ' A' ' 50' ' ' VAL . . . -70.99 77.78 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 111.102 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.716 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -144.94 106.9 0.41 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.733 . . . . 71.430000000000007 112.46 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.42 ' H ' HD21 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -101.33 -159.24 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 71.420000000000002 110.884 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.475 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 0.9 OUTLIER -126.62 121.3 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 75.030000000000001 111.159 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.758 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -94.69 171.47 8.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 75.239999999999995 110.87 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.421 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -113.88 128.86 56.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 75.140000000000001 111.12 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.534 ' N ' ' HA ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -142.72 91.29 2.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 75.5 110.903 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.0 p -94.81 149.4 21.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 73.430000000000007 111.144 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.18 179.46 17.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.778 -0.725 . . . . 73.230000000000004 112.509 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -76.41 -24.14 54.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.899 0.381 . . . . 75.019999999999996 110.884 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.59 -117.39 2.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 65.319999999999993 112.468 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.45 38.93 3.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 72.329999999999998 111.095 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.405 ' HA ' ' HB3' ' A' ' 86' ' ' ASP . . . -59.06 -171.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 71.540000000000006 111.083 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 12' ' ' TYR . . . -156.29 -95.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 71.219999999999999 111.109 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.758 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -162.29 -163.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 75.439999999999998 110.888 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -138.99 156.64 24.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.749 -0.739 . . . . 74.510000000000005 112.505 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.4 p -125.61 121.1 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 73.040000000000006 111.124 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.758 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -112.14 142.91 44.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 63.409999999999997 110.94 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.716 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 11.0 p -157.88 125.84 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 63.530000000000001 111.139 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.697 ' HB ' ' HA ' ' A' ' 80' ' ' ARG . 5.6 m -168.6 -125.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 72.109999999999999 111.14 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.48 ' H ' ' CG2' ' A' ' 74' ' ' THR . 3.8 ttm-85 -107.82 139.32 20.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 75.219999999999999 110.876 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.4 ' HD3' ' HB1' ' A' ' 55' ' ' ALA . 53.8 Cg_endo -69.75 13.89 0.27 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.679 2.252 . . . . 71.409999999999997 112.369 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.472 ' H ' ' C ' ' A' ' 75' ' ' ARG . 1.3 m-20 -94.1 23.79 4.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 72.540000000000006 110.877 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.51 -16.3 61.28 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.718 -0.753 . . . . 53.329999999999998 112.48 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.687 ' O ' ' HB ' ' A' ' 74' ' ' THR . 6.0 t -94.0 122.55 36.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.763 0.316 . . . . 64.019999999999996 111.105 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.697 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -141.65 161.52 37.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 72.219999999999999 110.852 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.758 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 94.1 t -118.05 85.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 73.439999999999998 111.103 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.444 ' HA ' ' CB ' ' A' ' 72' ' ' LEU . 6.9 tm-20 -77.27 121.86 24.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 71.140000000000001 110.841 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.3 t -100.33 137.4 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 73.219999999999999 111.124 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.46 ' C ' HG12 ' A' ' 91' ' ' VAL . 6.5 m-70 -92.56 118.23 30.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 63.399999999999999 110.871 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.729 ' CD2' ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -122.48 101.36 7.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 110.892 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.676 ' C ' ' H ' ' A' ' 88' ' ' ASP . 34.4 m-20 -140.78 131.74 26.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 110.858 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.36 11.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.854 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.676 ' H ' ' C ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -65.37 -5.93 8.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.856 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 74.27 6.88 4.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 75.120000000000005 110.865 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -141.54 7.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 74.439999999999998 110.894 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.672 ' CG2' ' HB2' ' A' ' 86' ' ' ASP . 40.9 t -118.31 69.52 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 111.137 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.91 10.72 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 70.120000000000005 110.953 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.23 -179.95 3.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 74.310000000000002 110.791 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 13.4 t -126.42 171.18 11.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 71.340000000000003 111.138 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -144.84 159.64 49.68 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.663 0.744 . . . . 74.400000000000006 110.86 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 107.01 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.648 2.232 . . . . 72.450000000000003 112.341 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.69 112.15 11.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 73.239999999999995 111.099 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -85.68 6.36 27.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 64.200000000000003 110.92 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.402 ' HA2' ' CB ' ' A' ' 42' ' ' ALA . . . 79.56 -20.93 4.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.744 -0.741 . . . . 65.310000000000002 112.502 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.36 -33.06 10.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 74.109999999999999 110.873 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.07 24.85 54.0 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 71.329999999999998 112.491 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 74.140000000000001 112.457 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.78 0.324 . . . . 74.439999999999998 110.806 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -65.41 -56.38 12.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 75.430000000000007 110.852 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 25.5 t0 -65.36 -115.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 62.009999999999998 110.862 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.517 ' C ' ' H ' ' A' ' 16' ' ' THR . 12.6 mm -100.13 108.64 53.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.586 0.708 . . . . 75.120000000000005 111.103 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 23.1 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.714 2.276 . . . . 74.349999999999994 112.322 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.517 ' H ' ' C ' ' A' ' 14' ' ' ILE . 3.1 m -131.17 20.22 4.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.230000000000004 111.163 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -165.99 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 62.340000000000003 111.113 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.405 ' H ' HD23 ' A' ' 92' ' ' LEU . 21.1 mt-10 -61.3 -105.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 71.519999999999996 110.873 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.8 8.23 44.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 75.310000000000002 110.898 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.769 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -65.29 -15.81 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 73.329999999999998 110.88 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -97.02 4.39 51.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 74.219999999999999 110.91 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -103.65 -42.21 5.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 74.120000000000005 110.868 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -66.35 -51.39 57.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 75.0 110.961 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.3 -27.86 4.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 75.329999999999998 112.5 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.35 49.23 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 71.230000000000004 111.122 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.442 ' HG3' HG23 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -70.36 -42.77 71.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 74.040000000000006 110.905 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.456 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -119.42 -93.28 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 71.209999999999994 111.1 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -150.39 -37.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 73.400000000000006 110.927 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.38 -0.05 1.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 74.219999999999999 110.841 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.62 -20.33 7.55 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.757 -0.735 . . . . 73.340000000000003 112.508 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.9 103.25 13.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 75.430000000000007 110.91 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.68 179.08 4.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.491 . . . . 65.439999999999998 110.846 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.3 119.14 37.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 64.400000000000006 110.911 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.521 ' CG1' ' H ' ' A' ' 35' ' ' THR . 8.4 t -84.2 -125.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 65.109999999999999 111.09 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.521 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 71.4 p -139.52 -71.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 70.540000000000006 111.129 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.22 -65.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.755 -0.736 . . . . 75.25 112.51 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 166.63 26.9 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.649 2.233 . . . . 74.310000000000002 112.325 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.558 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -72.21 -28.94 63.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 110.846 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.0 -32.9 62.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.095 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.95 -31.57 31.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 65.540000000000006 110.882 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -69.34 -43.13 74.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 71.230000000000004 110.872 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.564 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . . . -70.95 -33.28 70.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 111.129 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -81.01 -40.97 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 70.310000000000002 110.883 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.562 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -75.55 -63.06 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 53.43 111.12 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -53.54 -21.26 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 62.530000000000001 111.119 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.711 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -52.98 -68.92 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 63.140000000000001 111.062 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.614 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 19.0 t -111.75 -13.31 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 75.030000000000001 111.107 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.7 tp60 -80.53 -32.92 36.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 72.510000000000005 110.928 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 1.026 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.36 -6.68 17.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 71.329999999999998 111.153 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.987 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.08 -4.33 0.11 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.58 0.705 . . . . 75.319999999999993 111.094 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.026 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.1 Cg_endo -69.75 -24.46 29.69 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.731 2.288 . . . . 72.540000000000006 112.31 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.62 -56.33 2.26 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.718 -0.753 . . . . 72.129999999999995 112.487 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.1 -36.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.744 . . . . 64.540000000000006 112.473 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.746 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.7 t -146.42 150.44 35.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 65.209999999999994 111.185 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.12 80.3 1.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 72.349999999999994 111.095 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.721 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -146.86 99.51 0.21 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 62.439999999999998 112.491 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.492 ' O ' HD22 ' A' ' 72' ' ' LEU . 3.5 tt0 -99.79 -167.05 1.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 75.120000000000005 110.892 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.6 t -137.78 117.62 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 111.165 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.506 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 1.9 pp20? -96.08 155.16 16.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 74.5 110.857 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.453 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.5 t -127.65 118.7 24.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 74.540000000000006 111.178 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.62 170.88 14.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.420000000000002 110.916 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.75 114.48 22.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 62.340000000000003 111.128 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.43 -147.47 12.76 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 73.439999999999998 112.467 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -87.58 -1.63 58.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 73.239999999999995 110.904 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.02 -118.12 4.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 71.310000000000002 112.468 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.13 -78.27 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.775 0.321 . . . . 74.129999999999995 111.08 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -107.01 92.97 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 64.439999999999998 111.081 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.84 59.34 3.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 72.450000000000003 111.093 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CE1' ' HB2' ' A' ' 85' ' ' LEU . 2.6 p90 -110.74 132.11 54.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.409999999999997 110.935 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -118.71 150.37 18.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.777 -0.725 . . . . 73.109999999999999 112.494 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.5 119.78 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.368 . . . . 72.120000000000005 111.12 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.721 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -107.14 138.33 43.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 75.329999999999998 110.925 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.694 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.1 t -148.98 122.03 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 73.120000000000005 111.147 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.777 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 3.6 m -171.52 -128.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 71.439999999999998 111.121 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.48 ' H ' ' CG2' ' A' ' 74' ' ' THR . 0.0 OUTLIER -104.28 142.61 24.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.662 0.744 . . . . 74.430000000000007 110.844 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.485 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.9 Cg_endo -69.76 14.19 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.695 2.264 . . . . 74.219999999999999 112.311 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.474 ' H ' ' C ' ' A' ' 75' ' ' ARG . 7.2 m-20 -93.01 27.01 2.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.267 -0.424 . . . . 75.030000000000001 110.864 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.85 -12.89 51.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.792 -0.718 . . . . 70.230000000000004 112.51 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.587 ' O ' ' HB ' ' A' ' 74' ' ' THR . 33.6 p -97.18 106.64 19.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 73.530000000000001 111.141 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.777 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.7 OUTLIER -137.79 164.68 28.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 75.549999999999997 110.858 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 10.3 m -116.92 96.97 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 74.120000000000005 111.102 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.461 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 1.3 tm-20 -80.93 121.97 26.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 73.010000000000005 110.898 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.668 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.4 t -93.9 137.33 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 70.340000000000003 111.133 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.437 ' CD2' HG11 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -84.85 112.81 20.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 73.540000000000006 110.849 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.769 ' CD2' ' HG ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -121.21 109.53 15.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 71.219999999999999 110.911 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.628 ' C ' ' H ' ' A' ' 88' ' ' ASP . 2.2 t0 -140.28 131.35 26.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 110.864 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.8 7.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 70.409999999999997 110.865 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.628 ' H ' ' C ' ' A' ' 86' ' ' ASP . 19.8 t0 -66.44 -4.6 8.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 65.219999999999999 110.877 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 70.02 11.43 7.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 75.310000000000002 110.916 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.79 5.63 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 72.439999999999998 110.898 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.626 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 49.7 t -117.43 74.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 74.150000000000006 111.137 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.405 HD23 ' H ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -133.59 11.7 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 110.931 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.412 ' O ' HG11 ' A' ' 83' ' ' VAL . 59.5 m-20 -92.95 163.49 13.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 75.209999999999994 110.905 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.668 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 8.3 t -98.9 161.76 13.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 70.519999999999996 111.171 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -147.6 127.52 6.65 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 75.549999999999997 110.904 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 123.5 10.16 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.73 2.287 . . . . 71.219999999999999 112.306 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.59 161.66 18.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.109999999999999 111.135 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -128.8 -146.24 0.32 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.429 . . . . 72.420000000000002 110.887 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.62 -15.85 30.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.772 -0.728 . . . . 73.310000000000002 112.434 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.59 -36.35 13.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.369 . . . . 74.109999999999999 110.852 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.62 54.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 45.109999999999999 112.499 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.736 . . . . 65.430000000000007 112.485 -179.93 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.825 0.345 . . . . 72.209999999999994 110.864 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -75.09 -33.61 61.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 71.409999999999997 110.93 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.479 ' OD2' HD23 ' A' ' 20' ' ' LEU . 2.5 p-10 -64.53 -152.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 72.319999999999993 110.851 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.44 ' N ' ' OD2' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -78.17 163.37 62.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.652 0.739 . . . . 72.420000000000002 111.153 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -9.32 25.83 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.702 2.268 . . . . 73.219999999999999 112.383 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 p -154.2 130.15 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 73.340000000000003 111.144 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.614 ' OG1' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -149.76 -158.78 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 75.319999999999993 111.185 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -70.44 -101.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 64.25 110.892 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -91.17 11.21 24.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 74.030000000000001 110.881 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.623 ' CD2' ' HB3' ' A' ' 85' ' ' LEU . 10.7 mp -65.35 -30.08 70.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 74.200000000000003 110.956 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -80.31 4.72 16.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 75.0 110.962 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.12 -53.8 2.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 75.140000000000001 110.917 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -66.95 -46.55 74.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 75.439999999999998 110.935 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -46.94 -25.37 2.37 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 62.409999999999997 112.498 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 27' ' ' ALA . . . -51.2 -80.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 63.210000000000001 111.08 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.9 ptm -66.85 -0.49 3.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 73.409999999999997 110.873 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 25' ' ' ALA . . . -77.25 -32.93 56.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 73.519999999999996 111.071 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -82.95 10.05 8.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 73.219999999999999 110.856 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -68.6 -72.71 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 73.230000000000004 110.911 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.04 11.74 0.59 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 75.409999999999997 112.519 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 1.7 pt-20 -67.3 171.24 6.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 74.239999999999995 110.884 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -127.93 -153.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.239999999999995 110.844 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -109.85 163.61 13.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 75.400000000000006 110.835 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.642 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 1.0 OUTLIER -91.73 162.35 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 72.109999999999999 111.15 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.577 ' N ' ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -104.5 -32.73 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 74.040000000000006 111.163 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.404 ' H ' HG11 ' A' ' 34' ' ' VAL . . . -157.62 -139.09 2.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 73.319999999999993 112.498 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -160.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.669 2.246 . . . . 71.099999999999994 112.321 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -55.07 -34.21 63.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 70.019999999999996 110.896 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.86 -37.87 66.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 73.430000000000007 111.077 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -84.34 -42.05 16.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.888 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.513 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 7.1 ptt180 -61.9 -37.63 85.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 75.439999999999998 110.838 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.534 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -65.8 -34.76 78.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 53.240000000000002 111.093 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.488 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -78.08 -39.26 42.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 65.430000000000007 110.897 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.639 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -77.12 -58.55 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 64.239999999999995 111.084 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.538 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -57.2 -17.73 12.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 72.219999999999999 111.129 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.522 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -62.63 -79.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 111.118 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.749 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 61.1 t -110.91 -23.08 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 74.340000000000003 111.125 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.639 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 3.5 mt-30 -68.55 -27.7 66.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 74.409999999999997 110.883 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 1.056 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.77 -0.82 19.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 72.239999999999995 111.073 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 1.005 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.37 -1.1 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.62 0.724 . . . . 74.209999999999994 111.103 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.056 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.9 Cg_endo -69.76 -31.22 20.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.702 2.268 . . . . 74.420000000000002 112.33 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.98 -54.23 5.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 75.019999999999996 112.493 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.2 -33.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 35.520000000000003 112.525 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.62 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.4 m -145.08 152.65 40.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 62.210000000000001 111.152 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.57 76.07 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 72.319999999999993 111.11 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.697 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -146.59 104.94 0.31 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 73.510000000000005 112.515 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.544 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -98.56 -153.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 73.109999999999999 110.858 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -131.68 133.78 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 73.230000000000004 111.127 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.642 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -100.99 122.91 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 73.319999999999993 110.903 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.9 t -108.03 111.39 23.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 63.350000000000001 111.174 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.48 159.94 40.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 75.040000000000006 110.887 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 p -124.24 117.43 24.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 73.120000000000005 111.079 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.98 -147.87 11.85 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 74.439999999999998 112.497 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.33 -1.64 57.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.391 . . . . 74.420000000000002 110.894 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.51 -120.62 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.721 -0.752 . . . . 74.530000000000001 112.472 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.95 -75.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 63.420000000000002 111.057 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -104.67 85.85 2.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 73.239999999999995 111.038 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.49 59.26 4.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 70.019999999999996 111.072 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.422 ' HB2' ' HA ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -116.98 158.58 23.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 75.120000000000005 110.886 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -141.41 158.96 26.66 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.708 -0.758 . . . . 74.530000000000001 112.497 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -116.39 120.46 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 75.25 111.122 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.708 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -111.57 133.33 53.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 74.120000000000005 110.911 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.697 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.3 p -148.43 124.13 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.540000000000006 111.119 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.803 ' HB ' ' O ' ' A' ' 79' ' ' THR . 3.8 m -167.77 -129.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 73.319999999999993 111.178 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.496 ' H ' ' CG2' ' A' ' 74' ' ' THR . 0.3 OUTLIER -101.84 146.77 32.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.603 0.716 . . . . 74.150000000000006 110.895 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.72 7.68 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.699 2.266 . . . . 74.310000000000002 112.371 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 75' ' ' ARG . 21.6 m-20 -91.28 41.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 74.120000000000005 110.891 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.19 -4.94 16.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 65.299999999999997 112.527 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.803 ' O ' ' HB ' ' A' ' 74' ' ' THR . 43.9 p -96.07 117.02 29.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 75.409999999999997 111.161 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.613 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -144.75 158.1 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 74.230000000000004 110.867 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 31.4 m -118.13 92.13 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 62.200000000000003 111.126 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.562 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -81.12 123.43 28.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 73.420000000000002 110.888 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.679 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.4 t -94.93 131.75 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.499 . . . . 73.109999999999999 111.134 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.426 ' C ' HG11 ' A' ' 91' ' ' VAL . 1.2 t-160 -83.65 117.19 23.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 63.450000000000003 110.865 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.623 ' HB3' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -135.86 121.28 19.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 75.319999999999993 110.918 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.682 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 6.3 t0 -140.49 132.5 27.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 74.219999999999999 110.871 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -60.36 4.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 74.349999999999994 110.847 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.587 ' H ' ' C ' ' A' ' 86' ' ' ASP . 22.5 t0 -67.94 -3.92 11.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.519999999999996 110.879 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 69.31 14.85 8.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 75.5 110.865 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.05 -1.06 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 75.209999999999994 110.853 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.682 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 92.7 t -117.91 91.39 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 111.117 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.47 8.25 2.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.899 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.7 162.27 14.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 74.329999999999998 110.864 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.2 t -93.41 172.45 8.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 111.126 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 82' ' ' GLU . 3.4 tt0 -145.96 123.71 6.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.688 0.756 . . . . 65.510000000000005 110.852 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 129.48 17.58 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.249 . . . . 75.340000000000003 112.345 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -117.86 117.17 28.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 63.450000000000003 111.126 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 100' ' ' ASP . 3.4 m-20 -121.67 49.13 1.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 74.099999999999994 110.855 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.411 ' HA2' HH12 ' A' ' 80' ' ' ARG . . . 71.68 -16.92 1.28 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 75.0 112.485 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 98' ' ' ASP . 3.0 t0 -95.32 -62.14 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 72.019999999999996 110.857 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.36 26.02 60.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.759 -0.734 . . . . 73.150000000000006 112.472 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 75.409999999999997 112.48 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.428 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.817 0.341 . . . . 75.409999999999997 110.884 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -67.5 -54.34 20.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 75.040000000000006 110.938 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.405 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 9.0 t0 -64.19 -154.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 74.200000000000003 110.859 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 16' ' ' THR . 35.4 mm -92.24 123.68 61.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.612 0.72 . . . . 74.430000000000007 111.172 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 10.45 0.49 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.693 2.262 . . . . 72.230000000000004 112.324 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.445 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -124.24 43.74 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 73.310000000000002 111.184 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.425 ' HB ' HD23 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -97.89 -162.99 1.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 73.200000000000003 111.16 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -60.83 -102.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 71.129999999999995 110.936 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -96.85 7.16 47.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 75.109999999999999 110.887 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.714 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -66.49 -16.77 64.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 75.5 110.898 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -94.25 3.64 54.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 73.319999999999993 110.876 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -97.21 -53.36 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 75.140000000000001 110.907 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -64.73 -35.51 81.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 75.010000000000005 110.899 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -46.13 -30.06 3.79 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.732 -0.747 . . . . 73.340000000000003 112.486 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 28' ' ' PHE . . . -57.29 -57.36 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.826 0.346 . . . . 73.230000000000004 111.131 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.21 -5.06 16.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.519999999999996 110.882 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -113.06 38.83 2.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 70.530000000000001 111.107 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -110.41 14.7 22.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 72.340000000000003 110.9 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.28 -78.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 75.299999999999997 110.866 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.73 8.57 41.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.738 . . . . 64.430000000000007 112.478 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -64.61 103.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.875 0.369 . . . . 73.450000000000003 110.901 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.05 -172.53 2.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 70.420000000000002 110.886 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -115.78 120.85 40.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 72.010000000000005 110.87 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.602 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 46.1 t -71.93 159.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 63.210000000000001 111.13 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 65.8 p -99.59 -30.38 12.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 64.099999999999994 111.173 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.403 ' H ' HG13 ' A' ' 34' ' ' VAL . . . -150.42 -144.06 3.85 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 64.140000000000001 112.501 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -158.94 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.711 2.274 . . . . 75.120000000000005 112.4 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.431 ' HA ' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -56.69 -29.33 62.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 74.310000000000002 110.834 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.2 -43.57 70.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 63.119999999999997 111.085 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -85.6 -41.91 14.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 70.140000000000001 110.876 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.479 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -60.45 -36.16 77.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 110.86 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.527 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -65.25 -32.24 73.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 72.430000000000007 111.125 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.499 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 4.0 ptt180 -74.78 -40.97 60.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 71.519999999999996 110.898 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.499 ' N ' ' HG2' ' A' ' 43' ' ' ARG . . . -81.06 -57.84 3.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 72.349999999999994 111.142 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.496 ' HA ' ' HB2' ' A' ' 57' ' ' GLU . . . -52.12 -20.97 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 72.319999999999993 111.077 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.633 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -62.91 -76.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 70.109999999999999 111.11 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.712 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.3 t -111.4 -17.01 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.040000000000006 111.124 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.491 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -73.94 -32.0 63.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 71.510000000000005 110.908 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 1.017 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.39 -1.23 21.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 61.009999999999998 111.099 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.995 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.92 -2.7 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.656 0.741 . . . . 72.510000000000005 111.156 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.017 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.8 Cg_endo -69.78 -29.93 22.99 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.641 2.228 . . . . 71.329999999999998 112.345 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.52 -51.46 6.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.752 -0.737 . . . . 35.210000000000001 112.506 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.08 -33.55 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 70.019999999999996 112.518 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.671 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -145.74 151.1 37.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.79 0.328 . . . . 73.340000000000003 111.157 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.63 78.36 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 111.062 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.684 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -143.8 99.91 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 55.329999999999998 112.539 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.567 ' O ' HD22 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -92.86 -164.72 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 75.239999999999995 110.928 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 t -143.49 124.76 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 73.109999999999999 111.106 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.602 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 9.6 pt-20 -95.18 155.83 16.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 74.120000000000005 110.837 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.467 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.3 t -131.58 117.18 18.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.097 -0.501 . . . . 74.329999999999998 111.122 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -137.85 158.97 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 74.200000000000003 110.877 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -22.61 19.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 72.310000000000002 111.102 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 42.99 -157.46 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.739 -0.743 . . . . 65.040000000000006 112.516 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -91.81 -23.61 19.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.913 0.387 . . . . 65.049999999999997 110.871 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.54 -119.1 1.13 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.767 -0.73 . . . . 73.120000000000005 112.471 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.61 -81.63 0.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.752 0.311 . . . . 60.350000000000001 111.113 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.649 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -93.03 79.57 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 74.530000000000001 111.147 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.49 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -81.74 62.57 5.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 70.329999999999998 111.102 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.467 ' HB2' ' HA ' ' A' ' 60' ' ' THR . 0.1 OUTLIER -114.61 155.64 26.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 73.299999999999997 110.937 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.489 ' HA2' ' HG ' ' A' ' 85' ' ' LEU . . . -138.49 157.61 24.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 75.209999999999994 112.449 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 p -126.62 117.97 49.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 75.510000000000005 111.16 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.794 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -105.99 137.01 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.340000000000003 110.917 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.673 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.1 p -147.23 124.14 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 54.130000000000003 111.146 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.791 ' HB ' ' O ' ' A' ' 79' ' ' THR . 4.4 m -168.19 -129.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 52.509999999999998 111.116 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.506 ' H ' ' CG2' ' A' ' 74' ' ' THR . 0.6 OUTLIER -104.65 148.8 36.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.562 0.696 . . . . 73.519999999999996 110.838 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 6.76 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.7 2.267 . . . . 64.329999999999998 112.31 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -92.67 43.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 63.219999999999999 110.862 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.51 -5.26 23.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 74.430000000000007 112.477 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.791 ' O ' ' HB ' ' A' ' 74' ' ' THR . 13.9 p -93.42 123.67 36.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 72.129999999999995 111.147 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.551 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -146.69 156.69 43.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 73.140000000000001 110.826 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.794 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 97.0 t -115.75 83.55 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 72.340000000000003 111.154 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.562 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 3.7 tm-20 -75.93 122.0 23.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 75.439999999999998 110.894 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 4.8 t -105.49 138.55 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 73.140000000000001 111.069 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.478 ' C ' HG12 ' A' ' 91' ' ' VAL . 40.8 m-70 -83.69 115.05 22.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 74.099999999999994 110.843 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.714 ' CD2' ' HG ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -125.25 105.98 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 74.5 110.905 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.653 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 5.3 t0 -139.08 131.63 28.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.129999999999995 110.887 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.98 6.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 110.848 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.619 ' H ' ' C ' ' A' ' 86' ' ' ASP . 37.5 t0 -67.21 -3.28 7.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 74.109999999999999 110.904 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 67.9 12.42 8.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 74.140000000000001 110.876 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -139.01 3.53 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 75.040000000000006 110.86 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.653 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 60.8 t -117.74 73.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 74.439999999999998 111.119 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.48 12.61 4.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 73.439999999999998 110.895 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.404 ' O ' HG13 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -94.53 164.52 12.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 75.519999999999996 110.873 179.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 9.9 t -104.08 169.45 8.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 74.329999999999998 111.16 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.409 ' HB2' ' NE2' ' A' ' 84' ' ' HIS . 11.6 tp10 -146.95 124.74 5.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.652 0.739 . . . . 74.329999999999998 110.873 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 124.85 11.5 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.727 2.285 . . . . 74.200000000000003 112.363 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -115.49 117.4 30.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 63.130000000000003 111.086 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 100' ' ' ASP . 52.5 m-20 -124.33 46.0 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.510000000000005 110.843 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.28 -17.83 4.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 70.439999999999998 112.445 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 98' ' ' ASP . 4.0 m-20 -94.46 -56.6 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 72.310000000000002 110.828 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.48 23.16 44.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.721 . . . . 54.310000000000002 112.484 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 40.520000000000003 112.504 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 t0 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.786 0.327 . . . . 71.420000000000002 110.838 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -67.84 -21.47 65.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 73.310000000000002 110.915 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 85' ' ' LEU . 12.4 t70 -58.63 -87.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 74.040000000000006 110.867 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.43 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -114.79 165.32 14.21 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.693 0.759 . . . . 72.430000000000007 111.13 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.79 -1.12 7.95 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.252 . . . . 70.109999999999999 112.343 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.42 71.13 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 73.010000000000005 111.154 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.474 HG23 HD11 ' A' ' 92' ' ' LEU . 70.7 p -76.38 -166.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 71.150000000000006 111.134 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.461 ' C ' ' H ' ' A' ' 20' ' ' LEU . 2.9 mm-40 -130.56 -93.12 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 74.530000000000001 110.892 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -69.22 5.88 1.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 74.540000000000006 110.849 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 18' ' ' GLU . 10.8 mp -87.0 -34.07 19.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 75.439999999999998 110.931 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -64.89 -16.66 63.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 73.310000000000002 110.897 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.75 -63.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 72.430000000000007 110.87 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.6 -46.93 77.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 73.329999999999998 110.937 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.78 -53.15 8.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 62.310000000000002 112.487 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.64 51.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 70.219999999999999 111.102 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -35.71 80.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 74.310000000000002 110.917 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.407 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . . . -121.32 -97.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 73.439999999999998 111.141 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.426 ' O ' ' CB ' ' A' ' 29' ' ' ASP . 1.4 p90 -149.43 -18.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 75.450000000000003 110.857 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER 165.99 -10.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 74.209999999999994 110.839 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.69 -22.0 3.83 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.766 -0.731 . . . . 60.520000000000003 112.472 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.94 105.32 0.45 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 74.409999999999997 110.921 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.496 ' C ' ' HG3' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -70.17 -158.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 74.140000000000001 110.815 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -138.17 118.75 13.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 72.340000000000003 110.901 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 40.4 t -72.06 149.13 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 75.319999999999993 111.106 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -123.31 -0.59 8.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 74.349999999999994 111.16 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.83 -154.75 6.39 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.726 . . . . 73.510000000000005 112.512 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -166.12 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.667 2.244 . . . . 71.030000000000001 112.302 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -59.09 -30.43 68.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 74.120000000000005 110.812 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.93 -30.17 67.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 70.530000000000001 111.116 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 1.6 m-20 -76.51 -34.32 58.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 70.209999999999994 110.865 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.561 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -73.89 -44.18 56.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 74.010000000000005 110.853 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.538 ' HA ' ' NE ' ' A' ' 80' ' ' ARG . . . -67.88 -30.64 70.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.239999999999995 111.121 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.403 ' CG ' ' N ' ' A' ' 44' ' ' ALA . 14.7 ptt180 -85.1 -45.2 12.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 74.450000000000003 110.902 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.518 ' HB2' ' OE1' ' A' ' 57' ' ' GLU . . . -77.9 -60.58 2.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 73.140000000000001 111.106 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 41' ' ' ARG . . . -48.27 -22.18 0.63 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 71.299999999999997 111.082 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.675 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -54.55 -67.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 64.349999999999994 111.127 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.602 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 26.9 t -110.41 -15.82 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 71.329999999999998 111.136 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 50.0 mt-30 -80.74 -29.02 36.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 73.530000000000001 110.913 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 1.064 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.37 -10.86 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 72.209999999999994 111.087 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 1.0 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.74 0.07 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.634 0.731 . . . . 74.420000000000002 111.158 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.064 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.2 Cg_endo -69.76 -27.11 26.86 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.65 2.234 . . . . 63.340000000000003 112.335 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.11 -53.62 2.94 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 64.329999999999998 112.542 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.63 -35.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 62.310000000000002 112.489 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.803 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -146.26 149.35 33.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 64.109999999999999 111.143 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.82 82.83 1.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 62.149999999999999 111.102 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -140.62 99.68 0.25 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.713 -0.756 . . . . 73.319999999999993 112.478 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.518 ' OE1' ' HB2' ' A' ' 44' ' ' ALA . 63.3 tt0 -96.18 164.62 12.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.946 0.403 . . . . 73.540000000000006 110.843 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 t -111.76 119.13 59.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 73.439999999999998 111.112 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.745 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.21 133.57 43.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 52.219999999999999 110.898 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -133.39 121.86 22.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 74.239999999999995 111.131 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.465 ' H ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -123.16 162.76 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.430000000000007 110.854 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.41 135.72 34.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 61.520000000000003 111.106 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.44 -119.38 1.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 61.109999999999999 112.525 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -87.83 -23.62 23.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 73.420000000000002 110.889 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.3 -112.61 1.9 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 71.439999999999998 112.478 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.12 -82.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 75.420000000000002 111.104 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' CB ' ' HA ' ' A' ' 13' ' ' ASP . . . -75.78 125.93 30.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 73.230000000000004 111.072 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.47 74.52 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 71.150000000000006 111.071 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.745 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -165.38 -131.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 74.129999999999995 110.912 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.606 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -167.99 172.24 42.63 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 62.130000000000003 112.539 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 57' ' ' GLU . 6.0 p -130.07 120.16 48.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 72.319999999999993 111.129 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.705 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -98.36 142.3 30.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 75.439999999999998 110.919 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.655 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 10.9 t -152.03 114.15 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 71.129999999999995 111.121 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.74 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.6 m -169.45 -133.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.329999999999998 111.141 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.518 ' H ' ' CG2' ' A' ' 74' ' ' THR . 0.1 OUTLIER -104.62 144.77 29.39 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.636 0.731 . . . . 74.310000000000002 110.841 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.439 ' HD3' HG23 ' A' ' 50' ' ' VAL . 53.8 Cg_endo -69.75 13.84 0.28 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.712 2.275 . . . . 74.340000000000003 112.341 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 75' ' ' ARG . 20.2 m-20 -93.94 35.49 1.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 74.129999999999995 110.855 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.36 -13.2 41.47 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.683 -0.77 . . . . 71.109999999999999 112.509 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.74 ' O ' ' HB ' ' A' ' 74' ' ' THR . 37.6 p -95.28 119.7 34.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.749 0.309 . . . . 71.140000000000001 111.163 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.617 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -141.61 161.13 38.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.869 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 97.3 t -119.0 81.5 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.140000000000001 111.092 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 72' ' ' LEU . 15.2 pt-20 -77.68 116.73 18.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.450000000000003 110.864 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.729 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 0.8 OUTLIER -94.99 144.72 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 71.310000000000002 111.103 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 93' ' ' ASP . 2.5 t-160 -83.82 108.85 17.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 63.450000000000003 110.872 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.939 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 1.3 pp -124.98 110.26 13.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 75.299999999999997 110.919 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.585 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 3.9 m-20 -127.02 106.68 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 74.140000000000001 110.885 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.428 ' HA ' HG22 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -63.09 -0.34 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 110.892 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 86' ' ' ASP . 51.2 t0 -69.59 -13.15 62.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 73.040000000000006 110.876 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -165.66 -93.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 74.129999999999995 110.857 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.06 33.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 74.129999999999995 110.865 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.939 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 2.4 t -72.51 95.93 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 75.329999999999998 111.109 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -127.68 18.82 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 73.340000000000003 110.922 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 84' ' ' HIS . 9.0 t0 -75.99 128.78 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 73.439999999999998 110.895 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.729 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 7.0 t -79.23 155.8 28.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 73.030000000000001 111.119 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.95 153.1 53.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.666 0.746 . . . . 73.329999999999998 110.872 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 140.37 42.61 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.66 2.24 . . . . 61.109999999999999 112.35 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.42 111.06 17.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 74.430000000000007 111.103 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -96.28 4.26 52.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 73.319999999999993 110.911 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.78 -21.98 7.12 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.738 . . . . 61.420000000000002 112.497 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.34 -31.24 12.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.779 0.323 . . . . 73.549999999999997 110.835 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.16 26.07 58.44 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.773 -0.727 . . . . 62.039999999999999 112.442 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.769 -0.729 . . . . 63.450000000000003 112.489 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.815 0.34 . . . . 74.430000000000007 110.878 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -65.88 -37.09 85.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 110.922 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.411 ' CB ' ' HB2' ' A' ' 85' ' ' LEU . 11.8 p-10 -65.54 -149.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 74.510000000000005 110.846 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.43 127.92 88.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.672 0.748 . . . . 74.319999999999993 111.12 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -1.52 8.6 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.638 2.225 . . . . 74.439999999999998 112.364 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.79 38.54 3.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 71.150000000000006 111.094 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -73.07 -168.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 65.109999999999999 111.159 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -72.78 -100.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 70.310000000000002 110.925 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -98.73 8.29 45.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 72.319999999999993 110.894 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.664 ' CD2' ' HB3' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -72.21 -9.43 58.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 64.219999999999999 110.921 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -89.99 -8.81 50.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 74.209999999999994 110.964 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -74.39 -58.65 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 75.299999999999997 110.879 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -66.13 -42.66 88.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 74.230000000000004 110.874 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.71 -31.49 2.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.728 -0.748 . . . . 71.319999999999993 112.484 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.7 -72.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.318 . . . . 73.340000000000003 111.077 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.6 ptm -70.6 -7.1 41.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.099999999999994 110.904 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.427 ' HA ' ' HG3' ' A' ' 31' ' ' GLU . . . -65.53 -47.19 76.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 55.32 111.057 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -81.86 6.1 16.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 75.450000000000003 110.879 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -72.04 -68.59 0.45 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 110.857 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.89 8.98 2.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.776 -0.726 . . . . 72.409999999999997 112.532 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.427 ' HG3' ' HA ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -79.37 177.67 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 74.010000000000005 110.904 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.09 -168.8 2.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 75.209999999999994 110.874 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -109.54 119.88 40.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 73.010000000000005 110.909 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.498 ' CG1' ' H ' ' A' ' 35' ' ' THR . 2.2 t -73.12 -136.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 75.299999999999997 111.131 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.504 ' OG1' ' HD2' ' A' ' 37' ' ' PRO . 71.5 p -136.72 -47.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 73.010000000000005 111.158 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 163.0 -61.18 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 75.409999999999997 112.493 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.5 Cg_endo -69.7 159.18 54.39 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.747 2.298 . . . . 74.430000000000007 112.318 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 2.1 p30 -64.88 -26.04 68.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 75.140000000000001 110.852 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.03 -39.14 74.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 74.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -86.06 -39.85 16.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.340000000000003 110.882 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 6.8 ptt180 -68.05 -38.81 82.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 74.319999999999993 110.868 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.601 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -68.3 -35.29 77.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.530000000000001 111.071 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.03 -40.53 21.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 75.450000000000003 110.898 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 48' ' ' GLN . . . -77.48 -59.84 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 72.219999999999999 111.101 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.534 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -52.76 -20.22 3.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 111.091 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.65 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -63.63 -78.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 111.092 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.723 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.6 t -108.44 -17.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 73.109999999999999 111.179 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -74.41 -29.79 61.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.120000000000005 110.905 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 1.047 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.94 -2.82 19.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 70.200000000000003 111.132 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.999 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -95.7 -2.9 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.612 0.72 . . . . 75.019999999999996 111.143 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.047 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.9 Cg_endo -69.77 -27.66 26.13 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.666 2.244 . . . . 74.0 112.343 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.11 -57.15 2.87 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.78 -0.724 . . . . 65.239999999999995 112.502 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.07 -34.76 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 71.019999999999996 112.504 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.675 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -146.41 152.1 38.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 64.430000000000007 111.151 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.39 77.01 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 111.116 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.703 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -148.53 105.68 0.31 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 75.349999999999994 112.487 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.509 ' H ' HD23 ' A' ' 72' ' ' LEU . 3.2 tt0 -95.78 -171.95 2.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.907 0.384 . . . . 74.540000000000006 110.896 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.8 t -136.86 131.43 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 74.530000000000001 111.126 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -99.1 121.78 41.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 73.040000000000006 110.852 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 t -110.35 119.19 38.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 71.420000000000002 111.137 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -143.47 121.92 12.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 110.908 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.74 148.8 24.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 74.400000000000006 111.159 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.13 -106.71 0.99 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.781 -0.723 . . . . 53.240000000000002 112.529 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -87.91 -25.7 23.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 74.019999999999996 110.936 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.33 -121.56 2.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 60.0 112.465 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.32 33.87 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.768 0.318 . . . . 73.319999999999993 111.112 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.464 ' HA ' ' H ' ' A' ' 87' ' ' ARG . . . -63.71 -155.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 72.040000000000006 111.122 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.567 ' O ' ' O ' ' A' ' 61' ' ' GLU . . . -157.06 -104.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 71.109999999999999 111.111 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.564 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 2.9 t80 -170.29 -85.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.902 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.611 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -168.53 157.04 28.96 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 64.519999999999996 112.494 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.8 t -123.45 120.8 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.838 0.351 . . . . 73.530000000000001 111.093 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.672 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -106.17 134.19 49.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 73.230000000000004 110.93 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.703 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.2 p -147.67 118.61 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 72.129999999999995 111.12 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.744 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.7 m -169.19 -133.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 111.141 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.504 ' H ' ' CG2' ' A' ' 74' ' ' THR . 3.6 mtt-85 -101.53 148.4 35.18 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.636 0.732 . . . . 74.019999999999996 110.831 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.447 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.4 Cg_endo -69.84 9.41 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.652 2.234 . . . . 75.230000000000004 112.342 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 75' ' ' ARG . 40.6 m-20 -88.38 38.67 0.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 75.140000000000001 110.87 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.11 -7.05 8.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 64.200000000000003 112.428 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.744 ' O ' ' HB ' ' A' ' 74' ' ' THR . 31.1 p -98.85 115.42 28.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.793 0.33 . . . . 74.400000000000006 111.175 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.616 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -138.62 160.59 39.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 72.319999999999993 110.861 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 61.6 t -113.88 87.02 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 54.399999999999999 111.132 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -81.04 121.37 25.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.200000000000003 110.908 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.611 ' O ' ' CA ' ' A' ' 70' ' ' GLY . 1.8 t -97.55 160.57 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 111.137 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.3 OUTLIER -104.55 109.14 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 74.319999999999993 110.873 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.735 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -128.72 111.14 12.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 74.409999999999997 110.925 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.616 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 21.1 m-20 -136.51 108.66 7.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 64.519999999999996 110.846 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.464 ' H ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -66.36 0.61 2.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.540000000000006 110.903 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 89' ' ' PHE . 51.6 t0 -69.88 -11.88 61.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 73.420000000000002 110.852 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -166.54 -93.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 72.450000000000003 110.903 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 35.53 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 74.230000000000004 110.86 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.735 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 9.2 t -69.47 100.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 72.109999999999999 111.145 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -135.04 16.89 3.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 72.140000000000001 110.932 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 84' ' ' HIS . 14.6 t0 -80.75 147.65 30.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 63.219999999999999 110.881 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.425 ' HA ' HG12 ' A' ' 83' ' ' VAL . 15.3 t -90.38 165.0 14.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 74.400000000000006 111.11 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -146.45 122.61 5.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 71.129999999999995 110.915 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 128.91 16.73 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.684 2.256 . . . . 73.150000000000006 112.364 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.82 114.09 23.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 74.230000000000004 111.116 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 100' ' ' ASP . 4.8 t0 -124.9 46.4 2.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 73.030000000000001 110.898 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 -17.34 1.69 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 63.450000000000003 112.509 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 98' ' ' ASP . 0.4 OUTLIER -95.93 -65.39 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 74.319999999999993 110.88 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.64 21.67 12.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 75.439999999999998 112.467 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 74.140000000000001 112.486 -179.926 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.819 0.342 . . . . 74.540000000000006 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -74.1 -25.19 59.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 72.239999999999995 110.917 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -64.12 -151.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 75.140000000000001 110.886 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.456 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -102.3 166.88 11.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 65.010000000000005 111.086 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HD2' ' CB ' ' A' ' 14' ' ' ILE . 54.0 Cg_endo -69.76 -2.52 10.31 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 74.129999999999995 112.361 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.1 p -141.83 94.2 2.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 74.129999999999995 111.168 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.525 ' CG2' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -118.83 -167.25 1.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 75.010000000000005 111.141 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -110.36 -94.29 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 75.400000000000006 110.883 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -57.0 -17.9 11.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.937 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.455 ' CD1' ' HG ' ' A' ' 85' ' ' LEU . 2.4 mp -84.11 -19.51 34.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 71.239999999999995 110.88 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -66.23 -17.71 64.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 110.941 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.17 -22.58 15.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 74.0 110.891 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -66.72 -29.82 69.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 73.439999999999998 110.936 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.4 -29.7 1.83 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.733 -0.746 . . . . 73.200000000000003 112.503 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.403 ' O ' ' CD2' ' A' ' 28' ' ' PHE . . . -73.57 -64.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 73.019999999999996 111.105 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -7.02 8.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 70.329999999999998 110.872 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.79 25.3 10.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 74.439999999999998 111.072 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -73.54 2.3 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 71.349999999999994 110.862 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 t70 179.92 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 64.129999999999995 110.873 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.31 -2.48 48.79 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 74.219999999999999 112.473 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -94.4 105.05 17.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 71.450000000000003 110.913 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.409 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 3.9 m-20 -119.34 -152.29 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 73.120000000000005 110.855 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -118.63 109.57 16.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 74.209999999999994 110.84 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.632 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 21.3 t -81.03 -119.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 72.230000000000004 111.137 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.511 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 68.5 p -141.8 -77.85 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 63.299999999999997 111.123 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -171.73 -61.1 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.762 -0.732 . . . . 73.340000000000003 112.51 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.8 Cg_endo -69.77 158.96 55.15 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.692 2.262 . . . . 65.439999999999998 112.35 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.47 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -66.56 -32.44 73.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 74.239999999999995 110.861 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.66 -30.78 14.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 51.310000000000002 111.096 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.42 -31.85 26.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 73.099999999999994 110.859 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.47 ' HD3' ' CA ' ' A' ' 38' ' ' ASP . 9.0 ptt-85 -57.71 -36.69 72.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 75.400000000000006 110.852 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -71.25 -33.02 69.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 61.409999999999997 111.11 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.457 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 2.2 ptt85 -77.71 -38.73 46.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 75.230000000000004 110.898 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -79.74 -59.15 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 72.340000000000003 111.136 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.47 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -57.63 -18.29 19.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 62.310000000000002 111.104 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.577 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -59.45 -81.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 73.510000000000005 111.077 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.773 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 59.7 t -114.99 -15.96 9.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 111.117 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.2 mt-30 -73.78 -31.96 63.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 74.540000000000006 110.893 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 1.021 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.88 -1.58 20.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.439 . . . . 73.219999999999999 111.144 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.989 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.34 -5.48 0.11 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.602 0.715 . . . . 74.349999999999994 111.141 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.021 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.4 Cg_endo -69.73 -29.32 24.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.281 . . . . 74.329999999999998 112.319 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.44 -54.04 5.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.72 -0.752 . . . . 62.109999999999999 112.442 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.49 -33.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.725 -0.75 . . . . 71.409999999999997 112.458 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.587 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -145.92 156.0 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 74.549999999999997 111.141 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.43 ' CB ' HG21 ' A' ' 50' ' ' VAL . . . -71.28 76.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 72.150000000000006 111.084 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.741 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -145.99 107.26 0.41 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.744 -0.741 . . . . 72.140000000000001 112.517 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.472 ' HG2' ' HB1' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -98.1 -169.27 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.353 . . . . 73.209999999999994 110.909 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 53.4 t -141.56 110.93 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 74.409999999999997 111.092 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.761 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 5.0 mt-10 -94.96 162.87 13.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 63.229999999999997 110.906 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.598 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -126.26 119.56 27.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 71.120000000000005 111.162 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 159.51 37.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 75.340000000000003 110.914 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.0 p -125.1 100.52 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 72.450000000000003 111.126 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.83 -141.54 8.76 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 61.399999999999999 112.487 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -88.05 0.53 55.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.857 0.361 . . . . 73.439999999999998 110.874 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -102.75 -121.71 4.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 53.32 112.517 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.82 -77.07 0.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.743 0.306 . . . . 64.200000000000003 111.062 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -111.21 86.65 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 71.299999999999997 111.065 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.67 85.47 3.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 72.430000000000007 111.1 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.761 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 0.5 OUTLIER -115.55 158.72 22.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 74.510000000000005 110.873 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.637 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -124.94 127.69 6.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 73.310000000000002 112.481 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 0.2 OUTLIER -109.26 123.42 65.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 74.109999999999999 111.146 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.741 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -84.61 142.92 29.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 75.150000000000006 110.895 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.5 t -151.21 95.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 73.209999999999994 111.082 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.743 ' HB ' ' O ' ' A' ' 79' ' ' THR . 1.3 m -168.27 -149.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 111.16 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.559 ' H ' ' CG2' ' A' ' 74' ' ' THR . 7.7 mtm180 -103.94 151.92 38.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.614 0.721 . . . . 75.219999999999999 110.853 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 78' ' ' GLY . 53.8 Cg_endo -69.79 7.56 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.686 2.258 . . . . 61.109999999999999 112.368 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 75' ' ' ARG . 3.6 m-20 -76.49 19.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 75.319999999999993 110.877 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 76' ' ' PRO . . . 94.71 -14.09 65.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 53.32 112.484 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.743 ' O ' ' HB ' ' A' ' 74' ' ' THR . 3.0 t -98.05 125.37 43.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.778 0.323 . . . . 73.209999999999994 111.144 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.598 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -136.56 159.81 40.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 75.540000000000006 110.894 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 42.8 t -118.11 92.67 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 74.209999999999994 111.129 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 95' ' ' GLU . 87.3 tt0 -82.77 119.83 24.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 74.010000000000005 110.874 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.637 ' O ' ' HA2' ' A' ' 70' ' ' GLY . 2.0 t -100.01 111.61 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 111.159 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.461 ' O ' HD22 ' A' ' 85' ' ' LEU . 3.9 t-160 -86.68 110.53 19.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 64.129999999999995 110.857 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.641 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 3.0 mm? -127.6 127.96 44.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 74.150000000000006 110.923 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.76 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 13.3 t0 -135.45 132.68 37.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 63.420000000000002 110.869 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -57.99 2.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 75.530000000000001 110.885 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.599 ' H ' ' C ' ' A' ' 86' ' ' ASP . 4.7 t0 -66.78 -4.69 9.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 73.120000000000005 110.876 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 68.23 12.18 8.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 74.340000000000003 110.883 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -135.54 -1.23 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 75.450000000000003 110.851 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.76 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 96.8 t -116.67 92.91 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 63.329999999999998 111.151 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.553 ' HA ' ' CD1' ' A' ' 85' ' ' LEU . 5.3 mp -144.41 14.52 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 73.430000000000007 110.879 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.06 137.14 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.883 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -96.47 130.01 43.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 111.167 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLU . 71.4 tt0 -99.94 127.16 34.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.615 0.721 . . . . 73.219999999999999 110.933 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 114.63 3.77 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.675 2.25 . . . . 73.430000000000007 112.333 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.499 ' CB ' ' HB2' ' A' ' 80' ' ' ARG . . . -64.53 114.33 4.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 73.140000000000001 111.11 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -87.08 15.09 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 65.430000000000007 110.899 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.65 -21.51 2.46 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.763 . . . . 73.439999999999998 112.482 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 98' ' ' ASP . 5.4 m-20 -97.55 -38.44 9.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.835 0.35 . . . . 74.030000000000001 110.869 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.85 47.0 5.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 62.340000000000003 112.482 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 74.219999999999999 112.464 -179.937 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 75.340000000000003 110.867 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -68.93 -44.22 73.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.120000000000005 110.905 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.33 -147.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 70.310000000000002 110.857 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.433 ' CG2' ' H ' ' A' ' 16' ' ' THR . 26.3 mm -75.76 119.15 75.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.596 0.713 . . . . 74.439999999999998 111.138 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 4.06 2.38 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.74 2.293 . . . . 74.409999999999997 112.32 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.433 ' H ' ' CG2' ' A' ' 14' ' ' ILE . 2.8 m -115.03 20.95 14.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 63.409999999999997 111.193 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.48 HG22 ' CD2' ' A' ' 92' ' ' LEU . 1.2 p -81.36 -165.15 0.88 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 62.210000000000001 111.142 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 20' ' ' LEU . 1.1 mm-40 -71.89 -131.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.242 -0.435 . . . . 72.219999999999999 110.883 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.41 12.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 110.916 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.583 ' HG ' ' CD2' ' A' ' 85' ' ' LEU . 7.5 mp -57.42 -27.54 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 72.400000000000006 110.895 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -95.96 7.04 47.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.913 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -110.55 -42.72 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 72.219999999999999 110.861 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -65.11 -51.8 59.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 75.439999999999998 110.922 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.76 -54.55 6.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 72.349999999999994 112.528 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.96 52.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.768 0.318 . . . . 73.030000000000001 111.119 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.4 ptm -66.98 -39.8 87.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 75.439999999999998 110.911 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' HB1' ' CD1' ' A' ' 28' ' ' PHE . . . -120.77 -92.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 71.430000000000007 111.095 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.403 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 6.2 p90 -145.0 -27.17 0.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 110.855 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.68 28.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 73.430000000000007 110.848 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.16 9.62 25.18 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.729 -0.748 . . . . 63.520000000000003 112.519 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -93.61 98.46 11.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 74.420000000000002 110.909 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.84 -162.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 73.409999999999997 110.835 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -129.15 102.2 6.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 74.329999999999998 110.9 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 1.0 OUTLIER -72.7 159.0 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 71.230000000000004 111.124 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.513 ' N ' ' CG1' ' A' ' 34' ' ' VAL . 70.0 p -91.36 -38.07 12.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 71.109999999999999 111.143 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.47 -64.44 0.21 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.737 . . . . 63.420000000000002 112.476 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 160.4 49.83 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 75.549999999999997 112.338 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 2.2 p-10 -60.62 -29.18 69.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 75.349999999999994 110.866 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.04 -30.92 49.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 73.040000000000006 111.063 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.24 -35.04 28.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 73.230000000000004 110.896 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -71.74 -41.09 68.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 70.540000000000006 110.822 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.526 ' HA ' ' CD ' ' A' ' 80' ' ' ARG . . . -70.97 -35.05 71.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 72.150000000000006 111.072 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.7 ptt85 -80.57 -39.5 27.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 71.530000000000001 110.885 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.631 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -75.81 -60.38 2.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 62.130000000000003 111.064 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.612 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -56.47 -16.94 6.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 75.019999999999996 111.082 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.63 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -62.51 -67.42 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 74.549999999999997 111.112 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.686 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.7 t -122.31 -14.79 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 72.319999999999993 111.118 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.631 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 50.5 mt-30 -79.69 -41.46 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.230000000000004 110.906 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.908 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -104.71 -0.23 27.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 71.310000000000002 111.089 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.955 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -93.72 -11.68 0.17 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 74.0 111.089 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.955 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 54.2 Cg_endo -69.76 -28.04 25.75 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.681 2.254 . . . . 72.120000000000005 112.372 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.26 -44.14 44.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 73.299999999999997 112.475 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.36 -31.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 70.420000000000002 112.475 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.543 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -149.92 157.24 42.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.824 0.345 . . . . 73.219999999999999 111.139 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.452 ' CB ' HG23 ' A' ' 50' ' ' VAL . . . -71.0 75.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 52.25 111.111 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.662 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -146.58 111.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 72.439999999999998 112.456 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -103.93 -170.69 1.81 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 70.420000000000002 110.869 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.445 ' N ' ' HG2' ' A' ' 57' ' ' GLU . 3.3 t -131.21 120.77 47.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 75.530000000000001 111.14 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.556 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -93.38 126.07 38.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.540000000000006 110.872 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.8 t -107.99 105.31 15.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 72.439999999999998 111.148 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.36 158.19 45.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 73.319999999999993 110.903 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.6 p -125.13 113.77 18.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 74.329999999999998 111.143 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -92.46 -179.37 40.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.74 . . . . 73.420000000000002 112.491 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.63 -14.38 62.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 63.229999999999997 110.852 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -86.35 -111.18 0.83 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 55.130000000000003 112.458 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.99 -77.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.772 0.32 . . . . 72.310000000000002 111.1 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -108.67 158.21 17.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 60.409999999999997 111.103 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -151.94 49.78 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 64.010000000000005 111.107 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.493 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -120.35 129.32 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 75.310000000000002 110.979 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -112.05 159.03 13.94 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 34.229999999999997 112.516 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.5 p -124.25 113.23 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 74.319999999999993 111.146 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.662 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 2.3 tt -91.1 145.14 24.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 73.409999999999997 110.929 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.549 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 14.6 t -158.57 112.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 71.439999999999998 111.159 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.822 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -174.89 -148.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 74.439999999999998 111.119 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.449 ' C ' ' H ' ' A' ' 77' ' ' ASP . 9.9 mmm180 -106.0 143.86 27.75 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.59 0.71 . . . . 75.439999999999998 110.85 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.413 ' HD3' ' HB1' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.83 11.46 0.4 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.716 2.277 . . . . 72.329999999999998 112.301 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' A' ' 75' ' ' ARG . 9.0 m-20 -86.16 32.36 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 75.340000000000003 110.905 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.48 -14.58 34.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 60.310000000000002 112.495 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.486 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.4 t -99.81 106.17 18.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.786 0.327 . . . . 74.329999999999998 111.149 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.822 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -135.58 154.97 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 74.430000000000007 110.877 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.56 ' N ' ' OG1' ' A' ' 74' ' ' THR . 47.9 t -114.19 100.37 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.349999999999994 111.1 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.435 ' HB3' ' NE ' ' A' ' 41' ' ' ARG . 9.2 pt-20 -85.61 109.19 18.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 71.420000000000002 110.866 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.571 ' O ' HD21 ' A' ' 85' ' ' LEU . 2.1 t -99.62 107.84 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 111.136 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.536 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 5.4 m-70 -84.3 121.17 27.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.239999999999995 110.855 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.683 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -106.98 105.57 15.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 75.129999999999995 110.913 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.685 ' N ' ' HA ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -128.65 115.34 17.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 70.109999999999999 110.888 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -61.45 -7.8 3.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 71.209999999999994 110.85 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.71 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 24.5 t70 -83.72 32.81 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 72.209999999999994 110.839 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.71 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 18.8 m-85 97.68 -30.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 74.109999999999999 110.853 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.46 35.36 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 75.519999999999996 110.808 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.685 ' HA ' ' N ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -59.69 -28.0 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 73.430000000000007 111.115 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.48 ' CD2' HG22 ' A' ' 17' ' ' THR . 1.9 mt -122.43 29.57 6.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 74.019999999999996 110.893 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 84' ' ' HIS . 33.0 t70 -71.34 66.58 0.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.030000000000001 110.918 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.402 ' HB ' ' CG1' ' A' ' 83' ' ' VAL . 10.2 t -84.86 151.41 24.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 111.118 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -146.06 157.78 49.53 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.654 0.74 . . . . 74.430000000000007 110.861 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 131.92 22.19 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.633 2.222 . . . . 75.140000000000001 112.317 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -112.59 103.19 11.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 65.230000000000004 111.111 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.21 11.28 38.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 72.140000000000001 110.911 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.44 -19.32 28.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 54.140000000000001 112.495 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -95.67 -41.99 8.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 71.409999999999997 110.907 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.85 28.69 45.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 53.43 112.484 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.757 -0.735 . . . . 41.229999999999997 112.528 -179.94 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.804 0.335 . . . . 74.409999999999997 110.825 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.434 ' CE1' ' HB3' ' A' ' 33' ' ' GLU . 82.8 m-85 -65.43 -54.31 30.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 74.450000000000003 110.92 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.02 -158.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 71.120000000000005 110.878 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.2 mp -74.42 121.64 85.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.591 0.71 . . . . 73.409999999999997 111.13 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -5.47 16.26 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.689 2.259 . . . . 74.299999999999997 112.341 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 p -145.44 88.3 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.230000000000004 111.16 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.452 ' HB ' HD11 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -132.55 -159.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 74.120000000000005 111.149 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.08 -94.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 52.32 110.927 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -87.88 11.18 16.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 74.109999999999999 110.887 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.46 HD11 ' HG ' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -93.55 -34.72 13.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 73.5 110.922 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -67.45 -11.54 58.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 75.420000000000002 110.892 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -93.94 -59.76 1.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 71.019999999999996 110.842 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -66.32 -41.36 89.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 74.239999999999995 110.927 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.35 -34.89 1.72 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.717 -0.754 . . . . 64.25 112.44 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.9 -60.6 3.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.77 0.319 . . . . 74.329999999999998 111.061 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.5 ptp -69.79 -9.52 54.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 73.230000000000004 110.878 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.85 -19.67 57.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.109999999999999 111.056 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -82.03 8.94 9.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 73.530000000000001 110.896 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -70.7 -80.85 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 71.099999999999994 110.866 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.05 11.4 0.19 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 71.420000000000002 112.493 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.52 176.94 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 73.030000000000001 110.894 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.22 -164.12 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 74.239999999999995 110.86 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.434 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 1.5 pt-20 -111.0 166.58 10.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 73.230000000000004 110.883 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.497 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -100.03 167.8 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.485 . . . . 71.109999999999999 111.078 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.419 ' OG1' ' HD2' ' A' ' 37' ' ' PRO . 44.3 p -94.79 -42.08 8.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.148 -0.478 . . . . 71.230000000000004 111.188 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.89 -64.65 0.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.736 . . . . 64.120000000000005 112.501 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.8 Cg_endo -69.74 157.26 61.04 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.684 2.256 . . . . 74.409999999999997 112.333 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -59.79 -28.95 67.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 74.400000000000006 110.908 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.11 -33.51 57.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.010000000000005 111.137 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -84.1 -32.07 24.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 71.209999999999994 110.905 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HB2' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -69.45 -44.84 70.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 74.549999999999997 110.832 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.48 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . . . -71.77 -34.72 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 72.010000000000005 111.061 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 21.3 ptt85 -76.37 -39.84 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 73.439999999999998 110.863 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.564 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -75.44 -59.76 2.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 73.420000000000002 111.118 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -58.03 -13.55 4.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 72.129999999999995 111.089 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.555 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -71.28 -71.96 0.24 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 64.129999999999995 111.15 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.714 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.3 t -113.56 -9.34 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 74.319999999999993 111.147 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -83.0 -39.92 20.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.430000000000007 110.921 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.716 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -102.41 -5.87 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 71.209999999999994 111.067 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.94 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -81.13 -25.51 0.41 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.64 0.733 . . . . 74.140000000000001 111.129 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.94 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 53.9 Cg_endo -69.72 -10.19 27.97 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.69 2.26 . . . . 74.209999999999994 112.342 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.6 -27.34 15.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.74 . . . . 53.130000000000003 112.498 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.81 -32.54 0.3 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.737 . . . . 73.409999999999997 112.535 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.586 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -155.15 164.7 38.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 63.399999999999999 111.113 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.457 ' HA ' HG22 ' A' ' 50' ' ' VAL . . . -75.17 65.96 1.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 64.049999999999997 111.114 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.712 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -141.13 105.85 0.45 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 64.200000000000003 112.514 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -162.06 0.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 72.340000000000003 110.931 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 29.4 t -129.31 119.36 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 75.430000000000007 111.14 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.797 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 1.6 mt-10 -93.34 136.01 34.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 73.510000000000005 110.857 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.5 t -138.44 115.62 11.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 74.530000000000001 111.168 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.486 ' H ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -122.31 178.3 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 110.865 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.77 128.87 49.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 111.109 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.49 -144.77 5.87 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.768 -0.729 . . . . 35.329999999999998 112.517 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -87.25 -21.32 25.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.887 0.375 . . . . 75.230000000000004 110.889 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.67 -109.93 3.01 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.737 . . . . 73.439999999999998 112.516 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.47 -81.48 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.326 . . . . 54.32 111.113 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -78.08 128.04 33.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 64.049999999999997 111.105 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.69 45.71 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 73.329999999999998 111.067 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.797 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -170.86 -152.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 74.540000000000006 110.928 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 83' ' ' VAL . . . -158.8 -126.84 0.88 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 63.310000000000002 112.488 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 4.5 m -152.67 151.95 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.373 . . . . 73.200000000000003 111.131 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.712 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -104.81 152.41 22.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 75.450000000000003 110.923 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.532 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 2.1 p -155.17 106.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 75.420000000000002 111.119 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.834 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -172.32 -142.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 111.158 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.425 ' C ' ' H ' ' A' ' 77' ' ' ASP . 3.6 mtm180 -110.13 149.18 39.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.599 0.714 . . . . 72.239999999999995 110.887 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.437 ' HD3' ' HB3' ' A' ' 55' ' ' ALA . 53.4 Cg_endo -69.77 8.36 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.694 2.263 . . . . 74.319999999999993 112.361 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -82.16 33.09 0.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 71.239999999999995 110.914 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.73 -11.45 10.4 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.753 -0.737 . . . . 70.340000000000003 112.456 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.464 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.2 t -101.61 105.21 16.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.318 . . . . 75.310000000000002 111.168 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.834 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 2.4 ptp85 -138.64 157.48 46.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.209999999999994 110.856 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 18.0 m -114.03 96.65 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 74.129999999999995 111.098 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.438 ' HB3' ' CD2' ' A' ' 72' ' ' LEU . 1.3 pp20? -87.24 125.07 33.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 70.019999999999996 110.902 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.557 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 4.5 t -91.52 139.89 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 75.409999999999997 111.141 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.577 ' O ' ' CG1' ' A' ' 91' ' ' VAL . 12.7 t-160 -117.9 106.04 12.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 110.833 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.488 ' HA ' ' CG1' ' A' ' 91' ' ' VAL . 2.7 mt -131.6 139.12 49.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 75.219999999999999 110.893 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.611 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -103.68 111.77 24.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 73.140000000000001 110.84 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.458 ' C ' ' H ' ' A' ' 89' ' ' PHE . 1.3 tmt_? -50.07 -21.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 75.340000000000003 110.851 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.472 ' HB3' ' OD1' ' A' ' 86' ' ' ASP . 4.7 t0 -68.28 5.36 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 65.420000000000002 110.879 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.458 ' H ' ' C ' ' A' ' 87' ' ' ARG . 37.5 m-85 67.08 42.51 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 110.898 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.43 ' HD2' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -129.09 -29.76 2.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 73.349999999999994 110.848 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' A' ' 86' ' ' ASP . 54.2 t -125.0 125.82 70.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 74.349999999999994 111.133 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.41 ' CA ' HD23 ' A' ' 85' ' ' LEU . 1.9 mp -145.27 17.27 1.53 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 72.109999999999999 110.891 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 84' ' ' HIS . 21.1 t0 -101.35 143.97 30.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 72.030000000000001 110.867 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 13.9 t -84.83 176.3 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 73.540000000000006 111.133 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 82' ' ' GLU . 3.7 tt0 -145.72 128.89 8.27 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.604 0.716 . . . . 72.310000000000002 110.897 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 115.17 3.96 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 63.32 112.392 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.41 ' HB3' ' HG3' ' A' ' 80' ' ' ARG . . . -94.58 115.73 27.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 72.230000000000004 111.069 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -102.19 15.13 30.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 73.030000000000001 110.891 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.63 -19.46 9.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.745 -0.74 . . . . 74.450000000000003 112.514 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -96.11 -42.69 8.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 60.109999999999999 110.834 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.07 26.68 54.97 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.728 -0.748 . . . . 75.140000000000001 112.465 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.712 -0.756 . . . . 74.420000000000002 112.535 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.826 0.346 . . . . 70.409999999999997 110.856 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.413 ' CG ' HG23 ' A' ' 17' ' ' THR . 4.5 p90 -94.43 -175.44 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 75.340000000000003 110.907 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -119.4 -31.56 4.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.519 . . . . 75.25 110.852 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.511 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.8 OUTLIER -101.07 127.57 31.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.607 0.718 . . . . 74.239999999999995 111.129 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 18.73 0.19 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.747 2.298 . . . . 62.340000000000003 112.305 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.511 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -138.95 39.76 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 74.310000000000002 111.12 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.524 ' HB ' HD23 ' A' ' 20' ' ' LEU . 65.0 p -72.73 -166.5 0.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 75.200000000000003 111.161 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -132.79 -86.7 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 74.340000000000003 110.901 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -75.08 6.64 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 74.510000000000005 110.911 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.524 HD23 ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -92.59 -37.85 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 74.299999999999997 110.904 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -75.17 -7.49 53.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 73.219999999999999 110.969 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -94.43 -26.31 16.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 74.319999999999993 110.886 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -30.03 29.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 72.430000000000007 110.896 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.9 -30.7 1.04 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.746 -0.74 . . . . 60.009999999999998 112.486 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.56 -56.88 4.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 72.120000000000005 111.112 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.6 ptp -65.15 -11.77 43.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 74.099999999999994 110.866 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.5 26.11 7.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.450000000000003 111.104 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.416 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 7.4 p90 -63.15 -16.65 60.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 72.030000000000001 110.857 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -147.6 -44.97 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 110.881 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.97 -18.21 25.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.724 . . . . 64.409999999999997 112.46 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -64.7 92.12 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.883 0.373 . . . . 74.319999999999993 110.868 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.412 ' HB3' ' CD ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -103.22 -161.04 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 110.882 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -122.63 114.01 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 110.911 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.619 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 11.4 t -90.7 172.34 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 61.240000000000002 111.112 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.49 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 34.3 p -89.73 -54.1 4.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 74.329999999999998 111.178 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.73 -64.89 0.11 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.721 -0.752 . . . . 74.409999999999997 112.51 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.9 Cg_endo -69.74 159.04 54.9 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.693 2.262 . . . . 75.430000000000007 112.375 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -60.65 -29.0 68.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 74.010000000000005 110.882 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.37 -35.66 63.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 70.120000000000005 111.077 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.519 ' HA ' ' CG ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -85.45 -28.59 24.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 71.439999999999998 110.846 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.465 ' HD3' ' HA ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -73.99 -42.61 60.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 75.450000000000003 110.894 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.464 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . . . -70.43 -33.71 71.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 111.058 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.519 ' CG ' ' HA ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -79.72 -42.56 24.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 74.299999999999997 110.843 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -75.22 -61.61 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 72.109999999999999 111.097 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.627 ' CB ' ' HB2' ' A' ' 57' ' ' GLU . . . -51.08 -23.76 3.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 62.229999999999997 111.107 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.62 ' O ' ' CG2' ' A' ' 50' ' ' VAL . . . -51.93 -67.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 72.519999999999996 111.142 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.645 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 25.3 t -111.18 -22.0 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 111.119 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 45.2 mt-30 -73.98 -29.21 61.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 61.310000000000002 110.911 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 1.089 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.42 -6.95 15.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.340000000000003 111.134 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 14.3 t -95.66 1.92 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.713 . . . . 74.209999999999994 111.108 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 1.089 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.0 Cg_endo -69.71 -20.35 35.16 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.265 . . . . 75.030000000000001 112.373 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.72 -40.54 3.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.731 . . . . 64.140000000000001 112.52 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.96 -32.8 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.738 -0.744 . . . . 64.430000000000007 112.471 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.957 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -147.3 163.31 36.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 74.409999999999997 111.15 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.759 ' O ' ' HA ' ' A' ' 73' ' ' VAL . . . -76.81 69.06 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 61.229999999999997 111.08 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.815 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -111.22 82.27 0.3 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.721 -0.752 . . . . 70.230000000000004 112.488 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.627 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -88.98 175.92 7.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 74.219999999999999 110.91 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.472 ' O ' HG22 ' A' ' 34' ' ' VAL . 62.7 t -131.17 123.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.549999999999997 111.107 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.619 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 8.0 mt-10 -92.08 129.1 38.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.924 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -100.48 104.46 15.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 71.230000000000004 111.154 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.56 160.68 39.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 72.510000000000005 110.887 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -131.37 112.63 12.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 71.200000000000003 111.129 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.73 -178.53 43.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 75.310000000000002 112.487 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -65.13 -24.03 67.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.856 0.36 . . . . 75.540000000000006 110.855 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.72 -112.51 0.14 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.715 -0.755 . . . . 73.230000000000004 112.427 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 87' ' ' ARG . . . -111.7 -82.65 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.321 . . . . 63.450000000000003 111.102 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.85 161.53 14.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 75.010000000000005 111.074 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.78 72.6 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 72.420000000000002 111.138 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 59' ' ' GLU . 4.7 m-85 -115.79 125.12 52.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.968 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -105.93 110.21 3.34 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.695 -0.764 . . . . 65.340000000000003 112.457 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.4 t -102.45 113.95 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 74.200000000000003 111.128 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.815 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -105.72 131.72 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 74.420000000000002 110.94 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.759 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.3 p -139.1 119.41 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 70.230000000000004 111.138 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.808 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 2.3 m -170.11 -133.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 64.329999999999998 111.165 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.477 ' H ' ' CG2' ' A' ' 74' ' ' THR . 9.5 mtm180 -105.84 143.55 27.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 75.349999999999994 110.876 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 13.08 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.663 2.242 . . . . 72.120000000000005 112.361 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 75' ' ' ARG . 5.7 m-20 -88.79 24.6 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 73.540000000000006 110.9 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.21 -13.69 53.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.769 -0.729 . . . . 74.140000000000001 112.465 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.486 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.0 p -98.54 108.34 21.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.825 0.345 . . . . 73.400000000000006 111.155 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.808 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 2.2 ptp85 -140.09 163.07 33.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 74.409999999999997 110.895 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 60.1 t -120.58 105.0 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 74.200000000000003 111.177 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' ' HB ' ' A' ' 94' ' ' THR . 34.4 tt0 -82.62 142.84 31.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 72.5 110.938 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.595 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 12.1 m -118.37 118.24 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 111.123 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.654 ' N ' ' OG1' ' A' ' 94' ' ' THR . 0.0 OUTLIER -83.18 119.37 24.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 73.409999999999997 110.894 179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.656 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 2.8 pp -113.77 110.9 20.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 74.420000000000002 110.922 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.603 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -134.28 118.79 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 73.049999999999997 110.885 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.411 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 2.0 ttt180 -69.14 5.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 73.549999999999997 110.895 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.522 ' HB3' ' CE2' ' A' ' 89' ' ' PHE . 29.8 t0 -64.57 -25.43 67.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 74.230000000000004 110.876 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.522 ' CE2' ' HB3' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -160.69 -89.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 74.310000000000002 110.877 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.53 45.63 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 73.329999999999998 110.862 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -99.09 111.84 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 64.25 111.096 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.595 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 0.4 OUTLIER -128.23 17.06 6.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 73.319999999999993 110.937 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.622 ' C ' ' H ' ' A' ' 84' ' ' HIS . 10.2 t70 -140.49 151.51 44.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 73.409999999999997 110.874 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.654 ' OG1' ' N ' ' A' ' 84' ' ' HIS . 81.4 m -122.58 -101.52 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 52.329999999999998 111.101 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -166.47 154.74 9.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.63 0.729 . . . . 74.310000000000002 110.906 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 148.46 65.04 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.671 2.247 . . . . 75.349999999999994 112.352 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.58 161.15 20.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 74.409999999999997 111.117 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.98 0.41 6.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 74.049999999999997 110.878 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.0 -20.84 26.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.735 -0.745 . . . . 64.409999999999997 112.476 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -97.08 -16.79 20.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.871 0.367 . . . . 73.439999999999998 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.45 -20.32 79.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 33.140000000000001 112.508 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 74.040000000000006 112.49 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.6 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.81 0.338 . . . . 75.340000000000003 110.883 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -63.94 -22.49 66.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 110.946 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.23 -124.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 73.400000000000006 110.876 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.552 ' CG1' ' HD2' ' A' ' 15' ' ' PRO . 3.0 tt -92.0 139.36 24.47 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.606 0.717 . . . . 74.430000000000007 111.135 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.552 ' HD2' ' CG1' ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.75 23.87 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.717 2.278 . . . . 71.019999999999996 112.311 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.527 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -151.04 37.4 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 63.32 111.154 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.51 ' CB ' ' HB2' ' A' ' 20' ' ' LEU . 66.5 p -66.87 -165.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 75.129999999999995 111.15 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.444 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 3.0 mt-10 -123.46 -86.99 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.862 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.87 12.3 3.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 74.140000000000001 110.856 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.557 ' HG ' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -94.25 -36.31 12.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 74.099999999999994 110.964 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.444 ' CD2' ' O ' ' A' ' 18' ' ' GLU . 2.1 p90 -75.83 -2.41 29.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 74.209999999999994 110.865 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -96.25 -32.04 12.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 74.450000000000003 110.877 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -81.05 -31.02 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 73.519999999999996 110.917 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -41.82 -38.63 2.44 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.768 -0.73 . . . . 64.340000000000003 112.437 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.52 -60.68 3.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 74.420000000000002 111.118 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.1 ptm -67.57 -10.94 56.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 74.310000000000002 110.849 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.443 ' C ' ' H ' ' A' ' 29' ' ' ASP . . . -82.37 -29.93 30.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.422 . . . . 53.25 111.122 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -73.86 42.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 73.230000000000004 110.876 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -148.34 -41.87 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 70.430000000000007 110.872 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.34 13.27 3.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.711 -0.757 . . . . 63.109999999999999 112.484 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 27' ' ' ALA . 2.7 tt0 -58.16 104.49 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 73.120000000000005 110.859 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.41 -171.04 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 74.310000000000002 110.838 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -109.48 120.5 42.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 71.439999999999998 110.85 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.548 ' CG1' ' H ' ' A' ' 35' ' ' THR . 2.3 t -91.74 -140.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 73.219999999999999 111.132 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.548 ' H ' ' CG1' ' A' ' 34' ' ' VAL . 43.6 p -137.06 -63.92 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 75.439999999999998 111.146 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.05 -64.6 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.71 -0.757 . . . . 74.319999999999993 112.469 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.7 Cg_endo -69.77 167.17 25.23 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.636 2.224 . . . . 72.430000000000007 112.381 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -70.32 -26.06 63.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 73.239999999999995 110.835 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.51 -37.42 70.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 70.420000000000002 111.118 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.07 -33.54 24.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 73.230000000000004 110.893 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -71.23 -43.85 66.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 75.549999999999997 110.863 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . . . -70.48 -34.33 72.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 111.093 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -79.35 -41.02 28.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 74.439999999999998 110.905 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.58 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -77.34 -63.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 63.219999999999999 111.112 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.57 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -52.9 -19.72 2.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 55.210000000000001 111.074 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.701 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -53.63 -67.96 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 74.400000000000006 111.114 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.641 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.5 t -115.55 -13.85 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 72.519999999999996 111.093 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.58 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 41.5 mt-30 -80.09 -34.54 37.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 75.340000000000003 110.909 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.988 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.29 -4.1 19.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 75.120000000000005 111.1 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.988 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.71 -6.4 0.12 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.639 0.733 . . . . 75.25 111.172 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.988 ' CD ' ' N ' ' A' ' 50' ' ' VAL . 53.8 Cg_endo -69.83 -26.58 27.11 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 2.236 . . . . 75.040000000000006 112.361 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.83 -50.49 5.56 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.721 -0.752 . . . . 73.299999999999997 112.53 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.5 -32.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.703 -0.761 . . . . 63.200000000000003 112.486 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.659 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -146.94 150.73 35.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 75.239999999999995 111.148 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.409 ' CB ' HG22 ' A' ' 50' ' ' VAL . . . -71.98 79.1 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 62.0 111.076 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.748 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -145.64 101.89 0.25 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 64.109999999999999 112.496 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.5 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.5 tt0 -95.39 -177.72 4.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 63.119999999999997 110.9 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.409 HG23 ' HG3' ' A' ' 31' ' ' GLU . 82.1 t -132.29 118.11 34.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 71.299999999999997 111.121 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.772 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 7.6 pt-20 -92.47 159.5 15.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 75.239999999999995 110.906 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.486 ' HA ' ' CB ' ' A' ' 69' ' ' TYR . 1.6 t -132.8 116.4 16.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 73.120000000000005 111.146 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -136.73 163.71 29.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 70.230000000000004 110.876 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.09 149.89 38.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 74.439999999999998 111.166 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.07 -142.51 5.34 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 44.329999999999998 112.506 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.74 -22.06 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.379 . . . . 64.150000000000006 110.866 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.1 -114.34 3.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 74.319999999999993 112.449 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.05 -84.71 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.748 0.308 . . . . 75.040000000000006 111.107 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -76.34 131.78 39.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 111.112 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -150.4 60.72 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 50.119999999999997 111.113 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.772 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 4.2 p90 -128.19 -169.17 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 70.049999999999997 110.922 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -157.07 163.9 32.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.771 -0.728 . . . . 71.109999999999999 112.525 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 83' ' ' VAL . 61.1 t -136.85 122.69 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 73.349999999999994 111.09 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.748 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -110.56 141.5 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 110.948 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.655 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.2 p -152.19 124.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 74.420000000000002 111.106 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.819 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 3.0 m -171.82 -129.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 74.400000000000006 111.125 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.489 ' C ' ' H ' ' A' ' 77' ' ' ASP . 6.4 mtm-85 -103.53 141.5 22.62 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.624 0.726 . . . . 74.129999999999995 110.883 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.499 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.0 Cg_endo -69.74 15.57 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 70.209999999999994 112.342 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 75' ' ' ARG . 5.7 m-20 -93.69 24.52 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 110.879 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.25 -12.71 53.83 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.74 . . . . 72.329999999999998 112.5 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.43 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.7 t -98.64 103.95 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 74.239999999999995 111.152 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.819 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.9 OUTLIER -137.3 163.75 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 74.310000000000002 110.925 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 45.6 t -115.88 105.66 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 73.239999999999995 111.069 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.514 ' O ' ' HB ' ' A' ' 94' ' ' THR . 0.0 OUTLIER -88.65 139.29 30.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 75.530000000000001 110.874 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 71' ' ' VAL . 32.3 m -116.11 146.88 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 74.540000000000006 111.111 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.712 ' HB2' ' OG1' ' A' ' 94' ' ' THR . 2.1 t-160 -98.46 123.99 42.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 65.329999999999998 110.861 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.673 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -118.91 103.15 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.901 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.511 ' N ' HG12 ' A' ' 91' ' ' VAL . 1.6 t70 -131.37 111.62 12.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 70.019999999999996 110.899 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -70.99 4.21 2.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 110.867 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 86' ' ' ASP . 50.5 t0 -72.73 -13.92 61.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 64.010000000000005 110.841 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.63 -95.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.409999999999997 110.897 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -149.21 29.33 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 74.549999999999997 110.84 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 2.3 t -73.92 97.0 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 111.119 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.502 HD12 ' CD2' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -124.87 15.29 8.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.439999999999998 110.853 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' A' ' 84' ' ' HIS . 4.4 m-20 -154.61 157.95 38.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 40.100000000000001 110.845 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.712 ' OG1' ' HB2' ' A' ' 84' ' ' HIS . 86.0 m -130.39 -99.8 0.32 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 72.349999999999994 111.135 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -159.34 162.61 25.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.627 0.727 . . . . 73.340000000000003 110.883 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 104.48 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.652 2.235 . . . . 71.099999999999994 112.335 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.79 108.22 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 73.340000000000003 111.092 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.85 16.58 12.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 70.129999999999995 110.894 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.59 -19.91 21.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 73.510000000000005 112.513 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.4 -45.94 6.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 75.400000000000006 110.886 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.06 27.46 45.05 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 71.450000000000003 112.455 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.749 . . . . 54.210000000000001 112.468 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.837 0.351 . . . . 73.120000000000005 110.88 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -67.69 -41.69 83.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 110.909 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.454 ' CB ' ' HB2' ' A' ' 85' ' ' LEU . 3.8 p-10 -62.55 -161.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 75.420000000000002 110.868 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.819 HG13 HG23 ' A' ' 17' ' ' THR . 27.7 pt -86.73 129.57 52.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.646 0.736 . . . . 64.400000000000006 111.133 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 0.56 5.43 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.697 2.265 . . . . 40.420000000000002 112.326 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 m -109.1 25.02 12.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 73.409999999999997 111.136 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.097 HG22 HD23 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -78.86 -168.2 1.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 71.150000000000006 111.136 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -73.97 -100.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 73.150000000000006 110.883 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.06 7.76 45.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 71.230000000000004 110.892 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.641 HD23 ' HB3' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -69.08 -13.41 62.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 74.140000000000001 110.895 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -94.05 0.64 56.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 110.904 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.13 -40.41 8.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 64.019999999999996 110.869 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.543 ' OE1' HG21 ' A' ' 83' ' ' VAL . 4.7 mp0 -67.3 -43.98 80.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.040000000000006 110.926 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.563 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -43.88 -30.01 1.56 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.76 . . . . 44.350000000000001 112.512 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.16 -56.91 12.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 62.539999999999999 111.076 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.647 ' SD ' HG21 ' A' ' 73' ' ' VAL . 20.4 ptp -72.01 -5.03 32.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.443 . . . . 60.219999999999999 110.883 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 24' ' ' GLY . . . -74.43 -24.34 59.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 71.010000000000005 111.119 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -64.3 -9.09 15.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 64.530000000000001 110.861 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.09 -77.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 51.219999999999999 110.882 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.31 9.98 2.98 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 64.540000000000006 112.499 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.788 ' CD ' HG23 ' A' ' 58' ' ' VAL . 2.8 tt0 -60.02 99.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 74.209999999999994 110.872 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.05 -164.06 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 72.010000000000005 110.846 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.81 122.54 44.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 64.439999999999998 110.905 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.748 HG23 ' C ' ' A' ' 58' ' ' VAL . 2.7 t -84.1 -133.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 61.009999999999998 111.118 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.558 ' H ' HG12 ' A' ' 34' ' ' VAL . 21.0 p -136.09 -58.55 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 72.420000000000002 111.113 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.46 -68.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 71.209999999999994 112.494 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.4 Cg_endo -69.75 171.24 14.82 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 2.243 . . . . 72.230000000000004 112.362 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -71.92 -24.61 61.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 65.400000000000006 110.836 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.86 72.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 54.32 111.084 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.68 -41.35 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 60.310000000000002 110.887 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.512 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -61.24 -37.7 84.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 74.200000000000003 110.854 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.729 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -67.74 -33.97 75.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 71.430000000000007 111.09 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.483 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -78.88 -39.62 34.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 73.120000000000005 110.91 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.772 ' HB1' ' OE2' ' A' ' 57' ' ' GLU . . . -80.34 -60.79 2.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 50.020000000000003 111.103 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.763 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -52.71 -23.24 6.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 75.299999999999997 111.088 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -57.25 -77.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 50.520000000000003 111.056 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.698 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 40.6 t -113.32 -13.97 11.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 72.120000000000005 111.121 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.6 tp60 -75.92 -32.94 59.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 110.872 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.029 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.68 -2.63 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 54.140000000000001 111.101 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.974 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.1 -4.56 0.11 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.637 0.732 . . . . 71.510000000000005 111.146 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.029 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.3 Cg_endo -69.78 -28.16 25.5 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.676 2.251 . . . . 72.430000000000007 112.326 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.54 -54.95 3.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.758 . . . . 64.340000000000003 112.469 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.79 -33.45 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.7 -0.762 . . . . 74.099999999999994 112.474 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.698 HG22 ' O ' ' A' ' 74' ' ' THR . 0.2 OUTLIER -144.81 150.12 36.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 74.040000000000006 111.112 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.817 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.42 76.46 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 72.540000000000006 111.099 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.704 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -149.7 108.94 0.42 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 62.520000000000003 112.521 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.772 ' OE2' ' HB1' ' A' ' 44' ' ' ALA . 3.2 tt0 -102.97 -168.54 1.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.893 0.378 . . . . 75.129999999999995 110.888 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.788 HG23 ' CD ' ' A' ' 31' ' ' GLU . 1.3 t -132.98 118.29 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 54.32 111.117 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -96.98 158.14 15.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 74.129999999999995 110.923 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -137.06 111.02 8.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 72.340000000000003 111.159 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.95 166.39 16.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.888 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.81 118.15 29.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 61.240000000000002 111.163 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.07 -144.3 9.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 50.420000000000002 112.5 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.97 -14.29 42.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.901 0.382 . . . . 65.5 110.895 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.89 -120.89 1.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 71.340000000000003 112.491 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -121.97 -76.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 64.549999999999997 111.128 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.768 ' HB1' ' CE2' ' A' ' 69' ' ' TYR . . . -103.04 86.33 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 64.209999999999994 111.087 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.28 62.93 6.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 75.239999999999995 111.076 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.768 ' CE2' ' HB1' ' A' ' 67' ' ' ALA . 0.4 OUTLIER -109.04 174.39 5.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 110.913 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -153.91 157.75 27.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.725 -0.75 . . . . 44.399999999999999 112.454 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.642 HG12 HD21 ' A' ' 85' ' ' LEU . 3.4 p -132.6 115.03 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.372 . . . . 74.510000000000005 111.132 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.761 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -107.53 135.88 48.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 70.400000000000006 110.918 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.704 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.7 p -151.55 124.43 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 71.120000000000005 111.154 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.771 ' HB ' ' O ' ' A' ' 79' ' ' THR . 4.1 m -168.06 -131.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 74.450000000000003 111.17 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.599 ' H ' HG22 ' A' ' 74' ' ' THR . 0.5 OUTLIER -103.0 139.33 20.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.63 0.729 . . . . 64.109999999999999 110.886 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.636 ' HG3' HG21 ' A' ' 50' ' ' VAL . 53.9 Cg_endo -69.72 16.83 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.711 2.274 . . . . 62.039999999999999 112.34 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 75' ' ' ARG . 4.1 m-20 -94.97 13.61 24.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 71.340000000000003 110.874 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.84 -12.1 34.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 23.43 112.457 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.771 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.8 t -95.55 130.63 42.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 41.229999999999997 111.175 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.547 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -142.2 158.79 43.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 74.299999999999997 110.924 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.761 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 72.8 t -117.79 80.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 65.129999999999995 111.119 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB2' HD12 ' A' ' 72' ' ' LEU . 3.0 tp10 -75.09 121.82 22.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 110.853 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.0 t -103.82 139.5 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 63.340000000000003 111.172 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.63 ' C ' HG12 ' A' ' 91' ' ' VAL . 17.9 m-70 -86.61 118.13 25.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 73.25 110.843 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.642 HD21 HG12 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -128.3 105.86 8.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 74.319999999999993 110.91 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.66 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.3 t0 -139.66 131.96 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 71.409999999999997 110.843 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.641 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 2.0 tmt_? -61.21 5.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.219999999999999 110.863 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 86' ' ' ASP . 13.9 t0 -67.23 -3.33 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 110.863 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 67.53 12.2 8.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 110.879 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -137.31 2.18 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.882 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.66 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 58.5 t -116.38 70.87 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 63.219999999999999 111.143 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.097 HD23 HG22 ' A' ' 17' ' ' THR . 0.3 OUTLIER -128.56 12.47 6.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 71.109999999999999 110.941 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -92.92 -179.1 5.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 65.549999999999997 110.864 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.8 t -124.61 166.96 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 61.310000000000002 111.132 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -145.97 123.38 6.12 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.658 0.742 . . . . 75.420000000000002 110.872 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 96.48 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.637 2.225 . . . . 22.109999999999999 112.351 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 80' ' ' ARG . . . -64.09 111.35 2.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 71.409999999999997 111.097 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -88.83 11.03 19.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 62.329999999999998 110.831 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.18 -21.11 7.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.727 . . . . 31.440000000000001 112.462 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -97.92 -38.54 9.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.861 0.363 . . . . 73.239999999999995 110.888 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.26 25.14 52.6 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.751 . . . . 62.439999999999998 112.518 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.782 -0.723 . . . . 31.309999999999999 112.472 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.832 0.349 . . . . 75.349999999999994 110.879 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.428 ' HB2' ' CE2' ' A' ' 69' ' ' TYR . 77.6 m-85 -64.68 -32.91 74.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 110.929 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 10.6 p-10 -65.98 -122.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 63.450000000000003 110.885 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.844 HD12 HG11 ' A' ' 91' ' ' VAL . 30.8 mt -77.37 127.55 82.69 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.633 0.73 . . . . 61.030000000000001 111.138 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 15.86 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.637 2.225 . . . . 74.540000000000006 112.394 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.784 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -150.77 37.86 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 65.340000000000003 111.117 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.841 HG22 HD21 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -71.61 -161.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 64.209999999999994 111.133 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.408 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 29.4 mm-40 -84.13 -111.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 73.109999999999999 110.835 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -86.7 9.76 17.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.129999999999995 110.86 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.703 HD22 HG21 ' A' ' 17' ' ' THR . 0.3 OUTLIER -66.91 -12.23 58.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 72.420000000000002 110.877 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -63.65 -12.27 32.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 73.019999999999996 110.912 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -115.18 52.93 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 110.85 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.468 HE22 HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -58.19 88.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 74.549999999999997 110.904 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 42.93 38.17 3.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 63.439999999999998 112.487 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.86 -26.7 66.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 63.43 111.122 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.608 ' SD ' HG11 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -66.0 -9.9 34.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 73.549999999999997 110.846 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 29' ' ' ASP . . . -118.14 61.91 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 63.340000000000003 111.152 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -59.34 -6.15 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 75.129999999999995 110.926 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 27' ' ' ALA . 3.8 m-20 -126.08 -35.52 2.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 73.319999999999993 110.863 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 -20.52 60.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.716 -0.754 . . . . 42.409999999999997 112.475 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -62.47 93.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 61.140000000000001 110.892 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.09 179.62 3.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 64.25 110.873 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -95.62 115.73 27.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 64.530000000000001 110.894 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.739 HG22 ' OE1' ' A' ' 57' ' ' GLU . 3.1 t -75.03 -135.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 74.209999999999994 111.184 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.684 ' H ' HG12 ' A' ' 34' ' ' VAL . 80.6 p -140.15 -60.43 0.53 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 61.119999999999997 111.108 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.455 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 175.76 -60.88 0.11 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 54.119999999999997 112.5 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.9 Cg_endo -69.73 164.64 33.76 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.711 2.274 . . . . 73.019999999999996 112.369 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 9.0 p-10 -71.53 -25.67 62.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 55.420000000000002 110.804 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.14 -36.86 73.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 70.530000000000001 111.067 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 2.1 m-20 -83.49 -36.31 24.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 53.140000000000001 110.876 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.594 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 11.8 ptt180 -70.39 -43.97 68.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.842 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.712 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -69.39 -34.47 74.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 72.230000000000004 111.12 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 15.3 ptt85 -80.11 -41.5 25.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 53.43 110.851 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -75.26 -62.26 1.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 61.530000000000001 111.102 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -53.7 -19.57 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 52.399999999999999 111.101 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -60.15 -68.28 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 54.420000000000002 111.1 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.721 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 19.4 t -111.07 -10.45 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 74.549999999999997 111.158 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.619 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.2 tp60 -83.65 -38.61 21.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 72.319999999999993 110.93 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.755 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -101.88 -6.32 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 72.140000000000001 111.116 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.969 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -81.26 -24.79 0.39 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.657 0.741 . . . . 71.140000000000001 111.139 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.969 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 53.8 Cg_endo -69.78 -7.15 20.33 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.661 2.24 . . . . 72.010000000000005 112.399 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.04 -21.51 15.44 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 74.430000000000007 112.483 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.68 -33.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 55.329999999999998 112.487 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.686 ' O ' ' O ' ' A' ' 49' ' ' ALA . 2.0 t -155.16 161.86 41.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 74.209999999999994 111.133 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.741 ' HB1' ' NH2' ' A' ' 80' ' ' ARG . . . -76.63 69.48 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 71.349999999999994 111.089 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.712 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -144.29 103.15 0.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.735 -0.745 . . . . 74.030000000000001 112.463 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.739 ' OE1' HG22 ' A' ' 34' ' ' VAL . 3.8 tt0 -97.55 -171.89 2.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 63.340000000000003 110.889 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.727 ' C ' HG23 ' A' ' 34' ' ' VAL . 78.0 t -133.08 120.94 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 74.030000000000001 111.098 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 14.5 tm-20 -95.88 149.8 21.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 74.140000000000001 110.89 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.2 t -135.46 113.92 11.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.114 -0.493 . . . . 51.25 111.124 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.64 161.31 37.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 64.129999999999995 110.858 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.64 119.83 31.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 71.420000000000002 111.164 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.14 -159.65 30.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.742 -0.742 . . . . 70.049999999999997 112.554 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -82.97 -23.67 33.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 51.240000000000002 110.88 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.9 -112.99 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 42.130000000000003 112.466 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -114.25 -69.19 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 44.25 111.118 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.756 ' HB1' ' CE2' ' A' ' 69' ' ' TYR . . . -110.3 157.15 19.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 73.219999999999999 111.106 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -155.08 61.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 74.329999999999998 111.123 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.756 ' CE2' ' HB1' ' A' ' 67' ' ' ALA . 1.2 m-85 -113.67 173.43 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 73.150000000000006 110.922 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -159.59 117.55 0.78 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 44.219999999999999 112.472 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.624 HG23 HG22 ' A' ' 58' ' ' VAL . 7.1 p -108.52 122.01 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.914 0.388 . . . . 54.039999999999999 111.117 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.832 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -111.86 144.21 41.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 73.409999999999997 110.917 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.712 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 t -148.22 116.75 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 63.240000000000002 111.146 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.808 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 1.3 m -173.74 -135.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 72.019999999999996 111.166 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.44 ' H ' HG22 ' A' ' 74' ' ' THR . 20.0 mtm-85 -107.61 149.29 38.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.642 0.734 . . . . 72.219999999999999 110.857 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.72 5.13 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.702 2.268 . . . . 74.219999999999999 112.341 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.36 27.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 64.530000000000001 110.903 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.8 -11.03 15.77 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.727 -0.749 . . . . 74.109999999999999 112.485 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.1 p -98.62 102.27 13.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.807 0.337 . . . . 62.200000000000003 111.104 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.808 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 1.1 ptp85 -141.34 162.46 35.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 71.430000000000007 110.912 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 23.8 t -112.85 100.02 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 52.240000000000002 111.088 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.614 ' HG3' HD12 ' A' ' 72' ' ' LEU . 1.0 OUTLIER -89.06 117.72 28.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 75.349999999999994 110.884 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.655 HG13 ' HB ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -98.28 111.42 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 64.019999999999996 111.194 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.483 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 3.3 t-160 -78.45 123.22 26.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 65.040000000000006 110.868 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.689 HD22 ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -106.84 96.48 6.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 60.329999999999998 110.888 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.656 ' H ' ' HA ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -130.1 119.48 23.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 62.310000000000002 110.891 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.652 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -66.26 -6.67 14.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 61.420000000000002 110.895 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.681 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 15.0 t0 -84.01 31.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 73.010000000000005 110.893 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.681 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 19.5 m-85 98.03 -27.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 74.319999999999993 110.875 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 79.6 mmt-85 -91.83 38.84 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 110.893 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.844 HG11 HD12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -61.54 -40.18 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.400000000000006 111.14 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.841 HD21 HG22 ' A' ' 17' ' ' THR . 3.2 mm? -116.41 30.05 7.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 74.400000000000006 110.9 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 13.5 t0 -72.47 69.58 0.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 63.520000000000003 110.862 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.655 ' HB ' HG13 ' A' ' 83' ' ' VAL . 5.5 t -79.09 161.12 26.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 73.019999999999996 111.148 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.53 128.23 8.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.638 0.732 . . . . 62.329999999999998 110.88 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 95.33 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.669 2.246 . . . . 71.400000000000006 112.371 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.601 ' HB3' ' HG3' ' A' ' 80' ' ' ARG . . . -65.04 110.18 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 63.219999999999999 111.086 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -105.85 18.42 22.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 70.230000000000004 110.839 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.62 -19.15 30.18 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 62.539999999999999 112.474 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.09 -44.39 7.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.813 0.34 . . . . 64.120000000000005 110.836 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.65 23.61 57.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.716 -0.754 . . . . 61.140000000000001 112.466 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 60.420000000000002 112.477 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.85 0.357 . . . . 74.409999999999997 110.921 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.72 ' HA ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -113.6 179.96 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 73.030000000000001 110.908 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.636 ' CB ' ' HB3' ' A' ' 67' ' ' ALA . 15.7 p-10 -117.43 -46.73 2.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 71.549999999999997 110.873 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.652 HG23 ' CG ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -133.62 165.71 34.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 70.409999999999997 111.171 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HD2' HG22 ' A' ' 14' ' ' ILE . 53.4 Cg_endo -69.74 -3.68 12.48 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.71 2.273 . . . . 63.340000000000003 112.324 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -128.98 74.62 1.59 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 74.409999999999997 111.18 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.738 ' CG2' HD22 ' A' ' 20' ' ' LEU . 59.9 p -96.69 -166.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 75.109999999999999 111.111 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 92' ' ' LEU . 18.9 tt0 -129.55 -92.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 74.239999999999995 110.867 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -72.02 7.15 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 72.010000000000005 110.869 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.899 HD21 ' CB ' ' A' ' 85' ' ' LEU . 11.2 mp -84.72 -37.56 20.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 70.430000000000007 110.923 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -82.86 4.03 27.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 74.030000000000001 110.946 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.6 -52.77 3.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 63.240000000000002 110.911 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -78.12 -31.81 50.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 72.109999999999999 110.924 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.81 -41.63 4.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 65.150000000000006 112.521 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.51 -60.75 2.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.736 0.303 . . . . 63.409999999999997 111.107 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.486 ' HG3' HG21 ' A' ' 73' ' ' VAL . 1.2 ptm -69.51 -8.4 46.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 75.510000000000005 110.842 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.775 ' HB1' ' OE1' ' A' ' 31' ' ' GLU . . . -88.94 -32.99 17.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 54.240000000000002 111.093 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -75.73 46.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 74.329999999999998 110.839 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.21 -74.62 0.49 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.125 -0.488 . . . . 74.140000000000001 110.871 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.26 16.64 5.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.691 -0.766 . . . . 45.520000000000003 112.44 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.775 ' OE1' ' HB1' ' A' ' 27' ' ' ALA . 17.0 pt-20 -54.94 168.17 0.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 63.140000000000001 110.894 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.444 ' H ' ' HB2' ' A' ' 57' ' ' GLU . 0.5 OUTLIER -130.94 -165.92 1.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 75.099999999999994 110.866 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -128.84 120.46 26.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 64.219999999999999 110.902 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.611 HG22 ' CD ' ' A' ' 57' ' ' GLU . 40.1 t -73.32 162.67 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 61.32 111.096 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.566 ' N ' HG12 ' A' ' 34' ' ' VAL . 70.7 p -91.81 -49.03 6.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 73.439999999999998 111.118 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.07 -64.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 61.219999999999999 112.491 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 150.3 68.14 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.646 2.231 . . . . 74.540000000000006 112.366 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -59.01 -30.85 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 50.439999999999998 110.876 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.39 -28.7 60.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 61.350000000000001 111.063 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 0.6 OUTLIER -78.97 -30.02 44.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 73.019999999999996 110.848 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.622 ' NE ' ' HB1' ' A' ' 97' ' ' ALA . 3.2 ptt180 -68.57 -43.13 77.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 110.842 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -74.47 -32.04 62.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 74.340000000000003 111.123 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 19.7 ptt85 -77.93 -41.54 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 72.140000000000001 110.884 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -78.18 -62.29 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 63.439999999999998 111.058 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -51.54 -21.39 2.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 111.092 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.725 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -53.81 -66.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 73.519999999999996 111.094 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.751 ' HA ' HG12 ' A' ' 50' ' ' VAL . 22.0 t -111.35 -17.04 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 75.200000000000003 111.098 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 52.3 mt-30 -79.26 -28.92 42.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 65.519999999999996 110.952 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.101 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -109.31 -10.27 14.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 55.43 111.081 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.53 -0.03 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 70.019999999999996 111.126 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.101 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.5 Cg_endo -69.76 -27.23 26.73 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.689 2.259 . . . . 72.140000000000001 112.337 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.14 -51.83 3.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 61.439999999999998 112.464 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.24 -35.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 75.540000000000006 112.46 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.803 ' O ' ' O ' ' A' ' 49' ' ' ALA . 4.4 m -143.15 147.51 35.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.769 0.318 . . . . 75.409999999999997 111.128 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.82 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -74.24 81.43 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 51.420000000000002 111.156 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.691 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -145.41 97.9 0.19 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 50.340000000000003 112.516 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.611 ' CD ' HG22 ' A' ' 34' ' ' VAL . 1.1 pt-20 -99.43 -179.47 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 55.439999999999998 110.897 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.83 HG13 HG22 ' A' ' 71' ' ' VAL . 70.3 t -115.04 139.22 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 111.142 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.577 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 19.9 tt0 -106.88 155.89 19.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 73.120000000000005 110.879 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.411 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 1.2 t -129.35 110.77 12.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 65.409999999999997 111.162 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.13 160.52 38.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 63.219999999999999 110.894 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 64.4 p -132.69 93.21 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 65.219999999999999 111.113 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.2 -139.47 2.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.75 . . . . 65.239999999999995 112.445 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.15 -0.13 56.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.392 . . . . 75.510000000000005 110.881 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -100.7 -122.83 5.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.792 -0.718 . . . . 53.149999999999999 112.5 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.876 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -122.82 -82.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.795 0.331 . . . . 74.420000000000002 111.081 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.636 ' HB3' ' CB ' ' A' ' 13' ' ' ASP . . . -100.45 90.15 4.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 71.239999999999995 111.079 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.49 79.86 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 72.120000000000005 111.091 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.711 ' HB2' HD11 ' A' ' 85' ' ' LEU . 3.1 m-85 -106.75 163.27 13.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 110.927 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -137.65 107.02 0.56 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 63.100000000000001 112.474 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.83 HG22 HG13 ' A' ' 58' ' ' VAL . 10.7 t -103.11 111.07 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.899 0.381 . . . . 43.310000000000002 111.098 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.72 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -103.45 149.45 24.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.349999999999994 110.914 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.662 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.7 p -150.42 115.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 43.420000000000002 111.103 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.766 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 1.4 m -173.43 -136.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 71.540000000000006 111.126 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.506 ' H ' HG22 ' A' ' 74' ' ' THR . 0.6 OUTLIER -104.26 145.86 31.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.597 0.713 . . . . 73.140000000000001 110.847 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.433 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.9 Cg_endo -69.74 7.88 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.695 2.264 . . . . 63.329999999999998 112.329 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.3 25.81 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 75.5 110.885 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.45 -13.22 47.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 64.140000000000001 112.499 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.575 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.6 t -97.03 102.8 14.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 72.409999999999997 111.18 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.766 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.6 OUTLIER -138.3 162.47 34.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 53.43 110.909 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 5.1 m -118.03 98.04 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 70.510000000000005 111.121 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.474 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -81.52 127.05 32.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.901 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 71' ' ' VAL . 3.9 t -91.92 116.9 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 111.141 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 2.3 t-160 -84.36 117.35 23.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 75.25 110.833 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.925 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -123.49 122.89 39.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 65.400000000000006 110.912 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 7.8 t0 -132.74 119.46 20.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 75.209999999999994 110.85 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.876 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 2.1 tmt_? -68.44 0.19 4.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.109999999999999 110.864 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.549 ' HB3' ' CE1' ' A' ' 89' ' ' PHE . 6.5 t0 -65.79 -14.17 60.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 73.230000000000004 110.848 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -176.71 -91.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 71.209999999999994 110.915 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.65 ' O ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -150.31 31.44 0.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 74.239999999999995 110.876 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.928 ' O ' HG12 ' A' ' 91' ' ' VAL . 2.0 t -71.82 81.42 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 73.219999999999999 111.16 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.706 HD13 ' C ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -120.39 18.62 12.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 64.510000000000005 110.934 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -83.09 137.67 34.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 60.140000000000001 110.882 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.0 t -92.05 165.88 12.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 111.158 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -139.12 162.83 50.02 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.677 0.751 . . . . 74.409999999999997 110.858 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 92.85 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.712 2.275 . . . . 61.130000000000003 112.343 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.622 ' HB1' ' NE ' ' A' ' 41' ' ' ARG . . . -76.23 111.19 11.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 74.019999999999996 111.059 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 101' ' ' GLY . 19.8 t0 -122.25 113.0 18.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 65.319999999999993 110.863 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -47.06 -21.54 1.02 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.732 -0.747 . . . . 72.329999999999998 112.513 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -93.74 -24.92 17.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 75.239999999999995 110.913 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 98' ' ' ASP . . . 100.4 -6.39 57.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.748 -0.739 . . . . 75.120000000000005 112.517 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.698 -0.763 . . . . 75.549999999999997 112.498 -179.878 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.779 0.323 . . . . 35.140000000000001 110.842 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -67.13 -18.02 65.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 64.040000000000006 110.974 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.658 ' HB3' HD12 ' A' ' 85' ' ' LEU . 6.3 p-10 -58.44 -100.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 62.530000000000001 110.889 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.73 HG23 ' CG ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -113.7 163.9 17.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.616 0.722 . . . . 73.209999999999994 111.132 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' A' ' 14' ' ' ILE . 53.8 Cg_endo -69.79 -2.87 10.93 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.709 2.273 . . . . 62.229999999999997 112.294 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -144.22 72.66 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 65.329999999999998 111.129 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.497 ' HB ' ' HG ' ' A' ' 92' ' ' LEU . 3.9 p -74.6 -169.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 64.5 111.11 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 3.3 mm-40 -116.78 -97.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 75.209999999999994 110.896 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.4 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -77.29 6.04 7.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 73.129999999999995 110.908 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.662 HD21 HD13 ' A' ' 85' ' ' LEU . 2.3 tp -79.97 -2.2 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.473 . . . . 53.020000000000003 110.882 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.44 ' CD2' ' O ' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -59.91 -14.26 14.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.310000000000002 110.973 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.6 49.49 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 62.240000000000002 110.835 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 24' ' ' GLY . 1.1 pt20 -64.47 82.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 54.439999999999998 110.917 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.462 ' HA2' HG21 ' A' ' 73' ' ' VAL . . . 36.5 44.26 0.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 54.109999999999999 112.544 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.94 76.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.766 0.317 . . . . 52.119999999999997 111.09 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.892 ' HG3' HG21 ' A' ' 54' ' ' THR . 0.0 OUTLIER -69.49 -16.64 63.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.200000000000003 110.899 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.488 ' HB2' HG22 ' A' ' 54' ' ' THR . . . -117.73 54.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 60.299999999999997 111.086 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.47 49.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 64.140000000000001 110.906 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 175.22 -31.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 71.25 110.828 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.47 -2.68 56.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.752 . . . . 61.219999999999999 112.479 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.35 85.74 3.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 74.450000000000003 110.909 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.89 -167.24 1.2 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 73.200000000000003 110.869 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 22.1 pt-20 -101.67 166.27 10.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 74.140000000000001 110.885 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.761 HG23 ' C ' ' A' ' 58' ' ' VAL . 2.8 t -123.25 -139.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 111.163 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.721 ' H ' HG12 ' A' ' 34' ' ' VAL . 59.0 p -138.71 -70.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 72.140000000000001 111.166 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.475 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -175.24 -59.79 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 60.329999999999998 112.475 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.4 Cg_endo -69.8 164.16 35.62 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.267 . . . . 64.430000000000007 112.318 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -72.7 -25.09 61.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 110.919 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.36 82.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 54.340000000000003 111.12 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -80.58 -34.59 35.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 74.409999999999997 110.864 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.53 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 8.3 ptt180 -72.78 -45.67 57.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 74.209999999999994 110.872 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.663 ' HB1' ' HA2' ' A' ' 99' ' ' GLY . . . -64.65 -33.07 75.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 61.25 111.084 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 13.3 ptt85 -83.41 -43.36 15.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 62.329999999999998 110.86 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -74.88 -60.84 2.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 64.310000000000002 111.125 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.584 ' O ' ' HB1' ' A' ' 55' ' ' ALA . . . -51.47 -22.92 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 52.140000000000001 111.112 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.721 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -59.15 -75.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 74.150000000000006 111.075 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.651 ' HA ' HG12 ' A' ' 50' ' ' VAL . 26.3 t -107.78 -21.73 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 72.450000000000003 111.078 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -69.99 -31.48 69.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 64.219999999999999 110.917 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.06 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.34 -0.11 22.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 73.340000000000003 111.101 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.992 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -100.05 3.14 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.627 0.727 . . . . 54.43 111.158 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.06 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.8 Cg_endo -69.7 -27.39 26.82 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.769 2.313 . . . . 74.540000000000006 112.356 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.86 -49.38 5.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 62.049999999999997 112.455 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.33 -32.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.797 -0.715 . . . . 55.439999999999998 112.534 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.892 HG21 ' HG3' ' A' ' 26' ' ' MET . 11.8 t -141.91 149.83 40.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 72.129999999999995 111.182 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.861 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -74.99 78.83 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 24.539999999999999 111.121 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.603 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -144.86 101.17 0.24 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 72.129999999999995 112.5 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.691 ' H ' HD23 ' A' ' 72' ' ' LEU . 4.3 tt0 -95.4 -173.09 2.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 64.420000000000002 110.909 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.761 ' C ' HG23 ' A' ' 34' ' ' VAL . 20.2 t -135.5 116.69 19.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 63.229999999999997 111.139 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.593 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -94.89 150.84 19.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 61.43 110.829 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 69' ' ' TYR . 1.8 t -136.67 107.34 6.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 74.209999999999994 111.126 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 2.1 tt0 -129.39 167.76 17.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 74.510000000000005 110.911 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.74 120.51 34.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 64.340000000000003 111.139 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.2 -168.55 30.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 72.219999999999999 112.514 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -59.82 -23.45 63.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.907 0.384 . . . . 71.109999999999999 110.906 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.86 -118.2 1.56 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.777 -0.725 . . . . 72.340000000000003 112.495 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.47 -71.22 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.809 0.338 . . . . 62.340000000000003 111.13 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.728 ' HB3' ' H ' ' A' ' 87' ' ' ARG . . . -89.3 134.88 33.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 62.240000000000002 111.078 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -150.8 62.53 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 72.200000000000003 111.115 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.593 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -111.98 162.64 15.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 73.319999999999993 110.925 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.672 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -144.98 118.99 1.17 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.718 -0.754 . . . . 62.240000000000002 112.49 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.693 HG23 HG22 ' A' ' 58' ' ' VAL . 8.8 p -103.02 119.86 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.371 . . . . 62.210000000000001 111.111 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.955 HD22 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -104.27 142.65 34.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 54.210000000000001 110.902 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.603 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 2.8 t -150.8 117.01 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 72.230000000000004 111.158 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.762 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 2.2 m -169.14 -137.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 73.200000000000003 111.123 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.629 ' H ' HG22 ' A' ' 74' ' ' THR . 55.8 mtm180 -98.61 150.01 36.29 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.585 0.707 . . . . 74.200000000000003 110.888 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.573 ' CG ' HG21 ' A' ' 50' ' ' VAL . 53.7 Cg_endo -69.79 5.83 1.56 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.672 2.248 . . . . 61.240000000000002 112.336 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.57 29.4 0.31 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 71.040000000000006 110.901 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.24 -9.98 11.87 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.763 -0.732 . . . . 71.340000000000003 112.48 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.581 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.9 p -98.38 109.49 22.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 73.019999999999996 111.174 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.762 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -137.94 160.93 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 73.439999999999998 110.878 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.709 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 12.5 m -110.94 101.8 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 63.340000000000003 111.108 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.773 ' HB2' HD12 ' A' ' 72' ' ' LEU . 8.2 tm-20 -82.86 122.92 28.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 64.439999999999998 110.908 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 2.3 t -96.26 109.36 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 65.040000000000006 111.115 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 93' ' ' ASP . 4.2 p-80 -79.57 121.09 24.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 63.43 110.899 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.806 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -120.17 116.85 26.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 64.120000000000005 110.908 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.721 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 25.9 t0 -127.3 114.2 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 61.539999999999999 110.886 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.73 ' CG ' HG23 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -68.73 1.74 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 62.520000000000003 110.897 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.448 ' C ' ' CG ' ' A' ' 89' ' ' PHE . 52.1 t0 -70.31 -12.36 61.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 70.400000000000006 110.86 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.448 ' CG ' ' C ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -172.62 -94.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 70.230000000000004 110.853 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.633 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -150.59 30.7 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 74.239999999999995 110.875 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.974 ' O ' HG12 ' A' ' 91' ' ' VAL . 1.9 t -77.58 77.16 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 71.140000000000001 111.145 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.782 HD13 ' C ' ' A' ' 91' ' ' VAL . 0.3 OUTLIER -120.19 18.05 12.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 73.319999999999993 110.952 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 84' ' ' HIS . 1.1 m-20 -80.95 167.5 19.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 71.519999999999996 110.875 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.691 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 5.9 t -121.19 169.43 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 111.198 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -143.73 110.7 5.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.575 0.703 . . . . 74.400000000000006 110.894 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.61 ' HB3' HG12 ' A' ' 81' ' ' VAL . 54.3 Cg_endo -69.71 103.78 1.21 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.68 2.253 . . . . 61.399999999999999 112.4 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.448 ' HB3' HH22 ' A' ' 80' ' ' ARG . . . -116.33 -178.88 3.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 62.340000000000003 111.092 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.54 -156.62 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 74.239999999999995 110.845 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.663 ' HA2' ' HB1' ' A' ' 42' ' ' ALA . . . -65.16 -14.97 60.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 41.350000000000001 112.492 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.39 -53.09 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 64.030000000000001 110.847 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.54 28.89 4.39 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 72.200000000000003 112.48 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 72.310000000000002 112.512 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.832 0.349 . . . . 75.310000000000002 110.863 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -66.84 -52.16 46.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 73.120000000000005 110.906 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.85 ' H ' HD21 ' A' ' 85' ' ' LEU . 75.0 m-20 -58.22 -97.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 71.319999999999993 110.876 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.947 ' HB ' HG11 ' A' ' 91' ' ' VAL . 30.2 mt -101.72 105.28 40.23 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.617 0.722 . . . . 74.540000000000006 111.163 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 21.72 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 72.040000000000006 112.328 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.64 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.8 m -124.21 17.11 9.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 74.310000000000002 111.128 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.635 HG22 HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -76.2 -160.75 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 74.430000000000007 111.164 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -61.25 -109.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 70.239999999999995 110.899 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -97.21 11.3 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 75.120000000000005 110.893 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.605 HD22 ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -61.9 -34.65 76.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 65.519999999999996 110.915 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -86.34 7.83 23.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 73.519999999999996 110.951 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -108.5 -37.36 5.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 71.310000000000002 110.871 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.563 ' OE1' HG11 ' A' ' 73' ' ' VAL . 71.8 mm-40 -67.46 -45.53 75.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 53.420000000000002 110.921 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.625 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -43.91 -30.71 1.75 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 73.420000000000002 112.478 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.64 -72.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.754 0.312 . . . . 72.120000000000005 111.091 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.6 ptp -63.52 -3.69 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 72.439999999999998 110.881 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 24' ' ' GLY . . . -64.76 -26.79 68.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 64.120000000000005 111.129 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.454 ' C ' ' HD1' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -82.81 8.43 12.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 73.109999999999999 110.888 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -89.87 -78.35 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.139 -0.482 . . . . 63.210000000000001 110.832 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.13 -5.04 2.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 62.020000000000003 112.508 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' CG ' ' HA ' ' A' ' 27' ' ' ALA . 23.1 mt-10 -62.18 105.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 63.310000000000002 110.892 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -161.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 62.109999999999999 110.853 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -118.46 116.56 26.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 72.019999999999996 110.899 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.663 HG12 ' H ' ' A' ' 35' ' ' THR . 4.2 t -72.21 171.36 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 73.310000000000002 111.131 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.663 ' H ' HG12 ' A' ' 34' ' ' VAL . 71.9 p -91.97 -41.51 10.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 60.520000000000003 111.148 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.411 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 164.52 -62.95 0.24 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.718 -0.753 . . . . 63.450000000000003 112.479 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.428 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 54.2 Cg_endo -69.69 156.15 64.3 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.683 2.255 . . . . 75.239999999999995 112.377 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -60.82 -27.52 68.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 63.310000000000002 110.834 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.27 68.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 73.109999999999999 111.086 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.44 -32.81 23.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 64.319999999999993 110.841 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.599 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -69.99 -44.07 70.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 72.0 110.865 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.705 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.79 -35.01 72.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 73.140000000000001 111.106 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -79.41 -41.4 27.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 73.239999999999995 110.923 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.574 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -77.22 -61.71 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 62.229999999999997 111.097 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.655 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -53.05 -21.73 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 44.240000000000002 111.093 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.756 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -54.27 -71.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 72.430000000000007 111.093 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.772 ' HA ' HG12 ' A' ' 50' ' ' VAL . 21.5 t -111.9 -12.79 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 111.129 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.574 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.8 tp60 -80.5 -34.11 35.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.140000000000001 110.892 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.037 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.97 -5.66 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 62.229999999999997 111.119 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.32 -5.69 0.11 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.731 . . . . 65.209999999999994 111.112 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.037 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.7 Cg_endo -69.79 -26.57 27.29 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 72.120000000000005 112.356 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.37 -57.46 2.62 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.687 -0.768 . . . . 60.119999999999997 112.502 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.65 -34.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.723 -0.751 . . . . 55.439999999999998 112.496 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.716 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.4 m -149.1 151.47 34.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.777 0.322 . . . . 55.520000000000003 111.173 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.841 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.22 79.23 0.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 111.126 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.764 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -144.78 102.54 0.27 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 71.530000000000001 112.505 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.623 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.5 tt0 -95.46 -177.77 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 75.109999999999999 110.86 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.677 HG22 HG23 ' A' ' 71' ' ' VAL . 95.3 t -131.03 117.0 35.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 72.129999999999995 111.123 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.643 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 1.4 pp20? -95.57 129.91 42.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 71.0 110.911 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 t -100.38 118.29 36.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.479 . . . . 75.040000000000006 111.179 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.608 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -134.93 101.7 4.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 63.409999999999997 110.896 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.2 p -93.97 127.07 39.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 71.400000000000006 111.141 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.0 -154.98 10.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 75.019999999999996 112.499 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -87.77 -0.3 56.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.883 0.373 . . . . 71.010000000000005 110.877 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.98 -96.95 2.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.76 -0.733 . . . . 31.120000000000001 112.464 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.45 -136.07 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 74.450000000000003 111.112 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.656 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . . . -113.15 93.46 4.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 52.549999999999997 111.087 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.709 ' HB1' ' NE2' ' A' ' 84' ' ' HIS . . . -79.76 95.31 5.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 71.439999999999998 111.091 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.535 ' CE1' ' HB1' ' A' ' 67' ' ' ALA . 9.3 m-85 -116.66 115.75 26.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.209999999999994 110.897 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 84' ' ' HIS . . . -98.88 109.62 3.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 75.540000000000006 112.482 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.677 HG23 HG22 ' A' ' 58' ' ' VAL . 4.6 p -104.19 109.75 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 71.25 111.177 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.814 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -97.74 142.43 29.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 65.109999999999999 110.889 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.656 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.8 p -150.39 120.78 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 71.409999999999997 111.083 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.772 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 2.8 m -171.36 -130.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 62.130000000000003 111.139 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.499 ' H ' HG22 ' A' ' 74' ' ' THR . 2.1 mtt-85 -107.0 145.73 31.71 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.718 . . . . 72.420000000000002 110.83 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.73 13.36 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.653 2.235 . . . . 44.409999999999997 112.392 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 75' ' ' ARG . 3.9 m-20 -89.91 25.65 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.872 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.17 -12.52 43.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 74.099999999999994 112.488 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.547 ' O ' ' HB ' ' A' ' 74' ' ' THR . 24.7 p -97.45 105.25 17.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 51.140000000000001 111.145 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.772 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 1.3 ptp85 -139.57 162.27 35.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 74.120000000000005 110.931 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 42.8 t -115.09 100.5 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 65.230000000000004 111.177 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.524 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 5.4 tm-20 -84.51 115.91 22.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 73.540000000000006 110.877 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -102.53 105.44 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 73.099999999999994 111.147 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.709 ' NE2' ' HB1' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -83.76 124.74 31.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 74.219999999999999 110.893 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.85 HD21 ' H ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -111.39 111.76 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 74.230000000000004 110.946 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.601 ' N ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -126.42 114.98 18.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 74.409999999999997 110.907 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.803 ' HA ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -72.94 -0.25 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 73.120000000000005 110.844 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -74.04 -19.38 60.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 70.200000000000003 110.849 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 90' ' ' ARG . 3.9 p90 169.8 -36.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.109999999999999 110.906 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HB3' ' CB ' ' A' ' 93' ' ' ASP . 1.9 mmm180 -117.87 68.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 55.210000000000001 110.874 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.947 HG11 ' HB ' ' A' ' 14' ' ' ILE . 1.5 t -61.31 -14.23 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 73.319999999999993 111.147 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.635 HD12 HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -124.8 32.14 5.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 63.020000000000003 110.926 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 0.8 OUTLIER -65.75 80.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 65.0 110.879 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 10.1 t -79.76 153.51 29.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 111.088 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -148.76 129.76 7.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.678 0.751 . . . . 73.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 125.4 12.13 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.723 2.282 . . . . 75.400000000000006 112.37 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.539 ' HB2' HH11 ' A' ' 41' ' ' ARG . . . -115.26 108.93 17.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 72.400000000000006 111.09 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -103.99 20.79 17.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 73.310000000000002 110.854 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.12 -19.22 31.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.74 . . . . 61.340000000000003 112.466 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -94.66 -43.47 8.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 60.340000000000003 110.85 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.55 28.03 52.99 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 74.200000000000003 112.478 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 64.349999999999994 112.44 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.432 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 4.9 p-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.806 0.336 . . . . 62.340000000000003 110.873 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -67.66 -19.28 65.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.933 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.99 -161.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 73.109999999999999 110.905 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.709 HD13 ' HG3' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -117.42 156.92 48.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.6 0.715 . . . . 54.43 111.135 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.561 ' HD2' HG13 ' A' ' 14' ' ' ILE . 53.8 Cg_endo -69.72 45.38 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.676 2.251 . . . . 50.149999999999999 112.37 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -151.26 17.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 72.109999999999999 111.12 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.663 ' HB ' HD22 ' A' ' 20' ' ' LEU . 43.9 p -75.4 -167.41 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 73.310000000000002 111.139 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.662 ' HG2' HD23 ' A' ' 92' ' ' LEU . 2.9 mm-40 -116.0 -95.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 73.319999999999993 110.921 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -89.69 8.53 31.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 65.129999999999995 110.881 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -75.29 -10.97 59.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.25 110.912 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -76.36 -23.63 54.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.882 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -74.1 -34.58 64.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 110.888 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.528 ' HG3' HG21 ' A' ' 83' ' ' VAL . 19.6 mm-40 -66.37 -49.58 66.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 71.409999999999997 110.9 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -44.54 -30.43 2.13 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.71 -0.757 . . . . 72.129999999999995 112.496 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.28 -62.54 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.767 0.317 . . . . 70.510000000000005 111.052 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 35.1 tpp -67.09 -13.49 61.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 75.319999999999993 110.871 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 24' ' ' GLY . . . -67.07 -22.38 65.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 73.120000000000005 111.114 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -85.78 10.81 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 71.439999999999998 110.862 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.01 -75.67 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 65.230000000000004 110.909 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.08 13.66 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.704 -0.76 . . . . 64.439999999999998 112.491 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.581 ' HB3' HG23 ' A' ' 58' ' ' VAL . 20.9 mt-10 -59.59 104.57 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 65.239999999999995 110.881 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.93 -164.47 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 74.010000000000005 110.9 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.23 121.6 43.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 63.5 110.862 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.78 HG12 ' H ' ' A' ' 35' ' ' THR . 2.6 t -82.6 178.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 73.120000000000005 111.121 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.78 ' H ' HG12 ' A' ' 34' ' ' VAL . 71.0 p -94.35 -59.94 1.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 75.230000000000004 111.215 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.0 -64.6 0.1 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.733 . . . . 71.349999999999994 112.5 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 164.85 32.96 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 63.399999999999999 112.415 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -70.43 -26.07 63.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 64.150000000000006 110.865 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.73 -46.45 77.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 34.100000000000001 111.081 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -41.61 25.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 110.879 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.549 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -59.99 -37.93 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 75.040000000000006 110.882 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -62.9 -33.3 75.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 63.340000000000003 111.116 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.527 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 1.3 ptt-85 -78.66 -40.12 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 74.519999999999996 110.84 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.704 ' HB1' ' OE2' ' A' ' 57' ' ' GLU . . . -77.83 -59.32 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 75.140000000000001 111.154 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.748 ' HB2' HD23 ' A' ' 72' ' ' LEU . . . -54.64 -20.81 8.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 71.109999999999999 111.123 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -62.0 -81.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 75.120000000000005 111.089 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.784 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 58.4 t -108.8 -19.87 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 72.450000000000003 111.116 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 1.3 tp60 -69.33 -33.15 72.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 65.409999999999997 110.919 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.037 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.64 1.88 25.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 72.340000000000003 111.07 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.991 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.74 -7.17 0.12 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.637 0.732 . . . . 73.340000000000003 111.103 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.037 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.6 Cg_endo -69.75 -26.11 27.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.671 2.247 . . . . 65.310000000000002 112.327 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.71 -61.41 2.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.725 -0.75 . . . . 53.020000000000003 112.498 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -156.31 -33.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 65.040000000000006 112.473 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.724 HG22 ' O ' ' A' ' 74' ' ' THR . 0.3 OUTLIER -148.01 159.78 43.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 42.329999999999998 111.181 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.763 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.09 70.98 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 60.109999999999999 111.099 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.807 ' HA3' ' HA ' ' A' ' 73' ' ' VAL . . . -149.68 112.72 0.57 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 61.229999999999997 112.475 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.772 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.2 tt0 -98.49 -169.73 1.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.846 0.355 . . . . 73.019999999999996 110.89 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.761 ' C ' HG23 ' A' ' 34' ' ' VAL . 40.7 t -133.42 120.84 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 53.030000000000001 111.142 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.786 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 11.2 tm-20 -90.3 158.47 17.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.439999999999998 110.875 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 t -137.97 111.22 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 72.230000000000004 111.151 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.2 169.6 17.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 72.150000000000006 110.907 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.427 ' C ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -117.54 149.78 40.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 73.239999999999995 111.125 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.69 -154.29 8.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.758 -0.734 . . . . 74.340000000000003 112.53 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -78.44 -23.99 46.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.383 . . . . 63.140000000000001 110.935 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.79 -114.06 2.86 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.713 -0.756 . . . . 64.209999999999994 112.538 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -113.98 -78.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 64.420000000000002 111.093 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.658 ' O ' ' CG ' ' A' ' 86' ' ' ASP . . . -87.99 139.95 29.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 62.509999999999998 111.067 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -154.65 73.36 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 65.230000000000004 111.107 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.789 ' OH ' HD22 ' A' ' 85' ' ' LEU . 11.5 p90 -132.41 -172.16 2.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 75.040000000000006 110.918 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -153.96 129.12 2.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.727 -0.749 . . . . 33.420000000000002 112.474 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.417 ' O ' HG23 ' A' ' 83' ' ' VAL . 2.1 p -107.35 120.01 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 60.539999999999999 111.141 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.92 HD22 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -98.18 139.14 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 73.010000000000005 110.888 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.807 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 3.0 m -147.34 111.42 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 62.340000000000003 111.137 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.803 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.2 m -167.38 -137.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 42.340000000000003 111.112 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.631 ' H ' HG22 ' A' ' 74' ' ' THR . 10.7 mtm180 -108.28 153.88 41.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.59 0.709 . . . . 74.510000000000005 110.888 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.421 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.72 2.17 3.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.72 2.28 . . . . 65.109999999999999 112.372 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -85.94 45.94 1.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 52.020000000000003 110.877 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.95 -6.02 7.19 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 62.329999999999998 112.491 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.803 ' O ' ' HB ' ' A' ' 74' ' ' THR . 72.2 p -91.83 123.79 35.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 51.310000000000002 111.121 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.771 ' NE ' ' HB1' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -146.2 143.89 29.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 72.099999999999994 110.889 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.603 HG23 ' HG1' ' A' ' 74' ' ' THR . 87.1 t -110.87 84.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 72.109999999999999 111.114 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.623 ' HB2' HD12 ' A' ' 72' ' ' LEU . 2.4 tm-20 -77.52 118.0 19.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 72.209999999999994 110.899 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.623 ' O ' ' HA2' ' A' ' 70' ' ' GLY . 2.4 t -95.44 136.28 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 75.420000000000002 111.147 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.521 ' C ' HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -87.86 117.42 26.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 75.519999999999996 110.878 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.789 HD22 ' OH ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -124.75 111.88 16.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 75.049999999999997 110.945 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.878 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.6 t70 -138.75 120.94 15.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 64.310000000000002 110.831 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.709 ' HG3' HD13 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -55.81 1.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 72.129999999999995 110.854 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.611 ' H ' ' C ' ' A' ' 86' ' ' ASP . 49.8 t0 -65.83 -6.49 12.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 70.329999999999998 110.847 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 70.43 19.32 6.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 73.420000000000002 110.918 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.68 -0.03 1.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 54.119999999999997 110.846 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.878 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 89.2 t -120.94 70.02 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 70.340000000000003 111.128 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.662 HD23 ' HG2' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -124.55 14.36 8.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 71.409999999999997 110.935 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.407 ' O ' HG12 ' A' ' 83' ' ' VAL . 8.4 m-20 -94.69 -172.6 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 74.099999999999994 110.881 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.7 t -116.43 174.34 6.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 71.420000000000002 111.147 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 82' ' ' GLU . 2.6 tp10 -141.1 119.28 7.98 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.729 . . . . 74.340000000000003 110.908 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 115.64 4.19 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.653 2.236 . . . . 74.340000000000003 112.341 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.771 ' HB1' ' NE ' ' A' ' 80' ' ' ARG . . . -116.7 112.8 21.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 71.109999999999999 111.144 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -128.93 56.8 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 71.200000000000003 110.864 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.28 -17.95 2.91 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.761 -0.733 . . . . 71.239999999999995 112.517 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.25 -61.35 1.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 74.5 110.849 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.44 18.1 65.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 52.219999999999999 112.519 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 61.310000000000002 112.508 -179.906 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.832 0.348 . . . . 73.239999999999995 110.888 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -67.01 -42.5 84.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 74.329999999999998 110.935 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.67 ' OD1' ' HB3' ' A' ' 67' ' ' ALA . 13.0 t0 -66.31 -143.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 53.439999999999998 110.866 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.829 HG22 ' H ' ' A' ' 16' ' ' THR . 19.7 mm -75.32 114.07 31.98 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.613 0.72 . . . . 75.510000000000005 111.087 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 16.64 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.652 2.235 . . . . 71.420000000000002 112.366 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.829 ' H ' HG22 ' A' ' 14' ' ' ILE . 2.8 m -134.76 23.52 3.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 71.209999999999994 111.096 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.866 HG21 HG22 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -75.66 -145.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 75.420000000000002 111.127 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 17' ' ' THR . 59.5 mt-10 -84.65 -104.23 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 70.129999999999995 110.877 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.62 6.19 45.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 73.049999999999997 110.878 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 85' ' ' LEU . 7.7 mp -65.33 -34.87 79.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 75.310000000000002 110.923 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -83.26 3.73 30.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.972 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -105.6 -36.32 7.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 72.519999999999996 110.885 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -66.68 -49.01 67.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.477 . . . . 75.230000000000004 110.877 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -43.27 -33.09 1.88 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 64.450000000000003 112.507 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.37 -56.49 19.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.768 0.318 . . . . 64.430000000000007 111.05 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.651 ' SD ' HG11 ' A' ' 73' ' ' VAL . 19.6 ptp -70.18 -7.96 46.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 75.129999999999995 110.905 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.687 ' HB1' ' OE1' ' A' ' 31' ' ' GLU . . . -79.62 -17.49 53.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 43.240000000000002 111.096 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -82.43 9.74 8.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.898 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -93.69 -79.21 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 64.129999999999995 110.87 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.05 7.88 5.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 44.119999999999997 112.484 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.76 ' HG3' HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -61.92 152.4 32.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 73.239999999999995 110.891 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.518 ' N ' ' HG2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -116.47 -165.1 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 73.129999999999995 110.836 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -114.16 116.77 29.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 71.209999999999994 110.876 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 35' ' ' THR . 10.2 t -74.9 167.39 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 65.219999999999999 111.131 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.569 ' N ' HG12 ' A' ' 34' ' ' VAL . 65.7 p -94.67 -44.3 7.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 111.126 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 164.98 -61.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.727 . . . . 50.210000000000001 112.489 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.9 Cg_endo -69.71 159.73 52.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 74.209999999999994 112.357 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.601 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 1.2 t70 -65.06 -27.18 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 72.319999999999993 110.859 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -36.41 73.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 71.239999999999995 111.062 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -85.21 -37.34 20.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 71.420000000000002 110.863 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.601 ' NE ' ' HA ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -70.01 -45.57 66.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 71.120000000000005 110.859 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.669 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -68.74 -36.03 77.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 72.209999999999994 111.1 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 10.5 ptt180 -79.51 -41.47 27.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.349999999999994 110.858 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -74.7 -62.3 1.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 64.239999999999995 111.075 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.619 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -53.79 -19.64 4.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 60.439999999999998 111.097 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.693 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -55.43 -67.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 71.319999999999993 111.112 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.758 ' HA ' HG12 ' A' ' 50' ' ' VAL . 3.5 p -112.7 -18.48 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 74.329999999999998 111.159 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 17.1 mt-30 -77.67 -29.14 51.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 51.420000000000002 110.938 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.071 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.86 -7.81 15.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 72.319999999999993 111.131 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.988 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.46 -0.51 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.606 0.717 . . . . 70.140000000000001 111.149 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.071 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.2 Cg_endo -69.77 -29.1 24.37 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.654 2.236 . . . . 75.530000000000001 112.304 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.43 -52.27 4.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.736 -0.745 . . . . 60.210000000000001 112.479 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.1 -34.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 74.129999999999995 112.488 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.746 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -144.4 149.47 36.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 62.119999999999997 111.137 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.837 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -73.3 81.17 1.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 60.149999999999999 111.085 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.72 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -143.12 99.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 51.009999999999998 112.45 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.591 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.6 tt0 -90.66 179.97 5.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 74.019999999999996 110.925 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.76 HG23 ' HG3' ' A' ' 31' ' ' GLU . 69.3 t -130.81 121.97 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 51.219999999999999 111.153 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.465 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 11.8 tm-20 -93.39 153.56 18.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 75.409999999999997 110.91 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.436 ' HA ' ' CD2' ' A' ' 69' ' ' TYR . 1.5 t -132.98 112.34 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 63.299999999999997 111.094 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -140.91 162.91 34.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 65.200000000000003 110.854 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.92 120.07 34.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 71.329999999999998 111.134 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.41 -169.03 32.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 74.120000000000005 112.452 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.69 -23.12 49.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 75.040000000000006 110.908 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.52 -109.23 0.36 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.756 -0.735 . . . . 74.219999999999999 112.515 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.09 -74.43 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 55.32 111.122 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.67 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . . . -111.14 162.01 15.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 111.12 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -156.24 72.06 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 43.439999999999998 111.138 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.644 ' O ' HD12 ' A' ' 85' ' ' LEU . 4.2 m-85 -110.53 163.65 13.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 60.149999999999999 110.915 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.09 100.07 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.753 . . . . 74.0 112.479 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.499 HG23 HG22 ' A' ' 58' ' ' VAL . 5.3 p -101.18 119.37 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 72.430000000000007 111.151 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.833 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -113.26 144.63 42.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 72.400000000000006 110.934 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.651 HG11 ' SD ' ' A' ' 26' ' ' MET . 10.8 t -149.38 123.37 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.430000000000007 111.118 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.772 ' OG1' ' HA ' ' A' ' 80' ' ' ARG . 1.9 m -172.2 -135.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 71.530000000000001 111.127 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.547 ' H ' HG22 ' A' ' 74' ' ' THR . 27.0 mtm-85 -96.02 145.93 30.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.576 0.703 . . . . 75.340000000000003 110.866 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.587 ' CG ' HG21 ' A' ' 50' ' ' VAL . 53.2 Cg_endo -69.75 10.64 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.698 2.265 . . . . 54.130000000000003 112.339 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 75' ' ' ARG . 7.6 m-20 -88.59 25.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.510000000000005 110.854 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.24 -9.76 24.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 41.119999999999997 112.521 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 79' ' ' THR . 2.5 t -97.58 102.54 14.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 65.329999999999998 111.154 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.772 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -142.2 172.39 12.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 73.0 110.9 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 27.9 t -119.93 113.03 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 72.310000000000002 111.138 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.539 ' HA ' ' HB3' ' A' ' 72' ' ' LEU . 2.1 pt-20 -88.34 122.26 31.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.902 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.582 ' CG1' HD11 ' A' ' 20' ' ' LEU . 2.1 t -100.96 117.01 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 71.329999999999998 111.153 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.508 ' O ' ' O ' ' A' ' 91' ' ' VAL . 2.9 t-80 -82.02 116.2 21.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 73.340000000000003 110.846 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.768 ' HB3' HD23 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -104.03 98.09 7.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 74.230000000000004 110.937 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 1.03 ' H ' ' HA ' ' A' ' 91' ' ' VAL . 3.3 p30 -134.84 119.25 17.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 74.349999999999994 110.845 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.436 ' HG3' HD11 ' A' ' 14' ' ' ILE . 1.3 tmt_? -65.35 10.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 75.519999999999996 110.868 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.626 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 19.3 t0 -80.03 20.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 110.86 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.626 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 15.3 m-85 91.5 -17.8 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 73.409999999999997 110.908 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 38.23 3.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 62.329999999999998 110.895 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.03 ' HA ' ' H ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -64.35 -6.8 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 75.540000000000006 111.125 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.702 HD22 HG13 ' A' ' 91' ' ' VAL . 3.1 mm? -113.08 28.48 8.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 75.340000000000003 110.965 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -80.04 75.08 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 71.310000000000002 110.891 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.8 t -86.02 151.36 23.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 54.329999999999998 111.122 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.18 110.45 4.0 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.631 0.729 . . . . 73.099999999999994 110.884 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 120.22 7.04 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.686 2.257 . . . . 72.209999999999994 112.369 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.577 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . . . -116.81 167.47 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 63.340000000000003 111.081 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.49 7.71 7.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 65.219999999999999 110.859 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.432 ' HA2' ' CB ' ' A' ' 42' ' ' ALA . . . 86.1 -18.68 30.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 34.039999999999999 112.476 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.21 -16.55 22.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 74.200000000000003 110.859 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.53 -24.16 63.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 75.439999999999998 112.472 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 51.439999999999998 112.53 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.1 t0 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.834 0.349 . . . . 64.329999999999998 110.843 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -68.34 -43.89 76.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.904 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -60.74 -167.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.874 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.876 HG22 ' H ' ' A' ' 16' ' ' THR . 46.6 mm -76.69 122.07 85.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.62 0.724 . . . . 65.239999999999995 111.119 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 9.27 0.6 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.697 2.265 . . . . 74.349999999999994 112.3 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.876 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -125.52 36.69 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 62.450000000000003 111.133 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.902 HG22 HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -91.6 -166.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 62.450000000000003 111.176 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -64.42 -103.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 75.409999999999997 110.904 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.77 7.69 45.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.239999999999995 110.892 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.849 ' HG ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.02 -14.35 53.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 72.340000000000003 110.911 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -94.4 5.66 51.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 64.120000000000005 110.946 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -108.44 -43.36 4.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 72.319999999999993 110.905 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.664 ' HG3' HG21 ' A' ' 83' ' ' VAL . 4.4 mm100 -64.64 -53.04 53.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 73.340000000000003 110.9 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.54 -54.32 7.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.774 -0.726 . . . . 74.420000000000002 112.455 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.18 49.0 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.762 0.315 . . . . 63.340000000000003 111.124 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.2 ptm -66.47 -40.83 89.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 65.340000000000003 110.885 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' HB1' ' CE1' ' A' ' 28' ' ' PHE . . . -122.54 -92.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 62.43 111.055 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.483 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -145.12 -35.14 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 71.439999999999998 110.884 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.26 30.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.230000000000004 110.831 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.98 7.63 65.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 63.310000000000002 112.512 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.536 ' HB3' HG23 ' A' ' 58' ' ' VAL . 2.0 mm-40 -74.22 161.99 29.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 72.329999999999998 110.854 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.66 -166.03 1.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 70.230000000000004 110.837 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.13 118.94 22.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 72.109999999999999 110.91 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.67 HG22 ' OE2' ' A' ' 57' ' ' GLU . 87.6 t -71.36 155.76 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 54.450000000000003 111.119 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.471 ' N ' HG12 ' A' ' 34' ' ' VAL . 16.6 p -107.82 -22.04 12.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 72.150000000000006 111.211 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 34' ' ' VAL . . . -153.48 -139.71 2.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 41.32 112.455 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -162.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.722 2.282 . . . . 74.409999999999997 112.31 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.35 -27.42 64.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 64.409999999999997 110.896 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.81 -39.13 70.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 75.329999999999998 111.105 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -82.45 -37.58 25.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 54.409999999999997 110.874 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.581 ' HG3' ' HD3' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -68.53 -38.34 80.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.430000000000007 110.893 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 80' ' ' ARG . . . -63.47 -33.08 74.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 74.329999999999998 111.168 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.497 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 2.7 ptt85 -77.61 -40.45 42.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 54.329999999999998 110.909 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.772 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . . . -77.9 -57.53 3.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 73.319999999999993 111.105 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -52.78 -18.11 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 64.530000000000001 111.085 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.504 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -63.75 -78.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.530000000000001 111.096 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.739 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 80.5 t -111.91 -20.07 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 63.240000000000002 111.134 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 16.6 mt-30 -72.01 -26.62 62.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.94 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.106 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -109.09 -4.99 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 72.030000000000001 111.135 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.999 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.78 0.59 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.615 0.722 . . . . 64.409999999999997 111.123 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.106 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.0 Cg_endo -69.79 -26.47 27.41 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 55.420000000000002 112.33 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.36 -54.58 2.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 72.450000000000003 112.47 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.74 -31.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 41.109999999999999 112.512 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.737 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -140.51 146.14 37.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 65.200000000000003 111.17 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.772 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -74.68 74.87 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 63.509999999999998 111.116 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.725 ' HA3' ' HA ' ' A' ' 73' ' ' VAL . . . -153.45 109.34 0.4 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 73.129999999999995 112.483 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.867 ' HB3' ' HB2' ' A' ' 49' ' ' ALA . 2.3 pt-20 -100.91 -161.21 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 64.209999999999994 110.896 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 31' ' ' GLU . 60.0 t -128.84 142.88 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 72.409999999999997 111.096 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 1.0 OUTLIER -108.82 153.5 23.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 74.200000000000003 110.886 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.86 105.56 7.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 74.530000000000001 111.117 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -136.85 165.76 25.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 73.019999999999996 110.878 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -124.28 115.42 21.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 61.32 111.124 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.04 -151.31 14.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.731 -0.747 . . . . 43.43 112.518 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -78.38 -23.43 46.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.364 . . . . 73.25 110.88 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.86 -120.41 0.22 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 71.329999999999998 112.489 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -122.65 -76.95 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 62.310000000000002 111.117 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.852 ' HB1' ' CE2' ' A' ' 69' ' ' TYR . . . -102.9 92.53 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 43.409999999999997 111.082 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -84.55 72.98 10.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 71.420000000000002 111.085 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.852 ' CE2' ' HB1' ' A' ' 67' ' ' ALA . 6.8 m-85 -106.76 165.62 11.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.319999999999993 110.904 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -146.89 111.68 0.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 50.539999999999999 112.518 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 83' ' ' VAL . 7.2 p -102.66 117.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.362 . . . . 73.430000000000007 111.111 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.938 HD22 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -104.14 145.45 30.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 73.329999999999998 110.962 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.725 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 18.1 m -151.23 118.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 75.129999999999995 111.14 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.794 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.3 m -165.87 -136.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.340000000000003 111.153 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.613 ' H ' HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -102.68 149.85 37.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 73.319999999999993 110.858 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.53 ' CG ' HG21 ' A' ' 50' ' ' VAL . 53.3 Cg_endo -69.77 6.01 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.63 2.22 . . . . 64.239999999999995 112.359 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -85.91 35.34 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 72.329999999999998 110.837 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.41 -8.68 52.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 51.009999999999998 112.478 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.794 ' O ' ' HB ' ' A' ' 74' ' ' THR . 3.2 t -92.34 125.43 37.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 75.409999999999997 111.126 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -144.24 144.35 31.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 73.510000000000005 110.891 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.807 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 87.9 t -104.81 88.97 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 72.319999999999993 111.132 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.44 ' HB3' ' HD3' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -71.53 122.78 21.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 65.5 110.887 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.664 HG21 ' HG3' ' A' ' 23' ' ' GLN . 16.3 t -102.29 139.26 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 52.210000000000001 111.161 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 1.043 ' C ' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -89.43 115.14 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 64.040000000000006 110.883 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.043 HD13 ' C ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -125.62 105.63 9.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 73.310000000000002 110.937 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.798 ' CG ' HG11 ' A' ' 91' ' ' VAL . 4.3 m-20 -135.12 129.06 33.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 73.219999999999999 110.879 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -58.48 6.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 64.420000000000002 110.893 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.621 ' H ' ' C ' ' A' ' 86' ' ' ASP . 3.8 t0 -64.89 -5.84 6.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 110.88 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 70.71 13.17 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 110.903 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 2.73 1.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 72.540000000000006 110.909 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.798 HG11 ' CG ' ' A' ' 86' ' ' ASP . 69.0 t -119.13 81.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 52.240000000000002 111.069 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.902 HD23 HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -136.27 10.6 3.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 74.450000000000003 110.924 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -93.25 167.61 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 64.030000000000001 110.839 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.658 ' OG1' HG22 ' A' ' 83' ' ' VAL . 9.8 t -108.17 166.9 10.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 64.200000000000003 111.122 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -144.53 119.96 6.03 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.636 0.732 . . . . 73.329999999999998 110.885 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 119.02 6.03 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.697 2.264 . . . . 73.239999999999995 112.325 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -116.34 163.07 16.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 73.239999999999995 111.063 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -125.62 -135.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 74.040000000000006 110.816 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.13 -14.94 27.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.667 -0.778 . . . . 74.219999999999999 112.484 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -91.5 -48.66 6.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 70.450000000000003 110.862 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.76 23.2 9.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 71.310000000000002 112.465 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 60.210000000000001 112.49 -179.921 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.824 0.345 . . . . 64.430000000000007 110.865 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -67.59 -23.16 65.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 63.340000000000003 110.893 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.634 ' HA ' ' HB1' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -62.23 -157.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 70.150000000000006 110.859 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.557 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 20.7 pt -77.21 160.87 74.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.587 0.708 . . . . 73.129999999999995 111.153 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.8 -3.11 11.37 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.64 2.227 . . . . 65.109999999999999 112.358 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.0 p -148.2 79.87 1.46 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 70.030000000000001 111.153 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.985 HG22 HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -98.98 -166.34 1.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 72.209999999999994 111.153 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.56 ' HB2' HD23 ' A' ' 92' ' ' LEU . 10.6 tt0 -80.58 -100.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 64.140000000000001 110.881 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.58 10.83 40.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 110.908 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.773 HD13 ' CG ' ' A' ' 85' ' ' LEU . 3.3 tp -65.01 -21.15 66.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 75.200000000000003 110.904 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -83.78 7.12 18.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 54.119999999999997 110.918 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -108.8 -42.08 4.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 74.430000000000007 110.868 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.51 ' HG3' HG21 ' A' ' 83' ' ' VAL . 5.0 mm100 -66.43 -46.68 75.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 75.329999999999998 110.934 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.22 -29.19 1.57 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 70.439999999999998 112.513 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.25 -58.63 5.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.78 0.324 . . . . 62.310000000000002 111.121 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -9.99 59.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 54.009999999999998 110.865 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 31' ' ' GLU . . . -81.92 -17.84 45.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 72.420000000000002 111.085 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -79.04 5.07 12.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 71.010000000000005 110.915 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -73.63 -82.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 61.210000000000001 110.852 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.06 12.62 0.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 75.430000000000007 112.504 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -66.38 168.66 8.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 72.540000000000006 110.877 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 9.3 m-20 -112.12 -149.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 63.020000000000003 110.867 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.96 170.18 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 70.099999999999994 110.881 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 58' ' ' VAL . 14.8 t -118.45 169.42 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 72.519999999999996 111.105 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.623 ' N ' HG12 ' A' ' 34' ' ' VAL . 63.0 p -90.53 -41.59 11.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 111.137 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.423 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 162.01 -61.83 0.28 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 74.219999999999999 112.515 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 54.0 Cg_endo -69.74 157.01 61.9 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.712 2.275 . . . . 72.5 112.337 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -62.74 -26.84 68.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 73.099999999999994 110.889 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.28 -35.83 72.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 71.099999999999994 111.15 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.42 -36.13 24.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 65.430000000000007 110.893 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 12.8 ptt180 -70.22 -43.64 70.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 74.019999999999996 110.894 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.41 -34.41 72.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 71.549999999999997 111.143 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -79.92 -41.22 26.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 70.109999999999999 110.89 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.597 ' HB1' ' OE2' ' A' ' 57' ' ' GLU . . . -76.85 -62.24 1.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 44.340000000000003 111.067 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -52.74 -22.31 5.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 64.230000000000004 111.117 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.746 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -53.59 -69.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 63.43 111.154 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.705 ' HA ' HG12 ' A' ' 50' ' ' VAL . 21.3 t -112.17 -11.11 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 63.420000000000002 111.093 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.587 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.3 tp60 -83.19 -34.19 26.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 74.319999999999993 110.926 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.987 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.44 -6.02 18.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 44.140000000000001 111.098 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.979 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.93 -9.42 0.14 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.628 0.728 . . . . 64.420000000000002 111.152 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.987 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.6 Cg_endo -69.78 -22.73 31.59 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.68 2.253 . . . . 74.140000000000001 112.322 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.65 -54.36 2.96 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.794 -0.717 . . . . 73.319999999999993 112.488 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.64 -34.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 62.039999999999999 112.455 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.672 ' O ' ' O ' ' A' ' 49' ' ' ALA . 2.0 t -148.34 152.81 37.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.757 0.313 . . . . 72.420000000000002 111.194 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.777 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.38 75.28 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 71.209999999999994 111.077 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.757 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -147.09 104.51 0.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.722 . . . . 43.420000000000002 112.503 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.597 ' OE2' ' HB1' ' A' ' 44' ' ' ALA . 1.9 tt0 -97.6 -170.37 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.37 . . . . 64.400000000000006 110.888 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.741 ' O ' HG23 ' A' ' 34' ' ' VAL . 2.6 t -129.25 139.17 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 72.010000000000005 111.159 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.553 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 10.6 tt0 -106.31 128.16 53.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 64.430000000000007 110.923 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 60' ' ' THR . 1.7 t -118.31 95.57 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 51.439999999999998 111.077 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.434 ' C ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -137.28 168.87 18.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 61.340000000000003 110.85 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.4 m -98.07 -19.34 18.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 65.340000000000003 111.144 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 68' ' ' ALA . . . 49.97 -159.2 1.39 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 44.109999999999999 112.488 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.36 -25.37 23.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.357 . . . . 71.510000000000005 110.892 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.05 -116.89 0.47 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.683 -0.77 . . . . 64.219999999999999 112.475 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.814 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -120.11 -65.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 74.010000000000005 111.089 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.697 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -111.83 94.39 4.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 74.120000000000005 111.144 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.465 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . . . -87.71 84.67 7.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 74.349999999999994 111.063 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.708 ' CD1' HD21 ' A' ' 20' ' ' LEU . 6.5 t80 -110.81 123.43 50.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 64.040000000000006 110.92 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -126.32 111.89 1.51 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 73.129999999999995 112.476 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 83' ' ' VAL . 7.9 p -107.83 121.03 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 61.439999999999998 111.11 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.818 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -114.12 134.31 54.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 71.510000000000005 110.936 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.662 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.5 m -144.92 122.77 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 72.25 111.143 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.792 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 5.0 m -171.95 -126.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 43.43 111.131 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.508 ' N ' HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -106.33 146.08 32.28 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.665 0.745 . . . . 63.130000000000003 110.868 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.505 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.4 Cg_endo -69.74 12.36 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.667 2.245 . . . . 64.510000000000005 112.355 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 75' ' ' ARG . 38.2 t70 -91.55 28.82 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 64.549999999999997 110.835 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.35 -10.88 26.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 72.420000000000002 112.463 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.581 ' O ' ' HB ' ' A' ' 74' ' ' THR . 32.1 p -97.1 104.99 17.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 55.0 111.151 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.792 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.4 OUTLIER -138.17 165.7 25.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 72.299999999999997 110.85 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 5.7 m -115.0 98.94 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 64.519999999999996 111.166 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . 8.8 tm-20 -85.69 125.64 33.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 110.882 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.643 HG12 ' CD2' ' A' ' 85' ' ' LEU . 2.5 t -92.43 113.04 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 54.009999999999998 111.14 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.734 ' O ' HD22 ' A' ' 85' ' ' LEU . 1.0 OUTLIER -85.79 113.0 21.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 73.120000000000005 110.902 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.985 HD12 HG22 ' A' ' 17' ' ' THR . 4.0 mm? -130.36 121.76 26.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 63.450000000000003 110.877 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.708 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.4 t0 -137.8 134.92 35.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 65.200000000000003 110.892 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.814 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -59.35 3.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.439999999999998 110.827 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.564 ' H ' ' C ' ' A' ' 86' ' ' ASP . 8.2 t0 -65.7 -3.53 4.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 73.400000000000006 110.834 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 68.5 10.73 8.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 71.209999999999994 110.899 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.04 -1.29 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 74.200000000000003 110.871 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.708 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 58.3 t -117.6 90.99 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 74.519999999999996 111.123 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.911 ' HA ' HD13 ' A' ' 85' ' ' LEU . 5.5 mp -146.33 14.6 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 72.310000000000002 110.886 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -113.43 140.96 47.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 64.340000000000003 110.869 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.64 ' HB ' HG13 ' A' ' 83' ' ' VAL . 3.3 t -87.91 151.41 22.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 64.129999999999995 111.194 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -123.83 149.8 60.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 71.409999999999997 110.904 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 143.12 49.77 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.705 2.27 . . . . 72.409999999999997 112.325 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -118.81 110.2 16.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 64.140000000000001 111.067 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -98.46 4.79 48.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 73.329999999999998 110.818 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.61 -20.91 8.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.774 -0.727 . . . . 44.210000000000001 112.487 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.3 -16.03 20.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.825 0.345 . . . . 64.319999999999993 110.865 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.99 -14.0 54.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.796 -0.716 . . . . 70.409999999999997 112.488 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 74.140000000000001 112.479 -179.908 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.711 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 13.9 t70 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.83 0.348 . . . . 70.299999999999997 110.872 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.696 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 92.7 m-85 -67.52 -36.53 81.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 73.319999999999993 110.926 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.59 -164.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 71.409999999999997 110.831 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.863 HG22 ' H ' ' A' ' 16' ' ' THR . 24.4 mm -77.78 129.84 75.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.651 0.739 . . . . 71.310000000000002 111.13 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 18.0 0.2 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.645 2.23 . . . . 73.239999999999995 112.35 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.863 ' H ' HG22 ' A' ' 14' ' ' ILE . 3.1 m -138.73 27.13 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 51.140000000000001 111.172 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.919 HG22 ' CD2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -74.36 -167.5 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 74.109999999999999 111.132 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -63.94 -103.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 74.349999999999994 110.887 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.75 8.56 44.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 70.209999999999994 110.882 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.013 ' HG ' HD22 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.71 -13.24 53.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.200000000000003 110.911 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -95.34 7.74 45.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.454 . . . . 73.109999999999999 110.91 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -106.98 -40.08 5.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 61.240000000000002 110.855 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -66.24 -47.63 73.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 71.140000000000001 110.914 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -43.55 -31.9 1.81 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 65.230000000000004 112.485 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.33 -64.51 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 61.130000000000003 111.075 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.539 ' CE ' HG21 ' A' ' 73' ' ' VAL . 3.5 ppp? -70.45 -7.94 47.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 54.43 110.921 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.441 ' HA ' ' HB2' ' A' ' 31' ' ' GLU . . . -76.91 -19.98 56.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 60.240000000000002 111.087 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -77.97 5.79 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 70.109999999999999 110.864 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.72 -81.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 72.519999999999996 110.85 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.92 14.52 5.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 51.049999999999997 112.499 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HG2' HG23 ' A' ' 58' ' ' VAL . 1.1 tt0 -54.82 103.4 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.902 0.382 . . . . 74.310000000000002 110.926 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.406 ' N ' ' HG2' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -76.95 -170.2 1.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 70.109999999999999 110.857 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.18 125.46 52.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 53.439999999999998 110.863 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.807 HG23 ' OE1' ' A' ' 57' ' ' GLU . 1.9 t -71.03 161.92 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 71.340000000000003 111.101 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' CG1' ' A' ' 34' ' ' VAL . 1.7 p -84.93 -45.75 11.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 63.200000000000003 111.125 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.43 -81.17 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.724 -0.751 . . . . 73.129999999999995 112.476 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 169.48 18.78 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.701 2.267 . . . . 33.210000000000001 112.337 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -68.17 -26.39 65.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 63.310000000000002 110.872 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 43' ' ' ARG . . . -52.53 -28.4 20.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 55.229999999999997 111.098 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -76.81 -30.79 56.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 110.905 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.482 ' HG3' ' HD3' ' A' ' 80' ' ' ARG . 4.3 ptt180 -56.7 -38.96 73.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 72.099999999999994 110.892 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.949 ' HB2' ' HA2' ' A' ' 99' ' ' GLY . . . -70.12 -30.44 67.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 62.450000000000003 111.086 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 39' ' ' ALA . 10.5 mtt-85 -74.34 -45.16 48.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 72.530000000000001 110.875 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -78.25 -57.52 3.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 74.219999999999999 111.118 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 1.041 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -54.02 -17.36 2.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 64.129999999999995 111.106 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -62.69 -68.05 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 63.340000000000003 111.106 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.682 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 26.0 t -122.21 -14.16 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 51.119999999999997 111.14 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.587 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 27.9 mt-30 -79.64 -41.64 26.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 110.92 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.041 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . . . -104.43 0.05 28.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 53.229999999999997 111.074 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.976 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.29 -13.19 0.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 74.319999999999993 111.136 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.976 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 53.5 Cg_endo -69.77 -32.24 18.92 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.654 2.236 . . . . 73.129999999999995 112.362 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.16 -51.46 38.5 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.785 -0.722 . . . . 74.540000000000006 112.51 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.58 -33.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 25.23 112.496 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 74' ' ' THR . 0.2 OUTLIER -150.24 158.63 44.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 52.32 111.152 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.709 ' CA ' HG23 ' A' ' 50' ' ' VAL . . . -70.99 77.78 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 51.219999999999999 111.102 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.723 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -144.94 106.9 0.41 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.733 . . . . 71.430000000000007 112.46 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.807 ' OE1' HG23 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -101.33 -159.24 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 71.209999999999994 110.884 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -126.62 121.3 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 71.349999999999994 111.159 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.754 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -94.69 171.47 8.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 64.310000000000002 110.87 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -113.88 128.86 56.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 63.409999999999997 111.12 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.553 ' H ' ' HA ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -142.72 91.29 2.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 75.5 110.903 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.0 p -94.81 149.4 21.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 73.430000000000007 111.144 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.536 ' N ' ' HB3' ' A' ' 67' ' ' ALA . . . -134.18 179.46 17.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.778 -0.725 . . . . 73.230000000000004 112.509 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -76.41 -24.14 54.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.899 0.381 . . . . 75.019999999999996 110.884 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.59 -117.39 2.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 65.319999999999993 112.468 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -116.45 38.93 3.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 72.329999999999998 111.095 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.536 ' HB3' ' N ' ' A' ' 63' ' ' GLY . . . -59.06 -171.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 52.420000000000002 111.083 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.696 ' HB1' ' HB2' ' A' ' 12' ' ' TYR . . . -156.29 -95.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 71.219999999999999 111.109 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.754 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -162.29 -163.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 75.439999999999998 110.888 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -138.99 156.64 24.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.749 -0.739 . . . . 30.449999999999999 112.505 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.631 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.4 p -125.61 121.1 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 73.040000000000006 111.124 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.783 HD21 ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -112.14 142.91 44.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 51.420000000000002 110.94 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.723 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 11.0 p -157.88 125.84 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 63.530000000000001 111.139 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 54' ' ' THR . 5.6 m -168.6 -125.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 72.109999999999999 111.14 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.504 ' N ' HG22 ' A' ' 74' ' ' THR . 3.8 ttm-85 -107.82 139.32 20.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 75.219999999999999 110.876 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 13.89 0.27 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.679 2.252 . . . . 60.119999999999997 112.369 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 75' ' ' ARG . 1.3 m-20 -94.1 23.79 4.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 72.540000000000006 110.877 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.51 -16.3 61.28 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.718 -0.753 . . . . 53.109999999999999 112.48 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.696 ' O ' ' HB ' ' A' ' 74' ' ' THR . 6.0 t -94.0 122.55 36.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.763 0.316 . . . . 64.019999999999996 111.105 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.77 ' HB3' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -141.65 161.52 37.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 72.219999999999999 110.852 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 94.1 t -118.05 85.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 61.420000000000002 111.103 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.447 ' HA ' ' CB ' ' A' ' 72' ' ' LEU . 6.9 tm-20 -77.27 121.86 24.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 110.841 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.677 HG13 ' HB ' ' A' ' 94' ' ' THR . 3.3 t -100.33 137.4 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 73.219999999999999 111.124 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.838 ' C ' HD23 ' A' ' 85' ' ' LEU . 6.5 m-70 -92.56 118.23 30.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 63.399999999999999 110.871 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.013 HD22 ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -122.48 101.36 7.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.209999999999994 110.892 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.784 ' OD2' HG11 ' A' ' 91' ' ' VAL . 34.4 m-20 -140.78 131.74 26.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 110.858 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.748 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -61.36 11.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.854 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.643 ' H ' ' C ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -65.37 -5.93 8.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.856 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 74.27 6.88 4.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 55.43 110.865 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -141.54 7.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 110.894 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.784 HG11 ' OD2' ' A' ' 86' ' ' ASP . 40.9 t -118.31 69.52 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 73.430000000000007 111.137 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.919 ' CD2' HG22 ' A' ' 17' ' ' THR . 0.2 OUTLIER -129.91 10.72 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 50.530000000000001 110.953 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.23 -179.95 3.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 73.120000000000005 110.791 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.677 ' HB ' HG13 ' A' ' 83' ' ' VAL . 13.4 t -126.42 171.18 11.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 64.129999999999995 111.138 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -144.84 159.64 49.68 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.663 0.744 . . . . 72.519999999999996 110.86 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 107.01 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.648 2.232 . . . . 61.520000000000003 112.341 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.465 ' HB3' ' C ' ' A' ' 80' ' ' ARG . . . -75.69 112.15 11.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 73.239999999999995 111.099 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -85.68 6.36 27.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 64.200000000000003 110.92 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.949 ' HA2' ' HB2' ' A' ' 42' ' ' ALA . . . 79.56 -20.93 4.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.744 -0.741 . . . . 65.310000000000002 112.502 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.36 -33.06 10.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 74.109999999999999 110.873 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.07 24.85 54.0 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 61.109999999999999 112.491 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 74.140000000000001 112.457 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.754 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 15.9 t70 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.78 0.324 . . . . 65.109999999999999 110.806 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -65.41 -56.38 12.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 62.0 110.852 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.482 ' CG ' ' HB3' ' A' ' 67' ' ' ALA . 25.5 t0 -65.36 -115.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 61.119999999999997 110.862 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.73 HG22 ' H ' ' A' ' 16' ' ' THR . 12.6 mm -100.13 108.64 53.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.586 0.708 . . . . 75.120000000000005 111.103 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 23.1 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.714 2.276 . . . . 74.349999999999994 112.322 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.73 ' H ' HG22 ' A' ' 14' ' ' ILE . 3.1 m -131.17 20.22 4.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.230000000000004 111.163 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.988 HG22 HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -76.13 -165.99 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 62.340000000000003 111.113 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.698 ' HG3' HD22 ' A' ' 92' ' ' LEU . 21.1 mt-10 -61.3 -105.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 71.519999999999996 110.873 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.8 8.23 44.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 61.039999999999999 110.898 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.996 ' HG ' HD22 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -65.29 -15.81 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 65.329999999999998 110.88 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -97.02 4.39 51.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 62.329999999999998 110.91 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -103.65 -42.21 5.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 74.040000000000006 110.868 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.42 ' HB2' HG11 ' A' ' 71' ' ' VAL . 6.5 mm100 -66.35 -51.39 57.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 75.0 110.961 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.3 -27.86 4.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 50.020000000000003 112.5 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.35 49.23 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 43.399999999999999 111.122 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.468 ' SD ' HG11 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -70.36 -42.77 71.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 74.040000000000006 110.905 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.456 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -119.42 -93.28 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 52.219999999999999 111.1 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -150.39 -37.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.409999999999997 110.927 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.38 -0.05 1.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 74.219999999999999 110.841 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.62 -20.33 7.55 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.757 -0.735 . . . . 73.340000000000003 112.508 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.474 ' CG ' HG21 ' A' ' 58' ' ' VAL . 1.4 tm-20 -83.9 103.25 13.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 64.409999999999997 110.91 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.68 179.08 4.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.491 . . . . 65.439999999999998 110.846 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.3 119.14 37.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 64.400000000000006 110.911 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.676 HG23 ' C ' ' A' ' 58' ' ' VAL . 8.4 t -84.2 -125.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 60.310000000000002 111.09 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.565 ' N ' HG12 ' A' ' 34' ' ' VAL . 71.4 p -139.52 -71.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 70.540000000000006 111.129 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.22 -65.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.755 -0.736 . . . . 75.25 112.51 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 166.63 26.9 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.649 2.233 . . . . 74.310000000000002 112.325 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -72.21 -28.94 63.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 110.846 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.0 -32.9 62.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.095 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.95 -31.57 31.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 64.329999999999998 110.882 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -69.34 -43.13 74.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 71.230000000000004 110.872 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.711 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.95 -33.28 70.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 111.129 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -81.01 -40.97 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 62.310000000000002 110.883 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.562 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -75.55 -63.06 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 53.43 111.12 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -53.54 -21.26 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 44.100000000000001 111.119 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.721 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -52.98 -68.92 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 63.140000000000001 111.062 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.767 ' HA ' HG12 ' A' ' 50' ' ' VAL . 19.0 t -111.75 -13.31 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 72.5 111.107 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.7 tp60 -80.53 -32.92 36.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 71.430000000000007 110.928 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.046 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.36 -6.68 17.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 71.329999999999998 111.153 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.987 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.08 -4.33 0.11 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.58 0.705 . . . . 71.140000000000001 111.094 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.046 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.1 Cg_endo -69.75 -24.46 29.69 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.731 2.288 . . . . 60.25 112.31 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.62 -56.33 2.26 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.718 -0.753 . . . . 72.129999999999995 112.487 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.1 -36.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.744 . . . . 64.540000000000006 112.473 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.746 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.7 t -146.42 150.44 35.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 25.539999999999999 111.185 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.822 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -73.12 80.3 1.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 72.349999999999994 111.095 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.733 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -146.86 99.51 0.21 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 62.439999999999998 112.491 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.54 ' OE1' HG22 ' A' ' 34' ' ' VAL . 3.5 tt0 -99.79 -167.05 1.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 75.109999999999999 110.892 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.676 ' C ' HG23 ' A' ' 34' ' ' VAL . 11.6 t -137.78 117.62 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 111.165 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.514 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 1.9 pp20? -96.08 155.16 16.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 72.230000000000004 110.857 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.487 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.5 t -127.65 118.7 24.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 74.540000000000006 111.178 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.54 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -132.62 170.88 14.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.420000000000002 110.916 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.75 114.48 22.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 61.020000000000003 111.128 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.43 -147.47 12.76 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 63.210000000000001 112.467 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -87.58 -1.63 58.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 73.239999999999995 110.904 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.02 -118.12 4.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 71.150000000000006 112.468 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -119.13 -78.27 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.775 0.321 . . . . 64.140000000000001 111.08 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -107.01 92.97 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 50.130000000000003 111.081 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -80.84 59.34 3.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 72.450000000000003 111.093 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.754 ' HH ' ' N ' ' A' ' 11' ' ' ASP . 2.6 p90 -110.74 132.11 54.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.349999999999994 110.935 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -118.71 150.37 18.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.777 -0.725 . . . . 73.109999999999999 112.494 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.847 HG12 HD11 ' A' ' 85' ' ' LEU . 2.5 p -117.5 119.78 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.368 . . . . 72.040000000000006 111.12 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.777 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -107.14 138.33 43.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 72.400000000000006 110.925 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.703 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.1 t -148.98 122.03 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 63.229999999999997 111.147 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.787 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 3.6 m -171.52 -128.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 70.329999999999998 111.121 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.502 ' H ' HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -104.28 142.61 24.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.662 0.744 . . . . 73.140000000000001 110.844 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.599 ' HG3' HG21 ' A' ' 50' ' ' VAL . 53.9 Cg_endo -69.76 14.19 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.695 2.264 . . . . 74.219999999999999 112.311 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 75' ' ' ARG . 7.2 m-20 -93.01 27.01 2.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.267 -0.424 . . . . 75.030000000000001 110.864 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.85 -12.89 51.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.792 -0.718 . . . . 70.230000000000004 112.51 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.593 ' O ' ' HB ' ' A' ' 74' ' ' THR . 33.6 p -97.18 106.64 19.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 72.239999999999995 111.141 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.787 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.7 OUTLIER -137.79 164.68 28.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 73.219999999999999 110.858 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 10.3 m -116.92 96.97 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 74.120000000000005 111.102 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.578 ' HG3' HD12 ' A' ' 72' ' ' LEU . 1.3 tm-20 -80.93 121.97 26.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 73.010000000000005 110.898 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.66 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.4 t -93.9 137.33 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 55.039999999999999 111.133 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.844 ' C ' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -84.85 112.81 20.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 71.340000000000003 110.849 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.996 HD22 ' HG ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -121.21 109.53 15.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 71.219999999999999 110.911 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.666 ' HB2' HG11 ' A' ' 91' ' ' VAL . 2.2 t0 -140.28 131.35 26.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 62.340000000000003 110.864 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.456 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -60.8 7.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 62.340000000000003 110.865 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.609 ' H ' ' C ' ' A' ' 86' ' ' ASP . 19.8 t0 -66.44 -4.6 8.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 60.310000000000002 110.877 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 70.02 11.43 7.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 110.916 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.79 5.63 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 71.519999999999996 110.898 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 86' ' ' ASP . 49.7 t -117.43 74.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.5 111.137 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.988 HD23 HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -133.59 11.7 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 64.409999999999997 110.931 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -92.95 163.49 13.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 71.420000000000002 110.905 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 8.3 t -98.9 161.76 13.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 70.519999999999996 111.171 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -147.6 127.52 6.65 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 75.549999999999997 110.904 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 123.5 10.16 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.73 2.287 . . . . 54.509999999999998 112.306 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.59 161.66 18.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.109999999999999 111.135 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -128.8 -146.24 0.32 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.429 . . . . 45.229999999999997 110.887 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.62 -15.85 30.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.772 -0.728 . . . . 73.310000000000002 112.434 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.59 -36.35 13.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.369 . . . . 74.109999999999999 110.852 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.62 54.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 34.409999999999997 112.499 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.736 . . . . 62.009999999999998 112.485 -179.93 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.779 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.825 0.345 . . . . 72.209999999999994 110.864 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.537 ' HE2' HG11 ' A' ' 58' ' ' VAL . 65.2 m-85 -75.09 -33.61 61.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 71.409999999999997 110.93 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.678 ' CG ' HD23 ' A' ' 20' ' ' LEU . 2.5 p-10 -64.53 -152.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 72.319999999999993 110.851 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.731 HD12 ' O ' ' A' ' 16' ' ' THR . 0.5 OUTLIER -78.17 163.37 62.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.652 0.739 . . . . 72.420000000000002 111.153 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -9.32 25.83 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.702 2.268 . . . . 55.32 112.383 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.731 ' O ' HD12 ' A' ' 14' ' ' ILE . 2.6 p -154.2 130.15 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 71.409999999999997 111.144 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.084 HG22 HD23 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -149.76 -158.78 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 54.409999999999997 111.185 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -70.44 -101.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 64.25 110.892 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -91.17 11.21 24.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 64.109999999999999 110.881 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.957 HD21 ' HB3' ' A' ' 85' ' ' LEU . 10.7 mp -65.35 -30.08 70.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 73.420000000000002 110.956 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -80.31 4.72 16.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 74.150000000000006 110.962 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.12 -53.8 2.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 75.140000000000001 110.917 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.588 ' HB2' HG11 ' A' ' 71' ' ' VAL . 68.9 mm-40 -66.95 -46.55 74.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 74.150000000000006 110.935 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 27' ' ' ALA . . . -46.94 -25.37 2.37 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 62.409999999999997 112.498 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.2 -80.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 62.439999999999998 111.08 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.9 ptm -66.85 -0.49 3.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 62.229999999999997 110.873 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.695 ' HB1' ' OE2' ' A' ' 31' ' ' GLU . . . -77.25 -32.93 56.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 73.519999999999996 111.071 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -82.95 10.05 8.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 71.239999999999995 110.856 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -68.6 -72.71 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 73.230000000000004 110.911 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.04 11.74 0.59 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 75.010000000000005 112.519 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.695 ' OE2' ' HB1' ' A' ' 27' ' ' ALA . 1.7 pt-20 -67.3 171.24 6.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 74.239999999999995 110.884 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -127.93 -153.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.239999999999995 110.844 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -109.85 163.61 13.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 110.835 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.661 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 1.0 OUTLIER -91.73 162.35 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 33.43 111.15 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.577 ' N ' ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -104.5 -32.73 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 74.040000000000006 111.163 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.475 ' H ' HG13 ' A' ' 34' ' ' VAL . . . -157.62 -139.09 2.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 73.319999999999993 112.498 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -160.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.669 2.246 . . . . 71.099999999999994 112.321 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -55.07 -34.21 63.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 70.019999999999996 110.896 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.86 -37.87 66.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 73.430000000000007 111.077 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -84.34 -42.05 16.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.888 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 7.1 ptt180 -61.9 -37.63 85.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 75.439999999999998 110.838 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.679 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -65.8 -34.76 78.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 53.240000000000002 111.093 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -78.08 -39.26 42.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 65.430000000000007 110.897 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -77.12 -58.55 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 55.25 111.084 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.738 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -57.2 -17.73 12.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 72.219999999999999 111.129 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -62.63 -79.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 53.200000000000003 111.118 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.758 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 61.1 t -110.91 -23.08 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 74.340000000000003 111.125 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.637 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 3.5 mt-30 -68.55 -27.7 66.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 65.420000000000002 110.883 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.082 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.77 -0.82 19.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 72.239999999999995 111.073 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.005 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.37 -1.1 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.62 0.724 . . . . 74.109999999999999 111.103 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.082 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.9 Cg_endo -69.76 -31.22 20.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.702 2.268 . . . . 61.539999999999999 112.33 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.98 -54.23 5.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 74.129999999999995 112.493 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.2 -33.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 35.520000000000003 112.525 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.62 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.4 m -145.08 152.65 40.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 62.210000000000001 111.152 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.849 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.57 76.07 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 72.319999999999993 111.11 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.708 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -146.59 104.94 0.31 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 73.510000000000005 112.515 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.633 ' HG3' ' HB2' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -98.56 -153.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 73.109999999999999 110.858 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.68 HG13 ' CE1' ' A' ' 69' ' ' TYR . 54.9 t -131.68 133.78 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 73.230000000000004 111.127 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.661 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -100.99 122.91 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 110.903 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.9 t -108.03 111.39 23.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 63.350000000000001 111.174 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -137.48 159.94 40.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 75.040000000000006 110.887 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 p -124.24 117.43 24.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 73.120000000000005 111.079 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.98 -147.87 11.85 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 74.439999999999998 112.497 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.33 -1.64 57.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.391 . . . . 74.420000000000002 110.894 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.51 -120.62 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.721 -0.752 . . . . 74.530000000000001 112.472 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -122.95 -75.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 61.219999999999999 111.057 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.642 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -104.67 85.85 2.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 52.149999999999999 111.038 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -82.49 59.26 4.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 61.520000000000003 111.072 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.779 ' HH ' ' N ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -116.98 158.58 23.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 65.140000000000001 110.886 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -141.41 158.96 26.66 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.708 -0.758 . . . . 62.219999999999999 112.497 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.588 HG11 ' HB2' ' A' ' 23' ' ' GLN . 8.7 p -116.39 120.46 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 71.510000000000005 111.122 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.775 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -111.57 133.33 53.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 72.219999999999999 110.911 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.735 ' O ' HG22 ' A' ' 81' ' ' VAL . 7.3 p -148.43 124.13 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.540000000000006 111.119 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.811 ' HB ' ' O ' ' A' ' 79' ' ' THR . 3.8 m -167.77 -129.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 72.109999999999999 111.178 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.533 ' H ' HG22 ' A' ' 74' ' ' THR . 0.3 OUTLIER -101.84 146.77 32.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.603 0.716 . . . . 74.150000000000006 110.895 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.409 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.72 7.68 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.699 2.266 . . . . 63.140000000000001 112.371 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -91.28 41.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 74.120000000000005 110.891 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.19 -4.94 16.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 65.299999999999997 112.527 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.811 ' O ' ' HB ' ' A' ' 74' ' ' THR . 43.9 p -96.07 117.02 29.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 75.409999999999997 111.161 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.743 ' O ' ' HB3' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -144.75 158.1 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 73.439999999999998 110.867 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 73' ' ' VAL . 31.4 m -118.13 92.13 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 62.200000000000003 111.126 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.726 ' HB2' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -81.12 123.43 28.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 73.140000000000001 110.888 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.674 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.4 t -94.93 131.75 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.499 . . . . 53.450000000000003 111.134 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.65 117.19 23.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 63.450000000000003 110.865 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.957 ' HB3' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -135.86 121.28 19.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 63.299999999999997 110.918 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.689 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 6.3 t0 -140.49 132.5 27.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 74.219999999999999 110.871 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.713 ' HG3' HG23 ' A' ' 14' ' ' ILE . 2.7 tmt_? -60.36 4.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.430000000000007 110.847 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.557 ' H ' ' C ' ' A' ' 86' ' ' ASP . 22.5 t0 -67.94 -3.92 11.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 71.040000000000006 110.879 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 69.31 14.85 8.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 75.5 110.865 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.05 -1.06 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 75.209999999999994 110.853 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.689 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 92.7 t -117.91 91.39 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 111.117 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.084 HD23 HG22 ' A' ' 17' ' ' THR . 0.2 OUTLIER -140.47 8.25 2.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.899 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.7 162.27 14.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 74.329999999999998 110.864 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.2 t -93.41 172.45 8.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 111.126 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' GLU . 3.4 tt0 -145.96 123.71 6.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.688 0.756 . . . . 65.510000000000005 110.852 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 129.48 17.58 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.249 . . . . 75.340000000000003 112.345 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -117.86 117.17 28.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 63.450000000000003 111.126 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 100' ' ' ASP . 3.4 m-20 -121.67 49.13 1.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 74.099999999999994 110.855 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.429 ' HA2' HH12 ' A' ' 80' ' ' ARG . . . 71.68 -16.92 1.28 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 72.329999999999998 112.485 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 98' ' ' ASP . 3.0 t0 -95.32 -62.14 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 72.019999999999996 110.857 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.36 26.02 60.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.759 -0.734 . . . . 73.150000000000006 112.472 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 44.399999999999999 112.48 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.686 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.817 0.341 . . . . 72.349999999999994 110.884 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -67.5 -54.34 20.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 75.040000000000006 110.938 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.695 ' OD1' ' HB3' ' A' ' 67' ' ' ALA . 9.0 t0 -64.19 -154.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 74.200000000000003 110.859 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.822 HG22 ' H ' ' A' ' 16' ' ' THR . 35.4 mm -92.24 123.68 61.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.612 0.72 . . . . 60.299999999999997 111.172 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 10.45 0.49 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.693 2.262 . . . . 72.230000000000004 112.324 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.822 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -124.24 43.74 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 71.439999999999998 111.184 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.007 HG22 HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -97.89 -162.99 1.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 73.200000000000003 111.16 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.714 ' HG3' HD22 ' A' ' 92' ' ' LEU . 12.1 mt-10 -60.83 -102.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 71.129999999999995 110.936 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -96.85 7.16 47.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 75.109999999999999 110.887 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.992 ' HG ' HD22 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -66.49 -16.77 64.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 75.5 110.898 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -94.25 3.64 54.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 64.319999999999993 110.876 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -97.21 -53.36 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 75.140000000000001 110.907 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -64.73 -35.51 81.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 75.010000000000005 110.899 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -46.13 -30.06 3.79 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.732 -0.747 . . . . 71.299999999999997 112.486 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 28' ' ' PHE . . . -57.29 -57.36 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.826 0.346 . . . . 73.230000000000004 111.131 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.678 ' SD ' HG11 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -68.21 -5.06 16.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.519999999999996 110.882 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 31' ' ' GLU . . . -113.06 38.83 2.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 70.530000000000001 111.107 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -110.41 14.7 22.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 63.109999999999999 110.9 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.28 -78.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 75.299999999999997 110.866 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.73 8.57 41.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.738 . . . . 64.430000000000007 112.478 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.617 ' OE1' HG21 ' A' ' 58' ' ' VAL . 10.1 tt0 -64.61 103.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.875 0.369 . . . . 73.450000000000003 110.901 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' ' CG ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -102.05 -172.53 2.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 70.420000000000002 110.886 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -115.78 120.85 40.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 72.010000000000005 110.87 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.716 HG22 ' OE1' ' A' ' 57' ' ' GLU . 46.1 t -71.93 159.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 61.439999999999998 111.13 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.526 ' N ' HG12 ' A' ' 34' ' ' VAL . 65.8 p -99.59 -30.38 12.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 64.099999999999994 111.173 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.604 ' H ' HG12 ' A' ' 34' ' ' VAL . . . -150.42 -144.06 3.85 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 64.140000000000001 112.501 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -158.94 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.711 2.274 . . . . 75.120000000000005 112.4 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' HA ' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -56.69 -29.33 62.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 74.310000000000002 110.834 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.2 -43.57 70.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 63.119999999999997 111.085 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -85.6 -41.91 14.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 62.310000000000002 110.876 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -60.45 -36.16 77.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 60.109999999999999 110.86 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -65.25 -32.24 73.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 64.430000000000007 111.125 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.516 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 4.0 ptt180 -74.78 -40.97 60.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 70.049999999999997 110.898 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.583 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . . . -81.06 -57.84 3.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 72.349999999999994 111.142 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.716 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -52.12 -20.97 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 61.009999999999998 111.077 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.643 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -62.91 -76.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 64.099999999999994 111.11 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.703 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.3 t -111.4 -17.01 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 71.329999999999998 111.124 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.523 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -73.94 -32.0 63.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 71.510000000000005 110.908 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.041 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.39 -1.23 21.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 44.329999999999998 111.099 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.995 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.92 -2.7 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.656 0.741 . . . . 72.510000000000005 111.156 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.041 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.8 Cg_endo -69.78 -29.93 22.99 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.641 2.228 . . . . 71.329999999999998 112.345 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.52 -51.46 6.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.752 -0.737 . . . . 23.140000000000001 112.506 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.08 -33.55 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 70.019999999999996 112.518 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.671 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -145.74 151.1 37.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.79 0.328 . . . . 53.109999999999999 111.157 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.835 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.63 78.36 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 111.062 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.693 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -143.8 99.91 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 55.329999999999998 112.539 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.716 ' OE1' HG22 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -92.86 -164.72 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 74.540000000000006 110.928 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.617 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.1 t -143.49 124.76 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 63.329999999999998 111.106 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.615 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 9.6 pt-20 -95.18 155.83 16.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 70.049999999999997 110.837 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.506 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.3 t -131.58 117.18 18.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.097 -0.501 . . . . 74.140000000000001 111.122 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -137.85 158.97 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 71.430000000000007 110.877 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -22.61 19.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 72.310000000000002 111.102 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 42.99 -157.46 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.739 -0.743 . . . . 65.040000000000006 112.516 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -91.81 -23.61 19.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.913 0.387 . . . . 65.049999999999997 110.871 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.54 -119.1 1.13 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.767 -0.73 . . . . 73.120000000000005 112.471 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.61 -81.63 0.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.752 0.311 . . . . 44.409999999999997 111.113 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.695 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . . . -93.03 79.57 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 55.219999999999999 111.147 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.49 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -81.74 62.57 5.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 53.25 111.102 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.965 ' CZ ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -114.61 155.64 26.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 73.129999999999995 110.937 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.503 ' HA2' ' HG ' ' A' ' 85' ' ' LEU . . . -138.49 157.61 24.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 73.140000000000001 112.449 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.78 HG12 HD11 ' A' ' 85' ' ' LEU . 2.5 p -126.62 117.97 49.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 73.150000000000006 111.16 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.804 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -105.99 137.01 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 71.219999999999999 110.917 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.682 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.1 p -147.23 124.14 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 51.520000000000003 111.146 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.799 ' HB ' ' O ' ' A' ' 79' ' ' THR . 4.4 m -168.19 -129.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 52.509999999999998 111.116 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.695 ' HG3' HG22 ' A' ' 74' ' ' THR . 0.6 OUTLIER -104.65 148.8 36.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.562 0.696 . . . . 72.239999999999995 110.838 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 6.76 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.7 2.267 . . . . 64.329999999999998 112.31 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -92.67 43.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 63.219999999999999 110.862 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.51 -5.26 23.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 74.430000000000007 112.477 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.799 ' O ' ' HB ' ' A' ' 74' ' ' THR . 13.9 p -93.42 123.67 36.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 55.109999999999999 111.147 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.687 ' NE ' ' HB1' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -146.69 156.69 43.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 73.140000000000001 110.826 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.804 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 97.0 t -115.75 83.55 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 72.340000000000003 111.154 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.56 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 3.7 tm-20 -75.93 122.0 23.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 75.439999999999998 110.894 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 4.8 t -105.49 138.55 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 63.030000000000001 111.069 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.926 ' C ' HD23 ' A' ' 85' ' ' LEU . 40.8 m-70 -83.69 115.05 22.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 74.099999999999994 110.843 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.992 HD22 ' HG ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -125.25 105.98 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 73.230000000000004 110.905 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.66 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 5.3 t0 -139.08 131.63 28.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.129999999999995 110.887 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.98 6.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 110.848 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' A' ' 86' ' ' ASP . 37.5 t0 -67.21 -3.28 7.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 74.109999999999999 110.904 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 67.9 12.42 8.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 74.140000000000001 110.876 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -139.01 3.53 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 75.040000000000006 110.86 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.66 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 60.8 t -117.74 73.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 74.099999999999994 111.119 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.007 HD23 HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -132.48 12.61 4.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 71.230000000000004 110.895 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.53 164.52 12.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 75.519999999999996 110.873 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 9.9 t -104.08 169.45 8.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 74.329999999999998 111.16 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HB2' ' NE2' ' A' ' 84' ' ' HIS . 11.6 tp10 -146.95 124.74 5.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.652 0.739 . . . . 74.329999999999998 110.873 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 124.85 11.5 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.727 2.285 . . . . 74.200000000000003 112.363 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.687 ' HB1' ' NE ' ' A' ' 80' ' ' ARG . . . -115.49 117.4 30.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 63.130000000000003 111.086 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -124.33 46.0 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.510000000000005 110.843 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.404 ' HA2' HH12 ' A' ' 80' ' ' ARG . . . 77.28 -17.83 4.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 41.020000000000003 112.445 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.46 -56.6 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 72.310000000000002 110.828 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.48 23.16 44.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.721 . . . . 54.310000000000002 112.484 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 40.520000000000003 112.504 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 t0 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.786 0.327 . . . . 71.420000000000002 110.838 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -67.84 -21.47 65.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 72.340000000000003 110.915 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.58 ' HB2' HD13 ' A' ' 85' ' ' LEU . 12.4 t70 -58.63 -87.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 74.040000000000006 110.867 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 1.078 HD11 HD21 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -114.79 165.32 14.21 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.693 0.759 . . . . 61.030000000000001 111.13 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.507 ' HD2' HG22 ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.79 -1.12 7.95 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.252 . . . . 70.109999999999999 112.343 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.42 71.13 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 73.010000000000005 111.154 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.726 HG21 HD22 ' A' ' 20' ' ' LEU . 70.7 p -76.38 -166.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 71.150000000000006 111.134 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . 2.9 mm-40 -130.56 -93.12 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 74.25 110.892 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -69.22 5.88 1.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 74.540000000000006 110.849 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.915 HD21 ' CB ' ' A' ' 85' ' ' LEU . 10.8 mp -87.0 -34.07 19.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 75.439999999999998 110.931 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -64.89 -16.66 63.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 71.319999999999993 110.897 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.75 -63.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 72.349999999999994 110.87 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.6 -46.93 77.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 73.329999999999998 110.937 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.78 -53.15 8.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 53.119999999999997 112.487 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.64 51.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 62.240000000000002 111.102 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.683 ' HB3' HG11 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -67.2 -35.71 80.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 73.099999999999994 110.917 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.32 -97.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 73.439999999999998 111.141 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.426 ' O ' ' CB ' ' A' ' 29' ' ' ASP . 1.4 p90 -149.43 -18.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 75.450000000000003 110.857 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER 165.99 -10.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 74.209999999999994 110.839 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.69 -22.0 3.83 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.766 -0.731 . . . . 50.310000000000002 112.472 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.417 ' HG3' HG23 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -60.94 105.32 0.45 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 74.409999999999997 110.921 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.515 ' C ' ' HG3' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -70.17 -158.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 74.140000000000001 110.815 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -138.17 118.75 13.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 64.209999999999994 110.901 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 40.4 t -72.06 149.13 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 75.319999999999993 111.106 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -123.31 -0.59 8.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 71.109999999999999 111.16 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.405 ' H ' ' CG1' ' A' ' 34' ' ' VAL . . . -139.83 -154.75 6.39 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.726 . . . . 73.510000000000005 112.512 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HA ' ' OH ' ' A' ' 69' ' ' TYR . 53.7 Cg_endo -69.75 -166.12 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.667 2.244 . . . . 71.030000000000001 112.302 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.511 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -59.09 -30.43 68.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 74.120000000000005 110.812 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.93 -30.17 67.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 70.099999999999994 111.116 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.423 ' CB ' HG13 ' A' ' 34' ' ' VAL . 1.6 m-20 -76.51 -34.32 58.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 70.209999999999994 110.865 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.809 ' NH1' ' HB1' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -73.89 -44.18 56.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 74.010000000000005 110.853 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.729 ' HB2' ' HA2' ' A' ' 99' ' ' GLY . . . -67.88 -30.64 70.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.239999999999995 111.121 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.403 ' CG ' ' N ' ' A' ' 44' ' ' ALA . 14.7 ptt180 -85.1 -45.2 12.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 74.400000000000006 110.902 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.664 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . . . -77.9 -60.58 2.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 73.140000000000001 111.106 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -48.27 -22.18 0.63 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 55.210000000000001 111.082 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.681 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -54.55 -67.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 64.349999999999994 111.127 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.733 ' HA ' HG12 ' A' ' 50' ' ' VAL . 26.9 t -110.41 -15.82 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 71.109999999999999 111.136 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 50.0 mt-30 -80.74 -29.02 36.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 60.229999999999997 110.913 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.091 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.37 -10.86 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 72.209999999999994 111.087 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.0 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.74 0.07 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.634 0.731 . . . . 74.420000000000002 111.158 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.091 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.2 Cg_endo -69.76 -27.11 26.86 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.65 2.234 . . . . 63.340000000000003 112.335 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.11 -53.62 2.94 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 64.329999999999998 112.542 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.63 -35.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 62.310000000000002 112.489 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.803 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -146.26 149.35 33.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 45.350000000000001 111.143 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.812 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.82 82.83 1.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 62.149999999999999 111.102 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.717 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -140.62 99.68 0.25 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.713 -0.756 . . . . 73.319999999999993 112.478 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.664 ' OE1' ' HB3' ' A' ' 44' ' ' ALA . 63.3 tt0 -96.18 164.62 12.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.946 0.403 . . . . 63.43 110.843 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.417 HG23 ' HG3' ' A' ' 31' ' ' GLU . 2.1 t -111.76 119.13 59.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 73.400000000000006 111.112 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.759 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.21 133.57 43.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 51.439999999999998 110.898 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -133.39 121.86 22.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 54.140000000000001 111.131 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.477 ' H ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -123.16 162.76 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.430000000000007 110.854 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.41 135.72 34.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 61.520000000000003 111.106 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.44 -119.38 1.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 52.340000000000003 112.525 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -87.83 -23.62 23.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 64.230000000000004 110.889 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.3 -112.61 1.9 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 71.439999999999998 112.478 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.12 -82.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 75.420000000000002 111.104 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 13' ' ' ASP . . . -75.78 125.93 30.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 62.119999999999997 111.072 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.47 74.52 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 44.439999999999998 111.071 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.759 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -165.38 -131.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 74.129999999999995 110.912 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.606 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -167.99 172.24 42.63 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 62.130000000000003 112.539 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.803 HG12 HG22 ' A' ' 83' ' ' VAL . 6.0 p -130.07 120.16 48.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 72.319999999999993 111.129 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.991 HD23 ' HB3' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -98.36 142.3 30.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 74.109999999999999 110.919 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.683 HG11 ' HB3' ' A' ' 26' ' ' MET . 10.9 t -152.03 114.15 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 71.129999999999995 111.121 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.764 ' O ' HG22 ' A' ' 54' ' ' THR . 2.6 m -169.45 -133.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.329999999999998 111.141 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.568 ' H ' HG22 ' A' ' 74' ' ' THR . 0.1 OUTLIER -104.62 144.77 29.39 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.636 0.731 . . . . 72.319999999999993 110.841 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.8 Cg_endo -69.75 13.84 0.28 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.712 2.275 . . . . 70.420000000000002 112.341 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 75' ' ' ARG . 20.2 m-20 -93.94 35.49 1.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 74.129999999999995 110.855 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.36 -13.2 41.47 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.683 -0.77 . . . . 71.109999999999999 112.509 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.748 ' O ' ' HB ' ' A' ' 74' ' ' THR . 37.6 p -95.28 119.7 34.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.749 0.309 . . . . 71.140000000000001 111.163 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.991 ' HB3' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -141.61 161.13 38.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 73.510000000000005 110.869 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 97.3 t -119.0 81.5 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 64.209999999999994 111.092 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 72' ' ' LEU . 15.2 pt-20 -77.68 116.73 18.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.450000000000003 110.864 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.803 HG22 HG12 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -94.99 144.72 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 61.020000000000003 111.103 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -83.82 108.85 17.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 63.450000000000003 110.872 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.949 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 1.3 pp -124.98 110.26 13.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 75.299999999999997 110.919 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.585 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 3.9 m-20 -127.02 106.68 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 74.140000000000001 110.885 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.531 ' HG2' HG23 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -63.09 -0.34 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 110.892 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 86' ' ' ASP . 51.2 t0 -69.59 -13.15 62.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 73.040000000000006 110.876 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -165.66 -93.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 74.129999999999995 110.857 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.609 ' O ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -155.06 33.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 74.129999999999995 110.865 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.949 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 2.4 t -72.51 95.93 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 75.329999999999998 111.109 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.078 HD21 HD11 ' A' ' 14' ' ' ILE . 1.0 OUTLIER -127.68 18.82 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 72.510000000000005 110.922 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 84' ' ' HIS . 9.0 t0 -75.99 128.78 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 63.420000000000002 110.895 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.716 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 7.0 t -79.23 155.8 28.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 72.230000000000004 111.119 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.95 153.1 53.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.666 0.746 . . . . 73.329999999999998 110.872 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 140.37 42.61 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.66 2.24 . . . . 42.420000000000002 112.35 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.809 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -119.42 111.06 17.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 74.430000000000007 111.103 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -96.28 4.26 52.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 65.420000000000002 110.911 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.729 ' HA2' ' HB2' ' A' ' 42' ' ' ALA . . . 82.78 -21.98 7.12 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.738 . . . . 61.25 112.497 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.34 -31.24 12.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.779 0.323 . . . . 73.549999999999997 110.835 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.16 26.07 58.44 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.773 -0.727 . . . . 62.039999999999999 112.442 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.769 -0.729 . . . . 61.049999999999997 112.489 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.815 0.34 . . . . 71.129999999999995 110.878 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -65.88 -37.09 85.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 110.922 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' CB ' ' HB2' ' A' ' 85' ' ' LEU . 11.8 p-10 -65.54 -149.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 73.109999999999999 110.846 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.67 ' HB ' HG23 ' A' ' 17' ' ' THR . 0.1 OUTLIER -73.43 127.92 88.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.672 0.748 . . . . 64.109999999999999 111.12 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -1.52 8.6 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.638 2.225 . . . . 74.439999999999998 112.364 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.79 38.54 3.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 54.439999999999998 111.094 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.78 HG22 HD23 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -73.07 -168.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 61.420000000000002 111.159 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.634 ' H ' HD22 ' A' ' 92' ' ' LEU . 15.8 mm-40 -72.78 -100.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 70.310000000000002 110.925 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -98.73 8.29 45.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 72.299999999999997 110.894 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -72.21 -9.43 58.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 64.219999999999999 110.921 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -89.99 -8.81 50.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 74.209999999999994 110.964 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -74.39 -58.65 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 74.230000000000004 110.879 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.549 ' OE1' HG21 ' A' ' 83' ' ' VAL . 3.9 mp0 -66.13 -42.66 88.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 71.400000000000006 110.874 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.71 -31.49 2.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.728 -0.748 . . . . 71.319999999999993 112.484 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.7 -72.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.318 . . . . 42.32 111.077 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.6 ptm -70.6 -7.1 41.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.099999999999994 110.904 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' A' ' 31' ' ' GLU . . . -65.53 -47.19 76.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 52.039999999999999 111.057 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -81.86 6.1 16.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 75.450000000000003 110.879 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -72.04 -68.59 0.45 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 110.857 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.89 8.98 2.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.776 -0.726 . . . . 72.409999999999997 112.532 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HG3' ' HA ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -79.37 177.67 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 74.010000000000005 110.904 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.09 -168.8 2.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 75.209999999999994 110.874 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -109.54 119.88 40.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 110.909 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 35' ' ' THR . 2.2 t -73.12 -136.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 71.129999999999995 111.131 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.565 ' H ' HG12 ' A' ' 34' ' ' VAL . 71.5 p -136.72 -47.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 71.319999999999993 111.158 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.45 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 163.0 -61.18 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 61.009999999999998 112.493 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.5 Cg_endo -69.7 159.18 54.39 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.747 2.298 . . . . 64.510000000000005 112.318 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.411 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 2.1 p30 -64.88 -26.04 68.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 75.140000000000001 110.852 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.03 -39.14 74.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 74.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 1.9 m-20 -86.06 -39.85 16.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.340000000000003 110.882 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.633 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 6.8 ptt180 -68.05 -38.81 82.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 71.230000000000004 110.868 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.601 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -68.3 -35.29 77.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 52.399999999999999 111.071 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -82.03 -40.53 21.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 64.430000000000007 110.898 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.593 ' HB1' ' CD ' ' A' ' 57' ' ' GLU . . . -77.48 -59.84 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 63.310000000000002 111.101 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.733 ' HB2' HD23 ' A' ' 72' ' ' LEU . . . -52.76 -20.22 3.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 111.091 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.66 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -63.63 -78.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 111.092 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.719 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.6 t -108.44 -17.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 73.109999999999999 111.179 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.486 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -74.41 -29.79 61.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.120000000000005 110.905 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.068 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.94 -2.82 19.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 70.200000000000003 111.132 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.999 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -95.7 -2.9 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.612 0.72 . . . . 71.400000000000006 111.143 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.068 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.9 Cg_endo -69.77 -27.66 26.13 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.666 2.244 . . . . 65.230000000000004 112.343 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.11 -57.15 2.87 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.78 -0.724 . . . . 25.23 112.502 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.07 -34.76 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 71.019999999999996 112.504 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 74' ' ' THR . 0.2 OUTLIER -146.41 152.1 38.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 54.25 111.151 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.84 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.39 77.01 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 54.43 111.116 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.714 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -148.53 105.68 0.31 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 75.349999999999994 112.487 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.593 ' CD ' ' HB1' ' A' ' 44' ' ' ALA . 3.2 tt0 -95.78 -171.95 2.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.907 0.384 . . . . 74.540000000000006 110.896 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.037 HG13 HG22 ' A' ' 71' ' ' VAL . 83.8 t -136.86 131.43 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 60.439999999999998 111.126 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -99.1 121.78 41.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 71.120000000000005 110.852 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 t -110.35 119.19 38.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 55.329999999999998 111.137 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -143.47 121.92 12.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 50.130000000000003 110.908 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.74 148.8 24.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 72.099999999999994 111.159 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.13 -106.71 0.99 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.781 -0.723 . . . . 53.240000000000002 112.529 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -87.91 -25.7 23.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 70.030000000000001 110.936 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.33 -121.56 2.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 60.0 112.465 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.32 33.87 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.768 0.318 . . . . 61.140000000000001 111.112 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.51 ' HA ' ' H ' ' A' ' 87' ' ' ARG . . . -63.71 -155.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 72.040000000000006 111.122 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.567 ' O ' ' O ' ' A' ' 61' ' ' GLU . . . -157.06 -104.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 71.109999999999999 111.111 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.579 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 2.9 t80 -170.29 -85.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.902 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.611 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -168.53 157.04 28.96 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 53.340000000000003 112.494 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.037 HG22 HG13 ' A' ' 58' ' ' VAL . 89.8 t -123.45 120.8 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.838 0.351 . . . . 73.530000000000001 111.093 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.82 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -106.17 134.19 49.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 73.230000000000004 110.93 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.714 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.2 p -147.67 118.61 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 72.129999999999995 111.12 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.751 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.7 m -169.19 -133.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 111.141 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.557 ' H ' HG22 ' A' ' 74' ' ' THR . 3.6 mtt-85 -101.53 148.4 35.18 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.636 0.732 . . . . 71.25 110.831 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.4 Cg_endo -69.84 9.41 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.652 2.234 . . . . 75.230000000000004 112.342 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -88.38 38.67 0.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 75.140000000000001 110.87 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.11 -7.05 8.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 64.200000000000003 112.428 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.751 ' O ' ' HB ' ' A' ' 74' ' ' THR . 31.1 p -98.85 115.42 28.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.793 0.33 . . . . 73.040000000000006 111.175 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.727 ' O ' ' HB3' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -138.62 160.59 39.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 72.319999999999993 110.861 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 61.6 t -113.88 87.02 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 54.399999999999999 111.132 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -81.04 121.37 25.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.200000000000003 110.908 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.611 ' O ' ' CA ' ' A' ' 70' ' ' GLY . 1.8 t -97.55 160.57 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 63.32 111.137 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.691 ' C ' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -104.55 109.14 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 110.873 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.917 HD13 ' N ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -128.72 111.14 12.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 52.409999999999997 110.925 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.612 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 21.1 m-20 -136.51 108.66 7.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 64.519999999999996 110.846 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.51 ' H ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -66.36 0.61 2.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.099999999999994 110.903 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 89' ' ' PHE . 51.6 t0 -69.88 -11.88 61.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 72.420000000000002 110.852 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.484 ' CD1' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -166.54 -93.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 62.240000000000002 110.903 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 35.53 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 74.200000000000003 110.86 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.745 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 9.2 t -69.47 100.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 65.409999999999997 111.145 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.812 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -135.04 16.89 3.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 64.230000000000004 110.932 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 84' ' ' HIS . 14.6 t0 -80.75 147.65 30.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 61.399999999999999 110.881 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.434 ' HA ' HG13 ' A' ' 83' ' ' VAL . 15.3 t -90.38 165.0 14.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 74.400000000000006 111.11 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -146.45 122.61 5.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 71.129999999999995 110.915 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 128.91 16.73 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.684 2.256 . . . . 73.150000000000006 112.364 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -116.82 114.09 23.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 71.109999999999999 111.116 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 100' ' ' ASP . 4.8 t0 -124.9 46.4 2.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 72.299999999999997 110.898 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 -17.34 1.69 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 61.32 112.509 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 98' ' ' ASP . 0.4 OUTLIER -95.93 -65.39 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 74.319999999999993 110.88 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.64 21.67 12.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 53.039999999999999 112.467 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 74.140000000000001 112.486 -179.926 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.819 0.342 . . . . 73.409999999999997 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -74.1 -25.19 59.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 70.140000000000001 110.917 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.527 ' OD2' HD23 ' A' ' 20' ' ' LEU . 14.7 p-10 -64.12 -151.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 65.439999999999998 110.886 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.525 HG21 ' HG3' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -102.3 166.88 11.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 64.109999999999999 111.086 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' A' ' 14' ' ' ILE . 54.0 Cg_endo -69.76 -2.52 10.31 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 74.129999999999995 112.361 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.1 p -141.83 94.2 2.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 74.129999999999995 111.168 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.944 HG22 HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -118.83 -167.25 1.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 64.099999999999994 111.141 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.464 ' CB ' HD23 ' A' ' 92' ' ' LEU . 11.8 tt0 -110.36 -94.29 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 71.230000000000004 110.883 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -57.0 -17.9 11.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.937 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.784 HD13 ' CD2' ' A' ' 85' ' ' LEU . 2.4 mp -84.11 -19.51 34.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 62.140000000000001 110.88 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -66.23 -17.71 64.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 71.400000000000006 110.941 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.17 -22.58 15.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 74.0 110.891 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -66.72 -29.82 69.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 72.299999999999997 110.936 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.4 -29.7 1.83 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.733 -0.746 . . . . 44.539999999999999 112.503 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.403 ' O ' ' CD2' ' A' ' 28' ' ' PHE . . . -73.57 -64.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 51.340000000000003 111.105 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.791 ' CE ' HG11 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -64.36 -7.02 8.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 70.329999999999998 110.872 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' A' ' 31' ' ' GLU . . . -103.79 25.3 10.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.140000000000001 111.072 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -73.54 2.3 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 71.140000000000001 110.862 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 t70 179.92 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 53.32 110.873 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.31 -2.48 48.79 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 74.219999999999999 112.473 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.651 ' CG ' HG21 ' A' ' 58' ' ' VAL . 2.1 tm-20 -94.4 105.05 17.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 61.229999999999997 110.913 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 3.9 m-20 -119.34 -152.29 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 64.129999999999995 110.855 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -118.63 109.57 16.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 55.009999999999998 110.84 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 58' ' ' VAL . 21.3 t -81.03 -119.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 51.109999999999999 111.137 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.626 ' N ' HG12 ' A' ' 34' ' ' VAL . 68.5 p -141.8 -77.85 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 63.299999999999997 111.123 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.445 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -171.73 -61.1 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.762 -0.732 . . . . 73.329999999999998 112.51 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.8 Cg_endo -69.77 158.96 55.15 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.692 2.262 . . . . 65.439999999999998 112.35 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.474 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -66.56 -32.44 73.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 61.5 110.861 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.66 -30.78 14.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 32.409999999999997 111.096 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.42 -31.85 26.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 73.099999999999994 110.859 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HG2' ' N ' ' A' ' 42' ' ' ALA . 9.0 ptt-85 -57.71 -36.69 72.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 73.099999999999994 110.852 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.805 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -71.25 -33.02 69.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 61.409999999999997 111.11 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.474 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 2.2 ptt85 -77.71 -38.73 46.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 62.020000000000003 110.898 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.681 ' HB1' ' HG3' ' A' ' 57' ' ' GLU . . . -79.74 -59.15 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 72.340000000000003 111.136 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.848 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -57.63 -18.29 19.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 60.310000000000002 111.104 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.805 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -59.45 -81.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 42.420000000000002 111.077 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.766 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 59.7 t -114.99 -15.96 9.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 111.117 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.2 mt-30 -73.78 -31.96 63.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 65.319999999999993 110.893 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.041 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.88 -1.58 20.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.439 . . . . 73.219999999999999 111.144 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.989 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.34 -5.48 0.11 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.602 0.715 . . . . 74.349999999999994 111.141 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.041 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.4 Cg_endo -69.73 -29.32 24.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.281 . . . . 74.099999999999994 112.319 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.44 -54.04 5.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.72 -0.752 . . . . 45.350000000000001 112.442 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.49 -33.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.725 -0.75 . . . . 71.409999999999997 112.458 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.587 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -145.92 156.0 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 74.549999999999997 111.141 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.784 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.28 76.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 61.340000000000003 111.084 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.741 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -145.99 107.26 0.41 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.744 -0.741 . . . . 72.140000000000001 112.517 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.681 ' HG3' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -98.1 -169.27 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.353 . . . . 73.209999999999994 110.909 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.739 HG22 ' HB ' ' A' ' 71' ' ' VAL . 53.4 t -141.56 110.93 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 74.409999999999997 111.092 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.752 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 5.0 mt-10 -94.96 162.87 13.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 63.219999999999999 110.906 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.642 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -126.26 119.56 27.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 62.210000000000001 111.162 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 159.51 37.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 75.340000000000003 110.914 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.0 p -125.1 100.52 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 63.240000000000002 111.126 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.83 -141.54 8.76 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 61.399999999999999 112.487 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -88.05 0.53 55.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.857 0.361 . . . . 73.439999999999998 110.874 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -102.75 -121.71 4.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 53.32 112.517 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.666 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -120.82 -77.07 0.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.743 0.306 . . . . 60.539999999999999 111.062 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -111.21 86.65 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 54.43 111.065 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.818 ' HB2' ' OD2' ' A' ' 86' ' ' ASP . . . -98.67 85.47 3.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 51.32 111.1 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.752 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 0.5 OUTLIER -115.55 158.72 22.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 74.510000000000005 110.873 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.648 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -124.94 127.69 6.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 73.310000000000002 112.481 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.739 ' HB ' HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -109.26 123.42 65.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 71.409999999999997 111.146 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.797 HD22 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -84.61 142.92 29.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 75.150000000000006 110.895 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.791 HG11 ' CE ' ' A' ' 26' ' ' MET . 77.5 t -151.21 95.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 62.140000000000001 111.082 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.77 HG22 ' H ' ' A' ' 75' ' ' ARG . 1.3 m -168.27 -149.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 111.16 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.77 ' H ' HG22 ' A' ' 74' ' ' THR . 7.7 mtm180 -103.94 151.92 38.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.614 0.721 . . . . 75.219999999999999 110.853 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.8 Cg_endo -69.79 7.56 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.686 2.258 . . . . 61.109999999999999 112.368 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.49 19.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 75.319999999999993 110.877 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 76' ' ' PRO . . . 94.71 -14.09 65.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 52.32 112.484 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.747 ' O ' ' HB ' ' A' ' 74' ' ' THR . 3.0 t -98.05 125.37 43.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.778 0.323 . . . . 73.209999999999994 111.144 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.608 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -136.56 159.81 40.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 73.409999999999997 110.894 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 42.8 t -118.11 92.67 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 74.209999999999994 111.129 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.635 ' HB2' HD12 ' A' ' 72' ' ' LEU . 87.3 tt0 -82.77 119.83 24.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 74.010000000000005 110.874 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.648 ' O ' ' HA2' ' A' ' 70' ' ' GLY . 2.0 t -100.01 111.61 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 111.159 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.736 ' O ' HD22 ' A' ' 85' ' ' LEU . 3.9 t-160 -86.68 110.53 19.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 64.129999999999995 110.857 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.944 HD12 HG22 ' A' ' 17' ' ' THR . 3.0 mm? -127.6 127.96 44.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 74.150000000000006 110.923 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.818 ' OD2' ' HB2' ' A' ' 68' ' ' ALA . 13.3 t0 -135.45 132.68 37.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 63.420000000000002 110.869 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.666 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 3.2 tmt_? -57.99 2.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 64.230000000000004 110.885 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.566 ' H ' ' C ' ' A' ' 86' ' ' ASP . 4.7 t0 -66.78 -4.69 9.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 73.099999999999994 110.876 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 68.23 12.18 8.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 74.340000000000003 110.883 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -135.54 -1.23 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 65.519999999999996 110.851 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.769 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 96.8 t -116.67 92.91 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 63.329999999999998 111.151 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.792 ' HA ' HD13 ' A' ' 85' ' ' LEU . 5.3 mp -144.41 14.52 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 73.140000000000001 110.879 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.06 137.14 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 71.329999999999998 110.883 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.61 ' HB ' HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -96.47 130.01 43.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 72.140000000000001 111.167 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLU . 71.4 tt0 -99.94 127.16 34.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.615 0.721 . . . . 73.219999999999999 110.933 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 114.63 3.77 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.675 2.25 . . . . 63.119999999999997 112.333 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -64.53 114.33 4.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 44.420000000000002 111.11 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.08 15.09 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 65.430000000000007 110.899 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.65 -21.51 2.46 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.763 . . . . 71.409999999999997 112.482 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -97.55 -38.44 9.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.835 0.35 . . . . 72.450000000000003 110.869 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.85 47.0 5.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 62.329999999999998 112.482 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 65.129999999999995 112.464 -179.937 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.744 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 75.340000000000003 110.867 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -68.93 -44.22 73.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.120000000000005 110.905 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.439 ' OD2' HD23 ' A' ' 20' ' ' LEU . 5.9 p-10 -66.33 -147.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 70.310000000000002 110.857 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.883 HG22 ' H ' ' A' ' 16' ' ' THR . 26.3 mm -75.76 119.15 75.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.596 0.713 . . . . 71.349999999999994 111.138 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 4.06 2.38 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.74 2.293 . . . . 74.409999999999997 112.32 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.883 ' H ' HG22 ' A' ' 14' ' ' ILE . 2.8 m -115.03 20.95 14.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 63.409999999999997 111.193 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.902 ' CB ' HD22 ' A' ' 20' ' ' LEU . 1.2 p -81.36 -165.15 0.88 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 62.210000000000001 111.142 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.671 ' HG3' HD13 ' A' ' 92' ' ' LEU . 1.1 mm-40 -71.89 -131.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.242 -0.435 . . . . 72.219999999999999 110.883 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.41 12.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 55.32 110.916 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.902 HD22 ' CB ' ' A' ' 17' ' ' THR . 7.5 mp -57.42 -27.54 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 62.149999999999999 110.895 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -95.96 7.04 47.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.913 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -110.55 -42.72 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 72.219999999999999 110.861 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -65.11 -51.8 59.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 75.439999999999998 110.922 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.76 -54.55 6.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 72.349999999999994 112.528 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.96 52.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.768 0.318 . . . . 73.030000000000001 111.119 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.429 ' CE ' ' HB2' ' A' ' 27' ' ' ALA . 1.4 ptm -66.98 -39.8 87.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 72.239999999999995 110.911 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HB2' ' CE ' ' A' ' 26' ' ' MET . . . -120.77 -92.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 62.520000000000003 111.095 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -145.0 -27.17 0.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 110.855 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.68 28.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 73.319999999999993 110.848 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.16 9.62 25.18 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.729 -0.748 . . . . 52.539999999999999 112.519 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HB3' HG23 ' A' ' 58' ' ' VAL . 2.8 mp0 -93.61 98.46 11.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 74.420000000000002 110.909 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -65.84 -162.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 73.409999999999997 110.835 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -129.15 102.2 6.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 110.9 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.845 HG23 ' HG3' ' A' ' 57' ' ' GLU . 1.0 OUTLIER -72.7 159.0 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 71.230000000000004 111.124 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.526 HG23 ' CG ' ' A' ' 40' ' ' ASP . 70.0 p -91.36 -38.07 12.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 62.340000000000003 111.143 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' H ' HG13 ' A' ' 34' ' ' VAL . . . 166.47 -64.44 0.21 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.737 . . . . 63.420000000000002 112.476 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 160.4 49.83 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 64.530000000000001 112.338 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 2.2 p-10 -60.62 -29.18 69.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 75.349999999999994 110.866 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.04 -30.92 49.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 60.399999999999999 111.063 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.526 ' CG ' HG23 ' A' ' 35' ' ' THR . 0.4 OUTLIER -82.24 -35.04 28.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 63.439999999999998 110.896 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.526 ' HG3' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -71.74 -41.09 68.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 70.540000000000006 110.822 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.97 -35.05 71.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 65.109999999999999 111.072 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.7 ptt85 -80.57 -39.5 27.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 71.530000000000001 110.885 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.624 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -75.81 -60.38 2.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 52.240000000000002 111.064 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 1.029 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -56.47 -16.94 6.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 75.019999999999996 111.082 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -62.51 -67.42 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 71.219999999999999 111.112 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.673 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.7 t -122.31 -14.79 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 72.319999999999993 111.118 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.624 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 50.5 mt-30 -79.69 -41.46 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.140000000000001 110.906 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.029 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . . . -104.71 -0.23 27.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 71.310000000000002 111.089 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.978 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -93.72 -11.68 0.17 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 55.0 111.089 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.978 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 54.2 Cg_endo -69.76 -28.04 25.75 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.681 2.254 . . . . 72.120000000000005 112.372 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.26 -44.14 44.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 25.309999999999999 112.475 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.36 -31.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 70.420000000000002 112.475 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 74' ' ' THR . 1.0 OUTLIER -149.92 157.24 42.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.824 0.345 . . . . 61.43 111.139 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.708 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.0 75.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 41.210000000000001 111.111 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.662 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -146.58 111.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 72.439999999999998 112.456 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.845 ' HG3' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -103.93 -170.69 1.81 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 70.049999999999997 110.869 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.559 HG13 ' CE1' ' A' ' 69' ' ' TYR . 3.3 t -131.21 120.77 47.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 72.540000000000006 111.14 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.565 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -93.38 126.07 38.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.540000000000006 110.872 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.8 t -107.99 105.31 15.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 70.319999999999993 111.148 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.608 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -136.36 158.19 45.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 73.319999999999993 110.903 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.6 p -125.13 113.77 18.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 60.539999999999999 111.143 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -92.46 -179.37 40.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.74 . . . . 73.420000000000002 112.491 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.63 -14.38 62.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 52.450000000000003 110.852 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.415 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -86.35 -111.18 0.83 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 55.130000000000003 112.458 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -113.99 -77.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.772 0.32 . . . . 72.310000000000002 111.1 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -108.67 158.21 17.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 60.409999999999997 111.103 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -151.94 49.78 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 53.539999999999999 111.107 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.744 ' HH ' ' N ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -120.35 129.32 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 53.039999999999999 110.979 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -112.05 159.03 13.94 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 31.300000000000001 112.516 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 71' ' ' VAL . 5.5 p -124.25 113.23 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 72.0 111.146 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.916 HD21 ' HB3' ' A' ' 80' ' ' ARG . 2.3 tt -91.1 145.14 24.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 73.409999999999997 110.929 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.58 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 14.6 t -158.57 112.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 71.439999999999998 111.159 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.832 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -174.89 -148.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 72.209999999999994 111.119 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.454 ' H ' HG22 ' A' ' 74' ' ' THR . 9.9 mmm180 -106.0 143.86 27.75 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.59 0.71 . . . . 65.439999999999998 110.85 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.83 11.46 0.4 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.716 2.277 . . . . 72.329999999999998 112.301 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 75' ' ' ARG . 9.0 m-20 -86.16 32.36 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 75.340000000000003 110.905 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.48 -14.58 34.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 60.310000000000002 112.495 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.489 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.4 t -99.81 106.17 18.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.786 0.327 . . . . 71.400000000000006 111.149 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.916 ' HB3' HD21 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -135.58 154.97 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 74.430000000000007 110.877 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.56 ' N ' ' OG1' ' A' ' 74' ' ' THR . 47.9 t -114.19 100.37 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.349999999999994 111.1 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.696 ' HB3' HD12 ' A' ' 72' ' ' LEU . 9.2 pt-20 -85.61 109.19 18.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 71.420000000000002 110.866 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.855 HG13 ' HB ' ' A' ' 94' ' ' THR . 2.1 t -99.62 107.84 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 111.136 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.754 ' C ' HD23 ' A' ' 85' ' ' LEU . 5.4 m-70 -84.3 121.17 27.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 62.450000000000003 110.855 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.783 HD23 ' N ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -106.98 105.57 15.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 72.120000000000005 110.913 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.732 ' H ' ' HA ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -128.65 115.34 17.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 70.109999999999999 110.888 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.551 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 1.2 tmt_? -61.45 -7.8 3.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 53.310000000000002 110.85 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.689 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 24.5 t70 -83.72 32.81 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 72.209999999999994 110.839 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.689 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 18.8 m-85 97.68 -30.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 74.109999999999999 110.853 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.46 35.36 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 75.519999999999996 110.808 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.831 ' O ' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.69 -28.0 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 71.310000000000002 111.115 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.671 HD13 ' HG3' ' A' ' 18' ' ' GLU . 1.9 mt -122.43 29.57 6.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 74.019999999999996 110.893 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 84' ' ' HIS . 33.0 t70 -71.34 66.58 0.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.030000000000001 110.918 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.855 ' HB ' HG13 ' A' ' 83' ' ' VAL . 10.2 t -84.86 151.41 24.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 74.099999999999994 111.118 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -146.06 157.78 49.53 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.654 0.74 . . . . 73.540000000000006 110.861 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 131.92 22.19 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.633 2.222 . . . . 75.140000000000001 112.317 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -112.59 103.19 11.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 52.229999999999997 111.111 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.21 11.28 38.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 65.420000000000002 110.911 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 42' ' ' ALA . . . 86.44 -19.32 28.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 50.530000000000001 112.495 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -95.67 -41.99 8.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 71.409999999999997 110.907 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.85 28.69 45.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 32.119999999999997 112.484 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.757 -0.735 . . . . 41.229999999999997 112.528 -179.94 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.804 0.335 . . . . 74.209999999999994 110.825 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 33' ' ' GLU . 82.8 m-85 -65.43 -54.31 30.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 73.329999999999998 110.92 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.02 -158.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 71.120000000000005 110.878 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.492 HD11 ' N ' ' A' ' 87' ' ' ARG . 1.2 mp -74.42 121.64 85.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.591 0.71 . . . . 63.25 111.13 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -5.47 16.26 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.689 2.259 . . . . 72.450000000000003 112.341 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.466 ' H ' HG22 ' A' ' 14' ' ' ILE . 34.3 p -145.44 88.3 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.230000000000004 111.16 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.917 HG22 HD23 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -132.55 -159.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 74.120000000000005 111.149 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.08 -94.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 52.32 110.927 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -87.88 11.18 16.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 62.520000000000003 110.887 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.867 HD22 HD12 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -93.55 -34.72 13.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 73.5 110.922 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -67.45 -11.54 58.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.892 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -93.94 -59.76 1.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 62.119999999999997 110.842 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -66.32 -41.36 89.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 74.239999999999995 110.927 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -42.35 -34.89 1.72 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.717 -0.754 . . . . 64.25 112.44 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.9 -60.6 3.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.77 0.319 . . . . 72.439999999999998 111.061 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.5 ptp -69.79 -9.52 54.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 64.209999999999994 110.878 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 24' ' ' GLY . . . -76.85 -19.67 57.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.109999999999999 111.056 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -82.03 8.94 9.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 73.530000000000001 110.896 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -70.7 -80.85 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 55.530000000000001 110.866 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.05 11.4 0.19 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 71.420000000000002 112.493 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.699 ' OE1' HG23 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -67.52 176.94 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 60.509999999999998 110.894 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.22 -164.12 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 74.239999999999995 110.86 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.427 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 1.5 pt-20 -111.0 166.58 10.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 73.230000000000004 110.883 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -100.03 167.8 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.485 . . . . 71.109999999999999 111.078 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.58 ' N ' HG13 ' A' ' 34' ' ' VAL . 44.3 p -94.79 -42.08 8.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.148 -0.478 . . . . 71.230000000000004 111.188 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.426 ' N ' HG13 ' A' ' 34' ' ' VAL . . . 166.89 -64.65 0.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.736 . . . . 52.119999999999997 112.501 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.425 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.8 Cg_endo -69.74 157.26 61.04 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.684 2.256 . . . . 74.409999999999997 112.333 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -59.79 -28.95 67.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 55.219999999999999 110.908 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.11 -33.51 57.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 61.420000000000002 111.137 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.672 ' HB3' HG22 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -84.1 -32.07 24.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 71.209999999999994 110.905 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.912 ' HB2' HD21 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -69.45 -44.84 70.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 74.549999999999997 110.832 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.747 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -71.77 -34.72 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 72.010000000000005 111.061 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.3 ptt85 -76.37 -39.84 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 63.200000000000003 110.863 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.591 ' HA ' ' HB2' ' A' ' 48' ' ' GLN . . . -75.44 -59.76 2.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 73.420000000000002 111.118 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.731 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -58.03 -13.55 4.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 60.140000000000001 111.089 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.747 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -71.28 -71.96 0.24 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 44.039999999999999 111.15 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.714 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.3 t -113.56 -9.34 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 74.319999999999993 111.147 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -83.0 -39.92 20.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.430000000000007 110.921 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.731 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . . . -102.41 -5.87 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 70.049999999999997 111.067 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.959 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -81.13 -25.51 0.41 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.64 0.733 . . . . 72.120000000000005 111.129 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.959 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 53.9 Cg_endo -69.72 -10.19 27.97 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.69 2.26 . . . . 73.519999999999996 112.342 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.6 -27.34 15.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.74 . . . . 53.130000000000003 112.498 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.81 -32.54 0.3 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.737 . . . . 64.129999999999995 112.535 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.586 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -155.15 164.7 38.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 63.310000000000002 111.113 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.724 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -75.17 65.96 1.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 64.049999999999997 111.114 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.712 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -141.13 105.85 0.45 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 63.030000000000001 112.514 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.529 ' CG ' ' HB2' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -94.97 -162.06 0.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 72.340000000000003 110.931 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.723 HG22 ' CG1' ' A' ' 71' ' ' VAL . 29.4 t -129.31 119.36 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 75.430000000000007 111.14 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.814 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 1.6 mt-10 -93.34 136.01 34.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 73.510000000000005 110.857 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 60' ' ' THR . 3.5 t -138.44 115.62 11.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 74.200000000000003 111.168 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.802 ' C ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -122.31 178.3 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 110.865 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.77 128.87 49.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 52.109999999999999 111.109 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.469 ' N ' ' HB2' ' A' ' 68' ' ' ALA . . . -128.49 -144.77 5.87 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.768 -0.729 . . . . 35.329999999999998 112.517 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -87.25 -21.32 25.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.887 0.375 . . . . 75.230000000000004 110.889 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.67 -109.93 3.01 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.737 . . . . 73.439999999999998 112.516 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.47 -81.48 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.326 . . . . 54.32 111.113 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.691 ' HB3' ' HB2' ' A' ' 87' ' ' ARG . . . -78.08 128.04 33.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 53.439999999999998 111.105 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.802 ' HB3' ' C ' ' A' ' 61' ' ' GLU . . . -122.69 45.71 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 65.349999999999994 111.067 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.814 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -170.86 -152.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 74.450000000000003 110.928 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 83' ' ' VAL . . . -158.8 -126.84 0.88 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 63.310000000000002 112.488 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.723 ' CG1' HG22 ' A' ' 58' ' ' VAL . 4.5 m -152.67 151.95 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.373 . . . . 73.040000000000006 111.131 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.912 HD21 ' HB2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -104.81 152.41 22.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 72.5 110.923 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.698 ' O ' HG22 ' A' ' 81' ' ' VAL . 2.1 p -155.17 106.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 52.130000000000003 111.119 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.844 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -172.32 -142.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 111.158 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.456 ' H ' HG22 ' A' ' 74' ' ' THR . 3.6 mtm180 -110.13 149.18 39.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.599 0.714 . . . . 64.340000000000003 110.887 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' A' ' 55' ' ' ALA . 53.4 Cg_endo -69.77 8.36 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.694 2.263 . . . . 74.319999999999993 112.361 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.16 33.09 0.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 71.239999999999995 110.914 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.73 -11.45 10.4 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.753 -0.737 . . . . 70.340000000000003 112.456 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.469 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.2 t -101.61 105.21 16.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.318 . . . . 71.140000000000001 111.168 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.844 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 2.4 ptp85 -138.64 157.48 46.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 63.200000000000003 110.856 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 73' ' ' VAL . 18.0 m -114.03 96.65 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 111.098 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.735 ' HB3' HD23 ' A' ' 72' ' ' LEU . 1.3 pp20? -87.24 125.07 33.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 70.019999999999996 110.902 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.758 HG12 HD21 ' A' ' 85' ' ' LEU . 4.5 t -91.52 139.89 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 75.409999999999997 111.141 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.97 ' C ' HD23 ' A' ' 85' ' ' LEU . 1.2 t60 -117.9 106.04 12.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 110.833 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.97 HD23 ' C ' ' A' ' 84' ' ' HIS . 2.7 mt -131.6 139.12 49.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 51.32 110.893 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.631 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -103.68 111.77 24.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 73.140000000000001 110.84 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.691 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 1.3 tmt_? -50.07 -21.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 74.340000000000003 110.851 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.489 ' HB3' ' OD1' ' A' ' 86' ' ' ASP . 4.7 t0 -68.28 5.36 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 65.420000000000002 110.879 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.426 ' H ' ' C ' ' A' ' 87' ' ' ARG . 37.5 m-85 67.08 42.51 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 110.898 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.842 ' HG3' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -129.09 -29.76 2.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 71.140000000000001 110.848 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.944 HG12 ' HA ' ' A' ' 85' ' ' LEU . 54.2 t -125.0 125.82 70.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 63.32 111.133 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.917 HD23 HG22 ' A' ' 17' ' ' THR . 1.9 mp -145.27 17.27 1.53 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 64.219999999999999 110.891 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 84' ' ' HIS . 21.1 t0 -101.35 143.97 30.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 72.030000000000001 110.867 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.538 ' HB ' HG13 ' A' ' 83' ' ' VAL . 13.9 t -84.83 176.3 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 73.540000000000006 111.133 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 82' ' ' GLU . 3.7 tt0 -145.72 128.89 8.27 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.604 0.716 . . . . 72.310000000000002 110.897 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 115.17 3.96 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 63.32 112.392 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.821 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -94.58 115.73 27.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 71.430000000000007 111.069 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -102.19 15.13 30.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 73.030000000000001 110.891 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.63 -19.46 9.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.745 -0.74 . . . . 51.100000000000001 112.514 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -96.11 -42.69 8.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 52.539999999999999 110.834 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.07 26.68 54.97 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.728 -0.748 . . . . 75.140000000000001 112.465 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.712 -0.756 . . . . 74.420000000000002 112.535 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.826 0.346 . . . . 60.310000000000002 110.856 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.707 ' HA ' HD13 ' A' ' 85' ' ' LEU . 4.5 p90 -94.43 -175.44 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 54.509999999999998 110.907 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -119.4 -31.56 4.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.519 . . . . 64.420000000000002 110.852 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.733 ' O ' HG23 ' A' ' 17' ' ' THR . 0.8 OUTLIER -101.07 127.57 31.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.607 0.718 . . . . 74.239999999999995 111.129 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 18.73 0.19 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.747 2.298 . . . . 62.340000000000003 112.305 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -138.95 39.76 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 74.310000000000002 111.12 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 14' ' ' ILE . 65.0 p -72.73 -166.5 0.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 64.200000000000003 111.161 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -132.79 -86.7 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 110.901 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -75.08 6.64 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 71.420000000000002 110.911 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.907 HD21 ' HB3' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -92.59 -37.85 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 61.420000000000002 110.904 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -75.17 -7.49 53.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 110.969 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -94.43 -26.31 16.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 74.319999999999993 110.886 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -30.03 29.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 72.430000000000007 110.896 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.9 -30.7 1.04 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.746 -0.74 . . . . 50.439999999999998 112.486 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.56 -56.88 4.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 72.120000000000005 111.112 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.607 ' SD ' HG21 ' A' ' 73' ' ' VAL . 11.6 ptp -65.15 -11.77 43.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 73.049999999999997 110.866 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.933 ' HB1' ' HB2' ' A' ' 31' ' ' GLU . . . -101.5 26.11 7.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.450000000000003 111.104 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.416 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 7.4 p90 -63.15 -16.65 60.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 71.140000000000001 110.857 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -147.6 -44.97 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 72.540000000000006 110.881 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.97 -18.21 25.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.724 . . . . 64.409999999999997 112.46 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.933 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 1.9 tm-20 -64.7 92.12 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.883 0.373 . . . . 74.319999999999993 110.868 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.434 ' HB3' ' CD ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -103.22 -161.04 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 63.210000000000001 110.882 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -122.63 114.01 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 110.911 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 35' ' ' THR . 11.4 t -90.7 172.34 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 61.240000000000002 111.112 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.672 ' H ' HG12 ' A' ' 34' ' ' VAL . 34.3 p -89.73 -54.1 4.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 64.349999999999994 111.178 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.73 -64.89 0.11 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.721 -0.752 . . . . 74.409999999999997 112.51 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.461 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.9 Cg_endo -69.74 159.04 54.9 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.693 2.262 . . . . 75.430000000000007 112.375 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -60.65 -29.0 68.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 74.010000000000005 110.882 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.477 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . . . -54.37 -35.66 63.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 62.439999999999998 111.077 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.53 ' HA ' ' CG ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -85.45 -28.59 24.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 71.439999999999998 110.846 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 97' ' ' ALA . 0.6 OUTLIER -73.99 -42.61 60.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 60.020000000000003 110.894 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.43 -33.71 71.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 111.058 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.53 ' CG ' ' HA ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -79.72 -42.56 24.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 74.299999999999997 110.843 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -75.22 -61.61 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 44.420000000000002 111.097 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.983 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . . . -51.08 -23.76 3.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 62.229999999999997 111.107 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.62 ' O ' ' CG2' ' A' ' 50' ' ' VAL . . . -51.93 -67.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 70.219999999999999 111.142 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.638 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 25.3 t -111.18 -22.0 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 53.539999999999999 111.119 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 45.2 mt-30 -73.98 -29.21 61.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 61.310000000000002 110.911 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.109 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.42 -6.95 15.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 71.010000000000005 111.134 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 14.3 t -95.66 1.92 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.713 . . . . 62.119999999999997 111.108 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.109 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.0 Cg_endo -69.71 -20.35 35.16 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.265 . . . . 62.100000000000001 112.373 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.72 -40.54 3.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.731 . . . . 64.140000000000001 112.52 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.96 -32.8 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.738 -0.744 . . . . 64.430000000000007 112.471 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.957 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -147.3 163.31 36.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 74.409999999999997 111.15 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.77 ' O ' ' HA ' ' A' ' 73' ' ' VAL . . . -76.81 69.06 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 61.229999999999997 111.08 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.816 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -111.22 82.27 0.3 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.721 -0.752 . . . . 70.230000000000004 112.488 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.983 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -88.98 175.92 7.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 74.219999999999999 110.91 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.595 HG22 HG22 ' A' ' 71' ' ' VAL . 62.7 t -131.17 123.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.549999999999997 111.107 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.633 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 8.0 mt-10 -92.08 129.1 38.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.924 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -100.48 104.46 15.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 71.230000000000004 111.154 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.486 ' C ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.56 160.68 39.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 72.510000000000005 110.887 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -131.37 112.63 12.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 71.200000000000003 111.129 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.73 -178.53 43.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 75.310000000000002 112.487 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -65.13 -24.03 67.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.856 0.36 . . . . 74.030000000000001 110.855 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.72 -112.51 0.14 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.715 -0.755 . . . . 73.230000000000004 112.427 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 87' ' ' ARG . . . -111.7 -82.65 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.321 . . . . 63.399999999999999 111.102 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.85 161.53 14.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 54.149999999999999 111.074 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.486 ' HB3' ' C ' ' A' ' 61' ' ' GLU . . . -153.78 72.6 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 72.420000000000002 111.138 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.538 ' CB ' HD21 ' A' ' 85' ' ' LEU . 4.7 m-85 -115.79 125.12 52.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.968 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -105.93 110.21 3.34 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.695 -0.764 . . . . 65.340000000000003 112.457 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 57' ' ' GLU . 89.4 t -102.45 113.95 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 73.400000000000006 111.128 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.816 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -105.72 131.72 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 62.219999999999999 110.94 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.3 p -139.1 119.41 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 54.310000000000002 111.138 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.824 ' O ' HG22 ' A' ' 54' ' ' THR . 2.3 m -170.11 -133.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 64.329999999999998 111.165 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.521 ' H ' HG22 ' A' ' 74' ' ' THR . 9.5 mtm180 -105.84 143.55 27.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 75.349999999999994 110.876 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HA ' HH22 ' A' ' 80' ' ' ARG . 54.3 Cg_endo -69.75 13.08 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.663 2.242 . . . . 72.120000000000005 112.361 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 75' ' ' ARG . 5.7 m-20 -88.79 24.6 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 73.540000000000006 110.9 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.21 -13.69 53.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.769 -0.729 . . . . 53.100000000000001 112.465 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.491 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.0 p -98.54 108.34 21.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.825 0.345 . . . . 64.439999999999998 111.155 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.818 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 2.2 ptp85 -140.09 163.07 33.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 74.409999999999997 110.895 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 60.1 t -120.58 105.0 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 74.140000000000001 111.177 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.532 ' O ' ' HB ' ' A' ' 94' ' ' THR . 34.4 tt0 -82.62 142.84 31.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 72.5 110.938 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 12.1 m -118.37 118.24 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 72.109999999999999 111.123 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.658 ' H ' ' C ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -83.18 119.37 24.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 71.549999999999997 110.894 179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.907 ' HB3' HD21 ' A' ' 20' ' ' LEU . 2.8 pp -113.77 110.9 20.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 74.420000000000002 110.922 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.591 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -134.28 118.79 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 73.049999999999997 110.885 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.417 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 2.0 ttt180 -69.14 5.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 73.549999999999997 110.895 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.513 ' HB3' ' CE2' ' A' ' 89' ' ' PHE . 29.8 t0 -64.57 -25.43 67.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 74.230000000000004 110.876 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -160.69 -89.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 63.340000000000003 110.877 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.53 45.63 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 71.239999999999995 110.862 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.808 ' O ' HD13 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -99.09 111.84 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 61.229999999999997 111.096 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.808 HD13 ' O ' ' A' ' 91' ' ' VAL . 0.4 OUTLIER -128.23 17.06 6.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 53.210000000000001 110.937 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.658 ' C ' ' H ' ' A' ' 84' ' ' HIS . 10.2 t70 -140.49 151.51 44.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 73.409999999999997 110.874 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.654 ' OG1' ' N ' ' A' ' 84' ' ' HIS . 81.4 m -122.58 -101.52 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 52.329999999999998 111.101 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.505 ' N ' HG22 ' A' ' 94' ' ' THR . 8.4 pt-20 -166.47 154.74 9.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.63 0.729 . . . . 73.340000000000003 110.906 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 95' ' ' GLU . 53.4 Cg_endo -69.77 148.46 65.04 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.671 2.247 . . . . 75.349999999999994 112.352 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 41' ' ' ARG . . . -118.58 161.15 20.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 70.239999999999995 111.117 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.98 0.41 6.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 71.409999999999997 110.878 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.0 -20.84 26.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.735 -0.745 . . . . 64.409999999999997 112.476 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -97.08 -16.79 20.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.871 0.367 . . . . 73.439999999999998 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.45 -20.32 79.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 32.140000000000001 112.508 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 39' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 73.25 112.49 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.6 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.81 0.338 . . . . 75.340000000000003 110.883 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -63.94 -22.49 66.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 110.946 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' OD1' ' HB3' ' A' ' 67' ' ' ALA . 14.5 t70 -67.23 -124.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 71.299999999999997 110.876 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 17' ' ' THR . 3.0 tt -92.0 139.36 24.47 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.606 0.717 . . . . 72.319999999999993 111.135 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.75 23.87 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.717 2.278 . . . . 44.229999999999997 112.311 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.493 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -151.04 37.4 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 63.32 111.154 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.65 HG23 ' O ' ' A' ' 14' ' ' ILE . 66.5 p -66.87 -165.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 75.129999999999995 111.15 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.509 ' HG3' HD23 ' A' ' 92' ' ' LEU . 3.0 mt-10 -123.46 -86.99 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.862 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.87 12.3 3.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 71.150000000000006 110.856 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.774 ' CG ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -94.25 -36.31 12.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 74.099999999999994 110.964 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.444 ' CD2' ' O ' ' A' ' 18' ' ' GLU . 2.1 p90 -75.83 -2.41 29.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 71.239999999999995 110.865 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -96.25 -32.04 12.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 70.420000000000002 110.877 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -81.05 -31.02 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 73.519999999999996 110.917 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -41.82 -38.63 2.44 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.768 -0.73 . . . . 64.340000000000003 112.437 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.52 -60.68 3.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 74.420000000000002 111.118 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.743 ' HG3' HG21 ' A' ' 73' ' ' VAL . 1.1 ptm -67.57 -10.94 56.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 74.310000000000002 110.849 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HB1' ' OE1' ' A' ' 31' ' ' GLU . . . -82.37 -29.93 30.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.422 . . . . 41.420000000000002 111.122 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -73.86 42.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 73.230000000000004 110.876 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -148.34 -41.87 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 70.430000000000007 110.872 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.34 13.27 3.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.711 -0.757 . . . . 63.109999999999999 112.484 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.626 ' CD ' HG21 ' A' ' 58' ' ' VAL . 2.7 tt0 -58.16 104.49 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 71.049999999999997 110.859 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.41 -171.04 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 74.310000000000002 110.838 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -109.48 120.5 42.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 71.439999999999998 110.85 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.763 HG23 ' C ' ' A' ' 58' ' ' VAL . 2.3 t -91.74 -140.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 73.219999999999999 111.132 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.685 ' H ' HG12 ' A' ' 34' ' ' VAL . 43.6 p -137.06 -63.92 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 75.439999999999998 111.146 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.05 -64.6 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.71 -0.757 . . . . 74.319999999999993 112.469 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.415 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.7 Cg_endo -69.77 167.17 25.23 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.636 2.224 . . . . 72.430000000000007 112.381 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -70.32 -26.06 63.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 73.239999999999995 110.835 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.51 -37.42 70.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 70.420000000000002 111.118 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.07 -33.54 24.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 71.329999999999998 110.893 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -71.23 -43.85 66.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 75.549999999999997 110.863 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.753 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.48 -34.33 72.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 111.093 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -79.35 -41.02 28.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 74.439999999999998 110.905 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -77.34 -63.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 63.219999999999999 111.112 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -52.9 -19.72 2.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 55.140000000000001 111.074 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.753 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -53.63 -67.96 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 74.400000000000006 111.114 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.744 ' HA ' HG12 ' A' ' 50' ' ' VAL . 21.5 t -115.55 -13.85 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 72.519999999999996 111.093 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.57 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 41.5 mt-30 -80.09 -34.54 37.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 75.340000000000003 110.909 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.008 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.29 -4.1 19.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 75.120000000000005 111.1 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.988 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.71 -6.4 0.12 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.639 0.733 . . . . 75.25 111.172 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 1.008 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.8 Cg_endo -69.83 -26.58 27.11 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 2.236 . . . . 61.409999999999997 112.361 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.83 -50.49 5.56 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.721 -0.752 . . . . 52.140000000000001 112.53 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.5 -32.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.703 -0.761 . . . . 63.200000000000003 112.486 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.659 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -146.94 150.73 35.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 72.420000000000002 111.148 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.801 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.98 79.1 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 61.200000000000003 111.076 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.76 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -145.64 101.89 0.25 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 40.109999999999999 112.496 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.564 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.5 tt0 -95.39 -177.72 4.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 63.119999999999997 110.9 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.763 ' C ' HG23 ' A' ' 34' ' ' VAL . 82.1 t -132.29 118.11 34.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 62.240000000000002 111.121 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.779 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 7.6 pt-20 -92.47 159.5 15.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 72.409999999999997 110.906 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.502 ' HA ' ' CB ' ' A' ' 69' ' ' TYR . 1.6 t -132.8 116.4 16.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 52.340000000000003 111.146 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -136.73 163.71 29.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 70.230000000000004 110.876 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.423 ' CA ' ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -116.09 149.89 38.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 74.439999999999998 111.166 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.07 -142.51 5.34 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 34.420000000000002 112.506 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.74 -22.06 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.379 . . . . 64.150000000000006 110.866 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.1 -114.34 3.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 51.530000000000001 112.449 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.05 -84.71 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.748 0.308 . . . . 72.040000000000006 111.107 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -76.34 131.78 39.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 111.112 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB3' ' CA ' ' A' ' 62' ' ' THR . . . -150.4 60.72 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 44.520000000000003 111.113 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.91 ' CZ ' HD12 ' A' ' 85' ' ' LEU . 4.2 p90 -128.19 -169.17 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 61.299999999999997 110.922 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -157.07 163.9 32.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.771 -0.728 . . . . 71.109999999999999 112.525 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.756 HG22 HG22 ' A' ' 58' ' ' VAL . 61.1 t -136.85 122.69 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 62.450000000000003 111.09 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.76 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -110.56 141.5 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 110.948 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.743 HG21 ' HG3' ' A' ' 26' ' ' MET . 7.2 p -152.19 124.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 74.420000000000002 111.106 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.829 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 3.0 m -171.82 -129.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 74.400000000000006 111.125 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.48 ' H ' HG22 ' A' ' 74' ' ' THR . 6.4 mtm-85 -103.53 141.5 22.62 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.624 0.726 . . . . 73.420000000000002 110.883 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.51 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.0 Cg_endo -69.74 15.57 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 70.209999999999994 112.342 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 75' ' ' ARG . 5.7 m-20 -93.69 24.52 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 110.879 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.25 -12.71 53.83 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.74 . . . . 70.540000000000006 112.5 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 79' ' ' THR . 2.7 t -98.64 103.95 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 74.239999999999995 111.152 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.829 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.9 OUTLIER -137.3 163.75 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 62.219999999999999 110.925 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 45.6 t -115.88 105.66 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 71.540000000000006 111.069 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.672 ' CD ' HG21 ' A' ' 94' ' ' THR . 0.0 OUTLIER -88.65 139.29 30.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 75.530000000000001 110.874 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 1.016 HG23 HD21 ' A' ' 85' ' ' LEU . 32.3 m -116.11 146.88 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 44.439999999999998 111.111 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.897 ' C ' HD23 ' A' ' 85' ' ' LEU . 2.1 t-160 -98.46 123.99 42.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 65.329999999999998 110.861 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.016 HD21 HG23 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -118.91 103.15 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 72.319999999999993 110.901 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 1.6 t70 -131.37 111.62 12.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 70.019999999999996 110.899 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -70.99 4.21 2.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 71.310000000000002 110.867 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -72.73 -13.92 61.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 63.5 110.841 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.428 ' HB2' ' HD2' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -164.63 -95.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.409999999999997 110.897 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.881 ' O ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -149.21 29.33 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 70.340000000000003 110.84 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.847 ' C ' HD13 ' A' ' 92' ' ' LEU . 2.3 t -73.92 97.0 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 111.119 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.881 HD22 ' O ' ' A' ' 90' ' ' ARG . 0.4 OUTLIER -124.87 15.29 8.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.439999999999998 110.853 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.612 ' C ' ' H ' ' A' ' 84' ' ' HIS . 4.4 m-20 -154.61 157.95 38.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 33.439999999999998 110.845 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.704 ' OG1' ' HB2' ' A' ' 84' ' ' HIS . 86.0 m -130.39 -99.8 0.32 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 72.349999999999994 111.135 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.484 ' N ' HG22 ' A' ' 94' ' ' THR . 0.6 OUTLIER -159.34 162.61 25.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.627 0.727 . . . . 71.519999999999996 110.883 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 104.48 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.652 2.235 . . . . 64.319999999999993 112.335 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.619 ' HB3' ' HG3' ' A' ' 80' ' ' ARG . . . -66.79 108.22 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 54.530000000000001 111.092 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.85 16.58 12.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 64.349999999999994 110.894 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.59 -19.91 21.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 73.510000000000005 112.513 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.4 -45.94 6.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 75.400000000000006 110.886 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.06 27.46 45.05 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 42.149999999999999 112.455 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.749 . . . . 54.210000000000001 112.468 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.837 0.351 . . . . 73.120000000000005 110.88 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -67.69 -41.69 83.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 110.909 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.454 ' CB ' ' HB2' ' A' ' 85' ' ' LEU . 3.8 p-10 -62.55 -161.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 75.420000000000002 110.868 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.819 HG13 HG23 ' A' ' 17' ' ' THR . 27.7 pt -86.73 129.57 52.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.646 0.736 . . . . 64.400000000000006 111.133 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 0.56 5.43 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.697 2.265 . . . . 40.420000000000002 112.326 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 m -109.1 25.02 12.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 73.409999999999997 111.136 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.097 HG22 HD23 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -78.86 -168.2 1.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 71.150000000000006 111.136 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -73.97 -100.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 73.150000000000006 110.883 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.06 7.76 45.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 71.230000000000004 110.892 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.641 HD23 ' HB3' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -69.08 -13.41 62.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 74.140000000000001 110.895 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -94.05 0.64 56.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 110.904 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.13 -40.41 8.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 64.019999999999996 110.869 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.543 ' OE1' HG21 ' A' ' 83' ' ' VAL . 4.7 mp0 -67.3 -43.98 80.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.040000000000006 110.926 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.563 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -43.88 -30.01 1.56 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.76 . . . . 44.350000000000001 112.512 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.16 -56.91 12.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 62.539999999999999 111.076 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.647 ' SD ' HG21 ' A' ' 73' ' ' VAL . 20.4 ptp -72.01 -5.03 32.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.443 . . . . 60.219999999999999 110.883 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 24' ' ' GLY . . . -74.43 -24.34 59.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 71.010000000000005 111.119 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -64.3 -9.09 15.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 64.530000000000001 110.861 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.09 -77.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 51.219999999999999 110.882 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.31 9.98 2.98 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 64.540000000000006 112.499 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.788 ' CD ' HG23 ' A' ' 58' ' ' VAL . 2.8 tt0 -60.02 99.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 74.209999999999994 110.872 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.05 -164.06 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 72.010000000000005 110.846 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.81 122.54 44.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 64.439999999999998 110.905 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.748 HG23 ' C ' ' A' ' 58' ' ' VAL . 2.7 t -84.1 -133.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 61.009999999999998 111.118 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.558 ' H ' HG12 ' A' ' 34' ' ' VAL . 21.0 p -136.09 -58.55 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 72.420000000000002 111.113 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.46 -68.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 71.209999999999994 112.494 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.4 Cg_endo -69.75 171.24 14.82 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 2.243 . . . . 72.230000000000004 112.362 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -71.92 -24.61 61.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 65.400000000000006 110.836 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.86 72.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 54.32 111.084 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.68 -41.35 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 60.310000000000002 110.887 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.512 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -61.24 -37.7 84.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 74.200000000000003 110.854 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.729 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -67.74 -33.97 75.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 71.430000000000007 111.09 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.483 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -78.88 -39.62 34.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 73.120000000000005 110.91 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.772 ' HB1' ' OE2' ' A' ' 57' ' ' GLU . . . -80.34 -60.79 2.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 50.020000000000003 111.103 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.763 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -52.71 -23.24 6.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 75.299999999999997 111.088 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -57.25 -77.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 50.520000000000003 111.056 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.698 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 40.6 t -113.32 -13.97 11.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 72.120000000000005 111.121 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.6 tp60 -75.92 -32.94 59.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 110.872 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.029 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.68 -2.63 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 54.140000000000001 111.101 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.974 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.1 -4.56 0.11 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.637 0.732 . . . . 71.510000000000005 111.146 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.029 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.3 Cg_endo -69.78 -28.16 25.5 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.676 2.251 . . . . 72.430000000000007 112.326 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.54 -54.95 3.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.758 . . . . 64.340000000000003 112.469 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.79 -33.45 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.7 -0.762 . . . . 74.099999999999994 112.474 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.698 HG22 ' O ' ' A' ' 74' ' ' THR . 0.2 OUTLIER -144.81 150.12 36.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 74.040000000000006 111.112 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.817 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.42 76.46 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 72.540000000000006 111.099 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.704 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -149.7 108.94 0.42 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 62.520000000000003 112.521 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.772 ' OE2' ' HB1' ' A' ' 44' ' ' ALA . 3.2 tt0 -102.97 -168.54 1.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.893 0.378 . . . . 75.129999999999995 110.888 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.788 HG23 ' CD ' ' A' ' 31' ' ' GLU . 1.3 t -132.98 118.29 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 54.32 111.117 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -96.98 158.14 15.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 74.129999999999995 110.923 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -137.06 111.02 8.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 72.340000000000003 111.159 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.95 166.39 16.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.888 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.81 118.15 29.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 61.240000000000002 111.163 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.07 -144.3 9.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 50.420000000000002 112.5 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.97 -14.29 42.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.901 0.382 . . . . 65.5 110.895 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.89 -120.89 1.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 71.340000000000003 112.491 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -121.97 -76.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 64.549999999999997 111.128 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.768 ' HB1' ' CE2' ' A' ' 69' ' ' TYR . . . -103.04 86.33 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 64.209999999999994 111.087 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.28 62.93 6.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 75.239999999999995 111.076 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.768 ' CE2' ' HB1' ' A' ' 67' ' ' ALA . 0.4 OUTLIER -109.04 174.39 5.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 110.913 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -153.91 157.75 27.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.725 -0.75 . . . . 44.399999999999999 112.454 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.642 HG12 HD21 ' A' ' 85' ' ' LEU . 3.4 p -132.6 115.03 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.372 . . . . 74.510000000000005 111.132 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.761 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -107.53 135.88 48.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 70.400000000000006 110.918 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.704 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.7 p -151.55 124.43 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 71.120000000000005 111.154 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.771 ' HB ' ' O ' ' A' ' 79' ' ' THR . 4.1 m -168.06 -131.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 74.450000000000003 111.17 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.599 ' H ' HG22 ' A' ' 74' ' ' THR . 0.5 OUTLIER -103.0 139.33 20.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.63 0.729 . . . . 64.109999999999999 110.886 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.636 ' HG3' HG21 ' A' ' 50' ' ' VAL . 53.9 Cg_endo -69.72 16.83 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.711 2.274 . . . . 62.039999999999999 112.34 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 75' ' ' ARG . 4.1 m-20 -94.97 13.61 24.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 71.340000000000003 110.874 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.84 -12.1 34.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 23.43 112.457 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.771 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.8 t -95.55 130.63 42.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 41.229999999999997 111.175 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.547 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -142.2 158.79 43.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 74.299999999999997 110.924 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.761 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 72.8 t -117.79 80.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 65.129999999999995 111.119 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB2' HD12 ' A' ' 72' ' ' LEU . 3.0 tp10 -75.09 121.82 22.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 110.853 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.0 t -103.82 139.5 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 63.340000000000003 111.172 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.63 ' C ' HG12 ' A' ' 91' ' ' VAL . 17.9 m-70 -86.61 118.13 25.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 73.25 110.843 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.642 HD21 HG12 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -128.3 105.86 8.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 74.319999999999993 110.91 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.66 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.3 t0 -139.66 131.96 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 71.409999999999997 110.843 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.641 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 2.0 tmt_? -61.21 5.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.219999999999999 110.863 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 86' ' ' ASP . 13.9 t0 -67.23 -3.33 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 110.863 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 67.53 12.2 8.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 110.879 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -137.31 2.18 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.882 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.66 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 58.5 t -116.38 70.87 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 63.219999999999999 111.143 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.097 HD23 HG22 ' A' ' 17' ' ' THR . 0.3 OUTLIER -128.56 12.47 6.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 71.109999999999999 110.941 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -92.92 -179.1 5.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 65.549999999999997 110.864 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.8 t -124.61 166.96 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 61.310000000000002 111.132 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -145.97 123.38 6.12 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.658 0.742 . . . . 75.420000000000002 110.872 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 96.48 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.637 2.225 . . . . 22.109999999999999 112.351 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 80' ' ' ARG . . . -64.09 111.35 2.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 71.409999999999997 111.097 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -88.83 11.03 19.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 62.329999999999998 110.831 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.18 -21.11 7.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.727 . . . . 31.440000000000001 112.462 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -97.92 -38.54 9.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.861 0.363 . . . . 73.239999999999995 110.888 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.26 25.14 52.6 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.751 . . . . 62.439999999999998 112.518 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.782 -0.723 . . . . 31.309999999999999 112.472 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.832 0.349 . . . . 75.349999999999994 110.879 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.428 ' HB2' ' CE2' ' A' ' 69' ' ' TYR . 77.6 m-85 -64.68 -32.91 74.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 110.929 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 10.6 p-10 -65.98 -122.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 63.450000000000003 110.885 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.844 HD12 HG11 ' A' ' 91' ' ' VAL . 30.8 mt -77.37 127.55 82.69 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.633 0.73 . . . . 61.030000000000001 111.138 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 15.86 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.637 2.225 . . . . 74.540000000000006 112.394 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.784 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -150.77 37.86 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 65.340000000000003 111.117 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.841 HG22 HD21 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -71.61 -161.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 64.209999999999994 111.133 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.408 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 29.4 mm-40 -84.13 -111.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 73.109999999999999 110.835 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -86.7 9.76 17.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.129999999999995 110.86 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.703 HD22 HG21 ' A' ' 17' ' ' THR . 0.3 OUTLIER -66.91 -12.23 58.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 72.420000000000002 110.877 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -63.65 -12.27 32.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 73.019999999999996 110.912 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -115.18 52.93 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 110.85 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.468 HE22 HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -58.19 88.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 74.549999999999997 110.904 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 42.93 38.17 3.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 63.439999999999998 112.487 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.86 -26.7 66.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 63.43 111.122 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.608 ' SD ' HG11 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -66.0 -9.9 34.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 73.549999999999997 110.846 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 29' ' ' ASP . . . -118.14 61.91 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 63.340000000000003 111.152 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -59.34 -6.15 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 75.129999999999995 110.926 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 27' ' ' ALA . 3.8 m-20 -126.08 -35.52 2.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 73.319999999999993 110.863 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 -20.52 60.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.716 -0.754 . . . . 42.409999999999997 112.475 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -62.47 93.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 61.140000000000001 110.892 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.09 179.62 3.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 64.25 110.873 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -95.62 115.73 27.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 64.530000000000001 110.894 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.739 HG22 ' OE1' ' A' ' 57' ' ' GLU . 3.1 t -75.03 -135.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 74.209999999999994 111.184 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.684 ' H ' HG12 ' A' ' 34' ' ' VAL . 80.6 p -140.15 -60.43 0.53 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 61.119999999999997 111.108 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.455 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 175.76 -60.88 0.11 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 54.119999999999997 112.5 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.9 Cg_endo -69.73 164.64 33.76 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.711 2.274 . . . . 73.019999999999996 112.369 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 9.0 p-10 -71.53 -25.67 62.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 55.420000000000002 110.804 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.14 -36.86 73.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 70.530000000000001 111.067 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 2.1 m-20 -83.49 -36.31 24.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 53.140000000000001 110.876 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.594 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 11.8 ptt180 -70.39 -43.97 68.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.842 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.712 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -69.39 -34.47 74.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 72.230000000000004 111.12 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 15.3 ptt85 -80.11 -41.5 25.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 53.43 110.851 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -75.26 -62.26 1.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 61.530000000000001 111.102 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -53.7 -19.57 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 52.399999999999999 111.101 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -60.15 -68.28 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 54.420000000000002 111.1 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.721 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 19.4 t -111.07 -10.45 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 74.549999999999997 111.158 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.619 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.2 tp60 -83.65 -38.61 21.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 72.319999999999993 110.93 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.755 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -101.88 -6.32 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 72.140000000000001 111.116 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.969 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -81.26 -24.79 0.39 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.657 0.741 . . . . 71.140000000000001 111.139 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.969 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 53.8 Cg_endo -69.78 -7.15 20.33 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.661 2.24 . . . . 72.010000000000005 112.399 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.04 -21.51 15.44 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 74.430000000000007 112.483 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.68 -33.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 55.329999999999998 112.487 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.686 ' O ' ' O ' ' A' ' 49' ' ' ALA . 2.0 t -155.16 161.86 41.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 74.209999999999994 111.133 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.741 ' HB1' ' NH2' ' A' ' 80' ' ' ARG . . . -76.63 69.48 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 71.349999999999994 111.089 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.712 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -144.29 103.15 0.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.735 -0.745 . . . . 74.030000000000001 112.463 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.739 ' OE1' HG22 ' A' ' 34' ' ' VAL . 3.8 tt0 -97.55 -171.89 2.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 63.340000000000003 110.889 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.727 ' C ' HG23 ' A' ' 34' ' ' VAL . 78.0 t -133.08 120.94 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 74.030000000000001 111.098 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 14.5 tm-20 -95.88 149.8 21.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 74.140000000000001 110.89 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.2 t -135.46 113.92 11.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.114 -0.493 . . . . 51.25 111.124 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.64 161.31 37.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 64.129999999999995 110.858 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.64 119.83 31.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 71.420000000000002 111.164 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.14 -159.65 30.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.742 -0.742 . . . . 70.049999999999997 112.554 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -82.97 -23.67 33.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 51.240000000000002 110.88 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.9 -112.99 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 42.130000000000003 112.466 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -114.25 -69.19 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 44.25 111.118 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.756 ' HB1' ' CE2' ' A' ' 69' ' ' TYR . . . -110.3 157.15 19.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 73.219999999999999 111.106 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -155.08 61.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 74.329999999999998 111.123 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.756 ' CE2' ' HB1' ' A' ' 67' ' ' ALA . 1.2 m-85 -113.67 173.43 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 73.150000000000006 110.922 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -159.59 117.55 0.78 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 44.219999999999999 112.472 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.624 HG23 HG22 ' A' ' 58' ' ' VAL . 7.1 p -108.52 122.01 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.914 0.388 . . . . 54.039999999999999 111.117 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.832 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -111.86 144.21 41.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 73.409999999999997 110.917 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.712 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 t -148.22 116.75 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 63.240000000000002 111.146 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.808 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 1.3 m -173.74 -135.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 72.019999999999996 111.166 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.44 ' H ' HG22 ' A' ' 74' ' ' THR . 20.0 mtm-85 -107.61 149.29 38.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.642 0.734 . . . . 72.219999999999999 110.857 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.72 5.13 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.702 2.268 . . . . 74.219999999999999 112.341 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.36 27.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 64.530000000000001 110.903 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.8 -11.03 15.77 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.727 -0.749 . . . . 74.109999999999999 112.485 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.1 p -98.62 102.27 13.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.807 0.337 . . . . 62.200000000000003 111.104 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.808 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 1.1 ptp85 -141.34 162.46 35.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 71.430000000000007 110.912 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 23.8 t -112.85 100.02 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 52.240000000000002 111.088 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.614 ' HG3' HD12 ' A' ' 72' ' ' LEU . 1.0 OUTLIER -89.06 117.72 28.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 75.349999999999994 110.884 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.655 HG13 ' HB ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -98.28 111.42 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 64.019999999999996 111.194 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.483 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 3.3 t-160 -78.45 123.22 26.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 65.040000000000006 110.868 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.689 HD22 ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -106.84 96.48 6.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 60.329999999999998 110.888 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.656 ' H ' ' HA ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -130.1 119.48 23.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 62.310000000000002 110.891 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.652 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -66.26 -6.67 14.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 61.420000000000002 110.895 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.681 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 15.0 t0 -84.01 31.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 73.010000000000005 110.893 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.681 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 19.5 m-85 98.03 -27.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 74.319999999999993 110.875 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 79.6 mmt-85 -91.83 38.84 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 110.893 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.844 HG11 HD12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -61.54 -40.18 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.400000000000006 111.14 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.841 HD21 HG22 ' A' ' 17' ' ' THR . 3.2 mm? -116.41 30.05 7.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 74.400000000000006 110.9 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 13.5 t0 -72.47 69.58 0.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 63.520000000000003 110.862 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.655 ' HB ' HG13 ' A' ' 83' ' ' VAL . 5.5 t -79.09 161.12 26.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 73.019999999999996 111.148 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.53 128.23 8.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.638 0.732 . . . . 62.329999999999998 110.88 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 95.33 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.669 2.246 . . . . 71.400000000000006 112.371 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.601 ' HB3' ' HG3' ' A' ' 80' ' ' ARG . . . -65.04 110.18 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 63.219999999999999 111.086 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -105.85 18.42 22.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 70.230000000000004 110.839 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.62 -19.15 30.18 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 62.539999999999999 112.474 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.09 -44.39 7.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.813 0.34 . . . . 64.120000000000005 110.836 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.65 23.61 57.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.716 -0.754 . . . . 61.140000000000001 112.466 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 60.420000000000002 112.477 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.85 0.357 . . . . 74.409999999999997 110.921 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.72 ' HA ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -113.6 179.96 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 73.030000000000001 110.908 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.636 ' CB ' ' HB3' ' A' ' 67' ' ' ALA . 15.7 p-10 -117.43 -46.73 2.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 71.549999999999997 110.873 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.652 HG23 ' CG ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -133.62 165.71 34.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 70.409999999999997 111.171 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HD2' HG22 ' A' ' 14' ' ' ILE . 53.4 Cg_endo -69.74 -3.68 12.48 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.71 2.273 . . . . 63.340000000000003 112.324 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -128.98 74.62 1.59 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 74.409999999999997 111.18 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.738 ' CG2' HD22 ' A' ' 20' ' ' LEU . 59.9 p -96.69 -166.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 75.109999999999999 111.111 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 92' ' ' LEU . 18.9 tt0 -129.55 -92.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 74.239999999999995 110.867 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -72.02 7.15 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 72.010000000000005 110.869 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.899 HD21 ' CB ' ' A' ' 85' ' ' LEU . 11.2 mp -84.72 -37.56 20.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 70.430000000000007 110.923 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -82.86 4.03 27.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 74.030000000000001 110.946 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.6 -52.77 3.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 63.240000000000002 110.911 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -78.12 -31.81 50.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 72.109999999999999 110.924 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.81 -41.63 4.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 65.150000000000006 112.521 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.51 -60.75 2.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.736 0.303 . . . . 63.409999999999997 111.107 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.486 ' HG3' HG21 ' A' ' 73' ' ' VAL . 1.2 ptm -69.51 -8.4 46.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 75.510000000000005 110.842 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.775 ' HB1' ' OE1' ' A' ' 31' ' ' GLU . . . -88.94 -32.99 17.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 54.240000000000002 111.093 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -75.73 46.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 74.329999999999998 110.839 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.21 -74.62 0.49 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.125 -0.488 . . . . 74.140000000000001 110.871 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.26 16.64 5.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.691 -0.766 . . . . 45.520000000000003 112.44 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.775 ' OE1' ' HB1' ' A' ' 27' ' ' ALA . 17.0 pt-20 -54.94 168.17 0.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 63.140000000000001 110.894 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.444 ' H ' ' HB2' ' A' ' 57' ' ' GLU . 0.5 OUTLIER -130.94 -165.92 1.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 75.099999999999994 110.866 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -128.84 120.46 26.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 64.219999999999999 110.902 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.611 HG22 ' CD ' ' A' ' 57' ' ' GLU . 40.1 t -73.32 162.67 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 61.32 111.096 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.566 ' N ' HG12 ' A' ' 34' ' ' VAL . 70.7 p -91.81 -49.03 6.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 73.439999999999998 111.118 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.07 -64.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 61.219999999999999 112.491 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 150.3 68.14 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.646 2.231 . . . . 74.540000000000006 112.366 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -59.01 -30.85 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 50.439999999999998 110.876 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.39 -28.7 60.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 61.350000000000001 111.063 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 0.6 OUTLIER -78.97 -30.02 44.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 73.019999999999996 110.848 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.622 ' NE ' ' HB1' ' A' ' 97' ' ' ALA . 3.2 ptt180 -68.57 -43.13 77.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 110.842 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -74.47 -32.04 62.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 74.340000000000003 111.123 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 19.7 ptt85 -77.93 -41.54 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 72.140000000000001 110.884 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -78.18 -62.29 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 63.439999999999998 111.058 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -51.54 -21.39 2.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 111.092 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.725 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -53.81 -66.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 73.519999999999996 111.094 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.751 ' HA ' HG12 ' A' ' 50' ' ' VAL . 22.0 t -111.35 -17.04 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 75.200000000000003 111.098 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 52.3 mt-30 -79.26 -28.92 42.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 65.519999999999996 110.952 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.101 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -109.31 -10.27 14.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 55.43 111.081 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.53 -0.03 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 70.019999999999996 111.126 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.101 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.5 Cg_endo -69.76 -27.23 26.73 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.689 2.259 . . . . 72.140000000000001 112.337 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.14 -51.83 3.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 61.439999999999998 112.464 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.24 -35.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 75.540000000000006 112.46 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.803 ' O ' ' O ' ' A' ' 49' ' ' ALA . 4.4 m -143.15 147.51 35.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.769 0.318 . . . . 75.409999999999997 111.128 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.82 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -74.24 81.43 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 51.420000000000002 111.156 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.691 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -145.41 97.9 0.19 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 50.340000000000003 112.516 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.611 ' CD ' HG22 ' A' ' 34' ' ' VAL . 1.1 pt-20 -99.43 -179.47 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 55.439999999999998 110.897 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.83 HG13 HG22 ' A' ' 71' ' ' VAL . 70.3 t -115.04 139.22 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 111.142 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.577 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 19.9 tt0 -106.88 155.89 19.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 73.120000000000005 110.879 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.411 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 1.2 t -129.35 110.77 12.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 65.409999999999997 111.162 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.13 160.52 38.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 63.219999999999999 110.894 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 64.4 p -132.69 93.21 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 65.219999999999999 111.113 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.2 -139.47 2.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.75 . . . . 65.239999999999995 112.445 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.15 -0.13 56.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.392 . . . . 75.510000000000005 110.881 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -100.7 -122.83 5.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.792 -0.718 . . . . 53.149999999999999 112.5 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.876 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -122.82 -82.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.795 0.331 . . . . 74.420000000000002 111.081 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.636 ' HB3' ' CB ' ' A' ' 13' ' ' ASP . . . -100.45 90.15 4.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 71.239999999999995 111.079 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.49 79.86 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 72.120000000000005 111.091 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.711 ' HB2' HD11 ' A' ' 85' ' ' LEU . 3.1 m-85 -106.75 163.27 13.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 110.927 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -137.65 107.02 0.56 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 63.100000000000001 112.474 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.83 HG22 HG13 ' A' ' 58' ' ' VAL . 10.7 t -103.11 111.07 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.899 0.381 . . . . 43.310000000000002 111.098 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.72 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -103.45 149.45 24.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.349999999999994 110.914 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.662 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.7 p -150.42 115.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 43.420000000000002 111.103 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.766 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 1.4 m -173.43 -136.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 71.540000000000006 111.126 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.506 ' H ' HG22 ' A' ' 74' ' ' THR . 0.6 OUTLIER -104.26 145.86 31.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.597 0.713 . . . . 73.140000000000001 110.847 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.433 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.9 Cg_endo -69.74 7.88 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.695 2.264 . . . . 63.329999999999998 112.329 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.3 25.81 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 75.5 110.885 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.45 -13.22 47.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 64.140000000000001 112.499 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.575 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.6 t -97.03 102.8 14.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 72.409999999999997 111.18 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.766 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.6 OUTLIER -138.3 162.47 34.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 53.43 110.909 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 5.1 m -118.03 98.04 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 70.510000000000005 111.121 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.474 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -81.52 127.05 32.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.901 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 71' ' ' VAL . 3.9 t -91.92 116.9 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 111.141 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 2.3 t-160 -84.36 117.35 23.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 75.25 110.833 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.925 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -123.49 122.89 39.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 65.400000000000006 110.912 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 7.8 t0 -132.74 119.46 20.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 75.209999999999994 110.85 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.876 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 2.1 tmt_? -68.44 0.19 4.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.109999999999999 110.864 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.549 ' HB3' ' CE1' ' A' ' 89' ' ' PHE . 6.5 t0 -65.79 -14.17 60.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 73.230000000000004 110.848 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -176.71 -91.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 71.209999999999994 110.915 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.65 ' O ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -150.31 31.44 0.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 74.239999999999995 110.876 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.928 ' O ' HG12 ' A' ' 91' ' ' VAL . 2.0 t -71.82 81.42 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 73.219999999999999 111.16 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.706 HD13 ' C ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -120.39 18.62 12.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 64.510000000000005 110.934 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -83.09 137.67 34.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 60.140000000000001 110.882 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.0 t -92.05 165.88 12.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 111.158 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -139.12 162.83 50.02 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.677 0.751 . . . . 74.409999999999997 110.858 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 92.85 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.712 2.275 . . . . 61.130000000000003 112.343 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.622 ' HB1' ' NE ' ' A' ' 41' ' ' ARG . . . -76.23 111.19 11.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 74.019999999999996 111.059 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 101' ' ' GLY . 19.8 t0 -122.25 113.0 18.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 65.319999999999993 110.863 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -47.06 -21.54 1.02 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.732 -0.747 . . . . 72.329999999999998 112.513 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -93.74 -24.92 17.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 75.239999999999995 110.913 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 98' ' ' ASP . . . 100.4 -6.39 57.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.748 -0.739 . . . . 75.120000000000005 112.517 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.698 -0.763 . . . . 75.549999999999997 112.498 -179.878 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.779 0.323 . . . . 35.140000000000001 110.842 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -67.13 -18.02 65.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 64.040000000000006 110.974 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.658 ' HB3' HD12 ' A' ' 85' ' ' LEU . 6.3 p-10 -58.44 -100.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 62.530000000000001 110.889 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.73 HG23 ' CG ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -113.7 163.9 17.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.616 0.722 . . . . 73.209999999999994 111.132 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' A' ' 14' ' ' ILE . 53.8 Cg_endo -69.79 -2.87 10.93 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.709 2.273 . . . . 62.229999999999997 112.294 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -144.22 72.66 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 65.329999999999998 111.129 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.497 ' HB ' ' HG ' ' A' ' 92' ' ' LEU . 3.9 p -74.6 -169.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 64.5 111.11 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 3.3 mm-40 -116.78 -97.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 75.209999999999994 110.896 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.4 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -77.29 6.04 7.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 73.129999999999995 110.908 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.662 HD21 HD13 ' A' ' 85' ' ' LEU . 2.3 tp -79.97 -2.2 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.473 . . . . 53.020000000000003 110.882 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.44 ' CD2' ' O ' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -59.91 -14.26 14.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.310000000000002 110.973 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.6 49.49 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 62.240000000000002 110.835 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 24' ' ' GLY . 1.1 pt20 -64.47 82.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 54.439999999999998 110.917 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.462 ' HA2' HG21 ' A' ' 73' ' ' VAL . . . 36.5 44.26 0.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 54.109999999999999 112.544 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.94 76.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.766 0.317 . . . . 52.119999999999997 111.09 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.892 ' HG3' HG21 ' A' ' 54' ' ' THR . 0.0 OUTLIER -69.49 -16.64 63.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.200000000000003 110.899 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.488 ' HB2' HG22 ' A' ' 54' ' ' THR . . . -117.73 54.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 60.299999999999997 111.086 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.47 49.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 64.140000000000001 110.906 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 175.22 -31.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 71.25 110.828 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.47 -2.68 56.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.752 . . . . 61.219999999999999 112.479 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.35 85.74 3.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 74.450000000000003 110.909 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.89 -167.24 1.2 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 73.200000000000003 110.869 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 22.1 pt-20 -101.67 166.27 10.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 74.140000000000001 110.885 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.761 HG23 ' C ' ' A' ' 58' ' ' VAL . 2.8 t -123.25 -139.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 111.163 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.721 ' H ' HG12 ' A' ' 34' ' ' VAL . 59.0 p -138.71 -70.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 72.140000000000001 111.166 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.475 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -175.24 -59.79 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 60.329999999999998 112.475 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.4 Cg_endo -69.8 164.16 35.62 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.267 . . . . 64.430000000000007 112.318 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -72.7 -25.09 61.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 110.919 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.36 82.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 54.340000000000003 111.12 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -80.58 -34.59 35.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 74.409999999999997 110.864 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.53 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 8.3 ptt180 -72.78 -45.67 57.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 74.209999999999994 110.872 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.663 ' HB1' ' HA2' ' A' ' 99' ' ' GLY . . . -64.65 -33.07 75.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 61.25 111.084 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 13.3 ptt85 -83.41 -43.36 15.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 62.329999999999998 110.86 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -74.88 -60.84 2.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 64.310000000000002 111.125 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.584 ' O ' ' HB1' ' A' ' 55' ' ' ALA . . . -51.47 -22.92 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 52.140000000000001 111.112 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.721 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -59.15 -75.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 74.150000000000006 111.075 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.651 ' HA ' HG12 ' A' ' 50' ' ' VAL . 26.3 t -107.78 -21.73 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 72.450000000000003 111.078 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -69.99 -31.48 69.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 64.219999999999999 110.917 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.06 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.34 -0.11 22.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 73.340000000000003 111.101 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.992 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -100.05 3.14 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.627 0.727 . . . . 54.43 111.158 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.06 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.8 Cg_endo -69.7 -27.39 26.82 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.769 2.313 . . . . 74.540000000000006 112.356 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.86 -49.38 5.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 62.049999999999997 112.455 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.33 -32.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.797 -0.715 . . . . 55.439999999999998 112.534 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.892 HG21 ' HG3' ' A' ' 26' ' ' MET . 11.8 t -141.91 149.83 40.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 72.129999999999995 111.182 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.861 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -74.99 78.83 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 24.539999999999999 111.121 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.603 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -144.86 101.17 0.24 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 72.129999999999995 112.5 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.691 ' H ' HD23 ' A' ' 72' ' ' LEU . 4.3 tt0 -95.4 -173.09 2.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 64.420000000000002 110.909 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.761 ' C ' HG23 ' A' ' 34' ' ' VAL . 20.2 t -135.5 116.69 19.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 63.229999999999997 111.139 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.593 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -94.89 150.84 19.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 61.43 110.829 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 69' ' ' TYR . 1.8 t -136.67 107.34 6.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 74.209999999999994 111.126 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 2.1 tt0 -129.39 167.76 17.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 74.510000000000005 110.911 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.74 120.51 34.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 64.340000000000003 111.139 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.2 -168.55 30.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 72.219999999999999 112.514 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -59.82 -23.45 63.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.907 0.384 . . . . 71.109999999999999 110.906 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.86 -118.2 1.56 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.777 -0.725 . . . . 72.340000000000003 112.495 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.47 -71.22 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.809 0.338 . . . . 62.340000000000003 111.13 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.728 ' HB3' ' H ' ' A' ' 87' ' ' ARG . . . -89.3 134.88 33.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 62.240000000000002 111.078 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -150.8 62.53 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 72.200000000000003 111.115 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.593 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -111.98 162.64 15.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 73.319999999999993 110.925 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.672 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -144.98 118.99 1.17 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.718 -0.754 . . . . 62.240000000000002 112.49 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.693 HG23 HG22 ' A' ' 58' ' ' VAL . 8.8 p -103.02 119.86 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.371 . . . . 62.210000000000001 111.111 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.955 HD22 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -104.27 142.65 34.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 54.210000000000001 110.902 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.603 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 2.8 t -150.8 117.01 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 72.230000000000004 111.158 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.762 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 2.2 m -169.14 -137.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 73.200000000000003 111.123 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.629 ' H ' HG22 ' A' ' 74' ' ' THR . 55.8 mtm180 -98.61 150.01 36.29 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.585 0.707 . . . . 74.200000000000003 110.888 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.573 ' CG ' HG21 ' A' ' 50' ' ' VAL . 53.7 Cg_endo -69.79 5.83 1.56 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.672 2.248 . . . . 61.240000000000002 112.336 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.57 29.4 0.31 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 71.040000000000006 110.901 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.24 -9.98 11.87 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.763 -0.732 . . . . 71.340000000000003 112.48 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.581 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.9 p -98.38 109.49 22.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 73.019999999999996 111.174 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.762 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -137.94 160.93 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 73.439999999999998 110.878 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.709 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 12.5 m -110.94 101.8 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 63.340000000000003 111.108 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.773 ' HB2' HD12 ' A' ' 72' ' ' LEU . 8.2 tm-20 -82.86 122.92 28.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 64.439999999999998 110.908 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 2.3 t -96.26 109.36 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 65.040000000000006 111.115 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 93' ' ' ASP . 4.2 p-80 -79.57 121.09 24.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 63.43 110.899 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.806 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -120.17 116.85 26.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 64.120000000000005 110.908 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.721 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 25.9 t0 -127.3 114.2 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 61.539999999999999 110.886 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.73 ' CG ' HG23 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -68.73 1.74 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 62.520000000000003 110.897 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.448 ' C ' ' CG ' ' A' ' 89' ' ' PHE . 52.1 t0 -70.31 -12.36 61.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 70.400000000000006 110.86 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.448 ' CG ' ' C ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -172.62 -94.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 70.230000000000004 110.853 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.633 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -150.59 30.7 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 74.239999999999995 110.875 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.974 ' O ' HG12 ' A' ' 91' ' ' VAL . 1.9 t -77.58 77.16 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 71.140000000000001 111.145 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.782 HD13 ' C ' ' A' ' 91' ' ' VAL . 0.3 OUTLIER -120.19 18.05 12.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 73.319999999999993 110.952 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 84' ' ' HIS . 1.1 m-20 -80.95 167.5 19.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 71.519999999999996 110.875 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.691 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 5.9 t -121.19 169.43 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 111.198 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -143.73 110.7 5.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.575 0.703 . . . . 74.400000000000006 110.894 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.61 ' HB3' HG12 ' A' ' 81' ' ' VAL . 54.3 Cg_endo -69.71 103.78 1.21 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.68 2.253 . . . . 61.399999999999999 112.4 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.448 ' HB3' HH22 ' A' ' 80' ' ' ARG . . . -116.33 -178.88 3.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 62.340000000000003 111.092 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.54 -156.62 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 74.239999999999995 110.845 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.663 ' HA2' ' HB1' ' A' ' 42' ' ' ALA . . . -65.16 -14.97 60.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 41.350000000000001 112.492 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.39 -53.09 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 64.030000000000001 110.847 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.54 28.89 4.39 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 72.200000000000003 112.48 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 72.310000000000002 112.512 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.832 0.349 . . . . 75.310000000000002 110.863 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -66.84 -52.16 46.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 73.120000000000005 110.906 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.85 ' H ' HD21 ' A' ' 85' ' ' LEU . 75.0 m-20 -58.22 -97.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 71.319999999999993 110.876 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.947 ' HB ' HG11 ' A' ' 91' ' ' VAL . 30.2 mt -101.72 105.28 40.23 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.617 0.722 . . . . 74.540000000000006 111.163 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 21.72 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 72.040000000000006 112.328 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.64 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.8 m -124.21 17.11 9.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 74.310000000000002 111.128 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.635 HG22 HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -76.2 -160.75 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 74.430000000000007 111.164 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -61.25 -109.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 70.239999999999995 110.899 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -97.21 11.3 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 75.120000000000005 110.893 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.605 HD22 ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -61.9 -34.65 76.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 65.519999999999996 110.915 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -86.34 7.83 23.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 73.519999999999996 110.951 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -108.5 -37.36 5.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 71.310000000000002 110.871 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.563 ' OE1' HG11 ' A' ' 73' ' ' VAL . 71.8 mm-40 -67.46 -45.53 75.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 53.420000000000002 110.921 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.625 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -43.91 -30.71 1.75 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 73.420000000000002 112.478 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.64 -72.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.754 0.312 . . . . 72.120000000000005 111.091 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.6 ptp -63.52 -3.69 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 72.439999999999998 110.881 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 24' ' ' GLY . . . -64.76 -26.79 68.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 64.120000000000005 111.129 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.454 ' C ' ' HD1' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -82.81 8.43 12.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 73.109999999999999 110.888 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -89.87 -78.35 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.139 -0.482 . . . . 63.210000000000001 110.832 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.13 -5.04 2.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 62.020000000000003 112.508 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' CG ' ' HA ' ' A' ' 27' ' ' ALA . 23.1 mt-10 -62.18 105.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 63.310000000000002 110.892 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -161.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 62.109999999999999 110.853 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -118.46 116.56 26.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 72.019999999999996 110.899 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.663 HG12 ' H ' ' A' ' 35' ' ' THR . 4.2 t -72.21 171.36 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 73.310000000000002 111.131 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.663 ' H ' HG12 ' A' ' 34' ' ' VAL . 71.9 p -91.97 -41.51 10.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 60.520000000000003 111.148 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 164.52 -62.95 0.24 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.718 -0.753 . . . . 63.450000000000003 112.479 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.428 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 54.2 Cg_endo -69.69 156.15 64.3 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.683 2.255 . . . . 75.239999999999995 112.377 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -60.82 -27.52 68.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 63.310000000000002 110.834 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.27 68.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 73.109999999999999 111.086 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.44 -32.81 23.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 64.319999999999993 110.841 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.599 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -69.99 -44.07 70.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 72.0 110.865 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.705 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.79 -35.01 72.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 73.140000000000001 111.106 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -79.41 -41.4 27.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 73.239999999999995 110.923 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.574 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -77.22 -61.71 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 62.229999999999997 111.097 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.655 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -53.05 -21.73 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 44.240000000000002 111.093 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.756 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -54.27 -71.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 72.430000000000007 111.093 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.772 ' HA ' HG12 ' A' ' 50' ' ' VAL . 21.5 t -111.9 -12.79 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 111.129 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.574 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.8 tp60 -80.5 -34.11 35.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.140000000000001 110.892 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.037 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.97 -5.66 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 62.229999999999997 111.119 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.32 -5.69 0.11 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.731 . . . . 65.209999999999994 111.112 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.037 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.7 Cg_endo -69.79 -26.57 27.29 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 72.120000000000005 112.356 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.37 -57.46 2.62 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.687 -0.768 . . . . 60.119999999999997 112.502 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.65 -34.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.723 -0.751 . . . . 55.439999999999998 112.496 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.716 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.4 m -149.1 151.47 34.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.777 0.322 . . . . 55.520000000000003 111.173 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.841 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.22 79.23 0.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 111.126 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.764 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -144.78 102.54 0.27 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 71.530000000000001 112.505 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.623 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.5 tt0 -95.46 -177.77 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 75.109999999999999 110.86 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.677 HG22 HG23 ' A' ' 71' ' ' VAL . 95.3 t -131.03 117.0 35.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 72.129999999999995 111.123 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.643 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 1.4 pp20? -95.57 129.91 42.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 71.0 110.911 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 t -100.38 118.29 36.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.479 . . . . 75.040000000000006 111.179 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.608 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -134.93 101.7 4.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 63.409999999999997 110.896 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.2 p -93.97 127.07 39.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 71.400000000000006 111.141 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.0 -154.98 10.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 75.019999999999996 112.499 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -87.77 -0.3 56.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.883 0.373 . . . . 71.010000000000005 110.877 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.98 -96.95 2.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.76 -0.733 . . . . 31.120000000000001 112.464 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.45 -136.07 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 74.450000000000003 111.112 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.656 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . . . -113.15 93.46 4.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 52.549999999999997 111.087 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.709 ' HB1' ' NE2' ' A' ' 84' ' ' HIS . . . -79.76 95.31 5.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 71.439999999999998 111.091 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.535 ' CE1' ' HB1' ' A' ' 67' ' ' ALA . 9.3 m-85 -116.66 115.75 26.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.209999999999994 110.897 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 84' ' ' HIS . . . -98.88 109.62 3.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 75.540000000000006 112.482 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.677 HG23 HG22 ' A' ' 58' ' ' VAL . 4.6 p -104.19 109.75 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 71.25 111.177 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.814 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -97.74 142.43 29.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 65.109999999999999 110.889 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.656 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.8 p -150.39 120.78 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 71.409999999999997 111.083 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.772 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 2.8 m -171.36 -130.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 62.130000000000003 111.139 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.499 ' H ' HG22 ' A' ' 74' ' ' THR . 2.1 mtt-85 -107.0 145.73 31.71 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.718 . . . . 72.420000000000002 110.83 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.73 13.36 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.653 2.235 . . . . 44.409999999999997 112.392 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 75' ' ' ARG . 3.9 m-20 -89.91 25.65 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.872 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.17 -12.52 43.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 74.099999999999994 112.488 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.547 ' O ' ' HB ' ' A' ' 74' ' ' THR . 24.7 p -97.45 105.25 17.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 51.140000000000001 111.145 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.772 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 1.3 ptp85 -139.57 162.27 35.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 74.120000000000005 110.931 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 42.8 t -115.09 100.5 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 65.230000000000004 111.177 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.524 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 5.4 tm-20 -84.51 115.91 22.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 73.540000000000006 110.877 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -102.53 105.44 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 73.099999999999994 111.147 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.709 ' NE2' ' HB1' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -83.76 124.74 31.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 74.219999999999999 110.893 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.85 HD21 ' H ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -111.39 111.76 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 74.230000000000004 110.946 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.601 ' N ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -126.42 114.98 18.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 74.409999999999997 110.907 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.803 ' HA ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -72.94 -0.25 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 73.120000000000005 110.844 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -74.04 -19.38 60.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 70.200000000000003 110.849 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 90' ' ' ARG . 3.9 p90 169.8 -36.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.109999999999999 110.906 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HB3' ' CB ' ' A' ' 93' ' ' ASP . 1.9 mmm180 -117.87 68.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 55.210000000000001 110.874 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.947 HG11 ' HB ' ' A' ' 14' ' ' ILE . 1.5 t -61.31 -14.23 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 73.319999999999993 111.147 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.635 HD12 HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -124.8 32.14 5.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 63.020000000000003 110.926 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 0.8 OUTLIER -65.75 80.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 65.0 110.879 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 10.1 t -79.76 153.51 29.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 111.088 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -148.76 129.76 7.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.678 0.751 . . . . 73.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 125.4 12.13 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.723 2.282 . . . . 75.400000000000006 112.37 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.539 ' HB2' HH11 ' A' ' 41' ' ' ARG . . . -115.26 108.93 17.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 72.400000000000006 111.09 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -103.99 20.79 17.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 73.310000000000002 110.854 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.12 -19.22 31.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.74 . . . . 61.340000000000003 112.466 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -94.66 -43.47 8.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 60.340000000000003 110.85 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.55 28.03 52.99 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 74.200000000000003 112.478 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 64.349999999999994 112.44 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.432 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 4.9 p-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.806 0.336 . . . . 62.340000000000003 110.873 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -67.66 -19.28 65.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.933 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.99 -161.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 73.109999999999999 110.905 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.709 HD13 ' HG3' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -117.42 156.92 48.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.6 0.715 . . . . 54.43 111.135 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.561 ' HD2' HG13 ' A' ' 14' ' ' ILE . 53.8 Cg_endo -69.72 45.38 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.676 2.251 . . . . 50.149999999999999 112.37 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -151.26 17.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 72.109999999999999 111.12 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.663 ' HB ' HD22 ' A' ' 20' ' ' LEU . 43.9 p -75.4 -167.41 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 73.310000000000002 111.139 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.662 ' HG2' HD23 ' A' ' 92' ' ' LEU . 2.9 mm-40 -116.0 -95.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 73.319999999999993 110.921 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -89.69 8.53 31.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 65.129999999999995 110.881 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -75.29 -10.97 59.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.25 110.912 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -76.36 -23.63 54.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.882 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -74.1 -34.58 64.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 110.888 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.528 ' HG3' HG21 ' A' ' 83' ' ' VAL . 19.6 mm-40 -66.37 -49.58 66.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 71.409999999999997 110.9 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -44.54 -30.43 2.13 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.71 -0.757 . . . . 72.129999999999995 112.496 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.28 -62.54 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.767 0.317 . . . . 70.510000000000005 111.052 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 35.1 tpp -67.09 -13.49 61.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 75.319999999999993 110.871 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 24' ' ' GLY . . . -67.07 -22.38 65.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 73.120000000000005 111.114 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -85.78 10.81 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 71.439999999999998 110.862 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.01 -75.67 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 65.230000000000004 110.909 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.08 13.66 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.704 -0.76 . . . . 64.439999999999998 112.491 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.581 ' HB3' HG23 ' A' ' 58' ' ' VAL . 20.9 mt-10 -59.59 104.57 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 65.239999999999995 110.881 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.93 -164.47 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 74.010000000000005 110.9 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.23 121.6 43.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 63.5 110.862 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.78 HG12 ' H ' ' A' ' 35' ' ' THR . 2.6 t -82.6 178.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 73.120000000000005 111.121 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.78 ' H ' HG12 ' A' ' 34' ' ' VAL . 71.0 p -94.35 -59.94 1.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 75.230000000000004 111.215 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.0 -64.6 0.1 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.733 . . . . 71.349999999999994 112.5 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 164.85 32.96 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 63.399999999999999 112.415 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -70.43 -26.07 63.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 64.150000000000006 110.865 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.73 -46.45 77.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 34.100000000000001 111.081 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -41.61 25.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 110.879 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.549 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -59.99 -37.93 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 75.040000000000006 110.882 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -62.9 -33.3 75.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 63.340000000000003 111.116 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.527 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 1.3 ptt-85 -78.66 -40.12 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 74.519999999999996 110.84 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.704 ' HB1' ' OE2' ' A' ' 57' ' ' GLU . . . -77.83 -59.32 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 75.140000000000001 111.154 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.748 ' HB2' HD23 ' A' ' 72' ' ' LEU . . . -54.64 -20.81 8.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 71.109999999999999 111.123 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -62.0 -81.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 75.120000000000005 111.089 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.784 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 58.4 t -108.8 -19.87 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 72.450000000000003 111.116 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 1.3 tp60 -69.33 -33.15 72.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 65.409999999999997 110.919 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.037 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.64 1.88 25.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 72.340000000000003 111.07 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.991 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.74 -7.17 0.12 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.637 0.732 . . . . 73.340000000000003 111.103 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.037 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.6 Cg_endo -69.75 -26.11 27.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.671 2.247 . . . . 65.310000000000002 112.327 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.71 -61.41 2.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.725 -0.75 . . . . 53.020000000000003 112.498 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -156.31 -33.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 65.040000000000006 112.473 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.724 HG22 ' O ' ' A' ' 74' ' ' THR . 0.3 OUTLIER -148.01 159.78 43.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 42.329999999999998 111.181 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.763 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.09 70.98 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 60.109999999999999 111.099 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.807 ' HA3' ' HA ' ' A' ' 73' ' ' VAL . . . -149.68 112.72 0.57 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 61.229999999999997 112.475 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.772 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.2 tt0 -98.49 -169.73 1.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.846 0.355 . . . . 73.019999999999996 110.89 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.761 ' C ' HG23 ' A' ' 34' ' ' VAL . 40.7 t -133.42 120.84 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 53.030000000000001 111.142 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.786 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 11.2 tm-20 -90.3 158.47 17.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.439999999999998 110.875 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 t -137.97 111.22 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 72.230000000000004 111.151 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.2 169.6 17.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 72.150000000000006 110.907 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.427 ' C ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -117.54 149.78 40.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 73.239999999999995 111.125 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.69 -154.29 8.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.758 -0.734 . . . . 74.340000000000003 112.53 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -78.44 -23.99 46.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.383 . . . . 63.140000000000001 110.935 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.79 -114.06 2.86 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.713 -0.756 . . . . 64.209999999999994 112.538 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -113.98 -78.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 64.420000000000002 111.093 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.658 ' O ' ' CG ' ' A' ' 86' ' ' ASP . . . -87.99 139.95 29.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 62.509999999999998 111.067 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -154.65 73.36 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 65.230000000000004 111.107 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.789 ' OH ' HD22 ' A' ' 85' ' ' LEU . 11.5 p90 -132.41 -172.16 2.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 75.040000000000006 110.918 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -153.96 129.12 2.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.727 -0.749 . . . . 33.420000000000002 112.474 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.417 ' O ' HG23 ' A' ' 83' ' ' VAL . 2.1 p -107.35 120.01 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 60.539999999999999 111.141 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.92 HD22 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -98.18 139.14 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 73.010000000000005 110.888 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.807 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 3.0 m -147.34 111.42 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 62.340000000000003 111.137 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.803 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.2 m -167.38 -137.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 42.340000000000003 111.112 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.631 ' H ' HG22 ' A' ' 74' ' ' THR . 10.7 mtm180 -108.28 153.88 41.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.59 0.709 . . . . 74.510000000000005 110.888 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.421 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.72 2.17 3.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.72 2.28 . . . . 65.109999999999999 112.372 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -85.94 45.94 1.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 52.020000000000003 110.877 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.95 -6.02 7.19 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 62.329999999999998 112.491 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.803 ' O ' ' HB ' ' A' ' 74' ' ' THR . 72.2 p -91.83 123.79 35.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 51.310000000000002 111.121 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.771 ' NE ' ' HB1' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -146.2 143.89 29.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 72.099999999999994 110.889 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.603 HG23 ' HG1' ' A' ' 74' ' ' THR . 87.1 t -110.87 84.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 72.109999999999999 111.114 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.623 ' HB2' HD12 ' A' ' 72' ' ' LEU . 2.4 tm-20 -77.52 118.0 19.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 72.209999999999994 110.899 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.623 ' O ' ' HA2' ' A' ' 70' ' ' GLY . 2.4 t -95.44 136.28 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 75.420000000000002 111.147 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.521 ' C ' HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -87.86 117.42 26.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 75.519999999999996 110.878 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.789 HD22 ' OH ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -124.75 111.88 16.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 75.049999999999997 110.945 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.878 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.6 t70 -138.75 120.94 15.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 64.310000000000002 110.831 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.709 ' HG3' HD13 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -55.81 1.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 72.129999999999995 110.854 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.611 ' H ' ' C ' ' A' ' 86' ' ' ASP . 49.8 t0 -65.83 -6.49 12.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 70.329999999999998 110.847 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 70.43 19.32 6.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 73.420000000000002 110.918 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.68 -0.03 1.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 54.119999999999997 110.846 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.878 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 89.2 t -120.94 70.02 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 70.340000000000003 111.128 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.662 HD23 ' HG2' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -124.55 14.36 8.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 71.409999999999997 110.935 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.407 ' O ' HG12 ' A' ' 83' ' ' VAL . 8.4 m-20 -94.69 -172.6 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 74.099999999999994 110.881 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.7 t -116.43 174.34 6.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 71.420000000000002 111.147 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 82' ' ' GLU . 2.6 tp10 -141.1 119.28 7.98 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.729 . . . . 74.340000000000003 110.908 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 115.64 4.19 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.653 2.236 . . . . 74.340000000000003 112.341 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.771 ' HB1' ' NE ' ' A' ' 80' ' ' ARG . . . -116.7 112.8 21.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 71.109999999999999 111.144 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -128.93 56.8 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 71.200000000000003 110.864 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.28 -17.95 2.91 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.761 -0.733 . . . . 71.239999999999995 112.517 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.25 -61.35 1.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 74.5 110.849 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.44 18.1 65.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 52.219999999999999 112.519 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 61.310000000000002 112.508 -179.906 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.832 0.348 . . . . 73.239999999999995 110.888 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -67.01 -42.5 84.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 74.329999999999998 110.935 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.67 ' OD1' ' HB3' ' A' ' 67' ' ' ALA . 13.0 t0 -66.31 -143.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 53.439999999999998 110.866 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.829 HG22 ' H ' ' A' ' 16' ' ' THR . 19.7 mm -75.32 114.07 31.98 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.613 0.72 . . . . 75.510000000000005 111.087 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 16.64 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.652 2.235 . . . . 71.420000000000002 112.366 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.829 ' H ' HG22 ' A' ' 14' ' ' ILE . 2.8 m -134.76 23.52 3.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 71.209999999999994 111.096 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.866 HG21 HG22 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -75.66 -145.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 75.420000000000002 111.127 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 17' ' ' THR . 59.5 mt-10 -84.65 -104.23 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 70.129999999999995 110.877 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.62 6.19 45.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 73.049999999999997 110.878 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 85' ' ' LEU . 7.7 mp -65.33 -34.87 79.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 75.310000000000002 110.923 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -83.26 3.73 30.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.972 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -105.6 -36.32 7.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 72.519999999999996 110.885 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -66.68 -49.01 67.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.477 . . . . 75.230000000000004 110.877 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -43.27 -33.09 1.88 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 64.450000000000003 112.507 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.37 -56.49 19.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.768 0.318 . . . . 64.430000000000007 111.05 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.651 ' SD ' HG11 ' A' ' 73' ' ' VAL . 19.6 ptp -70.18 -7.96 46.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 75.129999999999995 110.905 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.687 ' HB1' ' OE1' ' A' ' 31' ' ' GLU . . . -79.62 -17.49 53.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 43.240000000000002 111.096 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -82.43 9.74 8.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.898 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -93.69 -79.21 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 64.129999999999995 110.87 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.05 7.88 5.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 44.119999999999997 112.484 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.76 ' HG3' HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -61.92 152.4 32.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 73.239999999999995 110.891 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.518 ' N ' ' HG2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -116.47 -165.1 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 73.129999999999995 110.836 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -114.16 116.77 29.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 71.209999999999994 110.876 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 35' ' ' THR . 10.2 t -74.9 167.39 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 65.219999999999999 111.131 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.569 ' N ' HG12 ' A' ' 34' ' ' VAL . 65.7 p -94.67 -44.3 7.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 111.126 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 164.98 -61.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.727 . . . . 50.210000000000001 112.489 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.9 Cg_endo -69.71 159.73 52.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 74.209999999999994 112.357 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.601 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 1.2 t70 -65.06 -27.18 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 72.319999999999993 110.859 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -36.41 73.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 71.239999999999995 111.062 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -85.21 -37.34 20.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 71.420000000000002 110.863 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.601 ' NE ' ' HA ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -70.01 -45.57 66.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 71.120000000000005 110.859 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.669 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -68.74 -36.03 77.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 72.209999999999994 111.1 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 10.5 ptt180 -79.51 -41.47 27.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.349999999999994 110.858 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -74.7 -62.3 1.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 64.239999999999995 111.075 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.619 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -53.79 -19.64 4.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 60.439999999999998 111.097 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.693 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -55.43 -67.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 71.319999999999993 111.112 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.758 ' HA ' HG12 ' A' ' 50' ' ' VAL . 3.5 p -112.7 -18.48 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 74.329999999999998 111.159 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 17.1 mt-30 -77.67 -29.14 51.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 51.420000000000002 110.938 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.071 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.86 -7.81 15.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 72.319999999999993 111.131 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.988 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.46 -0.51 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.606 0.717 . . . . 70.140000000000001 111.149 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.071 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.2 Cg_endo -69.77 -29.1 24.37 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.654 2.236 . . . . 75.530000000000001 112.304 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.43 -52.27 4.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.736 -0.745 . . . . 60.210000000000001 112.479 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.1 -34.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 74.129999999999995 112.488 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.746 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -144.4 149.47 36.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 62.119999999999997 111.137 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.837 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -73.3 81.17 1.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 60.149999999999999 111.085 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.72 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -143.12 99.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 51.009999999999998 112.45 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.591 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.6 tt0 -90.66 179.97 5.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 74.019999999999996 110.925 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.76 HG23 ' HG3' ' A' ' 31' ' ' GLU . 69.3 t -130.81 121.97 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 51.219999999999999 111.153 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.465 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 11.8 tm-20 -93.39 153.56 18.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 75.409999999999997 110.91 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.436 ' HA ' ' CD2' ' A' ' 69' ' ' TYR . 1.5 t -132.98 112.34 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 63.299999999999997 111.094 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -140.91 162.91 34.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 65.200000000000003 110.854 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.92 120.07 34.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 71.329999999999998 111.134 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.41 -169.03 32.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 74.120000000000005 112.452 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.69 -23.12 49.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 75.040000000000006 110.908 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.52 -109.23 0.36 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.756 -0.735 . . . . 74.219999999999999 112.515 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.09 -74.43 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 55.32 111.122 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.67 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . . . -111.14 162.01 15.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 111.12 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -156.24 72.06 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 43.439999999999998 111.138 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.644 ' O ' HD12 ' A' ' 85' ' ' LEU . 4.2 m-85 -110.53 163.65 13.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 60.149999999999999 110.915 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.09 100.07 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.753 . . . . 74.0 112.479 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.499 HG23 HG22 ' A' ' 58' ' ' VAL . 5.3 p -101.18 119.37 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 72.430000000000007 111.151 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.833 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -113.26 144.63 42.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 72.400000000000006 110.934 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.651 HG11 ' SD ' ' A' ' 26' ' ' MET . 10.8 t -149.38 123.37 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.430000000000007 111.118 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.772 ' OG1' ' HA ' ' A' ' 80' ' ' ARG . 1.9 m -172.2 -135.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 71.530000000000001 111.127 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.547 ' H ' HG22 ' A' ' 74' ' ' THR . 27.0 mtm-85 -96.02 145.93 30.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.576 0.703 . . . . 75.340000000000003 110.866 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.587 ' CG ' HG21 ' A' ' 50' ' ' VAL . 53.2 Cg_endo -69.75 10.64 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.698 2.265 . . . . 54.130000000000003 112.339 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 75' ' ' ARG . 7.6 m-20 -88.59 25.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.510000000000005 110.854 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.24 -9.76 24.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 41.119999999999997 112.521 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 79' ' ' THR . 2.5 t -97.58 102.54 14.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 65.329999999999998 111.154 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.772 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -142.2 172.39 12.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 73.0 110.9 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 27.9 t -119.93 113.03 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 72.310000000000002 111.138 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.539 ' HA ' ' HB3' ' A' ' 72' ' ' LEU . 2.1 pt-20 -88.34 122.26 31.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.902 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.582 ' CG1' HD11 ' A' ' 20' ' ' LEU . 2.1 t -100.96 117.01 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 71.329999999999998 111.153 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.508 ' O ' ' O ' ' A' ' 91' ' ' VAL . 2.9 t-80 -82.02 116.2 21.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 73.340000000000003 110.846 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.768 ' HB3' HD23 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -104.03 98.09 7.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 74.230000000000004 110.937 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 1.03 ' H ' ' HA ' ' A' ' 91' ' ' VAL . 3.3 p30 -134.84 119.25 17.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 74.349999999999994 110.845 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.436 ' HG3' HD11 ' A' ' 14' ' ' ILE . 1.3 tmt_? -65.35 10.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 75.519999999999996 110.868 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.626 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 19.3 t0 -80.03 20.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 110.86 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.626 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 15.3 m-85 91.5 -17.8 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 73.409999999999997 110.908 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 38.23 3.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 62.329999999999998 110.895 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.03 ' HA ' ' H ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -64.35 -6.8 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 75.540000000000006 111.125 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.702 HD22 HG13 ' A' ' 91' ' ' VAL . 3.1 mm? -113.08 28.48 8.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 75.340000000000003 110.965 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -80.04 75.08 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 71.310000000000002 110.891 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.8 t -86.02 151.36 23.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 54.329999999999998 111.122 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.18 110.45 4.0 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.631 0.729 . . . . 73.099999999999994 110.884 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 120.22 7.04 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.686 2.257 . . . . 72.209999999999994 112.369 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.577 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . . . -116.81 167.47 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 63.340000000000003 111.081 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.49 7.71 7.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 65.219999999999999 110.859 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.432 ' HA2' ' CB ' ' A' ' 42' ' ' ALA . . . 86.1 -18.68 30.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 34.039999999999999 112.476 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.21 -16.55 22.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 74.200000000000003 110.859 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.53 -24.16 63.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 75.439999999999998 112.472 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 51.439999999999998 112.53 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.1 t0 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.834 0.349 . . . . 64.329999999999998 110.843 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -68.34 -43.89 76.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.904 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -60.74 -167.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.874 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.876 HG22 ' H ' ' A' ' 16' ' ' THR . 46.6 mm -76.69 122.07 85.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.62 0.724 . . . . 65.239999999999995 111.119 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 9.27 0.6 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.697 2.265 . . . . 74.349999999999994 112.3 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.876 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -125.52 36.69 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 62.450000000000003 111.133 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.902 HG22 HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -91.6 -166.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 62.450000000000003 111.176 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -64.42 -103.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 75.409999999999997 110.904 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.77 7.69 45.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.239999999999995 110.892 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.849 ' HG ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.02 -14.35 53.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 72.340000000000003 110.911 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -94.4 5.66 51.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 64.120000000000005 110.946 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -108.44 -43.36 4.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 72.319999999999993 110.905 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.664 ' HG3' HG21 ' A' ' 83' ' ' VAL . 4.4 mm100 -64.64 -53.04 53.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 73.340000000000003 110.9 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.54 -54.32 7.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.774 -0.726 . . . . 74.420000000000002 112.455 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.18 49.0 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.762 0.315 . . . . 63.340000000000003 111.124 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.2 ptm -66.47 -40.83 89.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 65.340000000000003 110.885 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' HB1' ' CE1' ' A' ' 28' ' ' PHE . . . -122.54 -92.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 62.43 111.055 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.483 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -145.12 -35.14 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 71.439999999999998 110.884 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.26 30.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.230000000000004 110.831 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.98 7.63 65.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 63.310000000000002 112.512 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' HB3' HG23 ' A' ' 58' ' ' VAL . 2.0 mm-40 -74.22 161.99 29.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 72.329999999999998 110.854 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.66 -166.03 1.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 70.230000000000004 110.837 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.13 118.94 22.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 72.109999999999999 110.91 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.67 HG22 ' OE2' ' A' ' 57' ' ' GLU . 87.6 t -71.36 155.76 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 54.450000000000003 111.119 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.471 ' N ' HG12 ' A' ' 34' ' ' VAL . 16.6 p -107.82 -22.04 12.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 72.150000000000006 111.211 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 34' ' ' VAL . . . -153.48 -139.71 2.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 41.32 112.455 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -162.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.722 2.282 . . . . 74.409999999999997 112.31 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.35 -27.42 64.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 64.409999999999997 110.896 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.81 -39.13 70.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 75.329999999999998 111.105 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -82.45 -37.58 25.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 54.409999999999997 110.874 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.581 ' HG3' ' HD3' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -68.53 -38.34 80.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.430000000000007 110.893 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 80' ' ' ARG . . . -63.47 -33.08 74.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 74.329999999999998 111.168 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.497 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 2.7 ptt85 -77.61 -40.45 42.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 54.329999999999998 110.909 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.772 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . . . -77.9 -57.53 3.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 73.319999999999993 111.105 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -52.78 -18.11 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 64.530000000000001 111.085 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.504 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -63.75 -78.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.530000000000001 111.096 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.739 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 80.5 t -111.91 -20.07 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 63.240000000000002 111.134 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 16.6 mt-30 -72.01 -26.62 62.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.94 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.106 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -109.09 -4.99 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 72.030000000000001 111.135 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.999 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.78 0.59 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.615 0.722 . . . . 64.409999999999997 111.123 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.106 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.0 Cg_endo -69.79 -26.47 27.41 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 55.420000000000002 112.33 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.36 -54.58 2.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 72.450000000000003 112.47 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.74 -31.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 41.109999999999999 112.512 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.737 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -140.51 146.14 37.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 65.200000000000003 111.17 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.772 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -74.68 74.87 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 63.509999999999998 111.116 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.725 ' HA3' ' HA ' ' A' ' 73' ' ' VAL . . . -153.45 109.34 0.4 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 73.129999999999995 112.483 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.867 ' HB3' ' HB2' ' A' ' 49' ' ' ALA . 2.3 pt-20 -100.91 -161.21 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 64.209999999999994 110.896 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 31' ' ' GLU . 60.0 t -128.84 142.88 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 72.409999999999997 111.096 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 1.0 OUTLIER -108.82 153.5 23.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 74.200000000000003 110.886 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.86 105.56 7.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 74.530000000000001 111.117 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -136.85 165.76 25.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 73.019999999999996 110.878 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -124.28 115.42 21.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 61.32 111.124 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.04 -151.31 14.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.731 -0.747 . . . . 43.43 112.518 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -78.38 -23.43 46.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.364 . . . . 73.25 110.88 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.86 -120.41 0.22 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 71.329999999999998 112.489 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -122.65 -76.95 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 62.310000000000002 111.117 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.852 ' HB1' ' CE2' ' A' ' 69' ' ' TYR . . . -102.9 92.53 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 43.409999999999997 111.082 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -84.55 72.98 10.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 71.420000000000002 111.085 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.852 ' CE2' ' HB1' ' A' ' 67' ' ' ALA . 6.8 m-85 -106.76 165.62 11.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.319999999999993 110.904 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -146.89 111.68 0.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 50.539999999999999 112.518 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 83' ' ' VAL . 7.2 p -102.66 117.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.362 . . . . 73.430000000000007 111.111 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.938 HD22 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -104.14 145.45 30.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 73.329999999999998 110.962 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.725 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 18.1 m -151.23 118.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 75.129999999999995 111.14 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.794 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.3 m -165.87 -136.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.340000000000003 111.153 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.613 ' H ' HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -102.68 149.85 37.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 73.319999999999993 110.858 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.53 ' CG ' HG21 ' A' ' 50' ' ' VAL . 53.3 Cg_endo -69.77 6.01 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.63 2.22 . . . . 64.239999999999995 112.359 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -85.91 35.34 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 72.329999999999998 110.837 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.41 -8.68 52.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 51.009999999999998 112.478 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.794 ' O ' ' HB ' ' A' ' 74' ' ' THR . 3.2 t -92.34 125.43 37.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 75.409999999999997 111.126 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -144.24 144.35 31.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 73.510000000000005 110.891 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.807 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 87.9 t -104.81 88.97 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 72.319999999999993 111.132 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.44 ' HB3' ' HD3' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -71.53 122.78 21.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 65.5 110.887 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.664 HG21 ' HG3' ' A' ' 23' ' ' GLN . 16.3 t -102.29 139.26 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 52.210000000000001 111.161 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 1.043 ' C ' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -89.43 115.14 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 64.040000000000006 110.883 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.043 HD13 ' C ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -125.62 105.63 9.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 73.310000000000002 110.937 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.798 ' CG ' HG11 ' A' ' 91' ' ' VAL . 4.3 m-20 -135.12 129.06 33.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 73.219999999999999 110.879 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -58.48 6.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 64.420000000000002 110.893 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.621 ' H ' ' C ' ' A' ' 86' ' ' ASP . 3.8 t0 -64.89 -5.84 6.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 110.88 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 70.71 13.17 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 110.903 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 2.73 1.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 72.540000000000006 110.909 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.798 HG11 ' CG ' ' A' ' 86' ' ' ASP . 69.0 t -119.13 81.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 52.240000000000002 111.069 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.902 HD23 HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -136.27 10.6 3.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 74.450000000000003 110.924 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -93.25 167.61 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 64.030000000000001 110.839 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.658 ' OG1' HG22 ' A' ' 83' ' ' VAL . 9.8 t -108.17 166.9 10.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 64.200000000000003 111.122 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -144.53 119.96 6.03 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.636 0.732 . . . . 73.329999999999998 110.885 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 119.02 6.03 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.697 2.264 . . . . 73.239999999999995 112.325 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -116.34 163.07 16.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 73.239999999999995 111.063 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -125.62 -135.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 74.040000000000006 110.816 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.13 -14.94 27.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.667 -0.778 . . . . 74.219999999999999 112.484 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -91.5 -48.66 6.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 70.450000000000003 110.862 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.76 23.2 9.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 71.310000000000002 112.465 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 60.210000000000001 112.49 -179.921 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.824 0.345 . . . . 64.430000000000007 110.865 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -67.59 -23.16 65.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 63.340000000000003 110.893 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.634 ' HA ' ' HB1' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -62.23 -157.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 70.150000000000006 110.859 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.557 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 20.7 pt -77.21 160.87 74.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.587 0.708 . . . . 73.129999999999995 111.153 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.8 -3.11 11.37 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.64 2.227 . . . . 65.109999999999999 112.358 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.0 p -148.2 79.87 1.46 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 70.030000000000001 111.153 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.985 HG22 HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -98.98 -166.34 1.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 72.209999999999994 111.153 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.56 ' HB2' HD23 ' A' ' 92' ' ' LEU . 10.6 tt0 -80.58 -100.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 64.140000000000001 110.881 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.58 10.83 40.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 110.908 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.773 HD13 ' CG ' ' A' ' 85' ' ' LEU . 3.3 tp -65.01 -21.15 66.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 75.200000000000003 110.904 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -83.78 7.12 18.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 54.119999999999997 110.918 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -108.8 -42.08 4.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 74.430000000000007 110.868 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.51 ' HG3' HG21 ' A' ' 83' ' ' VAL . 5.0 mm100 -66.43 -46.68 75.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 75.329999999999998 110.934 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.22 -29.19 1.57 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 70.439999999999998 112.513 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.25 -58.63 5.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.78 0.324 . . . . 62.310000000000002 111.121 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -9.99 59.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 54.009999999999998 110.865 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 31' ' ' GLU . . . -81.92 -17.84 45.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 72.420000000000002 111.085 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -79.04 5.07 12.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 71.010000000000005 110.915 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -73.63 -82.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 61.210000000000001 110.852 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.06 12.62 0.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 75.430000000000007 112.504 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -66.38 168.66 8.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 72.540000000000006 110.877 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 9.3 m-20 -112.12 -149.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 63.020000000000003 110.867 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.96 170.18 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 70.099999999999994 110.881 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 58' ' ' VAL . 14.8 t -118.45 169.42 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 72.519999999999996 111.105 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.623 ' N ' HG12 ' A' ' 34' ' ' VAL . 63.0 p -90.53 -41.59 11.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 111.137 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.423 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 162.01 -61.83 0.28 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 74.219999999999999 112.515 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 54.0 Cg_endo -69.74 157.01 61.9 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.712 2.275 . . . . 72.5 112.337 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -62.74 -26.84 68.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 73.099999999999994 110.889 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.28 -35.83 72.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 71.099999999999994 111.15 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.42 -36.13 24.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 65.430000000000007 110.893 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 12.8 ptt180 -70.22 -43.64 70.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 74.019999999999996 110.894 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.41 -34.41 72.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 71.549999999999997 111.143 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -79.92 -41.22 26.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 70.109999999999999 110.89 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.597 ' HB1' ' OE2' ' A' ' 57' ' ' GLU . . . -76.85 -62.24 1.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 44.340000000000003 111.067 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -52.74 -22.31 5.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 64.230000000000004 111.117 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.746 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -53.59 -69.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 63.43 111.154 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.705 ' HA ' HG12 ' A' ' 50' ' ' VAL . 21.3 t -112.17 -11.11 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 63.420000000000002 111.093 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.587 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.3 tp60 -83.19 -34.19 26.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 74.319999999999993 110.926 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.987 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.44 -6.02 18.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 44.140000000000001 111.098 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.979 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.93 -9.42 0.14 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.628 0.728 . . . . 64.420000000000002 111.152 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.987 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.6 Cg_endo -69.78 -22.73 31.59 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.68 2.253 . . . . 74.140000000000001 112.322 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.65 -54.36 2.96 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.794 -0.717 . . . . 73.319999999999993 112.488 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.64 -34.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 62.039999999999999 112.455 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.672 ' O ' ' O ' ' A' ' 49' ' ' ALA . 2.0 t -148.34 152.81 37.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.757 0.313 . . . . 72.420000000000002 111.194 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.777 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.38 75.28 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 71.209999999999994 111.077 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.757 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -147.09 104.51 0.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.722 . . . . 43.420000000000002 112.503 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.597 ' OE2' ' HB1' ' A' ' 44' ' ' ALA . 1.9 tt0 -97.6 -170.37 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.37 . . . . 64.400000000000006 110.888 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.741 ' O ' HG23 ' A' ' 34' ' ' VAL . 2.6 t -129.25 139.17 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 72.010000000000005 111.159 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.553 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 10.6 tt0 -106.31 128.16 53.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 64.430000000000007 110.923 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 60' ' ' THR . 1.7 t -118.31 95.57 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 51.439999999999998 111.077 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.434 ' C ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -137.28 168.87 18.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 61.340000000000003 110.85 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.4 m -98.07 -19.34 18.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 65.340000000000003 111.144 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 68' ' ' ALA . . . 49.97 -159.2 1.39 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 44.109999999999999 112.488 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.36 -25.37 23.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.357 . . . . 71.510000000000005 110.892 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.05 -116.89 0.47 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.683 -0.77 . . . . 64.219999999999999 112.475 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.814 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -120.11 -65.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 74.010000000000005 111.089 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.697 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -111.83 94.39 4.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 74.120000000000005 111.144 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.465 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . . . -87.71 84.67 7.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 74.349999999999994 111.063 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.708 ' CD1' HD21 ' A' ' 20' ' ' LEU . 6.5 t80 -110.81 123.43 50.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 64.040000000000006 110.92 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -126.32 111.89 1.51 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 73.129999999999995 112.476 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 83' ' ' VAL . 7.9 p -107.83 121.03 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 61.439999999999998 111.11 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.818 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -114.12 134.31 54.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 71.510000000000005 110.936 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.662 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.5 m -144.92 122.77 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 72.25 111.143 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.792 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 5.0 m -171.95 -126.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 43.43 111.131 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.508 ' N ' HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -106.33 146.08 32.28 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.665 0.745 . . . . 63.130000000000003 110.868 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.505 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.4 Cg_endo -69.74 12.36 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.667 2.245 . . . . 64.510000000000005 112.355 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 75' ' ' ARG . 38.2 t70 -91.55 28.82 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 64.549999999999997 110.835 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.35 -10.88 26.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 72.420000000000002 112.463 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.581 ' O ' ' HB ' ' A' ' 74' ' ' THR . 32.1 p -97.1 104.99 17.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 55.0 111.151 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.792 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.4 OUTLIER -138.17 165.7 25.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 72.299999999999997 110.85 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 5.7 m -115.0 98.94 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 64.519999999999996 111.166 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . 8.8 tm-20 -85.69 125.64 33.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 110.882 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.643 HG12 ' CD2' ' A' ' 85' ' ' LEU . 2.5 t -92.43 113.04 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 54.009999999999998 111.14 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.734 ' O ' HD22 ' A' ' 85' ' ' LEU . 1.0 OUTLIER -85.79 113.0 21.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 73.120000000000005 110.902 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.985 HD12 HG22 ' A' ' 17' ' ' THR . 4.0 mm? -130.36 121.76 26.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 63.450000000000003 110.877 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.708 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.4 t0 -137.8 134.92 35.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 65.200000000000003 110.892 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.814 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -59.35 3.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.439999999999998 110.827 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.564 ' H ' ' C ' ' A' ' 86' ' ' ASP . 8.2 t0 -65.7 -3.53 4.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 73.400000000000006 110.834 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 68.5 10.73 8.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 71.209999999999994 110.899 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.04 -1.29 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 74.200000000000003 110.871 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.708 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 58.3 t -117.6 90.99 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 74.519999999999996 111.123 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.911 ' HA ' HD13 ' A' ' 85' ' ' LEU . 5.5 mp -146.33 14.6 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 72.310000000000002 110.886 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -113.43 140.96 47.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 64.340000000000003 110.869 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.64 ' HB ' HG13 ' A' ' 83' ' ' VAL . 3.3 t -87.91 151.41 22.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 64.129999999999995 111.194 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -123.83 149.8 60.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 71.409999999999997 110.904 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 143.12 49.77 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.705 2.27 . . . . 72.409999999999997 112.325 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -118.81 110.2 16.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 64.140000000000001 111.067 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -98.46 4.79 48.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 73.329999999999998 110.818 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.61 -20.91 8.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.774 -0.727 . . . . 44.210000000000001 112.487 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.3 -16.03 20.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.825 0.345 . . . . 64.319999999999993 110.865 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.99 -14.0 54.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.796 -0.716 . . . . 70.409999999999997 112.488 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 74.140000000000001 112.479 -179.908 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.711 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 13.9 t70 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.83 0.348 . . . . 70.299999999999997 110.872 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.696 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 92.7 m-85 -67.52 -36.53 81.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 73.319999999999993 110.926 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.59 -164.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 71.409999999999997 110.831 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.863 HG22 ' H ' ' A' ' 16' ' ' THR . 24.4 mm -77.78 129.84 75.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.651 0.739 . . . . 71.310000000000002 111.13 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 18.0 0.2 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.645 2.23 . . . . 73.239999999999995 112.35 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.863 ' H ' HG22 ' A' ' 14' ' ' ILE . 3.1 m -138.73 27.13 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 51.140000000000001 111.172 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.919 HG22 ' CD2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -74.36 -167.5 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 74.109999999999999 111.132 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -63.94 -103.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 74.349999999999994 110.887 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.75 8.56 44.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 70.209999999999994 110.882 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.013 ' HG ' HD22 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.71 -13.24 53.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.200000000000003 110.911 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -95.34 7.74 45.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.454 . . . . 73.109999999999999 110.91 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -106.98 -40.08 5.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 61.240000000000002 110.855 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -66.24 -47.63 73.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 71.140000000000001 110.914 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -43.55 -31.9 1.81 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 65.230000000000004 112.485 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.33 -64.51 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 61.130000000000003 111.075 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.539 ' CE ' HG21 ' A' ' 73' ' ' VAL . 3.5 ppp? -70.45 -7.94 47.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 54.43 110.921 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.441 ' HA ' ' HB2' ' A' ' 31' ' ' GLU . . . -76.91 -19.98 56.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 60.240000000000002 111.087 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -77.97 5.79 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 70.109999999999999 110.864 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.72 -81.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 72.519999999999996 110.85 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.92 14.52 5.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 51.049999999999997 112.499 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HG2' HG23 ' A' ' 58' ' ' VAL . 1.1 tt0 -54.82 103.4 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.902 0.382 . . . . 74.310000000000002 110.926 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.406 ' N ' ' HG2' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -76.95 -170.2 1.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 70.109999999999999 110.857 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.18 125.46 52.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 53.439999999999998 110.863 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.807 HG23 ' OE1' ' A' ' 57' ' ' GLU . 1.9 t -71.03 161.92 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 71.340000000000003 111.101 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' CG1' ' A' ' 34' ' ' VAL . 1.7 p -84.93 -45.75 11.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 63.200000000000003 111.125 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.43 -81.17 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.724 -0.751 . . . . 73.129999999999995 112.476 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 169.48 18.78 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.701 2.267 . . . . 33.210000000000001 112.337 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -68.17 -26.39 65.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 63.310000000000002 110.872 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 43' ' ' ARG . . . -52.53 -28.4 20.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 55.229999999999997 111.098 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -76.81 -30.79 56.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 110.905 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.482 ' HG3' ' HD3' ' A' ' 80' ' ' ARG . 4.3 ptt180 -56.7 -38.96 73.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 72.099999999999994 110.892 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.949 ' HB2' ' HA2' ' A' ' 99' ' ' GLY . . . -70.12 -30.44 67.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 62.450000000000003 111.086 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 39' ' ' ALA . 10.5 mtt-85 -74.34 -45.16 48.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 72.530000000000001 110.875 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -78.25 -57.52 3.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 74.219999999999999 111.118 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 1.041 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -54.02 -17.36 2.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 64.129999999999995 111.106 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -62.69 -68.05 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 63.340000000000003 111.106 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.682 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 26.0 t -122.21 -14.16 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 51.119999999999997 111.14 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.587 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 27.9 mt-30 -79.64 -41.64 26.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 110.92 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.041 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . . . -104.43 0.05 28.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 53.229999999999997 111.074 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.976 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.29 -13.19 0.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 74.319999999999993 111.136 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.976 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 53.5 Cg_endo -69.77 -32.24 18.92 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.654 2.236 . . . . 73.129999999999995 112.362 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.16 -51.46 38.5 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.785 -0.722 . . . . 74.540000000000006 112.51 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.58 -33.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 25.23 112.496 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 74' ' ' THR . 0.2 OUTLIER -150.24 158.63 44.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 52.32 111.152 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.709 ' CA ' HG23 ' A' ' 50' ' ' VAL . . . -70.99 77.78 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 51.219999999999999 111.102 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.723 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -144.94 106.9 0.41 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.733 . . . . 71.430000000000007 112.46 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.807 ' OE1' HG23 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -101.33 -159.24 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 71.209999999999994 110.884 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -126.62 121.3 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 71.349999999999994 111.159 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.754 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -94.69 171.47 8.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 64.310000000000002 110.87 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -113.88 128.86 56.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 63.409999999999997 111.12 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.553 ' H ' ' HA ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -142.72 91.29 2.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 75.5 110.903 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.0 p -94.81 149.4 21.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 73.430000000000007 111.144 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.536 ' N ' ' HB3' ' A' ' 67' ' ' ALA . . . -134.18 179.46 17.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.778 -0.725 . . . . 73.230000000000004 112.509 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -76.41 -24.14 54.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.899 0.381 . . . . 75.019999999999996 110.884 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.59 -117.39 2.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 65.319999999999993 112.468 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -116.45 38.93 3.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 72.329999999999998 111.095 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.536 ' HB3' ' N ' ' A' ' 63' ' ' GLY . . . -59.06 -171.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 52.420000000000002 111.083 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.696 ' HB1' ' HB2' ' A' ' 12' ' ' TYR . . . -156.29 -95.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 71.219999999999999 111.109 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.754 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -162.29 -163.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 75.439999999999998 110.888 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -138.99 156.64 24.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.749 -0.739 . . . . 30.449999999999999 112.505 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.631 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.4 p -125.61 121.1 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 73.040000000000006 111.124 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.783 HD21 ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -112.14 142.91 44.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 51.420000000000002 110.94 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.723 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 11.0 p -157.88 125.84 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 63.530000000000001 111.139 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 54' ' ' THR . 5.6 m -168.6 -125.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 72.109999999999999 111.14 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.504 ' N ' HG22 ' A' ' 74' ' ' THR . 3.8 ttm-85 -107.82 139.32 20.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 75.219999999999999 110.876 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 13.89 0.27 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.679 2.252 . . . . 60.119999999999997 112.369 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 75' ' ' ARG . 1.3 m-20 -94.1 23.79 4.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 72.540000000000006 110.877 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.51 -16.3 61.28 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.718 -0.753 . . . . 53.109999999999999 112.48 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.696 ' O ' ' HB ' ' A' ' 74' ' ' THR . 6.0 t -94.0 122.55 36.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.763 0.316 . . . . 64.019999999999996 111.105 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.77 ' HB3' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -141.65 161.52 37.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 72.219999999999999 110.852 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 94.1 t -118.05 85.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 61.420000000000002 111.103 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.447 ' HA ' ' CB ' ' A' ' 72' ' ' LEU . 6.9 tm-20 -77.27 121.86 24.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 110.841 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.677 HG13 ' HB ' ' A' ' 94' ' ' THR . 3.3 t -100.33 137.4 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 73.219999999999999 111.124 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.838 ' C ' HD23 ' A' ' 85' ' ' LEU . 6.5 m-70 -92.56 118.23 30.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 63.399999999999999 110.871 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.013 HD22 ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -122.48 101.36 7.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.209999999999994 110.892 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.784 ' OD2' HG11 ' A' ' 91' ' ' VAL . 34.4 m-20 -140.78 131.74 26.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 110.858 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.748 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -61.36 11.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.854 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.643 ' H ' ' C ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -65.37 -5.93 8.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.856 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 74.27 6.88 4.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 55.43 110.865 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -141.54 7.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 110.894 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.784 HG11 ' OD2' ' A' ' 86' ' ' ASP . 40.9 t -118.31 69.52 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 73.430000000000007 111.137 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.919 ' CD2' HG22 ' A' ' 17' ' ' THR . 0.2 OUTLIER -129.91 10.72 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 50.530000000000001 110.953 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.23 -179.95 3.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 73.120000000000005 110.791 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.677 ' HB ' HG13 ' A' ' 83' ' ' VAL . 13.4 t -126.42 171.18 11.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 64.129999999999995 111.138 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -144.84 159.64 49.68 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.663 0.744 . . . . 72.519999999999996 110.86 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 107.01 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.648 2.232 . . . . 61.520000000000003 112.341 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.465 ' HB3' ' C ' ' A' ' 80' ' ' ARG . . . -75.69 112.15 11.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 73.239999999999995 111.099 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -85.68 6.36 27.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 64.200000000000003 110.92 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.949 ' HA2' ' HB2' ' A' ' 42' ' ' ALA . . . 79.56 -20.93 4.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.744 -0.741 . . . . 65.310000000000002 112.502 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.36 -33.06 10.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 74.109999999999999 110.873 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.07 24.85 54.0 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 61.109999999999999 112.491 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 74.140000000000001 112.457 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.754 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 15.9 t70 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.78 0.324 . . . . 65.109999999999999 110.806 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -65.41 -56.38 12.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 62.0 110.852 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.482 ' CG ' ' HB3' ' A' ' 67' ' ' ALA . 25.5 t0 -65.36 -115.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 61.119999999999997 110.862 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.73 HG22 ' H ' ' A' ' 16' ' ' THR . 12.6 mm -100.13 108.64 53.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.586 0.708 . . . . 75.120000000000005 111.103 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 23.1 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.714 2.276 . . . . 74.349999999999994 112.322 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.73 ' H ' HG22 ' A' ' 14' ' ' ILE . 3.1 m -131.17 20.22 4.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.230000000000004 111.163 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.988 HG22 HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -76.13 -165.99 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 62.340000000000003 111.113 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.698 ' HG3' HD22 ' A' ' 92' ' ' LEU . 21.1 mt-10 -61.3 -105.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 71.519999999999996 110.873 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.8 8.23 44.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 61.039999999999999 110.898 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.996 ' HG ' HD22 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -65.29 -15.81 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 65.329999999999998 110.88 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -97.02 4.39 51.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 62.329999999999998 110.91 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -103.65 -42.21 5.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 74.040000000000006 110.868 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.42 ' HB2' HG11 ' A' ' 71' ' ' VAL . 6.5 mm100 -66.35 -51.39 57.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 75.0 110.961 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.3 -27.86 4.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 50.020000000000003 112.5 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.35 49.23 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 43.399999999999999 111.122 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.468 ' SD ' HG11 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -70.36 -42.77 71.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 74.040000000000006 110.905 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.456 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -119.42 -93.28 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 52.219999999999999 111.1 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -150.39 -37.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.409999999999997 110.927 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.38 -0.05 1.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 74.219999999999999 110.841 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.62 -20.33 7.55 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.757 -0.735 . . . . 73.340000000000003 112.508 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.474 ' CG ' HG21 ' A' ' 58' ' ' VAL . 1.4 tm-20 -83.9 103.25 13.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 64.409999999999997 110.91 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.68 179.08 4.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.491 . . . . 65.439999999999998 110.846 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.3 119.14 37.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 64.400000000000006 110.911 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.676 HG23 ' C ' ' A' ' 58' ' ' VAL . 8.4 t -84.2 -125.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 60.310000000000002 111.09 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.565 ' N ' HG12 ' A' ' 34' ' ' VAL . 71.4 p -139.52 -71.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 70.540000000000006 111.129 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.22 -65.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.755 -0.736 . . . . 75.25 112.51 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 166.63 26.9 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.649 2.233 . . . . 74.310000000000002 112.325 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -72.21 -28.94 63.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 110.846 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.0 -32.9 62.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 111.095 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.95 -31.57 31.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 64.329999999999998 110.882 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -69.34 -43.13 74.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 71.230000000000004 110.872 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.711 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.95 -33.28 70.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 111.129 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -81.01 -40.97 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 62.310000000000002 110.883 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.562 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -75.55 -63.06 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 53.43 111.12 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -53.54 -21.26 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 44.100000000000001 111.119 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.721 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -52.98 -68.92 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 63.140000000000001 111.062 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.767 ' HA ' HG12 ' A' ' 50' ' ' VAL . 19.0 t -111.75 -13.31 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 72.5 111.107 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.7 tp60 -80.53 -32.92 36.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 71.430000000000007 110.928 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.046 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.36 -6.68 17.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 71.329999999999998 111.153 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.987 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.08 -4.33 0.11 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.58 0.705 . . . . 71.140000000000001 111.094 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.046 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.1 Cg_endo -69.75 -24.46 29.69 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.731 2.288 . . . . 60.25 112.31 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.62 -56.33 2.26 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.718 -0.753 . . . . 72.129999999999995 112.487 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.1 -36.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.744 . . . . 64.540000000000006 112.473 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.746 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.7 t -146.42 150.44 35.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 25.539999999999999 111.185 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.822 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -73.12 80.3 1.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 72.349999999999994 111.095 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.733 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -146.86 99.51 0.21 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 62.439999999999998 112.491 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.54 ' OE1' HG22 ' A' ' 34' ' ' VAL . 3.5 tt0 -99.79 -167.05 1.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 75.109999999999999 110.892 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.676 ' C ' HG23 ' A' ' 34' ' ' VAL . 11.6 t -137.78 117.62 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 111.165 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.514 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 1.9 pp20? -96.08 155.16 16.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 72.230000000000004 110.857 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.487 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.5 t -127.65 118.7 24.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 74.540000000000006 111.178 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.54 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -132.62 170.88 14.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.420000000000002 110.916 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.75 114.48 22.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 61.020000000000003 111.128 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.43 -147.47 12.76 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 63.210000000000001 112.467 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -87.58 -1.63 58.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 73.239999999999995 110.904 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.02 -118.12 4.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 71.150000000000006 112.468 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -119.13 -78.27 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.775 0.321 . . . . 64.140000000000001 111.08 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -107.01 92.97 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 50.130000000000003 111.081 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -80.84 59.34 3.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 72.450000000000003 111.093 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.754 ' HH ' ' N ' ' A' ' 11' ' ' ASP . 2.6 p90 -110.74 132.11 54.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.349999999999994 110.935 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -118.71 150.37 18.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.777 -0.725 . . . . 73.109999999999999 112.494 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.847 HG12 HD11 ' A' ' 85' ' ' LEU . 2.5 p -117.5 119.78 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.368 . . . . 72.040000000000006 111.12 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.777 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -107.14 138.33 43.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 72.400000000000006 110.925 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.703 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.1 t -148.98 122.03 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 63.229999999999997 111.147 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.787 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 3.6 m -171.52 -128.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 70.329999999999998 111.121 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.502 ' H ' HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -104.28 142.61 24.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.662 0.744 . . . . 73.140000000000001 110.844 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.599 ' HG3' HG21 ' A' ' 50' ' ' VAL . 53.9 Cg_endo -69.76 14.19 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.695 2.264 . . . . 74.219999999999999 112.311 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 75' ' ' ARG . 7.2 m-20 -93.01 27.01 2.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.267 -0.424 . . . . 75.030000000000001 110.864 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.85 -12.89 51.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.792 -0.718 . . . . 70.230000000000004 112.51 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.593 ' O ' ' HB ' ' A' ' 74' ' ' THR . 33.6 p -97.18 106.64 19.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 72.239999999999995 111.141 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.787 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.7 OUTLIER -137.79 164.68 28.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 73.219999999999999 110.858 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 10.3 m -116.92 96.97 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 74.120000000000005 111.102 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.578 ' HG3' HD12 ' A' ' 72' ' ' LEU . 1.3 tm-20 -80.93 121.97 26.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 73.010000000000005 110.898 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.66 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.4 t -93.9 137.33 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 55.039999999999999 111.133 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.844 ' C ' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -84.85 112.81 20.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 71.340000000000003 110.849 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.996 HD22 ' HG ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -121.21 109.53 15.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 71.219999999999999 110.911 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.666 ' HB2' HG11 ' A' ' 91' ' ' VAL . 2.2 t0 -140.28 131.35 26.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 62.340000000000003 110.864 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.456 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -60.8 7.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 62.340000000000003 110.865 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.609 ' H ' ' C ' ' A' ' 86' ' ' ASP . 19.8 t0 -66.44 -4.6 8.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 60.310000000000002 110.877 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 70.02 11.43 7.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 110.916 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.79 5.63 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 71.519999999999996 110.898 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 86' ' ' ASP . 49.7 t -117.43 74.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.5 111.137 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.988 HD23 HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -133.59 11.7 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 64.409999999999997 110.931 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -92.95 163.49 13.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 71.420000000000002 110.905 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 8.3 t -98.9 161.76 13.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 70.519999999999996 111.171 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -147.6 127.52 6.65 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 75.549999999999997 110.904 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 123.5 10.16 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.73 2.287 . . . . 54.509999999999998 112.306 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.59 161.66 18.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.109999999999999 111.135 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -128.8 -146.24 0.32 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.429 . . . . 45.229999999999997 110.887 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.62 -15.85 30.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.772 -0.728 . . . . 73.310000000000002 112.434 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.59 -36.35 13.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.369 . . . . 74.109999999999999 110.852 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.62 54.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 34.409999999999997 112.499 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.736 . . . . 62.009999999999998 112.485 -179.93 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.779 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.825 0.345 . . . . 72.209999999999994 110.864 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.537 ' HE2' HG11 ' A' ' 58' ' ' VAL . 65.2 m-85 -75.09 -33.61 61.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 71.409999999999997 110.93 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.678 ' CG ' HD23 ' A' ' 20' ' ' LEU . 2.5 p-10 -64.53 -152.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 72.319999999999993 110.851 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.731 HD12 ' O ' ' A' ' 16' ' ' THR . 0.5 OUTLIER -78.17 163.37 62.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.652 0.739 . . . . 72.420000000000002 111.153 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -9.32 25.83 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.702 2.268 . . . . 55.32 112.383 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.731 ' O ' HD12 ' A' ' 14' ' ' ILE . 2.6 p -154.2 130.15 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 71.409999999999997 111.144 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.084 HG22 HD23 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -149.76 -158.78 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 54.409999999999997 111.185 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -70.44 -101.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 64.25 110.892 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -91.17 11.21 24.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 64.109999999999999 110.881 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.957 HD21 ' HB3' ' A' ' 85' ' ' LEU . 10.7 mp -65.35 -30.08 70.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 73.420000000000002 110.956 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -80.31 4.72 16.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 74.150000000000006 110.962 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.12 -53.8 2.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 75.140000000000001 110.917 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.588 ' HB2' HG11 ' A' ' 71' ' ' VAL . 68.9 mm-40 -66.95 -46.55 74.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 74.150000000000006 110.935 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 27' ' ' ALA . . . -46.94 -25.37 2.37 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 62.409999999999997 112.498 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.2 -80.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 62.439999999999998 111.08 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.9 ptm -66.85 -0.49 3.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 62.229999999999997 110.873 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.695 ' HB1' ' OE2' ' A' ' 31' ' ' GLU . . . -77.25 -32.93 56.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 73.519999999999996 111.071 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -82.95 10.05 8.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 71.239999999999995 110.856 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -68.6 -72.71 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 73.230000000000004 110.911 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.04 11.74 0.59 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 75.010000000000005 112.519 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.695 ' OE2' ' HB1' ' A' ' 27' ' ' ALA . 1.7 pt-20 -67.3 171.24 6.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 74.239999999999995 110.884 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -127.93 -153.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.239999999999995 110.844 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -109.85 163.61 13.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 110.835 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.661 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 1.0 OUTLIER -91.73 162.35 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 33.43 111.15 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.577 ' N ' ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -104.5 -32.73 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 74.040000000000006 111.163 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.475 ' H ' HG13 ' A' ' 34' ' ' VAL . . . -157.62 -139.09 2.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 73.319999999999993 112.498 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -160.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.669 2.246 . . . . 71.099999999999994 112.321 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -55.07 -34.21 63.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 70.019999999999996 110.896 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.86 -37.87 66.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 73.430000000000007 111.077 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -84.34 -42.05 16.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.888 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 7.1 ptt180 -61.9 -37.63 85.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 75.439999999999998 110.838 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.679 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -65.8 -34.76 78.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 53.240000000000002 111.093 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -78.08 -39.26 42.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 65.430000000000007 110.897 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -77.12 -58.55 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 55.25 111.084 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.738 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -57.2 -17.73 12.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 72.219999999999999 111.129 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -62.63 -79.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 53.200000000000003 111.118 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.758 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 61.1 t -110.91 -23.08 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 74.340000000000003 111.125 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.637 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 3.5 mt-30 -68.55 -27.7 66.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 65.420000000000002 110.883 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.082 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.77 -0.82 19.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 72.239999999999995 111.073 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.005 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.37 -1.1 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.62 0.724 . . . . 74.109999999999999 111.103 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.082 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.9 Cg_endo -69.76 -31.22 20.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.702 2.268 . . . . 61.539999999999999 112.33 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.98 -54.23 5.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 74.129999999999995 112.493 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.2 -33.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 35.520000000000003 112.525 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.62 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.4 m -145.08 152.65 40.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 62.210000000000001 111.152 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.849 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.57 76.07 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 72.319999999999993 111.11 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.708 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -146.59 104.94 0.31 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 73.510000000000005 112.515 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.633 ' HG3' ' HB2' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -98.56 -153.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 73.109999999999999 110.858 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.68 HG13 ' CE1' ' A' ' 69' ' ' TYR . 54.9 t -131.68 133.78 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 73.230000000000004 111.127 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.661 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -100.99 122.91 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 110.903 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.9 t -108.03 111.39 23.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 63.350000000000001 111.174 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -137.48 159.94 40.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 75.040000000000006 110.887 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 p -124.24 117.43 24.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 73.120000000000005 111.079 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.98 -147.87 11.85 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 74.439999999999998 112.497 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.33 -1.64 57.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.391 . . . . 74.420000000000002 110.894 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.51 -120.62 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.721 -0.752 . . . . 74.530000000000001 112.472 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -122.95 -75.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 61.219999999999999 111.057 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.642 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -104.67 85.85 2.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 52.149999999999999 111.038 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -82.49 59.26 4.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 61.520000000000003 111.072 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.779 ' HH ' ' N ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -116.98 158.58 23.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 65.140000000000001 110.886 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -141.41 158.96 26.66 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.708 -0.758 . . . . 62.219999999999999 112.497 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.588 HG11 ' HB2' ' A' ' 23' ' ' GLN . 8.7 p -116.39 120.46 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 71.510000000000005 111.122 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.775 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -111.57 133.33 53.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 72.219999999999999 110.911 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.735 ' O ' HG22 ' A' ' 81' ' ' VAL . 7.3 p -148.43 124.13 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.540000000000006 111.119 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.811 ' HB ' ' O ' ' A' ' 79' ' ' THR . 3.8 m -167.77 -129.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 72.109999999999999 111.178 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.533 ' H ' HG22 ' A' ' 74' ' ' THR . 0.3 OUTLIER -101.84 146.77 32.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.603 0.716 . . . . 74.150000000000006 110.895 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.409 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.72 7.68 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.699 2.266 . . . . 63.140000000000001 112.371 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -91.28 41.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 74.120000000000005 110.891 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.19 -4.94 16.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 65.299999999999997 112.527 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.811 ' O ' ' HB ' ' A' ' 74' ' ' THR . 43.9 p -96.07 117.02 29.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 75.409999999999997 111.161 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.743 ' O ' ' HB3' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -144.75 158.1 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 73.439999999999998 110.867 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 73' ' ' VAL . 31.4 m -118.13 92.13 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 62.200000000000003 111.126 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.726 ' HB2' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -81.12 123.43 28.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 73.140000000000001 110.888 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.674 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.4 t -94.93 131.75 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.499 . . . . 53.450000000000003 111.134 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.65 117.19 23.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 63.450000000000003 110.865 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.957 ' HB3' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -135.86 121.28 19.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 63.299999999999997 110.918 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.689 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 6.3 t0 -140.49 132.5 27.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 74.219999999999999 110.871 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.713 ' HG3' HG23 ' A' ' 14' ' ' ILE . 2.7 tmt_? -60.36 4.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.430000000000007 110.847 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.557 ' H ' ' C ' ' A' ' 86' ' ' ASP . 22.5 t0 -67.94 -3.92 11.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 71.040000000000006 110.879 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 69.31 14.85 8.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 75.5 110.865 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.05 -1.06 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 75.209999999999994 110.853 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.689 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 92.7 t -117.91 91.39 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 111.117 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.084 HD23 HG22 ' A' ' 17' ' ' THR . 0.2 OUTLIER -140.47 8.25 2.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.899 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.7 162.27 14.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 74.329999999999998 110.864 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.2 t -93.41 172.45 8.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 111.126 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' GLU . 3.4 tt0 -145.96 123.71 6.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.688 0.756 . . . . 65.510000000000005 110.852 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 129.48 17.58 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.249 . . . . 75.340000000000003 112.345 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -117.86 117.17 28.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 63.450000000000003 111.126 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 100' ' ' ASP . 3.4 m-20 -121.67 49.13 1.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 74.099999999999994 110.855 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.429 ' HA2' HH12 ' A' ' 80' ' ' ARG . . . 71.68 -16.92 1.28 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 72.329999999999998 112.485 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 98' ' ' ASP . 3.0 t0 -95.32 -62.14 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 72.019999999999996 110.857 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.36 26.02 60.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.759 -0.734 . . . . 73.150000000000006 112.472 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 44.399999999999999 112.48 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.686 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.817 0.341 . . . . 72.349999999999994 110.884 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -67.5 -54.34 20.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 75.040000000000006 110.938 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.695 ' OD1' ' HB3' ' A' ' 67' ' ' ALA . 9.0 t0 -64.19 -154.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 74.200000000000003 110.859 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.822 HG22 ' H ' ' A' ' 16' ' ' THR . 35.4 mm -92.24 123.68 61.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.612 0.72 . . . . 60.299999999999997 111.172 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 10.45 0.49 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.693 2.262 . . . . 72.230000000000004 112.324 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.822 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -124.24 43.74 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 71.439999999999998 111.184 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.007 HG22 HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -97.89 -162.99 1.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 73.200000000000003 111.16 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.714 ' HG3' HD22 ' A' ' 92' ' ' LEU . 12.1 mt-10 -60.83 -102.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 71.129999999999995 110.936 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -96.85 7.16 47.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 75.109999999999999 110.887 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.992 ' HG ' HD22 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -66.49 -16.77 64.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 75.5 110.898 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -94.25 3.64 54.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 64.319999999999993 110.876 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -97.21 -53.36 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 75.140000000000001 110.907 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -64.73 -35.51 81.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 75.010000000000005 110.899 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -46.13 -30.06 3.79 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.732 -0.747 . . . . 71.299999999999997 112.486 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 28' ' ' PHE . . . -57.29 -57.36 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.826 0.346 . . . . 73.230000000000004 111.131 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.678 ' SD ' HG11 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -68.21 -5.06 16.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.519999999999996 110.882 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 31' ' ' GLU . . . -113.06 38.83 2.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 70.530000000000001 111.107 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -110.41 14.7 22.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 63.109999999999999 110.9 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.28 -78.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 75.299999999999997 110.866 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.73 8.57 41.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.738 . . . . 64.430000000000007 112.478 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.617 ' OE1' HG21 ' A' ' 58' ' ' VAL . 10.1 tt0 -64.61 103.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.875 0.369 . . . . 73.450000000000003 110.901 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' ' CG ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -102.05 -172.53 2.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 70.420000000000002 110.886 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -115.78 120.85 40.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 72.010000000000005 110.87 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.716 HG22 ' OE1' ' A' ' 57' ' ' GLU . 46.1 t -71.93 159.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 61.439999999999998 111.13 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.526 ' N ' HG12 ' A' ' 34' ' ' VAL . 65.8 p -99.59 -30.38 12.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 64.099999999999994 111.173 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.604 ' H ' HG12 ' A' ' 34' ' ' VAL . . . -150.42 -144.06 3.85 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 64.140000000000001 112.501 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -158.94 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.711 2.274 . . . . 75.120000000000005 112.4 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' HA ' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -56.69 -29.33 62.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 74.310000000000002 110.834 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.2 -43.57 70.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 63.119999999999997 111.085 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -85.6 -41.91 14.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 62.310000000000002 110.876 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -60.45 -36.16 77.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 60.109999999999999 110.86 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -65.25 -32.24 73.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 64.430000000000007 111.125 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.516 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 4.0 ptt180 -74.78 -40.97 60.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 70.049999999999997 110.898 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.583 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . . . -81.06 -57.84 3.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 72.349999999999994 111.142 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.716 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -52.12 -20.97 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 61.009999999999998 111.077 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.643 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -62.91 -76.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 64.099999999999994 111.11 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.703 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.3 t -111.4 -17.01 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 71.329999999999998 111.124 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.523 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -73.94 -32.0 63.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 71.510000000000005 110.908 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.041 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.39 -1.23 21.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 44.329999999999998 111.099 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.995 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.92 -2.7 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.656 0.741 . . . . 72.510000000000005 111.156 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.041 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.8 Cg_endo -69.78 -29.93 22.99 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.641 2.228 . . . . 71.329999999999998 112.345 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.52 -51.46 6.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.752 -0.737 . . . . 23.140000000000001 112.506 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.08 -33.55 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 70.019999999999996 112.518 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.671 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -145.74 151.1 37.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.79 0.328 . . . . 53.109999999999999 111.157 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.835 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.63 78.36 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 111.062 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.693 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -143.8 99.91 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 55.329999999999998 112.539 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.716 ' OE1' HG22 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -92.86 -164.72 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 74.540000000000006 110.928 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.617 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.1 t -143.49 124.76 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 63.329999999999998 111.106 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.615 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 9.6 pt-20 -95.18 155.83 16.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 70.049999999999997 110.837 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.506 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.3 t -131.58 117.18 18.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.097 -0.501 . . . . 74.140000000000001 111.122 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -137.85 158.97 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 71.430000000000007 110.877 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -22.61 19.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 72.310000000000002 111.102 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 42.99 -157.46 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.739 -0.743 . . . . 65.040000000000006 112.516 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -91.81 -23.61 19.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.913 0.387 . . . . 65.049999999999997 110.871 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.54 -119.1 1.13 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.767 -0.73 . . . . 73.120000000000005 112.471 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.61 -81.63 0.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.752 0.311 . . . . 44.409999999999997 111.113 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.695 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . . . -93.03 79.57 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 55.219999999999999 111.147 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.49 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -81.74 62.57 5.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 53.25 111.102 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.965 ' CZ ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -114.61 155.64 26.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 73.129999999999995 110.937 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.503 ' HA2' ' HG ' ' A' ' 85' ' ' LEU . . . -138.49 157.61 24.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 73.140000000000001 112.449 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.78 HG12 HD11 ' A' ' 85' ' ' LEU . 2.5 p -126.62 117.97 49.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 73.150000000000006 111.16 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.804 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -105.99 137.01 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 71.219999999999999 110.917 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.682 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.1 p -147.23 124.14 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 51.520000000000003 111.146 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.799 ' HB ' ' O ' ' A' ' 79' ' ' THR . 4.4 m -168.19 -129.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 52.509999999999998 111.116 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.695 ' HG3' HG22 ' A' ' 74' ' ' THR . 0.6 OUTLIER -104.65 148.8 36.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.562 0.696 . . . . 72.239999999999995 110.838 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 6.76 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.7 2.267 . . . . 64.329999999999998 112.31 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -92.67 43.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 63.219999999999999 110.862 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.51 -5.26 23.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 74.430000000000007 112.477 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.799 ' O ' ' HB ' ' A' ' 74' ' ' THR . 13.9 p -93.42 123.67 36.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 55.109999999999999 111.147 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.687 ' NE ' ' HB1' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -146.69 156.69 43.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 73.140000000000001 110.826 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.804 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 97.0 t -115.75 83.55 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 72.340000000000003 111.154 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.56 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 3.7 tm-20 -75.93 122.0 23.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 75.439999999999998 110.894 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 4.8 t -105.49 138.55 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 63.030000000000001 111.069 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.926 ' C ' HD23 ' A' ' 85' ' ' LEU . 40.8 m-70 -83.69 115.05 22.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 74.099999999999994 110.843 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.992 HD22 ' HG ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -125.25 105.98 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 73.230000000000004 110.905 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.66 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 5.3 t0 -139.08 131.63 28.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.129999999999995 110.887 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.98 6.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 110.848 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' A' ' 86' ' ' ASP . 37.5 t0 -67.21 -3.28 7.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 74.109999999999999 110.904 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 67.9 12.42 8.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 74.140000000000001 110.876 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -139.01 3.53 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 75.040000000000006 110.86 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.66 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 60.8 t -117.74 73.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 74.099999999999994 111.119 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.007 HD23 HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -132.48 12.61 4.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 71.230000000000004 110.895 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.53 164.52 12.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 75.519999999999996 110.873 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 9.9 t -104.08 169.45 8.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 74.329999999999998 111.16 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HB2' ' NE2' ' A' ' 84' ' ' HIS . 11.6 tp10 -146.95 124.74 5.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.652 0.739 . . . . 74.329999999999998 110.873 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 124.85 11.5 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.727 2.285 . . . . 74.200000000000003 112.363 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.687 ' HB1' ' NE ' ' A' ' 80' ' ' ARG . . . -115.49 117.4 30.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 63.130000000000003 111.086 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -124.33 46.0 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.510000000000005 110.843 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.404 ' HA2' HH12 ' A' ' 80' ' ' ARG . . . 77.28 -17.83 4.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 41.020000000000003 112.445 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.46 -56.6 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 72.310000000000002 110.828 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.48 23.16 44.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.721 . . . . 54.310000000000002 112.484 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 40.520000000000003 112.504 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 t0 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.786 0.327 . . . . 71.420000000000002 110.838 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -67.84 -21.47 65.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 72.340000000000003 110.915 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.58 ' HB2' HD13 ' A' ' 85' ' ' LEU . 12.4 t70 -58.63 -87.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 74.040000000000006 110.867 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 1.078 HD11 HD21 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -114.79 165.32 14.21 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.693 0.759 . . . . 61.030000000000001 111.13 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.507 ' HD2' HG22 ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.79 -1.12 7.95 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.252 . . . . 70.109999999999999 112.343 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.42 71.13 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 73.010000000000005 111.154 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.726 HG21 HD22 ' A' ' 20' ' ' LEU . 70.7 p -76.38 -166.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 71.150000000000006 111.134 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . 2.9 mm-40 -130.56 -93.12 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 74.25 110.892 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -69.22 5.88 1.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 74.540000000000006 110.849 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.915 HD21 ' CB ' ' A' ' 85' ' ' LEU . 10.8 mp -87.0 -34.07 19.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 75.439999999999998 110.931 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -64.89 -16.66 63.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 71.319999999999993 110.897 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.75 -63.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 72.349999999999994 110.87 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.6 -46.93 77.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 73.329999999999998 110.937 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.78 -53.15 8.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 53.119999999999997 112.487 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.64 51.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 62.240000000000002 111.102 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.683 ' HB3' HG11 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -67.2 -35.71 80.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 73.099999999999994 110.917 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.32 -97.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 73.439999999999998 111.141 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.426 ' O ' ' CB ' ' A' ' 29' ' ' ASP . 1.4 p90 -149.43 -18.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 75.450000000000003 110.857 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER 165.99 -10.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 74.209999999999994 110.839 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.69 -22.0 3.83 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.766 -0.731 . . . . 50.310000000000002 112.472 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' HG3' HG23 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -60.94 105.32 0.45 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 74.409999999999997 110.921 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.515 ' C ' ' HG3' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -70.17 -158.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 74.140000000000001 110.815 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -138.17 118.75 13.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 64.209999999999994 110.901 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 40.4 t -72.06 149.13 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 75.319999999999993 111.106 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -123.31 -0.59 8.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 71.109999999999999 111.16 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' H ' ' CG1' ' A' ' 34' ' ' VAL . . . -139.83 -154.75 6.39 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.726 . . . . 73.510000000000005 112.512 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HA ' ' OH ' ' A' ' 69' ' ' TYR . 53.7 Cg_endo -69.75 -166.12 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.667 2.244 . . . . 71.030000000000001 112.302 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.511 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -59.09 -30.43 68.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 74.120000000000005 110.812 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.93 -30.17 67.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 70.099999999999994 111.116 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.423 ' CB ' HG13 ' A' ' 34' ' ' VAL . 1.6 m-20 -76.51 -34.32 58.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 70.209999999999994 110.865 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.809 ' NH1' ' HB1' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -73.89 -44.18 56.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 74.010000000000005 110.853 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.729 ' HB2' ' HA2' ' A' ' 99' ' ' GLY . . . -67.88 -30.64 70.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.239999999999995 111.121 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.403 ' CG ' ' N ' ' A' ' 44' ' ' ALA . 14.7 ptt180 -85.1 -45.2 12.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 74.400000000000006 110.902 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.664 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . . . -77.9 -60.58 2.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 73.140000000000001 111.106 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -48.27 -22.18 0.63 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 55.210000000000001 111.082 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.681 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -54.55 -67.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 64.349999999999994 111.127 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.733 ' HA ' HG12 ' A' ' 50' ' ' VAL . 26.9 t -110.41 -15.82 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 71.109999999999999 111.136 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 50.0 mt-30 -80.74 -29.02 36.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 60.229999999999997 110.913 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.091 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.37 -10.86 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 72.209999999999994 111.087 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.0 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.74 0.07 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.634 0.731 . . . . 74.420000000000002 111.158 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.091 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.2 Cg_endo -69.76 -27.11 26.86 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.65 2.234 . . . . 63.340000000000003 112.335 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.11 -53.62 2.94 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 64.329999999999998 112.542 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.63 -35.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 62.310000000000002 112.489 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.803 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -146.26 149.35 33.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 45.350000000000001 111.143 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.812 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.82 82.83 1.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 62.149999999999999 111.102 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.717 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -140.62 99.68 0.25 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.713 -0.756 . . . . 73.319999999999993 112.478 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.664 ' OE1' ' HB3' ' A' ' 44' ' ' ALA . 63.3 tt0 -96.18 164.62 12.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.946 0.403 . . . . 63.43 110.843 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.417 HG23 ' HG3' ' A' ' 31' ' ' GLU . 2.1 t -111.76 119.13 59.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 73.400000000000006 111.112 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.759 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.21 133.57 43.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 51.439999999999998 110.898 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -133.39 121.86 22.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 54.140000000000001 111.131 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.477 ' H ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -123.16 162.76 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.430000000000007 110.854 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.41 135.72 34.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 61.520000000000003 111.106 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.44 -119.38 1.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 52.340000000000003 112.525 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -87.83 -23.62 23.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 64.230000000000004 110.889 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.3 -112.61 1.9 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 71.439999999999998 112.478 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.12 -82.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 75.420000000000002 111.104 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 13' ' ' ASP . . . -75.78 125.93 30.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 62.119999999999997 111.072 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.47 74.52 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 44.439999999999998 111.071 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.759 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -165.38 -131.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 74.129999999999995 110.912 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.606 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -167.99 172.24 42.63 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 62.130000000000003 112.539 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.803 HG12 HG22 ' A' ' 83' ' ' VAL . 6.0 p -130.07 120.16 48.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 72.319999999999993 111.129 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.991 HD23 ' HB3' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -98.36 142.3 30.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 74.109999999999999 110.919 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.683 HG11 ' HB3' ' A' ' 26' ' ' MET . 10.9 t -152.03 114.15 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 71.129999999999995 111.121 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.764 ' O ' HG22 ' A' ' 54' ' ' THR . 2.6 m -169.45 -133.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.329999999999998 111.141 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.568 ' H ' HG22 ' A' ' 74' ' ' THR . 0.1 OUTLIER -104.62 144.77 29.39 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.636 0.731 . . . . 72.319999999999993 110.841 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.8 Cg_endo -69.75 13.84 0.28 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.712 2.275 . . . . 70.420000000000002 112.341 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 75' ' ' ARG . 20.2 m-20 -93.94 35.49 1.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 74.129999999999995 110.855 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.36 -13.2 41.47 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.683 -0.77 . . . . 71.109999999999999 112.509 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.748 ' O ' ' HB ' ' A' ' 74' ' ' THR . 37.6 p -95.28 119.7 34.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.749 0.309 . . . . 71.140000000000001 111.163 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.991 ' HB3' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -141.61 161.13 38.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 73.510000000000005 110.869 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 97.3 t -119.0 81.5 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 64.209999999999994 111.092 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 72' ' ' LEU . 15.2 pt-20 -77.68 116.73 18.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.450000000000003 110.864 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.803 HG22 HG12 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -94.99 144.72 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 61.020000000000003 111.103 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -83.82 108.85 17.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 63.450000000000003 110.872 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.949 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 1.3 pp -124.98 110.26 13.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 75.299999999999997 110.919 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.585 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 3.9 m-20 -127.02 106.68 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 74.140000000000001 110.885 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.531 ' HG2' HG23 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -63.09 -0.34 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 110.892 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 86' ' ' ASP . 51.2 t0 -69.59 -13.15 62.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 73.040000000000006 110.876 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -165.66 -93.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 74.129999999999995 110.857 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.609 ' O ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -155.06 33.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 74.129999999999995 110.865 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.949 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 2.4 t -72.51 95.93 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 75.329999999999998 111.109 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.078 HD21 HD11 ' A' ' 14' ' ' ILE . 1.0 OUTLIER -127.68 18.82 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 72.510000000000005 110.922 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 84' ' ' HIS . 9.0 t0 -75.99 128.78 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 63.420000000000002 110.895 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.716 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 7.0 t -79.23 155.8 28.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 72.230000000000004 111.119 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.95 153.1 53.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.666 0.746 . . . . 73.329999999999998 110.872 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 140.37 42.61 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.66 2.24 . . . . 42.420000000000002 112.35 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.809 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -119.42 111.06 17.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 74.430000000000007 111.103 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -96.28 4.26 52.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 65.420000000000002 110.911 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.729 ' HA2' ' HB2' ' A' ' 42' ' ' ALA . . . 82.78 -21.98 7.12 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.738 . . . . 61.25 112.497 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.34 -31.24 12.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.779 0.323 . . . . 73.549999999999997 110.835 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.16 26.07 58.44 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.773 -0.727 . . . . 62.039999999999999 112.442 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.769 -0.729 . . . . 61.049999999999997 112.489 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.815 0.34 . . . . 71.129999999999995 110.878 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -65.88 -37.09 85.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 110.922 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' CB ' ' HB2' ' A' ' 85' ' ' LEU . 11.8 p-10 -65.54 -149.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 73.109999999999999 110.846 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.67 ' HB ' HG23 ' A' ' 17' ' ' THR . 0.1 OUTLIER -73.43 127.92 88.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.672 0.748 . . . . 64.109999999999999 111.12 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -1.52 8.6 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.638 2.225 . . . . 74.439999999999998 112.364 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.79 38.54 3.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 54.439999999999998 111.094 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.78 HG22 HD23 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -73.07 -168.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 61.420000000000002 111.159 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.634 ' H ' HD22 ' A' ' 92' ' ' LEU . 15.8 mm-40 -72.78 -100.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 70.310000000000002 110.925 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -98.73 8.29 45.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 72.299999999999997 110.894 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -72.21 -9.43 58.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 64.219999999999999 110.921 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -89.99 -8.81 50.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 74.209999999999994 110.964 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -74.39 -58.65 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 74.230000000000004 110.879 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.549 ' OE1' HG21 ' A' ' 83' ' ' VAL . 3.9 mp0 -66.13 -42.66 88.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 71.400000000000006 110.874 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.71 -31.49 2.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.728 -0.748 . . . . 71.319999999999993 112.484 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.7 -72.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.318 . . . . 42.32 111.077 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.6 ptm -70.6 -7.1 41.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.099999999999994 110.904 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' A' ' 31' ' ' GLU . . . -65.53 -47.19 76.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 52.039999999999999 111.057 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -81.86 6.1 16.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 75.450000000000003 110.879 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -72.04 -68.59 0.45 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 110.857 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.89 8.98 2.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.776 -0.726 . . . . 72.409999999999997 112.532 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HG3' ' HA ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -79.37 177.67 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 74.010000000000005 110.904 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.09 -168.8 2.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 75.209999999999994 110.874 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -109.54 119.88 40.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 110.909 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 35' ' ' THR . 2.2 t -73.12 -136.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 71.129999999999995 111.131 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.565 ' H ' HG12 ' A' ' 34' ' ' VAL . 71.5 p -136.72 -47.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 71.319999999999993 111.158 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.45 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 163.0 -61.18 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 61.009999999999998 112.493 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.5 Cg_endo -69.7 159.18 54.39 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.747 2.298 . . . . 64.510000000000005 112.318 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.411 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 2.1 p30 -64.88 -26.04 68.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 75.140000000000001 110.852 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.03 -39.14 74.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 74.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 1.9 m-20 -86.06 -39.85 16.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.340000000000003 110.882 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.633 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 6.8 ptt180 -68.05 -38.81 82.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 71.230000000000004 110.868 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.601 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -68.3 -35.29 77.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 52.399999999999999 111.071 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -82.03 -40.53 21.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 64.430000000000007 110.898 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.593 ' HB1' ' CD ' ' A' ' 57' ' ' GLU . . . -77.48 -59.84 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 63.310000000000002 111.101 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.733 ' HB2' HD23 ' A' ' 72' ' ' LEU . . . -52.76 -20.22 3.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 111.091 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.66 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -63.63 -78.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 111.092 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.719 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.6 t -108.44 -17.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 73.109999999999999 111.179 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.486 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -74.41 -29.79 61.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.120000000000005 110.905 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.068 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.94 -2.82 19.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 70.200000000000003 111.132 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.999 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -95.7 -2.9 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.612 0.72 . . . . 71.400000000000006 111.143 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.068 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.9 Cg_endo -69.77 -27.66 26.13 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.666 2.244 . . . . 65.230000000000004 112.343 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.11 -57.15 2.87 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.78 -0.724 . . . . 25.23 112.502 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.07 -34.76 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 71.019999999999996 112.504 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 74' ' ' THR . 0.2 OUTLIER -146.41 152.1 38.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 54.25 111.151 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.84 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.39 77.01 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 54.43 111.116 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.714 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -148.53 105.68 0.31 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 75.349999999999994 112.487 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.593 ' CD ' ' HB1' ' A' ' 44' ' ' ALA . 3.2 tt0 -95.78 -171.95 2.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.907 0.384 . . . . 74.540000000000006 110.896 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.037 HG13 HG22 ' A' ' 71' ' ' VAL . 83.8 t -136.86 131.43 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 60.439999999999998 111.126 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -99.1 121.78 41.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 71.120000000000005 110.852 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 t -110.35 119.19 38.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 55.329999999999998 111.137 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -143.47 121.92 12.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 50.130000000000003 110.908 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.74 148.8 24.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 72.099999999999994 111.159 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.13 -106.71 0.99 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.781 -0.723 . . . . 53.240000000000002 112.529 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -87.91 -25.7 23.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 70.030000000000001 110.936 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.33 -121.56 2.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 60.0 112.465 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.32 33.87 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.768 0.318 . . . . 61.140000000000001 111.112 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.51 ' HA ' ' H ' ' A' ' 87' ' ' ARG . . . -63.71 -155.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 72.040000000000006 111.122 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.567 ' O ' ' O ' ' A' ' 61' ' ' GLU . . . -157.06 -104.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 71.109999999999999 111.111 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.579 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 2.9 t80 -170.29 -85.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.902 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.611 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -168.53 157.04 28.96 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 53.340000000000003 112.494 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.037 HG22 HG13 ' A' ' 58' ' ' VAL . 89.8 t -123.45 120.8 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.838 0.351 . . . . 73.530000000000001 111.093 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.82 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -106.17 134.19 49.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 73.230000000000004 110.93 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.714 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.2 p -147.67 118.61 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 72.129999999999995 111.12 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.751 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.7 m -169.19 -133.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 111.141 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.557 ' H ' HG22 ' A' ' 74' ' ' THR . 3.6 mtt-85 -101.53 148.4 35.18 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.636 0.732 . . . . 71.25 110.831 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.4 Cg_endo -69.84 9.41 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.652 2.234 . . . . 75.230000000000004 112.342 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -88.38 38.67 0.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 75.140000000000001 110.87 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.11 -7.05 8.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 64.200000000000003 112.428 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.751 ' O ' ' HB ' ' A' ' 74' ' ' THR . 31.1 p -98.85 115.42 28.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.793 0.33 . . . . 73.040000000000006 111.175 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.727 ' O ' ' HB3' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -138.62 160.59 39.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 72.319999999999993 110.861 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 61.6 t -113.88 87.02 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 54.399999999999999 111.132 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -81.04 121.37 25.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.200000000000003 110.908 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.611 ' O ' ' CA ' ' A' ' 70' ' ' GLY . 1.8 t -97.55 160.57 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 63.32 111.137 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.691 ' C ' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -104.55 109.14 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 110.873 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.917 HD13 ' N ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -128.72 111.14 12.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 52.409999999999997 110.925 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.612 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 21.1 m-20 -136.51 108.66 7.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 64.519999999999996 110.846 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.51 ' H ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -66.36 0.61 2.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.099999999999994 110.903 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 89' ' ' PHE . 51.6 t0 -69.88 -11.88 61.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 72.420000000000002 110.852 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.484 ' CD1' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -166.54 -93.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 62.240000000000002 110.903 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 35.53 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 74.200000000000003 110.86 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.745 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 9.2 t -69.47 100.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 65.409999999999997 111.145 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.812 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -135.04 16.89 3.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 64.230000000000004 110.932 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 84' ' ' HIS . 14.6 t0 -80.75 147.65 30.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 61.399999999999999 110.881 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.434 ' HA ' HG13 ' A' ' 83' ' ' VAL . 15.3 t -90.38 165.0 14.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 74.400000000000006 111.11 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -146.45 122.61 5.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 71.129999999999995 110.915 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 128.91 16.73 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.684 2.256 . . . . 73.150000000000006 112.364 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -116.82 114.09 23.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 71.109999999999999 111.116 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 100' ' ' ASP . 4.8 t0 -124.9 46.4 2.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 72.299999999999997 110.898 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 -17.34 1.69 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 61.32 112.509 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 98' ' ' ASP . 0.4 OUTLIER -95.93 -65.39 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 74.319999999999993 110.88 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.64 21.67 12.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 53.039999999999999 112.467 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 74.140000000000001 112.486 -179.926 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.819 0.342 . . . . 73.409999999999997 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -74.1 -25.19 59.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 70.140000000000001 110.917 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.527 ' OD2' HD23 ' A' ' 20' ' ' LEU . 14.7 p-10 -64.12 -151.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 65.439999999999998 110.886 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.525 HG21 ' HG3' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -102.3 166.88 11.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 64.109999999999999 111.086 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' A' ' 14' ' ' ILE . 54.0 Cg_endo -69.76 -2.52 10.31 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 74.129999999999995 112.361 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.1 p -141.83 94.2 2.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 74.129999999999995 111.168 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.944 HG22 HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -118.83 -167.25 1.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 64.099999999999994 111.141 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.464 ' CB ' HD23 ' A' ' 92' ' ' LEU . 11.8 tt0 -110.36 -94.29 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 71.230000000000004 110.883 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -57.0 -17.9 11.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.937 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.784 HD13 ' CD2' ' A' ' 85' ' ' LEU . 2.4 mp -84.11 -19.51 34.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 62.140000000000001 110.88 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -66.23 -17.71 64.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 71.400000000000006 110.941 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.17 -22.58 15.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 74.0 110.891 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -66.72 -29.82 69.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 72.299999999999997 110.936 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.4 -29.7 1.83 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.733 -0.746 . . . . 44.539999999999999 112.503 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.403 ' O ' ' CD2' ' A' ' 28' ' ' PHE . . . -73.57 -64.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 51.340000000000003 111.105 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.791 ' CE ' HG11 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -64.36 -7.02 8.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 70.329999999999998 110.872 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' A' ' 31' ' ' GLU . . . -103.79 25.3 10.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.140000000000001 111.072 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -73.54 2.3 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 71.140000000000001 110.862 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 t70 179.92 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 53.32 110.873 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.31 -2.48 48.79 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 74.219999999999999 112.473 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.651 ' CG ' HG21 ' A' ' 58' ' ' VAL . 2.1 tm-20 -94.4 105.05 17.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 61.229999999999997 110.913 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 3.9 m-20 -119.34 -152.29 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 64.129999999999995 110.855 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -118.63 109.57 16.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 55.009999999999998 110.84 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 58' ' ' VAL . 21.3 t -81.03 -119.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 51.109999999999999 111.137 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.626 ' N ' HG12 ' A' ' 34' ' ' VAL . 68.5 p -141.8 -77.85 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 63.299999999999997 111.123 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.445 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -171.73 -61.1 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.762 -0.732 . . . . 73.329999999999998 112.51 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.8 Cg_endo -69.77 158.96 55.15 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.692 2.262 . . . . 65.439999999999998 112.35 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.474 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -66.56 -32.44 73.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 61.5 110.861 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.66 -30.78 14.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 32.409999999999997 111.096 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.42 -31.85 26.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 73.099999999999994 110.859 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HG2' ' N ' ' A' ' 42' ' ' ALA . 9.0 ptt-85 -57.71 -36.69 72.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 73.099999999999994 110.852 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.805 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -71.25 -33.02 69.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 61.409999999999997 111.11 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.474 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 2.2 ptt85 -77.71 -38.73 46.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 62.020000000000003 110.898 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.681 ' HB1' ' HG3' ' A' ' 57' ' ' GLU . . . -79.74 -59.15 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 72.340000000000003 111.136 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.848 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -57.63 -18.29 19.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 60.310000000000002 111.104 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.805 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -59.45 -81.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 42.420000000000002 111.077 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.766 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 59.7 t -114.99 -15.96 9.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 111.117 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.2 mt-30 -73.78 -31.96 63.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 65.319999999999993 110.893 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.041 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.88 -1.58 20.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.439 . . . . 73.219999999999999 111.144 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.989 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.34 -5.48 0.11 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.602 0.715 . . . . 74.349999999999994 111.141 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.041 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.4 Cg_endo -69.73 -29.32 24.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.281 . . . . 74.099999999999994 112.319 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.44 -54.04 5.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.72 -0.752 . . . . 45.350000000000001 112.442 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.49 -33.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.725 -0.75 . . . . 71.409999999999997 112.458 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.587 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -145.92 156.0 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 74.549999999999997 111.141 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.784 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.28 76.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 61.340000000000003 111.084 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.741 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -145.99 107.26 0.41 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.744 -0.741 . . . . 72.140000000000001 112.517 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.681 ' HG3' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -98.1 -169.27 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.353 . . . . 73.209999999999994 110.909 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.739 HG22 ' HB ' ' A' ' 71' ' ' VAL . 53.4 t -141.56 110.93 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 74.409999999999997 111.092 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.752 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 5.0 mt-10 -94.96 162.87 13.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 63.219999999999999 110.906 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.642 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -126.26 119.56 27.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 62.210000000000001 111.162 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 159.51 37.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 75.340000000000003 110.914 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.0 p -125.1 100.52 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 63.240000000000002 111.126 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.83 -141.54 8.76 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 61.399999999999999 112.487 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -88.05 0.53 55.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.857 0.361 . . . . 73.439999999999998 110.874 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -102.75 -121.71 4.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 53.32 112.517 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.666 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -120.82 -77.07 0.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.743 0.306 . . . . 60.539999999999999 111.062 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -111.21 86.65 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 54.43 111.065 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.818 ' HB2' ' OD2' ' A' ' 86' ' ' ASP . . . -98.67 85.47 3.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 51.32 111.1 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.752 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 0.5 OUTLIER -115.55 158.72 22.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 74.510000000000005 110.873 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.648 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -124.94 127.69 6.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 73.310000000000002 112.481 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.739 ' HB ' HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -109.26 123.42 65.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 71.409999999999997 111.146 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.797 HD22 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -84.61 142.92 29.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 75.150000000000006 110.895 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.791 HG11 ' CE ' ' A' ' 26' ' ' MET . 77.5 t -151.21 95.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 62.140000000000001 111.082 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.77 HG22 ' H ' ' A' ' 75' ' ' ARG . 1.3 m -168.27 -149.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 111.16 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.77 ' H ' HG22 ' A' ' 74' ' ' THR . 7.7 mtm180 -103.94 151.92 38.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.614 0.721 . . . . 75.219999999999999 110.853 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.8 Cg_endo -69.79 7.56 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.686 2.258 . . . . 61.109999999999999 112.368 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.49 19.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 75.319999999999993 110.877 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 76' ' ' PRO . . . 94.71 -14.09 65.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 52.32 112.484 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.747 ' O ' ' HB ' ' A' ' 74' ' ' THR . 3.0 t -98.05 125.37 43.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.778 0.323 . . . . 73.209999999999994 111.144 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.608 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -136.56 159.81 40.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 73.409999999999997 110.894 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 42.8 t -118.11 92.67 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 74.209999999999994 111.129 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.635 ' HB2' HD12 ' A' ' 72' ' ' LEU . 87.3 tt0 -82.77 119.83 24.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 74.010000000000005 110.874 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.648 ' O ' ' HA2' ' A' ' 70' ' ' GLY . 2.0 t -100.01 111.61 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 111.159 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.736 ' O ' HD22 ' A' ' 85' ' ' LEU . 3.9 t-160 -86.68 110.53 19.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 64.129999999999995 110.857 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.944 HD12 HG22 ' A' ' 17' ' ' THR . 3.0 mm? -127.6 127.96 44.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 74.150000000000006 110.923 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.818 ' OD2' ' HB2' ' A' ' 68' ' ' ALA . 13.3 t0 -135.45 132.68 37.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 63.420000000000002 110.869 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.666 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 3.2 tmt_? -57.99 2.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 64.230000000000004 110.885 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.566 ' H ' ' C ' ' A' ' 86' ' ' ASP . 4.7 t0 -66.78 -4.69 9.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 73.099999999999994 110.876 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 68.23 12.18 8.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 74.340000000000003 110.883 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -135.54 -1.23 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 65.519999999999996 110.851 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.769 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 96.8 t -116.67 92.91 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 63.329999999999998 111.151 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.792 ' HA ' HD13 ' A' ' 85' ' ' LEU . 5.3 mp -144.41 14.52 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 73.140000000000001 110.879 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.06 137.14 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 71.329999999999998 110.883 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.61 ' HB ' HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -96.47 130.01 43.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 72.140000000000001 111.167 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLU . 71.4 tt0 -99.94 127.16 34.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.615 0.721 . . . . 73.219999999999999 110.933 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 114.63 3.77 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.675 2.25 . . . . 63.119999999999997 112.333 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -64.53 114.33 4.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 44.420000000000002 111.11 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.08 15.09 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 65.430000000000007 110.899 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.65 -21.51 2.46 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.763 . . . . 71.409999999999997 112.482 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -97.55 -38.44 9.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.835 0.35 . . . . 72.450000000000003 110.869 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.85 47.0 5.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 62.329999999999998 112.482 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 65.129999999999995 112.464 -179.937 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.744 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 75.340000000000003 110.867 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -68.93 -44.22 73.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.120000000000005 110.905 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.439 ' OD2' HD23 ' A' ' 20' ' ' LEU . 5.9 p-10 -66.33 -147.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 70.310000000000002 110.857 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.883 HG22 ' H ' ' A' ' 16' ' ' THR . 26.3 mm -75.76 119.15 75.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.596 0.713 . . . . 71.349999999999994 111.138 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 4.06 2.38 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.74 2.293 . . . . 74.409999999999997 112.32 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.883 ' H ' HG22 ' A' ' 14' ' ' ILE . 2.8 m -115.03 20.95 14.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 63.409999999999997 111.193 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.902 ' CB ' HD22 ' A' ' 20' ' ' LEU . 1.2 p -81.36 -165.15 0.88 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 62.210000000000001 111.142 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.671 ' HG3' HD13 ' A' ' 92' ' ' LEU . 1.1 mm-40 -71.89 -131.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.242 -0.435 . . . . 72.219999999999999 110.883 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.41 12.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 55.32 110.916 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.902 HD22 ' CB ' ' A' ' 17' ' ' THR . 7.5 mp -57.42 -27.54 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 62.149999999999999 110.895 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -95.96 7.04 47.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.913 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -110.55 -42.72 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 72.219999999999999 110.861 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -65.11 -51.8 59.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 75.439999999999998 110.922 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.76 -54.55 6.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 72.349999999999994 112.528 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.96 52.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.768 0.318 . . . . 73.030000000000001 111.119 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.429 ' CE ' ' HB2' ' A' ' 27' ' ' ALA . 1.4 ptm -66.98 -39.8 87.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 72.239999999999995 110.911 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HB2' ' CE ' ' A' ' 26' ' ' MET . . . -120.77 -92.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 62.520000000000003 111.095 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -145.0 -27.17 0.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 110.855 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.68 28.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 73.319999999999993 110.848 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.16 9.62 25.18 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.729 -0.748 . . . . 52.539999999999999 112.519 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HB3' HG23 ' A' ' 58' ' ' VAL . 2.8 mp0 -93.61 98.46 11.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 74.420000000000002 110.909 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -65.84 -162.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 73.409999999999997 110.835 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -129.15 102.2 6.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 110.9 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.845 HG23 ' HG3' ' A' ' 57' ' ' GLU . 1.0 OUTLIER -72.7 159.0 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 71.230000000000004 111.124 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.526 HG23 ' CG ' ' A' ' 40' ' ' ASP . 70.0 p -91.36 -38.07 12.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 62.340000000000003 111.143 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' H ' HG13 ' A' ' 34' ' ' VAL . . . 166.47 -64.44 0.21 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.737 . . . . 63.420000000000002 112.476 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 160.4 49.83 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 64.530000000000001 112.338 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 2.2 p-10 -60.62 -29.18 69.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 75.349999999999994 110.866 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.04 -30.92 49.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 60.399999999999999 111.063 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.526 ' CG ' HG23 ' A' ' 35' ' ' THR . 0.4 OUTLIER -82.24 -35.04 28.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 63.439999999999998 110.896 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.526 ' HG3' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -71.74 -41.09 68.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 70.540000000000006 110.822 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.97 -35.05 71.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 65.109999999999999 111.072 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.7 ptt85 -80.57 -39.5 27.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 71.530000000000001 110.885 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.624 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -75.81 -60.38 2.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 52.240000000000002 111.064 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 1.029 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -56.47 -16.94 6.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 75.019999999999996 111.082 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -62.51 -67.42 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 71.219999999999999 111.112 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.673 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.7 t -122.31 -14.79 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 72.319999999999993 111.118 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.624 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 50.5 mt-30 -79.69 -41.46 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.140000000000001 110.906 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.029 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . . . -104.71 -0.23 27.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 71.310000000000002 111.089 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.978 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -93.72 -11.68 0.17 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 55.0 111.089 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.978 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 54.2 Cg_endo -69.76 -28.04 25.75 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.681 2.254 . . . . 72.120000000000005 112.372 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.26 -44.14 44.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 25.309999999999999 112.475 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.36 -31.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 70.420000000000002 112.475 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 74' ' ' THR . 1.0 OUTLIER -149.92 157.24 42.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.824 0.345 . . . . 61.43 111.139 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.708 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.0 75.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 41.210000000000001 111.111 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.662 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -146.58 111.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 72.439999999999998 112.456 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.845 ' HG3' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -103.93 -170.69 1.81 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 70.049999999999997 110.869 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.559 HG13 ' CE1' ' A' ' 69' ' ' TYR . 3.3 t -131.21 120.77 47.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 72.540000000000006 111.14 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.565 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -93.38 126.07 38.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.540000000000006 110.872 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.8 t -107.99 105.31 15.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 70.319999999999993 111.148 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.608 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -136.36 158.19 45.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 73.319999999999993 110.903 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.6 p -125.13 113.77 18.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 60.539999999999999 111.143 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -92.46 -179.37 40.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.74 . . . . 73.420000000000002 112.491 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.63 -14.38 62.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 52.450000000000003 110.852 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -86.35 -111.18 0.83 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 55.130000000000003 112.458 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -113.99 -77.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.772 0.32 . . . . 72.310000000000002 111.1 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -108.67 158.21 17.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 60.409999999999997 111.103 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -151.94 49.78 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 53.539999999999999 111.107 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.744 ' HH ' ' N ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -120.35 129.32 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 53.039999999999999 110.979 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -112.05 159.03 13.94 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 31.300000000000001 112.516 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 71' ' ' VAL . 5.5 p -124.25 113.23 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 72.0 111.146 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.916 HD21 ' HB3' ' A' ' 80' ' ' ARG . 2.3 tt -91.1 145.14 24.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 73.409999999999997 110.929 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.58 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 14.6 t -158.57 112.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 71.439999999999998 111.159 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.832 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -174.89 -148.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 72.209999999999994 111.119 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.454 ' H ' HG22 ' A' ' 74' ' ' THR . 9.9 mmm180 -106.0 143.86 27.75 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.59 0.71 . . . . 65.439999999999998 110.85 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.83 11.46 0.4 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.716 2.277 . . . . 72.329999999999998 112.301 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 75' ' ' ARG . 9.0 m-20 -86.16 32.36 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 75.340000000000003 110.905 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.48 -14.58 34.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 60.310000000000002 112.495 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.489 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.4 t -99.81 106.17 18.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.786 0.327 . . . . 71.400000000000006 111.149 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.916 ' HB3' HD21 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -135.58 154.97 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 74.430000000000007 110.877 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.56 ' N ' ' OG1' ' A' ' 74' ' ' THR . 47.9 t -114.19 100.37 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.349999999999994 111.1 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.696 ' HB3' HD12 ' A' ' 72' ' ' LEU . 9.2 pt-20 -85.61 109.19 18.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 71.420000000000002 110.866 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.855 HG13 ' HB ' ' A' ' 94' ' ' THR . 2.1 t -99.62 107.84 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 111.136 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.754 ' C ' HD23 ' A' ' 85' ' ' LEU . 5.4 m-70 -84.3 121.17 27.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 62.450000000000003 110.855 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.783 HD23 ' N ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -106.98 105.57 15.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 72.120000000000005 110.913 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.732 ' H ' ' HA ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -128.65 115.34 17.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 70.109999999999999 110.888 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.551 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 1.2 tmt_? -61.45 -7.8 3.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 53.310000000000002 110.85 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.689 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 24.5 t70 -83.72 32.81 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 72.209999999999994 110.839 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.689 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 18.8 m-85 97.68 -30.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 74.109999999999999 110.853 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.46 35.36 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 75.519999999999996 110.808 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.831 ' O ' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.69 -28.0 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 71.310000000000002 111.115 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.671 HD13 ' HG3' ' A' ' 18' ' ' GLU . 1.9 mt -122.43 29.57 6.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 74.019999999999996 110.893 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 84' ' ' HIS . 33.0 t70 -71.34 66.58 0.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.030000000000001 110.918 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.855 ' HB ' HG13 ' A' ' 83' ' ' VAL . 10.2 t -84.86 151.41 24.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 74.099999999999994 111.118 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -146.06 157.78 49.53 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.654 0.74 . . . . 73.540000000000006 110.861 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 131.92 22.19 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.633 2.222 . . . . 75.140000000000001 112.317 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -112.59 103.19 11.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 52.229999999999997 111.111 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.21 11.28 38.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 65.420000000000002 110.911 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 42' ' ' ALA . . . 86.44 -19.32 28.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 50.530000000000001 112.495 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -95.67 -41.99 8.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 71.409999999999997 110.907 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.85 28.69 45.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 32.119999999999997 112.484 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.757 -0.735 . . . . 41.229999999999997 112.528 -179.94 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.804 0.335 . . . . 74.209999999999994 110.825 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 33' ' ' GLU . 82.8 m-85 -65.43 -54.31 30.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 73.329999999999998 110.92 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.02 -158.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 71.120000000000005 110.878 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.492 HD11 ' N ' ' A' ' 87' ' ' ARG . 1.2 mp -74.42 121.64 85.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.591 0.71 . . . . 63.25 111.13 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -5.47 16.26 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.689 2.259 . . . . 72.450000000000003 112.341 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.466 ' H ' HG22 ' A' ' 14' ' ' ILE . 34.3 p -145.44 88.3 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.230000000000004 111.16 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.917 HG22 HD23 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -132.55 -159.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 74.120000000000005 111.149 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.08 -94.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 52.32 110.927 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -87.88 11.18 16.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 62.520000000000003 110.887 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.867 HD22 HD12 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -93.55 -34.72 13.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 73.5 110.922 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -67.45 -11.54 58.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.892 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -93.94 -59.76 1.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 62.119999999999997 110.842 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -66.32 -41.36 89.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 74.239999999999995 110.927 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -42.35 -34.89 1.72 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.717 -0.754 . . . . 64.25 112.44 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.9 -60.6 3.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.77 0.319 . . . . 72.439999999999998 111.061 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.5 ptp -69.79 -9.52 54.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 64.209999999999994 110.878 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 24' ' ' GLY . . . -76.85 -19.67 57.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.109999999999999 111.056 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -82.03 8.94 9.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 73.530000000000001 110.896 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -70.7 -80.85 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 55.530000000000001 110.866 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.05 11.4 0.19 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 71.420000000000002 112.493 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.699 ' OE1' HG23 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -67.52 176.94 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 60.509999999999998 110.894 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.22 -164.12 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 74.239999999999995 110.86 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.427 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 1.5 pt-20 -111.0 166.58 10.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 73.230000000000004 110.883 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -100.03 167.8 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.485 . . . . 71.109999999999999 111.078 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.58 ' N ' HG13 ' A' ' 34' ' ' VAL . 44.3 p -94.79 -42.08 8.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.148 -0.478 . . . . 71.230000000000004 111.188 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.426 ' N ' HG13 ' A' ' 34' ' ' VAL . . . 166.89 -64.65 0.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.736 . . . . 52.119999999999997 112.501 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.425 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.8 Cg_endo -69.74 157.26 61.04 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.684 2.256 . . . . 74.409999999999997 112.333 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -59.79 -28.95 67.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 55.219999999999999 110.908 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.11 -33.51 57.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 61.420000000000002 111.137 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.672 ' HB3' HG22 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -84.1 -32.07 24.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 71.209999999999994 110.905 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.912 ' HB2' HD21 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -69.45 -44.84 70.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 74.549999999999997 110.832 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.747 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -71.77 -34.72 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 72.010000000000005 111.061 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.3 ptt85 -76.37 -39.84 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 63.200000000000003 110.863 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.591 ' HA ' ' HB2' ' A' ' 48' ' ' GLN . . . -75.44 -59.76 2.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 73.420000000000002 111.118 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.731 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -58.03 -13.55 4.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 60.140000000000001 111.089 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.747 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -71.28 -71.96 0.24 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 44.039999999999999 111.15 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.714 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.3 t -113.56 -9.34 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 74.319999999999993 111.147 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -83.0 -39.92 20.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.430000000000007 110.921 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.731 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . . . -102.41 -5.87 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 70.049999999999997 111.067 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.959 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -81.13 -25.51 0.41 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.64 0.733 . . . . 72.120000000000005 111.129 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.959 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 53.9 Cg_endo -69.72 -10.19 27.97 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.69 2.26 . . . . 73.519999999999996 112.342 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.6 -27.34 15.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.74 . . . . 53.130000000000003 112.498 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.81 -32.54 0.3 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.737 . . . . 64.129999999999995 112.535 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.586 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -155.15 164.7 38.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 63.310000000000002 111.113 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.724 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -75.17 65.96 1.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 64.049999999999997 111.114 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.712 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -141.13 105.85 0.45 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 63.030000000000001 112.514 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.529 ' CG ' ' HB2' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -94.97 -162.06 0.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 72.340000000000003 110.931 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.723 HG22 ' CG1' ' A' ' 71' ' ' VAL . 29.4 t -129.31 119.36 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 75.430000000000007 111.14 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.814 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 1.6 mt-10 -93.34 136.01 34.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 73.510000000000005 110.857 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 60' ' ' THR . 3.5 t -138.44 115.62 11.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 74.200000000000003 111.168 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.802 ' C ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -122.31 178.3 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 110.865 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.77 128.87 49.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 52.109999999999999 111.109 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.469 ' N ' ' HB2' ' A' ' 68' ' ' ALA . . . -128.49 -144.77 5.87 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.768 -0.729 . . . . 35.329999999999998 112.517 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -87.25 -21.32 25.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.887 0.375 . . . . 75.230000000000004 110.889 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.67 -109.93 3.01 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.737 . . . . 73.439999999999998 112.516 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.47 -81.48 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.326 . . . . 54.32 111.113 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.691 ' HB3' ' HB2' ' A' ' 87' ' ' ARG . . . -78.08 128.04 33.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 53.439999999999998 111.105 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.802 ' HB3' ' C ' ' A' ' 61' ' ' GLU . . . -122.69 45.71 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 65.349999999999994 111.067 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.814 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -170.86 -152.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 74.450000000000003 110.928 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 83' ' ' VAL . . . -158.8 -126.84 0.88 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 63.310000000000002 112.488 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.723 ' CG1' HG22 ' A' ' 58' ' ' VAL . 4.5 m -152.67 151.95 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.373 . . . . 73.040000000000006 111.131 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.912 HD21 ' HB2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -104.81 152.41 22.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 72.5 110.923 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.698 ' O ' HG22 ' A' ' 81' ' ' VAL . 2.1 p -155.17 106.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 52.130000000000003 111.119 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.844 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -172.32 -142.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 111.158 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.456 ' H ' HG22 ' A' ' 74' ' ' THR . 3.6 mtm180 -110.13 149.18 39.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.599 0.714 . . . . 64.340000000000003 110.887 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' A' ' 55' ' ' ALA . 53.4 Cg_endo -69.77 8.36 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.694 2.263 . . . . 74.319999999999993 112.361 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.16 33.09 0.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 71.239999999999995 110.914 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.73 -11.45 10.4 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.753 -0.737 . . . . 70.340000000000003 112.456 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.469 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.2 t -101.61 105.21 16.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.318 . . . . 71.140000000000001 111.168 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.844 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 2.4 ptp85 -138.64 157.48 46.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 63.200000000000003 110.856 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 73' ' ' VAL . 18.0 m -114.03 96.65 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 111.098 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.735 ' HB3' HD23 ' A' ' 72' ' ' LEU . 1.3 pp20? -87.24 125.07 33.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 70.019999999999996 110.902 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.758 HG12 HD21 ' A' ' 85' ' ' LEU . 4.5 t -91.52 139.89 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 75.409999999999997 111.141 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.97 ' C ' HD23 ' A' ' 85' ' ' LEU . 1.2 t60 -117.9 106.04 12.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 110.833 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.97 HD23 ' C ' ' A' ' 84' ' ' HIS . 2.7 mt -131.6 139.12 49.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 51.32 110.893 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.631 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -103.68 111.77 24.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 73.140000000000001 110.84 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.691 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 1.3 tmt_? -50.07 -21.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 74.340000000000003 110.851 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.489 ' HB3' ' OD1' ' A' ' 86' ' ' ASP . 4.7 t0 -68.28 5.36 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 65.420000000000002 110.879 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.426 ' H ' ' C ' ' A' ' 87' ' ' ARG . 37.5 m-85 67.08 42.51 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 110.898 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.842 ' HG3' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -129.09 -29.76 2.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 71.140000000000001 110.848 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.944 HG12 ' HA ' ' A' ' 85' ' ' LEU . 54.2 t -125.0 125.82 70.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 63.32 111.133 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.917 HD23 HG22 ' A' ' 17' ' ' THR . 1.9 mp -145.27 17.27 1.53 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 64.219999999999999 110.891 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 84' ' ' HIS . 21.1 t0 -101.35 143.97 30.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 72.030000000000001 110.867 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.538 ' HB ' HG13 ' A' ' 83' ' ' VAL . 13.9 t -84.83 176.3 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 73.540000000000006 111.133 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 82' ' ' GLU . 3.7 tt0 -145.72 128.89 8.27 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.604 0.716 . . . . 72.310000000000002 110.897 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 115.17 3.96 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 63.32 112.392 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.821 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -94.58 115.73 27.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 71.430000000000007 111.069 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -102.19 15.13 30.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 73.030000000000001 110.891 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.63 -19.46 9.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.745 -0.74 . . . . 51.100000000000001 112.514 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -96.11 -42.69 8.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 52.539999999999999 110.834 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.07 26.68 54.97 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.728 -0.748 . . . . 75.140000000000001 112.465 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.712 -0.756 . . . . 74.420000000000002 112.535 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.826 0.346 . . . . 60.310000000000002 110.856 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.707 ' HA ' HD13 ' A' ' 85' ' ' LEU . 4.5 p90 -94.43 -175.44 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 54.509999999999998 110.907 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -119.4 -31.56 4.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.519 . . . . 64.420000000000002 110.852 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.733 ' O ' HG23 ' A' ' 17' ' ' THR . 0.8 OUTLIER -101.07 127.57 31.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.607 0.718 . . . . 74.239999999999995 111.129 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 18.73 0.19 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.747 2.298 . . . . 62.340000000000003 112.305 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -138.95 39.76 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 74.310000000000002 111.12 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 14' ' ' ILE . 65.0 p -72.73 -166.5 0.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 64.200000000000003 111.161 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -132.79 -86.7 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 110.901 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -75.08 6.64 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 71.420000000000002 110.911 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.907 HD21 ' HB3' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -92.59 -37.85 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 61.420000000000002 110.904 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -75.17 -7.49 53.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 110.969 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -94.43 -26.31 16.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 74.319999999999993 110.886 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -30.03 29.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 72.430000000000007 110.896 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.9 -30.7 1.04 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.746 -0.74 . . . . 50.439999999999998 112.486 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.56 -56.88 4.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 72.120000000000005 111.112 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.607 ' SD ' HG21 ' A' ' 73' ' ' VAL . 11.6 ptp -65.15 -11.77 43.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 73.049999999999997 110.866 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.933 ' HB1' ' HB2' ' A' ' 31' ' ' GLU . . . -101.5 26.11 7.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.450000000000003 111.104 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.416 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 7.4 p90 -63.15 -16.65 60.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 71.140000000000001 110.857 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -147.6 -44.97 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 72.540000000000006 110.881 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.97 -18.21 25.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.724 . . . . 64.409999999999997 112.46 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.933 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 1.9 tm-20 -64.7 92.12 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.883 0.373 . . . . 74.319999999999993 110.868 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.434 ' HB3' ' CD ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -103.22 -161.04 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 63.210000000000001 110.882 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -122.63 114.01 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 110.911 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 35' ' ' THR . 11.4 t -90.7 172.34 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 61.240000000000002 111.112 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.672 ' H ' HG12 ' A' ' 34' ' ' VAL . 34.3 p -89.73 -54.1 4.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 64.349999999999994 111.178 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.73 -64.89 0.11 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.721 -0.752 . . . . 74.409999999999997 112.51 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.461 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.9 Cg_endo -69.74 159.04 54.9 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.693 2.262 . . . . 75.430000000000007 112.375 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -60.65 -29.0 68.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 74.010000000000005 110.882 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.477 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . . . -54.37 -35.66 63.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 62.439999999999998 111.077 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.53 ' HA ' ' CG ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -85.45 -28.59 24.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 71.439999999999998 110.846 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 97' ' ' ALA . 0.6 OUTLIER -73.99 -42.61 60.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 60.020000000000003 110.894 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.43 -33.71 71.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 111.058 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.53 ' CG ' ' HA ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -79.72 -42.56 24.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 74.299999999999997 110.843 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -75.22 -61.61 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 44.420000000000002 111.097 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.983 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . . . -51.08 -23.76 3.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 62.229999999999997 111.107 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.62 ' O ' ' CG2' ' A' ' 50' ' ' VAL . . . -51.93 -67.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 70.219999999999999 111.142 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.638 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 25.3 t -111.18 -22.0 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 53.539999999999999 111.119 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 45.2 mt-30 -73.98 -29.21 61.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 61.310000000000002 110.911 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.109 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.42 -6.95 15.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 71.010000000000005 111.134 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 14.3 t -95.66 1.92 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.713 . . . . 62.119999999999997 111.108 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.109 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.0 Cg_endo -69.71 -20.35 35.16 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.265 . . . . 62.100000000000001 112.373 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.72 -40.54 3.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.731 . . . . 64.140000000000001 112.52 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.96 -32.8 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.738 -0.744 . . . . 64.430000000000007 112.471 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.957 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -147.3 163.31 36.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 74.409999999999997 111.15 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.77 ' O ' ' HA ' ' A' ' 73' ' ' VAL . . . -76.81 69.06 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 61.229999999999997 111.08 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.816 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -111.22 82.27 0.3 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.721 -0.752 . . . . 70.230000000000004 112.488 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.983 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -88.98 175.92 7.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 74.219999999999999 110.91 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.595 HG22 HG22 ' A' ' 71' ' ' VAL . 62.7 t -131.17 123.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.549999999999997 111.107 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.633 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 8.0 mt-10 -92.08 129.1 38.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.924 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -100.48 104.46 15.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 71.230000000000004 111.154 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.486 ' C ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.56 160.68 39.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 72.510000000000005 110.887 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -131.37 112.63 12.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 71.200000000000003 111.129 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.73 -178.53 43.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 75.310000000000002 112.487 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -65.13 -24.03 67.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.856 0.36 . . . . 74.030000000000001 110.855 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.72 -112.51 0.14 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.715 -0.755 . . . . 73.230000000000004 112.427 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 87' ' ' ARG . . . -111.7 -82.65 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.321 . . . . 63.399999999999999 111.102 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.85 161.53 14.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 54.149999999999999 111.074 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.486 ' HB3' ' C ' ' A' ' 61' ' ' GLU . . . -153.78 72.6 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 72.420000000000002 111.138 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.538 ' CB ' HD21 ' A' ' 85' ' ' LEU . 4.7 m-85 -115.79 125.12 52.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.968 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -105.93 110.21 3.34 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.695 -0.764 . . . . 65.340000000000003 112.457 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 57' ' ' GLU . 89.4 t -102.45 113.95 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 73.400000000000006 111.128 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.816 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -105.72 131.72 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 62.219999999999999 110.94 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.3 p -139.1 119.41 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 54.310000000000002 111.138 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.824 ' O ' HG22 ' A' ' 54' ' ' THR . 2.3 m -170.11 -133.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 64.329999999999998 111.165 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' H ' HG22 ' A' ' 74' ' ' THR . 9.5 mtm180 -105.84 143.55 27.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 75.349999999999994 110.876 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HA ' HH22 ' A' ' 80' ' ' ARG . 54.3 Cg_endo -69.75 13.08 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.663 2.242 . . . . 72.120000000000005 112.361 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 75' ' ' ARG . 5.7 m-20 -88.79 24.6 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 73.540000000000006 110.9 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.21 -13.69 53.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.769 -0.729 . . . . 53.100000000000001 112.465 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.491 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.0 p -98.54 108.34 21.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.825 0.345 . . . . 64.439999999999998 111.155 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.818 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 2.2 ptp85 -140.09 163.07 33.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 74.409999999999997 110.895 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 60.1 t -120.58 105.0 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 74.140000000000001 111.177 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.532 ' O ' ' HB ' ' A' ' 94' ' ' THR . 34.4 tt0 -82.62 142.84 31.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 72.5 110.938 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 12.1 m -118.37 118.24 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 72.109999999999999 111.123 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.658 ' H ' ' C ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -83.18 119.37 24.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 71.549999999999997 110.894 179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.907 ' HB3' HD21 ' A' ' 20' ' ' LEU . 2.8 pp -113.77 110.9 20.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 74.420000000000002 110.922 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.591 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -134.28 118.79 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 73.049999999999997 110.885 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.417 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 2.0 ttt180 -69.14 5.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 73.549999999999997 110.895 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.513 ' HB3' ' CE2' ' A' ' 89' ' ' PHE . 29.8 t0 -64.57 -25.43 67.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 74.230000000000004 110.876 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -160.69 -89.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 63.340000000000003 110.877 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.53 45.63 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 71.239999999999995 110.862 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.808 ' O ' HD13 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -99.09 111.84 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 61.229999999999997 111.096 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.808 HD13 ' O ' ' A' ' 91' ' ' VAL . 0.4 OUTLIER -128.23 17.06 6.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 53.210000000000001 110.937 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.658 ' C ' ' H ' ' A' ' 84' ' ' HIS . 10.2 t70 -140.49 151.51 44.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 73.409999999999997 110.874 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.654 ' OG1' ' N ' ' A' ' 84' ' ' HIS . 81.4 m -122.58 -101.52 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 52.329999999999998 111.101 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.505 ' N ' HG22 ' A' ' 94' ' ' THR . 8.4 pt-20 -166.47 154.74 9.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.63 0.729 . . . . 73.340000000000003 110.906 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 95' ' ' GLU . 53.4 Cg_endo -69.77 148.46 65.04 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.671 2.247 . . . . 75.349999999999994 112.352 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 41' ' ' ARG . . . -118.58 161.15 20.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 70.239999999999995 111.117 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.98 0.41 6.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 71.409999999999997 110.878 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.0 -20.84 26.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.735 -0.745 . . . . 64.409999999999997 112.476 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -97.08 -16.79 20.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.871 0.367 . . . . 73.439999999999998 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.45 -20.32 79.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 32.140000000000001 112.508 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 39' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 73.25 112.49 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.6 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.81 0.338 . . . . 75.340000000000003 110.883 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -63.94 -22.49 66.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 110.946 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' OD1' ' HB3' ' A' ' 67' ' ' ALA . 14.5 t70 -67.23 -124.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 71.299999999999997 110.876 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 17' ' ' THR . 3.0 tt -92.0 139.36 24.47 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.606 0.717 . . . . 72.319999999999993 111.135 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.75 23.87 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.717 2.278 . . . . 44.229999999999997 112.311 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.493 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -151.04 37.4 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 63.32 111.154 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.65 HG23 ' O ' ' A' ' 14' ' ' ILE . 66.5 p -66.87 -165.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 75.129999999999995 111.15 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.509 ' HG3' HD23 ' A' ' 92' ' ' LEU . 3.0 mt-10 -123.46 -86.99 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.862 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.87 12.3 3.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 71.150000000000006 110.856 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.774 ' CG ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -94.25 -36.31 12.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 74.099999999999994 110.964 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.444 ' CD2' ' O ' ' A' ' 18' ' ' GLU . 2.1 p90 -75.83 -2.41 29.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 71.239999999999995 110.865 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -96.25 -32.04 12.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 70.420000000000002 110.877 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -81.05 -31.02 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 73.519999999999996 110.917 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -41.82 -38.63 2.44 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.768 -0.73 . . . . 64.340000000000003 112.437 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.52 -60.68 3.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 74.420000000000002 111.118 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.743 ' HG3' HG21 ' A' ' 73' ' ' VAL . 1.1 ptm -67.57 -10.94 56.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 74.310000000000002 110.849 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HB1' ' OE1' ' A' ' 31' ' ' GLU . . . -82.37 -29.93 30.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.422 . . . . 41.420000000000002 111.122 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -73.86 42.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 73.230000000000004 110.876 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -148.34 -41.87 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 70.430000000000007 110.872 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.34 13.27 3.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.711 -0.757 . . . . 63.109999999999999 112.484 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.626 ' CD ' HG21 ' A' ' 58' ' ' VAL . 2.7 tt0 -58.16 104.49 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 71.049999999999997 110.859 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.41 -171.04 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 74.310000000000002 110.838 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -109.48 120.5 42.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 71.439999999999998 110.85 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.763 HG23 ' C ' ' A' ' 58' ' ' VAL . 2.3 t -91.74 -140.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 73.219999999999999 111.132 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.685 ' H ' HG12 ' A' ' 34' ' ' VAL . 43.6 p -137.06 -63.92 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 75.439999999999998 111.146 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.05 -64.6 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.71 -0.757 . . . . 74.319999999999993 112.469 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.415 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.7 Cg_endo -69.77 167.17 25.23 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.636 2.224 . . . . 72.430000000000007 112.381 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -70.32 -26.06 63.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 73.239999999999995 110.835 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.51 -37.42 70.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 70.420000000000002 111.118 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.07 -33.54 24.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 71.329999999999998 110.893 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -71.23 -43.85 66.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 75.549999999999997 110.863 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.753 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.48 -34.33 72.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 111.093 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -79.35 -41.02 28.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 74.439999999999998 110.905 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -77.34 -63.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 63.219999999999999 111.112 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -52.9 -19.72 2.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 55.140000000000001 111.074 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.753 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -53.63 -67.96 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 74.400000000000006 111.114 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.744 ' HA ' HG12 ' A' ' 50' ' ' VAL . 21.5 t -115.55 -13.85 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 72.519999999999996 111.093 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.57 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 41.5 mt-30 -80.09 -34.54 37.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 75.340000000000003 110.909 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.008 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.29 -4.1 19.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 75.120000000000005 111.1 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.988 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.71 -6.4 0.12 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.639 0.733 . . . . 75.25 111.172 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 1.008 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.8 Cg_endo -69.83 -26.58 27.11 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 2.236 . . . . 61.409999999999997 112.361 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.83 -50.49 5.56 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.721 -0.752 . . . . 52.140000000000001 112.53 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.5 -32.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.703 -0.761 . . . . 63.200000000000003 112.486 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.659 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -146.94 150.73 35.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 72.420000000000002 111.148 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.801 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.98 79.1 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 61.200000000000003 111.076 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.76 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -145.64 101.89 0.25 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 40.109999999999999 112.496 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.564 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.5 tt0 -95.39 -177.72 4.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 63.119999999999997 110.9 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.763 ' C ' HG23 ' A' ' 34' ' ' VAL . 82.1 t -132.29 118.11 34.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 62.240000000000002 111.121 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.779 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 7.6 pt-20 -92.47 159.5 15.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 72.409999999999997 110.906 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.502 ' HA ' ' CB ' ' A' ' 69' ' ' TYR . 1.6 t -132.8 116.4 16.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 52.340000000000003 111.146 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -136.73 163.71 29.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 70.230000000000004 110.876 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.423 ' CA ' ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -116.09 149.89 38.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 74.439999999999998 111.166 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.07 -142.51 5.34 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 34.420000000000002 112.506 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.74 -22.06 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.379 . . . . 64.150000000000006 110.866 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.1 -114.34 3.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 51.530000000000001 112.449 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.05 -84.71 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.748 0.308 . . . . 72.040000000000006 111.107 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -76.34 131.78 39.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 111.112 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB3' ' CA ' ' A' ' 62' ' ' THR . . . -150.4 60.72 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 44.520000000000003 111.113 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.91 ' CZ ' HD12 ' A' ' 85' ' ' LEU . 4.2 p90 -128.19 -169.17 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 61.299999999999997 110.922 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -157.07 163.9 32.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.771 -0.728 . . . . 71.109999999999999 112.525 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.756 HG22 HG22 ' A' ' 58' ' ' VAL . 61.1 t -136.85 122.69 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 62.450000000000003 111.09 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.76 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -110.56 141.5 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 110.948 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.743 HG21 ' HG3' ' A' ' 26' ' ' MET . 7.2 p -152.19 124.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 74.420000000000002 111.106 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.829 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 3.0 m -171.82 -129.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 74.400000000000006 111.125 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.48 ' H ' HG22 ' A' ' 74' ' ' THR . 6.4 mtm-85 -103.53 141.5 22.62 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.624 0.726 . . . . 73.420000000000002 110.883 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.51 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.0 Cg_endo -69.74 15.57 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 70.209999999999994 112.342 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 75' ' ' ARG . 5.7 m-20 -93.69 24.52 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 110.879 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.25 -12.71 53.83 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.74 . . . . 70.540000000000006 112.5 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 79' ' ' THR . 2.7 t -98.64 103.95 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 74.239999999999995 111.152 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.829 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.9 OUTLIER -137.3 163.75 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 62.219999999999999 110.925 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 45.6 t -115.88 105.66 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 71.540000000000006 111.069 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.672 ' CD ' HG21 ' A' ' 94' ' ' THR . 0.0 OUTLIER -88.65 139.29 30.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 75.530000000000001 110.874 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 1.016 HG23 HD21 ' A' ' 85' ' ' LEU . 32.3 m -116.11 146.88 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 44.439999999999998 111.111 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.897 ' C ' HD23 ' A' ' 85' ' ' LEU . 2.1 t-160 -98.46 123.99 42.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 65.329999999999998 110.861 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.016 HD21 HG23 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -118.91 103.15 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 72.319999999999993 110.901 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 1.6 t70 -131.37 111.62 12.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 70.019999999999996 110.899 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -70.99 4.21 2.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 71.310000000000002 110.867 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -72.73 -13.92 61.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 63.5 110.841 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.428 ' HB2' ' HD2' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -164.63 -95.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.409999999999997 110.897 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.881 ' O ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -149.21 29.33 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 70.340000000000003 110.84 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.847 ' C ' HD13 ' A' ' 92' ' ' LEU . 2.3 t -73.92 97.0 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 111.119 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.881 HD22 ' O ' ' A' ' 90' ' ' ARG . 0.4 OUTLIER -124.87 15.29 8.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.439999999999998 110.853 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.612 ' C ' ' H ' ' A' ' 84' ' ' HIS . 4.4 m-20 -154.61 157.95 38.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 33.439999999999998 110.845 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.704 ' OG1' ' HB2' ' A' ' 84' ' ' HIS . 86.0 m -130.39 -99.8 0.32 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 72.349999999999994 111.135 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.484 ' N ' HG22 ' A' ' 94' ' ' THR . 0.6 OUTLIER -159.34 162.61 25.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.627 0.727 . . . . 71.519999999999996 110.883 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 104.48 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.652 2.235 . . . . 64.319999999999993 112.335 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.619 ' HB3' ' HG3' ' A' ' 80' ' ' ARG . . . -66.79 108.22 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 54.530000000000001 111.092 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.85 16.58 12.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 64.349999999999994 110.894 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.59 -19.91 21.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 73.510000000000005 112.513 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.4 -45.94 6.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 75.400000000000006 110.886 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.06 27.46 45.05 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 42.149999999999999 112.455 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.749 . . . . 54.210000000000001 112.468 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.837 0.351 . . . . 73.12 110.88 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -67.69 -41.69 83.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.909 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.454 ' CB ' ' HB2' ' A' ' 85' ' ' LEU . 3.8 p-10 -62.55 -161.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 75.42 110.868 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.819 HG13 HG23 ' A' ' 17' ' ' THR . 27.7 pt -86.73 129.57 52.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.646 0.736 . . . . 64.4 111.133 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 0.56 5.43 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.697 2.265 . . . . 40.42 112.326 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 m -109.1 25.02 12.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 73.41 111.136 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.097 HG22 HD23 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -78.86 -168.2 1.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 71.15 111.136 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -73.97 -100.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 73.15 110.883 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.06 7.76 45.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 71.23 110.892 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.641 HD23 ' HB3' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -69.08 -13.41 62.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 74.14 110.895 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -94.05 0.64 56.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 74.24 110.904 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.13 -40.41 8.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 64.02 110.869 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.684 ' NE2' HG21 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -67.3 -43.98 80.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.04 110.926 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.563 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -43.88 -30.01 1.56 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.76 . . . . 44.35 112.512 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.16 -56.91 12.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 62.54 111.076 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.647 ' SD ' HG21 ' A' ' 73' ' ' VAL . 20.4 ptp -72.01 -5.03 32.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.443 . . . . 60.22 110.883 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 24' ' ' GLY . . . -74.43 -24.34 59.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 71.01 111.119 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -64.3 -9.09 15.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 64.53 110.861 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.09 -77.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 51.22 110.882 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.31 9.98 2.98 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 64.54 112.499 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.788 ' CD ' HG23 ' A' ' 58' ' ' VAL . 2.8 tt0 -60.02 99.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 74.21 110.872 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.05 -164.06 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 72.01 110.846 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.81 122.54 44.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 64.44 110.905 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.748 HG23 ' C ' ' A' ' 58' ' ' VAL . 2.7 t -84.1 -133.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 61.01 111.118 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.558 ' H ' HG12 ' A' ' 34' ' ' VAL . 21.0 p -136.09 -58.55 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 72.42 111.113 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.46 -68.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 71.21 112.494 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.4 Cg_endo -69.75 171.24 14.82 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 2.243 . . . . 72.23 112.362 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -71.92 -24.61 61.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 65.4 110.836 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.86 72.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 54.32 111.084 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.68 -41.35 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 60.31 110.887 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.512 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -61.24 -37.7 84.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 74.2 110.854 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.729 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -67.74 -33.97 75.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 71.43 111.09 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.483 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -78.88 -39.62 34.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 73.12 110.91 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.772 ' HB1' ' OE2' ' A' ' 57' ' ' GLU . . . -80.34 -60.79 2.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 50.02 111.103 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.763 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -52.71 -23.24 6.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 75.3 111.088 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -57.25 -77.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 50.52 111.056 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.698 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 40.6 t -113.32 -13.97 11.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 72.12 111.121 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.6 tp60 -75.92 -32.94 59.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.54 110.872 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.029 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.68 -2.63 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 54.14 111.101 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.974 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.1 -4.56 0.11 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.637 0.732 . . . . 71.51 111.146 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.029 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.3 Cg_endo -69.78 -28.16 25.5 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.676 2.251 . . . . 72.43 112.326 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.54 -54.95 3.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.758 . . . . 64.34 112.469 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.79 -33.45 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.7 -0.762 . . . . 74.1 112.474 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.698 HG22 ' O ' ' A' ' 74' ' ' THR . 0.2 OUTLIER -144.81 150.12 36.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 74.04 111.112 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.817 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.42 76.46 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 72.54 111.099 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.704 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -149.7 108.94 0.42 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 62.52 112.521 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.772 ' OE2' ' HB1' ' A' ' 44' ' ' ALA . 3.2 tt0 -102.97 -168.54 1.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.893 0.378 . . . . 75.13 110.888 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.788 HG23 ' CD ' ' A' ' 31' ' ' GLU . 1.3 t -132.98 118.29 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 54.32 111.117 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -96.98 158.14 15.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 74.13 110.923 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -137.06 111.02 8.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 72.34 111.159 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.95 166.39 16.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.888 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.81 118.15 29.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 61.24 111.163 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.07 -144.3 9.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 50.42 112.5 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.97 -14.29 42.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.901 0.382 . . . . 65.5 110.895 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.89 -120.89 1.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 71.34 112.491 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -121.97 -76.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 64.55 111.128 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.768 ' HB1' ' CE2' ' A' ' 69' ' ' TYR . . . -103.04 86.33 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 64.21 111.087 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.28 62.93 6.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 75.24 111.076 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.768 ' CE2' ' HB1' ' A' ' 67' ' ' ALA . 0.4 OUTLIER -109.04 174.39 5.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.913 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -153.91 157.75 27.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.725 -0.75 . . . . 44.4 112.454 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.642 HG12 HD21 ' A' ' 85' ' ' LEU . 3.4 p -132.6 115.03 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.372 . . . . 74.51 111.132 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.761 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -107.53 135.88 48.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 70.4 110.918 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.704 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.7 p -151.55 124.43 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 71.12 111.154 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.771 ' HB ' ' O ' ' A' ' 79' ' ' THR . 4.1 m -168.06 -131.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 74.45 111.17 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.599 ' H ' HG22 ' A' ' 74' ' ' THR . 0.5 OUTLIER -103.0 139.33 20.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.63 0.729 . . . . 64.11 110.886 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.636 ' HG3' HG21 ' A' ' 50' ' ' VAL . 53.9 Cg_endo -69.72 16.83 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.711 2.274 . . . . 62.04 112.34 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 75' ' ' ARG . 4.1 m-20 -94.97 13.61 24.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 71.34 110.874 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.84 -12.1 34.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 23.43 112.457 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.771 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.8 t -95.55 130.63 42.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 41.23 111.175 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.547 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -142.2 158.79 43.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 74.3 110.924 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.761 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 72.8 t -117.79 80.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 65.13 111.119 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB2' HD12 ' A' ' 72' ' ' LEU . 3.0 tp10 -75.09 121.82 22.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 74.12 110.853 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.684 HG21 ' NE2' ' A' ' 23' ' ' GLN . 3.0 t -103.82 139.5 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 63.34 111.172 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.63 ' C ' HG12 ' A' ' 91' ' ' VAL . 17.9 m-70 -86.61 118.13 25.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 73.25 110.843 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.642 HD21 HG12 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -128.3 105.86 8.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 74.32 110.91 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.66 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.3 t0 -139.66 131.96 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 71.41 110.843 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.641 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 2.0 tmt_? -61.21 5.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.22 110.863 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 86' ' ' ASP . 13.9 t0 -67.23 -3.33 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 75.32 110.863 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 67.53 12.2 8.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.879 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -137.31 2.18 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 73.11 110.882 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.66 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 58.5 t -116.38 70.87 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 63.22 111.143 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.097 HD23 HG22 ' A' ' 17' ' ' THR . 0.3 OUTLIER -128.56 12.47 6.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 71.11 110.941 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -92.92 -179.1 5.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 65.55 110.864 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.8 t -124.61 166.96 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 61.31 111.132 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -145.97 123.38 6.12 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.658 0.742 . . . . 75.42 110.872 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 96.48 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.637 2.225 . . . . 22.11 112.351 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 80' ' ' ARG . . . -64.09 111.35 2.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 71.41 111.097 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -88.83 11.03 19.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 62.33 110.831 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.18 -21.11 7.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.727 . . . . 31.44 112.462 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -97.92 -38.54 9.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.861 0.363 . . . . 73.24 110.888 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.26 25.14 52.6 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.751 . . . . 62.44 112.518 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.782 -0.723 . . . . 31.31 112.472 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.832 0.349 . . . . 75.35 110.879 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.428 ' HB2' ' CE2' ' A' ' 69' ' ' TYR . 77.6 m-85 -64.68 -32.91 74.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.24 110.929 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 10.6 p-10 -65.98 -122.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 63.45 110.885 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.844 HD12 HG11 ' A' ' 91' ' ' VAL . 30.8 mt -77.37 127.55 82.69 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.633 0.73 . . . . 61.03 111.138 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 15.86 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.637 2.225 . . . . 74.54 112.394 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.784 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -150.77 37.86 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 65.34 111.117 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.841 HG22 HD21 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -71.61 -161.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 64.21 111.133 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.408 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 29.4 mm-40 -84.13 -111.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 73.11 110.835 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -86.7 9.76 17.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.13 110.86 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.703 HD22 HG21 ' A' ' 17' ' ' THR . 0.3 OUTLIER -66.91 -12.23 58.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 72.42 110.877 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -63.65 -12.27 32.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 73.02 110.912 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -115.18 52.93 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.85 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.468 HE22 HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -58.19 88.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 74.55 110.904 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 42.93 38.17 3.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 63.44 112.487 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.86 -26.7 66.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 63.43 111.122 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.608 ' SD ' HG11 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -66.0 -9.9 34.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 73.55 110.846 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 29' ' ' ASP . . . -118.14 61.91 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 63.34 111.152 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -59.34 -6.15 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 75.13 110.926 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 27' ' ' ALA . 3.8 m-20 -126.08 -35.52 2.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 73.32 110.863 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 -20.52 60.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.716 -0.754 . . . . 42.41 112.475 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -62.47 93.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 61.14 110.892 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.09 179.62 3.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 64.25 110.873 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -95.62 115.73 27.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 64.53 110.894 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.739 HG22 ' OE1' ' A' ' 57' ' ' GLU . 3.1 t -75.03 -135.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 74.21 111.184 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.684 ' H ' HG12 ' A' ' 34' ' ' VAL . 80.6 p -140.15 -60.43 0.53 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 61.12 111.108 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.455 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 175.76 -60.88 0.11 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 54.12 112.5 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.9 Cg_endo -69.73 164.64 33.76 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.711 2.274 . . . . 73.02 112.369 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 9.0 p-10 -71.53 -25.67 62.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 55.42 110.804 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.14 -36.86 73.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 70.53 111.067 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 2.1 m-20 -83.49 -36.31 24.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 53.14 110.876 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.594 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 11.8 ptt180 -70.39 -43.97 68.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 74.12 110.842 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.712 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -69.39 -34.47 74.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 72.23 111.12 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 15.3 ptt85 -80.11 -41.5 25.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 53.43 110.851 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -75.26 -62.26 1.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 61.53 111.102 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -53.7 -19.57 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 52.4 111.101 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -60.15 -68.28 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 54.42 111.1 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.721 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 19.4 t -111.07 -10.45 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 74.55 111.158 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.619 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.2 tp60 -83.65 -38.61 21.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 72.32 110.93 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.755 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -101.88 -6.32 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 72.14 111.116 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.969 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -81.26 -24.79 0.39 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.657 0.741 . . . . 71.14 111.139 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.969 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 53.8 Cg_endo -69.78 -7.15 20.33 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.661 2.24 . . . . 72.01 112.399 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.04 -21.51 15.44 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 74.43 112.483 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.68 -33.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 55.33 112.487 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.686 ' O ' ' O ' ' A' ' 49' ' ' ALA . 2.0 t -155.16 161.86 41.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 74.21 111.133 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.741 ' HB1' ' NH2' ' A' ' 80' ' ' ARG . . . -76.63 69.48 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 71.35 111.089 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.712 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -144.29 103.15 0.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.735 -0.745 . . . . 74.03 112.463 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.739 ' OE1' HG22 ' A' ' 34' ' ' VAL . 3.8 tt0 -97.55 -171.89 2.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 63.34 110.889 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.727 ' C ' HG23 ' A' ' 34' ' ' VAL . 78.0 t -133.08 120.94 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 74.03 111.098 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 14.5 tm-20 -95.88 149.8 21.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 74.14 110.89 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.2 t -135.46 113.92 11.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.114 -0.493 . . . . 51.25 111.124 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.64 161.31 37.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 64.13 110.858 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.64 119.83 31.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 71.42 111.164 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.14 -159.65 30.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.742 -0.742 . . . . 70.05 112.554 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -82.97 -23.67 33.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 51.24 110.88 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.9 -112.99 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 42.13 112.466 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -114.25 -69.19 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 44.25 111.118 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.756 ' HB1' ' CE2' ' A' ' 69' ' ' TYR . . . -110.3 157.15 19.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 73.22 111.106 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -155.08 61.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 74.33 111.123 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.756 ' CE2' ' HB1' ' A' ' 67' ' ' ALA . 1.2 m-85 -113.67 173.43 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 73.15 110.922 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -159.59 117.55 0.78 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 44.22 112.472 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.624 HG23 HG22 ' A' ' 58' ' ' VAL . 7.1 p -108.52 122.01 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.914 0.388 . . . . 54.04 111.117 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.832 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -111.86 144.21 41.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 73.41 110.917 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.712 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 t -148.22 116.75 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 63.24 111.146 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.808 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 1.3 m -173.74 -135.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 72.02 111.166 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.44 ' H ' HG22 ' A' ' 74' ' ' THR . 20.0 mtm-85 -107.61 149.29 38.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.642 0.734 . . . . 72.22 110.857 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.72 5.13 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.702 2.268 . . . . 74.22 112.341 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.36 27.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 64.53 110.903 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.8 -11.03 15.77 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.727 -0.749 . . . . 74.11 112.485 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.1 p -98.62 102.27 13.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.807 0.337 . . . . 62.2 111.104 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.808 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 1.1 ptp85 -141.34 162.46 35.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 71.43 110.912 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 23.8 t -112.85 100.02 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 52.24 111.088 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.614 ' HG3' HD12 ' A' ' 72' ' ' LEU . 1.0 OUTLIER -89.06 117.72 28.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 75.35 110.884 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.655 HG13 ' HB ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -98.28 111.42 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 64.02 111.194 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.483 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 3.3 t-160 -78.45 123.22 26.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 65.04 110.868 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.689 HD22 ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -106.84 96.48 6.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 60.33 110.888 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.656 ' H ' ' HA ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -130.1 119.48 23.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 62.31 110.891 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.652 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -66.26 -6.67 14.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 61.42 110.895 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.681 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 15.0 t0 -84.01 31.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 73.01 110.893 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.681 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 19.5 m-85 98.03 -27.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 74.32 110.875 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 79.6 mmt-85 -91.83 38.84 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 64.41 110.893 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.844 HG11 HD12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -61.54 -40.18 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.4 111.14 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.841 HD21 HG22 ' A' ' 17' ' ' THR . 3.2 mm? -116.41 30.05 7.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 74.4 110.9 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 13.5 t0 -72.47 69.58 0.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 63.52 110.862 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.655 ' HB ' HG13 ' A' ' 83' ' ' VAL . 5.5 t -79.09 161.12 26.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 73.02 111.148 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.53 128.23 8.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.638 0.732 . . . . 62.33 110.88 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 95.33 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.669 2.246 . . . . 71.4 112.371 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.601 ' HB3' ' HG3' ' A' ' 80' ' ' ARG . . . -65.04 110.18 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 63.22 111.086 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -105.85 18.42 22.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 70.23 110.839 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.62 -19.15 30.18 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 62.54 112.474 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.09 -44.39 7.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.813 0.34 . . . . 64.12 110.836 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.65 23.61 57.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.716 -0.754 . . . . 61.14 112.466 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 60.42 112.477 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.85 0.357 . . . . 74.41 110.921 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.72 ' HA ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -113.6 179.96 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 73.03 110.908 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.636 ' CB ' ' HB3' ' A' ' 67' ' ' ALA . 15.7 p-10 -117.43 -46.73 2.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 71.55 110.873 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.652 HG23 ' CG ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -133.62 165.71 34.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 70.41 111.171 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HD2' HG22 ' A' ' 14' ' ' ILE . 53.4 Cg_endo -69.74 -3.68 12.48 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.71 2.273 . . . . 63.34 112.324 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -128.98 74.62 1.59 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 74.41 111.18 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.738 ' CG2' HD22 ' A' ' 20' ' ' LEU . 59.9 p -96.69 -166.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 75.11 111.111 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 92' ' ' LEU . 18.9 tt0 -129.55 -92.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 74.24 110.867 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -72.02 7.15 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 72.01 110.869 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.899 HD21 ' CB ' ' A' ' 85' ' ' LEU . 11.2 mp -84.72 -37.56 20.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 70.43 110.923 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -82.86 4.03 27.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 74.03 110.946 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.6 -52.77 3.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 63.24 110.911 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -78.12 -31.81 50.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 72.11 110.924 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.81 -41.63 4.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 65.15 112.521 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.51 -60.75 2.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.736 0.303 . . . . 63.41 111.107 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.486 ' HG3' HG21 ' A' ' 73' ' ' VAL . 1.2 ptm -69.51 -8.4 46.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 75.51 110.842 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.775 ' HB1' ' OE1' ' A' ' 31' ' ' GLU . . . -88.94 -32.99 17.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 54.24 111.093 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -75.73 46.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 74.33 110.839 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.21 -74.62 0.49 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.125 -0.488 . . . . 74.14 110.871 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.26 16.64 5.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.691 -0.766 . . . . 45.52 112.44 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.775 ' OE1' ' HB1' ' A' ' 27' ' ' ALA . 17.0 pt-20 -54.94 168.17 0.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 63.14 110.894 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.444 ' H ' ' HB2' ' A' ' 57' ' ' GLU . 0.5 OUTLIER -130.94 -165.92 1.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 75.1 110.866 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -128.84 120.46 26.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 64.22 110.902 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.611 HG22 ' CD ' ' A' ' 57' ' ' GLU . 40.1 t -73.32 162.67 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 61.32 111.096 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.566 ' N ' HG12 ' A' ' 34' ' ' VAL . 70.7 p -91.81 -49.03 6.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 73.44 111.118 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.07 -64.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 61.22 112.491 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 150.3 68.14 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.646 2.231 . . . . 74.54 112.366 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -59.01 -30.85 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 50.44 110.876 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.39 -28.7 60.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 61.35 111.063 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 0.6 OUTLIER -78.97 -30.02 44.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 73.02 110.848 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.622 ' NE ' ' HB1' ' A' ' 97' ' ' ALA . 3.2 ptt180 -68.57 -43.13 77.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 75.33 110.842 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -74.47 -32.04 62.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 74.34 111.123 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 19.7 ptt85 -77.93 -41.54 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 72.14 110.884 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -78.18 -62.29 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 63.44 111.058 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -51.54 -21.39 2.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 73.41 111.092 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.725 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -53.81 -66.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 73.52 111.094 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.751 ' HA ' HG12 ' A' ' 50' ' ' VAL . 22.0 t -111.35 -17.04 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 75.2 111.098 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 52.3 mt-30 -79.26 -28.92 42.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 65.52 110.952 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.101 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -109.31 -10.27 14.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 55.43 111.081 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.53 -0.03 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 70.02 111.126 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.101 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.5 Cg_endo -69.76 -27.23 26.73 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.689 2.259 . . . . 72.14 112.337 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.14 -51.83 3.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 61.44 112.464 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.24 -35.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 75.54 112.46 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.803 ' O ' ' O ' ' A' ' 49' ' ' ALA . 4.4 m -143.15 147.51 35.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.769 0.318 . . . . 75.41 111.128 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.82 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -74.24 81.43 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 51.42 111.156 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.691 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -145.41 97.9 0.19 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 50.34 112.516 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.611 ' CD ' HG22 ' A' ' 34' ' ' VAL . 1.1 pt-20 -99.43 -179.47 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 55.44 110.897 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.83 HG13 HG22 ' A' ' 71' ' ' VAL . 70.3 t -115.04 139.22 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 73.14 111.142 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.577 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 19.9 tt0 -106.88 155.89 19.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 73.12 110.879 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.411 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 1.2 t -129.35 110.77 12.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 65.41 111.162 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.13 160.52 38.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 63.22 110.894 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 64.4 p -132.69 93.21 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 65.22 111.113 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.2 -139.47 2.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.75 . . . . 65.24 112.445 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.15 -0.13 56.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.392 . . . . 75.51 110.881 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -100.7 -122.83 5.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.792 -0.718 . . . . 53.15 112.5 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.876 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -122.82 -82.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.795 0.331 . . . . 74.42 111.081 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.636 ' HB3' ' CB ' ' A' ' 13' ' ' ASP . . . -100.45 90.15 4.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 71.24 111.079 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.49 79.86 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 72.12 111.091 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.711 ' HB2' HD11 ' A' ' 85' ' ' LEU . 3.1 m-85 -106.75 163.27 13.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 72.43 110.927 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -137.65 107.02 0.56 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 63.1 112.474 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.83 HG22 HG13 ' A' ' 58' ' ' VAL . 10.7 t -103.11 111.07 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.899 0.381 . . . . 43.31 111.098 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.72 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -103.45 149.45 24.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.35 110.914 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.662 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.7 p -150.42 115.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 43.42 111.103 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.766 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 1.4 m -173.43 -136.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 71.54 111.126 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.506 ' H ' HG22 ' A' ' 74' ' ' THR . 0.6 OUTLIER -104.26 145.86 31.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.597 0.713 . . . . 73.14 110.847 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.433 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.9 Cg_endo -69.74 7.88 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.695 2.264 . . . . 63.33 112.329 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.3 25.81 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 75.5 110.885 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.45 -13.22 47.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 64.14 112.499 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.575 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.6 t -97.03 102.8 14.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 72.41 111.18 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.766 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.6 OUTLIER -138.3 162.47 34.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 53.43 110.909 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 5.1 m -118.03 98.04 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 70.51 111.121 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.474 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -81.52 127.05 32.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 74.51 110.901 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 71' ' ' VAL . 3.9 t -91.92 116.9 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 74.12 111.141 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 2.3 t-160 -84.36 117.35 23.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 75.25 110.833 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.925 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -123.49 122.89 39.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 65.4 110.912 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 7.8 t0 -132.74 119.46 20.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 75.21 110.85 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.876 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 2.1 tmt_? -68.44 0.19 4.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.11 110.864 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.549 ' HB3' ' CE1' ' A' ' 89' ' ' PHE . 6.5 t0 -65.79 -14.17 60.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 73.23 110.848 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -176.71 -91.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 71.21 110.915 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.65 ' O ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -150.31 31.44 0.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.876 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.928 HG12 ' O ' ' A' ' 91' ' ' VAL . 2.0 t -71.82 81.42 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 73.22 111.16 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.706 HD13 ' C ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -120.39 18.62 12.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 64.51 110.934 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -83.09 137.67 34.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 60.14 110.882 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.0 t -92.05 165.88 12.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 73.12 111.158 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -139.12 162.83 50.02 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.677 0.751 . . . . 74.41 110.858 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 92.85 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.712 2.275 . . . . 61.13 112.343 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.622 ' HB1' ' NE ' ' A' ' 41' ' ' ARG . . . -76.23 111.19 11.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 74.02 111.059 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 101' ' ' GLY . 19.8 t0 -122.25 113.0 18.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 65.32 110.863 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -47.06 -21.54 1.02 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.732 -0.747 . . . . 72.33 112.513 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -93.74 -24.92 17.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 75.24 110.913 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 98' ' ' ASP . . . 100.4 -6.39 57.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.748 -0.739 . . . . 75.12 112.517 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.698 -0.763 . . . . 75.55 112.498 -179.878 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.779 0.323 . . . . 35.14 110.842 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -67.13 -18.02 65.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 64.04 110.974 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.658 ' HB3' HD12 ' A' ' 85' ' ' LEU . 6.3 p-10 -58.44 -100.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 62.53 110.889 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.73 HG23 ' CG ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -113.7 163.9 17.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.616 0.722 . . . . 73.21 111.132 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' A' ' 14' ' ' ILE . 53.8 Cg_endo -69.79 -2.87 10.93 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.709 2.273 . . . . 62.23 112.294 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -144.22 72.66 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 65.33 111.129 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.497 ' HB ' ' HG ' ' A' ' 92' ' ' LEU . 3.9 p -74.6 -169.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 64.5 111.11 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 3.3 mm-40 -116.78 -97.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 75.21 110.896 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.4 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -77.29 6.04 7.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 73.13 110.908 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.662 HD21 HD13 ' A' ' 85' ' ' LEU . 2.3 tp -79.97 -2.2 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.473 . . . . 53.02 110.882 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.44 ' CD2' ' O ' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -59.91 -14.26 14.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.31 110.973 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.6 49.49 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 62.24 110.835 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 24' ' ' GLY . 1.1 pt20 -64.47 82.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 54.44 110.917 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.462 ' HA2' HG21 ' A' ' 73' ' ' VAL . . . 36.5 44.26 0.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 54.11 112.544 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.94 76.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.766 0.317 . . . . 52.12 111.09 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.892 ' HG3' HG21 ' A' ' 54' ' ' THR . 0.0 OUTLIER -69.49 -16.64 63.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.2 110.899 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.488 ' HB2' HG22 ' A' ' 54' ' ' THR . . . -117.73 54.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 60.3 111.086 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.47 49.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 64.14 110.906 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 175.22 -31.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 71.25 110.828 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.47 -2.68 56.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.752 . . . . 61.22 112.479 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.35 85.74 3.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 74.45 110.909 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.89 -167.24 1.2 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 73.2 110.869 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 22.1 pt-20 -101.67 166.27 10.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 74.14 110.885 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.761 HG23 ' C ' ' A' ' 58' ' ' VAL . 2.8 t -123.25 -139.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 73.34 111.163 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.721 ' H ' HG12 ' A' ' 34' ' ' VAL . 59.0 p -138.71 -70.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 72.14 111.166 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.475 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -175.24 -59.79 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 60.33 112.475 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.4 Cg_endo -69.8 164.16 35.62 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.267 . . . . 64.43 112.318 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -72.7 -25.09 61.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.919 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.36 82.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 54.34 111.12 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -80.58 -34.59 35.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 74.41 110.864 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.53 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 8.3 ptt180 -72.78 -45.67 57.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 74.21 110.872 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.663 ' HB1' ' HA2' ' A' ' 99' ' ' GLY . . . -64.65 -33.07 75.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 61.25 111.084 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 13.3 ptt85 -83.41 -43.36 15.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 62.33 110.86 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -74.88 -60.84 2.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 64.31 111.125 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.584 ' O ' ' HB1' ' A' ' 55' ' ' ALA . . . -51.47 -22.92 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 52.14 111.112 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.721 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -59.15 -75.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 74.15 111.075 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.651 ' HA ' HG12 ' A' ' 50' ' ' VAL . 26.3 t -107.78 -21.73 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 72.45 111.078 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -69.99 -31.48 69.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 64.22 110.917 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.06 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.34 -0.11 22.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 73.34 111.101 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.992 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -100.05 3.14 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.627 0.727 . . . . 54.43 111.158 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.06 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.8 Cg_endo -69.7 -27.39 26.82 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.769 2.313 . . . . 74.54 112.356 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.86 -49.38 5.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 62.05 112.455 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.33 -32.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.797 -0.715 . . . . 55.44 112.534 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.892 HG21 ' HG3' ' A' ' 26' ' ' MET . 11.8 t -141.91 149.83 40.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 72.13 111.182 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.861 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -74.99 78.83 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 24.54 111.121 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.603 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -144.86 101.17 0.24 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 72.13 112.5 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.691 ' H ' HD23 ' A' ' 72' ' ' LEU . 4.3 tt0 -95.4 -173.09 2.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 64.42 110.909 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.761 ' C ' HG23 ' A' ' 34' ' ' VAL . 20.2 t -135.5 116.69 19.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 63.23 111.139 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.593 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -94.89 150.84 19.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 61.43 110.829 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 69' ' ' TYR . 1.8 t -136.67 107.34 6.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 74.21 111.126 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 2.1 tt0 -129.39 167.76 17.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 74.51 110.911 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.74 120.51 34.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 64.34 111.139 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.2 -168.55 30.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 72.22 112.514 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -59.82 -23.45 63.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.907 0.384 . . . . 71.11 110.906 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.86 -118.2 1.56 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.777 -0.725 . . . . 72.34 112.495 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.47 -71.22 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.809 0.338 . . . . 62.34 111.13 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.728 ' HB3' ' H ' ' A' ' 87' ' ' ARG . . . -89.3 134.88 33.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 62.24 111.078 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -150.8 62.53 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 72.2 111.115 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.593 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -111.98 162.64 15.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 73.32 110.925 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.672 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -144.98 118.99 1.17 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.718 -0.754 . . . . 62.24 112.49 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.693 HG23 HG22 ' A' ' 58' ' ' VAL . 8.8 p -103.02 119.86 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.371 . . . . 62.21 111.111 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.955 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -104.27 142.65 34.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 54.21 110.902 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.603 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 2.8 t -150.8 117.01 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 72.23 111.158 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.762 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 2.2 m -169.14 -137.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 73.2 111.123 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.629 ' H ' HG22 ' A' ' 74' ' ' THR . 55.8 mtm180 -98.61 150.01 36.29 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.585 0.707 . . . . 74.2 110.888 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.573 ' CG ' HG21 ' A' ' 50' ' ' VAL . 53.7 Cg_endo -69.79 5.83 1.56 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.672 2.248 . . . . 61.24 112.336 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.57 29.4 0.31 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 71.04 110.901 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.24 -9.98 11.87 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.763 -0.732 . . . . 71.34 112.48 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.581 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.9 p -98.38 109.49 22.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 73.02 111.174 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.762 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -137.94 160.93 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 73.44 110.878 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.709 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 12.5 m -110.94 101.8 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 63.34 111.108 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.773 ' HB2' HD12 ' A' ' 72' ' ' LEU . 8.2 tm-20 -82.86 122.92 28.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 64.44 110.908 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 2.3 t -96.26 109.36 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 65.04 111.115 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 93' ' ' ASP . 4.2 p-80 -79.57 121.09 24.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 63.43 110.899 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.806 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -120.17 116.85 26.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 64.12 110.908 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.721 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 25.9 t0 -127.3 114.2 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 61.54 110.886 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.73 ' CG ' HG23 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -68.73 1.74 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 62.52 110.897 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.448 ' C ' ' CG ' ' A' ' 89' ' ' PHE . 52.1 t0 -70.31 -12.36 61.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 70.4 110.86 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.448 ' CG ' ' C ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -172.62 -94.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 70.23 110.853 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.633 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -150.59 30.7 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.875 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.974 HG12 ' O ' ' A' ' 91' ' ' VAL . 1.9 t -77.58 77.16 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 71.14 111.145 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.782 HD13 ' C ' ' A' ' 91' ' ' VAL . 0.3 OUTLIER -120.19 18.05 12.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.952 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 84' ' ' HIS . 1.1 m-20 -80.95 167.5 19.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 71.52 110.875 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.691 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 5.9 t -121.19 169.43 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 75.53 111.198 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -143.73 110.7 5.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.575 0.703 . . . . 74.4 110.894 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.61 ' HB3' HG12 ' A' ' 81' ' ' VAL . 54.3 Cg_endo -69.71 103.78 1.21 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.68 2.253 . . . . 61.4 112.4 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.448 ' HB3' HH22 ' A' ' 80' ' ' ARG . . . -116.33 -178.88 3.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 62.34 111.092 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.54 -156.62 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 74.24 110.845 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.663 ' HA2' ' HB1' ' A' ' 42' ' ' ALA . . . -65.16 -14.97 60.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 41.35 112.492 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.39 -53.09 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 64.03 110.847 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.54 28.89 4.39 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 72.2 112.48 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 72.31 112.512 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.832 0.349 . . . . 75.31 110.863 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -66.84 -52.16 46.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 73.12 110.906 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.85 ' H ' HD21 ' A' ' 85' ' ' LEU . 75.0 m-20 -58.22 -97.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 71.32 110.876 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.947 ' HB ' HG11 ' A' ' 91' ' ' VAL . 30.2 mt -101.72 105.28 40.23 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.617 0.722 . . . . 74.54 111.163 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 21.72 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 72.04 112.328 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.64 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.8 m -124.21 17.11 9.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 74.31 111.128 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.635 HG22 HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -76.2 -160.75 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 74.43 111.164 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -61.25 -109.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 70.24 110.899 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -97.21 11.3 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 75.12 110.893 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.605 HD22 ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -61.9 -34.65 76.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 65.52 110.915 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -86.34 7.83 23.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 73.52 110.951 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -108.5 -37.36 5.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 71.31 110.871 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.706 ' NE2' HG11 ' A' ' 73' ' ' VAL . 20.4 mm100 -67.46 -45.53 75.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 53.42 110.921 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.625 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -43.91 -30.71 1.75 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 73.42 112.478 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.64 -72.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.754 0.312 . . . . 72.12 111.091 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.6 ptp -63.52 -3.69 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 72.44 110.881 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 24' ' ' GLY . . . -64.76 -26.79 68.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 64.12 111.129 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.454 ' HD1' ' C ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -82.81 8.43 12.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 73.11 110.888 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -89.87 -78.35 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.139 -0.482 . . . . 63.21 110.832 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.13 -5.04 2.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 62.02 112.508 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' CG ' ' HA ' ' A' ' 27' ' ' ALA . 23.1 mt-10 -62.18 105.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 63.31 110.892 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -161.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 62.11 110.853 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -118.46 116.56 26.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 72.02 110.899 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.663 HG12 ' H ' ' A' ' 35' ' ' THR . 4.2 t -72.21 171.36 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 73.31 111.131 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.663 ' H ' HG12 ' A' ' 34' ' ' VAL . 71.9 p -91.97 -41.51 10.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 60.52 111.148 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.411 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 164.52 -62.95 0.24 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.718 -0.753 . . . . 63.45 112.479 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.428 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 54.2 Cg_endo -69.69 156.15 64.3 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.683 2.255 . . . . 75.24 112.377 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -60.82 -27.52 68.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 63.31 110.834 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.27 68.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 73.11 111.086 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.44 -32.81 23.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 64.32 110.841 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.599 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -69.99 -44.07 70.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 72.0 110.865 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.705 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.79 -35.01 72.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 73.14 111.106 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -79.41 -41.4 27.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 73.24 110.923 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.574 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -77.22 -61.71 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 62.23 111.097 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.655 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -53.05 -21.73 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 44.24 111.093 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.756 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -54.27 -71.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 72.43 111.093 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.772 ' HA ' HG12 ' A' ' 50' ' ' VAL . 21.5 t -111.9 -12.79 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.52 111.129 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.574 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.8 tp60 -80.5 -34.11 35.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.14 110.892 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.037 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.97 -5.66 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 62.23 111.119 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.32 -5.69 0.11 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.731 . . . . 65.21 111.112 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.037 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.7 Cg_endo -69.79 -26.57 27.29 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 72.12 112.356 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.37 -57.46 2.62 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.687 -0.768 . . . . 60.12 112.502 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.65 -34.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.723 -0.751 . . . . 55.44 112.496 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.716 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.4 m -149.1 151.47 34.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.777 0.322 . . . . 55.52 111.173 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.841 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.22 79.23 0.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 73.42 111.126 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.764 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -144.78 102.54 0.27 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 71.53 112.505 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.623 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.5 tt0 -95.46 -177.77 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 75.11 110.86 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.677 HG22 HG23 ' A' ' 71' ' ' VAL . 95.3 t -131.03 117.0 35.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 72.13 111.123 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.643 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 1.4 pp20? -95.57 129.91 42.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 71.0 110.911 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 t -100.38 118.29 36.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.479 . . . . 75.04 111.179 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.608 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -134.93 101.7 4.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 63.41 110.896 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.2 p -93.97 127.07 39.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 71.4 111.141 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.0 -154.98 10.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 75.02 112.499 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -87.77 -0.3 56.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.883 0.373 . . . . 71.01 110.877 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.98 -96.95 2.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.76 -0.733 . . . . 31.12 112.464 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.45 -136.07 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 74.45 111.112 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.656 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . . . -113.15 93.46 4.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 52.55 111.087 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.709 ' HB1' ' NE2' ' A' ' 84' ' ' HIS . . . -79.76 95.31 5.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 71.44 111.091 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.535 ' CE1' ' HB1' ' A' ' 67' ' ' ALA . 9.3 m-85 -116.66 115.75 26.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.21 110.897 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 84' ' ' HIS . . . -98.88 109.62 3.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 75.54 112.482 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.677 HG23 HG22 ' A' ' 58' ' ' VAL . 4.6 p -104.19 109.75 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 71.25 111.177 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.814 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -97.74 142.43 29.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 65.11 110.889 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.706 HG11 ' NE2' ' A' ' 23' ' ' GLN . 5.8 p -150.39 120.78 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 71.41 111.083 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.772 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 2.8 m -171.36 -130.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 62.13 111.139 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.499 ' H ' HG22 ' A' ' 74' ' ' THR . 2.1 mtt-85 -107.0 145.73 31.71 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.718 . . . . 72.42 110.83 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.73 13.36 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.653 2.235 . . . . 44.41 112.392 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 75' ' ' ARG . 3.9 m-20 -89.91 25.65 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.872 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.17 -12.52 43.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 74.1 112.488 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.547 ' O ' ' HB ' ' A' ' 74' ' ' THR . 24.7 p -97.45 105.25 17.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 51.14 111.145 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.772 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 1.3 ptp85 -139.57 162.27 35.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 74.12 110.931 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 42.8 t -115.09 100.5 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 65.23 111.177 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.524 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 5.4 tm-20 -84.51 115.91 22.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 73.54 110.877 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -102.53 105.44 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 73.1 111.147 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.709 ' NE2' ' HB1' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -83.76 124.74 31.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.893 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.85 HD21 ' H ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -111.39 111.76 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 74.23 110.946 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.601 ' N ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -126.42 114.98 18.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 74.41 110.907 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.803 ' HA ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -72.94 -0.25 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 73.12 110.844 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -74.04 -19.38 60.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 70.2 110.849 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 90' ' ' ARG . 3.9 p90 169.8 -36.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.11 110.906 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HB3' ' CB ' ' A' ' 93' ' ' ASP . 1.9 mmm180 -117.87 68.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 55.21 110.874 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.947 HG11 ' HB ' ' A' ' 14' ' ' ILE . 1.5 t -61.31 -14.23 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.147 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.635 HD12 HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -124.8 32.14 5.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 63.02 110.926 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 0.8 OUTLIER -65.75 80.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 65.0 110.879 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 10.1 t -79.76 153.51 29.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.42 111.088 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -148.76 129.76 7.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.678 0.751 . . . . 73.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 125.4 12.13 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.723 2.282 . . . . 75.4 112.37 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.539 ' HB2' HH11 ' A' ' 41' ' ' ARG . . . -115.26 108.93 17.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 72.4 111.09 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -103.99 20.79 17.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 73.31 110.854 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.12 -19.22 31.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.74 . . . . 61.34 112.466 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -94.66 -43.47 8.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 60.34 110.85 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.55 28.03 52.99 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 74.2 112.478 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 64.35 112.44 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.432 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 4.9 p-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.806 0.336 . . . . 62.34 110.873 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -67.66 -19.28 65.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.933 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.99 -161.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 73.11 110.905 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.709 HD13 ' HG3' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -117.42 156.92 48.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.6 0.715 . . . . 54.43 111.135 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.561 ' HD2' HG13 ' A' ' 14' ' ' ILE . 53.8 Cg_endo -69.72 45.38 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.676 2.251 . . . . 50.15 112.37 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -151.26 17.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 72.11 111.12 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.663 ' HB ' HD22 ' A' ' 20' ' ' LEU . 43.9 p -75.4 -167.41 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 73.31 111.139 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.662 ' HG2' HD23 ' A' ' 92' ' ' LEU . 2.9 mm-40 -116.0 -95.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 73.32 110.921 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -89.69 8.53 31.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 65.13 110.881 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -75.29 -10.97 59.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.25 110.912 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -76.36 -23.63 54.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 74.21 110.882 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -74.1 -34.58 64.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.888 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.528 ' HG3' HG21 ' A' ' 83' ' ' VAL . 19.6 mm-40 -66.37 -49.58 66.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 71.41 110.9 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -44.54 -30.43 2.13 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.71 -0.757 . . . . 72.13 112.496 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.28 -62.54 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.767 0.317 . . . . 70.51 111.052 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 35.1 tpp -67.09 -13.49 61.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 75.32 110.871 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 24' ' ' GLY . . . -67.07 -22.38 65.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 73.12 111.114 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -85.78 10.81 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 71.44 110.862 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.01 -75.67 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 65.23 110.909 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.08 13.66 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.704 -0.76 . . . . 64.44 112.491 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.581 ' HB3' HG23 ' A' ' 58' ' ' VAL . 20.9 mt-10 -59.59 104.57 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 65.24 110.881 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.93 -164.47 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 74.01 110.9 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.23 121.6 43.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 63.5 110.862 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.78 HG12 ' H ' ' A' ' 35' ' ' THR . 2.6 t -82.6 178.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 73.12 111.121 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.78 ' H ' HG12 ' A' ' 34' ' ' VAL . 71.0 p -94.35 -59.94 1.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 75.23 111.215 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.0 -64.6 0.1 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.733 . . . . 71.35 112.5 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 164.85 32.96 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 63.4 112.415 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -70.43 -26.07 63.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 64.15 110.865 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.73 -46.45 77.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 34.1 111.081 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -41.61 25.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.879 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.549 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -59.99 -37.93 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 75.04 110.882 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -62.9 -33.3 75.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 63.34 111.116 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.527 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 1.3 ptt-85 -78.66 -40.12 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 74.52 110.84 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.704 ' HB1' ' OE2' ' A' ' 57' ' ' GLU . . . -77.83 -59.32 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 75.14 111.154 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.748 ' HB2' HD23 ' A' ' 72' ' ' LEU . . . -54.64 -20.81 8.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 71.11 111.123 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -62.0 -81.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 75.12 111.089 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.784 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 58.4 t -108.8 -19.87 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 72.45 111.116 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 1.3 tp60 -69.33 -33.15 72.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 65.41 110.919 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.037 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.64 1.88 25.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 72.34 111.07 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.991 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.74 -7.17 0.12 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.637 0.732 . . . . 73.34 111.103 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.037 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.6 Cg_endo -69.75 -26.11 27.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.671 2.247 . . . . 65.31 112.327 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.71 -61.41 2.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.725 -0.75 . . . . 53.02 112.498 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -156.31 -33.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 65.04 112.473 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.724 HG22 ' O ' ' A' ' 74' ' ' THR . 0.3 OUTLIER -148.01 159.78 43.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 42.33 111.181 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.763 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.09 70.98 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 60.11 111.099 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.807 ' HA3' ' HA ' ' A' ' 73' ' ' VAL . . . -149.68 112.72 0.57 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 61.23 112.475 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.772 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.2 tt0 -98.49 -169.73 1.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.846 0.355 . . . . 73.02 110.89 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.761 ' C ' HG23 ' A' ' 34' ' ' VAL . 40.7 t -133.42 120.84 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 53.03 111.142 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.786 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 11.2 tm-20 -90.3 158.47 17.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.875 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 t -137.97 111.22 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 72.23 111.151 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.2 169.6 17.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 72.15 110.907 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.427 ' C ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -117.54 149.78 40.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 73.24 111.125 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.69 -154.29 8.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.758 -0.734 . . . . 74.34 112.53 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -78.44 -23.99 46.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.383 . . . . 63.14 110.935 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.79 -114.06 2.86 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.713 -0.756 . . . . 64.21 112.538 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -113.98 -78.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 64.42 111.093 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.658 ' O ' ' CG ' ' A' ' 86' ' ' ASP . . . -87.99 139.95 29.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 62.51 111.067 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB3' ' C ' ' A' ' 62' ' ' THR . . . -154.65 73.36 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 65.23 111.107 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.789 ' OH ' HD22 ' A' ' 85' ' ' LEU . 11.5 p90 -132.41 -172.16 2.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 75.04 110.918 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -153.96 129.12 2.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.727 -0.749 . . . . 33.42 112.474 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.417 ' O ' HG23 ' A' ' 83' ' ' VAL . 2.1 p -107.35 120.01 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 60.54 111.141 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.92 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -98.18 139.14 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 73.01 110.888 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.807 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 3.0 m -147.34 111.42 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 62.34 111.137 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.803 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.2 m -167.38 -137.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 42.34 111.112 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.631 ' H ' HG22 ' A' ' 74' ' ' THR . 10.7 mtm180 -108.28 153.88 41.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.59 0.709 . . . . 74.51 110.888 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.421 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.72 2.17 3.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.72 2.28 . . . . 65.11 112.372 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -85.94 45.94 1.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 52.02 110.877 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.95 -6.02 7.19 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 62.33 112.491 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.803 ' O ' ' HB ' ' A' ' 74' ' ' THR . 72.2 p -91.83 123.79 35.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 51.31 111.121 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.771 ' NE ' ' HB1' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -146.2 143.89 29.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 72.1 110.889 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.603 HG23 ' HG1' ' A' ' 74' ' ' THR . 87.1 t -110.87 84.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 72.11 111.114 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.623 ' HB2' HD12 ' A' ' 72' ' ' LEU . 2.4 tm-20 -77.52 118.0 19.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 72.21 110.899 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.623 ' O ' ' HA2' ' A' ' 70' ' ' GLY . 2.4 t -95.44 136.28 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 75.42 111.147 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.521 ' C ' HG12 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -87.86 117.42 26.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 75.52 110.878 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.789 HD22 ' OH ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -124.75 111.88 16.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 75.05 110.945 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.878 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.6 t70 -138.75 120.94 15.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 64.31 110.831 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.709 ' HG3' HD13 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -55.81 1.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 72.13 110.854 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.611 ' H ' ' C ' ' A' ' 86' ' ' ASP . 49.8 t0 -65.83 -6.49 12.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 70.33 110.847 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 70.43 19.32 6.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.918 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.68 -0.03 1.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 54.12 110.846 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.878 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 89.2 t -120.94 70.02 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 70.34 111.128 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.662 HD23 ' HG2' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -124.55 14.36 8.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 71.41 110.935 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.407 ' O ' HG12 ' A' ' 83' ' ' VAL . 8.4 m-20 -94.69 -172.6 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 74.1 110.881 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.7 t -116.43 174.34 6.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 71.42 111.147 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 82' ' ' GLU . 2.6 tp10 -141.1 119.28 7.98 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.729 . . . . 74.34 110.908 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 115.64 4.19 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.653 2.236 . . . . 74.34 112.341 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.771 ' HB1' ' NE ' ' A' ' 80' ' ' ARG . . . -116.7 112.8 21.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 71.11 111.144 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -128.93 56.8 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 71.2 110.864 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.28 -17.95 2.91 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.761 -0.733 . . . . 71.24 112.517 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.25 -61.35 1.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 74.5 110.849 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.44 18.1 65.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 52.22 112.519 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 61.31 112.508 -179.906 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.832 0.348 . . . . 73.24 110.888 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -67.01 -42.5 84.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 74.33 110.935 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.67 ' OD1' ' HB3' ' A' ' 67' ' ' ALA . 13.0 t0 -66.31 -143.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 53.44 110.866 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.829 HG22 ' H ' ' A' ' 16' ' ' THR . 19.7 mm -75.32 114.07 31.98 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.613 0.72 . . . . 75.51 111.087 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 16.64 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.652 2.235 . . . . 71.42 112.366 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.829 ' H ' HG22 ' A' ' 14' ' ' ILE . 2.8 m -134.76 23.52 3.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 71.21 111.096 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.866 HG21 HG22 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -75.66 -145.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 75.42 111.127 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 17' ' ' THR . 59.5 mt-10 -84.65 -104.23 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 70.13 110.877 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.62 6.19 45.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 73.05 110.878 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 85' ' ' LEU . 7.7 mp -65.33 -34.87 79.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 75.31 110.923 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -83.26 3.73 30.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.972 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -105.6 -36.32 7.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 72.52 110.885 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -66.68 -49.01 67.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.477 . . . . 75.23 110.877 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -43.27 -33.09 1.88 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 64.45 112.507 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.37 -56.49 19.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.768 0.318 . . . . 64.43 111.05 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.651 ' SD ' HG11 ' A' ' 73' ' ' VAL . 19.6 ptp -70.18 -7.96 46.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 75.13 110.905 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.687 ' HB1' ' OE1' ' A' ' 31' ' ' GLU . . . -79.62 -17.49 53.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 43.24 111.096 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -82.43 9.74 8.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.32 110.898 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -93.69 -79.21 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 64.13 110.87 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.05 7.88 5.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 44.12 112.484 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.76 ' HG3' HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -61.92 152.4 32.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 73.24 110.891 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.518 ' N ' ' HG2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -116.47 -165.1 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 73.13 110.836 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -114.16 116.77 29.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 71.21 110.876 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 35' ' ' THR . 10.2 t -74.9 167.39 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 65.22 111.131 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.569 ' N ' HG12 ' A' ' 34' ' ' VAL . 65.7 p -94.67 -44.3 7.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 72.32 111.126 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 164.98 -61.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.727 . . . . 50.21 112.489 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.9 Cg_endo -69.71 159.73 52.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 74.21 112.357 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.601 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 1.2 t70 -65.06 -27.18 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 72.32 110.859 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -36.41 73.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 71.24 111.062 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -85.21 -37.34 20.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 71.42 110.863 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.601 ' NE ' ' HA ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -70.01 -45.57 66.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 71.12 110.859 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.669 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -68.74 -36.03 77.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 72.21 111.1 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 10.5 ptt180 -79.51 -41.47 27.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.35 110.858 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -74.7 -62.3 1.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 64.24 111.075 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.619 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -53.79 -19.64 4.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 60.44 111.097 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.693 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -55.43 -67.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 71.32 111.112 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.758 ' HA ' HG12 ' A' ' 50' ' ' VAL . 3.5 p -112.7 -18.48 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 74.33 111.159 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 5.4 mt-30 -77.67 -29.14 51.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 51.42 110.938 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.071 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.86 -7.81 15.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 72.32 111.131 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.988 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.46 -0.51 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.606 0.717 . . . . 70.14 111.149 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.071 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.2 Cg_endo -69.77 -29.1 24.37 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.654 2.236 . . . . 75.53 112.304 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.43 -52.27 4.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.736 -0.745 . . . . 60.21 112.479 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.1 -34.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 74.13 112.488 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.746 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -144.4 149.47 36.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 62.12 111.137 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.837 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -73.3 81.17 1.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 60.15 111.085 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.72 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -143.12 99.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 51.01 112.45 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.591 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.6 tt0 -90.66 179.97 5.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 74.02 110.925 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.76 HG23 ' HG3' ' A' ' 31' ' ' GLU . 69.3 t -130.81 121.97 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 51.22 111.153 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.465 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 11.8 tm-20 -93.39 153.56 18.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 75.41 110.91 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.436 ' HA ' ' CD2' ' A' ' 69' ' ' TYR . 1.5 t -132.98 112.34 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 63.3 111.094 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -140.91 162.91 34.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 65.2 110.854 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.92 120.07 34.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 71.33 111.134 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.41 -169.03 32.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 74.12 112.452 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.69 -23.12 49.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 75.04 110.908 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.52 -109.23 0.36 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.756 -0.735 . . . . 74.22 112.515 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.09 -74.43 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 55.32 111.122 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.67 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . . . -111.14 162.01 15.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.12 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -156.24 72.06 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 43.44 111.138 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.644 ' O ' HD12 ' A' ' 85' ' ' LEU . 4.2 m-85 -110.53 163.65 13.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 60.15 110.915 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.09 100.07 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.753 . . . . 74.0 112.479 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.499 HG23 HG22 ' A' ' 58' ' ' VAL . 5.3 p -101.18 119.37 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 72.43 111.151 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.833 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -113.26 144.63 42.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 72.4 110.934 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.651 HG11 ' SD ' ' A' ' 26' ' ' MET . 10.8 t -149.38 123.37 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.43 111.118 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.772 ' OG1' ' HA ' ' A' ' 80' ' ' ARG . 1.9 m -172.2 -135.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 71.53 111.127 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.547 ' H ' HG22 ' A' ' 74' ' ' THR . 27.0 mtm-85 -96.02 145.93 30.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.576 0.703 . . . . 75.34 110.866 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.587 ' CG ' HG21 ' A' ' 50' ' ' VAL . 53.2 Cg_endo -69.75 10.64 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.698 2.265 . . . . 54.13 112.339 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 75' ' ' ARG . 7.6 m-20 -88.59 25.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.51 110.854 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.24 -9.76 24.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 41.12 112.521 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 79' ' ' THR . 2.5 t -97.58 102.54 14.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 65.33 111.154 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.772 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -142.2 172.39 12.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 73.0 110.9 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 27.9 t -119.93 113.03 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 72.31 111.138 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.539 ' HA ' ' HB3' ' A' ' 72' ' ' LEU . 2.1 pt-20 -88.34 122.26 31.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 75.21 110.902 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.582 ' CG1' HD11 ' A' ' 20' ' ' LEU . 2.1 t -100.96 117.01 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 71.33 111.153 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.508 ' O ' ' O ' ' A' ' 91' ' ' VAL . 3.5 t-160 -82.02 116.2 21.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 73.34 110.846 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.768 ' HB3' HD23 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -104.03 98.09 7.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.937 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 1.03 ' H ' ' HA ' ' A' ' 91' ' ' VAL . 3.3 p30 -134.84 119.25 17.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 74.35 110.845 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.436 ' HG3' HD11 ' A' ' 14' ' ' ILE . 1.3 tmt_? -65.35 10.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 75.52 110.868 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.626 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 19.3 t0 -80.03 20.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 74.42 110.86 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.626 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 15.3 m-85 91.5 -17.8 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 73.41 110.908 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 38.23 3.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 62.33 110.895 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.03 ' HA ' ' H ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -64.35 -6.8 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 75.54 111.125 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.702 HD22 HG13 ' A' ' 91' ' ' VAL . 3.1 mm? -113.08 28.48 8.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 75.34 110.965 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -80.04 75.08 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 71.31 110.891 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.8 t -86.02 151.36 23.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 54.33 111.122 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.18 110.45 4.0 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.631 0.729 . . . . 73.1 110.884 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 120.22 7.04 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.686 2.257 . . . . 72.21 112.369 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.577 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . . . -116.81 167.47 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 63.34 111.081 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.49 7.71 7.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 65.22 110.859 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.432 ' HA2' ' CB ' ' A' ' 42' ' ' ALA . . . 86.1 -18.68 30.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 34.04 112.476 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.21 -16.55 22.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 74.2 110.859 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.53 -24.16 63.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 75.44 112.472 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 51.44 112.53 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.1 t0 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.834 0.349 . . . . 64.33 110.843 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -68.34 -43.89 76.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.904 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -60.74 -167.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.874 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.876 HG22 ' H ' ' A' ' 16' ' ' THR . 46.6 mm -76.69 122.07 85.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.62 0.724 . . . . 65.24 111.119 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 9.27 0.6 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.697 2.265 . . . . 74.35 112.3 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.876 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -125.52 36.69 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 62.45 111.133 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.902 HG22 HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -91.6 -166.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 62.45 111.176 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -64.42 -103.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 75.41 110.904 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.77 7.69 45.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.24 110.892 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.849 ' HG ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.02 -14.35 53.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 72.34 110.911 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -94.4 5.66 51.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 64.12 110.946 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -108.44 -43.36 4.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 72.32 110.905 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.664 ' HG3' HG21 ' A' ' 83' ' ' VAL . 4.4 mm100 -64.64 -53.04 53.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 73.34 110.9 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.54 -54.32 7.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.774 -0.726 . . . . 74.42 112.455 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.18 49.0 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.762 0.315 . . . . 63.34 111.124 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.2 ptm -66.47 -40.83 89.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 65.34 110.885 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' HB1' ' CE1' ' A' ' 28' ' ' PHE . . . -122.54 -92.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 62.43 111.055 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.483 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -145.12 -35.14 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 71.44 110.884 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.26 30.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.23 110.831 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.98 7.63 65.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 63.31 112.512 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.536 ' HB3' HG23 ' A' ' 58' ' ' VAL . 2.0 mm-40 -74.22 161.99 29.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 72.33 110.854 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.66 -166.03 1.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 70.23 110.837 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.13 118.94 22.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 72.11 110.91 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.67 HG22 ' OE2' ' A' ' 57' ' ' GLU . 87.6 t -71.36 155.76 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 54.45 111.119 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.471 ' N ' HG12 ' A' ' 34' ' ' VAL . 16.6 p -107.82 -22.04 12.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 72.15 111.211 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 34' ' ' VAL . . . -153.48 -139.71 2.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 41.32 112.455 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -162.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.722 2.282 . . . . 74.41 112.31 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.35 -27.42 64.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 64.41 110.896 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.81 -39.13 70.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 75.33 111.105 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -82.45 -37.58 25.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 54.41 110.874 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.581 ' HG3' ' HD3' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -68.53 -38.34 80.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.893 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 80' ' ' ARG . . . -63.47 -33.08 74.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 74.33 111.168 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.497 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 2.7 ptt85 -77.61 -40.45 42.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 54.33 110.909 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.772 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . . . -77.9 -57.53 3.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 73.32 111.105 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -52.78 -18.11 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 64.53 111.085 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.504 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -63.75 -78.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.53 111.096 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.739 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 80.5 t -111.91 -20.07 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 63.24 111.134 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 16.6 mt-30 -72.01 -26.62 62.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 73.11 110.94 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.106 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -109.09 -4.99 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 72.03 111.135 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.999 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.78 0.59 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.615 0.722 . . . . 64.41 111.123 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.106 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.0 Cg_endo -69.79 -26.47 27.41 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 55.42 112.33 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.36 -54.58 2.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 72.45 112.47 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.74 -31.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 41.11 112.512 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.737 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -140.51 146.14 37.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 65.2 111.17 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.772 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -74.68 74.87 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 63.51 111.116 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.725 ' HA3' ' HA ' ' A' ' 73' ' ' VAL . . . -153.45 109.34 0.4 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 73.13 112.483 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.867 ' HB3' ' HB2' ' A' ' 49' ' ' ALA . 2.3 pt-20 -100.91 -161.21 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 64.21 110.896 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 31' ' ' GLU . 60.0 t -128.84 142.88 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 72.41 111.096 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 1.0 OUTLIER -108.82 153.5 23.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 74.2 110.886 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.86 105.56 7.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 74.53 111.117 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -136.85 165.76 25.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 73.02 110.878 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -124.28 115.42 21.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 61.32 111.124 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.04 -151.31 14.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.731 -0.747 . . . . 43.43 112.518 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -78.38 -23.43 46.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.364 . . . . 73.25 110.88 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.86 -120.41 0.22 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 71.33 112.489 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -122.65 -76.95 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 62.31 111.117 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.852 ' HB1' ' CE2' ' A' ' 69' ' ' TYR . . . -102.9 92.53 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 43.41 111.082 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -84.55 72.98 10.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 71.42 111.085 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.852 ' CE2' ' HB1' ' A' ' 67' ' ' ALA . 6.8 m-85 -106.76 165.62 11.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.32 110.904 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -146.89 111.68 0.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 50.54 112.518 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 83' ' ' VAL . 7.2 p -102.66 117.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.362 . . . . 73.43 111.111 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.938 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -104.14 145.45 30.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.962 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.725 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 18.1 m -151.23 118.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 75.13 111.14 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.794 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.3 m -165.87 -136.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.34 111.153 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.613 ' H ' HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -102.68 149.85 37.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 73.32 110.858 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.53 ' CG ' HG21 ' A' ' 50' ' ' VAL . 53.3 Cg_endo -69.77 6.01 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.63 2.22 . . . . 64.24 112.359 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -85.91 35.34 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 72.33 110.837 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.41 -8.68 52.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 51.01 112.478 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.794 ' O ' ' HB ' ' A' ' 74' ' ' THR . 3.2 t -92.34 125.43 37.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 75.41 111.126 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -144.24 144.35 31.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.891 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.807 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 87.9 t -104.81 88.97 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 72.32 111.132 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.44 ' HB3' ' HD3' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -71.53 122.78 21.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 65.5 110.887 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.664 HG21 ' HG3' ' A' ' 23' ' ' GLN . 16.3 t -102.29 139.26 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 52.21 111.161 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 1.043 ' C ' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -89.43 115.14 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 64.04 110.883 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.043 HD13 ' C ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -125.62 105.63 9.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 73.31 110.937 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.798 ' CG ' HG11 ' A' ' 91' ' ' VAL . 4.3 m-20 -135.12 129.06 33.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 73.22 110.879 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -58.48 6.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 64.42 110.893 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.621 ' H ' ' C ' ' A' ' 86' ' ' ASP . 3.8 t0 -64.89 -5.84 6.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 72.32 110.88 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 70.71 13.17 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.12 110.903 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 2.73 1.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 72.54 110.909 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.798 HG11 ' CG ' ' A' ' 86' ' ' ASP . 69.0 t -119.13 81.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 52.24 111.069 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.902 HD23 HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -136.27 10.6 3.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 74.45 110.924 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -93.25 167.61 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 64.03 110.839 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.658 ' OG1' HG22 ' A' ' 83' ' ' VAL . 9.8 t -108.17 166.9 10.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 64.2 111.122 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -144.53 119.96 6.03 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.636 0.732 . . . . 73.33 110.885 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 119.02 6.03 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.697 2.264 . . . . 73.24 112.325 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -116.34 163.07 16.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 73.24 111.063 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -125.62 -135.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 74.04 110.816 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.13 -14.94 27.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.667 -0.778 . . . . 74.22 112.484 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -91.5 -48.66 6.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 70.45 110.862 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.76 23.2 9.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 71.31 112.465 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 60.21 112.49 -179.921 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.824 0.345 . . . . 64.43 110.865 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -67.59 -23.16 65.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 63.34 110.893 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.634 ' HA ' ' HB1' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -62.23 -157.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 70.15 110.859 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.557 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 20.7 pt -77.21 160.87 74.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.587 0.708 . . . . 73.13 111.153 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.8 -3.11 11.37 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.64 2.227 . . . . 65.11 112.358 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.0 p -148.2 79.87 1.46 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 70.03 111.153 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.985 HG22 HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -98.98 -166.34 1.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 72.21 111.153 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.56 ' HB2' HD23 ' A' ' 92' ' ' LEU . 10.6 tt0 -80.58 -100.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 64.14 110.881 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.58 10.83 40.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.908 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.773 HD13 ' CG ' ' A' ' 85' ' ' LEU . 3.3 tp -65.01 -21.15 66.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 75.2 110.904 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -83.78 7.12 18.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 54.12 110.918 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -108.8 -42.08 4.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 74.43 110.868 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.51 ' HG3' HG21 ' A' ' 83' ' ' VAL . 5.0 mm100 -66.43 -46.68 75.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 75.33 110.934 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.22 -29.19 1.57 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 70.44 112.513 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.25 -58.63 5.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.78 0.324 . . . . 62.31 111.121 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -9.99 59.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 54.01 110.865 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 31' ' ' GLU . . . -81.92 -17.84 45.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 72.42 111.085 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -79.04 5.07 12.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 71.01 110.915 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -73.63 -82.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 61.21 110.852 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.06 12.62 0.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 75.43 112.504 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -66.38 168.66 8.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 72.54 110.877 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 9.3 m-20 -112.12 -149.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 63.02 110.867 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.96 170.18 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 70.1 110.881 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 58' ' ' VAL . 14.8 t -118.45 169.42 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 72.52 111.105 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.623 ' N ' HG12 ' A' ' 34' ' ' VAL . 63.0 p -90.53 -41.59 11.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 74.34 111.137 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.423 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 162.01 -61.83 0.28 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 74.22 112.515 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 54.0 Cg_endo -69.74 157.01 61.9 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.712 2.275 . . . . 72.5 112.337 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -62.74 -26.84 68.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 73.1 110.889 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.28 -35.83 72.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 71.1 111.15 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.42 -36.13 24.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 65.43 110.893 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 12.8 ptt180 -70.22 -43.64 70.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 74.02 110.894 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.41 -34.41 72.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 71.55 111.143 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -79.92 -41.22 26.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 70.11 110.89 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.597 ' HB1' ' OE2' ' A' ' 57' ' ' GLU . . . -76.85 -62.24 1.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 44.34 111.067 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -52.74 -22.31 5.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 64.23 111.117 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.746 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -53.59 -69.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 63.43 111.154 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.705 ' HA ' HG12 ' A' ' 50' ' ' VAL . 21.3 t -112.17 -11.11 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 63.42 111.093 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.587 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.3 tp60 -83.19 -34.19 26.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 74.32 110.926 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.987 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.44 -6.02 18.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 44.14 111.098 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.979 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.93 -9.42 0.14 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.628 0.728 . . . . 64.42 111.152 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.987 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.6 Cg_endo -69.78 -22.73 31.59 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.68 2.253 . . . . 74.14 112.322 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.65 -54.36 2.96 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.794 -0.717 . . . . 73.32 112.488 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.64 -34.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 62.04 112.455 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.672 ' O ' ' O ' ' A' ' 49' ' ' ALA . 2.0 t -148.34 152.81 37.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.757 0.313 . . . . 72.42 111.194 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.777 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.38 75.28 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 71.21 111.077 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.757 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -147.09 104.51 0.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.722 . . . . 43.42 112.503 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.597 ' OE2' ' HB1' ' A' ' 44' ' ' ALA . 1.9 tt0 -97.6 -170.37 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.37 . . . . 64.4 110.888 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.741 ' O ' HG23 ' A' ' 34' ' ' VAL . 2.6 t -129.25 139.17 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 72.01 111.159 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.553 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 10.6 tt0 -106.31 128.16 53.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 64.43 110.923 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 60' ' ' THR . 1.7 t -118.31 95.57 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 51.44 111.077 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.434 ' C ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -137.28 168.87 18.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 61.34 110.85 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.4 m -98.07 -19.34 18.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 65.34 111.144 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 68' ' ' ALA . . . 49.97 -159.2 1.39 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 44.11 112.488 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.36 -25.37 23.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.357 . . . . 71.51 110.892 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.05 -116.89 0.47 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.683 -0.77 . . . . 64.22 112.475 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.814 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -120.11 -65.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 74.01 111.089 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.697 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -111.83 94.39 4.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 74.12 111.144 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.465 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . . . -87.71 84.67 7.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 74.35 111.063 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.708 ' CD1' HD21 ' A' ' 20' ' ' LEU . 6.5 t80 -110.81 123.43 50.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 64.04 110.92 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -126.32 111.89 1.51 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 73.13 112.476 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 83' ' ' VAL . 7.9 p -107.83 121.03 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 61.44 111.11 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.818 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -114.12 134.31 54.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 71.51 110.936 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.662 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.5 m -144.92 122.77 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 72.25 111.143 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.792 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 5.0 m -171.95 -126.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 43.43 111.131 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.508 ' N ' HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -106.33 146.08 32.28 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.665 0.745 . . . . 63.13 110.868 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.505 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.4 Cg_endo -69.74 12.36 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.667 2.245 . . . . 64.51 112.355 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 75' ' ' ARG . 38.2 t70 -91.55 28.82 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 64.55 110.835 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.35 -10.88 26.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 72.42 112.463 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.581 ' O ' ' HB ' ' A' ' 74' ' ' THR . 32.1 p -97.1 104.99 17.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 55.0 111.151 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.792 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.4 OUTLIER -138.17 165.7 25.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 72.3 110.85 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 5.7 m -115.0 98.94 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 64.52 111.166 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . 8.8 tm-20 -85.69 125.64 33.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.41 110.882 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.643 HG12 ' CD2' ' A' ' 85' ' ' LEU . 2.5 t -92.43 113.04 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 54.01 111.14 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.734 ' O ' HD22 ' A' ' 85' ' ' LEU . 2.4 t-160 -85.79 113.0 21.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.902 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.985 HD12 HG22 ' A' ' 17' ' ' THR . 4.0 mm? -130.36 121.76 26.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 63.45 110.877 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.708 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.4 t0 -137.8 134.92 35.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 65.2 110.892 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.814 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -59.35 3.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.44 110.827 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.564 ' H ' ' C ' ' A' ' 86' ' ' ASP . 8.2 t0 -65.7 -3.53 4.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 73.4 110.834 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 68.5 10.73 8.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 71.21 110.899 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.04 -1.29 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 74.2 110.871 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.708 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 58.3 t -117.6 90.99 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 74.52 111.123 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.911 ' HA ' HD13 ' A' ' 85' ' ' LEU . 5.5 mp -146.33 14.6 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 72.31 110.886 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -113.43 140.96 47.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 64.34 110.869 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.64 ' HB ' HG13 ' A' ' 83' ' ' VAL . 3.3 t -87.91 151.41 22.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 64.13 111.194 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -123.83 149.8 60.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 71.41 110.904 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 143.12 49.77 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.705 2.27 . . . . 72.41 112.325 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -118.81 110.2 16.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 64.14 111.067 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -98.46 4.79 48.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.818 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.61 -20.91 8.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.774 -0.727 . . . . 44.21 112.487 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.3 -16.03 20.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.825 0.345 . . . . 64.32 110.865 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.99 -14.0 54.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.796 -0.716 . . . . 70.41 112.488 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 74.14 112.479 -179.908 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.711 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 13.9 t70 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.83 0.348 . . . . 70.3 110.872 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.696 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 92.7 m-85 -67.52 -36.53 81.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 73.32 110.926 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.59 -164.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 71.41 110.831 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.863 HG22 ' H ' ' A' ' 16' ' ' THR . 24.4 mm -77.78 129.84 75.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.651 0.739 . . . . 71.31 111.13 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 18.0 0.2 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.645 2.23 . . . . 73.24 112.35 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.863 ' H ' HG22 ' A' ' 14' ' ' ILE . 3.1 m -138.73 27.13 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 51.14 111.172 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.919 HG22 ' CD2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -74.36 -167.5 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 74.11 111.132 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -63.94 -103.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.887 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.75 8.56 44.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 70.21 110.882 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.013 ' HG ' HD22 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.71 -13.24 53.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.2 110.911 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -95.34 7.74 45.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.454 . . . . 73.11 110.91 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -106.98 -40.08 5.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 61.24 110.855 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -66.24 -47.63 73.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 71.14 110.914 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -43.55 -31.9 1.81 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 65.23 112.485 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.33 -64.51 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 61.13 111.075 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.539 ' CE ' HG21 ' A' ' 73' ' ' VAL . 3.5 ppp? -70.45 -7.94 47.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 54.43 110.921 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.441 ' HA ' ' HB2' ' A' ' 31' ' ' GLU . . . -76.91 -19.98 56.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 60.24 111.087 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -77.97 5.79 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 70.11 110.864 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.72 -81.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 72.52 110.85 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.92 14.52 5.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 51.05 112.499 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HG2' HG23 ' A' ' 58' ' ' VAL . 1.1 tt0 -54.82 103.4 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.902 0.382 . . . . 74.31 110.926 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.406 ' N ' ' HG2' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -76.95 -170.2 1.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 70.11 110.857 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.18 125.46 52.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 53.44 110.863 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.807 HG23 ' OE1' ' A' ' 57' ' ' GLU . 1.9 t -71.03 161.92 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 71.34 111.101 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' CG1' ' A' ' 34' ' ' VAL . 1.7 p -84.93 -45.75 11.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 63.2 111.125 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.43 -81.17 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.724 -0.751 . . . . 73.13 112.476 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 169.48 18.78 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.701 2.267 . . . . 33.21 112.337 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -68.17 -26.39 65.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 63.31 110.872 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 43' ' ' ARG . . . -52.53 -28.4 20.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 55.23 111.098 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -76.81 -30.79 56.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 74.42 110.905 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.482 ' HG3' ' HD3' ' A' ' 80' ' ' ARG . 4.3 ptt180 -56.7 -38.96 73.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 72.1 110.892 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.949 ' HB2' ' HA2' ' A' ' 99' ' ' GLY . . . -70.12 -30.44 67.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 62.45 111.086 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 39' ' ' ALA . 10.5 mtt-85 -74.34 -45.16 48.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 72.53 110.875 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -78.25 -57.52 3.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 74.22 111.118 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 1.041 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -54.02 -17.36 2.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 64.13 111.106 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -62.69 -68.05 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 63.34 111.106 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.682 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 26.0 t -122.21 -14.16 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 51.12 111.14 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.587 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 27.9 mt-30 -79.64 -41.64 26.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 73.11 110.92 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.041 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . . . -104.43 0.05 28.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 53.23 111.074 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.976 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.29 -13.19 0.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 74.32 111.136 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.976 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 53.5 Cg_endo -69.77 -32.24 18.92 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.654 2.236 . . . . 73.13 112.362 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.16 -51.46 38.5 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.785 -0.722 . . . . 74.54 112.51 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.58 -33.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 25.23 112.496 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 74' ' ' THR . 0.2 OUTLIER -150.24 158.63 44.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 52.32 111.152 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.709 ' CA ' HG23 ' A' ' 50' ' ' VAL . . . -70.99 77.78 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 51.22 111.102 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.723 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -144.94 106.9 0.41 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.733 . . . . 71.43 112.46 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.807 ' OE1' HG23 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -101.33 -159.24 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 71.21 110.884 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -126.62 121.3 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 71.35 111.159 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.754 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -94.69 171.47 8.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 64.31 110.87 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -113.88 128.86 56.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 63.41 111.12 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.553 ' H ' ' HA ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -142.72 91.29 2.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 75.5 110.903 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.0 p -94.81 149.4 21.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 73.43 111.144 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.536 ' N ' ' HB3' ' A' ' 67' ' ' ALA . . . -134.18 179.46 17.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.778 -0.725 . . . . 73.23 112.509 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -76.41 -24.14 54.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.899 0.381 . . . . 75.02 110.884 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.59 -117.39 2.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 65.32 112.468 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -116.45 38.93 3.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 72.33 111.095 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.536 ' HB3' ' N ' ' A' ' 63' ' ' GLY . . . -59.06 -171.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 52.42 111.083 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.696 ' HB1' ' HB2' ' A' ' 12' ' ' TYR . . . -156.29 -95.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 71.22 111.109 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.754 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -162.29 -163.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 75.44 110.888 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -138.99 156.64 24.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.749 -0.739 . . . . 30.45 112.505 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.631 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.4 p -125.61 121.1 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 73.04 111.124 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.783 HD21 ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -112.14 142.91 44.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 51.42 110.94 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.723 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 11.0 p -157.88 125.84 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 63.53 111.139 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 54' ' ' THR . 5.6 m -168.6 -125.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 72.11 111.14 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.504 ' N ' HG22 ' A' ' 74' ' ' THR . 3.8 ttm-85 -107.82 139.32 20.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 75.22 110.876 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 13.89 0.27 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.679 2.252 . . . . 60.12 112.369 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 75' ' ' ARG . 1.3 m-20 -94.1 23.79 4.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 72.54 110.877 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.51 -16.3 61.28 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.718 -0.753 . . . . 53.11 112.48 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.696 ' O ' ' HB ' ' A' ' 74' ' ' THR . 6.0 t -94.0 122.55 36.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.763 0.316 . . . . 64.02 111.105 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.77 ' HB3' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -141.65 161.52 37.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 72.22 110.852 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 94.1 t -118.05 85.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 61.42 111.103 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.447 ' HA ' ' CB ' ' A' ' 72' ' ' LEU . 6.9 tm-20 -77.27 121.86 24.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.841 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.677 HG13 ' HB ' ' A' ' 94' ' ' THR . 3.3 t -100.33 137.4 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 73.22 111.124 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.838 ' C ' HD23 ' A' ' 85' ' ' LEU . 6.5 m-70 -92.56 118.23 30.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 63.4 110.871 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.013 HD22 ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -122.48 101.36 7.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.21 110.892 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.784 ' OD2' HG11 ' A' ' 91' ' ' VAL . 34.4 m-20 -140.78 131.74 26.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 75.11 110.858 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.748 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -61.36 11.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 72.24 110.854 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.643 ' H ' ' C ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -65.37 -5.93 8.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.22 110.856 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 74.27 6.88 4.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 55.43 110.865 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -141.54 7.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.34 110.894 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.784 HG11 ' OD2' ' A' ' 86' ' ' ASP . 40.9 t -118.31 69.52 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 73.43 111.137 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.919 ' CD2' HG22 ' A' ' 17' ' ' THR . 0.2 OUTLIER -129.91 10.72 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 50.53 110.953 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.23 -179.95 3.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 73.12 110.791 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.677 ' HB ' HG13 ' A' ' 83' ' ' VAL . 13.4 t -126.42 171.18 11.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 64.13 111.138 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -144.84 159.64 49.68 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.663 0.744 . . . . 72.52 110.86 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 107.01 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.648 2.232 . . . . 61.52 112.341 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.465 ' HB3' ' C ' ' A' ' 80' ' ' ARG . . . -75.69 112.15 11.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 73.24 111.099 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -85.68 6.36 27.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 64.2 110.92 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.949 ' HA2' ' HB2' ' A' ' 42' ' ' ALA . . . 79.56 -20.93 4.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.744 -0.741 . . . . 65.31 112.502 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.36 -33.06 10.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 74.11 110.873 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.07 24.85 54.0 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 61.11 112.491 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 74.14 112.457 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.754 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 15.9 t70 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.78 0.324 . . . . 65.11 110.806 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -65.41 -56.38 12.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 62.0 110.852 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.482 ' CG ' ' HB3' ' A' ' 67' ' ' ALA . 25.5 t0 -65.36 -115.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 61.12 110.862 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.73 HG22 ' H ' ' A' ' 16' ' ' THR . 12.6 mm -100.13 108.64 53.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.586 0.708 . . . . 75.12 111.103 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 23.1 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.714 2.276 . . . . 74.35 112.322 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.73 ' H ' HG22 ' A' ' 14' ' ' ILE . 3.1 m -131.17 20.22 4.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.23 111.163 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.988 HG22 HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -76.13 -165.99 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 62.34 111.113 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.698 ' HG3' HD22 ' A' ' 92' ' ' LEU . 21.1 mt-10 -61.3 -105.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 71.52 110.873 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.8 8.23 44.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 61.04 110.898 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.996 ' HG ' HD22 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -65.29 -15.81 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 65.33 110.88 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -97.02 4.39 51.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 62.33 110.91 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -103.65 -42.21 5.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 74.04 110.868 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.42 ' HB2' HG11 ' A' ' 71' ' ' VAL . 6.5 mm100 -66.35 -51.39 57.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 75.0 110.961 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.3 -27.86 4.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 50.02 112.5 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.35 49.23 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 43.4 111.122 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.468 ' SD ' HG11 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -70.36 -42.77 71.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 74.04 110.905 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.456 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -119.42 -93.28 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 52.22 111.1 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -150.39 -37.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.41 110.927 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.38 -0.05 1.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 74.22 110.841 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.62 -20.33 7.55 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.757 -0.735 . . . . 73.34 112.508 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.474 ' CG ' HG21 ' A' ' 58' ' ' VAL . 1.4 tm-20 -83.9 103.25 13.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 64.41 110.91 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.68 179.08 4.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.491 . . . . 65.44 110.846 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.3 119.14 37.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 64.4 110.911 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.676 HG23 ' C ' ' A' ' 58' ' ' VAL . 8.4 t -84.2 -125.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 60.31 111.09 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.565 ' N ' HG12 ' A' ' 34' ' ' VAL . 71.4 p -139.52 -71.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 70.54 111.129 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.22 -65.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.755 -0.736 . . . . 75.25 112.51 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 166.63 26.9 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.649 2.233 . . . . 74.31 112.325 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -72.21 -28.94 63.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 71.53 110.846 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.0 -32.9 62.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 73.14 111.095 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.95 -31.57 31.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 64.33 110.882 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -69.34 -43.13 74.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 71.23 110.872 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.711 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.95 -33.28 70.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 71.43 111.129 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -81.01 -40.97 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 62.31 110.883 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.562 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -75.55 -63.06 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 53.43 111.12 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -53.54 -21.26 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 44.1 111.119 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.721 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -52.98 -68.92 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 63.14 111.062 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.767 ' HA ' HG12 ' A' ' 50' ' ' VAL . 19.0 t -111.75 -13.31 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 72.5 111.107 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.7 tp60 -80.53 -32.92 36.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 71.43 110.928 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.046 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.36 -6.68 17.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 71.33 111.153 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.987 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.08 -4.33 0.11 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.58 0.705 . . . . 71.14 111.094 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.046 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.1 Cg_endo -69.75 -24.46 29.69 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.731 2.288 . . . . 60.25 112.31 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.62 -56.33 2.26 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.718 -0.753 . . . . 72.13 112.487 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.1 -36.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.744 . . . . 64.54 112.473 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.746 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.7 t -146.42 150.44 35.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 25.54 111.185 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.822 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -73.12 80.3 1.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 72.35 111.095 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.733 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -146.86 99.51 0.21 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 62.44 112.491 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.54 ' OE1' HG22 ' A' ' 34' ' ' VAL . 3.5 tt0 -99.79 -167.05 1.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 75.11 110.892 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.676 ' C ' HG23 ' A' ' 34' ' ' VAL . 11.6 t -137.78 117.62 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 73.24 111.165 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.514 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 1.9 pp20? -96.08 155.16 16.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 72.23 110.857 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.487 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.5 t -127.65 118.7 24.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 74.54 111.178 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.54 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -132.62 170.88 14.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.42 110.916 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.75 114.48 22.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 61.02 111.128 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.43 -147.47 12.76 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 63.21 112.467 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -87.58 -1.63 58.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 73.24 110.904 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.02 -118.12 4.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 71.15 112.468 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -119.13 -78.27 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.775 0.321 . . . . 64.14 111.08 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -107.01 92.97 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 50.13 111.081 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -80.84 59.34 3.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 72.45 111.093 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.754 ' HH ' ' N ' ' A' ' 11' ' ' ASP . 2.6 p90 -110.74 132.11 54.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.35 110.935 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -118.71 150.37 18.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.777 -0.725 . . . . 73.11 112.494 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.847 HG12 HD11 ' A' ' 85' ' ' LEU . 2.5 p -117.5 119.78 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.368 . . . . 72.04 111.12 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.777 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -107.14 138.33 43.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 72.4 110.925 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.703 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.1 t -148.98 122.03 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 63.23 111.147 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.787 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 3.6 m -171.52 -128.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 70.33 111.121 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.502 ' H ' HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -104.28 142.61 24.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.662 0.744 . . . . 73.14 110.844 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.599 ' HG3' HG21 ' A' ' 50' ' ' VAL . 53.9 Cg_endo -69.76 14.19 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.695 2.264 . . . . 74.22 112.311 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 75' ' ' ARG . 7.2 m-20 -93.01 27.01 2.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.267 -0.424 . . . . 75.03 110.864 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.85 -12.89 51.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.792 -0.718 . . . . 70.23 112.51 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.593 ' O ' ' HB ' ' A' ' 74' ' ' THR . 33.6 p -97.18 106.64 19.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 72.24 111.141 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.787 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.7 OUTLIER -137.79 164.68 28.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 73.22 110.858 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 10.3 m -116.92 96.97 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 74.12 111.102 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.578 ' HG3' HD12 ' A' ' 72' ' ' LEU . 1.3 tm-20 -80.93 121.97 26.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 73.01 110.898 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.66 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.4 t -93.9 137.33 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 55.04 111.133 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.844 ' C ' HD23 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -84.85 112.81 20.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 71.34 110.849 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.996 HD22 ' HG ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -121.21 109.53 15.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 71.22 110.911 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.666 ' HB2' HG11 ' A' ' 91' ' ' VAL . 2.2 t0 -140.28 131.35 26.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 62.34 110.864 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.456 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -60.8 7.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 62.34 110.865 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.609 ' H ' ' C ' ' A' ' 86' ' ' ASP . 19.8 t0 -66.44 -4.6 8.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 60.31 110.877 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 70.02 11.43 7.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 74.24 110.916 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.79 5.63 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 71.52 110.898 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 86' ' ' ASP . 49.7 t -117.43 74.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.5 111.137 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.988 HD23 HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -133.59 11.7 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 64.41 110.931 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -92.95 163.49 13.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 71.42 110.905 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 8.3 t -98.9 161.76 13.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 70.52 111.171 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -147.6 127.52 6.65 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 75.55 110.904 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 123.5 10.16 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.73 2.287 . . . . 54.51 112.306 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.59 161.66 18.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.11 111.135 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -128.8 -146.24 0.32 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.429 . . . . 45.23 110.887 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.62 -15.85 30.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.772 -0.728 . . . . 73.31 112.434 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.59 -36.35 13.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.369 . . . . 74.11 110.852 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.62 54.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 34.41 112.499 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.736 . . . . 62.01 112.485 -179.93 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.779 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.825 0.345 . . . . 72.21 110.864 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.537 ' HE2' HG11 ' A' ' 58' ' ' VAL . 65.2 m-85 -75.09 -33.61 61.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 71.41 110.93 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.678 ' CG ' HD23 ' A' ' 20' ' ' LEU . 2.5 p-10 -64.53 -152.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 72.32 110.851 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.731 HD12 ' O ' ' A' ' 16' ' ' THR . 0.5 OUTLIER -78.17 163.37 62.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.652 0.739 . . . . 72.42 111.153 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -9.32 25.83 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.702 2.268 . . . . 55.32 112.383 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.731 ' O ' HD12 ' A' ' 14' ' ' ILE . 2.6 p -154.2 130.15 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 71.41 111.144 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.084 HG22 HD23 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -149.76 -158.78 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 54.41 111.185 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -70.44 -101.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 64.25 110.892 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -91.17 11.21 24.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 64.11 110.881 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.957 HD21 ' HB3' ' A' ' 85' ' ' LEU . 10.7 mp -65.35 -30.08 70.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 73.42 110.956 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -80.31 4.72 16.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 74.15 110.962 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.12 -53.8 2.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 75.14 110.917 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.588 ' HB2' HG11 ' A' ' 71' ' ' VAL . 68.9 mm-40 -66.95 -46.55 74.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 74.15 110.935 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 27' ' ' ALA . . . -46.94 -25.37 2.37 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 62.41 112.498 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.2 -80.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 62.44 111.08 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.9 ptm -66.85 -0.49 3.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 62.23 110.873 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.695 ' HB1' ' OE2' ' A' ' 31' ' ' GLU . . . -77.25 -32.93 56.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 73.52 111.071 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -82.95 10.05 8.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 71.24 110.856 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -68.6 -72.71 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 73.23 110.911 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.04 11.74 0.59 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 75.01 112.519 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.695 ' OE2' ' HB1' ' A' ' 27' ' ' ALA . 1.7 pt-20 -67.3 171.24 6.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 74.24 110.884 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -127.93 -153.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.24 110.844 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -109.85 163.61 13.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.835 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.661 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 1.0 OUTLIER -91.73 162.35 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 33.43 111.15 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.577 ' N ' ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -104.5 -32.73 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 74.04 111.163 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.475 ' H ' HG13 ' A' ' 34' ' ' VAL . . . -157.62 -139.09 2.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 73.32 112.498 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -160.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.669 2.246 . . . . 71.1 112.321 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -55.07 -34.21 63.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 70.02 110.896 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.86 -37.87 66.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 73.43 111.077 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -84.34 -42.05 16.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.888 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 7.1 ptt180 -61.9 -37.63 85.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 75.44 110.838 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.679 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -65.8 -34.76 78.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 53.24 111.093 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -78.08 -39.26 42.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 65.43 110.897 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -77.12 -58.55 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 55.25 111.084 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.738 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -57.2 -17.73 12.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 72.22 111.129 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -62.63 -79.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 53.2 111.118 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.758 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 61.1 t -110.91 -23.08 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 74.34 111.125 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.637 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 3.5 mt-30 -68.55 -27.7 66.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 65.42 110.883 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.082 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.77 -0.82 19.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 72.24 111.073 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.005 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.37 -1.1 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.62 0.724 . . . . 74.11 111.103 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.082 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.9 Cg_endo -69.76 -31.22 20.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.702 2.268 . . . . 61.54 112.33 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.98 -54.23 5.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 74.13 112.493 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.2 -33.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 35.52 112.525 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.62 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.4 m -145.08 152.65 40.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 62.21 111.152 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.849 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.57 76.07 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 72.32 111.11 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.708 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -146.59 104.94 0.31 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 73.51 112.515 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.633 ' HG3' ' HB2' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -98.56 -153.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 73.11 110.858 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.68 HG13 ' CE1' ' A' ' 69' ' ' TYR . 54.9 t -131.68 133.78 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 73.23 111.127 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.661 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -100.99 122.91 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 72.23 110.903 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.9 t -108.03 111.39 23.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 63.35 111.174 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -137.48 159.94 40.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 75.04 110.887 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 p -124.24 117.43 24.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 73.12 111.079 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.98 -147.87 11.85 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 74.44 112.497 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.33 -1.64 57.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.391 . . . . 74.42 110.894 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.51 -120.62 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.721 -0.752 . . . . 74.53 112.472 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -122.95 -75.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 61.22 111.057 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.642 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -104.67 85.85 2.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 52.15 111.038 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -82.49 59.26 4.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 61.52 111.072 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.779 ' HH ' ' N ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -116.98 158.58 23.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 65.14 110.886 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -141.41 158.96 26.66 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.708 -0.758 . . . . 62.22 112.497 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.588 HG11 ' HB2' ' A' ' 23' ' ' GLN . 8.7 p -116.39 120.46 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 71.51 111.122 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.775 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -111.57 133.33 53.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 72.22 110.911 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.735 ' O ' HG22 ' A' ' 81' ' ' VAL . 7.3 p -148.43 124.13 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.54 111.119 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.811 ' HB ' ' O ' ' A' ' 79' ' ' THR . 3.8 m -167.77 -129.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.178 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.533 ' H ' HG22 ' A' ' 74' ' ' THR . 0.3 OUTLIER -101.84 146.77 32.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.603 0.716 . . . . 74.15 110.895 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.409 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.72 7.68 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.699 2.266 . . . . 63.14 112.371 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -91.28 41.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 74.12 110.891 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.19 -4.94 16.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 65.3 112.527 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.811 ' O ' ' HB ' ' A' ' 74' ' ' THR . 43.9 p -96.07 117.02 29.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 75.41 111.161 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.743 ' O ' ' HB3' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -144.75 158.1 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 73.44 110.867 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 73' ' ' VAL . 31.4 m -118.13 92.13 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 62.2 111.126 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.726 ' HB2' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -81.12 123.43 28.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 73.14 110.888 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.674 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.4 t -94.93 131.75 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.499 . . . . 53.45 111.134 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -83.65 117.19 23.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 63.45 110.865 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.957 ' HB3' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -135.86 121.28 19.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 63.3 110.918 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.689 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 6.3 t0 -140.49 132.5 27.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 74.22 110.871 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.713 ' HG3' HG23 ' A' ' 14' ' ' ILE . 2.7 tmt_? -60.36 4.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.43 110.847 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.557 ' H ' ' C ' ' A' ' 86' ' ' ASP . 22.5 t0 -67.94 -3.92 11.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 71.04 110.879 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 69.31 14.85 8.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 75.5 110.865 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.05 -1.06 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 75.21 110.853 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.689 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 92.7 t -117.91 91.39 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.43 111.117 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.084 HD23 HG22 ' A' ' 17' ' ' THR . 0.2 OUTLIER -140.47 8.25 2.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.32 110.899 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.7 162.27 14.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 74.33 110.864 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.2 t -93.41 172.45 8.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 74.34 111.126 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' GLU . 3.4 tt0 -145.96 123.71 6.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.688 0.756 . . . . 65.51 110.852 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 129.48 17.58 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.249 . . . . 75.34 112.345 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -117.86 117.17 28.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 63.45 111.126 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 100' ' ' ASP . 3.4 m-20 -121.67 49.13 1.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 74.1 110.855 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.429 ' HA2' HH12 ' A' ' 80' ' ' ARG . . . 71.68 -16.92 1.28 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 72.33 112.485 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 98' ' ' ASP . 3.0 t0 -95.32 -62.14 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 72.02 110.857 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.36 26.02 60.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.759 -0.734 . . . . 73.15 112.472 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 44.4 112.48 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.686 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.817 0.341 . . . . 72.35 110.884 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -67.5 -54.34 20.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 75.04 110.938 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.695 ' OD1' ' HB3' ' A' ' 67' ' ' ALA . 9.0 t0 -64.19 -154.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 74.2 110.859 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.822 HG22 ' H ' ' A' ' 16' ' ' THR . 35.4 mm -92.24 123.68 61.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.612 0.72 . . . . 60.3 111.172 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 10.45 0.49 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.693 2.262 . . . . 72.23 112.324 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.822 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -124.24 43.74 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 71.44 111.184 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.007 HG22 HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -97.89 -162.99 1.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 73.2 111.16 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.714 ' HG3' HD22 ' A' ' 92' ' ' LEU . 12.1 mt-10 -60.83 -102.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 71.13 110.936 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -96.85 7.16 47.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 75.11 110.887 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.992 ' HG ' HD22 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -66.49 -16.77 64.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 75.5 110.898 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -94.25 3.64 54.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 64.32 110.876 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -97.21 -53.36 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 75.14 110.907 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -64.73 -35.51 81.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 75.01 110.899 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -46.13 -30.06 3.79 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.732 -0.747 . . . . 71.3 112.486 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 28' ' ' PHE . . . -57.29 -57.36 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.826 0.346 . . . . 73.23 111.131 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.678 ' SD ' HG11 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -68.21 -5.06 16.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.52 110.882 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 31' ' ' GLU . . . -113.06 38.83 2.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 70.53 111.107 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -110.41 14.7 22.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 63.11 110.9 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.28 -78.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 75.3 110.866 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.73 8.57 41.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.738 . . . . 64.43 112.478 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.617 ' OE1' HG21 ' A' ' 58' ' ' VAL . 10.1 tt0 -64.61 103.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.875 0.369 . . . . 73.45 110.901 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' ' CG ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -102.05 -172.53 2.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 70.42 110.886 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -115.78 120.85 40.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 72.01 110.87 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.716 HG22 ' OE1' ' A' ' 57' ' ' GLU . 46.1 t -71.93 159.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 61.44 111.13 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.526 ' N ' HG12 ' A' ' 34' ' ' VAL . 65.8 p -99.59 -30.38 12.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 64.1 111.173 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.604 ' H ' HG12 ' A' ' 34' ' ' VAL . . . -150.42 -144.06 3.85 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 64.14 112.501 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -158.94 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.711 2.274 . . . . 75.12 112.4 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' HA ' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -56.69 -29.33 62.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 74.31 110.834 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.2 -43.57 70.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 63.12 111.085 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -85.6 -41.91 14.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 62.31 110.876 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -60.45 -36.16 77.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 60.11 110.86 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -65.25 -32.24 73.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 64.43 111.125 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.516 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 4.0 ptt180 -74.78 -40.97 60.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 70.05 110.898 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.583 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . . . -81.06 -57.84 3.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 72.35 111.142 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.716 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -52.12 -20.97 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 61.01 111.077 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.643 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -62.91 -76.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 64.1 111.11 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.703 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.3 t -111.4 -17.01 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 71.33 111.124 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.523 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -73.94 -32.0 63.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 71.51 110.908 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.041 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.39 -1.23 21.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 44.33 111.099 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.995 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.92 -2.7 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.656 0.741 . . . . 72.51 111.156 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.041 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.8 Cg_endo -69.78 -29.93 22.99 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.641 2.228 . . . . 71.33 112.345 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.52 -51.46 6.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.752 -0.737 . . . . 23.14 112.506 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.08 -33.55 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 70.02 112.518 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.671 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -145.74 151.1 37.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.79 0.328 . . . . 53.11 111.157 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.835 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.63 78.36 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.23 111.062 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.693 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -143.8 99.91 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 55.33 112.539 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.716 ' OE1' HG22 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -92.86 -164.72 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 74.54 110.928 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.617 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.1 t -143.49 124.76 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 63.33 111.106 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.615 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 9.6 pt-20 -95.18 155.83 16.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 70.05 110.837 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.506 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.3 t -131.58 117.18 18.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.097 -0.501 . . . . 74.14 111.122 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -137.85 158.97 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 71.43 110.877 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -22.61 19.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 72.31 111.102 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 42.99 -157.46 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.739 -0.743 . . . . 65.04 112.516 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -91.81 -23.61 19.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.913 0.387 . . . . 65.05 110.871 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.54 -119.1 1.13 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.767 -0.73 . . . . 73.12 112.471 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.61 -81.63 0.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.752 0.311 . . . . 44.41 111.113 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.695 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . . . -93.03 79.57 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 55.22 111.147 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.49 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -81.74 62.57 5.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 53.25 111.102 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.965 ' CZ ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -114.61 155.64 26.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 73.13 110.937 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.503 ' HA2' ' HG ' ' A' ' 85' ' ' LEU . . . -138.49 157.61 24.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 73.14 112.449 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.78 HG12 HD11 ' A' ' 85' ' ' LEU . 2.5 p -126.62 117.97 49.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 73.15 111.16 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.804 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -105.99 137.01 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 71.22 110.917 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.682 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.1 p -147.23 124.14 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 51.52 111.146 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.799 ' HB ' ' O ' ' A' ' 79' ' ' THR . 4.4 m -168.19 -129.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 52.51 111.116 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.695 ' HG3' HG22 ' A' ' 74' ' ' THR . 0.6 OUTLIER -104.65 148.8 36.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.562 0.696 . . . . 72.24 110.838 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 6.76 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.7 2.267 . . . . 64.33 112.31 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -92.67 43.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 63.22 110.862 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.51 -5.26 23.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 74.43 112.477 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.799 ' O ' ' HB ' ' A' ' 74' ' ' THR . 13.9 p -93.42 123.67 36.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 55.11 111.147 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.687 ' NE ' ' HB1' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -146.69 156.69 43.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 73.14 110.826 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.804 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 97.0 t -115.75 83.55 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 72.34 111.154 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.56 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 3.7 tm-20 -75.93 122.0 23.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 75.44 110.894 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 4.8 t -105.49 138.55 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 63.03 111.069 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.926 ' C ' HD23 ' A' ' 85' ' ' LEU . 40.8 m-70 -83.69 115.05 22.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 74.1 110.843 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.992 HD22 ' HG ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -125.25 105.98 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 73.23 110.905 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.66 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 5.3 t0 -139.08 131.63 28.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.13 110.887 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.98 6.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 72.42 110.848 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' A' ' 86' ' ' ASP . 37.5 t0 -67.21 -3.28 7.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 74.11 110.904 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 67.9 12.42 8.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 74.14 110.876 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -139.01 3.53 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 75.04 110.86 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.66 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 60.8 t -117.74 73.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 74.1 111.119 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.007 HD23 HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -132.48 12.61 4.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 71.23 110.895 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.53 164.52 12.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 75.52 110.873 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 9.9 t -104.08 169.45 8.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 74.33 111.16 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HB2' ' NE2' ' A' ' 84' ' ' HIS . 11.6 tp10 -146.95 124.74 5.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.652 0.739 . . . . 74.33 110.873 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 124.85 11.5 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.727 2.285 . . . . 74.2 112.363 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.687 ' HB1' ' NE ' ' A' ' 80' ' ' ARG . . . -115.49 117.4 30.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 63.13 111.086 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -124.33 46.0 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.51 110.843 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.404 ' HA2' HH12 ' A' ' 80' ' ' ARG . . . 77.28 -17.83 4.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 41.02 112.445 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.46 -56.6 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 72.31 110.828 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.48 23.16 44.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.721 . . . . 54.31 112.484 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 40.52 112.504 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 t0 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.786 0.327 . . . . 71.42 110.838 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -67.84 -21.47 65.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 72.34 110.915 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.58 ' HB2' HD13 ' A' ' 85' ' ' LEU . 12.4 t70 -58.63 -87.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 74.04 110.867 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 1.078 HD11 HD21 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -114.79 165.32 14.21 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.693 0.759 . . . . 61.03 111.13 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.507 ' HD2' HG22 ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.79 -1.12 7.95 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.252 . . . . 70.11 112.343 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.42 71.13 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 73.01 111.154 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.726 HG21 HD22 ' A' ' 20' ' ' LEU . 70.7 p -76.38 -166.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 71.15 111.134 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . 2.9 mm-40 -130.56 -93.12 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 74.25 110.892 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -69.22 5.88 1.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 74.54 110.849 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.915 HD21 ' CB ' ' A' ' 85' ' ' LEU . 10.8 mp -87.0 -34.07 19.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 75.44 110.931 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -64.89 -16.66 63.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 71.32 110.897 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.75 -63.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 72.35 110.87 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.6 -46.93 77.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 73.33 110.937 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.78 -53.15 8.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 53.12 112.487 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.64 51.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 62.24 111.102 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.683 ' HB3' HG11 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -67.2 -35.71 80.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 73.1 110.917 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.32 -97.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 73.44 111.141 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.426 ' O ' ' CB ' ' A' ' 29' ' ' ASP . 1.4 p90 -149.43 -18.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 75.45 110.857 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER 165.99 -10.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.839 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.69 -22.0 3.83 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.766 -0.731 . . . . 50.31 112.472 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.417 ' HG3' HG23 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -60.94 105.32 0.45 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 74.41 110.921 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.515 ' C ' ' HG3' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -70.17 -158.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 74.14 110.815 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -138.17 118.75 13.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 64.21 110.901 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 40.4 t -72.06 149.13 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 75.32 111.106 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -123.31 -0.59 8.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 71.11 111.16 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.405 ' H ' ' CG1' ' A' ' 34' ' ' VAL . . . -139.83 -154.75 6.39 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.726 . . . . 73.51 112.512 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HA ' ' OH ' ' A' ' 69' ' ' TYR . 53.7 Cg_endo -69.75 -166.12 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.667 2.244 . . . . 71.03 112.302 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.511 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -59.09 -30.43 68.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 74.12 110.812 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.93 -30.17 67.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 70.1 111.116 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.423 ' CB ' HG13 ' A' ' 34' ' ' VAL . 1.6 m-20 -76.51 -34.32 58.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 70.21 110.865 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.809 ' NH1' ' HB1' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -73.89 -44.18 56.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 74.01 110.853 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.729 ' HB2' ' HA2' ' A' ' 99' ' ' GLY . . . -67.88 -30.64 70.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.24 111.121 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.403 ' CG ' ' N ' ' A' ' 44' ' ' ALA . 14.7 ptt180 -85.1 -45.2 12.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 74.4 110.902 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.664 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . . . -77.9 -60.58 2.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 73.14 111.106 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -48.27 -22.18 0.63 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 55.21 111.082 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.681 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -54.55 -67.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 64.35 111.127 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.733 ' HA ' HG12 ' A' ' 50' ' ' VAL . 26.9 t -110.41 -15.82 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 71.11 111.136 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 50.0 mt-30 -80.74 -29.02 36.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 60.23 110.913 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.091 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.37 -10.86 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 72.21 111.087 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.0 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.74 0.07 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.634 0.731 . . . . 74.42 111.158 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.091 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.2 Cg_endo -69.76 -27.11 26.86 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.65 2.234 . . . . 63.34 112.335 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.11 -53.62 2.94 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 64.33 112.542 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.63 -35.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 62.31 112.489 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.803 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -146.26 149.35 33.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 45.35 111.143 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.812 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.82 82.83 1.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 62.15 111.102 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.717 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -140.62 99.68 0.25 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.713 -0.756 . . . . 73.32 112.478 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.664 ' OE1' ' HB3' ' A' ' 44' ' ' ALA . 63.3 tt0 -96.18 164.62 12.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.946 0.403 . . . . 63.43 110.843 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.417 HG23 ' HG3' ' A' ' 31' ' ' GLU . 2.1 t -111.76 119.13 59.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 73.4 111.112 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.759 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.21 133.57 43.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 51.44 110.898 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -133.39 121.86 22.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 54.14 111.131 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.477 ' H ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -123.16 162.76 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.43 110.854 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.41 135.72 34.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 61.52 111.106 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.44 -119.38 1.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 52.34 112.525 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -87.83 -23.62 23.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 64.23 110.889 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.3 -112.61 1.9 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 71.44 112.478 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.12 -82.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 75.42 111.104 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 13' ' ' ASP . . . -75.78 125.93 30.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 62.12 111.072 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.47 74.52 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 44.44 111.071 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.759 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -165.38 -131.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 74.13 110.912 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.606 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -167.99 172.24 42.63 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 62.13 112.539 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.803 HG12 HG22 ' A' ' 83' ' ' VAL . 6.0 p -130.07 120.16 48.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 72.32 111.129 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.991 HD23 ' HB3' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -98.36 142.3 30.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 74.11 110.919 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.683 HG11 ' HB3' ' A' ' 26' ' ' MET . 10.9 t -152.03 114.15 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 71.13 111.121 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.764 ' O ' HG22 ' A' ' 54' ' ' THR . 2.6 m -169.45 -133.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.33 111.141 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.568 ' H ' HG22 ' A' ' 74' ' ' THR . 0.1 OUTLIER -104.62 144.77 29.39 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.636 0.731 . . . . 72.32 110.841 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.8 Cg_endo -69.75 13.84 0.28 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.712 2.275 . . . . 70.42 112.341 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 75' ' ' ARG . 20.2 m-20 -93.94 35.49 1.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 74.13 110.855 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.36 -13.2 41.47 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.683 -0.77 . . . . 71.11 112.509 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.748 ' O ' ' HB ' ' A' ' 74' ' ' THR . 37.6 p -95.28 119.7 34.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.749 0.309 . . . . 71.14 111.163 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.991 ' HB3' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -141.61 161.13 38.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 73.51 110.869 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 97.3 t -119.0 81.5 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 64.21 111.092 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 72' ' ' LEU . 15.2 pt-20 -77.68 116.73 18.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.45 110.864 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.803 HG22 HG12 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -94.99 144.72 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 61.02 111.103 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 93' ' ' ASP . 2.5 t-160 -83.82 108.85 17.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 63.45 110.872 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.949 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 1.3 pp -124.98 110.26 13.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 75.3 110.919 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.585 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 3.9 m-20 -127.02 106.68 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 74.14 110.885 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.531 ' HG2' HG23 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -63.09 -0.34 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 72.12 110.892 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 86' ' ' ASP . 51.2 t0 -69.59 -13.15 62.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 73.04 110.876 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -165.66 -93.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 74.13 110.857 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.609 ' O ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -155.06 33.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 74.13 110.865 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.949 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 2.4 t -72.51 95.93 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 75.33 111.109 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.078 HD21 HD11 ' A' ' 14' ' ' ILE . 1.0 OUTLIER -127.68 18.82 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 72.51 110.922 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 84' ' ' HIS . 9.0 t0 -75.99 128.78 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 63.42 110.895 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.716 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 7.0 t -79.23 155.8 28.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 72.23 111.119 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.95 153.1 53.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.666 0.746 . . . . 73.33 110.872 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 140.37 42.61 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.66 2.24 . . . . 42.42 112.35 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.809 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -119.42 111.06 17.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 74.43 111.103 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -96.28 4.26 52.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 65.42 110.911 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.729 ' HA2' ' HB2' ' A' ' 42' ' ' ALA . . . 82.78 -21.98 7.12 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.738 . . . . 61.25 112.497 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.34 -31.24 12.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.779 0.323 . . . . 73.55 110.835 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.16 26.07 58.44 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.773 -0.727 . . . . 62.04 112.442 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.769 -0.729 . . . . 61.05 112.489 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.815 0.34 . . . . 71.13 110.878 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -65.88 -37.09 85.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 74.52 110.922 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' CB ' ' HB2' ' A' ' 85' ' ' LEU . 11.8 p-10 -65.54 -149.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 73.11 110.846 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.67 ' HB ' HG23 ' A' ' 17' ' ' THR . 0.1 OUTLIER -73.43 127.92 88.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.672 0.748 . . . . 64.11 111.12 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -1.52 8.6 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.638 2.225 . . . . 74.44 112.364 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.79 38.54 3.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 54.44 111.094 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.78 HG22 HD23 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -73.07 -168.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 61.42 111.159 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.634 ' H ' HD22 ' A' ' 92' ' ' LEU . 15.8 mm-40 -72.78 -100.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 70.31 110.925 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -98.73 8.29 45.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 72.3 110.894 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -72.21 -9.43 58.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 64.22 110.921 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -89.99 -8.81 50.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 74.21 110.964 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -74.39 -58.65 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 74.23 110.879 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.549 ' OE1' HG21 ' A' ' 83' ' ' VAL . 3.9 mp0 -66.13 -42.66 88.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 71.4 110.874 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.71 -31.49 2.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.728 -0.748 . . . . 71.32 112.484 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.7 -72.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.318 . . . . 42.32 111.077 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.6 ptm -70.6 -7.1 41.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.1 110.904 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' A' ' 31' ' ' GLU . . . -65.53 -47.19 76.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 52.04 111.057 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -81.86 6.1 16.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 75.45 110.879 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -72.04 -68.59 0.45 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 74.4 110.857 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.89 8.98 2.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.776 -0.726 . . . . 72.41 112.532 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HG3' ' HA ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -79.37 177.67 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 74.01 110.904 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.09 -168.8 2.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 75.21 110.874 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -109.54 119.88 40.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 72.42 110.909 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 35' ' ' THR . 2.2 t -73.12 -136.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 71.13 111.131 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.565 ' H ' HG12 ' A' ' 34' ' ' VAL . 71.5 p -136.72 -47.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 71.32 111.158 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.45 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 163.0 -61.18 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 61.01 112.493 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.5 Cg_endo -69.7 159.18 54.39 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.747 2.298 . . . . 64.51 112.318 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.411 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 2.1 p30 -64.88 -26.04 68.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 75.14 110.852 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.03 -39.14 74.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 74.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 1.9 m-20 -86.06 -39.85 16.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.34 110.882 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.633 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 6.8 ptt180 -68.05 -38.81 82.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 71.23 110.868 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.601 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -68.3 -35.29 77.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 52.4 111.071 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -82.03 -40.53 21.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 64.43 110.898 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.593 ' HB1' ' CD ' ' A' ' 57' ' ' GLU . . . -77.48 -59.84 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 63.31 111.101 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.733 ' HB2' HD23 ' A' ' 72' ' ' LEU . . . -52.76 -20.22 3.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 74.21 111.091 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.66 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -63.63 -78.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 74.24 111.092 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.719 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.6 t -108.44 -17.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 73.11 111.179 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.486 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -74.41 -29.79 61.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.12 110.905 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.068 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.94 -2.82 19.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 70.2 111.132 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.999 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -95.7 -2.9 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.612 0.72 . . . . 71.4 111.143 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.068 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.9 Cg_endo -69.77 -27.66 26.13 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.666 2.244 . . . . 65.23 112.343 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.11 -57.15 2.87 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.78 -0.724 . . . . 25.23 112.502 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.07 -34.76 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 71.02 112.504 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 74' ' ' THR . 0.2 OUTLIER -146.41 152.1 38.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 54.25 111.151 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.84 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.39 77.01 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 54.43 111.116 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.714 ' HA3' ' HA ' ' A' ' 73' ' ' VAL . . . -148.53 105.68 0.31 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 75.35 112.487 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.593 ' CD ' ' HB1' ' A' ' 44' ' ' ALA . 3.2 tt0 -95.78 -171.95 2.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.907 0.384 . . . . 74.54 110.896 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.037 HG13 HG22 ' A' ' 71' ' ' VAL . 83.8 t -136.86 131.43 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 60.44 111.126 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -99.1 121.78 41.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 71.12 110.852 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 t -110.35 119.19 38.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 55.33 111.137 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -143.47 121.92 12.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 50.13 110.908 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.74 148.8 24.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 72.1 111.159 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.13 -106.71 0.99 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.781 -0.723 . . . . 53.24 112.529 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -87.91 -25.7 23.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 70.03 110.936 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.33 -121.56 2.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 60.0 112.465 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.32 33.87 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.768 0.318 . . . . 61.14 111.112 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.51 ' HA ' ' H ' ' A' ' 87' ' ' ARG . . . -63.71 -155.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 72.04 111.122 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.567 ' O ' ' O ' ' A' ' 61' ' ' GLU . . . -157.06 -104.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 71.11 111.111 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.579 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 2.9 t80 -170.29 -85.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 72.23 110.902 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.611 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -168.53 157.04 28.96 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 53.34 112.494 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.037 HG22 HG13 ' A' ' 58' ' ' VAL . 89.8 t -123.45 120.8 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.838 0.351 . . . . 73.53 111.093 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.82 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -106.17 134.19 49.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 73.23 110.93 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.714 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 5.2 p -147.67 118.61 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 72.13 111.12 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.751 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.7 m -169.19 -133.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 73.33 111.141 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.557 ' H ' HG22 ' A' ' 74' ' ' THR . 3.6 mtt-85 -101.53 148.4 35.18 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.636 0.732 . . . . 71.25 110.831 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.4 Cg_endo -69.84 9.41 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.652 2.234 . . . . 75.23 112.342 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -88.38 38.67 0.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 75.14 110.87 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.11 -7.05 8.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 64.2 112.428 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.751 ' O ' ' HB ' ' A' ' 74' ' ' THR . 31.1 p -98.85 115.42 28.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.793 0.33 . . . . 73.04 111.175 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.727 ' O ' ' HB3' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -138.62 160.59 39.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 72.32 110.861 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 61.6 t -113.88 87.02 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 54.4 111.132 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -81.04 121.37 25.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.2 110.908 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.611 ' O ' ' CA ' ' A' ' 70' ' ' GLY . 1.8 t -97.55 160.57 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 63.32 111.137 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.691 ' C ' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -104.55 109.14 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 73.12 110.873 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.917 HD13 ' N ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -128.72 111.14 12.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 52.41 110.925 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.612 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 21.1 m-20 -136.51 108.66 7.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 64.52 110.846 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.51 ' H ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -66.36 0.61 2.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.1 110.903 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 89' ' ' PHE . 51.6 t0 -69.88 -11.88 61.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.852 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.484 ' CD1' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -166.54 -93.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 62.24 110.903 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 35.53 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 74.2 110.86 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.745 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 9.2 t -69.47 100.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 65.41 111.145 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.812 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -135.04 16.89 3.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 64.23 110.932 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 84' ' ' HIS . 14.6 t0 -80.75 147.65 30.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 61.4 110.881 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.434 ' HA ' HG13 ' A' ' 83' ' ' VAL . 15.3 t -90.38 165.0 14.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 74.4 111.11 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -146.45 122.61 5.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 71.13 110.915 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 128.91 16.73 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.684 2.256 . . . . 73.15 112.364 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -116.82 114.09 23.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 71.11 111.116 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 100' ' ' ASP . 4.8 t0 -124.9 46.4 2.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 72.3 110.898 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 -17.34 1.69 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 61.32 112.509 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 98' ' ' ASP . 0.4 OUTLIER -95.93 -65.39 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 74.32 110.88 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.64 21.67 12.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 53.04 112.467 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 74.14 112.486 -179.926 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.819 0.342 . . . . 73.41 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -74.1 -25.19 59.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 70.14 110.917 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.527 ' OD2' HD23 ' A' ' 20' ' ' LEU . 14.7 p-10 -64.12 -151.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 65.44 110.886 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.525 HG21 ' HG3' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -102.3 166.88 11.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 64.11 111.086 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' A' ' 14' ' ' ILE . 54.0 Cg_endo -69.76 -2.52 10.31 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 74.13 112.361 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.1 p -141.83 94.2 2.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 74.13 111.168 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.944 HG22 HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -118.83 -167.25 1.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 64.1 111.141 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.464 ' CB ' HD23 ' A' ' 92' ' ' LEU . 11.8 tt0 -110.36 -94.29 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 71.23 110.883 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -57.0 -17.9 11.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 74.43 110.937 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.784 HD13 ' CD2' ' A' ' 85' ' ' LEU . 2.4 mp -84.11 -19.51 34.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 62.14 110.88 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -66.23 -17.71 64.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 71.4 110.941 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.17 -22.58 15.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 74.0 110.891 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -66.72 -29.82 69.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 72.3 110.936 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.4 -29.7 1.83 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.733 -0.746 . . . . 44.54 112.503 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.403 ' O ' ' CD2' ' A' ' 28' ' ' PHE . . . -73.57 -64.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 51.34 111.105 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.791 ' CE ' HG11 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -64.36 -7.02 8.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 70.33 110.872 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' A' ' 31' ' ' GLU . . . -103.79 25.3 10.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.14 111.072 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -73.54 2.3 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 71.14 110.862 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 t70 179.92 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 53.32 110.873 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.31 -2.48 48.79 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 74.22 112.473 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.651 ' CG ' HG21 ' A' ' 58' ' ' VAL . 2.1 tm-20 -94.4 105.05 17.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 61.23 110.913 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 3.9 m-20 -119.34 -152.29 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 64.13 110.855 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -118.63 109.57 16.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 55.01 110.84 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 58' ' ' VAL . 21.3 t -81.03 -119.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 51.11 111.137 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.626 ' N ' HG12 ' A' ' 34' ' ' VAL . 68.5 p -141.8 -77.85 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 63.3 111.123 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.445 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -171.73 -61.1 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.762 -0.732 . . . . 73.33 112.51 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.8 Cg_endo -69.77 158.96 55.15 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.692 2.262 . . . . 65.44 112.35 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.474 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -66.56 -32.44 73.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 61.5 110.861 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.66 -30.78 14.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 32.41 111.096 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.42 -31.85 26.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 73.1 110.859 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HG2' ' N ' ' A' ' 42' ' ' ALA . 9.0 ptt-85 -57.71 -36.69 72.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 73.1 110.852 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.805 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -71.25 -33.02 69.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 61.41 111.11 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.474 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 2.2 ptt85 -77.71 -38.73 46.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 62.02 110.898 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.681 ' HB1' ' HG3' ' A' ' 57' ' ' GLU . . . -79.74 -59.15 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 72.34 111.136 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.848 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -57.63 -18.29 19.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 60.31 111.104 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.805 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -59.45 -81.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 42.42 111.077 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.766 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 59.7 t -114.99 -15.96 9.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 74.14 111.117 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.2 mt-30 -73.78 -31.96 63.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 65.32 110.893 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.041 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.88 -1.58 20.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.439 . . . . 73.22 111.144 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.989 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.34 -5.48 0.11 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.602 0.715 . . . . 74.35 111.141 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.041 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.4 Cg_endo -69.73 -29.32 24.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.281 . . . . 74.1 112.319 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.44 -54.04 5.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.72 -0.752 . . . . 45.35 112.442 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.49 -33.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.725 -0.75 . . . . 71.41 112.458 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.587 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -145.92 156.0 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 74.55 111.141 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.784 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.28 76.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 61.34 111.084 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.741 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -145.99 107.26 0.41 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.744 -0.741 . . . . 72.14 112.517 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.681 ' HG3' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -98.1 -169.27 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.353 . . . . 73.21 110.909 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.739 HG22 ' HB ' ' A' ' 71' ' ' VAL . 53.4 t -141.56 110.93 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 74.41 111.092 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.752 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 5.0 mt-10 -94.96 162.87 13.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 63.22 110.906 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.642 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -126.26 119.56 27.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 62.21 111.162 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 159.51 37.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 75.34 110.914 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.0 p -125.1 100.52 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 63.24 111.126 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.83 -141.54 8.76 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 61.4 112.487 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -88.05 0.53 55.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.857 0.361 . . . . 73.44 110.874 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -102.75 -121.71 4.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 53.32 112.517 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.666 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -120.82 -77.07 0.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.743 0.306 . . . . 60.54 111.062 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -111.21 86.65 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 54.43 111.065 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.818 ' HB2' ' OD2' ' A' ' 86' ' ' ASP . . . -98.67 85.47 3.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 51.32 111.1 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.752 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 0.5 OUTLIER -115.55 158.72 22.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 74.51 110.873 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.648 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -124.94 127.69 6.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 73.31 112.481 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.739 ' HB ' HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -109.26 123.42 65.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 71.41 111.146 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.797 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -84.61 142.92 29.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 75.15 110.895 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.791 HG11 ' CE ' ' A' ' 26' ' ' MET . 77.5 t -151.21 95.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 62.14 111.082 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.77 HG22 ' H ' ' A' ' 75' ' ' ARG . 1.3 m -168.27 -149.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 73.42 111.16 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.77 ' H ' HG22 ' A' ' 74' ' ' THR . 7.7 mtm180 -103.94 151.92 38.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.614 0.721 . . . . 75.22 110.853 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.8 Cg_endo -69.79 7.56 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.686 2.258 . . . . 61.11 112.368 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.49 19.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 75.32 110.877 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 76' ' ' PRO . . . 94.71 -14.09 65.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 52.32 112.484 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.747 ' O ' ' HB ' ' A' ' 74' ' ' THR . 3.0 t -98.05 125.37 43.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.778 0.323 . . . . 73.21 111.144 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.608 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -136.56 159.81 40.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 73.41 110.894 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 42.8 t -118.11 92.67 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 74.21 111.129 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.635 ' HB2' HD12 ' A' ' 72' ' ' LEU . 87.3 tt0 -82.77 119.83 24.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 74.01 110.874 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.648 ' O ' ' HA2' ' A' ' 70' ' ' GLY . 2.0 t -100.01 111.61 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.42 111.159 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.736 ' O ' HD22 ' A' ' 85' ' ' LEU . 3.9 t-160 -86.68 110.53 19.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 64.13 110.857 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.944 HD12 HG22 ' A' ' 17' ' ' THR . 3.0 mm? -127.6 127.96 44.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 74.15 110.923 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.818 ' OD2' ' HB2' ' A' ' 68' ' ' ALA . 13.3 t0 -135.45 132.68 37.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.869 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.666 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 3.2 tmt_? -57.99 2.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 64.23 110.885 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.566 ' H ' ' C ' ' A' ' 86' ' ' ASP . 4.7 t0 -66.78 -4.69 9.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 73.1 110.876 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 68.23 12.18 8.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 74.34 110.883 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -135.54 -1.23 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 65.52 110.851 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.769 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 96.8 t -116.67 92.91 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 63.33 111.151 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.792 ' HA ' HD13 ' A' ' 85' ' ' LEU . 5.3 mp -144.41 14.52 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 73.14 110.879 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.06 137.14 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 71.33 110.883 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.61 ' HB ' HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -96.47 130.01 43.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 72.14 111.167 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLU . 71.4 tt0 -99.94 127.16 34.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.615 0.721 . . . . 73.22 110.933 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 114.63 3.77 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.675 2.25 . . . . 63.12 112.333 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -64.53 114.33 4.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 44.42 111.11 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.08 15.09 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 65.43 110.899 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.65 -21.51 2.46 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.763 . . . . 71.41 112.482 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -97.55 -38.44 9.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.835 0.35 . . . . 72.45 110.869 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.85 47.0 5.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 62.33 112.482 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 65.13 112.464 -179.937 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.744 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 75.34 110.867 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -68.93 -44.22 73.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.12 110.905 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.439 ' OD2' HD23 ' A' ' 20' ' ' LEU . 5.9 p-10 -66.33 -147.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 70.31 110.857 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.883 HG22 ' H ' ' A' ' 16' ' ' THR . 26.3 mm -75.76 119.15 75.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.596 0.713 . . . . 71.35 111.138 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 4.06 2.38 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.74 2.293 . . . . 74.41 112.32 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.883 ' H ' HG22 ' A' ' 14' ' ' ILE . 2.8 m -115.03 20.95 14.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 63.41 111.193 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.902 ' CB ' HD22 ' A' ' 20' ' ' LEU . 1.2 p -81.36 -165.15 0.88 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 62.21 111.142 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.671 ' HG3' HD13 ' A' ' 92' ' ' LEU . 1.1 mm-40 -71.89 -131.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.242 -0.435 . . . . 72.22 110.883 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.41 12.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 55.32 110.916 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.902 HD22 ' CB ' ' A' ' 17' ' ' THR . 7.5 mp -57.42 -27.54 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 62.15 110.895 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -95.96 7.04 47.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.913 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -110.55 -42.72 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 72.22 110.861 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -65.11 -51.8 59.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 75.44 110.922 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.76 -54.55 6.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 72.35 112.528 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.96 52.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.768 0.318 . . . . 73.03 111.119 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.429 ' CE ' ' HB2' ' A' ' 27' ' ' ALA . 1.4 ptm -66.98 -39.8 87.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 72.24 110.911 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HB2' ' CE ' ' A' ' 26' ' ' MET . . . -120.77 -92.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 62.52 111.095 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -145.0 -27.17 0.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.855 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.68 28.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 73.32 110.848 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.16 9.62 25.18 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.729 -0.748 . . . . 52.54 112.519 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HB3' HG23 ' A' ' 58' ' ' VAL . 2.8 mp0 -93.61 98.46 11.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 74.42 110.909 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -65.84 -162.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 73.41 110.835 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -129.15 102.2 6.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 72.22 110.9 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.845 HG23 ' HG3' ' A' ' 57' ' ' GLU . 1.0 OUTLIER -72.7 159.0 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 71.23 111.124 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.526 HG23 ' CG ' ' A' ' 40' ' ' ASP . 70.0 p -91.36 -38.07 12.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 62.34 111.143 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' H ' HG13 ' A' ' 34' ' ' VAL . . . 166.47 -64.44 0.21 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.737 . . . . 63.42 112.476 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 160.4 49.83 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 64.53 112.338 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 2.2 p-10 -60.62 -29.18 69.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 75.35 110.866 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.04 -30.92 49.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 60.4 111.063 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.526 ' CG ' HG23 ' A' ' 35' ' ' THR . 0.4 OUTLIER -82.24 -35.04 28.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 63.44 110.896 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.526 ' HG3' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -71.74 -41.09 68.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 70.54 110.822 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.97 -35.05 71.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 65.11 111.072 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.7 ptt85 -80.57 -39.5 27.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 71.53 110.885 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.624 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -75.81 -60.38 2.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 52.24 111.064 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 1.029 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -56.47 -16.94 6.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 75.02 111.082 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -62.51 -67.42 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 71.22 111.112 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.673 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.7 t -122.31 -14.79 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 72.32 111.118 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.624 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 50.5 mt-30 -79.69 -41.46 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.14 110.906 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.029 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . . . -104.71 -0.23 27.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 71.31 111.089 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.978 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -93.72 -11.68 0.17 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 55.0 111.089 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.978 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 54.2 Cg_endo -69.76 -28.04 25.75 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.681 2.254 . . . . 72.12 112.372 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.26 -44.14 44.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 25.31 112.475 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.36 -31.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 70.42 112.475 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 74' ' ' THR . 1.0 OUTLIER -149.92 157.24 42.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.824 0.345 . . . . 61.43 111.139 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.708 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.0 75.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 41.21 111.111 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.662 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -146.58 111.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 72.44 112.456 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.845 ' HG3' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -103.93 -170.69 1.81 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 70.05 110.869 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.559 HG13 ' CE1' ' A' ' 69' ' ' TYR . 3.3 t -131.21 120.77 47.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 72.54 111.14 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.565 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -93.38 126.07 38.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.54 110.872 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.8 t -107.99 105.31 15.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 70.32 111.148 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.608 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -136.36 158.19 45.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 73.32 110.903 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.6 p -125.13 113.77 18.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 60.54 111.143 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -92.46 -179.37 40.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.74 . . . . 73.42 112.491 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.63 -14.38 62.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 52.45 110.852 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.415 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -86.35 -111.18 0.83 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 55.13 112.458 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -113.99 -77.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.772 0.32 . . . . 72.31 111.1 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -108.67 158.21 17.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 60.41 111.103 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -151.94 49.78 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 53.54 111.107 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.744 ' HH ' ' N ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -120.35 129.32 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 53.04 110.979 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -112.05 159.03 13.94 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 31.3 112.516 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 71' ' ' VAL . 5.5 p -124.25 113.23 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 72.0 111.146 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.916 HD21 ' HB3' ' A' ' 80' ' ' ARG . 2.3 tt -91.1 145.14 24.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.929 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.58 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 14.6 t -158.57 112.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 71.44 111.159 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.832 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -174.89 -148.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 72.21 111.119 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.454 ' H ' HG22 ' A' ' 74' ' ' THR . 9.9 mmm180 -106.0 143.86 27.75 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.59 0.71 . . . . 65.44 110.85 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.83 11.46 0.4 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.716 2.277 . . . . 72.33 112.301 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 75' ' ' ARG . 9.0 m-20 -86.16 32.36 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 75.34 110.905 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.48 -14.58 34.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 60.31 112.495 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.489 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.4 t -99.81 106.17 18.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.786 0.327 . . . . 71.4 111.149 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.916 ' HB3' HD21 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -135.58 154.97 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 74.43 110.877 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.56 ' N ' ' OG1' ' A' ' 74' ' ' THR . 47.9 t -114.19 100.37 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.35 111.1 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.696 ' HB3' HD12 ' A' ' 72' ' ' LEU . 9.2 pt-20 -85.61 109.19 18.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 71.42 110.866 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.855 HG13 ' HB ' ' A' ' 94' ' ' THR . 2.1 t -99.62 107.84 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 74.44 111.136 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.754 ' C ' HD23 ' A' ' 85' ' ' LEU . 5.4 m-70 -84.3 121.17 27.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 62.45 110.855 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.783 ' N ' HD23 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -106.98 105.57 15.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 72.12 110.913 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.732 ' H ' ' HA ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -128.65 115.34 17.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 70.11 110.888 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.551 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 1.2 tmt_? -61.45 -7.8 3.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 53.31 110.85 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.689 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 24.5 t70 -83.72 32.81 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 72.21 110.839 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.689 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 18.8 m-85 97.68 -30.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 74.11 110.853 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.46 35.36 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 75.52 110.808 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.831 ' O ' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.69 -28.0 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 71.31 111.115 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.671 HD13 ' HG3' ' A' ' 18' ' ' GLU . 1.9 mt -122.43 29.57 6.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 74.02 110.893 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 84' ' ' HIS . 33.0 t70 -71.34 66.58 0.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.03 110.918 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.855 ' HB ' HG13 ' A' ' 83' ' ' VAL . 10.2 t -84.86 151.41 24.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 74.1 111.118 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -146.06 157.78 49.53 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.654 0.74 . . . . 73.54 110.861 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 131.92 22.19 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.633 2.222 . . . . 75.14 112.317 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -112.59 103.19 11.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 52.23 111.111 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.21 11.28 38.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 65.42 110.911 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 42' ' ' ALA . . . 86.44 -19.32 28.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 50.53 112.495 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -95.67 -41.99 8.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 71.41 110.907 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.85 28.69 45.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 32.12 112.484 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.757 -0.735 . . . . 41.23 112.528 -179.94 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.804 0.335 . . . . 74.21 110.825 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 33' ' ' GLU . 82.8 m-85 -65.43 -54.31 30.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 73.33 110.92 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.02 -158.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 71.12 110.878 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.492 HD11 ' N ' ' A' ' 87' ' ' ARG . 1.2 mp -74.42 121.64 85.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.591 0.71 . . . . 63.25 111.13 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -5.47 16.26 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.689 2.259 . . . . 72.45 112.341 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.466 ' H ' HG22 ' A' ' 14' ' ' ILE . 34.3 p -145.44 88.3 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.23 111.16 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.917 HG22 HD23 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -132.55 -159.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 74.12 111.149 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.08 -94.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 52.32 110.927 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -87.88 11.18 16.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 62.52 110.887 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.867 HD22 HD12 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -93.55 -34.72 13.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 73.5 110.922 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -67.45 -11.54 58.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 73.34 110.892 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -93.94 -59.76 1.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 62.12 110.842 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -66.32 -41.36 89.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 74.24 110.927 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -42.35 -34.89 1.72 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.717 -0.754 . . . . 64.25 112.44 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.9 -60.6 3.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.77 0.319 . . . . 72.44 111.061 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.5 ptp -69.79 -9.52 54.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 64.21 110.878 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 24' ' ' GLY . . . -76.85 -19.67 57.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.11 111.056 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -82.03 8.94 9.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 73.53 110.896 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -70.7 -80.85 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 55.53 110.866 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.05 11.4 0.19 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 71.42 112.493 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.699 ' OE1' HG23 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -67.52 176.94 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 60.51 110.894 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.22 -164.12 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 74.24 110.86 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.427 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 1.5 pt-20 -111.0 166.58 10.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 73.23 110.883 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -100.03 167.8 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.485 . . . . 71.11 111.078 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.58 ' N ' HG13 ' A' ' 34' ' ' VAL . 44.3 p -94.79 -42.08 8.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.148 -0.478 . . . . 71.23 111.188 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.426 ' N ' HG13 ' A' ' 34' ' ' VAL . . . 166.89 -64.65 0.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.736 . . . . 52.12 112.501 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.425 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.8 Cg_endo -69.74 157.26 61.04 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.684 2.256 . . . . 74.41 112.333 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -59.79 -28.95 67.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 55.22 110.908 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.11 -33.51 57.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 61.42 111.137 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.672 ' HB3' HG22 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -84.1 -32.07 24.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 71.21 110.905 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.912 ' HB2' HD21 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -69.45 -44.84 70.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 74.55 110.832 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.747 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -71.77 -34.72 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 72.01 111.061 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.3 ptt85 -76.37 -39.84 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 63.2 110.863 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.591 ' HA ' ' HB2' ' A' ' 48' ' ' GLN . . . -75.44 -59.76 2.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 73.42 111.118 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.731 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -58.03 -13.55 4.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 60.14 111.089 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.747 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -71.28 -71.96 0.24 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 44.04 111.15 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.714 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.3 t -113.56 -9.34 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 74.32 111.147 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -83.0 -39.92 20.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.43 110.921 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.731 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . . . -102.41 -5.87 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 70.05 111.067 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.959 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -81.13 -25.51 0.41 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.64 0.733 . . . . 72.12 111.129 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.959 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 53.9 Cg_endo -69.72 -10.19 27.97 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.69 2.26 . . . . 73.52 112.342 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.6 -27.34 15.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.74 . . . . 53.13 112.498 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.81 -32.54 0.3 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.737 . . . . 64.13 112.535 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.586 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -155.15 164.7 38.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 63.31 111.113 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.724 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -75.17 65.96 1.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 64.05 111.114 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.712 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -141.13 105.85 0.45 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 63.03 112.514 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.529 ' CG ' ' HB2' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -94.97 -162.06 0.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 72.34 110.931 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.723 HG22 ' CG1' ' A' ' 71' ' ' VAL . 29.4 t -129.31 119.36 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 75.43 111.14 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.814 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 1.6 mt-10 -93.34 136.01 34.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 73.51 110.857 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 60' ' ' THR . 3.5 t -138.44 115.62 11.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 74.2 111.168 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.802 ' C ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -122.31 178.3 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 74.43 110.865 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.77 128.87 49.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 52.11 111.109 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.469 ' N ' ' HB2' ' A' ' 68' ' ' ALA . . . -128.49 -144.77 5.87 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.768 -0.729 . . . . 35.33 112.517 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -87.25 -21.32 25.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.887 0.375 . . . . 75.23 110.889 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.67 -109.93 3.01 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.737 . . . . 73.44 112.516 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.47 -81.48 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.326 . . . . 54.32 111.113 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.691 ' HB3' ' HB2' ' A' ' 87' ' ' ARG . . . -78.08 128.04 33.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 53.44 111.105 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.802 ' HB3' ' C ' ' A' ' 61' ' ' GLU . . . -122.69 45.71 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 65.35 111.067 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.814 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -170.86 -152.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 74.45 110.928 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 83' ' ' VAL . . . -158.8 -126.84 0.88 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 63.31 112.488 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.723 ' CG1' HG22 ' A' ' 58' ' ' VAL . 4.5 m -152.67 151.95 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.373 . . . . 73.04 111.131 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.912 HD21 ' HB2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -104.81 152.41 22.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 72.5 110.923 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.698 ' O ' HG22 ' A' ' 81' ' ' VAL . 2.1 p -155.17 106.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 52.13 111.119 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.844 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -172.32 -142.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 75.44 111.158 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.456 ' H ' HG22 ' A' ' 74' ' ' THR . 3.6 mtm180 -110.13 149.18 39.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.599 0.714 . . . . 64.34 110.887 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' A' ' 55' ' ' ALA . 53.4 Cg_endo -69.77 8.36 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.694 2.263 . . . . 74.32 112.361 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.16 33.09 0.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 71.24 110.914 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.73 -11.45 10.4 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.753 -0.737 . . . . 70.34 112.456 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.469 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.2 t -101.61 105.21 16.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.318 . . . . 71.14 111.168 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.844 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 2.4 ptp85 -138.64 157.48 46.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 63.2 110.856 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 73' ' ' VAL . 18.0 m -114.03 96.65 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 74.12 111.098 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.735 ' HB3' HD23 ' A' ' 72' ' ' LEU . 1.3 pp20? -87.24 125.07 33.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 70.02 110.902 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.758 HG12 HD21 ' A' ' 85' ' ' LEU . 4.5 t -91.52 139.89 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 75.41 111.141 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.97 ' C ' HD23 ' A' ' 85' ' ' LEU . 12.7 t-160 -117.9 106.04 12.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 74.41 110.833 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.97 HD23 ' C ' ' A' ' 84' ' ' HIS . 2.7 mt -131.6 139.12 49.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 51.32 110.893 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.631 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -103.68 111.77 24.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 73.14 110.84 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.691 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 1.3 tmt_? -50.07 -21.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 74.34 110.851 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.489 ' HB3' ' OD1' ' A' ' 86' ' ' ASP . 4.7 t0 -68.28 5.36 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 65.42 110.879 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.426 ' H ' ' C ' ' A' ' 87' ' ' ARG . 37.5 m-85 67.08 42.51 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 72.23 110.898 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.842 ' HG3' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -129.09 -29.76 2.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 71.14 110.848 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.944 HG12 ' HA ' ' A' ' 85' ' ' LEU . 54.2 t -125.0 125.82 70.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 63.32 111.133 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.917 HD23 HG22 ' A' ' 17' ' ' THR . 1.9 mp -145.27 17.27 1.53 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 64.22 110.891 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 84' ' ' HIS . 21.1 t0 -101.35 143.97 30.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 72.03 110.867 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.538 ' HB ' HG13 ' A' ' 83' ' ' VAL . 13.9 t -84.83 176.3 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 73.54 111.133 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 82' ' ' GLU . 3.7 tt0 -145.72 128.89 8.27 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.604 0.716 . . . . 72.31 110.897 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 115.17 3.96 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 63.32 112.392 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.821 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -94.58 115.73 27.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 71.43 111.069 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -102.19 15.13 30.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 73.03 110.891 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.63 -19.46 9.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.745 -0.74 . . . . 51.1 112.514 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -96.11 -42.69 8.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 52.54 110.834 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.07 26.68 54.97 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.728 -0.748 . . . . 75.14 112.465 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.712 -0.756 . . . . 74.42 112.535 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.826 0.346 . . . . 60.31 110.856 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.707 ' HA ' HD13 ' A' ' 85' ' ' LEU . 4.5 p90 -94.43 -175.44 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 54.51 110.907 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -119.4 -31.56 4.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.519 . . . . 64.42 110.852 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.733 ' O ' HG23 ' A' ' 17' ' ' THR . 0.8 OUTLIER -101.07 127.57 31.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.607 0.718 . . . . 74.24 111.129 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 18.73 0.19 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.747 2.298 . . . . 62.34 112.305 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -138.95 39.76 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 74.31 111.12 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 14' ' ' ILE . 65.0 p -72.73 -166.5 0.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 64.2 111.161 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -132.79 -86.7 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 71.44 110.901 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -75.08 6.64 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 71.42 110.911 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.907 HD21 ' HB3' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -92.59 -37.85 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 61.42 110.904 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -75.17 -7.49 53.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 73.11 110.969 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -94.43 -26.31 16.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 74.32 110.886 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -30.03 29.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 72.43 110.896 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.9 -30.7 1.04 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.746 -0.74 . . . . 50.44 112.486 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.56 -56.88 4.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 72.12 111.112 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.607 ' SD ' HG21 ' A' ' 73' ' ' VAL . 11.6 ptp -65.15 -11.77 43.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 73.05 110.866 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.933 ' HB1' ' HB2' ' A' ' 31' ' ' GLU . . . -101.5 26.11 7.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.45 111.104 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 28' ' ' PHE . 7.4 p90 -63.15 -16.65 60.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 71.14 110.857 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -147.6 -44.97 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 72.54 110.881 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.97 -18.21 25.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.724 . . . . 64.41 112.46 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.933 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 1.9 tm-20 -64.7 92.12 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.883 0.373 . . . . 74.32 110.868 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.434 ' HB3' ' CD ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -103.22 -161.04 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 63.21 110.882 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -122.63 114.01 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.32 110.911 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 35' ' ' THR . 11.4 t -90.7 172.34 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 61.24 111.112 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.672 ' H ' HG12 ' A' ' 34' ' ' VAL . 34.3 p -89.73 -54.1 4.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 64.35 111.178 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.73 -64.89 0.11 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.721 -0.752 . . . . 74.41 112.51 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.461 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.9 Cg_endo -69.74 159.04 54.9 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.693 2.262 . . . . 75.43 112.375 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -60.65 -29.0 68.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 74.01 110.882 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.477 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . . . -54.37 -35.66 63.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 62.44 111.077 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.53 ' HA ' ' CG ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -85.45 -28.59 24.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 71.44 110.846 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 97' ' ' ALA . 0.6 OUTLIER -73.99 -42.61 60.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 60.02 110.894 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.43 -33.71 71.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 74.42 111.058 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.53 ' CG ' ' HA ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -79.72 -42.56 24.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 74.3 110.843 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -75.22 -61.61 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 44.42 111.097 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.983 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . . . -51.08 -23.76 3.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 62.23 111.107 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.62 ' O ' ' CG2' ' A' ' 50' ' ' VAL . . . -51.93 -67.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 70.22 111.142 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.638 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 25.3 t -111.18 -22.0 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 53.54 111.119 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 45.2 mt-30 -73.98 -29.21 61.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 61.31 110.911 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.109 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.42 -6.95 15.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 71.01 111.134 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 14.3 t -95.66 1.92 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.713 . . . . 62.12 111.108 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.109 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.0 Cg_endo -69.71 -20.35 35.16 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.265 . . . . 62.1 112.373 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.72 -40.54 3.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.731 . . . . 64.14 112.52 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.96 -32.8 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.738 -0.744 . . . . 64.43 112.471 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.957 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -147.3 163.31 36.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 74.41 111.15 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.77 ' O ' ' HA ' ' A' ' 73' ' ' VAL . . . -76.81 69.06 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 61.23 111.08 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.816 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -111.22 82.27 0.3 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.721 -0.752 . . . . 70.23 112.488 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.983 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -88.98 175.92 7.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 74.22 110.91 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.595 HG22 HG22 ' A' ' 71' ' ' VAL . 62.7 t -131.17 123.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.55 111.107 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.633 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 8.0 mt-10 -92.08 129.1 38.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.924 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -100.48 104.46 15.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 71.23 111.154 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.486 ' C ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.56 160.68 39.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 72.51 110.887 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -131.37 112.63 12.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 71.2 111.129 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.73 -178.53 43.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 75.31 112.487 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -65.13 -24.03 67.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.856 0.36 . . . . 74.03 110.855 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.72 -112.51 0.14 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.715 -0.755 . . . . 73.23 112.427 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 87' ' ' ARG . . . -111.7 -82.65 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.321 . . . . 63.4 111.102 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.85 161.53 14.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 54.15 111.074 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.486 ' HB3' ' C ' ' A' ' 61' ' ' GLU . . . -153.78 72.6 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 72.42 111.138 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.538 ' CB ' HD21 ' A' ' 85' ' ' LEU . 4.7 m-85 -115.79 125.12 52.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 73.11 110.968 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -105.93 110.21 3.34 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.695 -0.764 . . . . 65.34 112.457 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 57' ' ' GLU . 89.4 t -102.45 113.95 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 73.4 111.128 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.816 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -105.72 131.72 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 62.22 110.94 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.3 p -139.1 119.41 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 54.31 111.138 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.824 ' O ' HG22 ' A' ' 54' ' ' THR . 2.3 m -170.11 -133.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 64.33 111.165 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.521 ' H ' HG22 ' A' ' 74' ' ' THR . 9.5 mtm180 -105.84 143.55 27.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 75.35 110.876 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HA ' HH22 ' A' ' 80' ' ' ARG . 54.3 Cg_endo -69.75 13.08 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.663 2.242 . . . . 72.12 112.361 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 75' ' ' ARG . 5.7 m-20 -88.79 24.6 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 73.54 110.9 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.21 -13.69 53.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.769 -0.729 . . . . 53.1 112.465 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.491 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.0 p -98.54 108.34 21.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.825 0.345 . . . . 64.44 111.155 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.818 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 2.2 ptp85 -140.09 163.07 33.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 74.41 110.895 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 60.1 t -120.58 105.0 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 74.14 111.177 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.532 ' O ' ' HB ' ' A' ' 94' ' ' THR . 34.4 tt0 -82.62 142.84 31.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 72.5 110.938 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 12.1 m -118.37 118.24 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 72.11 111.123 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.658 ' H ' ' C ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -83.18 119.37 24.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 71.55 110.894 179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.907 ' HB3' HD21 ' A' ' 20' ' ' LEU . 2.8 pp -113.77 110.9 20.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 74.42 110.922 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.591 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -134.28 118.79 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 73.05 110.885 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.417 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 2.0 ttt180 -69.14 5.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 73.55 110.895 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.513 ' HB3' ' CE2' ' A' ' 89' ' ' PHE . 29.8 t0 -64.57 -25.43 67.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.876 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -160.69 -89.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 63.34 110.877 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.53 45.63 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 71.24 110.862 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.808 ' O ' HD13 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -99.09 111.84 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 61.23 111.096 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.808 HD13 ' O ' ' A' ' 91' ' ' VAL . 0.4 OUTLIER -128.23 17.06 6.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 53.21 110.937 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.658 ' C ' ' H ' ' A' ' 84' ' ' HIS . 10.2 t70 -140.49 151.51 44.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 73.41 110.874 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.654 ' OG1' ' N ' ' A' ' 84' ' ' HIS . 81.4 m -122.58 -101.52 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 52.33 111.101 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.505 ' N ' HG22 ' A' ' 94' ' ' THR . 8.4 pt-20 -166.47 154.74 9.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.63 0.729 . . . . 73.34 110.906 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 95' ' ' GLU . 53.4 Cg_endo -69.77 148.46 65.04 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.671 2.247 . . . . 75.35 112.352 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 41' ' ' ARG . . . -118.58 161.15 20.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 70.24 111.117 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.98 0.41 6.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 71.41 110.878 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.0 -20.84 26.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.735 -0.745 . . . . 64.41 112.476 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -97.08 -16.79 20.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.871 0.367 . . . . 73.44 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.45 -20.32 79.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 32.14 112.508 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 39' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 73.25 112.49 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.6 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.81 0.338 . . . . 75.34 110.883 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -63.94 -22.49 66.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 73.33 110.946 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' OD1' ' HB3' ' A' ' 67' ' ' ALA . 14.5 t70 -67.23 -124.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 71.3 110.876 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 17' ' ' THR . 3.0 tt -92.0 139.36 24.47 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.606 0.717 . . . . 72.32 111.135 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.75 23.87 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.717 2.278 . . . . 44.23 112.311 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.493 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -151.04 37.4 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 63.32 111.154 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.65 HG23 ' O ' ' A' ' 14' ' ' ILE . 66.5 p -66.87 -165.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 75.13 111.15 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.509 ' HG3' HD23 ' A' ' 92' ' ' LEU . 3.0 mt-10 -123.46 -86.99 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 74.42 110.862 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.87 12.3 3.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 71.15 110.856 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.774 ' CG ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -94.25 -36.31 12.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 74.1 110.964 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.444 ' CD2' ' O ' ' A' ' 18' ' ' GLU . 2.1 p90 -75.83 -2.41 29.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 71.24 110.865 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -96.25 -32.04 12.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 70.42 110.877 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -81.05 -31.02 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 73.52 110.917 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -41.82 -38.63 2.44 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.768 -0.73 . . . . 64.34 112.437 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.52 -60.68 3.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 74.42 111.118 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.743 ' HG3' HG21 ' A' ' 73' ' ' VAL . 1.1 ptm -67.57 -10.94 56.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 74.31 110.849 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HB1' ' OE1' ' A' ' 31' ' ' GLU . . . -82.37 -29.93 30.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.422 . . . . 41.42 111.122 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -73.86 42.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.876 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -148.34 -41.87 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 70.43 110.872 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.34 13.27 3.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.711 -0.757 . . . . 63.11 112.484 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.626 ' CD ' HG21 ' A' ' 58' ' ' VAL . 2.7 tt0 -58.16 104.49 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 71.05 110.859 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.41 -171.04 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 74.31 110.838 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -109.48 120.5 42.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 71.44 110.85 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.763 HG23 ' C ' ' A' ' 58' ' ' VAL . 2.3 t -91.74 -140.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 73.22 111.132 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.685 ' H ' HG12 ' A' ' 34' ' ' VAL . 43.6 p -137.06 -63.92 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 75.44 111.146 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.05 -64.6 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.71 -0.757 . . . . 74.32 112.469 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.415 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.7 Cg_endo -69.77 167.17 25.23 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.636 2.224 . . . . 72.43 112.381 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -70.32 -26.06 63.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 73.24 110.835 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.51 -37.42 70.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 70.42 111.118 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.07 -33.54 24.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 71.33 110.893 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -71.23 -43.85 66.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 75.55 110.863 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.753 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.48 -34.33 72.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.33 111.093 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -79.35 -41.02 28.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 74.44 110.905 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -77.34 -63.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 63.22 111.112 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -52.9 -19.72 2.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 55.14 111.074 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.753 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -53.63 -67.96 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 74.4 111.114 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.744 ' HA ' HG12 ' A' ' 50' ' ' VAL . 21.5 t -115.55 -13.85 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 72.52 111.093 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.57 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 41.5 mt-30 -80.09 -34.54 37.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 75.34 110.909 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.008 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.29 -4.1 19.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 75.12 111.1 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.988 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.71 -6.4 0.12 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.639 0.733 . . . . 75.25 111.172 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 1.008 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.8 Cg_endo -69.83 -26.58 27.11 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 2.236 . . . . 61.41 112.361 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.83 -50.49 5.56 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.721 -0.752 . . . . 52.14 112.53 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.5 -32.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.703 -0.761 . . . . 63.2 112.486 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.659 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -146.94 150.73 35.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 72.42 111.148 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.801 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.98 79.1 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 61.2 111.076 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.76 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -145.64 101.89 0.25 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 40.11 112.496 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.564 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.5 tt0 -95.39 -177.72 4.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 63.12 110.9 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.763 ' C ' HG23 ' A' ' 34' ' ' VAL . 82.1 t -132.29 118.11 34.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 62.24 111.121 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.779 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 7.6 pt-20 -92.47 159.5 15.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 72.41 110.906 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.502 ' HA ' ' CB ' ' A' ' 69' ' ' TYR . 1.6 t -132.8 116.4 16.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 52.34 111.146 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -136.73 163.71 29.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 70.23 110.876 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.423 ' CA ' ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -116.09 149.89 38.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 74.44 111.166 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.07 -142.51 5.34 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 34.42 112.506 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.74 -22.06 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.379 . . . . 64.15 110.866 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.1 -114.34 3.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 51.53 112.449 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.05 -84.71 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.748 0.308 . . . . 72.04 111.107 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -76.34 131.78 39.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.34 111.112 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB3' ' CA ' ' A' ' 62' ' ' THR . . . -150.4 60.72 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 44.52 111.113 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.91 ' CZ ' HD12 ' A' ' 85' ' ' LEU . 4.2 p90 -128.19 -169.17 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 61.3 110.922 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -157.07 163.9 32.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.771 -0.728 . . . . 71.11 112.525 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.756 HG22 HG22 ' A' ' 58' ' ' VAL . 61.1 t -136.85 122.69 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 62.45 111.09 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.76 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -110.56 141.5 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.21 110.948 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.743 HG21 ' HG3' ' A' ' 26' ' ' MET . 7.2 p -152.19 124.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 74.42 111.106 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.829 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 3.0 m -171.82 -129.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 74.4 111.125 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.48 ' H ' HG22 ' A' ' 74' ' ' THR . 6.4 mtm-85 -103.53 141.5 22.62 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.624 0.726 . . . . 73.42 110.883 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.51 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.0 Cg_endo -69.74 15.57 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 70.21 112.342 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 75' ' ' ARG . 5.7 m-20 -93.69 24.52 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.41 110.879 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.25 -12.71 53.83 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.74 . . . . 70.54 112.5 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 79' ' ' THR . 2.7 t -98.64 103.95 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 74.24 111.152 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.829 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.9 OUTLIER -137.3 163.75 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 62.22 110.925 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 45.6 t -115.88 105.66 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 71.54 111.069 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.672 ' CD ' HG21 ' A' ' 94' ' ' THR . 0.0 OUTLIER -88.65 139.29 30.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 75.53 110.874 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 1.016 HG23 HD21 ' A' ' 85' ' ' LEU . 32.3 m -116.11 146.88 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 44.44 111.111 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.897 ' C ' HD23 ' A' ' 85' ' ' LEU . 2.1 t-160 -98.46 123.99 42.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 65.33 110.861 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.016 HD21 HG23 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -118.91 103.15 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 72.32 110.901 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 1.6 t70 -131.37 111.62 12.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 70.02 110.899 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -70.99 4.21 2.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 71.31 110.867 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -72.73 -13.92 61.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 63.5 110.841 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.428 ' HB2' ' HD2' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -164.63 -95.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.41 110.897 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.881 ' O ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -149.21 29.33 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 70.34 110.84 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.847 ' C ' HD13 ' A' ' 92' ' ' LEU . 2.3 t -73.92 97.0 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.119 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.881 HD22 ' O ' ' A' ' 90' ' ' ARG . 0.4 OUTLIER -124.87 15.29 8.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.44 110.853 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.612 ' C ' ' H ' ' A' ' 84' ' ' HIS . 4.4 m-20 -154.61 157.95 38.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 33.44 110.845 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.704 ' OG1' ' HB2' ' A' ' 84' ' ' HIS . 86.0 m -130.39 -99.8 0.32 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 72.35 111.135 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.484 ' N ' HG22 ' A' ' 94' ' ' THR . 0.6 OUTLIER -159.34 162.61 25.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.627 0.727 . . . . 71.52 110.883 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 104.48 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.652 2.235 . . . . 64.32 112.335 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.619 ' HB3' ' HG3' ' A' ' 80' ' ' ARG . . . -66.79 108.22 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 54.53 111.092 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.85 16.58 12.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 64.35 110.894 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.59 -19.91 21.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 73.51 112.513 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.4 -45.94 6.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 75.4 110.886 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.06 27.46 45.05 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 42.15 112.455 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.749 . . . . 54.21 112.468 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.837 0.351 . . . . 73.12 110.88 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -67.69 -41.69 83.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.909 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.454 ' CB ' ' HB2' ' A' ' 85' ' ' LEU . 3.8 p-10 -62.55 -161.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 75.42 110.868 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.819 HG13 HG23 ' A' ' 17' ' ' THR . 27.7 pt -86.73 129.57 52.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.646 0.736 . . . . 64.4 111.133 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 0.56 5.43 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.697 2.265 . . . . 40.42 112.326 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 m -109.1 25.02 12.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 73.41 111.136 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.097 HG22 HD23 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -78.86 -168.2 1.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 71.15 111.136 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -73.97 -100.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 73.15 110.883 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.06 7.76 45.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 71.23 110.892 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.641 HD23 ' HB3' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -69.08 -13.41 62.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 74.14 110.895 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -94.05 0.64 56.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 74.24 110.904 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.13 -40.41 8.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 64.02 110.869 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.684 ' NE2' HG21 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -67.3 -43.98 80.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.04 110.926 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.563 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -43.88 -30.01 1.56 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.76 . . . . 44.35 112.512 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.16 -56.91 12.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 62.54 111.076 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.647 ' SD ' HG21 ' A' ' 73' ' ' VAL . 20.4 ptp -72.01 -5.03 32.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.443 . . . . 60.22 110.883 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 24' ' ' GLY . . . -74.43 -24.34 59.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 71.01 111.119 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -64.3 -9.09 15.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 64.53 110.861 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.09 -77.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 51.22 110.882 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.31 9.98 2.98 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 64.54 112.499 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.788 ' CD ' HG23 ' A' ' 58' ' ' VAL . 2.8 tt0 -60.02 99.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 74.21 110.872 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.05 -164.06 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 72.01 110.846 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.81 122.54 44.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 64.44 110.905 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.748 HG23 ' C ' ' A' ' 58' ' ' VAL . 2.7 t -84.1 -133.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 61.01 111.118 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.558 ' H ' HG12 ' A' ' 34' ' ' VAL . 21.0 p -136.09 -58.55 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 72.42 111.113 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.46 -68.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 71.21 112.494 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.4 Cg_endo -69.75 171.24 14.82 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 2.243 . . . . 72.23 112.362 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -71.92 -24.61 61.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 65.4 110.836 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.86 72.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 54.32 111.084 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.68 -41.35 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 60.31 110.887 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.512 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -61.24 -37.7 84.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 74.2 110.854 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.729 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -67.74 -33.97 75.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 71.43 111.09 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.483 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -78.88 -39.62 34.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 73.12 110.91 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.772 ' HB1' ' OE2' ' A' ' 57' ' ' GLU . . . -80.34 -60.79 2.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 50.02 111.103 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.763 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -52.71 -23.24 6.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 75.3 111.088 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -57.25 -77.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 50.52 111.056 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.698 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 40.6 t -113.32 -13.97 11.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 72.12 111.121 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.6 tp60 -75.92 -32.94 59.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.54 110.872 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.029 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.68 -2.63 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 54.14 111.101 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.974 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.1 -4.56 0.11 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.637 0.732 . . . . 71.51 111.146 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.029 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.3 Cg_endo -69.78 -28.16 25.5 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.676 2.251 . . . . 72.43 112.326 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.54 -54.95 3.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.758 . . . . 64.34 112.469 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.79 -33.45 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.7 -0.762 . . . . 74.1 112.474 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.698 HG22 ' O ' ' A' ' 74' ' ' THR . 0.2 OUTLIER -144.81 150.12 36.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 74.04 111.112 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.817 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.42 76.46 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 72.54 111.099 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.704 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -149.7 108.94 0.42 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 62.52 112.521 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.772 ' OE2' ' HB1' ' A' ' 44' ' ' ALA . 3.2 tt0 -102.97 -168.54 1.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.893 0.378 . . . . 75.13 110.888 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.788 HG23 ' CD ' ' A' ' 31' ' ' GLU . 1.3 t -132.98 118.29 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 54.32 111.117 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -96.98 158.14 15.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 74.13 110.923 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -137.06 111.02 8.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 72.34 111.159 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.95 166.39 16.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.888 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.81 118.15 29.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 61.24 111.163 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.07 -144.3 9.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 50.42 112.5 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.97 -14.29 42.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.901 0.382 . . . . 65.5 110.895 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.89 -120.89 1.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 71.34 112.491 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -121.97 -76.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 64.55 111.128 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.768 ' HB1' ' CE2' ' A' ' 69' ' ' TYR . . . -103.04 86.33 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 64.21 111.087 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.28 62.93 6.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 75.24 111.076 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.768 ' CE2' ' HB1' ' A' ' 67' ' ' ALA . 0.4 OUTLIER -109.04 174.39 5.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.913 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -153.91 157.75 27.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.725 -0.75 . . . . 44.4 112.454 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.642 HG12 HD21 ' A' ' 85' ' ' LEU . 3.4 p -132.6 115.03 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.372 . . . . 74.51 111.132 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.761 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -107.53 135.88 48.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 70.4 110.918 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.704 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.7 p -151.55 124.43 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 71.12 111.154 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.771 ' HB ' ' O ' ' A' ' 79' ' ' THR . 4.1 m -168.06 -131.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 74.45 111.17 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.599 ' H ' HG22 ' A' ' 74' ' ' THR . 0.5 OUTLIER -103.0 139.33 20.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.63 0.729 . . . . 64.11 110.886 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.636 ' HG3' HG21 ' A' ' 50' ' ' VAL . 53.9 Cg_endo -69.72 16.83 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.711 2.274 . . . . 62.04 112.34 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 75' ' ' ARG . 4.1 m-20 -94.97 13.61 24.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 71.34 110.874 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.84 -12.1 34.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 23.43 112.457 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.771 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.8 t -95.55 130.63 42.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 41.23 111.175 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.547 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -142.2 158.79 43.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 74.3 110.924 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.761 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 72.8 t -117.79 80.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 65.13 111.119 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB2' HD12 ' A' ' 72' ' ' LEU . 3.0 tp10 -75.09 121.82 22.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 74.12 110.853 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.684 HG21 ' NE2' ' A' ' 23' ' ' GLN . 3.0 t -103.82 139.5 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 63.34 111.172 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.63 ' C ' HG12 ' A' ' 91' ' ' VAL . 17.9 m-70 -86.61 118.13 25.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 73.25 110.843 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.642 HD21 HG12 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -128.3 105.86 8.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 74.32 110.91 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.66 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.3 t0 -139.66 131.96 28.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 71.41 110.843 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.641 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 2.0 tmt_? -61.21 5.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.22 110.863 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 86' ' ' ASP . 13.9 t0 -67.23 -3.33 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 75.32 110.863 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 67.53 12.2 8.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.879 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -137.31 2.18 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 73.11 110.882 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.66 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 58.5 t -116.38 70.87 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 63.22 111.143 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.097 HD23 HG22 ' A' ' 17' ' ' THR . 0.3 OUTLIER -128.56 12.47 6.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 71.11 110.941 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -92.92 -179.1 5.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 65.55 110.864 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.8 t -124.61 166.96 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 61.31 111.132 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -145.97 123.38 6.12 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.658 0.742 . . . . 75.42 110.872 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 96.48 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.637 2.225 . . . . 22.11 112.351 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 80' ' ' ARG . . . -64.09 111.35 2.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 71.41 111.097 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -88.83 11.03 19.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 62.33 110.831 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.18 -21.11 7.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.727 . . . . 31.44 112.462 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -97.92 -38.54 9.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.861 0.363 . . . . 73.24 110.888 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.26 25.14 52.6 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.751 . . . . 62.44 112.518 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.782 -0.723 . . . . 31.31 112.472 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.832 0.349 . . . . 75.35 110.879 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.428 ' HB2' ' CE2' ' A' ' 69' ' ' TYR . 77.6 m-85 -64.68 -32.91 74.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.24 110.929 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 10.6 p-10 -65.98 -122.83 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 63.45 110.885 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.844 HD12 HG11 ' A' ' 91' ' ' VAL . 30.8 mt -77.37 127.55 82.69 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.633 0.73 . . . . 61.03 111.138 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 15.86 0.23 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.637 2.225 . . . . 74.54 112.394 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.784 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -150.77 37.86 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 65.34 111.117 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.841 HG22 HD21 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -71.61 -161.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 64.21 111.133 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.408 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 29.4 mm-40 -84.13 -111.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 73.11 110.835 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -86.7 9.76 17.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.13 110.86 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.703 HD22 HG21 ' A' ' 17' ' ' THR . 0.3 OUTLIER -66.91 -12.23 58.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 72.42 110.877 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -63.65 -12.27 32.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 73.02 110.912 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -115.18 52.93 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.85 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.468 HE22 HD13 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -58.19 88.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 74.55 110.904 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 42.93 38.17 3.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 63.44 112.487 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.86 -26.7 66.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 63.43 111.122 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.608 ' SD ' HG11 ' A' ' 73' ' ' VAL . 0.7 OUTLIER -66.0 -9.9 34.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 73.55 110.846 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 29' ' ' ASP . . . -118.14 61.91 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 63.34 111.152 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -59.34 -6.15 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 75.13 110.926 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 27' ' ' ALA . 3.8 m-20 -126.08 -35.52 2.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 73.32 110.863 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.18 -20.52 60.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.716 -0.754 . . . . 42.41 112.475 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -62.47 93.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 61.14 110.892 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.09 179.62 3.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 64.25 110.873 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -95.62 115.73 27.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 64.53 110.894 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.739 HG22 ' OE1' ' A' ' 57' ' ' GLU . 3.1 t -75.03 -135.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 74.21 111.184 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.684 ' H ' HG12 ' A' ' 34' ' ' VAL . 80.6 p -140.15 -60.43 0.53 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 61.12 111.108 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.455 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 175.76 -60.88 0.11 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 54.12 112.5 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.9 Cg_endo -69.73 164.64 33.76 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.711 2.274 . . . . 73.02 112.369 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 9.0 p-10 -71.53 -25.67 62.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 55.42 110.804 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.14 -36.86 73.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 70.53 111.067 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 2.1 m-20 -83.49 -36.31 24.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 53.14 110.876 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.594 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 11.8 ptt180 -70.39 -43.97 68.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 74.12 110.842 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.712 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -69.39 -34.47 74.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 72.23 111.12 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 15.3 ptt85 -80.11 -41.5 25.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 53.43 110.851 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.619 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -75.26 -62.26 1.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 61.53 111.102 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -53.7 -19.57 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 52.4 111.101 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -60.15 -68.28 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 54.42 111.1 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.721 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 19.4 t -111.07 -10.45 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 74.55 111.158 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.619 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.2 tp60 -83.65 -38.61 21.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 72.32 110.93 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.755 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -101.88 -6.32 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 72.14 111.116 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.969 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -81.26 -24.79 0.39 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.657 0.741 . . . . 71.14 111.139 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.969 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 53.8 Cg_endo -69.78 -7.15 20.33 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.661 2.24 . . . . 72.01 112.399 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.04 -21.51 15.44 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 74.43 112.483 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.68 -33.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 55.33 112.487 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.686 ' O ' ' O ' ' A' ' 49' ' ' ALA . 2.0 t -155.16 161.86 41.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 74.21 111.133 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.741 ' HB1' ' NH2' ' A' ' 80' ' ' ARG . . . -76.63 69.48 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 71.35 111.089 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.712 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -144.29 103.15 0.29 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.735 -0.745 . . . . 74.03 112.463 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.739 ' OE1' HG22 ' A' ' 34' ' ' VAL . 3.8 tt0 -97.55 -171.89 2.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 63.34 110.889 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.727 ' C ' HG23 ' A' ' 34' ' ' VAL . 78.0 t -133.08 120.94 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 74.03 111.098 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 14.5 tm-20 -95.88 149.8 21.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 74.14 110.89 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.2 t -135.46 113.92 11.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.114 -0.493 . . . . 51.25 111.124 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.64 161.31 37.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 64.13 110.858 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.64 119.83 31.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 71.42 111.164 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.14 -159.65 30.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.742 -0.742 . . . . 70.05 112.554 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -82.97 -23.67 33.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 51.24 110.88 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.9 -112.99 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 42.13 112.466 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -114.25 -69.19 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 44.25 111.118 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.756 ' HB1' ' CE2' ' A' ' 69' ' ' TYR . . . -110.3 157.15 19.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 73.22 111.106 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -155.08 61.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 74.33 111.123 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.756 ' CE2' ' HB1' ' A' ' 67' ' ' ALA . 1.2 m-85 -113.67 173.43 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 73.15 110.922 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -159.59 117.55 0.78 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 44.22 112.472 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.624 HG23 HG22 ' A' ' 58' ' ' VAL . 7.1 p -108.52 122.01 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.914 0.388 . . . . 54.04 111.117 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.832 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -111.86 144.21 41.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 73.41 110.917 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.712 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 t -148.22 116.75 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 63.24 111.146 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.808 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 1.3 m -173.74 -135.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 72.02 111.166 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.44 ' H ' HG22 ' A' ' 74' ' ' THR . 20.0 mtm-85 -107.61 149.29 38.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.642 0.734 . . . . 72.22 110.857 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.72 5.13 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.702 2.268 . . . . 74.22 112.341 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.36 27.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 64.53 110.903 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.8 -11.03 15.77 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.727 -0.749 . . . . 74.11 112.485 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.1 p -98.62 102.27 13.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.807 0.337 . . . . 62.2 111.104 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.808 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 1.1 ptp85 -141.34 162.46 35.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 71.43 110.912 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 23.8 t -112.85 100.02 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 52.24 111.088 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.614 ' HG3' HD12 ' A' ' 72' ' ' LEU . 1.0 OUTLIER -89.06 117.72 28.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 75.35 110.884 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.655 HG13 ' HB ' ' A' ' 94' ' ' THR . 0.2 OUTLIER -98.28 111.42 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 64.02 111.194 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.483 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 3.3 t-160 -78.45 123.22 26.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 65.04 110.868 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.689 HD22 ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -106.84 96.48 6.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 60.33 110.888 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.656 ' H ' ' HA ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -130.1 119.48 23.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 62.31 110.891 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.652 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -66.26 -6.67 14.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 61.42 110.895 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.681 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 15.0 t0 -84.01 31.02 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 73.01 110.893 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.681 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 19.5 m-85 98.03 -27.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 74.32 110.875 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 79.6 mmt-85 -91.83 38.84 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 64.41 110.893 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.844 HG11 HD12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -61.54 -40.18 85.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.4 111.14 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.841 HD21 HG22 ' A' ' 17' ' ' THR . 3.2 mm? -116.41 30.05 7.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 74.4 110.9 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 13.5 t0 -72.47 69.58 0.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 63.52 110.862 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.655 ' HB ' HG13 ' A' ' 83' ' ' VAL . 5.5 t -79.09 161.12 26.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 73.02 111.148 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.53 128.23 8.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.638 0.732 . . . . 62.33 110.88 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 95.33 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.669 2.246 . . . . 71.4 112.371 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.601 ' HB3' ' HG3' ' A' ' 80' ' ' ARG . . . -65.04 110.18 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 63.22 111.086 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -105.85 18.42 22.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 70.23 110.839 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.62 -19.15 30.18 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.731 . . . . 62.54 112.474 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.09 -44.39 7.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.813 0.34 . . . . 64.12 110.836 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.65 23.61 57.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.716 -0.754 . . . . 61.14 112.466 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 60.42 112.477 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.85 0.357 . . . . 74.41 110.921 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.72 ' HA ' HD13 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -113.6 179.96 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 73.03 110.908 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.636 ' CB ' ' HB3' ' A' ' 67' ' ' ALA . 15.7 p-10 -117.43 -46.73 2.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.113 -0.494 . . . . 71.55 110.873 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.652 HG23 ' CG ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -133.62 165.71 34.69 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 70.41 111.171 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HD2' HG22 ' A' ' 14' ' ' ILE . 53.4 Cg_endo -69.74 -3.68 12.48 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.71 2.273 . . . . 63.34 112.324 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -128.98 74.62 1.59 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 74.41 111.18 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.738 ' CG2' HD22 ' A' ' 20' ' ' LEU . 59.9 p -96.69 -166.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 75.11 111.111 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 92' ' ' LEU . 18.9 tt0 -129.55 -92.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 74.24 110.867 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -72.02 7.15 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 72.01 110.869 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.899 HD21 ' CB ' ' A' ' 85' ' ' LEU . 11.2 mp -84.72 -37.56 20.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 70.43 110.923 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -82.86 4.03 27.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 74.03 110.946 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.6 -52.77 3.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 63.24 110.911 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -78.12 -31.81 50.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 72.11 110.924 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.81 -41.63 4.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 65.15 112.521 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.51 -60.75 2.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.736 0.303 . . . . 63.41 111.107 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.486 ' HG3' HG21 ' A' ' 73' ' ' VAL . 1.2 ptm -69.51 -8.4 46.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 75.51 110.842 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.775 ' HB1' ' OE1' ' A' ' 31' ' ' GLU . . . -88.94 -32.99 17.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 54.24 111.093 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -75.73 46.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 74.33 110.839 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.21 -74.62 0.49 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.125 -0.488 . . . . 74.14 110.871 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.26 16.64 5.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.691 -0.766 . . . . 45.52 112.44 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.775 ' OE1' ' HB1' ' A' ' 27' ' ' ALA . 17.0 pt-20 -54.94 168.17 0.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 63.14 110.894 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.444 ' H ' ' HB2' ' A' ' 57' ' ' GLU . 0.5 OUTLIER -130.94 -165.92 1.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 75.1 110.866 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -128.84 120.46 26.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 64.22 110.902 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.611 HG22 ' CD ' ' A' ' 57' ' ' GLU . 40.1 t -73.32 162.67 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 61.32 111.096 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.566 ' N ' HG12 ' A' ' 34' ' ' VAL . 70.7 p -91.81 -49.03 6.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 73.44 111.118 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.07 -64.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 61.22 112.491 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 150.3 68.14 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.646 2.231 . . . . 74.54 112.366 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -59.01 -30.85 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 50.44 110.876 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.39 -28.7 60.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 61.35 111.063 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 0.6 OUTLIER -78.97 -30.02 44.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 73.02 110.848 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.622 ' NE ' ' HB1' ' A' ' 97' ' ' ALA . 3.2 ptt180 -68.57 -43.13 77.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 75.33 110.842 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -74.47 -32.04 62.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 74.34 111.123 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 19.7 ptt85 -77.93 -41.54 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 72.14 110.884 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -78.18 -62.29 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 63.44 111.058 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -51.54 -21.39 2.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 73.41 111.092 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.725 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -53.81 -66.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 73.52 111.094 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.751 ' HA ' HG12 ' A' ' 50' ' ' VAL . 22.0 t -111.35 -17.04 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 75.2 111.098 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 52.3 mt-30 -79.26 -28.92 42.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 65.52 110.952 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.101 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -109.31 -10.27 14.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 55.43 111.081 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.53 -0.03 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 70.02 111.126 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.101 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.5 Cg_endo -69.76 -27.23 26.73 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.689 2.259 . . . . 72.14 112.337 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.14 -51.83 3.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.771 -0.728 . . . . 61.44 112.464 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.24 -35.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 75.54 112.46 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.803 ' O ' ' O ' ' A' ' 49' ' ' ALA . 4.4 m -143.15 147.51 35.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.769 0.318 . . . . 75.41 111.128 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.82 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -74.24 81.43 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 51.42 111.156 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.691 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -145.41 97.9 0.19 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 50.34 112.516 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.611 ' CD ' HG22 ' A' ' 34' ' ' VAL . 1.1 pt-20 -99.43 -179.47 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 55.44 110.897 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.83 HG13 HG22 ' A' ' 71' ' ' VAL . 70.3 t -115.04 139.22 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 73.14 111.142 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.577 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 19.9 tt0 -106.88 155.89 19.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 73.12 110.879 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.411 ' HA ' ' CG ' ' A' ' 69' ' ' TYR . 1.2 t -129.35 110.77 12.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 65.41 111.162 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.13 160.52 38.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 63.22 110.894 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 64.4 p -132.69 93.21 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 65.22 111.113 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.2 -139.47 2.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.75 . . . . 65.24 112.445 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.15 -0.13 56.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.392 . . . . 75.51 110.881 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -100.7 -122.83 5.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.792 -0.718 . . . . 53.15 112.5 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.876 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -122.82 -82.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.795 0.331 . . . . 74.42 111.081 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.636 ' HB3' ' CB ' ' A' ' 13' ' ' ASP . . . -100.45 90.15 4.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 71.24 111.079 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.49 79.86 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 72.12 111.091 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.711 ' HB2' HD11 ' A' ' 85' ' ' LEU . 3.1 m-85 -106.75 163.27 13.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 72.43 110.927 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -137.65 107.02 0.56 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 63.1 112.474 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.83 HG22 HG13 ' A' ' 58' ' ' VAL . 10.7 t -103.11 111.07 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.899 0.381 . . . . 43.31 111.098 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.72 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -103.45 149.45 24.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.35 110.914 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.662 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.7 p -150.42 115.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 43.42 111.103 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.766 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 1.4 m -173.43 -136.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 71.54 111.126 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.506 ' H ' HG22 ' A' ' 74' ' ' THR . 0.6 OUTLIER -104.26 145.86 31.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.597 0.713 . . . . 73.14 110.847 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.433 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.9 Cg_endo -69.74 7.88 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.695 2.264 . . . . 63.33 112.329 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.3 25.81 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 75.5 110.885 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.45 -13.22 47.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 64.14 112.499 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.575 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.6 t -97.03 102.8 14.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 72.41 111.18 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.766 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.6 OUTLIER -138.3 162.47 34.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 53.43 110.909 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 5.1 m -118.03 98.04 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 70.51 111.121 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.474 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -81.52 127.05 32.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 74.51 110.901 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 71' ' ' VAL . 3.9 t -91.92 116.9 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 74.12 111.141 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 2.3 t-160 -84.36 117.35 23.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 75.25 110.833 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.925 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -123.49 122.89 39.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 65.4 110.912 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 7.8 t0 -132.74 119.46 20.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 75.21 110.85 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.876 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 2.1 tmt_? -68.44 0.19 4.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.11 110.864 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.549 ' HB3' ' CE1' ' A' ' 89' ' ' PHE . 6.5 t0 -65.79 -14.17 60.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 73.23 110.848 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -176.71 -91.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 71.21 110.915 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.65 ' O ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -150.31 31.44 0.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.876 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.928 HG12 ' O ' ' A' ' 91' ' ' VAL . 2.0 t -71.82 81.42 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 73.22 111.16 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.706 HD13 ' C ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -120.39 18.62 12.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 64.51 110.934 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -83.09 137.67 34.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 60.14 110.882 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 3.0 t -92.05 165.88 12.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 73.12 111.158 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -139.12 162.83 50.02 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.677 0.751 . . . . 74.41 110.858 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 92.85 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.712 2.275 . . . . 61.13 112.343 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.622 ' HB1' ' NE ' ' A' ' 41' ' ' ARG . . . -76.23 111.19 11.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 74.02 111.059 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 101' ' ' GLY . 19.8 t0 -122.25 113.0 18.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 65.32 110.863 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -47.06 -21.54 1.02 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.732 -0.747 . . . . 72.33 112.513 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -93.74 -24.92 17.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 75.24 110.913 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 98' ' ' ASP . . . 100.4 -6.39 57.68 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.748 -0.739 . . . . 75.12 112.517 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.698 -0.763 . . . . 75.55 112.498 -179.878 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.779 0.323 . . . . 35.14 110.842 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -67.13 -18.02 65.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 64.04 110.974 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.658 ' HB3' HD12 ' A' ' 85' ' ' LEU . 6.3 p-10 -58.44 -100.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 62.53 110.889 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.73 HG23 ' CG ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -113.7 163.9 17.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.616 0.722 . . . . 73.21 111.132 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' A' ' 14' ' ' ILE . 53.8 Cg_endo -69.79 -2.87 10.93 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.709 2.273 . . . . 62.23 112.294 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -144.22 72.66 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 65.33 111.129 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.497 ' HB ' ' HG ' ' A' ' 92' ' ' LEU . 3.9 p -74.6 -169.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 64.5 111.11 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 92' ' ' LEU . 3.3 mm-40 -116.78 -97.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 75.21 110.896 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.4 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -77.29 6.04 7.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 73.13 110.908 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.662 HD21 HD13 ' A' ' 85' ' ' LEU . 2.3 tp -79.97 -2.2 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.473 . . . . 53.02 110.882 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.44 ' CD2' ' O ' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -59.91 -14.26 14.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.31 110.973 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.6 49.49 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 62.24 110.835 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 24' ' ' GLY . 1.1 pt20 -64.47 82.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 54.44 110.917 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.462 ' HA2' HG21 ' A' ' 73' ' ' VAL . . . 36.5 44.26 0.85 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.734 -0.746 . . . . 54.11 112.544 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.94 76.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.766 0.317 . . . . 52.12 111.09 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.892 ' HG3' HG21 ' A' ' 54' ' ' THR . 0.0 OUTLIER -69.49 -16.64 63.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 74.2 110.899 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.488 ' HB2' HG22 ' A' ' 54' ' ' THR . . . -117.73 54.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 60.3 111.086 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.47 49.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 64.14 110.906 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 175.22 -31.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 71.25 110.828 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.47 -2.68 56.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.752 . . . . 61.22 112.479 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.35 85.74 3.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 74.45 110.909 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.89 -167.24 1.2 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 73.2 110.869 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 58' ' ' VAL . 22.1 pt-20 -101.67 166.27 10.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 74.14 110.885 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.761 HG23 ' C ' ' A' ' 58' ' ' VAL . 2.8 t -123.25 -139.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 73.34 111.163 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.721 ' H ' HG12 ' A' ' 34' ' ' VAL . 59.0 p -138.71 -70.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 72.14 111.166 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.475 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -175.24 -59.79 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 60.33 112.475 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.4 Cg_endo -69.8 164.16 35.62 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.7 2.267 . . . . 64.43 112.318 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -72.7 -25.09 61.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.919 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.36 82.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 54.34 111.12 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -80.58 -34.59 35.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 74.41 110.864 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.53 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 8.3 ptt180 -72.78 -45.67 57.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 74.21 110.872 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.663 ' HB1' ' HA2' ' A' ' 99' ' ' GLY . . . -64.65 -33.07 75.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 61.25 111.084 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 13.3 ptt85 -83.41 -43.36 15.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 62.33 110.86 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -74.88 -60.84 2.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 64.31 111.125 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.584 ' O ' ' HB1' ' A' ' 55' ' ' ALA . . . -51.47 -22.92 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 52.14 111.112 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.721 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -59.15 -75.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 74.15 111.075 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.651 ' HA ' HG12 ' A' ' 50' ' ' VAL . 26.3 t -107.78 -21.73 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 72.45 111.078 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -69.99 -31.48 69.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 64.22 110.917 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.06 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.34 -0.11 22.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 73.34 111.101 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.992 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -100.05 3.14 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.627 0.727 . . . . 54.43 111.158 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.06 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.8 Cg_endo -69.7 -27.39 26.82 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.769 2.313 . . . . 74.54 112.356 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.86 -49.38 5.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 62.05 112.455 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.33 -32.25 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.797 -0.715 . . . . 55.44 112.534 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.892 HG21 ' HG3' ' A' ' 26' ' ' MET . 11.8 t -141.91 149.83 40.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 72.13 111.182 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.861 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -74.99 78.83 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 24.54 111.121 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.603 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -144.86 101.17 0.24 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 72.13 112.5 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.691 ' H ' HD23 ' A' ' 72' ' ' LEU . 4.3 tt0 -95.4 -173.09 2.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 64.42 110.909 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.761 ' C ' HG23 ' A' ' 34' ' ' VAL . 20.2 t -135.5 116.69 19.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 63.23 111.139 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.593 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -94.89 150.84 19.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 61.43 110.829 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 69' ' ' TYR . 1.8 t -136.67 107.34 6.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 74.21 111.126 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 2.1 tt0 -129.39 167.76 17.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 74.51 110.911 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.74 120.51 34.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 64.34 111.139 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.2 -168.55 30.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 72.22 112.514 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -59.82 -23.45 63.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.907 0.384 . . . . 71.11 110.906 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.86 -118.2 1.56 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.777 -0.725 . . . . 72.34 112.495 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.47 -71.22 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.809 0.338 . . . . 62.34 111.13 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.728 ' HB3' ' H ' ' A' ' 87' ' ' ARG . . . -89.3 134.88 33.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 62.24 111.078 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -150.8 62.53 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 72.2 111.115 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.593 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.4 OUTLIER -111.98 162.64 15.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 73.32 110.925 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.672 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -144.98 118.99 1.17 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.718 -0.754 . . . . 62.24 112.49 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.693 HG23 HG22 ' A' ' 58' ' ' VAL . 8.8 p -103.02 119.86 52.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.371 . . . . 62.21 111.111 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.955 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -104.27 142.65 34.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 54.21 110.902 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.603 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 2.8 t -150.8 117.01 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 72.23 111.158 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.762 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 2.2 m -169.14 -137.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 73.2 111.123 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.629 ' H ' HG22 ' A' ' 74' ' ' THR . 55.8 mtm180 -98.61 150.01 36.29 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.585 0.707 . . . . 74.2 110.888 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.573 ' CG ' HG21 ' A' ' 50' ' ' VAL . 53.7 Cg_endo -69.79 5.83 1.56 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.672 2.248 . . . . 61.24 112.336 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.57 29.4 0.31 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 71.04 110.901 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.24 -9.98 11.87 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.763 -0.732 . . . . 71.34 112.48 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.581 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.9 p -98.38 109.49 22.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 73.02 111.174 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.762 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -137.94 160.93 38.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 73.44 110.878 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.709 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 12.5 m -110.94 101.8 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 63.34 111.108 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.773 ' HB2' HD12 ' A' ' 72' ' ' LEU . 8.2 tm-20 -82.86 122.92 28.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 64.44 110.908 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 2.3 t -96.26 109.36 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 65.04 111.115 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 93' ' ' ASP . 4.2 p-80 -79.57 121.09 24.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 63.43 110.899 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.806 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -120.17 116.85 26.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 64.12 110.908 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.721 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 25.9 t0 -127.3 114.2 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 61.54 110.886 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.73 ' CG ' HG23 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -68.73 1.74 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 62.52 110.897 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.448 ' C ' ' CG ' ' A' ' 89' ' ' PHE . 52.1 t0 -70.31 -12.36 61.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 70.4 110.86 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.448 ' CG ' ' C ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -172.62 -94.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 70.23 110.853 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.633 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -150.59 30.7 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.875 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.974 HG12 ' O ' ' A' ' 91' ' ' VAL . 1.9 t -77.58 77.16 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 71.14 111.145 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.782 HD13 ' C ' ' A' ' 91' ' ' VAL . 0.3 OUTLIER -120.19 18.05 12.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.952 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 84' ' ' HIS . 1.1 m-20 -80.95 167.5 19.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 71.52 110.875 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.691 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 5.9 t -121.19 169.43 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 75.53 111.198 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -143.73 110.7 5.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.575 0.703 . . . . 74.4 110.894 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.61 ' HB3' HG12 ' A' ' 81' ' ' VAL . 54.3 Cg_endo -69.71 103.78 1.21 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.68 2.253 . . . . 61.4 112.4 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.448 ' HB3' HH22 ' A' ' 80' ' ' ARG . . . -116.33 -178.88 3.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 62.34 111.092 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.54 -156.62 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 74.24 110.845 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.663 ' HA2' ' HB1' ' A' ' 42' ' ' ALA . . . -65.16 -14.97 60.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 41.35 112.492 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.39 -53.09 4.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 64.03 110.847 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.54 28.89 4.39 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 72.2 112.48 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 72.31 112.512 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.832 0.349 . . . . 75.31 110.863 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -66.84 -52.16 46.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 73.12 110.906 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.85 ' H ' HD21 ' A' ' 85' ' ' LEU . 75.0 m-20 -58.22 -97.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 71.32 110.876 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.947 ' HB ' HG11 ' A' ' 91' ' ' VAL . 30.2 mt -101.72 105.28 40.23 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.617 0.722 . . . . 74.54 111.163 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 21.72 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 72.04 112.328 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.64 ' H ' HG22 ' A' ' 14' ' ' ILE . 1.8 m -124.21 17.11 9.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 74.31 111.128 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.635 HG22 HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -76.2 -160.75 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 74.43 111.164 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -61.25 -109.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 70.24 110.899 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -97.21 11.3 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 75.12 110.893 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.605 HD22 ' HB ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -61.9 -34.65 76.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 65.52 110.915 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -86.34 7.83 23.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 73.52 110.951 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -108.5 -37.36 5.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 71.31 110.871 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.706 ' NE2' HG11 ' A' ' 73' ' ' VAL . 20.4 mm100 -67.46 -45.53 75.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 53.42 110.921 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.625 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -43.91 -30.71 1.75 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 73.42 112.478 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.64 -72.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.754 0.312 . . . . 72.12 111.091 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.6 ptp -63.52 -3.69 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 72.44 110.881 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 24' ' ' GLY . . . -64.76 -26.79 68.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 64.12 111.129 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.454 ' HD1' ' C ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -82.81 8.43 12.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 73.11 110.888 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -89.87 -78.35 0.37 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.139 -0.482 . . . . 63.21 110.832 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.13 -5.04 2.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 62.02 112.508 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' CG ' ' HA ' ' A' ' 27' ' ' ALA . 23.1 mt-10 -62.18 105.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 63.31 110.892 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -161.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 62.11 110.853 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -118.46 116.56 26.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 72.02 110.899 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.663 HG12 ' H ' ' A' ' 35' ' ' THR . 4.2 t -72.21 171.36 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 73.31 111.131 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.663 ' H ' HG12 ' A' ' 34' ' ' VAL . 71.9 p -91.97 -41.51 10.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 60.52 111.148 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 164.52 -62.95 0.24 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.718 -0.753 . . . . 63.45 112.479 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.428 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 54.2 Cg_endo -69.69 156.15 64.3 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.683 2.255 . . . . 75.24 112.377 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -60.82 -27.52 68.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 63.31 110.834 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.27 68.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 73.11 111.086 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.44 -32.81 23.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 64.32 110.841 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.599 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -69.99 -44.07 70.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 72.0 110.865 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.705 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.79 -35.01 72.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 73.14 111.106 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -79.41 -41.4 27.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 73.24 110.923 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.574 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -77.22 -61.71 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 62.23 111.097 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.655 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -53.05 -21.73 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 44.24 111.093 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.756 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -54.27 -71.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 72.43 111.093 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.772 ' HA ' HG12 ' A' ' 50' ' ' VAL . 21.5 t -111.9 -12.79 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.52 111.129 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.574 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.8 tp60 -80.5 -34.11 35.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.14 110.892 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.037 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.97 -5.66 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 62.23 111.119 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.32 -5.69 0.11 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.731 . . . . 65.21 111.112 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.037 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.7 Cg_endo -69.79 -26.57 27.29 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 72.12 112.356 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.37 -57.46 2.62 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.687 -0.768 . . . . 60.12 112.502 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.65 -34.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.723 -0.751 . . . . 55.44 112.496 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.716 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.4 m -149.1 151.47 34.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.777 0.322 . . . . 55.52 111.173 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.841 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.22 79.23 0.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 73.42 111.126 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.764 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -144.78 102.54 0.27 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 71.53 112.505 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.623 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.5 tt0 -95.46 -177.77 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 75.11 110.86 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.677 HG22 HG23 ' A' ' 71' ' ' VAL . 95.3 t -131.03 117.0 35.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 72.13 111.123 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.643 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 1.4 pp20? -95.57 129.91 42.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 71.0 110.911 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 t -100.38 118.29 36.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.479 . . . . 75.04 111.179 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.608 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -134.93 101.7 4.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 63.41 110.896 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.2 p -93.97 127.07 39.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 71.4 111.141 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.0 -154.98 10.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.742 -0.742 . . . . 75.02 112.499 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -87.77 -0.3 56.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.883 0.373 . . . . 71.01 110.877 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.98 -96.95 2.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.76 -0.733 . . . . 31.12 112.464 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.45 -136.07 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 74.45 111.112 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.656 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . . . -113.15 93.46 4.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 52.55 111.087 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.709 ' HB1' ' NE2' ' A' ' 84' ' ' HIS . . . -79.76 95.31 5.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 71.44 111.091 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.535 ' CE1' ' HB1' ' A' ' 67' ' ' ALA . 9.3 m-85 -116.66 115.75 26.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.21 110.897 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 84' ' ' HIS . . . -98.88 109.62 3.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 75.54 112.482 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.677 HG23 HG22 ' A' ' 58' ' ' VAL . 4.6 p -104.19 109.75 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 71.25 111.177 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.814 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -97.74 142.43 29.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 65.11 110.889 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.706 HG11 ' NE2' ' A' ' 23' ' ' GLN . 5.8 p -150.39 120.78 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 71.41 111.083 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.772 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 2.8 m -171.36 -130.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 62.13 111.139 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.499 ' H ' HG22 ' A' ' 74' ' ' THR . 2.1 mtt-85 -107.0 145.73 31.71 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.718 . . . . 72.42 110.83 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.73 13.36 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.653 2.235 . . . . 44.41 112.392 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 75' ' ' ARG . 3.9 m-20 -89.91 25.65 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.872 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.17 -12.52 43.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 74.1 112.488 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.547 ' O ' ' HB ' ' A' ' 74' ' ' THR . 24.7 p -97.45 105.25 17.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 51.14 111.145 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.772 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 1.3 ptp85 -139.57 162.27 35.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 74.12 110.931 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 42.8 t -115.09 100.5 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 65.23 111.177 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.524 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 5.4 tm-20 -84.51 115.91 22.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 73.54 110.877 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -102.53 105.44 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 73.1 111.147 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.709 ' NE2' ' HB1' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -83.76 124.74 31.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.893 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.85 HD21 ' H ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -111.39 111.76 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 74.23 110.946 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.601 ' N ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -126.42 114.98 18.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 74.41 110.907 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.803 ' HA ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -72.94 -0.25 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 73.12 110.844 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -74.04 -19.38 60.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 70.2 110.849 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 90' ' ' ARG . 3.9 p90 169.8 -36.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.11 110.906 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HB3' ' CB ' ' A' ' 93' ' ' ASP . 1.9 mmm180 -117.87 68.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 55.21 110.874 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.947 HG11 ' HB ' ' A' ' 14' ' ' ILE . 1.5 t -61.31 -14.23 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 73.32 111.147 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.635 HD12 HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -124.8 32.14 5.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 63.02 110.926 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 0.8 OUTLIER -65.75 80.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 65.0 110.879 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 10.1 t -79.76 153.51 29.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.42 111.088 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -148.76 129.76 7.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.678 0.751 . . . . 73.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 125.4 12.13 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.723 2.282 . . . . 75.4 112.37 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.539 ' HB2' HH11 ' A' ' 41' ' ' ARG . . . -115.26 108.93 17.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 72.4 111.09 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -103.99 20.79 17.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 73.31 110.854 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.12 -19.22 31.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.74 . . . . 61.34 112.466 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -94.66 -43.47 8.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 60.34 110.85 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.55 28.03 52.99 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 74.2 112.478 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 64.35 112.44 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.432 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 4.9 p-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.806 0.336 . . . . 62.34 110.873 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -67.66 -19.28 65.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.933 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.99 -161.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 73.11 110.905 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.709 HD13 ' HG3' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -117.42 156.92 48.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.6 0.715 . . . . 54.43 111.135 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.561 ' HD2' HG13 ' A' ' 14' ' ' ILE . 53.8 Cg_endo -69.72 45.38 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.676 2.251 . . . . 50.15 112.37 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 m -151.26 17.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 72.11 111.12 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.663 ' HB ' HD22 ' A' ' 20' ' ' LEU . 43.9 p -75.4 -167.41 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 73.31 111.139 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.662 ' HG2' HD23 ' A' ' 92' ' ' LEU . 2.9 mm-40 -116.0 -95.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 73.32 110.921 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -89.69 8.53 31.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 65.13 110.881 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -75.29 -10.97 59.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.25 110.912 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -76.36 -23.63 54.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 74.21 110.882 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -74.1 -34.58 64.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.888 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.528 ' HG3' HG21 ' A' ' 83' ' ' VAL . 19.6 mm-40 -66.37 -49.58 66.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 71.41 110.9 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -44.54 -30.43 2.13 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.71 -0.757 . . . . 72.13 112.496 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.28 -62.54 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.767 0.317 . . . . 70.51 111.052 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 35.1 tpp -67.09 -13.49 61.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 75.32 110.871 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 24' ' ' GLY . . . -67.07 -22.38 65.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 73.12 111.114 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -85.78 10.81 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 71.44 110.862 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.01 -75.67 0.51 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 65.23 110.909 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.08 13.66 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.704 -0.76 . . . . 64.44 112.491 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.581 ' HB3' HG23 ' A' ' 58' ' ' VAL . 20.9 mt-10 -59.59 104.57 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 65.24 110.881 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.93 -164.47 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 74.01 110.9 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.23 121.6 43.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 63.5 110.862 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.78 HG12 ' H ' ' A' ' 35' ' ' THR . 2.6 t -82.6 178.1 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 73.12 111.121 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.78 ' H ' HG12 ' A' ' 34' ' ' VAL . 71.0 p -94.35 -59.94 1.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 75.23 111.215 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.0 -64.6 0.1 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.733 . . . . 71.35 112.5 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 164.85 32.96 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 63.4 112.415 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -70.43 -26.07 63.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 64.15 110.865 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.73 -46.45 77.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 34.1 111.081 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -41.61 25.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.879 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.549 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -59.99 -37.93 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 75.04 110.882 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -62.9 -33.3 75.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 63.34 111.116 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.527 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 1.3 ptt-85 -78.66 -40.12 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 74.52 110.84 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.704 ' HB1' ' OE2' ' A' ' 57' ' ' GLU . . . -77.83 -59.32 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 75.14 111.154 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.748 ' HB2' HD23 ' A' ' 72' ' ' LEU . . . -54.64 -20.81 8.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 71.11 111.123 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -62.0 -81.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 75.12 111.089 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.784 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 58.4 t -108.8 -19.87 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 72.45 111.116 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 44' ' ' ALA . 1.3 tp60 -69.33 -33.15 72.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 65.41 110.919 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.037 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.64 1.88 25.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 72.34 111.07 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.991 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.74 -7.17 0.12 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.637 0.732 . . . . 73.34 111.103 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.037 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.6 Cg_endo -69.75 -26.11 27.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.671 2.247 . . . . 65.31 112.327 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.71 -61.41 2.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.725 -0.75 . . . . 53.02 112.498 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -156.31 -33.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 65.04 112.473 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.724 HG22 ' O ' ' A' ' 74' ' ' THR . 0.3 OUTLIER -148.01 159.78 43.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 42.33 111.181 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.763 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.09 70.98 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 60.11 111.099 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.807 ' HA3' ' HA ' ' A' ' 73' ' ' VAL . . . -149.68 112.72 0.57 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 61.23 112.475 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.772 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.2 tt0 -98.49 -169.73 1.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.846 0.355 . . . . 73.02 110.89 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.761 ' C ' HG23 ' A' ' 34' ' ' VAL . 40.7 t -133.42 120.84 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 53.03 111.142 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.786 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 11.2 tm-20 -90.3 158.47 17.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.875 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 t -137.97 111.22 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 72.23 111.151 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.2 169.6 17.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 72.15 110.907 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.427 ' C ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -117.54 149.78 40.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 73.24 111.125 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.69 -154.29 8.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.758 -0.734 . . . . 74.34 112.53 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -78.44 -23.99 46.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.905 0.383 . . . . 63.14 110.935 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.79 -114.06 2.86 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.713 -0.756 . . . . 64.21 112.538 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -113.98 -78.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 64.42 111.093 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.658 ' O ' ' CG ' ' A' ' 86' ' ' ASP . . . -87.99 139.95 29.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 62.51 111.067 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB3' ' C ' ' A' ' 62' ' ' THR . . . -154.65 73.36 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 65.23 111.107 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.789 ' OH ' HD22 ' A' ' 85' ' ' LEU . 11.5 p90 -132.41 -172.16 2.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 75.04 110.918 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -153.96 129.12 2.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.727 -0.749 . . . . 33.42 112.474 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.417 ' O ' HG23 ' A' ' 83' ' ' VAL . 2.1 p -107.35 120.01 57.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 60.54 111.141 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.92 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -98.18 139.14 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 73.01 110.888 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.807 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 3.0 m -147.34 111.42 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 62.34 111.137 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.803 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.2 m -167.38 -137.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 42.34 111.112 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.631 ' H ' HG22 ' A' ' 74' ' ' THR . 10.7 mtm180 -108.28 153.88 41.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.59 0.709 . . . . 74.51 110.888 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.421 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.72 2.17 3.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.72 2.28 . . . . 65.11 112.372 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -85.94 45.94 1.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 52.02 110.877 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.95 -6.02 7.19 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 62.33 112.491 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.803 ' O ' ' HB ' ' A' ' 74' ' ' THR . 72.2 p -91.83 123.79 35.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 51.31 111.121 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.771 ' NE ' ' HB1' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -146.2 143.89 29.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 72.1 110.889 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.603 HG23 ' HG1' ' A' ' 74' ' ' THR . 87.1 t -110.87 84.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 72.11 111.114 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.623 ' HB2' HD12 ' A' ' 72' ' ' LEU . 2.4 tm-20 -77.52 118.0 19.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 72.21 110.899 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.623 ' O ' ' HA2' ' A' ' 70' ' ' GLY . 2.4 t -95.44 136.28 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 75.42 111.147 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.521 ' C ' HG12 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -87.86 117.42 26.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 75.52 110.878 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.789 HD22 ' OH ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -124.75 111.88 16.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 75.05 110.945 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.878 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.6 t70 -138.75 120.94 15.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 64.31 110.831 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.709 ' HG3' HD13 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -55.81 1.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 72.13 110.854 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.611 ' H ' ' C ' ' A' ' 86' ' ' ASP . 49.8 t0 -65.83 -6.49 12.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 70.33 110.847 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 70.43 19.32 6.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.918 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.68 -0.03 1.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 54.12 110.846 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.878 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 89.2 t -120.94 70.02 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 70.34 111.128 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.662 HD23 ' HG2' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -124.55 14.36 8.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 71.41 110.935 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.407 ' O ' HG12 ' A' ' 83' ' ' VAL . 8.4 m-20 -94.69 -172.6 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 74.1 110.881 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.7 t -116.43 174.34 6.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 71.42 111.147 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 82' ' ' GLU . 2.6 tp10 -141.1 119.28 7.98 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.729 . . . . 74.34 110.908 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 115.64 4.19 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.653 2.236 . . . . 74.34 112.341 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.771 ' HB1' ' NE ' ' A' ' 80' ' ' ARG . . . -116.7 112.8 21.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 71.11 111.144 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -128.93 56.8 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 71.2 110.864 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.28 -17.95 2.91 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.761 -0.733 . . . . 71.24 112.517 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.25 -61.35 1.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 74.5 110.849 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.44 18.1 65.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 52.22 112.519 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 61.31 112.508 -179.906 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.832 0.348 . . . . 73.24 110.888 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -67.01 -42.5 84.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.468 . . . . 74.33 110.935 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.67 ' OD1' ' HB3' ' A' ' 67' ' ' ALA . 13.0 t0 -66.31 -143.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 53.44 110.866 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.829 HG22 ' H ' ' A' ' 16' ' ' THR . 19.7 mm -75.32 114.07 31.98 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.613 0.72 . . . . 75.51 111.087 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 16.64 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.652 2.235 . . . . 71.42 112.366 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.829 ' H ' HG22 ' A' ' 14' ' ' ILE . 2.8 m -134.76 23.52 3.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.182 -0.463 . . . . 71.21 111.096 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.866 HG21 HG22 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -75.66 -145.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 75.42 111.127 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 17' ' ' THR . 59.5 mt-10 -84.65 -104.23 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 70.13 110.877 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.62 6.19 45.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 73.05 110.878 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 85' ' ' LEU . 7.7 mp -65.33 -34.87 79.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 75.31 110.923 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -83.26 3.73 30.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.972 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -105.6 -36.32 7.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 72.52 110.885 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -66.68 -49.01 67.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.477 . . . . 75.23 110.877 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -43.27 -33.09 1.88 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 64.45 112.507 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.37 -56.49 19.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.768 0.318 . . . . 64.43 111.05 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.651 ' SD ' HG11 ' A' ' 73' ' ' VAL . 19.6 ptp -70.18 -7.96 46.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 75.13 110.905 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.687 ' HB1' ' OE1' ' A' ' 31' ' ' GLU . . . -79.62 -17.49 53.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 43.24 111.096 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -82.43 9.74 8.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.32 110.898 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -93.69 -79.21 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 64.13 110.87 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.05 7.88 5.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 44.12 112.484 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.76 ' HG3' HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -61.92 152.4 32.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 73.24 110.891 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.518 ' N ' ' HG2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -116.47 -165.1 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 73.13 110.836 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -114.16 116.77 29.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 71.21 110.876 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 35' ' ' THR . 10.2 t -74.9 167.39 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 65.22 111.131 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.569 ' N ' HG12 ' A' ' 34' ' ' VAL . 65.7 p -94.67 -44.3 7.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 72.32 111.126 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 164.98 -61.77 0.24 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.727 . . . . 50.21 112.489 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.9 Cg_endo -69.71 159.73 52.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 74.21 112.357 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.601 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 1.2 t70 -65.06 -27.18 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 72.32 110.859 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -36.41 73.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 71.24 111.062 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -85.21 -37.34 20.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 71.42 110.863 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.601 ' NE ' ' HA ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -70.01 -45.57 66.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 71.12 110.859 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.669 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -68.74 -36.03 77.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 72.21 111.1 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 40' ' ' ASP . 10.5 ptt180 -79.51 -41.47 27.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.35 110.858 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -74.7 -62.3 1.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 64.24 111.075 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.619 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . . . -53.79 -19.64 4.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 60.44 111.097 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.693 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -55.43 -67.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 71.32 111.112 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.758 ' HA ' HG12 ' A' ' 50' ' ' VAL . 3.5 p -112.7 -18.48 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 74.33 111.159 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 5.4 mt-30 -77.67 -29.14 51.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 51.42 110.938 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.071 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.86 -7.81 15.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 72.32 111.131 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.988 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.46 -0.51 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.606 0.717 . . . . 70.14 111.149 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.071 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.2 Cg_endo -69.77 -29.1 24.37 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.654 2.236 . . . . 75.53 112.304 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.43 -52.27 4.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.736 -0.745 . . . . 60.21 112.479 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.1 -34.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 74.13 112.488 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.746 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -144.4 149.47 36.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 62.12 111.137 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.837 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -73.3 81.17 1.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 60.15 111.085 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.72 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -143.12 99.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 51.01 112.45 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.591 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.6 tt0 -90.66 179.97 5.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 74.02 110.925 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.76 HG23 ' HG3' ' A' ' 31' ' ' GLU . 69.3 t -130.81 121.97 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 51.22 111.153 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.465 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 11.8 tm-20 -93.39 153.56 18.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 75.41 110.91 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.436 ' HA ' ' CD2' ' A' ' 69' ' ' TYR . 1.5 t -132.98 112.34 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 63.3 111.094 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -140.91 162.91 34.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 65.2 110.854 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.92 120.07 34.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 71.33 111.134 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.41 -169.03 32.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 74.12 112.452 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.69 -23.12 49.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 75.04 110.908 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.52 -109.23 0.36 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.756 -0.735 . . . . 74.22 112.515 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.09 -74.43 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 55.32 111.122 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.67 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . . . -111.14 162.01 15.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.12 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -156.24 72.06 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 43.44 111.138 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.644 ' O ' HD12 ' A' ' 85' ' ' LEU . 4.2 m-85 -110.53 163.65 13.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 60.15 110.915 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.09 100.07 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.753 . . . . 74.0 112.479 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.499 HG23 HG22 ' A' ' 58' ' ' VAL . 5.3 p -101.18 119.37 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 72.43 111.151 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.833 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -113.26 144.63 42.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 72.4 110.934 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.651 HG11 ' SD ' ' A' ' 26' ' ' MET . 10.8 t -149.38 123.37 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.43 111.118 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.772 ' OG1' ' HA ' ' A' ' 80' ' ' ARG . 1.9 m -172.2 -135.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 71.53 111.127 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.547 ' H ' HG22 ' A' ' 74' ' ' THR . 27.0 mtm-85 -96.02 145.93 30.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.576 0.703 . . . . 75.34 110.866 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.587 ' CG ' HG21 ' A' ' 50' ' ' VAL . 53.2 Cg_endo -69.75 10.64 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.698 2.265 . . . . 54.13 112.339 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 75' ' ' ARG . 7.6 m-20 -88.59 25.7 1.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.51 110.854 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.24 -9.76 24.98 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.756 -0.735 . . . . 41.12 112.521 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 79' ' ' THR . 2.5 t -97.58 102.54 14.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 65.33 111.154 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.772 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -142.2 172.39 12.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 73.0 110.9 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 27.9 t -119.93 113.03 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 72.31 111.138 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.539 ' HA ' ' HB3' ' A' ' 72' ' ' LEU . 2.1 pt-20 -88.34 122.26 31.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 75.21 110.902 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.582 ' CG1' HD11 ' A' ' 20' ' ' LEU . 2.1 t -100.96 117.01 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 71.33 111.153 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.508 ' O ' ' O ' ' A' ' 91' ' ' VAL . 3.5 t-160 -82.02 116.2 21.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 73.34 110.846 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.768 ' HB3' HD23 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -104.03 98.09 7.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.937 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 1.03 ' H ' ' HA ' ' A' ' 91' ' ' VAL . 3.3 p30 -134.84 119.25 17.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 74.35 110.845 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.436 ' HG3' HD11 ' A' ' 14' ' ' ILE . 1.3 tmt_? -65.35 10.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 75.52 110.868 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.626 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 19.3 t0 -80.03 20.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 74.42 110.86 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.626 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 15.3 m-85 91.5 -17.8 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 73.41 110.908 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.75 38.23 3.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 62.33 110.895 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.03 ' HA ' ' H ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -64.35 -6.8 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 75.54 111.125 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.702 HD22 HG13 ' A' ' 91' ' ' VAL . 3.1 mm? -113.08 28.48 8.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 75.34 110.965 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 84' ' ' HIS . 0.4 OUTLIER -80.04 75.08 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 71.31 110.891 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.8 t -86.02 151.36 23.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 54.33 111.122 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.18 110.45 4.0 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.631 0.729 . . . . 73.1 110.884 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 120.22 7.04 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.686 2.257 . . . . 72.21 112.369 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.577 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . . . -116.81 167.47 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 63.34 111.081 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.49 7.71 7.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 65.22 110.859 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.432 ' HA2' ' CB ' ' A' ' 42' ' ' ALA . . . 86.1 -18.68 30.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 34.04 112.476 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.21 -16.55 22.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.338 . . . . 74.2 110.859 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.53 -24.16 63.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 75.44 112.472 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 51.44 112.53 -179.916 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.1 t0 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.834 0.349 . . . . 64.33 110.843 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -68.34 -43.89 76.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.904 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -60.74 -167.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.874 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.876 HG22 ' H ' ' A' ' 16' ' ' THR . 46.6 mm -76.69 122.07 85.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.62 0.724 . . . . 65.24 111.119 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 9.27 0.6 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.697 2.265 . . . . 74.35 112.3 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.876 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -125.52 36.69 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 62.45 111.133 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.902 HG22 HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -91.6 -166.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 62.45 111.176 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -64.42 -103.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 75.41 110.904 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.77 7.69 45.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.24 110.892 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.849 ' HG ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.02 -14.35 53.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 72.34 110.911 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -94.4 5.66 51.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 64.12 110.946 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -108.44 -43.36 4.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 72.32 110.905 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.664 ' HG3' HG21 ' A' ' 83' ' ' VAL . 4.4 mm100 -64.64 -53.04 53.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 73.34 110.9 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.54 -54.32 7.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.774 -0.726 . . . . 74.42 112.455 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.18 49.0 1.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.762 0.315 . . . . 63.34 111.124 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.2 ptm -66.47 -40.83 89.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 65.34 110.885 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' HB1' ' CE1' ' A' ' 28' ' ' PHE . . . -122.54 -92.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 62.43 111.055 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.483 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -145.12 -35.14 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 71.44 110.884 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.26 30.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.23 110.831 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.98 7.63 65.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 63.31 112.512 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' HB3' HG23 ' A' ' 58' ' ' VAL . 2.0 mm-40 -74.22 161.99 29.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 72.33 110.854 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.66 -166.03 1.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 70.23 110.837 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.13 118.94 22.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 72.11 110.91 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.67 HG22 ' OE2' ' A' ' 57' ' ' GLU . 87.6 t -71.36 155.76 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 54.45 111.119 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.471 ' N ' HG12 ' A' ' 34' ' ' VAL . 16.6 p -107.82 -22.04 12.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 72.15 111.211 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 34' ' ' VAL . . . -153.48 -139.71 2.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 41.32 112.455 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -162.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.722 2.282 . . . . 74.41 112.31 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.35 -27.42 64.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 64.41 110.896 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.81 -39.13 70.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 75.33 111.105 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -82.45 -37.58 25.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 54.41 110.874 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.581 ' HG3' ' HD3' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -68.53 -38.34 80.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.893 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 80' ' ' ARG . . . -63.47 -33.08 74.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 74.33 111.168 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.497 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 2.7 ptt85 -77.61 -40.45 42.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 54.33 110.909 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.772 ' HB3' ' OE2' ' A' ' 57' ' ' GLU . . . -77.9 -57.53 3.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 73.32 111.105 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -52.78 -18.11 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 64.53 111.085 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.504 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -63.75 -78.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.53 111.096 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.739 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 80.5 t -111.91 -20.07 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 63.24 111.134 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 16.6 mt-30 -72.01 -26.62 62.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 73.11 110.94 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.106 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -109.09 -4.99 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 72.03 111.135 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.999 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.78 0.59 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.615 0.722 . . . . 64.41 111.123 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.106 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.0 Cg_endo -69.79 -26.47 27.41 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 55.42 112.33 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.36 -54.58 2.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 72.45 112.47 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.74 -31.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 41.11 112.512 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.737 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -140.51 146.14 37.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 65.2 111.17 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.772 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -74.68 74.87 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 63.51 111.116 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.725 ' HA3' ' HA ' ' A' ' 73' ' ' VAL . . . -153.45 109.34 0.4 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 73.13 112.483 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.867 ' HB3' ' HB2' ' A' ' 49' ' ' ALA . 2.3 pt-20 -100.91 -161.21 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 64.21 110.896 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 31' ' ' GLU . 60.0 t -128.84 142.88 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 72.41 111.096 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 1.0 OUTLIER -108.82 153.5 23.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 74.2 110.886 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.86 105.56 7.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 74.53 111.117 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -136.85 165.76 25.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 73.02 110.878 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -124.28 115.42 21.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 61.32 111.124 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.04 -151.31 14.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.731 -0.747 . . . . 43.43 112.518 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -78.38 -23.43 46.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.364 . . . . 73.25 110.88 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.86 -120.41 0.22 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 71.33 112.489 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -122.65 -76.95 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.332 . . . . 62.31 111.117 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.852 ' HB1' ' CE2' ' A' ' 69' ' ' TYR . . . -102.9 92.53 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 43.41 111.082 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -84.55 72.98 10.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 71.42 111.085 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.852 ' CE2' ' HB1' ' A' ' 67' ' ' ALA . 6.8 m-85 -106.76 165.62 11.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.32 110.904 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -146.89 111.68 0.57 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 50.54 112.518 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 83' ' ' VAL . 7.2 p -102.66 117.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.362 . . . . 73.43 111.111 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.938 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -104.14 145.45 30.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.962 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.725 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 18.1 m -151.23 118.13 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 75.13 111.14 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.794 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.3 m -165.87 -136.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.34 111.153 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.613 ' H ' HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -102.68 149.85 37.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 73.32 110.858 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.53 ' CG ' HG21 ' A' ' 50' ' ' VAL . 53.3 Cg_endo -69.77 6.01 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.63 2.22 . . . . 64.24 112.359 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -85.91 35.34 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 72.33 110.837 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.41 -8.68 52.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 51.01 112.478 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.794 ' O ' ' HB ' ' A' ' 74' ' ' THR . 3.2 t -92.34 125.43 37.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.788 0.328 . . . . 75.41 111.126 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -144.24 144.35 31.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.891 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.807 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 87.9 t -104.81 88.97 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 72.32 111.132 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.44 ' HB3' ' HD3' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -71.53 122.78 21.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 65.5 110.887 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.664 HG21 ' HG3' ' A' ' 23' ' ' GLN . 16.3 t -102.29 139.26 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 52.21 111.161 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 1.043 ' C ' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -89.43 115.14 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 64.04 110.883 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.043 HD13 ' C ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -125.62 105.63 9.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 73.31 110.937 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.798 ' CG ' HG11 ' A' ' 91' ' ' VAL . 4.3 m-20 -135.12 129.06 33.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 73.22 110.879 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -58.48 6.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 64.42 110.893 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.621 ' H ' ' C ' ' A' ' 86' ' ' ASP . 3.8 t0 -64.89 -5.84 6.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 72.32 110.88 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 70.71 13.17 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.12 110.903 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.96 2.73 1.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 72.54 110.909 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.798 HG11 ' CG ' ' A' ' 86' ' ' ASP . 69.0 t -119.13 81.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 52.24 111.069 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.902 HD23 HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -136.27 10.6 3.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 74.45 110.924 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -93.25 167.61 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 64.03 110.839 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.658 ' OG1' HG22 ' A' ' 83' ' ' VAL . 9.8 t -108.17 166.9 10.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 64.2 111.122 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -144.53 119.96 6.03 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.636 0.732 . . . . 73.33 110.885 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 119.02 6.03 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.697 2.264 . . . . 73.24 112.325 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -116.34 163.07 16.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 73.24 111.063 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -125.62 -135.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 74.04 110.816 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.13 -14.94 27.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.667 -0.778 . . . . 74.22 112.484 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -91.5 -48.66 6.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 70.45 110.862 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.76 23.2 9.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 71.31 112.465 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 60.21 112.49 -179.921 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.824 0.345 . . . . 64.43 110.865 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -67.59 -23.16 65.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 63.34 110.893 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.634 ' HA ' ' HB1' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -62.23 -157.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 70.15 110.859 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.557 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 20.7 pt -77.21 160.87 74.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.587 0.708 . . . . 73.13 111.153 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.8 -3.11 11.37 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.64 2.227 . . . . 65.11 112.358 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.0 p -148.2 79.87 1.46 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 70.03 111.153 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.985 HG22 HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -98.98 -166.34 1.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 72.21 111.153 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.56 ' HB2' HD23 ' A' ' 92' ' ' LEU . 10.6 tt0 -80.58 -100.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 64.14 110.881 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.58 10.83 40.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.908 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.773 HD13 ' CG ' ' A' ' 85' ' ' LEU . 3.3 tp -65.01 -21.15 66.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 75.2 110.904 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -83.78 7.12 18.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 54.12 110.918 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -108.8 -42.08 4.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 74.43 110.868 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.51 ' HG3' HG21 ' A' ' 83' ' ' VAL . 5.0 mm100 -66.43 -46.68 75.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 75.33 110.934 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.22 -29.19 1.57 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 70.44 112.513 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.25 -58.63 5.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.78 0.324 . . . . 62.31 111.121 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -9.99 59.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 54.01 110.865 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 31' ' ' GLU . . . -81.92 -17.84 45.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 72.42 111.085 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -79.04 5.07 12.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 71.01 110.915 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -73.63 -82.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 61.21 110.852 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.06 12.62 0.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 75.43 112.504 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -66.38 168.66 8.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 72.54 110.877 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 9.3 m-20 -112.12 -149.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 63.02 110.867 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.96 170.18 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 70.1 110.881 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 58' ' ' VAL . 14.8 t -118.45 169.42 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 72.52 111.105 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.623 ' N ' HG12 ' A' ' 34' ' ' VAL . 63.0 p -90.53 -41.59 11.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 74.34 111.137 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.423 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 162.01 -61.83 0.28 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 74.22 112.515 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 54.0 Cg_endo -69.74 157.01 61.9 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.712 2.275 . . . . 72.5 112.337 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -62.74 -26.84 68.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 73.1 110.889 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.28 -35.83 72.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 71.1 111.15 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.42 -36.13 24.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 65.43 110.893 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 12.8 ptt180 -70.22 -43.64 70.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 74.02 110.894 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.41 -34.41 72.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 71.55 111.143 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -79.92 -41.22 26.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 70.11 110.89 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.597 ' HB1' ' OE2' ' A' ' 57' ' ' GLU . . . -76.85 -62.24 1.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 44.34 111.067 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -52.74 -22.31 5.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 64.23 111.117 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.746 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -53.59 -69.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 63.43 111.154 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.705 ' HA ' HG12 ' A' ' 50' ' ' VAL . 21.3 t -112.17 -11.11 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 63.42 111.093 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.587 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.3 tp60 -83.19 -34.19 26.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 74.32 110.926 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.987 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -106.44 -6.02 18.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 44.14 111.098 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.979 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.93 -9.42 0.14 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.628 0.728 . . . . 64.42 111.152 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.987 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.6 Cg_endo -69.78 -22.73 31.59 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.68 2.253 . . . . 74.14 112.322 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.65 -54.36 2.96 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.794 -0.717 . . . . 73.32 112.488 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.64 -34.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 62.04 112.455 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.672 ' O ' ' O ' ' A' ' 49' ' ' ALA . 2.0 t -148.34 152.81 37.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.757 0.313 . . . . 72.42 111.194 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.777 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.38 75.28 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 71.21 111.077 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.757 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -147.09 104.51 0.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.722 . . . . 43.42 112.503 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.597 ' OE2' ' HB1' ' A' ' 44' ' ' ALA . 1.9 tt0 -97.6 -170.37 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.37 . . . . 64.4 110.888 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.741 ' O ' HG23 ' A' ' 34' ' ' VAL . 2.6 t -129.25 139.17 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 72.01 111.159 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.553 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 10.6 tt0 -106.31 128.16 53.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 64.43 110.923 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 60' ' ' THR . 1.7 t -118.31 95.57 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 51.44 111.077 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.434 ' C ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -137.28 168.87 18.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 61.34 110.85 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.4 m -98.07 -19.34 18.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 65.34 111.144 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 68' ' ' ALA . . . 49.97 -159.2 1.39 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 44.11 112.488 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.36 -25.37 23.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.357 . . . . 71.51 110.892 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.05 -116.89 0.47 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.683 -0.77 . . . . 64.22 112.475 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.814 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -120.11 -65.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 74.01 111.089 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.697 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -111.83 94.39 4.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 74.12 111.144 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.465 ' HB2' ' HA3' ' A' ' 63' ' ' GLY . . . -87.71 84.67 7.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 74.35 111.063 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.708 ' CD1' HD21 ' A' ' 20' ' ' LEU . 6.5 t80 -110.81 123.43 50.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 64.04 110.92 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -126.32 111.89 1.51 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 73.13 112.476 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 83' ' ' VAL . 7.9 p -107.83 121.03 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 61.44 111.11 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.818 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -114.12 134.31 54.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 71.51 110.936 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.662 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.5 m -144.92 122.77 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 72.25 111.143 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.792 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 5.0 m -171.95 -126.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 43.43 111.131 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.508 ' N ' HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -106.33 146.08 32.28 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.665 0.745 . . . . 63.13 110.868 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.505 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.4 Cg_endo -69.74 12.36 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.667 2.245 . . . . 64.51 112.355 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 75' ' ' ARG . 38.2 t70 -91.55 28.82 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 64.55 110.835 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.35 -10.88 26.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 72.42 112.463 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.581 ' O ' ' HB ' ' A' ' 74' ' ' THR . 32.1 p -97.1 104.99 17.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 55.0 111.151 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.792 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.4 OUTLIER -138.17 165.7 25.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 72.3 110.85 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 5.7 m -115.0 98.94 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 64.52 111.166 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 72' ' ' LEU . 8.8 tm-20 -85.69 125.64 33.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.41 110.882 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.643 HG12 ' CD2' ' A' ' 85' ' ' LEU . 2.5 t -92.43 113.04 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 54.01 111.14 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.734 ' O ' HD22 ' A' ' 85' ' ' LEU . 2.4 t-160 -85.79 113.0 21.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.902 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.985 HD12 HG22 ' A' ' 17' ' ' THR . 4.0 mm? -130.36 121.76 26.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 63.45 110.877 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.708 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 4.4 t0 -137.8 134.92 35.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 65.2 110.892 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.814 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -59.35 3.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.44 110.827 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.564 ' H ' ' C ' ' A' ' 86' ' ' ASP . 8.2 t0 -65.7 -3.53 4.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 73.4 110.834 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 68.5 10.73 8.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 71.21 110.899 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.04 -1.29 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 74.2 110.871 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.708 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 58.3 t -117.6 90.99 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 74.52 111.123 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.911 ' HA ' HD13 ' A' ' 85' ' ' LEU . 5.5 mp -146.33 14.6 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 72.31 110.886 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -113.43 140.96 47.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 64.34 110.869 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.64 ' HB ' HG13 ' A' ' 83' ' ' VAL . 3.3 t -87.91 151.41 22.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 64.13 111.194 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -123.83 149.8 60.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 71.41 110.904 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 143.12 49.77 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.705 2.27 . . . . 72.41 112.325 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -118.81 110.2 16.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 64.14 111.067 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -98.46 4.79 48.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.818 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.61 -20.91 8.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.774 -0.727 . . . . 44.21 112.487 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.3 -16.03 20.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.825 0.345 . . . . 64.32 110.865 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.99 -14.0 54.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.796 -0.716 . . . . 70.41 112.488 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 74.14 112.479 -179.908 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.711 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 13.9 t70 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.83 0.348 . . . . 70.3 110.872 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.696 ' HB2' ' HB1' ' A' ' 68' ' ' ALA . 92.7 m-85 -67.52 -36.53 81.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 73.32 110.926 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.59 -164.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 71.41 110.831 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.863 HG22 ' H ' ' A' ' 16' ' ' THR . 24.4 mm -77.78 129.84 75.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.651 0.739 . . . . 71.31 111.13 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 18.0 0.2 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.645 2.23 . . . . 73.24 112.35 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.863 ' H ' HG22 ' A' ' 14' ' ' ILE . 3.1 m -138.73 27.13 2.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 51.14 111.172 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.919 HG22 ' CD2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -74.36 -167.5 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 74.11 111.132 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -63.94 -103.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.887 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.75 8.56 44.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 70.21 110.882 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.013 ' HG ' HD22 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.71 -13.24 53.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.2 110.911 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -95.34 7.74 45.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.454 . . . . 73.11 110.91 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -106.98 -40.08 5.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 61.24 110.855 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -66.24 -47.63 73.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 71.14 110.914 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -43.55 -31.9 1.81 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 65.23 112.485 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.33 -64.51 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 61.13 111.075 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.539 ' CE ' HG21 ' A' ' 73' ' ' VAL . 3.5 ppp? -70.45 -7.94 47.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 54.43 110.921 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.441 ' HA ' ' HB2' ' A' ' 31' ' ' GLU . . . -76.91 -19.98 56.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 60.24 111.087 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -77.97 5.79 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 70.11 110.864 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -87.72 -81.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 72.52 110.85 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.92 14.52 5.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 51.05 112.499 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HG2' HG23 ' A' ' 58' ' ' VAL . 1.1 tt0 -54.82 103.4 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.902 0.382 . . . . 74.31 110.926 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.406 ' N ' ' HG2' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -76.95 -170.2 1.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 70.11 110.857 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.18 125.46 52.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 53.44 110.863 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.807 HG23 ' OE1' ' A' ' 57' ' ' GLU . 1.9 t -71.03 161.92 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 71.34 111.101 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' CG1' ' A' ' 34' ' ' VAL . 1.7 p -84.93 -45.75 11.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 63.2 111.125 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.43 -81.17 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.724 -0.751 . . . . 73.13 112.476 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 169.48 18.78 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.701 2.267 . . . . 33.21 112.337 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -68.17 -26.39 65.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 63.31 110.872 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 43' ' ' ARG . . . -52.53 -28.4 20.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 55.23 111.098 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -76.81 -30.79 56.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 74.42 110.905 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.482 ' HG3' ' HD3' ' A' ' 80' ' ' ARG . 4.3 ptt180 -56.7 -38.96 73.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 72.1 110.892 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.949 ' HB2' ' HA2' ' A' ' 99' ' ' GLY . . . -70.12 -30.44 67.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 62.45 111.086 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 39' ' ' ALA . 10.5 mtt-85 -74.34 -45.16 48.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 72.53 110.875 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -78.25 -57.52 3.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 74.22 111.118 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 1.041 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -54.02 -17.36 2.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 64.13 111.106 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -62.69 -68.05 0.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 63.34 111.106 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.682 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 26.0 t -122.21 -14.16 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 51.12 111.14 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.587 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 27.9 mt-30 -79.64 -41.64 26.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 73.11 110.92 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.041 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . . . -104.43 0.05 28.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 53.23 111.074 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.976 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -92.29 -13.19 0.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 74.32 111.136 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.976 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 53.5 Cg_endo -69.77 -32.24 18.92 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.654 2.236 . . . . 73.13 112.362 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.16 -51.46 38.5 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.785 -0.722 . . . . 74.54 112.51 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.58 -33.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 25.23 112.496 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 74' ' ' THR . 0.2 OUTLIER -150.24 158.63 44.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 52.32 111.152 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.709 ' CA ' HG23 ' A' ' 50' ' ' VAL . . . -70.99 77.78 0.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 51.22 111.102 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.723 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -144.94 106.9 0.41 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.733 . . . . 71.43 112.46 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.807 ' OE1' HG23 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -101.33 -159.24 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 71.21 110.884 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -126.62 121.3 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 71.35 111.159 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.754 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -94.69 171.47 8.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 64.31 110.87 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -113.88 128.86 56.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 63.41 111.12 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.553 ' H ' ' HA ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -142.72 91.29 2.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 75.5 110.903 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.0 p -94.81 149.4 21.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 73.43 111.144 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.536 ' N ' ' HB3' ' A' ' 67' ' ' ALA . . . -134.18 179.46 17.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.778 -0.725 . . . . 73.23 112.509 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -76.41 -24.14 54.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.899 0.381 . . . . 75.02 110.884 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.59 -117.39 2.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 65.32 112.468 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.748 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -116.45 38.93 3.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 72.33 111.095 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.536 ' HB3' ' N ' ' A' ' 63' ' ' GLY . . . -59.06 -171.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 52.42 111.083 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.696 ' HB1' ' HB2' ' A' ' 12' ' ' TYR . . . -156.29 -95.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 71.22 111.109 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.754 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -162.29 -163.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 75.44 110.888 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -138.99 156.64 24.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.749 -0.739 . . . . 30.45 112.505 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.631 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.4 p -125.61 121.1 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 73.04 111.124 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.783 HD21 ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -112.14 142.91 44.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 51.42 110.94 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.723 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 11.0 p -157.88 125.84 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 63.53 111.139 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 54' ' ' THR . 5.6 m -168.6 -125.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 72.11 111.14 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.504 ' N ' HG22 ' A' ' 74' ' ' THR . 3.8 ttm-85 -107.82 139.32 20.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 75.22 110.876 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 13.89 0.27 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.679 2.252 . . . . 60.12 112.369 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 75' ' ' ARG . 1.3 m-20 -94.1 23.79 4.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 72.54 110.877 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.51 -16.3 61.28 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.718 -0.753 . . . . 53.11 112.48 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.696 ' O ' ' HB ' ' A' ' 74' ' ' THR . 6.0 t -94.0 122.55 36.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.763 0.316 . . . . 64.02 111.105 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.77 ' HB3' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -141.65 161.52 37.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 72.22 110.852 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 94.1 t -118.05 85.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 61.42 111.103 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.447 ' HA ' ' CB ' ' A' ' 72' ' ' LEU . 6.9 tm-20 -77.27 121.86 24.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.841 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.677 HG13 ' HB ' ' A' ' 94' ' ' THR . 3.3 t -100.33 137.4 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 73.22 111.124 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.838 ' C ' HD23 ' A' ' 85' ' ' LEU . 6.5 m-70 -92.56 118.23 30.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 63.4 110.871 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.013 HD22 ' HG ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -122.48 101.36 7.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.21 110.892 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.784 ' OD2' HG11 ' A' ' 91' ' ' VAL . 34.4 m-20 -140.78 131.74 26.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 75.11 110.858 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.748 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -61.36 11.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 72.24 110.854 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.643 ' H ' ' C ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -65.37 -5.93 8.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.22 110.856 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 74.27 6.88 4.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 55.43 110.865 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -141.54 7.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.34 110.894 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.784 HG11 ' OD2' ' A' ' 86' ' ' ASP . 40.9 t -118.31 69.52 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 73.43 111.137 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.919 ' CD2' HG22 ' A' ' 17' ' ' THR . 0.2 OUTLIER -129.91 10.72 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 50.53 110.953 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.23 -179.95 3.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 73.12 110.791 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.677 ' HB ' HG13 ' A' ' 83' ' ' VAL . 13.4 t -126.42 171.18 11.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 64.13 111.138 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -144.84 159.64 49.68 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.663 0.744 . . . . 72.52 110.86 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 107.01 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.648 2.232 . . . . 61.52 112.341 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.465 ' HB3' ' C ' ' A' ' 80' ' ' ARG . . . -75.69 112.15 11.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 73.24 111.099 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -85.68 6.36 27.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 64.2 110.92 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.949 ' HA2' ' HB2' ' A' ' 42' ' ' ALA . . . 79.56 -20.93 4.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.744 -0.741 . . . . 65.31 112.502 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.36 -33.06 10.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 74.11 110.873 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.07 24.85 54.0 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 61.11 112.491 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.689 -0.767 . . . . 74.14 112.457 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.754 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 15.9 t70 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.78 0.324 . . . . 65.11 110.806 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -65.41 -56.38 12.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 62.0 110.852 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.482 ' CG ' ' HB3' ' A' ' 67' ' ' ALA . 25.5 t0 -65.36 -115.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 61.12 110.862 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.73 HG22 ' H ' ' A' ' 16' ' ' THR . 12.6 mm -100.13 108.64 53.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.586 0.708 . . . . 75.12 111.103 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 23.1 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.714 2.276 . . . . 74.35 112.322 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.73 ' H ' HG22 ' A' ' 14' ' ' ILE . 3.1 m -131.17 20.22 4.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.23 111.163 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.988 HG22 HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -76.13 -165.99 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 62.34 111.113 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.698 ' HG3' HD22 ' A' ' 92' ' ' LEU . 21.1 mt-10 -61.3 -105.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 71.52 110.873 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.8 8.23 44.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 61.04 110.898 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.996 ' HG ' HD22 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -65.29 -15.81 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 65.33 110.88 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -97.02 4.39 51.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 62.33 110.91 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -103.65 -42.21 5.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 74.04 110.868 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.42 ' HB2' HG11 ' A' ' 71' ' ' VAL . 6.5 mm100 -66.35 -51.39 57.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 75.0 110.961 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.3 -27.86 4.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 50.02 112.5 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.35 49.23 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 43.4 111.122 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.468 ' SD ' HG11 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -70.36 -42.77 71.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 74.04 110.905 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.456 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -119.42 -93.28 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 52.22 111.1 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -150.39 -37.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.41 110.927 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.38 -0.05 1.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 74.22 110.841 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.62 -20.33 7.55 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.757 -0.735 . . . . 73.34 112.508 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.474 ' CG ' HG21 ' A' ' 58' ' ' VAL . 1.4 tm-20 -83.9 103.25 13.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 64.41 110.91 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.68 179.08 4.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.491 . . . . 65.44 110.846 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.3 119.14 37.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 64.4 110.911 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.676 HG23 ' C ' ' A' ' 58' ' ' VAL . 8.4 t -84.2 -125.61 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 60.31 111.09 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.565 ' N ' HG12 ' A' ' 34' ' ' VAL . 71.4 p -139.52 -71.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 70.54 111.129 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.22 -65.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.755 -0.736 . . . . 75.25 112.51 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 166.63 26.9 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.649 2.233 . . . . 74.31 112.325 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -72.21 -28.94 63.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 71.53 110.846 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.0 -32.9 62.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 73.14 111.095 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.95 -31.57 31.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 64.33 110.882 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -69.34 -43.13 74.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 71.23 110.872 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.711 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.95 -33.28 70.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 71.43 111.129 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -81.01 -40.97 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 62.31 110.883 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.562 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -75.55 -63.06 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 53.43 111.12 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -53.54 -21.26 6.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 44.1 111.119 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.721 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -52.98 -68.92 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 63.14 111.062 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.767 ' HA ' HG12 ' A' ' 50' ' ' VAL . 19.0 t -111.75 -13.31 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 72.5 111.107 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 44' ' ' ALA . 1.7 tp60 -80.53 -32.92 36.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 71.43 110.928 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.046 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.36 -6.68 17.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 71.33 111.153 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.987 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -95.08 -4.33 0.11 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.58 0.705 . . . . 71.14 111.094 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.046 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.1 Cg_endo -69.75 -24.46 29.69 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.731 2.288 . . . . 60.25 112.31 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.62 -56.33 2.26 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.718 -0.753 . . . . 72.13 112.487 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.1 -36.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.744 . . . . 64.54 112.473 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.746 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.7 t -146.42 150.44 35.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.781 0.324 . . . . 25.54 111.185 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.822 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -73.12 80.3 1.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 72.35 111.095 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.733 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -146.86 99.51 0.21 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 62.44 112.491 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.54 ' OE1' HG22 ' A' ' 34' ' ' VAL . 3.5 tt0 -99.79 -167.05 1.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 75.11 110.892 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.676 ' C ' HG23 ' A' ' 34' ' ' VAL . 11.6 t -137.78 117.62 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 73.24 111.165 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.514 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 1.9 pp20? -96.08 155.16 16.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 72.23 110.857 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.487 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.5 t -127.65 118.7 24.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 74.54 111.178 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.54 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -132.62 170.88 14.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.42 110.916 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.75 114.48 22.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 61.02 111.128 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.43 -147.47 12.76 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 63.21 112.467 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -87.58 -1.63 58.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 73.24 110.904 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.02 -118.12 4.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 71.15 112.468 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -119.13 -78.27 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.775 0.321 . . . . 64.14 111.08 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -107.01 92.97 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 50.13 111.081 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -80.84 59.34 3.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 72.45 111.093 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.754 ' HH ' ' N ' ' A' ' 11' ' ' ASP . 2.6 p90 -110.74 132.11 54.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.35 110.935 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -118.71 150.37 18.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.777 -0.725 . . . . 73.11 112.494 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.847 HG12 HD11 ' A' ' 85' ' ' LEU . 2.5 p -117.5 119.78 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.368 . . . . 72.04 111.12 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.777 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -107.14 138.33 43.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 72.4 110.925 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.703 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 5.1 t -148.98 122.03 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 63.23 111.147 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.787 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 3.6 m -171.52 -128.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 70.33 111.121 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.502 ' H ' HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -104.28 142.61 24.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.662 0.744 . . . . 73.14 110.844 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.599 ' HG3' HG21 ' A' ' 50' ' ' VAL . 53.9 Cg_endo -69.76 14.19 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.695 2.264 . . . . 74.22 112.311 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 75' ' ' ARG . 7.2 m-20 -93.01 27.01 2.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.267 -0.424 . . . . 75.03 110.864 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.85 -12.89 51.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.792 -0.718 . . . . 70.23 112.51 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.593 ' O ' ' HB ' ' A' ' 74' ' ' THR . 33.6 p -97.18 106.64 19.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 72.24 111.141 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.787 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.7 OUTLIER -137.79 164.68 28.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 73.22 110.858 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 10.3 m -116.92 96.97 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 74.12 111.102 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.578 ' HG3' HD12 ' A' ' 72' ' ' LEU . 1.3 tm-20 -80.93 121.97 26.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 73.01 110.898 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.66 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.4 t -93.9 137.33 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 55.04 111.133 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.844 ' C ' HD23 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -84.85 112.81 20.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 71.34 110.849 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.996 HD22 ' HG ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -121.21 109.53 15.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 71.22 110.911 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.666 ' HB2' HG11 ' A' ' 91' ' ' VAL . 2.2 t0 -140.28 131.35 26.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 62.34 110.864 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.456 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -60.8 7.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 62.34 110.865 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.609 ' H ' ' C ' ' A' ' 86' ' ' ASP . 19.8 t0 -66.44 -4.6 8.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 60.31 110.877 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 70.02 11.43 7.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 74.24 110.916 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.79 5.63 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 71.52 110.898 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 86' ' ' ASP . 49.7 t -117.43 74.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.5 111.137 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.988 HD23 HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -133.59 11.7 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 64.41 110.931 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -92.95 163.49 13.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 71.42 110.905 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 8.3 t -98.9 161.76 13.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 70.52 111.171 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -147.6 127.52 6.65 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 75.55 110.904 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 123.5 10.16 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.73 2.287 . . . . 54.51 112.306 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.59 161.66 18.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.11 111.135 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -128.8 -146.24 0.32 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.429 . . . . 45.23 110.887 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.62 -15.85 30.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.772 -0.728 . . . . 73.31 112.434 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.59 -36.35 13.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.876 0.369 . . . . 74.11 110.852 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.62 54.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 34.41 112.499 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.736 . . . . 62.01 112.485 -179.93 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.779 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.825 0.345 . . . . 72.21 110.864 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.537 ' HE2' HG11 ' A' ' 58' ' ' VAL . 65.2 m-85 -75.09 -33.61 61.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 71.41 110.93 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.678 ' CG ' HD23 ' A' ' 20' ' ' LEU . 2.5 p-10 -64.53 -152.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 72.32 110.851 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.731 HD12 ' O ' ' A' ' 16' ' ' THR . 0.5 OUTLIER -78.17 163.37 62.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.652 0.739 . . . . 72.42 111.153 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -9.32 25.83 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.702 2.268 . . . . 55.32 112.383 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.731 ' O ' HD12 ' A' ' 14' ' ' ILE . 2.6 p -154.2 130.15 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 71.41 111.144 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.084 HG22 HD23 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -149.76 -158.78 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 54.41 111.185 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -70.44 -101.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 64.25 110.892 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -91.17 11.21 24.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 64.11 110.881 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.957 HD21 ' HB3' ' A' ' 85' ' ' LEU . 10.7 mp -65.35 -30.08 70.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 73.42 110.956 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -80.31 4.72 16.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 74.15 110.962 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.12 -53.8 2.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 75.14 110.917 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.588 ' HB2' HG11 ' A' ' 71' ' ' VAL . 68.9 mm-40 -66.95 -46.55 74.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 74.15 110.935 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 27' ' ' ALA . . . -46.94 -25.37 2.37 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.75 -0.738 . . . . 62.41 112.498 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.2 -80.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 62.44 111.08 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.9 ptm -66.85 -0.49 3.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 62.23 110.873 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.695 ' HB1' ' OE2' ' A' ' 31' ' ' GLU . . . -77.25 -32.93 56.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 73.52 111.071 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -82.95 10.05 8.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 71.24 110.856 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -68.6 -72.71 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 73.23 110.911 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.04 11.74 0.59 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 75.01 112.519 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.695 ' OE2' ' HB1' ' A' ' 27' ' ' ALA . 1.7 pt-20 -67.3 171.24 6.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 74.24 110.884 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -127.93 -153.79 0.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.24 110.844 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -109.85 163.61 13.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.835 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.661 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 1.0 OUTLIER -91.73 162.35 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 33.43 111.15 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.577 ' N ' ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -104.5 -32.73 8.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 74.04 111.163 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.475 ' H ' HG13 ' A' ' 34' ' ' VAL . . . -157.62 -139.09 2.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 73.32 112.498 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -160.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.669 2.246 . . . . 71.1 112.321 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -55.07 -34.21 63.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 70.02 110.896 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.86 -37.87 66.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 73.43 111.077 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -84.34 -42.05 16.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.888 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 7.1 ptt180 -61.9 -37.63 85.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 75.44 110.838 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.679 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -65.8 -34.76 78.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 53.24 111.093 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -78.08 -39.26 42.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 65.43 110.897 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -77.12 -58.55 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 55.25 111.084 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.738 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -57.2 -17.73 12.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 72.22 111.129 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -62.63 -79.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 53.2 111.118 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.758 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 61.1 t -110.91 -23.08 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 74.34 111.125 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.637 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 3.5 mt-30 -68.55 -27.7 66.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 65.42 110.883 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.082 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.77 -0.82 19.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 72.24 111.073 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.005 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.37 -1.1 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.62 0.724 . . . . 74.11 111.103 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.082 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.9 Cg_endo -69.76 -31.22 20.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.702 2.268 . . . . 61.54 112.33 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.98 -54.23 5.39 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 74.13 112.493 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.2 -33.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 35.52 112.525 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.62 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.4 m -145.08 152.65 40.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 62.21 111.152 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.849 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.57 76.07 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 72.32 111.11 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.708 ' CA ' ' HA ' ' A' ' 73' ' ' VAL . . . -146.59 104.94 0.31 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 73.51 112.515 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.633 ' HG3' ' HB2' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -98.56 -153.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 73.11 110.858 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.68 HG13 ' CE1' ' A' ' 69' ' ' TYR . 54.9 t -131.68 133.78 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 73.23 111.127 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.661 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -100.99 122.91 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 72.23 110.903 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.9 t -108.03 111.39 23.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 63.35 111.174 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -137.48 159.94 40.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 75.04 110.887 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 p -124.24 117.43 24.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 73.12 111.079 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.98 -147.87 11.85 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.778 -0.725 . . . . 74.44 112.497 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.33 -1.64 57.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.391 . . . . 74.42 110.894 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.51 -120.62 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.721 -0.752 . . . . 74.53 112.472 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -122.95 -75.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 61.22 111.057 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.642 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -104.67 85.85 2.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 52.15 111.038 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -82.49 59.26 4.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 61.52 111.072 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.779 ' HH ' ' N ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -116.98 158.58 23.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 65.14 110.886 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -141.41 158.96 26.66 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.708 -0.758 . . . . 62.22 112.497 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.588 HG11 ' HB2' ' A' ' 23' ' ' GLN . 8.7 p -116.39 120.46 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 71.51 111.122 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.775 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -111.57 133.33 53.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 72.22 110.911 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.735 ' O ' HG22 ' A' ' 81' ' ' VAL . 7.3 p -148.43 124.13 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.54 111.119 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.811 ' HB ' ' O ' ' A' ' 79' ' ' THR . 3.8 m -167.77 -129.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.178 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.533 ' H ' HG22 ' A' ' 74' ' ' THR . 0.3 OUTLIER -101.84 146.77 32.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.603 0.716 . . . . 74.15 110.895 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.409 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.2 Cg_endo -69.72 7.68 0.93 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.699 2.266 . . . . 63.14 112.371 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -91.28 41.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 74.12 110.891 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.19 -4.94 16.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 65.3 112.527 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.811 ' O ' ' HB ' ' A' ' 74' ' ' THR . 43.9 p -96.07 117.02 29.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 75.41 111.161 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.743 ' O ' ' HB3' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -144.75 158.1 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 73.44 110.867 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 73' ' ' VAL . 31.4 m -118.13 92.13 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 62.2 111.126 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.726 ' HB2' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -81.12 123.43 28.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 73.14 110.888 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.674 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 3.4 t -94.93 131.75 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.499 . . . . 53.45 111.134 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -83.65 117.19 23.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 63.45 110.865 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.957 ' HB3' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -135.86 121.28 19.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 63.3 110.918 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.689 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 6.3 t0 -140.49 132.5 27.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 74.22 110.871 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.713 ' HG3' HG23 ' A' ' 14' ' ' ILE . 2.7 tmt_? -60.36 4.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.43 110.847 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.557 ' H ' ' C ' ' A' ' 86' ' ' ASP . 22.5 t0 -67.94 -3.92 11.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 71.04 110.879 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 69.31 14.85 8.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 75.5 110.865 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.05 -1.06 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 75.21 110.853 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.689 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 92.7 t -117.91 91.39 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.43 111.117 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.084 HD23 HG22 ' A' ' 17' ' ' THR . 0.2 OUTLIER -140.47 8.25 2.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.32 110.899 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.7 162.27 14.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 74.33 110.864 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 14.2 t -93.41 172.45 8.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 74.34 111.126 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' GLU . 3.4 tt0 -145.96 123.71 6.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.688 0.756 . . . . 65.51 110.852 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 129.48 17.58 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.249 . . . . 75.34 112.345 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -117.86 117.17 28.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 63.45 111.126 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 100' ' ' ASP . 3.4 m-20 -121.67 49.13 1.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 74.1 110.855 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.429 ' HA2' HH12 ' A' ' 80' ' ' ARG . . . 71.68 -16.92 1.28 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 72.33 112.485 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 98' ' ' ASP . 3.0 t0 -95.32 -62.14 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.894 0.378 . . . . 72.02 110.857 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.36 26.02 60.25 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.759 -0.734 . . . . 73.15 112.472 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 44.4 112.48 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.686 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.817 0.341 . . . . 72.35 110.884 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -67.5 -54.34 20.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 75.04 110.938 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.695 ' OD1' ' HB3' ' A' ' 67' ' ' ALA . 9.0 t0 -64.19 -154.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 74.2 110.859 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.822 HG22 ' H ' ' A' ' 16' ' ' THR . 35.4 mm -92.24 123.68 61.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.612 0.72 . . . . 60.3 111.172 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 10.45 0.49 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.693 2.262 . . . . 72.23 112.324 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.822 ' H ' HG22 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -124.24 43.74 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 71.44 111.184 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.007 HG22 HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -97.89 -162.99 1.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 73.2 111.16 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.714 ' HG3' HD22 ' A' ' 92' ' ' LEU . 12.1 mt-10 -60.83 -102.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 71.13 110.936 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -96.85 7.16 47.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 75.11 110.887 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.992 ' HG ' HD22 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -66.49 -16.77 64.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 75.5 110.898 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -94.25 3.64 54.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 64.32 110.876 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -97.21 -53.36 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 75.14 110.907 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -64.73 -35.51 81.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 75.01 110.899 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -46.13 -30.06 3.79 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.732 -0.747 . . . . 71.3 112.486 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 28' ' ' PHE . . . -57.29 -57.36 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.826 0.346 . . . . 73.23 111.131 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.678 ' SD ' HG11 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -68.21 -5.06 16.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.52 110.882 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 31' ' ' GLU . . . -113.06 38.83 2.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 70.53 111.107 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -110.41 14.7 22.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 63.11 110.9 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.28 -78.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 75.3 110.866 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.73 8.57 41.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.738 . . . . 64.43 112.478 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.617 ' OE1' HG21 ' A' ' 58' ' ' VAL . 10.1 tt0 -64.61 103.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.875 0.369 . . . . 73.45 110.901 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' ' CG ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -102.05 -172.53 2.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 70.42 110.886 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -115.78 120.85 40.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 72.01 110.87 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.716 HG22 ' OE1' ' A' ' 57' ' ' GLU . 46.1 t -71.93 159.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 61.44 111.13 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.526 ' N ' HG12 ' A' ' 34' ' ' VAL . 65.8 p -99.59 -30.38 12.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 64.1 111.173 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.604 ' H ' HG12 ' A' ' 34' ' ' VAL . . . -150.42 -144.06 3.85 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 64.14 112.501 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -158.94 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.711 2.274 . . . . 75.12 112.4 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' HA ' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -56.69 -29.33 62.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 74.31 110.834 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.2 -43.57 70.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 63.12 111.085 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -85.6 -41.91 14.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 62.31 110.876 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HG3' ' CD ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -60.45 -36.16 77.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 60.11 110.86 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -65.25 -32.24 73.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 64.43 111.125 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.516 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 4.0 ptt180 -74.78 -40.97 60.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 70.05 110.898 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.583 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . . . -81.06 -57.84 3.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 72.35 111.142 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.716 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -52.12 -20.97 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 61.01 111.077 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.643 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -62.91 -76.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 64.1 111.11 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.703 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.3 t -111.4 -17.01 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 71.33 111.124 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.523 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -73.94 -32.0 63.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 71.51 110.908 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.041 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.39 -1.23 21.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 44.33 111.099 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.995 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.92 -2.7 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.656 0.741 . . . . 72.51 111.156 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.041 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.8 Cg_endo -69.78 -29.93 22.99 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.641 2.228 . . . . 71.33 112.345 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.52 -51.46 6.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.752 -0.737 . . . . 23.14 112.506 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.08 -33.55 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.748 -0.739 . . . . 70.02 112.518 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.671 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -145.74 151.1 37.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.79 0.328 . . . . 53.11 111.157 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.835 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.63 78.36 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.23 111.062 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.693 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -143.8 99.91 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 55.33 112.539 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.716 ' OE1' HG22 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -92.86 -164.72 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 74.54 110.928 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.617 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.1 t -143.49 124.76 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 63.33 111.106 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.615 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 9.6 pt-20 -95.18 155.83 16.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 70.05 110.837 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.506 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.3 t -131.58 117.18 18.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.097 -0.501 . . . . 74.14 111.122 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -137.85 158.97 43.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 71.43 110.877 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -22.61 19.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 72.31 111.102 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 42.99 -157.46 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.739 -0.743 . . . . 65.04 112.516 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -91.81 -23.61 19.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.913 0.387 . . . . 65.05 110.871 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.54 -119.1 1.13 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.767 -0.73 . . . . 73.12 112.471 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.61 -81.63 0.62 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.752 0.311 . . . . 44.41 111.113 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.695 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . . . -93.03 79.57 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 55.22 111.147 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.49 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -81.74 62.57 5.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 53.25 111.102 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.965 ' CZ ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -114.61 155.64 26.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 73.13 110.937 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.503 ' HA2' ' HG ' ' A' ' 85' ' ' LEU . . . -138.49 157.61 24.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 73.14 112.449 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.78 HG12 HD11 ' A' ' 85' ' ' LEU . 2.5 p -126.62 117.97 49.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 73.15 111.16 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.804 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -105.99 137.01 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 71.22 110.917 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.682 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 7.1 p -147.23 124.14 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 51.52 111.146 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.799 ' HB ' ' O ' ' A' ' 79' ' ' THR . 4.4 m -168.19 -129.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 52.51 111.116 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.695 ' HG3' HG22 ' A' ' 74' ' ' THR . 0.6 OUTLIER -104.65 148.8 36.64 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.562 0.696 . . . . 72.24 110.838 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 6.76 1.2 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.7 2.267 . . . . 64.33 112.31 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -92.67 43.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 63.22 110.862 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.51 -5.26 23.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 74.43 112.477 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.799 ' O ' ' HB ' ' A' ' 74' ' ' THR . 13.9 p -93.42 123.67 36.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 55.11 111.147 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.687 ' NE ' ' HB1' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -146.69 156.69 43.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 73.14 110.826 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.804 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 97.0 t -115.75 83.55 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 72.34 111.154 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.56 ' CA ' ' HB3' ' A' ' 72' ' ' LEU . 3.7 tm-20 -75.93 122.0 23.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 75.44 110.894 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 94' ' ' THR . 4.8 t -105.49 138.55 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 63.03 111.069 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.926 ' C ' HD23 ' A' ' 85' ' ' LEU . 40.8 m-70 -83.69 115.05 22.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 74.1 110.843 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.992 HD22 ' HG ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -125.25 105.98 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 73.23 110.905 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.66 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 5.3 t0 -139.08 131.63 28.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.13 110.887 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.98 6.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 72.42 110.848 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' A' ' 86' ' ' ASP . 37.5 t0 -67.21 -3.28 7.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 74.11 110.904 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 67.9 12.42 8.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 74.14 110.876 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -139.01 3.53 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 75.04 110.86 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.66 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 60.8 t -117.74 73.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 74.1 111.119 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.007 HD23 HG22 ' A' ' 17' ' ' THR . 0.0 OUTLIER -132.48 12.61 4.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 71.23 110.895 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.53 164.52 12.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 75.52 110.873 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 9.9 t -104.08 169.45 8.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 74.33 111.16 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HB2' ' NE2' ' A' ' 84' ' ' HIS . 11.6 tp10 -146.95 124.74 5.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.652 0.739 . . . . 74.33 110.873 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 124.85 11.5 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.727 2.285 . . . . 74.2 112.363 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.687 ' HB1' ' NE ' ' A' ' 80' ' ' ARG . . . -115.49 117.4 30.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 63.13 111.086 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -124.33 46.0 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.51 110.843 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.404 ' HA2' HH12 ' A' ' 80' ' ' ARG . . . 77.28 -17.83 4.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 41.02 112.445 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.46 -56.6 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 72.31 110.828 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.48 23.16 44.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.721 . . . . 54.31 112.484 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 40.52 112.504 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 t0 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.786 0.327 . . . . 71.42 110.838 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -67.84 -21.47 65.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 72.34 110.915 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.58 ' HB2' HD13 ' A' ' 85' ' ' LEU . 12.4 t70 -58.63 -87.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 74.04 110.867 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 1.078 HD11 HD21 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -114.79 165.32 14.21 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.693 0.759 . . . . 61.03 111.13 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.507 ' HD2' HG22 ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.79 -1.12 7.95 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.679 2.252 . . . . 70.11 112.343 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.42 71.13 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 73.01 111.154 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.726 HG21 HD22 ' A' ' 20' ' ' LEU . 70.7 p -76.38 -166.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 71.15 111.134 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . 2.9 mm-40 -130.56 -93.12 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 74.25 110.892 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -69.22 5.88 1.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 74.54 110.849 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.915 HD21 ' CB ' ' A' ' 85' ' ' LEU . 10.8 mp -87.0 -34.07 19.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 75.44 110.931 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -64.89 -16.66 63.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 71.32 110.897 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.75 -63.18 1.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 72.35 110.87 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -65.6 -46.93 77.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 73.33 110.937 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.78 -53.15 8.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 53.12 112.487 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.64 51.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 62.24 111.102 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.683 ' HB3' HG11 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -67.2 -35.71 80.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 73.1 110.917 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.32 -97.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 73.44 111.141 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.426 ' O ' ' CB ' ' A' ' 29' ' ' ASP . 1.4 p90 -149.43 -18.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 75.45 110.857 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER 165.99 -10.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.839 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.69 -22.0 3.83 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.766 -0.731 . . . . 50.31 112.472 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' HG3' HG23 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -60.94 105.32 0.45 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 74.41 110.921 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.515 ' C ' ' HG3' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -70.17 -158.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 74.14 110.815 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -138.17 118.75 13.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 64.21 110.901 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 59' ' ' GLU . 40.4 t -72.06 149.13 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 75.32 111.106 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -123.31 -0.59 8.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 71.11 111.16 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' H ' ' CG1' ' A' ' 34' ' ' VAL . . . -139.83 -154.75 6.39 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.726 . . . . 73.51 112.512 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HA ' ' OH ' ' A' ' 69' ' ' TYR . 53.7 Cg_endo -69.75 -166.12 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.667 2.244 . . . . 71.03 112.302 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.511 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -59.09 -30.43 68.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 74.12 110.812 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.93 -30.17 67.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 70.1 111.116 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.423 ' CB ' HG13 ' A' ' 34' ' ' VAL . 1.6 m-20 -76.51 -34.32 58.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 70.21 110.865 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.809 ' NH1' ' HB1' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -73.89 -44.18 56.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 74.01 110.853 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.729 ' HB2' ' HA2' ' A' ' 99' ' ' GLY . . . -67.88 -30.64 70.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.24 111.121 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.403 ' CG ' ' N ' ' A' ' 44' ' ' ALA . 14.7 ptt180 -85.1 -45.2 12.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 74.4 110.902 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.664 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . . . -77.9 -60.58 2.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 73.14 111.106 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 41' ' ' ARG . . . -48.27 -22.18 0.63 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 55.21 111.082 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.681 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -54.55 -67.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 64.35 111.127 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.733 ' HA ' HG12 ' A' ' 50' ' ' VAL . 26.9 t -110.41 -15.82 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 71.11 111.136 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 50.0 mt-30 -80.74 -29.02 36.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 60.23 110.913 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.091 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.37 -10.86 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 72.21 111.087 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.0 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -96.74 0.07 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.634 0.731 . . . . 74.42 111.158 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.091 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.2 Cg_endo -69.76 -27.11 26.86 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.65 2.234 . . . . 63.34 112.335 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.11 -53.62 2.94 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 64.33 112.542 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.63 -35.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.738 . . . . 62.31 112.489 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.803 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -146.26 149.35 33.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 45.35 111.143 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.812 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.82 82.83 1.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 62.15 111.102 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.717 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -140.62 99.68 0.25 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.713 -0.756 . . . . 73.32 112.478 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.664 ' OE1' ' HB3' ' A' ' 44' ' ' ALA . 63.3 tt0 -96.18 164.62 12.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.946 0.403 . . . . 63.43 110.843 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.417 HG23 ' HG3' ' A' ' 31' ' ' GLU . 2.1 t -111.76 119.13 59.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 73.4 111.112 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.759 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.21 133.57 43.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 51.44 110.898 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -133.39 121.86 22.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 54.14 111.131 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.477 ' H ' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -123.16 162.76 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.43 110.854 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.41 135.72 34.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 61.52 111.106 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.44 -119.38 1.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 52.34 112.525 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -87.83 -23.62 23.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 64.23 110.889 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.3 -112.61 1.9 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 71.44 112.478 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.12 -82.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 75.42 111.104 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 13' ' ' ASP . . . -75.78 125.93 30.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 62.12 111.072 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.47 74.52 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 44.44 111.071 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.759 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.2 OUTLIER -165.38 -131.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 74.13 110.912 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.606 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -167.99 172.24 42.63 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 62.13 112.539 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.803 HG12 HG22 ' A' ' 83' ' ' VAL . 6.0 p -130.07 120.16 48.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 72.32 111.129 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.991 HD23 ' HB3' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -98.36 142.3 30.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 74.11 110.919 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.683 HG11 ' HB3' ' A' ' 26' ' ' MET . 10.9 t -152.03 114.15 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 71.13 111.121 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.764 ' O ' HG22 ' A' ' 54' ' ' THR . 2.6 m -169.45 -133.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.33 111.141 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.568 ' H ' HG22 ' A' ' 74' ' ' THR . 0.1 OUTLIER -104.62 144.77 29.39 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.636 0.731 . . . . 72.32 110.841 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.8 Cg_endo -69.75 13.84 0.28 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.712 2.275 . . . . 70.42 112.341 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 75' ' ' ARG . 20.2 m-20 -93.94 35.49 1.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 74.13 110.855 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.36 -13.2 41.47 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.683 -0.77 . . . . 71.11 112.509 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.748 ' O ' ' HB ' ' A' ' 74' ' ' THR . 37.6 p -95.28 119.7 34.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.749 0.309 . . . . 71.14 111.163 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.991 ' HB3' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -141.61 161.13 38.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 73.51 110.869 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 97.3 t -119.0 81.5 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 64.21 111.092 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 72' ' ' LEU . 15.2 pt-20 -77.68 116.73 18.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.45 110.864 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.803 HG22 HG12 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -94.99 144.72 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.487 . . . . 61.02 111.103 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 93' ' ' ASP . 2.5 t-160 -83.82 108.85 17.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 63.45 110.872 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.949 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 1.3 pp -124.98 110.26 13.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 75.3 110.919 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.585 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 3.9 m-20 -127.02 106.68 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 74.14 110.885 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.531 ' HG2' HG23 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -63.09 -0.34 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 72.12 110.892 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 86' ' ' ASP . 51.2 t0 -69.59 -13.15 62.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 73.04 110.876 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -165.66 -93.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 74.13 110.857 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.609 ' O ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -155.06 33.12 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 74.13 110.865 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.949 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 2.4 t -72.51 95.93 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 75.33 111.109 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.078 HD21 HD11 ' A' ' 14' ' ' ILE . 1.0 OUTLIER -127.68 18.82 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 72.51 110.922 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 84' ' ' HIS . 9.0 t0 -75.99 128.78 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 63.42 110.895 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.716 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 7.0 t -79.23 155.8 28.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 72.23 111.119 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.95 153.1 53.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.666 0.746 . . . . 73.33 110.872 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 140.37 42.61 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.66 2.24 . . . . 42.42 112.35 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.809 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -119.42 111.06 17.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 74.43 111.103 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -96.28 4.26 52.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 65.42 110.911 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.729 ' HA2' ' HB2' ' A' ' 42' ' ' ALA . . . 82.78 -21.98 7.12 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.738 . . . . 61.25 112.497 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.34 -31.24 12.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.779 0.323 . . . . 73.55 110.835 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.16 26.07 58.44 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.773 -0.727 . . . . 62.04 112.442 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.769 -0.729 . . . . 61.05 112.489 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.815 0.34 . . . . 71.13 110.878 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -65.88 -37.09 85.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 74.52 110.922 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' CB ' ' HB2' ' A' ' 85' ' ' LEU . 11.8 p-10 -65.54 -149.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 73.11 110.846 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.67 ' HB ' HG23 ' A' ' 17' ' ' THR . 0.1 OUTLIER -73.43 127.92 88.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.672 0.748 . . . . 64.11 111.12 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -1.52 8.6 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.638 2.225 . . . . 74.44 112.364 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.79 38.54 3.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 54.44 111.094 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.78 HG22 HD23 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -73.07 -168.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 61.42 111.159 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.634 ' H ' HD22 ' A' ' 92' ' ' LEU . 15.8 mm-40 -72.78 -100.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 70.31 110.925 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -98.73 8.29 45.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 72.3 110.894 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -72.21 -9.43 58.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 64.22 110.921 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -89.99 -8.81 50.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 74.21 110.964 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -74.39 -58.65 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 74.23 110.879 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.549 ' OE1' HG21 ' A' ' 83' ' ' VAL . 3.9 mp0 -66.13 -42.66 88.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 71.4 110.874 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.71 -31.49 2.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.728 -0.748 . . . . 71.32 112.484 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.7 -72.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.318 . . . . 42.32 111.077 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.6 ptm -70.6 -7.1 41.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.1 110.904 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' A' ' 31' ' ' GLU . . . -65.53 -47.19 76.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 52.04 111.057 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -81.86 6.1 16.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 75.45 110.879 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -72.04 -68.59 0.45 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 74.4 110.857 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.89 8.98 2.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.776 -0.726 . . . . 72.41 112.532 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HG3' ' HA ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -79.37 177.67 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 74.01 110.904 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.09 -168.8 2.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 75.21 110.874 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -109.54 119.88 40.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 72.42 110.909 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 35' ' ' THR . 2.2 t -73.12 -136.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 71.13 111.131 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.565 ' H ' HG12 ' A' ' 34' ' ' VAL . 71.5 p -136.72 -47.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 71.32 111.158 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.45 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . 163.0 -61.18 0.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 61.01 112.493 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.5 Cg_endo -69.7 159.18 54.39 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.747 2.298 . . . . 64.51 112.318 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.411 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 2.1 p30 -64.88 -26.04 68.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 75.14 110.852 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.03 -39.14 74.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 74.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 1.9 m-20 -86.06 -39.85 16.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.34 110.882 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.633 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 6.8 ptt180 -68.05 -38.81 82.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 71.23 110.868 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.601 ' HA ' ' HD3' ' A' ' 80' ' ' ARG . . . -68.3 -35.29 77.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 52.4 111.071 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -82.03 -40.53 21.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 64.43 110.898 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.593 ' HB1' ' CD ' ' A' ' 57' ' ' GLU . . . -77.48 -59.84 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 63.31 111.101 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.733 ' HB2' HD23 ' A' ' 72' ' ' LEU . . . -52.76 -20.22 3.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 74.21 111.091 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.66 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -63.63 -78.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 74.24 111.092 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.719 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.6 t -108.44 -17.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 73.11 111.179 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.486 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -74.41 -29.79 61.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.12 110.905 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.068 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.94 -2.82 19.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 70.2 111.132 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.999 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -95.7 -2.9 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.612 0.72 . . . . 71.4 111.143 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.068 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.9 Cg_endo -69.77 -27.66 26.13 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.666 2.244 . . . . 65.23 112.343 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.11 -57.15 2.87 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.78 -0.724 . . . . 25.23 112.502 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.07 -34.76 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 71.02 112.504 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 74' ' ' THR . 0.2 OUTLIER -146.41 152.1 38.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 54.25 111.151 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.84 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -72.39 77.01 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 54.43 111.116 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.714 ' HA3' ' HA ' ' A' ' 73' ' ' VAL . . . -148.53 105.68 0.31 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 75.35 112.487 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.593 ' CD ' ' HB1' ' A' ' 44' ' ' ALA . 3.2 tt0 -95.78 -171.95 2.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.907 0.384 . . . . 74.54 110.896 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.037 HG13 HG22 ' A' ' 71' ' ' VAL . 83.8 t -136.86 131.43 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 60.44 111.126 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -99.1 121.78 41.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 71.12 110.852 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.1 t -110.35 119.19 38.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 55.33 111.137 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -143.47 121.92 12.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 50.13 110.908 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.74 148.8 24.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 72.1 111.159 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.13 -106.71 0.99 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.781 -0.723 . . . . 53.24 112.529 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -87.91 -25.7 23.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 70.03 110.936 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.33 -121.56 2.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 60.0 112.465 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.32 33.87 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.768 0.318 . . . . 61.14 111.112 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.51 ' HA ' ' H ' ' A' ' 87' ' ' ARG . . . -63.71 -155.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 72.04 111.122 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.567 ' O ' ' O ' ' A' ' 61' ' ' GLU . . . -157.06 -104.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 71.11 111.111 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.579 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 2.9 t80 -170.29 -85.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 72.23 110.902 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.611 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -168.53 157.04 28.96 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 53.34 112.494 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.037 HG22 HG13 ' A' ' 58' ' ' VAL . 89.8 t -123.45 120.8 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.838 0.351 . . . . 73.53 111.093 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.82 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -106.17 134.19 49.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 73.23 110.93 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.714 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 5.2 p -147.67 118.61 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 72.13 111.12 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.751 ' HB ' ' O ' ' A' ' 79' ' ' THR . 2.7 m -169.19 -133.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 73.33 111.141 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.557 ' H ' HG22 ' A' ' 74' ' ' THR . 3.6 mtt-85 -101.53 148.4 35.18 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.636 0.732 . . . . 71.25 110.831 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.4 Cg_endo -69.84 9.41 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.652 2.234 . . . . 75.23 112.342 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -88.38 38.67 0.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 75.14 110.87 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.11 -7.05 8.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 64.2 112.428 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.751 ' O ' ' HB ' ' A' ' 74' ' ' THR . 31.1 p -98.85 115.42 28.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.793 0.33 . . . . 73.04 111.175 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.727 ' O ' ' HB3' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -138.62 160.59 39.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 72.32 110.861 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 61.6 t -113.88 87.02 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 54.4 111.132 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -81.04 121.37 25.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.2 110.908 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.611 ' O ' ' CA ' ' A' ' 70' ' ' GLY . 1.8 t -97.55 160.57 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 63.32 111.137 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.691 ' C ' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -104.55 109.14 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 73.12 110.873 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.917 HD13 ' N ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -128.72 111.14 12.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 52.41 110.925 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.612 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 21.1 m-20 -136.51 108.66 7.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 64.52 110.846 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.51 ' H ' ' HA ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -66.36 0.61 2.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.1 110.903 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 89' ' ' PHE . 51.6 t0 -69.88 -11.88 61.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.852 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.484 ' CD1' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -166.54 -93.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 62.24 110.903 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.13 35.53 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 74.2 110.86 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.745 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 9.2 t -69.47 100.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 65.41 111.145 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.812 ' HA ' HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -135.04 16.89 3.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 64.23 110.932 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 84' ' ' HIS . 14.6 t0 -80.75 147.65 30.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 61.4 110.881 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.434 ' HA ' HG13 ' A' ' 83' ' ' VAL . 15.3 t -90.38 165.0 14.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 74.4 111.11 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -146.45 122.61 5.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 71.13 110.915 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 128.91 16.73 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.684 2.256 . . . . 73.15 112.364 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -116.82 114.09 23.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 71.11 111.116 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 100' ' ' ASP . 4.8 t0 -124.9 46.4 2.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 72.3 110.898 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 -17.34 1.69 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 61.32 112.509 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 98' ' ' ASP . 0.4 OUTLIER -95.93 -65.39 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 74.32 110.88 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.64 21.67 12.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 53.04 112.467 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 74.14 112.486 -179.926 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.819 0.342 . . . . 73.41 110.815 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -74.1 -25.19 59.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 70.14 110.917 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.527 ' OD2' HD23 ' A' ' 20' ' ' LEU . 14.7 p-10 -64.12 -151.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 65.44 110.886 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.525 HG21 ' HG3' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -102.3 166.88 11.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 64.11 111.086 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' A' ' 14' ' ' ILE . 54.0 Cg_endo -69.76 -2.52 10.31 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 74.13 112.361 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.1 p -141.83 94.2 2.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 74.13 111.168 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.944 HG22 HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -118.83 -167.25 1.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 64.1 111.141 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.464 ' CB ' HD23 ' A' ' 92' ' ' LEU . 11.8 tt0 -110.36 -94.29 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 71.23 110.883 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -57.0 -17.9 11.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 74.43 110.937 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.784 HD13 ' CD2' ' A' ' 85' ' ' LEU . 2.4 mp -84.11 -19.51 34.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 62.14 110.88 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -66.23 -17.71 64.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 71.4 110.941 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.17 -22.58 15.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 74.0 110.891 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -66.72 -29.82 69.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 72.3 110.936 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.4 -29.7 1.83 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.733 -0.746 . . . . 44.54 112.503 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.403 ' O ' ' CD2' ' A' ' 28' ' ' PHE . . . -73.57 -64.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 51.34 111.105 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.791 ' CE ' HG11 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -64.36 -7.02 8.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 70.33 110.872 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' A' ' 31' ' ' GLU . . . -103.79 25.3 10.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.14 111.072 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -73.54 2.3 8.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 71.14 110.862 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 t70 179.92 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 53.32 110.873 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.31 -2.48 48.79 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.695 -0.764 . . . . 74.22 112.473 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.651 ' CG ' HG21 ' A' ' 58' ' ' VAL . 2.1 tm-20 -94.4 105.05 17.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 61.23 110.913 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 3.9 m-20 -119.34 -152.29 0.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 64.13 110.855 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -118.63 109.57 16.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 55.01 110.84 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 58' ' ' VAL . 21.3 t -81.03 -119.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 51.11 111.137 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.626 ' N ' HG12 ' A' ' 34' ' ' VAL . 68.5 p -141.8 -77.85 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 63.3 111.123 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.445 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -171.73 -61.1 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.762 -0.732 . . . . 73.33 112.51 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 36' ' ' GLY . 53.8 Cg_endo -69.77 158.96 55.15 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.692 2.262 . . . . 65.44 112.35 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.474 ' CA ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -66.56 -32.44 73.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 61.5 110.861 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.66 -30.78 14.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 32.41 111.096 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.42 -31.85 26.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 73.1 110.859 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HG2' ' N ' ' A' ' 42' ' ' ALA . 9.0 ptt-85 -57.71 -36.69 72.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 73.1 110.852 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.805 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -71.25 -33.02 69.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 61.41 111.11 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.474 ' HG2' ' N ' ' A' ' 44' ' ' ALA . 2.2 ptt85 -77.71 -38.73 46.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 62.02 110.898 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.681 ' HB1' ' HG3' ' A' ' 57' ' ' GLU . . . -79.74 -59.15 2.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 72.34 111.136 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.848 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -57.63 -18.29 19.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 60.31 111.104 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.805 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -59.45 -81.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 42.42 111.077 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.766 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 59.7 t -114.99 -15.96 9.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 74.14 111.117 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.2 mt-30 -73.78 -31.96 63.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 65.32 110.893 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.041 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.88 -1.58 20.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.439 . . . . 73.22 111.144 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.989 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.34 -5.48 0.11 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.602 0.715 . . . . 74.35 111.141 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.041 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.4 Cg_endo -69.73 -29.32 24.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.281 . . . . 74.1 112.319 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.44 -54.04 5.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.72 -0.752 . . . . 45.35 112.442 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.49 -33.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.725 -0.75 . . . . 71.41 112.458 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.587 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -145.92 156.0 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 74.55 111.141 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.784 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.28 76.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 61.34 111.084 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.741 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -145.99 107.26 0.41 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.744 -0.741 . . . . 72.14 112.517 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.681 ' HG3' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -98.1 -169.27 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.353 . . . . 73.21 110.909 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.739 HG22 ' HB ' ' A' ' 71' ' ' VAL . 53.4 t -141.56 110.93 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 74.41 111.092 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.752 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 5.0 mt-10 -94.96 162.87 13.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 63.22 110.906 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.642 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -126.26 119.56 27.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 62.21 111.162 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.21 159.51 37.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 75.34 110.914 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.0 p -125.1 100.52 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 63.24 111.126 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.83 -141.54 8.76 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 61.4 112.487 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -88.05 0.53 55.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.857 0.361 . . . . 73.44 110.874 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -102.75 -121.71 4.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 53.32 112.517 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.666 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -120.82 -77.07 0.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.743 0.306 . . . . 60.54 111.062 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -111.21 86.65 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 54.43 111.065 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.818 ' HB2' ' OD2' ' A' ' 86' ' ' ASP . . . -98.67 85.47 3.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 51.32 111.1 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.752 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 0.5 OUTLIER -115.55 158.72 22.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 74.51 110.873 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.648 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -124.94 127.69 6.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 73.31 112.481 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.739 ' HB ' HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -109.26 123.42 65.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 71.41 111.146 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.797 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -84.61 142.92 29.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 75.15 110.895 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.791 HG11 ' CE ' ' A' ' 26' ' ' MET . 77.5 t -151.21 95.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 62.14 111.082 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.77 HG22 ' H ' ' A' ' 75' ' ' ARG . 1.3 m -168.27 -149.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 73.42 111.16 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.77 ' H ' HG22 ' A' ' 74' ' ' THR . 7.7 mtm180 -103.94 151.92 38.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.614 0.721 . . . . 75.22 110.853 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 53.8 Cg_endo -69.79 7.56 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.686 2.258 . . . . 61.11 112.368 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.49 19.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 75.32 110.877 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 76' ' ' PRO . . . 94.71 -14.09 65.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 52.32 112.484 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.747 ' O ' ' HB ' ' A' ' 74' ' ' THR . 3.0 t -98.05 125.37 43.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.778 0.323 . . . . 73.21 111.144 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.608 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -136.56 159.81 40.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 73.41 110.894 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 42.8 t -118.11 92.67 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 74.21 111.129 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.635 ' HB2' HD12 ' A' ' 72' ' ' LEU . 87.3 tt0 -82.77 119.83 24.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 74.01 110.874 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.648 ' O ' ' HA2' ' A' ' 70' ' ' GLY . 2.0 t -100.01 111.61 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.42 111.159 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.736 ' O ' HD22 ' A' ' 85' ' ' LEU . 3.9 t-160 -86.68 110.53 19.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 64.13 110.857 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.944 HD12 HG22 ' A' ' 17' ' ' THR . 3.0 mm? -127.6 127.96 44.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 74.15 110.923 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.818 ' OD2' ' HB2' ' A' ' 68' ' ' ALA . 13.3 t0 -135.45 132.68 37.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.869 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.666 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 3.2 tmt_? -57.99 2.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 64.23 110.885 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.566 ' H ' ' C ' ' A' ' 86' ' ' ASP . 4.7 t0 -66.78 -4.69 9.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 73.1 110.876 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 68.23 12.18 8.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 74.34 110.883 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -135.54 -1.23 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 65.52 110.851 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.769 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 96.8 t -116.67 92.91 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 63.33 111.151 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.792 ' HA ' HD13 ' A' ' 85' ' ' LEU . 5.3 mp -144.41 14.52 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 73.14 110.879 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.06 137.14 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 71.33 110.883 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.61 ' HB ' HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -96.47 130.01 43.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 72.14 111.167 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLU . 71.4 tt0 -99.94 127.16 34.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.615 0.721 . . . . 73.22 110.933 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 114.63 3.77 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.675 2.25 . . . . 63.12 112.333 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -64.53 114.33 4.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 44.42 111.11 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.08 15.09 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 65.43 110.899 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.65 -21.51 2.46 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.763 . . . . 71.41 112.482 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -97.55 -38.44 9.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.835 0.35 . . . . 72.45 110.869 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.85 47.0 5.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 62.33 112.482 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 65.13 112.464 -179.937 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.744 ' N ' ' HH ' ' A' ' 69' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 75.34 110.867 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -68.93 -44.22 73.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.12 110.905 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.439 ' OD2' HD23 ' A' ' 20' ' ' LEU . 5.9 p-10 -66.33 -147.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 70.31 110.857 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.883 HG22 ' H ' ' A' ' 16' ' ' THR . 26.3 mm -75.76 119.15 75.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.596 0.713 . . . . 71.35 111.138 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 4.06 2.38 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.74 2.293 . . . . 74.41 112.32 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.883 ' H ' HG22 ' A' ' 14' ' ' ILE . 2.8 m -115.03 20.95 14.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 63.41 111.193 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.902 ' CB ' HD22 ' A' ' 20' ' ' LEU . 1.2 p -81.36 -165.15 0.88 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 62.21 111.142 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.671 ' HG3' HD13 ' A' ' 92' ' ' LEU . 1.1 mm-40 -71.89 -131.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.242 -0.435 . . . . 72.22 110.883 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.41 12.47 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 55.32 110.916 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.902 HD22 ' CB ' ' A' ' 17' ' ' THR . 7.5 mp -57.42 -27.54 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 62.15 110.895 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -95.96 7.04 47.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.913 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -110.55 -42.72 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 72.22 110.861 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -65.11 -51.8 59.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 75.44 110.922 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.76 -54.55 6.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 72.35 112.528 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.96 52.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.768 0.318 . . . . 73.03 111.119 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.429 ' CE ' ' HB2' ' A' ' 27' ' ' ALA . 1.4 ptm -66.98 -39.8 87.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 72.24 110.911 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HB2' ' CE ' ' A' ' 26' ' ' MET . . . -120.77 -92.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 62.52 111.095 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -145.0 -27.17 0.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.855 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.68 28.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 73.32 110.848 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.16 9.62 25.18 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.729 -0.748 . . . . 52.54 112.519 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HB3' HG23 ' A' ' 58' ' ' VAL . 2.8 mp0 -93.61 98.46 11.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 74.42 110.909 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -65.84 -162.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 73.41 110.835 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -129.15 102.2 6.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 72.22 110.9 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.845 HG23 ' HG3' ' A' ' 57' ' ' GLU . 1.0 OUTLIER -72.7 159.0 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 71.23 111.124 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.526 HG23 ' CG ' ' A' ' 40' ' ' ASP . 70.0 p -91.36 -38.07 12.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 62.34 111.143 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' H ' HG13 ' A' ' 34' ' ' VAL . . . 166.47 -64.44 0.21 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.737 . . . . 63.42 112.476 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 160.4 49.83 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 64.53 112.338 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 2.2 p-10 -60.62 -29.18 69.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 75.35 110.866 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.04 -30.92 49.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 60.4 111.063 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.526 ' CG ' HG23 ' A' ' 35' ' ' THR . 0.4 OUTLIER -82.24 -35.04 28.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 63.44 110.896 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.526 ' HG3' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -71.74 -41.09 68.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 70.54 110.822 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.97 -35.05 71.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 65.11 111.072 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.7 ptt85 -80.57 -39.5 27.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 71.53 110.885 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.624 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -75.81 -60.38 2.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 52.24 111.064 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 1.029 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -56.47 -16.94 6.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 75.02 111.082 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -62.51 -67.42 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 71.22 111.112 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.673 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.7 t -122.31 -14.79 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 72.32 111.118 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.624 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 50.5 mt-30 -79.69 -41.46 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.14 110.906 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.029 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . . . -104.71 -0.23 27.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 71.31 111.089 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.978 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -93.72 -11.68 0.17 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 55.0 111.089 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.978 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 54.2 Cg_endo -69.76 -28.04 25.75 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.681 2.254 . . . . 72.12 112.372 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.26 -44.14 44.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 25.31 112.475 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.36 -31.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 70.42 112.475 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 74' ' ' THR . 1.0 OUTLIER -149.92 157.24 42.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.824 0.345 . . . . 61.43 111.139 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.708 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.0 75.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 41.21 111.111 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.662 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -146.58 111.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 72.44 112.456 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.845 ' HG3' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -103.93 -170.69 1.81 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 70.05 110.869 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.559 HG13 ' CE1' ' A' ' 69' ' ' TYR . 3.3 t -131.21 120.77 47.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 72.54 111.14 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.565 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -93.38 126.07 38.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.54 110.872 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 69' ' ' TYR . 1.8 t -107.99 105.31 15.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 70.32 111.148 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.608 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -136.36 158.19 45.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 73.32 110.903 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.6 p -125.13 113.77 18.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 60.54 111.143 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -92.46 -179.37 40.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.74 . . . . 73.42 112.491 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.63 -14.38 62.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 52.45 110.852 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' HA3' ' HB2' ' A' ' 88' ' ' ASP . . . -86.35 -111.18 0.83 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 55.13 112.458 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . . . -113.99 -77.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.772 0.32 . . . . 72.31 111.1 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -108.67 158.21 17.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 60.41 111.103 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 61' ' ' GLU . . . -151.94 49.78 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 53.54 111.107 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.744 ' HH ' ' N ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -120.35 129.32 53.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 53.04 110.979 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -112.05 159.03 13.94 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 31.3 112.516 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 71' ' ' VAL . 5.5 p -124.25 113.23 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 72.0 111.146 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.916 HD21 ' HB3' ' A' ' 80' ' ' ARG . 2.3 tt -91.1 145.14 24.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.929 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.58 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 14.6 t -158.57 112.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 71.44 111.159 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.832 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -174.89 -148.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 72.21 111.119 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.454 ' H ' HG22 ' A' ' 74' ' ' THR . 9.9 mmm180 -106.0 143.86 27.75 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.59 0.71 . . . . 65.44 110.85 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.83 11.46 0.4 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.716 2.277 . . . . 72.33 112.301 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 75' ' ' ARG . 9.0 m-20 -86.16 32.36 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 75.34 110.905 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.48 -14.58 34.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 60.31 112.495 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.489 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.4 t -99.81 106.17 18.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.786 0.327 . . . . 71.4 111.149 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.916 ' HB3' HD21 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -135.58 154.97 51.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 74.43 110.877 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.56 ' N ' ' OG1' ' A' ' 74' ' ' THR . 47.9 t -114.19 100.37 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.35 111.1 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.696 ' HB3' HD12 ' A' ' 72' ' ' LEU . 9.2 pt-20 -85.61 109.19 18.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 71.42 110.866 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.855 HG13 ' HB ' ' A' ' 94' ' ' THR . 2.1 t -99.62 107.84 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 74.44 111.136 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.754 ' C ' HD23 ' A' ' 85' ' ' LEU . 5.4 m-70 -84.3 121.17 27.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 62.45 110.855 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.783 ' N ' HD23 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -106.98 105.57 15.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 72.12 110.913 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.732 ' H ' ' HA ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -128.65 115.34 17.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 70.11 110.888 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.551 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 1.2 tmt_? -61.45 -7.8 3.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 53.31 110.85 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.689 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 24.5 t70 -83.72 32.81 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 72.21 110.839 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.689 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 18.8 m-85 97.68 -30.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 74.11 110.853 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.46 35.36 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 75.52 110.808 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.831 ' O ' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.69 -28.0 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 71.31 111.115 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.671 HD13 ' HG3' ' A' ' 18' ' ' GLU . 1.9 mt -122.43 29.57 6.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 74.02 110.893 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 84' ' ' HIS . 33.0 t70 -71.34 66.58 0.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.03 110.918 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.855 ' HB ' HG13 ' A' ' 83' ' ' VAL . 10.2 t -84.86 151.41 24.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 74.1 111.118 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -146.06 157.78 49.53 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.654 0.74 . . . . 73.54 110.861 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 131.92 22.19 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.633 2.222 . . . . 75.14 112.317 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 80' ' ' ARG . . . -112.59 103.19 11.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 52.23 111.111 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.21 11.28 38.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 65.42 110.911 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 42' ' ' ALA . . . 86.44 -19.32 28.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 50.53 112.495 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -95.67 -41.99 8.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 71.41 110.907 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.85 28.69 45.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 32.12 112.484 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.757 -0.735 . . . . 41.23 112.528 -179.94 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.804 0.335 . . . . 74.21 110.825 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 33' ' ' GLU . 82.8 m-85 -65.43 -54.31 30.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 73.33 110.92 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.02 -158.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 71.12 110.878 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.492 HD11 ' N ' ' A' ' 87' ' ' ARG . 1.2 mp -74.42 121.64 85.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.591 0.71 . . . . 63.25 111.13 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -5.47 16.26 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.689 2.259 . . . . 72.45 112.341 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.466 ' H ' HG22 ' A' ' 14' ' ' ILE . 34.3 p -145.44 88.3 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.23 111.16 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.917 HG22 HD23 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -132.55 -159.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 74.12 111.149 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.08 -94.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 52.32 110.927 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -87.88 11.18 16.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 62.52 110.887 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.867 HD22 HD12 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -93.55 -34.72 13.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 73.5 110.922 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -67.45 -11.54 58.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 73.34 110.892 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -93.94 -59.76 1.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 62.12 110.842 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -66.32 -41.36 89.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 74.24 110.927 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 27' ' ' ALA . . . -42.35 -34.89 1.72 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.717 -0.754 . . . . 64.25 112.44 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.9 -60.6 3.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.77 0.319 . . . . 72.44 111.061 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.5 ptp -69.79 -9.52 54.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 64.21 110.878 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 24' ' ' GLY . . . -76.85 -19.67 57.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.11 111.056 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -82.03 8.94 9.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 73.53 110.896 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -70.7 -80.85 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 55.53 110.866 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.05 11.4 0.19 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 71.42 112.493 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.699 ' OE1' HG23 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -67.52 176.94 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.826 0.346 . . . . 60.51 110.894 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.22 -164.12 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 74.24 110.86 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.427 ' HB3' ' CE1' ' A' ' 12' ' ' TYR . 1.5 pt-20 -111.0 166.58 10.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 73.23 110.883 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -100.03 167.8 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.485 . . . . 71.11 111.078 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.58 ' N ' HG13 ' A' ' 34' ' ' VAL . 44.3 p -94.79 -42.08 8.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.148 -0.478 . . . . 71.23 111.188 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.426 ' N ' HG13 ' A' ' 34' ' ' VAL . . . 166.89 -64.65 0.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.736 . . . . 52.12 112.501 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.425 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.8 Cg_endo -69.74 157.26 61.04 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.684 2.256 . . . . 74.41 112.333 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -59.79 -28.95 67.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 55.22 110.908 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.11 -33.51 57.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 61.42 111.137 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.672 ' HB3' HG22 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -84.1 -32.07 24.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 71.21 110.905 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.912 ' HB2' HD21 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -69.45 -44.84 70.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 74.55 110.832 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.747 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -71.77 -34.72 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 72.01 111.061 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.3 ptt85 -76.37 -39.84 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 63.2 110.863 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.591 ' HA ' ' HB2' ' A' ' 48' ' ' GLN . . . -75.44 -59.76 2.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 73.42 111.118 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.731 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -58.03 -13.55 4.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 60.14 111.089 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.747 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -71.28 -71.96 0.24 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 44.04 111.15 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.714 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.3 t -113.56 -9.34 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 74.32 111.147 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -83.0 -39.92 20.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.43 110.921 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.731 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . . . -102.41 -5.87 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 70.05 111.067 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.959 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -81.13 -25.51 0.41 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.64 0.733 . . . . 72.12 111.129 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.959 ' HD2' ' N ' ' A' ' 50' ' ' VAL . 53.9 Cg_endo -69.72 -10.19 27.97 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.69 2.26 . . . . 73.52 112.342 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.6 -27.34 15.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.74 . . . . 53.13 112.498 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.81 -32.54 0.3 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.737 . . . . 64.13 112.535 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.586 ' O ' ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -155.15 164.7 38.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 63.31 111.113 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.724 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -75.17 65.96 1.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 64.05 111.114 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.712 ' CA ' ' O ' ' A' ' 72' ' ' LEU . . . -141.13 105.85 0.45 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 63.03 112.514 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.529 ' CG ' ' HB2' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -94.97 -162.06 0.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 72.34 110.931 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.723 HG22 ' CG1' ' A' ' 71' ' ' VAL . 29.4 t -129.31 119.36 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 75.43 111.14 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.814 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 1.6 mt-10 -93.34 136.01 34.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 73.51 110.857 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 60' ' ' THR . 3.5 t -138.44 115.62 11.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 74.2 111.168 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.802 ' C ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -122.31 178.3 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 74.43 110.865 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.77 128.87 49.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 52.11 111.109 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.469 ' N ' ' HB2' ' A' ' 68' ' ' ALA . . . -128.49 -144.77 5.87 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.768 -0.729 . . . . 35.33 112.517 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -87.25 -21.32 25.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.887 0.375 . . . . 75.23 110.889 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.67 -109.93 3.01 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.737 . . . . 73.44 112.516 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.47 -81.48 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.326 . . . . 54.32 111.113 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.691 ' HB3' ' HB2' ' A' ' 87' ' ' ARG . . . -78.08 128.04 33.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 53.44 111.105 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.802 ' HB3' ' C ' ' A' ' 61' ' ' GLU . . . -122.69 45.71 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 65.35 111.067 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.814 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -170.86 -152.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 74.45 110.928 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 83' ' ' VAL . . . -158.8 -126.84 0.88 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 63.31 112.488 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.723 ' CG1' HG22 ' A' ' 58' ' ' VAL . 4.5 m -152.67 151.95 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.373 . . . . 73.04 111.131 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.912 HD21 ' HB2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -104.81 152.41 22.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 72.5 110.923 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.698 ' O ' HG22 ' A' ' 81' ' ' VAL . 2.1 p -155.17 106.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 52.13 111.119 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.844 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -172.32 -142.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 75.44 111.158 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.456 ' H ' HG22 ' A' ' 74' ' ' THR . 3.6 mtm180 -110.13 149.18 39.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.599 0.714 . . . . 64.34 110.887 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' A' ' 55' ' ' ALA . 53.4 Cg_endo -69.77 8.36 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.694 2.263 . . . . 74.32 112.361 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.16 33.09 0.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 71.24 110.914 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.73 -11.45 10.4 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.753 -0.737 . . . . 70.34 112.456 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.469 ' O ' ' HB ' ' A' ' 74' ' ' THR . 2.2 t -101.61 105.21 16.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.318 . . . . 71.14 111.168 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.844 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 2.4 ptp85 -138.64 157.48 46.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 63.2 110.856 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 73' ' ' VAL . 18.0 m -114.03 96.65 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 74.12 111.098 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.735 ' HB3' HD23 ' A' ' 72' ' ' LEU . 1.3 pp20? -87.24 125.07 33.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 70.02 110.902 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.758 HG12 HD21 ' A' ' 85' ' ' LEU . 4.5 t -91.52 139.89 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 75.41 111.141 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.97 ' C ' HD23 ' A' ' 85' ' ' LEU . 12.7 t-160 -117.9 106.04 12.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 74.41 110.833 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.97 HD23 ' C ' ' A' ' 84' ' ' HIS . 2.7 mt -131.6 139.12 49.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 51.32 110.893 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.631 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -103.68 111.77 24.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 73.14 110.84 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.691 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 1.3 tmt_? -50.07 -21.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 74.34 110.851 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.489 ' HB3' ' OD1' ' A' ' 86' ' ' ASP . 4.7 t0 -68.28 5.36 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 65.42 110.879 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.426 ' H ' ' C ' ' A' ' 87' ' ' ARG . 37.5 m-85 67.08 42.51 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 72.23 110.898 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.842 ' HG3' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -129.09 -29.76 2.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 71.14 110.848 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.944 HG12 ' HA ' ' A' ' 85' ' ' LEU . 54.2 t -125.0 125.82 70.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 63.32 111.133 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.917 HD23 HG22 ' A' ' 17' ' ' THR . 1.9 mp -145.27 17.27 1.53 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 64.22 110.891 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 84' ' ' HIS . 21.1 t0 -101.35 143.97 30.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 72.03 110.867 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.538 ' HB ' HG13 ' A' ' 83' ' ' VAL . 13.9 t -84.83 176.3 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 73.54 111.133 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 82' ' ' GLU . 3.7 tt0 -145.72 128.89 8.27 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.604 0.716 . . . . 72.31 110.897 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 115.17 3.96 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 63.32 112.392 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.821 ' HB1' ' NH1' ' A' ' 41' ' ' ARG . . . -94.58 115.73 27.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 71.43 111.069 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -102.19 15.13 30.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 73.03 110.891 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.63 -19.46 9.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.745 -0.74 . . . . 51.1 112.514 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -96.11 -42.69 8.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.847 0.356 . . . . 52.54 110.834 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.07 26.68 54.97 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.728 -0.748 . . . . 75.14 112.465 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.712 -0.756 . . . . 74.42 112.535 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.826 0.346 . . . . 60.31 110.856 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.707 ' HA ' HD13 ' A' ' 85' ' ' LEU . 4.5 p90 -94.43 -175.44 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 54.51 110.907 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -119.4 -31.56 4.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.519 . . . . 64.42 110.852 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.733 ' O ' HG23 ' A' ' 17' ' ' THR . 0.8 OUTLIER -101.07 127.57 31.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.607 0.718 . . . . 74.24 111.129 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 18.73 0.19 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.747 2.298 . . . . 62.34 112.305 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -138.95 39.76 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 74.31 111.12 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 14' ' ' ILE . 65.0 p -72.73 -166.5 0.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 64.2 111.161 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -132.79 -86.7 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 71.44 110.901 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -75.08 6.64 4.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 71.42 110.911 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.907 HD21 ' HB3' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -92.59 -37.85 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 61.42 110.904 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -75.17 -7.49 53.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 73.11 110.969 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -94.43 -26.31 16.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 74.32 110.886 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -30.03 29.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 72.43 110.896 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -42.9 -30.7 1.04 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.746 -0.74 . . . . 50.44 112.486 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.56 -56.88 4.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 72.12 111.112 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.607 ' SD ' HG21 ' A' ' 73' ' ' VAL . 11.6 ptp -65.15 -11.77 43.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 73.05 110.866 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.933 ' HB1' ' HB2' ' A' ' 31' ' ' GLU . . . -101.5 26.11 7.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.45 111.104 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 28' ' ' PHE . 7.4 p90 -63.15 -16.65 60.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 71.14 110.857 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -147.6 -44.97 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 72.54 110.881 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.97 -18.21 25.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.724 . . . . 64.41 112.46 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.933 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 1.9 tm-20 -64.7 92.12 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.883 0.373 . . . . 74.32 110.868 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.434 ' HB3' ' CD ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -103.22 -161.04 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 63.21 110.882 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -122.63 114.01 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.32 110.911 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 35' ' ' THR . 11.4 t -90.7 172.34 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 61.24 111.112 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.672 ' H ' HG12 ' A' ' 34' ' ' VAL . 34.3 p -89.73 -54.1 4.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 64.35 111.178 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.73 -64.89 0.11 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.721 -0.752 . . . . 74.41 112.51 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.461 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.9 Cg_endo -69.74 159.04 54.9 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.693 2.262 . . . . 75.43 112.375 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -60.65 -29.0 68.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 74.01 110.882 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.477 ' HB2' ' HA3' ' A' ' 102' ' ' GLY . . . -54.37 -35.66 63.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 62.44 111.077 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.53 ' HA ' ' CG ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -85.45 -28.59 24.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 71.44 110.846 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 97' ' ' ALA . 0.6 OUTLIER -73.99 -42.61 60.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 60.02 110.894 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.43 -33.71 71.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 74.42 111.058 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.53 ' CG ' ' HA ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -79.72 -42.56 24.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 74.3 110.843 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -75.22 -61.61 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 44.42 111.097 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.983 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . . . -51.08 -23.76 3.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 62.23 111.107 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.62 ' O ' ' CG2' ' A' ' 50' ' ' VAL . . . -51.93 -67.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 70.22 111.142 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.638 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 25.3 t -111.18 -22.0 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 53.54 111.119 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 45.2 mt-30 -73.98 -29.21 61.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 61.31 110.911 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.109 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -108.42 -6.95 15.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 71.01 111.134 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.993 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 14.3 t -95.66 1.92 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.713 . . . . 62.12 111.108 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.109 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 54.0 Cg_endo -69.71 -20.35 35.16 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.265 . . . . 62.1 112.373 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.72 -40.54 3.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.731 . . . . 64.14 112.52 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.96 -32.8 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.738 -0.744 . . . . 64.43 112.471 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.957 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -147.3 163.31 36.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 74.41 111.15 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.77 ' O ' ' HA ' ' A' ' 73' ' ' VAL . . . -76.81 69.06 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 61.23 111.08 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.816 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -111.22 82.27 0.3 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.721 -0.752 . . . . 70.23 112.488 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.983 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -88.98 175.92 7.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 74.22 110.91 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.595 HG22 HG22 ' A' ' 71' ' ' VAL . 62.7 t -131.17 123.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.55 111.107 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.633 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 8.0 mt-10 -92.08 129.1 38.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.924 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.7 t -100.48 104.46 15.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 71.23 111.154 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.486 ' C ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.56 160.68 39.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 72.51 110.887 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -131.37 112.63 12.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 71.2 111.129 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.73 -178.53 43.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 75.31 112.487 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -65.13 -24.03 67.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.856 0.36 . . . . 74.03 110.855 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.72 -112.51 0.14 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.715 -0.755 . . . . 73.23 112.427 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 87' ' ' ARG . . . -111.7 -82.65 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.321 . . . . 63.4 111.102 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.85 161.53 14.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 54.15 111.074 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.486 ' HB3' ' C ' ' A' ' 61' ' ' GLU . . . -153.78 72.6 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 72.42 111.138 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.538 ' CB ' HD21 ' A' ' 85' ' ' LEU . 4.7 m-85 -115.79 125.12 52.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 73.11 110.968 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 83' ' ' VAL . . . -105.93 110.21 3.34 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.695 -0.764 . . . . 65.34 112.457 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 57' ' ' GLU . 89.4 t -102.45 113.95 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 73.4 111.128 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.816 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -105.72 131.72 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 62.22 110.94 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' A' ' 55' ' ' ALA . 7.3 p -139.1 119.41 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 54.31 111.138 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.824 ' O ' HG22 ' A' ' 54' ' ' THR . 2.3 m -170.11 -133.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 64.33 111.165 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' H ' HG22 ' A' ' 74' ' ' THR . 9.5 mtm180 -105.84 143.55 27.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 75.35 110.876 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HA ' HH22 ' A' ' 80' ' ' ARG . 54.3 Cg_endo -69.75 13.08 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.663 2.242 . . . . 72.12 112.361 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 75' ' ' ARG . 5.7 m-20 -88.79 24.6 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 73.54 110.9 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.21 -13.69 53.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.769 -0.729 . . . . 53.1 112.465 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.491 ' O ' ' HB ' ' A' ' 74' ' ' THR . 19.0 p -98.54 108.34 21.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.825 0.345 . . . . 64.44 111.155 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.818 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 2.2 ptp85 -140.09 163.07 33.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 74.41 110.895 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 60.1 t -120.58 105.0 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 74.14 111.177 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.532 ' O ' ' HB ' ' A' ' 94' ' ' THR . 34.4 tt0 -82.62 142.84 31.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 72.5 110.938 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 12.1 m -118.37 118.24 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 72.11 111.123 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.658 ' H ' ' C ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -83.18 119.37 24.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 71.55 110.894 179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.907 ' HB3' HD21 ' A' ' 20' ' ' LEU . 2.8 pp -113.77 110.9 20.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 74.42 110.922 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.591 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -134.28 118.79 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 73.05 110.885 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.417 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 2.0 ttt180 -69.14 5.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 73.55 110.895 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.513 ' HB3' ' CE2' ' A' ' 89' ' ' PHE . 29.8 t0 -64.57 -25.43 67.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.876 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -160.69 -89.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 63.34 110.877 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.53 45.63 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 71.24 110.862 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.808 ' O ' HD13 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -99.09 111.84 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 61.23 111.096 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.808 HD13 ' O ' ' A' ' 91' ' ' VAL . 0.4 OUTLIER -128.23 17.06 6.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.173 -0.467 . . . . 53.21 110.937 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.658 ' C ' ' H ' ' A' ' 84' ' ' HIS . 10.2 t70 -140.49 151.51 44.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 73.41 110.874 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.654 ' OG1' ' N ' ' A' ' 84' ' ' HIS . 81.4 m -122.58 -101.52 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 52.33 111.101 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.505 ' N ' HG22 ' A' ' 94' ' ' THR . 8.4 pt-20 -166.47 154.74 9.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.63 0.729 . . . . 73.34 110.906 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 95' ' ' GLU . 53.4 Cg_endo -69.77 148.46 65.04 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.671 2.247 . . . . 75.35 112.352 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.674 ' HB2' ' CZ ' ' A' ' 41' ' ' ARG . . . -118.58 161.15 20.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 70.24 111.117 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.98 0.41 6.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 71.41 110.878 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.0 -20.84 26.82 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.735 -0.745 . . . . 64.41 112.476 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -97.08 -16.79 20.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.871 0.367 . . . . 73.44 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.45 -20.32 79.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 32.14 112.508 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 39' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 73.25 112.49 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.6 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.81 0.338 . . . . 75.34 110.883 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -63.94 -22.49 66.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 73.33 110.946 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' OD1' ' HB3' ' A' ' 67' ' ' ALA . 14.5 t70 -67.23 -124.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 71.3 110.876 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 17' ' ' THR . 3.0 tt -92.0 139.36 24.47 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.606 0.717 . . . . 72.32 111.135 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 14' ' ' ILE . 53.7 Cg_endo -69.75 23.87 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.717 2.278 . . . . 44.23 112.311 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.493 ' H ' ' C ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -151.04 37.4 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 63.32 111.154 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.65 HG23 ' O ' ' A' ' 14' ' ' ILE . 66.5 p -66.87 -165.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 75.13 111.15 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.509 ' HG3' HD23 ' A' ' 92' ' ' LEU . 3.0 mt-10 -123.46 -86.99 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 74.42 110.862 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.87 12.3 3.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 71.15 110.856 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.774 ' CG ' HD22 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -94.25 -36.31 12.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 74.1 110.964 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.444 ' CD2' ' O ' ' A' ' 18' ' ' GLU . 2.1 p90 -75.83 -2.41 29.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 71.24 110.865 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -96.25 -32.04 12.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 70.42 110.877 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -81.05 -31.02 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 73.52 110.917 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -41.82 -38.63 2.44 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.768 -0.73 . . . . 64.34 112.437 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.52 -60.68 3.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 74.42 111.118 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.743 ' HG3' HG21 ' A' ' 73' ' ' VAL . 1.1 ptm -67.57 -10.94 56.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 74.31 110.849 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HB1' ' OE1' ' A' ' 31' ' ' GLU . . . -82.37 -29.93 30.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.422 . . . . 41.42 111.122 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -73.86 42.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.876 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -148.34 -41.87 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 70.43 110.872 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.34 13.27 3.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.711 -0.757 . . . . 63.11 112.484 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.626 ' CD ' HG21 ' A' ' 58' ' ' VAL . 2.7 tt0 -58.16 104.49 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 71.05 110.859 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.41 -171.04 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 74.31 110.838 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -109.48 120.5 42.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 71.44 110.85 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.763 HG23 ' C ' ' A' ' 58' ' ' VAL . 2.3 t -91.74 -140.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 73.22 111.132 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.685 ' H ' HG12 ' A' ' 34' ' ' VAL . 43.6 p -137.06 -63.92 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 75.44 111.146 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.05 -64.6 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.71 -0.757 . . . . 74.32 112.469 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.415 ' HD2' ' OG1' ' A' ' 35' ' ' THR . 53.7 Cg_endo -69.77 167.17 25.23 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.636 2.224 . . . . 72.43 112.381 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -70.32 -26.06 63.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 73.24 110.835 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.51 -37.42 70.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 70.42 111.118 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.07 -33.54 24.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 71.33 110.893 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -71.23 -43.85 66.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 75.55 110.863 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.753 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -70.48 -34.33 72.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.33 111.093 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -79.35 -41.02 28.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 74.44 110.905 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -77.34 -63.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 63.22 111.112 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . . . -52.9 -19.72 2.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 55.14 111.074 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.753 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -53.63 -67.96 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 74.4 111.114 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.744 ' HA ' HG12 ' A' ' 50' ' ' VAL . 21.5 t -115.55 -13.85 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 72.52 111.093 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.57 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 41.5 mt-30 -80.09 -34.54 37.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 75.34 110.909 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.008 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -107.29 -4.1 19.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 75.12 111.1 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.988 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -94.71 -6.4 0.12 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.639 0.733 . . . . 75.25 111.172 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 1.008 ' HD2' ' C ' ' A' ' 49' ' ' ALA . 53.8 Cg_endo -69.83 -26.58 27.11 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.654 2.236 . . . . 61.41 112.361 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.83 -50.49 5.56 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.721 -0.752 . . . . 52.14 112.53 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.5 -32.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.703 -0.761 . . . . 63.2 112.486 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.659 ' O ' ' O ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -146.94 150.73 35.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 72.42 111.148 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.801 ' N ' HG23 ' A' ' 50' ' ' VAL . . . -71.98 79.1 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 61.2 111.076 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.76 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -145.64 101.89 0.25 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 40.11 112.496 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.564 ' H ' ' CD2' ' A' ' 72' ' ' LEU . 6.5 tt0 -95.39 -177.72 4.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 63.12 110.9 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.763 ' C ' HG23 ' A' ' 34' ' ' VAL . 82.1 t -132.29 118.11 34.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 62.24 111.121 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.779 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 7.6 pt-20 -92.47 159.5 15.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 72.41 110.906 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.502 ' HA ' ' CB ' ' A' ' 69' ' ' TYR . 1.6 t -132.8 116.4 16.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 52.34 111.146 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -136.73 163.71 29.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 70.23 110.876 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.423 ' CA ' ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -116.09 149.89 38.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 74.44 111.166 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.07 -142.51 5.34 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.751 -0.738 . . . . 34.42 112.506 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.74 -22.06 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.379 . . . . 64.15 110.866 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -101.1 -114.34 3.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 51.53 112.449 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.05 -84.71 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.748 0.308 . . . . 72.04 111.107 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 86' ' ' ASP . . . -76.34 131.78 39.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.34 111.112 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB3' ' CA ' ' A' ' 62' ' ' THR . . . -150.4 60.72 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 44.52 111.113 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.91 ' CZ ' HD12 ' A' ' 85' ' ' LEU . 4.2 p90 -128.19 -169.17 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 61.3 110.922 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 83' ' ' VAL . . . -157.07 163.9 32.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.771 -0.728 . . . . 71.11 112.525 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.756 HG22 HG22 ' A' ' 58' ' ' VAL . 61.1 t -136.85 122.69 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 62.45 111.09 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.76 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -110.56 141.5 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.21 110.948 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.743 HG21 ' HG3' ' A' ' 26' ' ' MET . 7.2 p -152.19 124.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 74.42 111.106 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.829 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . 3.0 m -171.82 -129.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 74.4 111.125 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.48 ' H ' HG22 ' A' ' 74' ' ' THR . 6.4 mtm-85 -103.53 141.5 22.62 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.624 0.726 . . . . 73.42 110.883 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.51 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 54.0 Cg_endo -69.74 15.57 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.688 2.259 . . . . 70.21 112.342 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 75' ' ' ARG . 5.7 m-20 -93.69 24.52 4.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.41 110.879 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.25 -12.71 53.83 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.74 . . . . 70.54 112.5 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 79' ' ' THR . 2.7 t -98.64 103.95 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 74.24 111.152 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.829 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 0.9 OUTLIER -137.3 163.75 30.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 62.22 110.925 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 45.6 t -115.88 105.66 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 71.54 111.069 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.672 ' CD ' HG21 ' A' ' 94' ' ' THR . 0.0 OUTLIER -88.65 139.29 30.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 75.53 110.874 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 1.016 HG23 HD21 ' A' ' 85' ' ' LEU . 32.3 m -116.11 146.88 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 44.44 111.111 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.897 ' C ' HD23 ' A' ' 85' ' ' LEU . 2.1 t-160 -98.46 123.99 42.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 65.33 110.861 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.016 HD21 HG23 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -118.91 103.15 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 72.32 110.901 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 1.6 t70 -131.37 111.62 12.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 70.02 110.899 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -70.99 4.21 2.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 71.31 110.867 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -72.73 -13.92 61.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 63.5 110.841 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.428 ' HB2' ' HD2' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -164.63 -95.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.41 110.897 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.881 ' O ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -149.21 29.33 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 70.34 110.84 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.847 ' C ' HD13 ' A' ' 92' ' ' LEU . 2.3 t -73.92 97.0 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.119 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.881 HD22 ' O ' ' A' ' 90' ' ' ARG . 0.4 OUTLIER -124.87 15.29 8.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.44 110.853 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.612 ' C ' ' H ' ' A' ' 84' ' ' HIS . 4.4 m-20 -154.61 157.95 38.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 33.44 110.845 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.704 ' OG1' ' HB2' ' A' ' 84' ' ' HIS . 86.0 m -130.39 -99.8 0.32 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 72.35 111.135 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.484 ' N ' HG22 ' A' ' 94' ' ' THR . 0.6 OUTLIER -159.34 162.61 25.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.627 0.727 . . . . 71.52 110.883 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 104.48 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.652 2.235 . . . . 64.32 112.335 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.619 ' HB3' ' HG3' ' A' ' 80' ' ' ARG . . . -66.79 108.22 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 54.53 111.092 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.85 16.58 12.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 64.35 110.894 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.59 -19.91 21.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 73.51 112.513 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.4 -45.94 6.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 75.4 110.886 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.06 27.46 45.05 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 42.15 112.455 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.749 . . . . 54.21 112.468 -179.93 . . . . . . . . 0 0 . 1 stop_ save_